data_1ttf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ttf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.436 ' N ' ' OE2' ' A' ' 9' ' ' GLU . 1.5 mp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.436 ' OE2' ' N ' ' A' ' 8' ' ' LEU . 7.4 mp0 -147.87 168.47 22.12 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.526 -0.869 . . . . 0.0 111.14 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.6 t -100.41 133.01 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.767 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.12 -35.62 8.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 118.706 -1.197 . . . . 0.0 110.863 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 174.64 170.98 0.24 Allowed 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.162 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.66 167.68 12.65 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.534 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.28 161.64 29.13 Favored Pre-proline 0 C--N 1.3 -1.561 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.246 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.466 ' O ' ' OG1' ' A' ' 16' ' ' THR . 14.0 Cg_exo -45.41 103.86 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 120.684 0.923 . . . . 0.0 111.123 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 15' ' ' PRO . 3.1 p 59.25 49.21 9.33 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.905 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 p -171.93 137.22 0.95 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.662 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.9 tp -130.35 147.99 52.12 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.767 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.47 114.13 21.82 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.54 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -110.01 147.66 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.225 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.51 137.57 28.58 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.296 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 11.8 p90 . . . . . 0 N--CA 1.484 1.243 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.458 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.741 0.305 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -68.78 0.16 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.692 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.79 164.29 28.97 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.177 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -113.74 158.78 20.5 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.895 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.486 ' CG ' ' OE2' ' A' ' 47' ' ' GLU . 2.9 ttt180 -139.33 105.48 5.23 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.064 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.59 ' N ' ' CD1' ' A' ' 34' ' ' ILE . 2.7 mp -96.76 120.31 45.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.169 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.0 p -126.65 137.19 53.26 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.561 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.443 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 6.9 p90 -142.16 155.95 45.33 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 118.741 -1.184 . . . . 0.0 110.427 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.72 137.41 4.75 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.421 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.35 132.97 40.07 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.681 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.5 m . . . . . 0 C--N 1.305 -1.336 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.742 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.7 t . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.694 0.283 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -167.6 171.86 9.9 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 117.979 -1.488 . . . . 0.0 112.499 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.486 ' OE2' ' CG ' ' A' ' 33' ' ' ARG . 0.8 OUTLIER -150.78 159.56 44.45 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.157 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 11.7 p90 -160.22 136.63 8.82 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 118.423 -1.311 . . . . 0.0 111.523 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.0 p -92.66 159.73 15.32 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.431 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -152.08 142.96 15.47 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.178 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.71 29.9 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 120.953 1.102 . . . . 0.0 112.387 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.552 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 57.42 13.56 11.2 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.251 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.44 -31.08 37.57 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.012 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -92.53 119.27 31.84 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.91 -21.73 34.1 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.373 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.4 p -119.54 -178.9 3.72 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.891 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -167.58 143.66 4.12 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.581 -1.248 . . . . 0.0 111.706 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.2 m -110.8 112.2 23.9 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.726 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.92 140.8 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.466 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -145.54 163.89 33.33 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.466 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.13 10.83 33.4 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.593 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 1.6 pt? -91.98 -177.28 4.66 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.264 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.56 110.29 40.84 Favored Pre-proline 0 N--CA 1.49 1.569 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.047 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.66 137.53 80.67 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 120.599 0.866 . . . . 0.0 111.816 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.09 60.32 1.86 Allowed Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.544 -1.312 . . . . 0.0 109.999 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 p -169.51 156.9 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.471 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -74.99 142.38 43.87 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.081 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -137.89 130.19 29.15 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.124 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.57 125.97 49.48 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.509 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 tt -115.93 148.46 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.8 m -145.5 121.48 10.69 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.338 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.6 m -108.41 122.12 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.434 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.49 101.94 11.43 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.278 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.06 113.28 24.95 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.403 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.7 t -107.54 128.4 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.225 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.1 p . . . . . 0 N--CA 1.49 1.541 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.58 179.904 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo . . . . . 0 C--O 1.215 -0.639 0 N-CA-C 111.063 -0.399 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.4 tt -147.41 150.51 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 118.654 -1.218 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.52 150.42 45.09 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.099 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 pt -152.34 141.87 14.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.674 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -93.19 145.53 24.36 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.256 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -156.25 140.71 16.77 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.218 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -84.05 118.98 24.41 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.26 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.769 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.441 ' OE2' ' N ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -170.12 176.89 4.45 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.362 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.0 t -95.66 129.95 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.448 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 m -101.77 -6.5 9.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.774 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.75 161.21 11.03 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.779 -1.168 . . . . 0.0 111.81 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.85 129.14 8.21 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.318 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.442 ' OG1' ' OG ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -137.88 165.12 36.15 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.476 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.461 ' O ' ' CB ' ' A' ' 16' ' ' THR . 3.2 Cg_exo -53.11 104.31 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.198 1.265 . . . . 0.0 111.94 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.7 OUTLIER 77.91 34.48 0.32 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.13 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.442 ' OG ' ' OG1' ' A' ' 14' ' ' THR . 0.8 OUTLIER -169.46 126.42 0.91 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.716 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 tp -125.58 126.9 45.53 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.1 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.4 tp -103.5 114.05 28.03 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.469 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.47 159.31 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.596 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.77 145.91 17.51 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.659 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 13.7 p90 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 119.189 -1.004 . . . . 0.0 111.452 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.523 ' NE ' ' OH ' ' A' ' 31' ' ' TYR . 2.2 mtt180 -69.93 -75.63 0.11 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.419 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.523 ' OH ' ' NE ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -153.84 167.68 28.85 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.604 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -123.85 156.04 36.93 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.146 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -140.31 110.12 6.42 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.678 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 mp -95.14 123.49 47.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.904 -1.043 . . . . 0.0 111.338 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -125.58 132.12 52.59 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.711 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.551 ' OH ' ' CE2' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -144.77 167.62 22.15 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.338 -1.345 . . . . 0.0 112.484 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.77 159.14 17.37 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.6 160.74 3.09 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.047 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.306 -1.299 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.724 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 t . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.889 0.376 . . . . 0.0 111.509 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.587 ' NE2' ' H ' ' A' ' 47' ' ' GLU . 50.5 tp60 -171.47 162.92 6.74 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.843 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.587 ' H ' ' NE2' ' A' ' 46' ' ' GLN . 5.0 pt-20 -147.63 148.17 30.79 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.576 -0.849 . . . . 0.0 110.949 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.551 ' CE2' ' OH ' ' A' ' 36' ' ' TYR . 0.9 OUTLIER -147.84 170.97 16.47 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 118.864 -1.134 . . . . 0.0 111.421 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 50.2 p -104.89 174.26 5.95 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.883 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.598 ' C ' ' H ' ' A' ' 52' ' ' GLY . 11.3 p -165.79 137.66 3.18 Favored Pre-proline 0 CA--C 1.564 1.503 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.163 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 53' ' ' SER . 5.2 Cg_exo -56.0 14.19 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 121.216 1.277 . . . . 0.0 113.731 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 54.02 9.24 1.28 Allowed Glycine 0 N--CA 1.495 2.623 0 C-N-CA 119.36 -1.4 . . . . 0.0 111.119 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -72.42 -41.05 66.63 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.969 -1.092 . . . . 0.0 110.287 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -118.83 116.31 26.24 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.075 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 m -79.85 58.24 2.8 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.105 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 p -154.28 148.35 25.75 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.371 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.16 150.68 9.54 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 t -117.31 145.56 43.92 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.759 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -135.69 133.8 51.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.41 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.5 m -130.6 165.59 22.45 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.581 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.44 49.22 4.73 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.169 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.29 -155.19 0.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.636 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.6 99.1 17.36 Favored Pre-proline 0 N--CA 1.493 1.71 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.08 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.97 145.14 94.25 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.757 0.971 . . . . 0.0 111.593 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.92 49.97 4.83 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.668 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.3 p -159.02 152.92 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.393 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.13 151.33 31.49 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.109 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.17 121.22 8.84 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.695 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 m -105.78 121.2 43.55 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.646 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 pp -110.18 158.46 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.569 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 55.0 m -153.18 123.19 6.95 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.067 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.5 m -108.63 141.93 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.514 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -112.38 105.65 13.98 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.844 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.74 94.6 9.56 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.063 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -89.6 112.44 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.307 -1.248 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.502 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo . . . . . 0 C--O 1.215 -0.627 0 N-CA-C 113.9 0.692 . . . . 0.0 113.9 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.9 tt -150.43 157.59 5.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.573 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.9 p -144.83 160.69 40.87 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.563 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.97 145.57 16.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.526 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.605 ' ND2' ' N ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -91.48 144.73 25.26 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.639 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.605 ' N ' ' ND2' ' A' ' 91' ' ' ASN . 57.8 t80 -161.3 135.73 7.12 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.838 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.79 132.58 34.57 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.194 -1.003 . . . . 0.0 110.205 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 116.258 -1.83 . . . . 0.0 110.818 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.689 0.281 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -169.3 146.01 3.43 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.124 -1.031 . . . . 0.0 111.112 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.0 t -85.32 116.17 28.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.736 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 t -90.27 -18.82 7.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.768 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.39 159.0 4.5 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.094 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.37 81.41 1.12 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.445 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -77.72 160.62 74.1 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.541 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.92 3.83 0.48 Allowed 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.344 1.363 . . . . 0.0 111.779 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.491 ' H ' ' C ' ' A' ' 14' ' ' THR . 1.8 m -152.91 25.3 0.56 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.895 -1.122 . . . . 0.0 111.9 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.17 131.74 0.08 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.954 -1.099 . . . . 0.0 111.287 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 tp -115.72 136.24 53.25 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.52 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.33 116.71 26.77 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.475 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.415 ' C ' ' HG ' ' A' ' 21' ' ' SER . 2.2 pt -111.28 158.59 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.174 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.415 ' HG ' ' C ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -150.13 133.52 16.47 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.92 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 p90 . . . . . 0 N--CA 1.486 1.334 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.252 179.918 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.743 0.306 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.537 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -87.48 -73.53 0.47 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 118.961 -1.095 . . . . 0.0 110.828 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 2.5 m-85 -146.58 167.5 23.57 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.975 -1.09 . . . . 0.0 111.976 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -131.01 145.39 52.03 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.024 -1.444 . . . . 0.0 108.65 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -132.59 121.39 23.15 Favored 'General case' 0 N--CA 1.508 2.44 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.137 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.555 ' N ' ' CD1' ' A' ' 34' ' ' ILE . 1.7 mp -97.48 102.58 13.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.715 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.9 p -109.61 129.95 55.55 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 12.6 p90 -140.52 165.06 28.49 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.78 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 168.6 165.02 25.29 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.867 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -66.29 146.39 54.65 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.381 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.443 ' OG1' ' OG1' ' A' ' 69' ' ' THR . 24.4 m . . . . . 0 N--CA 1.489 1.48 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.595 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.4 t . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 121.185 0.517 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -169.08 -159.06 0.22 Allowed 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.987 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -170.12 161.16 8.42 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.189 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 7.2 p90 -152.68 140.27 19.79 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.636 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 50.8 p -82.8 174.05 11.31 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.541 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 52' ' ' GLY . 5.6 p -166.21 139.23 3.3 Favored Pre-proline 0 C--N 1.305 -1.351 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.949 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.0 Cg_endo -62.5 28.3 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 121.0 1.134 . . . . 0.0 112.916 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 48.55 11.06 0.14 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.996 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -76.84 -38.92 52.88 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.57 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -93.12 131.06 38.5 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.494 -0.883 . . . . 0.0 110.622 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -84.83 -1.24 56.2 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.441 -0.904 . . . . 0.0 111.294 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.5 p -120.11 167.84 11.81 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.722 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.13 136.24 18.69 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.236 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.6 m -99.69 145.8 27.22 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.8 mt -144.32 149.19 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.616 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.4 174.45 10.91 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.75 64.64 3.55 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.784 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.01 -125.17 0.28 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.782 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.495 ' N ' ' HH ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -170.84 121.72 0.53 Allowed Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.192 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.58 142.91 73.11 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 120.566 0.844 . . . . 0.0 112.075 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.18 80.92 0.09 OUTLIER Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.387 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.446 ' CG1' ' CE2' ' A' ' 68' ' ' TYR . 7.5 p -170.4 152.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.538 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -82.48 108.65 16.05 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.495 ' HH ' ' N ' ' A' ' 63' ' ' LYS . 4.6 m-85 -105.4 130.68 53.45 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.85 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.443 ' OG1' ' OG1' ' A' ' 39' ' ' THR . 0.9 OUTLIER -97.73 119.09 35.69 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.012 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.4 HD13 ' H ' ' A' ' 71' ' ' THR . 5.2 tp -98.3 137.38 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.235 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.4 ' H ' HD13 ' A' ' 70' ' ' ILE . 82.3 m -139.35 127.77 22.87 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.073 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -118.33 151.59 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.459 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -115.89 133.32 56.15 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.009 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.53 84.36 2.19 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 123.795 0.685 . . . . 0.0 109.466 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -95.3 124.81 48.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.584 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 p . . . . . 0 C--N 1.302 -1.494 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.876 179.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 C--O 1.214 -0.706 0 CA-C-O 121.377 0.49 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.3 tt -158.38 139.63 4.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.611 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.3 p -149.69 166.84 28.16 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 118.216 -1.394 . . . . 0.0 113.039 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 pt -154.42 150.7 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.524 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.513 ' H ' ' ND2' ' A' ' 91' ' ' ASN . 0.0 OUTLIER -82.81 141.23 32.47 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.281 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -146.59 120.91 9.59 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.763 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -85.48 116.51 23.83 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.567 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 116.355 -1.783 . . . . 0.0 111.096 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -169.9 168.06 8.88 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 117.499 -1.68 . . . . 0.0 112.963 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.0 t -96.23 111.52 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.374 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 24.7 t -77.82 -9.5 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.25 -0.98 . . . . 0.0 111.58 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' VAL . . . 169.94 168.03 0.06 Allowed 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.441 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.34 147.59 27.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.811 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.62 161.13 30.11 Favored Pre-proline 0 C--N 1.305 -1.34 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.461 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.457 ' O ' ' OG1' ' A' ' 16' ' ' THR . 3.6 Cg_exo -51.29 111.88 0.67 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 120.97 1.113 . . . . 0.0 111.083 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 15' ' ' PRO . 1.6 p 64.51 37.92 7.74 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.83 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.92 128.29 1.64 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.662 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.33 145.47 51.79 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.335 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.17 109.77 15.82 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.065 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -109.12 146.69 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.145 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.68 131.05 22.22 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.398 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 5.5 p90 . . . . . 0 N--CA 1.483 1.182 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.497 179.952 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.79 0.328 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.55 HH21 ' HH ' ' A' ' 31' ' ' TYR . 9.3 ttt180 -55.15 -60.47 3.34 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.092 -1.043 . . . . 0.0 110.037 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.55 ' HH ' HH21 ' A' ' 30' ' ' ARG . 1.1 p90 -168.95 170.16 9.19 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 118.424 -1.311 . . . . 0.0 112.746 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.05 144.32 48.98 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.189 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.34 109.53 16.4 Favored 'General case' 0 N--CA 1.509 2.494 0 C-N-CA 118.999 -1.081 . . . . 0.0 110.244 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.2 mp -96.97 113.95 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.34 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 64.2 p -113.43 142.78 45.49 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.935 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -146.71 151.77 37.74 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.753 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.88 164.92 19.03 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -53.5 155.79 2.81 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.765 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.463 ' OG1' ' OG1' ' A' ' 69' ' ' THR . 1.8 m . . . . . 0 N--CA 1.489 1.523 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.304 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 46' ' ' GLN . 50.9 t . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.336 0.112 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.467 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -175.99 -166.35 0.18 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.162 -1.415 . . . . 0.0 111.753 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -160.25 169.22 23.66 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.916 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.488 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 19.0 p90 -161.03 131.08 5.0 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.674 -0.811 . . . . 0.0 109.901 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.27 166.25 11.07 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.15 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.581 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -146.72 159.16 44.72 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.936 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.47 15.84 0.05 OUTLIER 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 121.135 1.223 . . . . 0.0 112.298 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 62.29 24.21 65.22 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.208 -1.473 . . . . 0.0 110.116 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.35 -36.92 11.19 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.107 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -89.83 116.3 27.81 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.8 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.63 4.42 24.89 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.68 159.43 42.0 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.474 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.45 164.29 21.99 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.434 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.6 m -134.02 146.82 50.74 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.479 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -137.36 158.0 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.052 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.6 m -149.56 174.45 12.52 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.655 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.71 12.73 52.74 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.777 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.07 -158.77 0.67 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.626 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.02 122.19 4.18 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.598 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.71 144.3 97.1 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 120.512 0.808 . . . . 0.0 111.336 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.61 50.77 4.1 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.762 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.6 p -165.16 139.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.419 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.402 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -64.41 133.33 52.33 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.929 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -132.0 129.86 40.67 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.174 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.463 ' OG1' ' OG1' ' A' ' 39' ' ' THR . 0.1 OUTLIER -107.2 128.89 54.82 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.914 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.404 ' C ' ' HG1' ' A' ' 71' ' ' THR . 4.4 tt -119.7 145.0 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.409 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.404 ' HG1' ' C ' ' A' ' 70' ' ' ILE . 81.4 m -142.43 125.26 16.04 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.525 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.57 137.0 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 119.613 -0.835 . . . . 0.0 111.011 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -110.18 143.82 39.75 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.37 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.5 91.25 3.49 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.612 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.8 t -102.91 117.2 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.485 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.401 ' HA ' ' H ' ' A' ' 30' ' ' ARG . 14.0 t . . . . . 0 N--CA 1.486 1.371 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.218 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 C--O 1.216 -0.623 0 N-CA-C 110.501 -0.615 . . . . 0.0 110.501 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -145.4 153.45 13.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.961 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.9 p -151.06 153.72 35.62 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.774 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.7 143.22 21.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.732 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.09 153.64 18.03 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.316 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -169.26 135.29 1.63 Allowed 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.322 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -79.86 106.71 12.08 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.312 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.887 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.327 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 10' ' ' VAL . 18.5 tt0 -173.03 162.19 4.54 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.534 -1.266 . . . . 0.0 112.271 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.444 ' N ' ' CG ' ' A' ' 9' ' ' GLU . 61.5 t -91.44 114.36 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.33 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.22 -52.45 15.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 118.825 -1.15 . . . . 0.0 111.422 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.66 158.32 43.96 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.951 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.11 106.72 4.08 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 16' ' ' THR . 1.0 OUTLIER -104.69 155.21 37.8 Favored Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.631 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.43 3.28 0.2 Allowed 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 121.147 1.231 . . . . 0.0 112.353 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' THR . 3.0 m -149.38 24.11 0.91 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.859 -1.136 . . . . 0.0 111.477 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.1 OUTLIER 175.96 145.17 0.08 Allowed 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.296 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.46 124.64 32.47 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.387 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 tt -95.66 102.21 13.99 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.635 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 pp -109.68 143.5 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.446 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.76 139.28 53.79 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.569 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 46.9 p90 . . . . . 0 N--CA 1.505 2.278 0 C-N-CA 118.125 -1.43 . . . . 0.0 113.726 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.5 t . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.881 0.372 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.82 -43.28 13.43 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.555 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -143.34 176.12 9.39 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.818 -1.153 . . . . 0.0 112.323 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -144.06 137.27 27.49 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.663 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -129.23 110.17 11.75 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.17 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -101.68 112.89 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.758 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 p -113.84 135.06 54.38 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.585 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -140.07 154.48 47.08 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 118.61 -1.236 . . . . 0.0 111.026 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.93 162.42 22.19 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 39' ' ' THR . 1.4 tm-20 -55.6 152.69 8.84 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.549 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.482 ' N ' ' CD ' ' A' ' 38' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.242 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.7 t . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -172.0 -159.0 0.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.578 -1.249 . . . . 0.0 111.678 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -165.71 156.63 13.62 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.802 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 3.5 p90 -146.72 154.76 41.79 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.569 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.4 p -115.69 155.98 26.75 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.738 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.597 ' C ' ' H ' ' A' ' 52' ' ' GLY . 32.9 m -148.77 151.43 35.35 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.661 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.92 19.89 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.06 1.173 . . . . 0.0 112.597 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 60.22 24.63 61.34 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.474 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -45.02 16.42 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.002 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -89.15 144.87 25.81 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.838 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.5 m -96.01 -12.22 25.29 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.262 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.9 p -138.35 177.3 7.98 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.399 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.11 151.61 4.01 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.824 -1.15 . . . . 0.0 111.294 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.6 m -112.65 104.05 12.11 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.982 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.37 166.82 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.262 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.4 t -142.97 -179.0 6.1 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.963 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.52 60.21 1.38 Allowed Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.528 -1.32 . . . . 0.0 109.952 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.93 -155.55 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.908 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -150.73 137.43 11.36 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.054 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.64 151.94 82.71 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 120.915 1.077 . . . . 0.0 112.672 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.97 77.91 0.08 OUTLIER Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.932 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -162.27 144.28 3.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.005 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.438 ' CG ' HD22 ' A' ' 91' ' ' ASN . 6.8 t70 -76.26 117.02 17.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.293 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -117.54 129.56 55.87 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.537 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.2 120.67 39.91 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.34 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.405 ' C ' ' HG1' ' A' ' 71' ' ' THR . 1.2 tt -111.38 146.47 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.437 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.405 ' HG1' ' C ' ' A' ' 70' ' ' ILE . 20.6 m -148.69 141.64 24.78 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.184 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.63 131.8 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.285 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -104.6 123.12 47.0 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.19 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.31 89.99 5.29 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.47 118.41 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.98 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 C--N 1.309 -1.192 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.032 179.929 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo . . . . . 0 C--O 1.216 -0.576 0 N-CA-C 110.859 -0.477 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.3 tt -144.79 131.74 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 118.529 -1.268 . . . . 0.0 111.465 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.401 ' OG ' ' CG2' ' A' ' 71' ' ' THR . 31.8 m -120.38 155.74 32.8 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.657 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.86 135.46 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.534 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.438 HD22 ' CG ' ' A' ' 67' ' ' ASP . 10.5 t30 -86.13 133.66 33.86 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.59 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -140.48 132.27 27.46 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.321 -0.951 . . . . 0.0 111.174 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.04 105.82 18.03 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.091 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 116.431 -1.747 . . . . 0.0 110.868 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -149.71 147.91 28.62 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.241 -1.384 . . . . 0.0 112.412 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.5 t -103.51 111.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.031 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.87 -27.35 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.693 -1.203 . . . . 0.0 111.951 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.09 151.05 27.87 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.851 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.32 121.06 7.54 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.297 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.56 ' C ' ' H ' ' A' ' 16' ' ' THR . 1.1 p -134.13 153.49 79.61 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.32 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -64.29 10.48 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 120.98 1.12 . . . . 0.0 111.648 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.56 ' H ' ' C ' ' A' ' 14' ' ' THR . 5.0 m -140.84 6.31 2.01 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.051 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 p 179.26 148.82 0.25 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.307 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.81 120.08 27.06 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.462 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 tt -98.07 102.42 14.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.924 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 pp -100.25 155.21 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.503 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.37 143.74 30.29 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.0 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.7 p90 . . . . . 0 N--CA 1.478 0.94 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.216 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 120.584 0.231 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.414 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 4.3 mtp180 -54.51 -48.58 71.74 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.35 -1.34 . . . . 0.0 108.93 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.414 ' CG ' ' C ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER 175.93 164.58 0.37 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.849 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -114.01 155.16 26.39 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.11 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.613 ' HE ' ' CG2' ' A' ' 49' ' ' THR . 4.0 ttm180 -135.15 107.52 7.29 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.405 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.3 mt -98.96 109.07 23.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.864 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 45.1 p -113.01 134.56 54.46 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.471 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.437 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 9.7 p90 -136.9 153.37 50.76 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.262 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.88 149.41 9.21 Favored Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -86.65 139.83 30.41 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.729 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.9 m . . . . . 0 N--CA 1.486 1.363 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.889 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.1 t . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.738 0.304 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -173.34 -167.75 0.41 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.976 -1.09 . . . . 0.0 111.527 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -153.34 170.2 21.23 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.918 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -159.07 129.56 5.91 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.202 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.613 ' CG2' ' HE ' ' A' ' 33' ' ' ARG . 34.3 p -95.95 162.21 13.66 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.436 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.596 ' C ' ' H ' ' A' ' 52' ' ' GLY . 35.3 m -150.33 150.58 29.49 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.717 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.86 9.87 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 120.92 1.08 . . . . 0.0 112.225 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 72.93 13.56 78.93 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.244 -1.455 . . . . 0.0 109.949 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.25 -29.89 22.77 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.629 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -80.86 118.36 22.3 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.284 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.47 -15.37 57.89 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.371 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.0 p -144.46 176.79 9.12 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.485 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -171.79 160.52 5.63 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.219 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -121.54 143.56 49.21 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.274 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.32 163.9 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.805 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.2 m -143.21 -170.72 3.33 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.442 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.71 55.14 4.66 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.309 -1.424 . . . . 0.0 110.495 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.61 -158.52 0.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.707 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -140.28 155.05 70.41 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.295 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.28 102.55 0.39 Allowed 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.315 1.343 . . . . 0.0 112.739 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.89 95.82 0.03 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.537 -1.315 . . . . 0.0 111.474 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.9 p -157.54 137.5 4.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.826 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -50.59 116.17 1.81 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.763 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.67 130.11 52.59 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.79 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.1 m -117.67 126.47 52.56 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.564 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.57 157.19 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.419 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.08 117.09 10.51 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.448 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.1 m -111.43 126.64 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.557 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -109.16 130.3 55.49 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.157 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.33 91.48 3.67 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.217 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.1 t -91.91 123.2 43.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.081 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.482 1.144 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.994 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo . . . . . 0 C--O 1.216 -0.611 0 CA-C-O 120.818 0.258 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.8 tt -144.42 139.62 24.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.378 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.2 p -128.48 160.42 32.36 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.817 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.0 pt -144.72 139.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.763 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.58 110.73 21.88 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.756 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 93' ' ' ARG . 5.9 t80 -143.05 138.82 30.21 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.616 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.436 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 10.5 mtp180 -72.16 110.59 6.72 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.597 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 116.371 -1.776 . . . . 0.0 110.984 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.454 ' H ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.022 0.439 . . . . 0.0 110.609 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -154.45 176.29 12.54 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.876 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 t -93.78 132.95 36.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.797 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.531 ' CG2' ' HG ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -111.69 -4.36 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.13 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.8 144.86 2.33 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.434 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.91 102.15 3.85 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.843 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.593 ' C ' ' H ' ' A' ' 16' ' ' THR . 22.6 p -97.15 152.5 38.33 Favored Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.271 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.36 14.12 0.04 OUTLIER 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 121.305 1.337 . . . . 0.0 112.726 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.593 ' H ' ' C ' ' A' ' 14' ' ' THR . 3.2 m -159.64 21.62 0.18 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.032 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.435 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER 173.93 149.73 0.08 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.182 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.37 157.72 37.77 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.416 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.6 116.71 21.45 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.264 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pt -106.0 152.27 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.102 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.531 ' HG ' ' CG2' ' A' ' 11' ' ' VAL . 2.4 m -150.27 124.78 9.62 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.029 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 7.2 p90 . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.419 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.657 0.265 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.545 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 2.7 mmp_? -79.83 -67.86 0.72 Allowed 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 118.931 -1.107 . . . . 0.0 109.548 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.545 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 2.1 m-85 -149.35 154.37 38.85 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.646 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -110.35 165.46 11.76 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -146.87 110.76 5.0 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.319 -1.352 . . . . 0.0 110.697 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mp -102.66 117.53 48.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.511 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 p -119.14 135.22 54.77 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.137 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.654 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -124.54 156.41 37.38 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.661 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.22 130.47 1.41 Allowed Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.341 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -75.53 143.71 42.32 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.635 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 m . . . . . 0 C--N 1.303 -1.435 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.778 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.297 0.57 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -173.36 177.78 2.54 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.661 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -167.35 166.1 14.72 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.894 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -162.12 157.48 23.35 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.907 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.4 p -102.66 166.07 10.71 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.159 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.597 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -153.49 147.04 18.22 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.512 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.0 OUTLIER -59.85 17.98 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.393 1.396 . . . . 0.0 112.989 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 62.43 -2.21 1.25 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -81.0 -43.35 19.74 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.433 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HZ2' ' HG1' ' A' ' 56' ' ' THR . 0.0 OUTLIER -77.42 104.55 8.01 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.914 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 m -79.24 8.15 6.48 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.085 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.53 ' HG1' ' HZ2' ' A' ' 54' ' ' LYS . 1.9 p -137.5 159.62 41.44 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.518 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.57 144.5 3.61 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.332 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.3 m -95.33 146.33 24.46 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.308 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 tt -141.08 145.33 25.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.842 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.24 167.51 22.26 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.061 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.66 49.27 1.11 Allowed Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.796 -1.192 . . . . 0.0 110.867 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.99 -156.45 0.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.434 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -144.32 158.99 53.57 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.801 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.71 106.49 0.37 Allowed 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 121.384 1.389 . . . . 0.0 112.013 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.74 89.19 0.03 OUTLIER Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.472 -1.347 . . . . 0.0 111.05 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.2 136.68 12.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.926 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -52.75 124.05 12.9 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.009 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.32 126.84 41.57 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.445 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.2 m -107.84 110.85 22.73 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.103 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -96.19 137.35 24.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.23 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.7 m -138.31 139.17 38.97 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.286 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.44 139.08 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.066 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.462 ' CE2' ' CG ' ' A' ' 87' ' ' PRO . 1.7 m-85 -118.56 113.89 21.97 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.783 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.03 125.56 35.86 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.953 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.92 100.91 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.621 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.306 -1.289 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.251 179.985 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.462 ' CG ' ' CE2' ' A' ' 73' ' ' TYR . 12.6 Cg_exo . . . . . 0 C--O 1.215 -0.642 0 N-CA-C 110.687 -0.544 . . . . 0.0 110.687 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.42 162.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 118.491 -1.284 . . . . 0.0 111.403 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.6 p -147.74 157.66 43.65 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.085 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.7 pt -144.15 143.5 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.711 -0.795 . . . . 0.0 110.68 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -93.77 149.78 20.95 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.133 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -172.26 132.96 0.65 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.644 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.65 122.8 28.59 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.326 -0.949 . . . . 0.0 110.379 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 116.336 -1.792 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -158.27 176.45 12.46 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.418 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.24 124.2 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.937 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 t -69.5 -72.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.171 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.84 174.29 11.62 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.777 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -131.7 168.37 17.87 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.13 160.64 36.8 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.278 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 16' ' ' THR . 2.6 Cg_exo -50.54 99.64 0.04 OUTLIER 'Trans proline' 0 C--O 1.212 -0.786 0 C-N-CA 120.656 0.904 . . . . 0.0 111.092 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.463 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.6 OUTLIER 75.05 41.03 0.32 Allowed 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.304 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.48 141.05 2.9 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.12 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 tp -130.25 152.07 50.08 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.7 tp -126.11 110.55 13.64 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.157 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -101.63 157.79 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.441 -0.903 . . . . 0.0 111.228 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.64 137.57 18.13 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.552 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.2 p90 . . . . . 0 N--CA 1.49 1.541 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.952 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.4 t . . . . . 0 N--CA 1.477 0.905 0 CA-C-O 121.024 0.44 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.444 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 20.5 mmm-85 -76.32 -61.06 2.07 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.217 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 75.9 m-85 -154.16 169.56 23.3 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.297 -1.361 . . . . 0.0 112.68 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.56 133.51 38.43 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.744 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -123.27 118.88 28.59 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.889 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.5 mt -101.03 123.31 53.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.9 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 p -124.59 136.36 53.89 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.543 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 7.9 p90 -139.83 161.65 37.05 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.81 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.5 152.31 13.15 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.442 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.91 145.04 38.49 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.557 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 C--N 1.303 -1.446 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.792 -179.935 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 121.077 0.465 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -171.7 -159.22 0.14 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.012 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.31 172.15 7.42 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.315 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -161.79 138.08 8.02 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.941 -1.104 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.9 p -86.65 152.35 22.65 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.152 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 p -165.13 136.55 3.25 Favored Pre-proline 0 C--N 1.301 -1.522 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.44 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.513 ' C ' ' H ' ' A' ' 53' ' ' SER . 3.5 Cg_exo -51.94 134.95 50.27 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 120.295 0.663 . . . . 0.0 111.471 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.18 3.61 1.07 Allowed Glycine 0 N--CA 1.484 1.898 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.899 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -68.87 -34.62 75.75 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 118.876 -1.13 . . . . 0.0 110.285 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -79.68 119.65 22.91 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.796 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.5 -7.17 59.58 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.236 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.6 p -137.37 160.16 39.87 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.605 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.95 141.96 17.1 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.311 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.9 m -101.98 144.04 31.09 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.436 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.4 tt -141.33 149.34 20.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.204 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 16' ' ' THR . 14.2 t -149.25 124.99 10.47 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.748 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.07 14.81 0.1 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.287 -1.435 . . . . 0.0 110.541 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.31 -155.17 0.48 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.716 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -130.25 145.62 58.12 Favored Pre-proline 0 N--CA 1.493 1.703 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.4 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -71.07 121.87 8.24 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 120.863 1.042 . . . . 0.0 113.022 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.18 89.85 0.07 OUTLIER Glycine 0 N--CA 1.502 3.063 0 C-N-CA 119.989 -1.101 . . . . 0.0 112.93 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.9 p -171.89 148.86 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.176 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.15 142.02 57.19 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.792 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -144.08 151.37 39.53 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.25 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.83 125.02 46.47 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.516 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.3 tp -111.49 136.16 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.132 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.5 m -138.91 121.92 16.73 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.632 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.7 m -105.6 144.02 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.137 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.47 92.27 3.9 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.417 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.48 90.27 5.65 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.248 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 t -77.26 114.11 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.629 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.484 1.241 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.469 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo . . . . . 0 C--O 1.213 -0.771 0 CA-C-O 121.609 0.587 . . . . 0.0 113.526 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.7 tt -143.75 129.92 16.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.854 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.0 p -129.84 165.12 22.65 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.275 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -151.45 146.86 15.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.415 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.15 149.28 28.04 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.219 -0.993 . . . . 0.0 110.194 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -158.44 134.81 9.37 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.194 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.75 114.28 26.52 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.979 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 116.27 -1.824 . . . . 0.0 110.955 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -178.26 176.89 1.04 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 118.729 -1.189 . . . . 0.0 111.97 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.0 t -99.09 116.04 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.964 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.467 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 5.5 t -71.1 -25.43 25.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.797 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 11' ' ' VAL . . . 163.78 168.6 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.78 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -129.22 157.93 40.44 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.155 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.68 161.93 28.77 Favored Pre-proline 0 C--N 1.305 -1.334 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.767 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 16' ' ' THR . 6.1 Cg_exo -54.65 106.22 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 121.217 1.278 . . . . 0.0 111.849 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.464 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER 74.54 34.11 0.79 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.856 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 99.5 p -172.14 138.77 1.02 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.026 -1.07 . . . . 0.0 111.199 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.0 tp -131.05 122.3 26.52 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.902 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.94 113.64 25.2 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.354 -0.938 . . . . 0.0 112.156 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 pt -105.41 167.11 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.549 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -160.66 133.98 6.68 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.324 -1.35 . . . . 0.0 111.807 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.9 p90 . . . . . 0 N--CA 1.479 1.012 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.053 179.904 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 121.033 0.444 . . . . 0.0 111.985 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.405 ' CG ' ' CE2' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -68.75 -50.65 48.84 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.433 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.405 ' CE2' ' CG ' ' A' ' 30' ' ' ARG . 0.7 OUTLIER 177.28 168.89 0.6 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.9 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -121.92 165.33 16.12 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.334 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -141.03 106.92 5.14 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.505 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.8 mt -98.43 111.55 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.43 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 p -124.34 133.22 53.5 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.106 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.628 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -128.27 138.88 52.62 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.13 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.01 137.84 5.93 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.223 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -67.2 163.79 19.59 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.596 -0.842 . . . . 0.0 111.126 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 C--N 1.301 -1.501 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.54 -179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 120.741 0.305 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -171.84 169.54 5.77 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.837 -1.145 . . . . 0.0 111.466 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.76 159.47 44.11 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.298 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -168.76 134.38 1.7 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 118.941 -1.104 . . . . 0.0 111.053 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.5 162.32 14.26 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.058 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.594 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -145.96 161.56 39.29 Favored Pre-proline 0 C--N 1.307 -1.265 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.104 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.96 20.09 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 120.925 1.083 . . . . 0.0 111.858 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 55.2 22.89 31.06 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.335 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.24 -40.04 9.36 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.989 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -72.82 117.2 14.24 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.77 -23.15 42.4 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.664 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.5 p -125.01 161.65 26.24 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.0 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.83 150.89 26.53 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.75 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.2 m -123.72 108.0 12.07 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.419 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.2 pt -108.75 159.24 8.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.832 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 16' ' ' THR . 15.3 t -145.27 140.99 28.2 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.181 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 164.0 11.11 0.03 OUTLIER Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.455 -1.355 . . . . 0.0 110.872 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.586 ' N ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -131.09 150.59 52.08 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.886 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.669 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -126.24 -38.33 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.851 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.026 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.669 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 5.4 Cg_endo -80.81 -168.57 0.65 Allowed 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 121.425 1.417 . . . . 0.0 111.629 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -130.42 73.54 0.46 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.491 ' CG2' ' N ' ' A' ' 67' ' ' ASP . 14.1 p -114.14 174.5 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.573 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.491 ' N ' ' CG2' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -59.97 140.34 56.81 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.991 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.35 123.41 20.32 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.553 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.85 113.23 25.97 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.17 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -102.19 150.11 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.108 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -144.52 127.45 16.41 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.507 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.54 143.72 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.765 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -114.3 137.15 52.16 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.656 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.77 97.86 5.83 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.26 132.99 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.28 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 C--N 1.309 -1.174 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.832 179.9 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 C--O 1.216 -0.606 0 CA-C-O 120.712 0.213 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.3 tt -137.09 135.06 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.117 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.04 164.81 27.14 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.196 -1.002 . . . . 0.0 112.697 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -146.37 154.13 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.574 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.57 145.75 29.57 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.257 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -159.98 147.27 16.45 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.164 -1.015 . . . . 0.0 111.075 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.556 ' CD ' ' N ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -88.01 103.24 15.52 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.739 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 116.503 -1.713 . . . . 0.0 110.614 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 tt . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.469 ' O ' ' OG ' ' A' ' 21' ' ' SER . 5.8 pt-20 -179.04 163.81 1.37 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.632 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.2 t -75.75 132.89 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.361 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.475 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 9.2 p -104.61 -23.07 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 118.601 -1.239 . . . . 0.0 112.383 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 11' ' ' VAL . . . 165.78 174.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.568 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.39 152.31 42.71 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.715 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.435 ' OG1' ' OG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -116.95 163.41 22.96 Favored Pre-proline 0 N--CA 1.486 1.356 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.282 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.47 ' O ' ' OG1' ' A' ' 16' ' ' THR . 10.2 Cg_exo -46.84 103.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 120.54 0.827 . . . . 0.0 110.477 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 15' ' ' PRO . 1.6 p 69.7 37.9 1.79 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.597 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.435 ' OG ' ' OG1' ' A' ' 14' ' ' THR . 0.4 OUTLIER -157.54 145.96 19.28 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.312 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.6 tp -123.41 122.53 38.51 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.988 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.56 121.58 38.54 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.092 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -124.36 151.88 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -122.97 131.73 53.84 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.132 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.522 ' NE1' ' CE2' ' A' ' 32' ' ' TYR . 25.6 p90 . . . . . 0 N--CA 1.513 2.711 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -60.39 3.42 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 118.783 -1.167 . . . . 0.0 108.143 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -154.13 161.48 41.85 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.036 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.522 ' CE2' ' NE1' ' A' ' 22' ' ' TRP . 3.2 m-85 -108.03 164.1 12.57 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.351 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -147.05 95.13 2.52 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.191 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.5 mt -91.26 135.15 27.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.399 -0.921 . . . . 0.0 111.605 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 p -138.63 137.38 36.86 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.825 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.603 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -137.88 160.2 39.94 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.797 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.21 135.77 3.17 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.405 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.86 108.36 8.67 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.466 -0.893 . . . . 0.0 110.769 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.3 m . . . . . 0 C--N 1.303 -1.423 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.768 -179.996 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 121.144 0.497 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -173.59 -170.26 0.58 Allowed 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.8 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -168.69 176.52 5.56 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.673 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -176.13 150.24 0.94 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.336 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.5 p -111.58 153.65 25.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.05 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.529 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -143.06 150.14 51.58 Favored Pre-proline 0 C--N 1.303 -1.453 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.905 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.521 ' C ' ' H ' ' A' ' 53' ' ' SER . 3.7 Cg_endo -65.78 28.74 0.1 OUTLIER 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 120.923 1.082 . . . . 0.0 112.483 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 53.59 8.6 0.9 Allowed Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.063 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.521 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -72.27 -32.14 66.38 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.547 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -95.72 154.44 17.22 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.29 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 m -104.01 -22.79 13.4 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.135 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.0 p -122.91 -175.25 3.12 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.324 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -171.11 175.09 4.43 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.297 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.8 t -131.08 141.71 50.2 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.528 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.2 mt -132.31 111.32 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.408 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -109.05 147.54 32.2 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.585 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.19 20.66 4.33 Favored Glycine 0 N--CA 1.501 2.996 0 C-N-CA 119.841 -1.171 . . . . 0.0 110.255 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.591 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -106.46 -174.28 2.5 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.42 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -136.84 122.55 13.21 Favored Pre-proline 0 N--CA 1.487 1.422 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.883 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.08 118.8 5.73 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 120.209 0.606 . . . . 0.0 111.671 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.38 64.7 0.7 Allowed Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.607 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 p -164.69 148.37 2.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 119.156 -1.017 . . . . 0.0 111.592 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -70.31 152.45 44.15 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.893 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.63 140.83 26.32 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.711 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.2 m -117.88 107.42 14.08 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.411 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.473 ' CG1' ' N ' ' A' ' 71' ' ' THR . 5.1 tt -102.61 160.92 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.014 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.473 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 91.0 m -160.5 139.59 10.58 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.167 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 m -131.36 123.71 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.663 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.89 129.99 53.13 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.392 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.19 104.18 14.3 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.99 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.28 121.04 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 119.049 -1.061 . . . . 0.0 112.443 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.487 1.377 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.585 179.849 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--O 1.216 -0.606 0 N-CA-C 110.572 -0.588 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 tt -151.29 135.27 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 117.983 -1.487 . . . . 0.0 111.723 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.73 139.5 52.65 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.734 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 pt -149.7 157.94 6.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 118.749 -1.18 . . . . 0.0 111.806 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.4 ' ND2' ' H ' ' A' ' 91' ' ' ASN . 0.0 OUTLIER -95.97 159.77 14.8 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.796 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -167.69 130.86 1.66 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.06 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.3 mtm-85 -88.34 119.31 28.64 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.145 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 116.337 -1.792 . . . . 0.0 110.975 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.424 ' O ' ' OE1' ' A' ' 9' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -157.92 158.24 34.64 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.871 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.3 t -93.56 115.22 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.576 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.487 ' CG2' ' OG ' ' A' ' 21' ' ' SER . 2.2 t -70.75 -68.71 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 118.818 -1.153 . . . . 0.0 111.197 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.12 174.82 12.76 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.522 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.54 162.87 34.34 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -135.16 161.17 65.09 Favored Pre-proline 0 N--CA 1.484 1.238 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.734 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.76 -14.38 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 120.893 1.062 . . . . 0.0 110.944 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 14' ' ' THR . 7.8 p -158.4 50.8 0.4 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.69 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.56 143.13 0.18 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.437 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.5 tp -130.16 140.83 50.72 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.111 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.91 110.19 17.43 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.42 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 pp -106.41 147.04 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.487 ' OG ' ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -145.46 136.74 24.95 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.271 -0.971 . . . . 0.0 110.609 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.0 p90 . . . . . 0 C--N 1.308 -1.201 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.523 -179.998 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 t . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.664 0.268 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -73.0 -70.17 0.37 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.484 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -158.66 163.24 37.06 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.61 -1.236 . . . . 0.0 112.046 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -121.0 152.59 38.4 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.661 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 -131.0 115.33 16.34 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.296 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 mp -106.81 113.45 43.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.548 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -119.56 137.94 53.52 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.709 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.565 ' OH ' ' CE2' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -136.71 157.54 46.53 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.195 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.53 153.23 9.78 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -67.9 160.29 28.8 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.457 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.302 -1.46 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.0 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.477 0.911 0 CA-C-O 120.881 0.372 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -175.19 178.48 1.71 Allowed 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.129 -1.028 . . . . 0.0 111.359 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -170.8 150.35 3.22 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.363 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.565 ' CE2' ' OH ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -146.03 164.62 31.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.673 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.2 p -116.89 156.3 27.58 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.436 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.579 ' C ' ' H ' ' A' ' 52' ' ' GLY . 6.0 m -146.28 151.67 44.66 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.805 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.96 20.83 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.074 1.182 . . . . 0.0 112.586 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 66.75 4.75 27.79 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.219 -1.467 . . . . 0.0 110.211 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.71 -45.98 14.93 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.759 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.66 107.42 7.81 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.605 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.8 m -82.81 14.2 3.38 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -138.65 163.42 32.14 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.633 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.5 139.43 7.92 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.587 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.9 m -110.12 134.12 52.51 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.607 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -132.53 154.54 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.017 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t -136.45 -167.89 2.15 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.511 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.12 73.96 0.53 Allowed Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.309 -1.424 . . . . 0.0 109.867 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mt -126.74 177.57 6.48 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.312 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.54 128.27 25.88 Favored Pre-proline 0 CA--C 1.559 1.324 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -53.76 98.01 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 120.415 0.743 . . . . 0.0 112.889 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.11 97.29 0.22 Allowed Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.124 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -167.11 138.72 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.639 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.35 109.8 0.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.882 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.8 140.39 42.31 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.962 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.57 130.39 52.6 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.548 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.67 162.57 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.618 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.6 m -150.55 116.31 5.53 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.761 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 72' ' ' VAL . 6.0 m -102.74 121.22 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.859 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -99.1 130.95 45.45 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.581 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.44 89.64 3.1 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.884 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.6 t -92.39 127.93 44.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.103 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.485 1.283 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.567 179.959 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--O 1.216 -0.606 0 N-CA-C 110.844 -0.483 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -148.29 162.16 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 118.554 -1.258 . . . . 0.0 110.732 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.88 164.71 28.96 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.086 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 pt -150.41 135.54 10.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.542 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -109.48 131.87 54.66 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.84 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -161.71 135.75 6.75 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.487 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -68.32 114.1 6.48 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.659 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 116.29 -1.814 . . . . 0.0 110.729 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.501 2.089 0 N-CA-C 111.093 0.034 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -175.82 157.89 2.03 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 118.719 -1.192 . . . . 0.0 112.55 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.69 113.73 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 t -71.72 -71.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 118.758 -1.177 . . . . 0.0 112.169 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.99 175.52 10.39 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.022 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.45 147.56 51.7 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.074 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -142.82 161.37 49.35 Favored Pre-proline 0 C--N 1.305 -1.335 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.355 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.58 106.96 0.19 Allowed 'Trans proline' 0 C--O 1.211 -0.832 0 C-N-CA 121.045 1.163 . . . . 0.0 112.156 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 72.66 -3.71 2.29 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.99 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.439 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -130.26 136.48 49.22 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.707 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 tp -130.86 154.19 48.32 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.791 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.5 tp -116.79 122.09 43.42 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 pt -124.25 160.41 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -134.18 140.52 46.58 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.963 -1.471 . . . . 0.0 107.325 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 14.5 p90 . . . . . 0 N--CA 1.505 2.31 0 C-N-CA 118.402 -1.319 . . . . 0.0 114.069 -179.773 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.414 ' CD ' ' CZ ' ' A' ' 31' ' ' TYR . 1.6 ttm-85 -57.83 -64.84 0.77 Allowed 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.668 -1.213 . . . . 0.0 109.115 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.414 ' CZ ' ' CD ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -127.26 147.51 50.22 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.117 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -110.36 130.3 55.58 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.959 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -114.04 101.43 9.22 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.3 mt -92.94 123.86 45.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.862 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.2 p -124.93 135.11 52.54 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.765 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -130.06 155.49 46.07 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.086 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.11 151.32 12.78 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.977 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -85.92 136.17 33.39 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.662 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.305 -1.36 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.916 179.997 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.854 0.359 . . . . 0.0 111.92 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -157.28 168.7 26.64 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.076 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' OE1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -143.94 175.11 10.27 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.979 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.4 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 25.7 p90 -163.28 134.68 4.87 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.954 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.4 ' H ' ' HG1' ' A' ' 49' ' ' THR . 34.0 p -87.45 164.55 16.12 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.254 -0.979 . . . . 0.0 111.288 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.59 ' C ' ' H ' ' A' ' 52' ' ' GLY . 14.5 p -162.31 138.34 5.76 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.069 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.461 ' C ' ' H ' ' A' ' 53' ' ' SER . 3.2 Cg_exo -60.56 23.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 120.953 1.102 . . . . 0.0 113.258 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 49.67 12.31 0.39 Allowed Glycine 0 N--CA 1.495 2.625 0 C-N-CA 119.488 -1.339 . . . . 0.0 110.77 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -59.77 -24.65 64.25 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.588 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -121.07 129.78 53.48 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.465 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -79.82 -9.62 59.68 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.037 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.3 p -140.09 154.86 47.17 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.763 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.84 160.67 25.39 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.674 -1.211 . . . . 0.0 111.499 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.6 m -90.24 157.47 17.67 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.535 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.441 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 6.0 tt -150.75 128.96 2.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 119.396 -0.921 . . . . 0.0 110.416 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 t -134.66 117.29 15.91 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.699 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.69 -28.22 0.02 OUTLIER Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.607 -1.282 . . . . 0.0 110.146 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.457 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -78.85 -166.45 0.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.887 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.571 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 0.5 OUTLIER -165.33 -42.4 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.456 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.95 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 63' ' ' LYS . 8.9 Cg_endo -85.56 -174.81 1.72 Allowed 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 121.358 1.372 . . . . 0.0 111.574 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.68 72.73 0.43 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.515 ' CG2' ' N ' ' A' ' 67' ' ' ASP . 5.1 p -124.31 169.52 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.239 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.515 ' N ' ' CG2' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -49.1 110.51 0.37 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.879 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.99 134.81 54.31 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.724 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.45 134.36 55.17 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.509 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.44 158.72 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.908 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 m -153.31 140.83 19.81 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 118.326 -1.35 . . . . 0.0 112.521 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.8 m -114.39 121.84 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -94.15 109.81 21.57 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.746 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.3 94.11 8.37 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.674 -1.211 . . . . 0.0 109.625 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.09 125.98 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.867 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.487 1.38 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.964 179.982 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 C--O 1.215 -0.639 0 CA-C-O 120.716 0.215 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.5 tt -138.65 121.66 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.746 -0.782 . . . . 0.0 108.916 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.49 164.9 16.44 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.61 140.38 20.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.051 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -103.09 146.56 28.19 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.528 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -172.53 142.08 1.21 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.541 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -75.2 108.87 8.25 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.311 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 116.389 -1.767 . . . . 0.0 110.714 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -163.58 174.69 11.47 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 117.502 -1.679 . . . . 0.0 113.468 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.5 t -92.96 128.39 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.809 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.27 -2.41 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.47 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.19 160.42 9.65 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.914 -1.114 . . . . 0.0 111.251 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.62 150.01 27.23 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.529 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.611 ' HG1' ' CB ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -137.4 162.11 56.92 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.874 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -55.39 -6.74 0.98 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.056 1.171 . . . . 0.0 111.433 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.467 ' H ' ' C ' ' A' ' 14' ' ' THR . 0.6 OUTLIER -160.09 42.88 0.2 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.382 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.611 ' CB ' ' HG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER 179.5 146.87 0.21 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.045 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.1 tp -130.44 120.57 24.41 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.28 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.7 tt -96.8 104.68 16.7 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.502 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -104.88 153.43 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.652 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.08 144.58 24.92 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 9.9 p90 . . . . . 0 C--N 1.31 -1.112 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.041 179.913 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.735 0.303 . . . . 0.0 110.509 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -65.2 0.61 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.39 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.92 159.0 36.09 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.666 -1.214 . . . . 0.0 111.789 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -119.4 146.04 45.7 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.56 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -129.56 111.21 12.5 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.4 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.8 mp -100.93 120.97 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.153 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 p -122.04 136.95 54.97 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.97 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 1.8 p90 -130.77 146.92 52.36 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.85 138.79 5.01 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.8 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -72.9 141.62 47.89 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.517 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 m . . . . . 0 C--N 1.304 -1.383 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.718 179.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.0 t . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 121.091 0.472 . . . . 0.0 110.403 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -172.24 -167.86 0.5 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.231 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.89 163.57 11.6 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.698 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 9.7 p90 -153.96 141.84 20.15 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.403 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -100.21 159.93 14.72 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.893 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -147.29 157.36 45.68 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.121 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.56 10.76 0.1 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.141 1.227 . . . . 0.0 112.096 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 61.07 26.86 66.32 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.062 -1.542 . . . . 0.0 109.818 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.63 -53.65 4.43 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.63 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -90.62 123.37 34.2 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.1 m -86.39 27.62 0.92 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.244 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.8 p -145.44 162.98 36.05 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.5 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.1 154.53 5.07 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.805 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.2 m -130.93 115.69 16.87 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.053 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.37 171.49 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.673 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 53.0 m -148.57 173.12 13.49 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.619 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.75 49.19 1.3 Allowed Glycine 0 N--CA 1.498 2.799 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.403 ' CD1' ' C ' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -130.51 -175.37 3.63 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.866 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -117.55 135.32 23.22 Favored Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.69 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.53 148.27 93.39 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.052 1.168 . . . . 0.0 112.799 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.18 82.91 0.03 OUTLIER Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.388 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -167.55 145.68 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 118.956 -1.098 . . . . 0.0 111.444 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -61.3 140.87 57.9 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.413 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.46 118.18 10.46 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.59 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.5 m -100.66 116.97 33.82 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.827 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 tt -107.37 149.13 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.11 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 m -141.81 120.6 12.68 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.912 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.9 m -105.91 124.63 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.596 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -102.51 94.15 5.51 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.972 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.95 132.04 36.2 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.704 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -136.09 119.43 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.969 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.2 m . . . . . 0 N--CA 1.488 1.426 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.898 179.933 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 C--O 1.214 -0.68 0 CA-C-O 121.215 0.423 . . . . 0.0 112.248 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 tt -145.89 153.42 13.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.092 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.43 151.58 46.37 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.069 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -145.76 140.25 21.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.58 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -88.88 151.28 22.44 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.755 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -162.46 134.94 5.64 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.138 -1.025 . . . . 0.0 111.102 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.2 mtt180 -93.84 110.69 22.33 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.992 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 116.395 -1.764 . . . . 0.0 110.574 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -170.15 170.56 7.32 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.322 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.91 149.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.969 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.98 -6.41 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.794 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.84 161.09 7.08 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.813 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.59 145.85 27.01 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.784 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -130.74 161.0 63.79 Favored Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.901 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.04 -10.08 2.54 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 121.236 1.29 . . . . 0.0 111.771 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 m -159.68 44.32 0.23 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.1 OUTLIER 177.26 149.45 0.15 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.237 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.9 tp -131.18 148.64 52.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.062 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.71 116.91 24.56 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.696 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.3 pt -104.87 170.71 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.764 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.34 135.12 13.65 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.144 -1.023 . . . . 0.0 111.126 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.9 p90 . . . . . 0 C--N 1.311 -1.1 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.46 179.955 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.486 0.184 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.486 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 3.8 mmm180 -73.79 -78.09 0.1 Allowed 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.32 -1.352 . . . . 0.0 108.773 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -149.79 153.61 37.1 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.526 -1.27 . . . . 0.0 112.022 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.16 167.58 9.9 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.175 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -145.07 106.65 4.24 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.674 -1.21 . . . . 0.0 111.419 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 mt -100.21 106.19 18.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.364 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 43.3 p -107.45 136.66 46.88 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.494 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.419 ' HD1' ' H ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -134.34 132.05 39.05 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.614 -0.834 . . . . 0.0 112.036 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -158.66 153.46 24.6 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -49.57 171.43 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.62 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 39' ' ' THR . 3.6 t . . . . . 0 N--CA 1.49 1.569 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.665 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.8 t . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 111.313 0.116 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.633 ' CG ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -174.48 -140.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.305 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.633 ' H ' ' CG ' ' A' ' 46' ' ' GLN . 9.1 pt-20 -171.91 168.48 5.99 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.667 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -161.61 141.37 10.29 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.63 165.76 11.82 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.419 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.579 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -150.28 160.3 33.43 Favored Pre-proline 0 C--N 1.304 -1.411 0 C-N-CA 119.486 -0.885 . . . . 0.0 110.005 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.09 21.11 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.158 1.239 . . . . 0.0 112.254 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 42.81 32.59 1.42 Allowed Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.675 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.14 -53.29 3.69 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.554 -0.858 . . . . 0.0 111.267 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -75.86 136.22 40.16 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.08 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 m -83.83 -13.58 53.38 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.529 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.4 p -131.4 152.95 50.19 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.915 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.35 157.51 37.24 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.292 -1.363 . . . . 0.0 112.137 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 49.4 m -98.5 130.97 45.09 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.708 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.1 tp -130.43 121.64 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.433 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.9 t -117.23 -168.77 1.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.32 51.11 5.1 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.73 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.36 -160.97 1.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.701 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -136.35 139.25 29.17 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.215 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -61.94 118.13 5.0 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 120.935 1.09 . . . . 0.0 111.614 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.79 89.08 0.07 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.531 -1.318 . . . . 0.0 111.031 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.5 p -163.48 138.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.135 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.89 114.38 5.67 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.824 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -119.89 145.92 46.25 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.978 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.6 m -112.92 111.44 22.2 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.294 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.403 ' CD1' ' C ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -102.36 130.46 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.081 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.403 ' N ' ' CD1' ' A' ' 70' ' ' ILE . 2.2 m -133.41 141.83 48.05 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.398 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.18 138.22 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.275 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.36 122.95 41.91 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.733 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.59 116.41 32.68 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.244 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.33 108.76 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.468 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.406 179.962 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.455 -0.793 0 N-CA-C 110.598 -0.578 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.94 156.4 6.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 C-N-CA 118.595 -1.242 . . . . 0.0 111.17 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.3 p -142.04 144.84 33.81 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.66 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -149.54 145.76 17.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.24 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.81 141.64 28.44 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.069 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -149.02 128.36 12.96 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.623 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -78.97 106.88 11.31 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.708 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 116.142 -1.885 . . . . 0.0 111.016 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.466 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.4 mp . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.566 0.222 . . . . 0.0 110.728 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -175.38 -176.72 0.94 Allowed 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.649 -1.22 . . . . 0.0 112.229 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.2 t -93.35 146.95 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.64 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -94.25 -63.47 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.472 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.49 172.4 15.03 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.173 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.8 174.8 10.18 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.428 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.51 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -148.71 160.77 35.05 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.533 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -52.98 -6.29 0.25 Allowed 'Trans proline' 0 C--O 1.216 -0.587 0 C-N-CA 121.364 1.376 . . . . 0.0 111.851 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 14' ' ' THR . 2.0 t -165.22 48.94 0.1 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.414 ' OG ' ' OG1' ' A' ' 14' ' ' THR . 0.1 OUTLIER 174.87 147.5 0.08 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.798 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 tp -127.29 133.96 50.09 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.457 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.83 111.75 24.04 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.395 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 pp -110.95 145.25 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.678 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.7 m -141.95 126.1 17.42 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.189 -1.004 . . . . 0.0 111.046 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.6 p90 . . . . . 0 N--CA 1.475 0.821 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.778 179.87 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.622 0.248 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.542 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.24 -63.68 1.11 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.126 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 9.0 m-85 -143.93 164.31 30.95 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.089 -1.045 . . . . 0.0 112.282 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.99 146.05 50.48 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.396 -1.274 . . . . 0.0 108.298 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.513 ' HE ' ' CG2' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -137.19 136.36 38.12 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.778 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.513 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 3.5 mp -121.09 119.92 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.293 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -114.19 138.06 50.96 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.593 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 8.3 p90 -135.84 154.2 51.25 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.803 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.16 169.61 42.61 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -76.01 -162.9 0.25 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.847 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.489 1.515 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.31 -179.86 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.6 t . . . . . 0 CA--C 1.502 -0.869 0 CA-C-O 121.165 0.507 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -175.69 -169.79 0.37 Allowed 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.194 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -164.36 160.48 20.86 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.855 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.436 ' O ' ' CD1' ' A' ' 48' ' ' PHE . 42.3 p90 -155.51 142.46 19.08 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.726 -1.189 . . . . 0.0 111.185 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.9 140.78 29.13 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.348 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.6 155.69 80.3 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.056 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.579 ' C ' ' H ' ' A' ' 53' ' ' SER . 0.9 OUTLIER -61.66 118.23 5.09 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 120.436 0.757 . . . . 0.0 110.795 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -49.41 -6.46 0.06 OUTLIER Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.034 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.579 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -64.12 -36.45 84.06 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.25 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -83.72 157.63 22.08 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.059 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -120.65 -6.28 9.69 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.607 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.6 p -133.22 161.8 33.5 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.163 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.14 165.18 27.37 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.8 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.1 m -128.98 118.24 22.27 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.493 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.1 pt -108.4 149.23 11.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.701 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 16' ' ' THR . 8.4 t -144.88 151.27 38.46 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.971 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.19 7.6 1.71 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.585 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -130.62 -179.61 5.39 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.12 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -125.66 118.05 24.5 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.814 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.1 112.64 1.74 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 120.399 0.733 . . . . 0.0 111.346 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 94' ' ' THR . . . 158.28 30.84 0.02 OUTLIER Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.687 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p -165.68 164.8 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.406 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.33 104.64 1.55 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.2 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.13 152.9 26.47 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.376 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 m -121.05 128.06 52.29 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.539 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.483 ' CD1' ' N ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -114.02 136.32 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.63 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.483 ' N ' ' CD1' ' A' ' 70' ' ' ILE . 47.2 m -132.96 145.48 50.93 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.95 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.0 m -128.57 140.54 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.383 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -118.42 141.47 48.52 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.439 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.08 105.86 12.28 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.075 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.513 ' CG2' ' HE ' ' A' ' 33' ' ' ARG . 3.5 t -108.03 130.86 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.489 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.1 p . . . . . 0 N--CA 1.484 1.25 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.629 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo . . . . . 0 C--O 1.216 -0.603 0 N-CA-C 110.977 -0.432 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.5 tt -150.65 154.09 9.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 C-N-CA 118.851 -1.14 . . . . 0.0 111.27 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.438 ' OG ' ' OG1' ' A' ' 71' ' ' THR . 14.8 m -134.94 163.07 30.66 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.412 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 pt -145.64 137.74 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.648 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.06 128.99 46.06 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.702 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.521 ' CZ ' ' O ' ' A' ' 93' ' ' ARG . 13.5 t80 -152.23 149.51 28.8 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.246 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.521 ' O ' ' CZ ' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -83.4 120.53 26.0 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.878 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 116.313 -1.803 . . . . 0.0 110.62 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.716 0.293 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -175.32 172.92 2.63 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.308 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.61 133.97 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.69 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.602 ' CG2' ' HG ' ' A' ' 21' ' ' SER . 1.6 t -92.97 -39.44 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.266 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.37 166.33 20.81 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.876 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.63 82.71 1.46 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.746 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.407 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -65.69 160.73 58.82 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.234 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -4.84 3.63 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 121.093 1.196 . . . . 0.0 111.499 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.424 ' O ' ' OG ' ' A' ' 60' ' ' SER . 16.2 m -149.13 39.93 0.85 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.523 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 172.68 143.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.515 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.54 140.01 53.34 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.231 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.35 116.74 26.83 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.915 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 pp -112.55 150.51 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.228 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.602 ' HG ' ' CG2' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -144.12 140.36 29.38 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.652 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.6 p90 . . . . . 0 C--N 1.304 -1.404 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.555 179.845 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 120.688 0.28 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -78.44 -70.75 0.47 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.649 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.63 161.32 41.94 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.125 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -120.51 131.97 54.96 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.957 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttp-105 -118.59 113.09 20.72 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.244 -0.983 . . . . 0.0 110.525 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.0 mt -95.84 122.91 47.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.338 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -125.69 130.87 52.41 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.212 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.59 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -148.14 166.73 27.0 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.671 -1.212 . . . . 0.0 112.306 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.94 146.73 4.76 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -53.53 169.93 0.12 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.577 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 63.4 m . . . . . 0 C--N 1.304 -1.387 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.717 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.492 ' CG1' ' H ' ' A' ' 46' ' ' GLN . 49.3 t . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 111.17 0.063 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.492 ' H ' ' CG1' ' A' ' 45' ' ' VAL . 4.3 pt20 -176.1 -133.12 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.361 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -171.1 161.26 6.72 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.346 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.564 ' CE2' ' OH ' ' A' ' 36' ' ' TYR . 2.7 p90 -152.56 161.22 42.88 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.0 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 p -113.75 156.85 23.08 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.534 -0.866 . . . . 0.0 112.293 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.565 ' C ' ' H ' ' A' ' 52' ' ' GLY . 2.4 m -147.42 154.29 45.06 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.956 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 53' ' ' SER . 1.1 Cg_endo -63.1 23.28 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.016 1.144 . . . . 0.0 112.931 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 52.57 13.93 2.19 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.083 -1.532 . . . . 0.0 110.693 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -74.93 -39.51 61.34 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.194 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.72 130.47 43.96 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.119 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.9 m -87.95 24.46 1.79 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.558 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.2 164.27 30.64 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.789 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.63 141.22 17.87 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.668 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.0 m -117.19 139.33 50.9 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.401 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.0 tt -141.59 140.41 31.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.319 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 16' ' ' THR . 4.2 t -141.86 176.45 8.92 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.22 48.48 6.41 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.193 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.37 -158.83 0.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.114 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -135.41 101.52 11.0 Favored Pre-proline 0 N--CA 1.487 1.421 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.828 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -61.95 153.86 65.69 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 120.598 0.865 . . . . 0.0 111.671 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.61 47.97 4.1 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.577 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -161.87 160.31 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 C-N-CA 119.009 -1.077 . . . . 0.0 111.595 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.84 153.61 32.61 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.081 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.81 117.48 6.19 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.774 -1.171 . . . . 0.0 111.648 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.53 119.52 36.23 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.313 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.7 125.98 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.403 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.6 m -131.14 138.86 49.67 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.485 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -126.22 131.3 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.76 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -100.95 117.0 34.14 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.232 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.05 110.21 22.49 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.528 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.35 117.04 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.956 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.306 -1.289 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.586 179.746 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo . . . . . 0 C--O 1.215 -0.652 0 CA-C-O 121.361 0.484 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.43 ' CG2' ' O ' ' A' ' 88' ' ' ILE . 13.1 tt -152.27 127.86 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.37 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.6 p -117.17 150.88 37.99 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.592 -0.843 . . . . 0.0 112.339 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.82 133.37 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.283 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 91' ' ' ASN . 19.2 p-10 -80.57 145.41 31.77 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.1 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -160.1 132.67 6.47 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.46 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 1.4 ptp180 -90.94 123.84 34.74 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.109 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 116.343 -1.789 . . . . 0.0 110.663 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.642 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.959 0 CA-C-O 120.581 0.229 . . . . 0.0 110.501 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -175.72 -179.02 1.15 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.392 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t -91.21 127.56 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.857 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.96 -21.1 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.584 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -179.86 161.8 1.0 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.478 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.81 115.66 13.94 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.219 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -96.09 162.07 25.09 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.533 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.505 ' O ' ' OG1' ' A' ' 16' ' ' THR . 7.9 Cg_exo -47.23 96.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 120.763 0.976 . . . . 0.0 110.704 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 15' ' ' PRO . 2.2 p 70.49 47.15 0.52 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.662 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.56 119.73 1.22 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.388 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 tp -105.72 137.0 44.31 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.287 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.28 103.03 8.26 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.855 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pt -97.95 173.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.505 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.57 131.28 3.03 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.242 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.426 ' CE3' ' N ' ' A' ' 22' ' ' TRP . 10.4 p90 . . . . . 0 CA--C 1.493 -1.218 0 C-N-CA 119.156 -1.017 . . . . 0.0 111.028 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 30' ' ' ARG . 74.3 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.006 0.432 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.407 ' N ' ' CG1' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -74.58 -65.43 0.86 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.047 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -160.25 -178.62 7.09 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 117.924 -1.51 . . . . 0.0 113.317 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.42 174.41 10.65 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.704 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.59 148.28 37.25 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.17 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.28 108.11 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.121 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -119.18 137.63 53.5 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.476 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -137.54 140.18 40.9 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 118.846 -1.142 . . . . 0.0 110.899 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.38 151.7 21.03 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.72 159.34 33.97 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.634 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.478 ' O ' ' CG2' ' A' ' 39' ' ' THR . 22.2 m . . . . . 0 N--CA 1.485 1.315 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.885 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.985 0.422 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.447 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -175.71 -176.29 0.85 Allowed 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 118.525 -1.27 . . . . 0.0 111.513 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 46' ' ' GLN . 9.0 pt-20 -158.16 170.53 22.06 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.205 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -165.92 145.9 6.42 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.02 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.9 p -91.14 169.92 10.45 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.79 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.592 ' C ' ' H ' ' A' ' 52' ' ' GLY . 9.3 p -161.36 136.31 5.49 Favored Pre-proline 0 C--N 1.304 -1.399 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.25 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.533 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.6 Cg_endo -61.7 22.88 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 120.955 1.103 . . . . 0.0 112.828 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 53.26 7.86 0.63 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.491 -1.338 . . . . 0.0 110.312 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -71.62 -29.42 64.64 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.86 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.7 mttm -94.45 153.0 18.15 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.808 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.75 -12.65 17.48 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.721 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 p -130.61 170.99 13.55 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.092 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.37 132.06 9.59 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.578 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.7 m -104.13 128.75 51.82 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.205 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.7 mt -126.82 139.76 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.992 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.91 131.73 47.59 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.411 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.67 2.29 0.19 Allowed Glycine 0 N--CA 1.484 1.881 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 mp -91.43 178.1 6.05 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.29 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.606 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 1.0 OUTLIER -176.82 -42.38 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.733 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 63' ' ' LYS . 4.3 Cg_endo -79.81 -172.02 1.41 Allowed 'Trans proline' 0 C--O 1.217 -0.564 0 C-N-CA 121.548 1.499 . . . . 0.0 111.734 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.91 81.61 0.23 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.595 ' CG2' ' H ' ' A' ' 67' ' ' ASP . 11.8 p -132.05 -177.78 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.998 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.595 ' H ' ' CG2' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -66.93 125.38 25.75 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.142 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.09 130.96 53.31 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.318 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.81 123.81 48.56 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.721 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.447 ' C ' ' HG1' ' A' ' 71' ' ' THR . 1.9 pp -116.05 164.16 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.165 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.447 ' HG1' ' C ' ' A' ' 70' ' ' ILE . 95.9 m -152.18 143.74 23.48 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.632 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.91 139.73 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.715 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -109.07 143.26 38.64 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.536 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.13 91.48 3.55 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.812 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.2 t -94.9 107.65 19.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 119.095 -1.042 . . . . 0.0 113.277 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 m . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 179.649 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 C--O 1.214 -0.691 0 N-CA-C 110.929 -0.45 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.4 tt -143.9 139.59 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.949 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.1 p -124.63 150.99 45.42 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -143.72 163.0 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.505 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -103.05 147.64 26.71 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.147 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -154.12 135.49 14.15 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.811 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 5.6 ptt85 -90.32 107.04 18.9 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.46 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.681 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.522 ' H ' ' CD2' ' A' ' 8' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -168.65 136.44 2.05 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.026 -1.47 . . . . 0.0 112.646 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -88.46 142.4 12.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.879 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.47 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 3.6 p -130.52 1.62 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 119.074 -1.05 . . . . 0.0 112.177 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 177.79 155.61 0.34 Allowed 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.6 -1.24 . . . . 0.0 111.395 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.74 104.79 2.17 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.2 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.511 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -91.66 160.81 35.66 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.002 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.29 -0.4 0.31 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.998 1.132 . . . . 0.0 112.098 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.511 ' H ' ' C ' ' A' ' 14' ' ' THR . 25.5 p -151.39 28.97 0.64 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.699 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.47 151.05 0.57 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.69 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.6 123.98 30.71 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.975 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tp -104.14 116.66 32.59 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.803 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.0 pt -107.1 173.49 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.123 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.68 139.03 7.47 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.295 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 18.3 p90 . . . . . 0 N--CA 1.486 1.367 0 C-N-CA 118.402 -1.319 . . . . 0.0 113.052 -179.841 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.898 0.38 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.401 ' H ' ' HA ' ' A' ' 76' ' ' THR . 2.7 tpt85 -56.03 -61.46 2.36 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.315 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.74 169.33 21.66 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.611 -1.236 . . . . 0.0 112.151 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -116.55 158.32 23.85 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.96 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -138.58 112.25 8.29 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.215 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.4 mt -102.18 127.37 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.866 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -128.9 137.57 51.5 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.958 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.574 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 3.0 p90 -145.55 154.93 42.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 118.351 -1.339 . . . . 0.0 112.204 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -176.24 138.53 4.14 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -64.23 145.48 55.91 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 118.976 -1.09 . . . . 0.0 110.538 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.301 -1.542 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.238 -179.93 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.0 t . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 120.804 0.335 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.49 ' CG ' ' H ' ' A' ' 47' ' ' GLU . 3.8 tp60 -171.57 -151.38 0.07 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.659 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.49 ' H ' ' CG ' ' A' ' 46' ' ' GLN . 3.2 pt-20 -170.18 161.69 8.5 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.377 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -159.02 156.6 29.63 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.869 -1.132 . . . . 0.0 111.054 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.4 p -101.67 157.97 16.44 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.754 -0.779 . . . . 0.0 111.641 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.4 p -165.61 134.14 2.51 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.462 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.537 ' C ' ' H ' ' A' ' 53' ' ' SER . 6.3 Cg_exo -56.49 124.97 17.54 Favored 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 120.274 0.649 . . . . 0.0 111.484 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.05 1.7 0.79 Allowed Glycine 0 N--CA 1.483 1.806 0 C-N-CA 119.45 -1.357 . . . . 0.0 110.694 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.537 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -59.57 -35.28 73.94 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 118.845 -1.142 . . . . 0.0 109.636 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' C ' ' H ' ' A' ' 56' ' ' THR . 46.8 mmtt -98.4 120.25 38.5 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.059 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 m -79.59 21.25 0.52 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.122 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.414 ' H ' ' C ' ' A' ' 54' ' ' LYS . 65.4 p -143.72 149.3 36.96 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.308 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.62 150.11 26.03 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.394 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.1 m -95.05 158.44 15.46 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.128 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -146.9 139.01 19.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 119.506 -0.877 . . . . 0.0 110.026 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.3 -178.08 6.2 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.061 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.32 21.65 21.76 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.779 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.06 -164.65 1.39 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.993 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -177.68 -42.39 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.355 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.295 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 63' ' ' LYS . 1.9 Cg_endo -77.16 -170.16 0.87 Allowed 'Trans proline' 0 C--O 1.214 -0.725 0 C-N-CA 121.762 1.641 . . . . 0.0 112.87 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.71 84.21 0.19 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.514 ' CG2' ' H ' ' A' ' 67' ' ' ASP . 12.2 p -130.2 177.55 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.387 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.514 ' H ' ' CG2' ' A' ' 66' ' ' VAL . 7.9 t70 -45.44 148.27 0.7 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.097 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.58 111.3 5.02 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.528 -1.269 . . . . 0.0 112.294 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.48 132.98 34.27 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.181 -1.008 . . . . 0.0 108.85 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.442 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 7.2 tt -127.64 132.17 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.192 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' A' ' 35' ' ' THR . 24.1 p -125.1 121.98 35.86 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.575 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.37 129.0 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.641 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -103.72 140.81 37.1 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.406 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.97 91.22 3.5 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.135 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.0 t -93.8 124.03 46.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.717 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.401 ' HA ' ' H ' ' A' ' 30' ' ' ARG . 13.3 t . . . . . 0 N--CA 1.487 1.38 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.062 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 C--O 1.215 -0.662 0 CA-C-O 120.957 0.316 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.435 ' O ' ' OG ' ' A' ' 89' ' ' SER . 12.4 tt -145.89 154.62 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.696 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 15.2 m -161.34 147.21 14.15 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 118.446 -1.302 . . . . 0.0 112.204 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pt -150.01 164.38 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.228 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.74 136.4 34.06 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.497 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -140.88 133.55 28.74 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.371 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -87.84 108.51 19.19 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.589 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 116.502 -1.713 . . . . 0.0 110.745 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.629 0.252 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -139.46 162.36 35.24 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.8 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.6 102.25 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.123 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 47.8 t -71.78 3.42 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.296 -0.961 . . . . 0.0 111.474 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 11' ' ' VAL . . . 168.81 154.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.341 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.58 93.85 2.11 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.684 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.529 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -91.27 162.27 32.63 Favored Pre-proline 0 N--CA 1.485 1.288 0 C-N-CA 119.436 -0.905 . . . . 0.0 110.613 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.72 9.55 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.428 1.419 . . . . 0.0 112.089 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.529 ' H ' ' C ' ' A' ' 14' ' ' THR . 4.4 t -168.77 28.1 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.063 -1.055 . . . . 0.0 110.806 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -173.65 141.68 0.87 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.526 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.2 tp -130.62 146.49 52.13 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.789 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.33 106.64 9.16 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.184 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.423 ' O ' ' OG ' ' A' ' 21' ' ' SER . 2.2 pt -103.35 169.7 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.461 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 20' ' ' ILE . 8.2 m -164.04 134.03 4.11 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.457 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 14.3 p90 . . . . . 0 N--CA 1.49 1.536 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.682 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.955 0.407 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.14 -65.85 0.96 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.069 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -160.48 163.59 32.83 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.038 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -120.42 146.89 45.76 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.691 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -129.03 110.08 11.75 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.779 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.598 ' N ' ' CD1' ' A' ' 34' ' ' ILE . 2.7 mp -100.81 108.48 23.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.788 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 p -104.63 147.71 27.35 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.213 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -149.39 148.36 29.39 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 117.987 -1.485 . . . . 0.0 112.088 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.26 150.85 7.92 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -78.56 -174.54 3.89 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.767 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--N 1.304 -1.409 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.684 179.954 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 46' ' ' GLN . 21.3 t . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 119.99 -0.052 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.488 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 30.7 tt0 -168.72 166.98 11.5 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 117.482 -1.687 . . . . 0.0 112.606 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.488 ' N ' ' CG ' ' A' ' 46' ' ' GLN . 3.3 pt-20 -161.17 156.42 24.3 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.445 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 1.4 p90 -139.58 167.13 22.8 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.488 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.5 p -131.27 148.66 52.71 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.606 -0.837 . . . . 0.0 111.538 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.573 ' C ' ' H ' ' A' ' 52' ' ' GLY . 10.3 m -140.72 151.78 64.09 Favored Pre-proline 0 N--CA 1.486 1.349 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.861 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.16 14.35 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 120.898 1.065 . . . . 0.0 112.173 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 70.69 16.41 74.17 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.809 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.82 -40.34 20.5 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.915 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -84.16 121.44 27.46 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.623 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 m -83.03 -9.79 59.08 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.062 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.66 168.63 11.19 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.285 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.1 136.15 6.59 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.514 -1.275 . . . . 0.0 111.947 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -105.14 136.88 43.82 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.826 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -134.13 144.56 35.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.429 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.14 135.62 20.63 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.112 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.86 -37.44 0.24 Allowed Glycine 0 N--CA 1.486 1.981 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.387 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -163.32 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.75 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -176.91 -40.79 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.604 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 63' ' ' LYS . 8.7 Cg_endo -83.4 -169.34 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.579 1.519 . . . . 0.0 111.731 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.33 74.68 0.4 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 67' ' ' ASP . 8.9 p -119.4 170.81 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.077 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.498 ' N ' ' CG2' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -64.86 97.51 0.23 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.442 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -89.59 130.26 35.92 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.631 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.41 149.2 29.06 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.793 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.492 ' C ' ' HG1' ' A' ' 71' ' ' THR . 1.5 pp -140.6 161.09 24.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.629 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.492 ' HG1' ' C ' ' A' ' 70' ' ' ILE . 20.4 m -149.61 123.32 9.22 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.68 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.03 136.92 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.355 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.47 116.25 31.06 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.294 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.66 97.64 8.88 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.256 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.0 t -99.53 116.9 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.483 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.683 179.971 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo . . . . . 0 C--O 1.215 -0.627 0 N-CA-C 111.231 -0.334 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -155.81 156.04 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.992 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.39 156.52 46.37 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.684 -0.807 . . . . 0.0 110.942 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -145.49 152.06 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.979 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.98 146.92 34.43 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.77 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -158.66 145.86 17.63 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.682 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.465 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 1.5 ptt85 -83.85 98.79 9.93 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.254 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -171.97 161.17 5.63 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.357 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.9 t -89.06 115.34 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.32 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.461 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 2.7 t -69.43 -26.58 31.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.565 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 11' ' ' VAL . . . 167.59 178.51 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.96 119.74 12.56 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.626 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.9 162.49 22.06 Favored Pre-proline 0 C--N 1.3 -1.584 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.708 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 16' ' ' THR . 4.5 Cg_exo -53.95 94.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 120.733 0.955 . . . . 0.0 110.673 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.489 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER 81.06 41.66 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.881 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.32 137.51 1.89 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.685 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.64 148.6 43.16 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 tt -129.66 105.53 8.11 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.006 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.45 168.3 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.449 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -161.82 132.21 4.93 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.591 -1.244 . . . . 0.0 111.584 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.8 p90 . . . . . 0 N--CA 1.482 1.127 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.556 179.882 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.77 0.319 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.03 -76.59 0.1 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.393 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -147.13 168.17 22.3 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.148 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -120.83 160.32 23.64 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.285 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -127.33 146.15 50.55 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.466 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.4 mt -137.8 99.46 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.679 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.28 137.61 43.92 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.108 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -145.28 148.03 33.01 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.242 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.58 140.75 6.66 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.58 143.42 48.25 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.09 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.305 -1.363 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.725 -179.98 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.457 0.17 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 3.8 pt20 -173.25 -152.71 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.019 -1.073 . . . . 0.0 111.404 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.484 ' N ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -159.19 173.4 16.42 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.163 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -165.08 148.24 8.34 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.517 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.21 167.22 10.73 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.339 -0.944 . . . . 0.0 112.682 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -147.21 158.18 44.74 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.667 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.16 6.26 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 121.175 1.25 . . . . 0.0 112.172 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 70.52 -1.14 22.56 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.338 -1.411 . . . . 0.0 110.275 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.39 -37.09 57.67 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.884 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -80.63 116.32 20.6 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.575 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.9 m -82.31 -2.07 51.58 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.111 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.2 p -133.09 157.56 44.97 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.513 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.03 140.67 13.36 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.579 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m -103.77 139.64 38.72 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.274 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 tt -135.42 149.2 28.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.843 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -141.48 -154.68 0.53 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.397 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.91 46.25 94.93 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.276 -1.44 . . . . 0.0 110.629 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.42 ' CD1' ' C ' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -130.45 -172.94 2.93 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.04 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -118.05 130.03 24.99 Favored Pre-proline 0 N--CA 1.49 1.526 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.967 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.62 140.51 87.03 Favored 'Trans proline' 0 C--O 1.217 -0.546 0 C-N-CA 120.409 0.74 . . . . 0.0 111.353 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.57 83.76 0.05 OUTLIER Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.462 -1.352 . . . . 0.0 110.553 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.1 p -165.29 148.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.153 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.92 149.49 47.74 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.616 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.37 137.09 21.59 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.846 -1.142 . . . . 0.0 111.9 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.57 119.35 35.28 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.918 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.431 ' C ' ' HG1' ' A' ' 71' ' ' THR . 3.7 tt -118.38 152.66 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.064 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 70' ' ' ILE . 50.7 m -140.51 126.15 19.12 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.656 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.18 144.84 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.782 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -119.22 125.19 48.57 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.782 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.81 86.78 4.8 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.41 118.57 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 118.962 -1.095 . . . . 0.0 112.338 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.308 -1.204 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.906 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 C--O 1.215 -0.626 0 N-CA-C 111.363 -0.283 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.406 ' O ' ' CG2' ' A' ' 88' ' ' ILE . 13.1 tt -146.49 132.13 12.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.236 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.7 p -130.79 152.33 50.25 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.494 -0.882 . . . . 0.0 112.19 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.91 146.4 18.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.187 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -92.24 151.19 20.46 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.832 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -155.04 136.85 14.46 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.649 -1.22 . . . . 0.0 111.699 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.09 110.69 22.9 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.85 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 116.338 -1.792 . . . . 0.0 110.769 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 120.344 0.116 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.521 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 12.3 mp0 -135.38 163.88 29.02 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.776 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.9 t -89.48 116.5 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.697 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.462 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 1.9 t -82.51 -6.97 10.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.649 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 11' ' ' VAL . . . 169.23 166.3 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.526 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.38 144.77 24.81 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.164 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.72 ' HG1' ' HG ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -138.38 160.16 64.93 Favored Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.528 -179.941 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.413 ' C ' ' OG1' ' A' ' 16' ' ' THR . 5.4 Cg_exo -48.36 -8.88 0.07 OUTLIER 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.404 1.403 . . . . 0.0 112.306 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.494 ' H ' ' C ' ' A' ' 14' ' ' THR . 0.2 OUTLIER -164.29 41.7 0.09 Allowed 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.007 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.72 ' HG ' ' HG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -175.09 136.04 0.37 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.229 -179.966 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 tp -130.5 125.63 34.83 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.071 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tt -106.53 126.63 52.5 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.716 -0.793 . . . . 0.0 110.365 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.427 ' C ' ' HG ' ' A' ' 21' ' ' SER . 9.5 pt -126.76 164.58 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.966 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.454 ' HG ' ' CG2' ' A' ' 11' ' ' VAL . 5.2 m -161.62 146.66 13.37 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.542 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 . . . . . 0 N--CA 1.483 1.194 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.975 179.966 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.325 0.583 . . . . 0.0 112.152 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 19.8 mtp180 -108.92 -53.12 2.68 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.095 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 30' ' ' ARG . 44.3 m-85 -160.28 157.96 29.01 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.221 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.46 111.64 20.28 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.52 -1.218 . . . . 0.0 107.954 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.9 mtt-85 -100.12 145.06 28.42 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.2 mp -141.21 110.4 2.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.601 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 p -121.73 151.4 40.56 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.036 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 15.2 p90 -144.13 155.34 43.89 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 118.584 -1.246 . . . . 0.0 111.67 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.48 147.19 5.58 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.795 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -62.17 166.7 4.58 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.444 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--N 1.307 -1.252 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.81 179.984 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.5 t . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.867 0.365 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -164.01 167.95 19.83 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.594 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -148.0 146.87 29.09 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.186 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 10.6 p90 -154.23 134.89 13.57 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 118.72 -1.192 . . . . 0.0 111.276 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 t -100.49 147.52 25.8 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.496 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.81 150.83 61.13 Favored Pre-proline 0 C--N 1.301 -1.527 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.252 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.589 ' C ' ' H ' ' A' ' 53' ' ' SER . 6.2 Cg_exo -52.77 125.17 17.23 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 120.499 0.8 . . . . 0.0 110.882 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.66 17.6 0.07 OUTLIER Glycine 0 N--CA 1.487 2.09 0 C-N-CA 119.61 -1.281 . . . . 0.0 111.726 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.589 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -73.18 -41.54 63.73 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 118.859 -1.136 . . . . 0.0 110.184 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -87.71 -172.5 3.9 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.341 -0.943 . . . . 0.0 110.63 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.37 14.06 2.38 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.441 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.0 p -126.82 174.4 8.81 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.615 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.18 122.52 0.67 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.443 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.25 146.54 24.27 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.698 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mt -136.78 147.11 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.995 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.5 t -150.57 153.97 36.72 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.419 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 62' ' ' LEU . . . 123.07 -9.27 9.0 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 61' ' ' GLY . 2.1 mt -49.79 -178.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.785 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.574 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -176.39 -43.24 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 119.416 -0.914 . . . . 0.0 112.36 179.948 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 63' ' ' LYS . 4.2 Cg_endo -79.46 -168.17 0.6 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.657 1.571 . . . . 0.0 111.776 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -154.66 87.47 0.13 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.744 -1.743 . . . . 0.0 108.744 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.618 ' CG2' ' H ' ' A' ' 67' ' ' ASP . 11.5 p -156.54 -177.2 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 118.944 -1.103 . . . . 0.0 111.715 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.618 ' H ' ' CG2' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -57.75 98.65 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.634 179.982 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -94.11 132.03 39.04 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.278 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 m -112.85 127.57 56.22 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.747 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 pp -113.86 151.2 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.203 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.3 m -143.32 120.85 11.73 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.016 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.43 141.21 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.768 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 97.15 6.52 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.343 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.29 92.2 2.74 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.533 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.54 115.67 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.696 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.489 1.5 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.43 179.926 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo . . . . . 0 C--O 1.215 -0.671 0 N-CA-C 111.286 -0.313 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.0 156.5 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.4 p -145.27 159.89 42.33 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.235 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -148.76 149.71 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.6 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.38 154.55 18.7 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.542 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -175.55 135.07 0.31 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.737 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -61.65 96.42 0.06 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.295 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 116.502 -1.713 . . . . 0.0 110.583 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 120.768 0.318 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -159.73 140.84 12.55 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.869 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.83 109.64 13.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.391 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.1 t -70.17 -64.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.221 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.59 166.62 30.64 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.861 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.32 127.39 45.48 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.424 ' OG1' ' OG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -103.26 161.85 21.82 Favored Pre-proline 0 C--N 1.308 -1.206 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.299 -180.0 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.479 ' O ' ' OG1' ' A' ' 16' ' ' THR . 4.9 Cg_exo -49.28 99.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 120.547 0.831 . . . . 0.0 110.614 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 15' ' ' PRO . 1.7 p 69.14 44.59 0.97 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.52 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.424 ' OG ' ' OG1' ' A' ' 14' ' ' THR . 0.3 OUTLIER -165.33 146.92 7.52 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.274 179.937 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mt -128.31 142.94 50.99 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.759 -0.777 . . . . 0.0 111.497 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.0 tt -115.91 102.23 9.48 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.831 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.57 146.58 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.72 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -139.77 132.3 28.7 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.227 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 12.6 p90 . . . . . 0 N--CA 1.496 1.867 0 C-N-CA 118.796 -1.162 . . . . 0.0 112.447 -179.788 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.773 0.32 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.523 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -87.81 -61.47 1.71 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.483 -179.984 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 46.3 m-85 -147.45 168.0 23.0 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.167 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.28 137.47 42.53 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.256 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.09 128.9 23.24 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 118.236 -1.386 . . . . 0.0 111.274 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.2 mt -111.54 135.17 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.891 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 p -128.05 135.07 49.35 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.463 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.499 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 6.7 p90 -135.91 160.6 38.08 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.653 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . 165.65 139.87 2.75 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -57.35 -161.01 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.48 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.428 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.7 t . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 121.117 0.484 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.584 ' NE2' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -175.22 -175.5 0.84 Allowed 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.13 -179.883 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.584 ' H ' ' NE2' ' A' ' 46' ' ' GLN . 6.5 pt-20 -157.6 167.79 29.12 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.222 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -159.47 147.53 17.46 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.237 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.5 p -97.66 124.64 42.05 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.399 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.64 151.29 49.68 Favored Pre-proline 0 N--CA 1.49 1.574 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.292 179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.548 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.2 Cg_endo -61.66 126.42 19.0 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 120.678 0.918 . . . . 0.0 110.517 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.46 -9.25 0.08 OUTLIER Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.98 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.548 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -71.3 -43.18 67.62 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.496 179.983 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 mmtm -67.77 132.72 47.96 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.301 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -103.07 -5.29 23.48 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.465 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.6 p -134.8 172.93 12.28 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.46 151.84 4.6 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.102 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.5 m -121.38 117.56 27.23 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.701 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.12 157.96 9.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.929 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -145.61 178.2 8.31 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.146 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.98 53.39 2.86 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.239 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.57 -156.4 0.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.809 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -140.28 148.83 55.72 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.43 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -68.21 123.13 10.24 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 121.052 1.168 . . . . 0.0 112.439 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.22 91.75 0.04 OUTLIER Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.787 -1.197 . . . . 0.0 111.777 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.2 p -167.48 144.96 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.211 -0.996 . . . . 0.0 110.864 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.29 153.76 6.74 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.16 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.79 134.48 18.81 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.238 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.1 m -125.61 120.92 32.11 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.623 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 pp -115.63 163.12 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.92 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.443 ' OG1' ' OG ' ' A' ' 89' ' ' SER . 17.1 m -152.54 127.73 9.8 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.361 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 m -121.91 136.86 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.274 -0.971 . . . . 0.0 111.796 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -115.34 126.63 54.67 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.389 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.08 98.14 7.82 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.583 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.6 t -86.36 117.54 31.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.644 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.28 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.732 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo . . . . . 0 C--O 1.215 -0.663 0 N-CA-C 110.264 -0.706 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.517 ' C ' ' HG ' ' A' ' 89' ' ' SER . 5.9 tt -153.57 160.12 3.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 117.961 -1.496 . . . . 0.0 112.304 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.517 ' HG ' ' C ' ' A' ' 88' ' ' ILE . 16.3 m -145.55 149.43 34.58 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.222 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 pt -147.03 154.9 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 118.956 -1.098 . . . . 0.0 111.387 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 92' ' ' TYR . 16.9 t-20 -89.77 164.15 14.78 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.554 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.447 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 22.6 t80 -172.32 129.67 0.58 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.209 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.481 ' CD ' ' N ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -90.39 111.06 22.15 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.082 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 116.295 -1.812 . . . . 0.0 110.666 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 120.446 0.165 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -174.14 159.16 3.17 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.89 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.1 t -91.98 135.51 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.516 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.77 -59.19 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 118.677 -1.209 . . . . 0.0 111.81 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.39 169.25 21.28 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.568 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.96 80.92 1.7 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.938 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.549 ' HG1' ' CB ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -66.92 161.18 64.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.24 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -54.36 -10.12 2.01 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.362 1.375 . . . . 0.0 111.757 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.413 ' H ' ' C ' ' A' ' 14' ' ' THR . 9.5 m -159.07 44.61 0.26 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.504 -0.879 . . . . 0.0 110.476 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.549 ' CB ' ' HG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -175.86 114.82 0.13 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.555 180.0 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.5 tp -109.81 112.15 24.03 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.336 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.22 122.48 31.08 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.297 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.71 148.23 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.73 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.45 136.41 46.7 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.954 179.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 45.7 p90 . . . . . 0 N--CA 1.507 2.378 0 C-N-CA 118.334 -1.346 . . . . 0.0 113.221 -179.893 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.1 t . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.818 0.342 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -65.34 -47.3 76.94 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.031 -1.068 . . . . 0.0 109.931 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -159.06 168.55 26.39 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.324 179.92 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -113.87 165.91 12.11 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.457 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -141.64 100.19 3.71 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.849 -0.741 . . . . 0.0 109.356 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.12 131.46 45.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.469 -0.892 . . . . 0.0 112.342 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.2 p -127.08 136.73 52.56 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.383 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 2.3 p90 -142.46 159.66 41.79 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 118.556 -1.258 . . . . 0.0 111.682 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.58 150.06 5.88 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -70.26 156.97 38.52 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.491 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.0 m . . . . . 0 C--N 1.302 -1.499 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.539 -179.933 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 121.141 0.496 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -174.68 -166.11 0.23 Allowed 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.827 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -162.07 174.49 12.93 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.004 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.582 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -170.59 153.7 4.28 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.997 179.677 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 p -113.01 157.33 21.66 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.475 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.581 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -145.44 159.88 46.9 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.493 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -64.81 22.65 0.07 OUTLIER 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 121.372 1.381 . . . . 0.0 112.179 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 48.33 20.71 1.61 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.148 -1.501 . . . . 0.0 110.394 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -45.98 16.8 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.663 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -90.55 130.4 36.59 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.274 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.4 m -81.32 -4.47 55.73 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.622 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -133.74 162.35 32.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.188 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.92 171.77 13.83 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.589 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.6 m -144.44 117.06 8.64 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.633 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.2 mt -111.39 150.02 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.559 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.3 m -136.92 -8.13 1.83 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.788 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.41 52.17 1.81 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.419 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.29 -172.97 2.92 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.998 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.532 ' H ' ' HH ' ' A' ' 68' ' ' TYR . 22.5 mmtt -131.91 102.15 14.93 Favored Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.911 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.29 144.22 61.5 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 120.657 0.905 . . . . 0.0 111.321 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.37 38.62 1.76 Allowed Glycine 0 N--CA 1.498 2.793 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.672 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' A' ' 67' ' ' ASP . 5.3 p -169.05 165.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.631 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.49 ' N ' ' CG2' ' A' ' 66' ' ' VAL . 4.4 t70 -60.31 145.89 46.01 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.675 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.532 ' HH ' ' H ' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -145.32 119.06 9.2 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.422 -179.904 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -105.59 136.77 44.58 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.565 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.443 ' CG1' ' N ' ' A' ' 71' ' ' THR . 2.1 tt -134.36 156.54 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.876 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.616 ' HG1' ' CB ' ' A' ' 89' ' ' SER . 48.9 m -147.99 138.1 22.72 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.585 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -114.28 129.87 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.407 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -111.23 114.86 28.38 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.639 -179.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.07 96.52 9.7 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.172 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.34 146.24 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.161 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.141 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo . . . . . 0 C--O 1.216 -0.602 0 N-CA-C 110.351 -0.673 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.3 tt -144.19 138.43 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 118.66 -1.216 . . . . 0.0 110.61 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.616 ' CB ' ' HG1' ' A' ' 71' ' ' THR . 89.4 p -119.42 122.36 41.57 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.597 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.646 ' CD1' ' H ' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -120.5 145.09 27.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.681 -179.971 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -97.45 153.4 18.14 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.861 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.451 ' O ' ' O ' ' A' ' 68' ' ' TYR . 24.5 t80 -165.18 135.43 3.74 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 119.234 -0.986 . . . . 0.0 111.026 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.33 127.35 43.21 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.91 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 116.339 -1.791 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -164.75 161.65 20.69 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 117.206 -1.798 . . . . 0.0 113.78 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.9 t -103.53 135.36 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-N 114.238 -1.346 . . . . 0.0 108.502 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.49 -10.08 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.762 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 175.22 170.0 0.3 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.413 -1.315 . . . . 0.0 111.886 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.59 134.31 16.6 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.656 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -126.45 162.01 49.12 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.73 179.986 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -52.04 -12.88 1.55 Allowed 'Trans proline' 0 C--O 1.213 -0.745 0 C-N-CA 121.135 1.223 . . . . 0.0 111.865 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.14 48.99 0.39 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.03 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER 173.06 139.1 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.983 -179.998 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 tp -130.65 132.33 45.38 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.493 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.477 ' CD1' ' HG1' ' A' ' 58' ' ' THR . 2.2 tp -93.56 126.67 38.84 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.034 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 pp -128.17 156.14 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.166 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.91 145.11 29.7 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.936 -1.105 . . . . 0.0 111.61 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 7.3 p90 . . . . . 0 C--N 1.308 -1.236 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.153 179.761 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.627 0.251 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -93.4 -57.57 2.56 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.975 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -165.03 166.73 19.04 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.826 -1.149 . . . . 0.0 112.028 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.481 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 2.1 m-85 -120.0 156.0 31.74 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.439 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -135.19 104.6 5.96 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.864 179.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -96.28 122.03 47.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.682 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -120.18 141.38 49.94 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.638 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -139.16 144.38 38.56 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.898 -1.121 . . . . 0.0 111.28 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.42 153.26 18.66 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -74.31 166.83 22.8 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.006 -179.944 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.9 m . . . . . 0 C--N 1.306 -1.283 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.915 179.996 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.417 ' CG2' ' OE2' ' A' ' 38' ' ' GLU . 61.4 t . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.008 -0.044 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.48 174.1 8.17 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 117.061 -1.856 . . . . 0.0 113.02 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -169.06 167.18 10.72 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.226 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -164.11 160.55 21.63 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.94 161.53 20.73 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.643 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.581 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -148.66 159.41 38.37 Favored Pre-proline 0 C--N 1.309 -1.187 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.129 179.977 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -64.99 22.25 0.08 OUTLIER 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.002 1.135 . . . . 0.0 112.107 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 49.3 17.65 1.17 Allowed Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.776 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.56 -43.33 14.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -79.09 123.33 27.24 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.951 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.7 m -81.2 -12.68 59.1 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.446 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.0 p -138.62 148.56 44.25 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.173 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.95 165.03 30.65 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.921 -1.111 . . . . 0.0 111.435 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.477 ' HG1' ' CD1' ' A' ' 19' ' ' LEU . 27.7 m -104.17 130.23 51.91 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.167 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -112.21 123.29 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.719 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 51.6 m -129.81 157.48 42.09 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.307 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.78 -20.44 1.81 Allowed Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.576 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.452 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -79.35 -172.03 3.01 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.016 179.956 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.582 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -157.3 -43.73 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.487 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.487 179.967 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.582 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 10.3 Cg_endo -89.19 -167.65 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.517 1.478 . . . . 0.0 111.658 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -132.53 81.18 0.32 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 107.483 -2.247 . . . . 0.0 107.483 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.529 ' CG2' ' N ' ' A' ' 67' ' ' ASP . 7.5 p -133.61 175.33 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.055 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.529 ' N ' ' CG2' ' A' ' 66' ' ' VAL . 4.3 t70 -50.8 120.55 4.89 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.135 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.02 129.11 46.19 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.173 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.0 126.48 52.38 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.06 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 pp -112.23 152.66 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.847 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.411 ' OG1' ' OG ' ' A' ' 89' ' ' SER . 52.9 m -145.49 143.95 30.29 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.955 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.2 m -125.19 139.34 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.635 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -117.49 100.45 7.66 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.794 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.481 ' CB ' ' CZ ' ' A' ' 32' ' ' TYR . . . -79.44 83.35 5.46 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.86 140.03 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 118.997 -1.081 . . . . 0.0 113.544 -179.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 p . . . . . 0 C--N 1.308 -1.217 0 CA-C-N 114.134 -1.393 . . . . 0.0 108.128 179.772 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 C--O 1.215 -0.649 0 CA-C-O 121.283 0.451 . . . . 0.0 112.752 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.8 tt -149.3 137.03 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.373 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.411 ' OG ' ' OG1' ' A' ' 71' ' ' THR . 4.2 m -128.2 134.63 49.06 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.902 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.7 136.01 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.104 179.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.18 145.18 26.29 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.867 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.455 ' CG ' ' N ' ' A' ' 93' ' ' ARG . 24.3 t80 -167.28 158.2 11.65 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.984 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.455 ' N ' ' CG ' ' A' ' 92' ' ' TYR . 7.2 mtm-85 -93.34 113.55 25.76 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.975 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 116.581 -1.676 . . . . 0.0 110.436 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 9.5 mp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.46 0.171 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -171.32 166.07 7.09 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.587 -1.245 . . . . 0.0 111.933 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.6 t -92.62 143.48 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.848 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.6 p -128.92 -2.93 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.48 -179.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -179.81 147.54 0.29 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.491 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -176.57 112.17 0.1 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.631 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.64 ' O ' ' N ' ' A' ' 16' ' ' THR . 0.2 OUTLIER -148.51 -75.62 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 117.921 -1.512 . . . . 0.0 113.049 179.968 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 17' ' ' SER . 6.8 Cg_endo -53.21 78.37 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.779 0 CA-C-N 119.491 0.854 . . . . 0.0 110.863 -179.571 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 14' ' ' THR . 3.0 m 35.51 32.49 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.074 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 15' ' ' PRO . 1.6 m -139.79 148.95 42.94 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.941 -1.103 . . . . 0.0 112.447 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.6 tp -113.09 142.04 46.19 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.575 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 tp -117.2 107.29 14.26 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.047 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 pt -106.24 157.95 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.361 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.98 138.3 18.46 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.824 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 9.3 p90 . . . . . 0 C--N 1.316 -0.873 0 C-N-CA 118.816 -1.154 . . . . 0.0 111.346 179.881 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.0 t . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 120.895 0.379 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.1 mmm-85 -54.61 -42.88 71.67 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.23 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -179.58 165.71 1.36 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.443 -1.303 . . . . 0.0 112.234 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -115.73 163.08 16.35 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.14 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.475 HH21 ' CG2' ' A' ' 49' ' ' THR . 21.2 ttm180 -146.56 106.16 3.95 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.39 -1.324 . . . . 0.0 111.038 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.583 ' N ' ' CD1' ' A' ' 34' ' ' ILE . 1.9 mp -99.9 122.02 51.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.329 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 p -119.59 139.08 52.73 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.699 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 6.4 p90 -136.51 155.35 50.09 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.14 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.57 143.36 6.11 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.464 ' CD ' ' N ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -71.54 176.62 4.6 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.636 -0.825 . . . . 0.0 110.808 179.931 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.487 1.386 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.017 179.952 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.694 0.283 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -172.11 -163.49 0.25 Allowed 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 118.476 -1.289 . . . . 0.0 111.966 -179.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.71 168.77 21.07 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.771 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -159.84 139.27 11.17 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.548 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.475 ' CG2' HH21 ' A' ' 33' ' ' ARG . 23.3 p -105.07 164.74 11.58 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.644 -0.822 . . . . 0.0 112.393 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.583 ' C ' ' H ' ' A' ' 52' ' ' GLY . 26.9 m -148.06 152.58 40.25 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.42 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -55.63 6.52 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 120.942 1.095 . . . . 0.0 112.612 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 80.86 -4.05 72.24 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.978 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.67 -27.19 45.16 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.079 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -80.45 108.74 14.33 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.01 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -81.31 -19.64 42.49 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.394 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.8 p -135.17 150.08 50.07 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.8 168.36 26.58 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.997 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -117.11 158.31 24.43 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.398 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.6 mt -143.03 155.06 17.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.396 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.415 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -139.52 135.64 33.67 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.875 -179.999 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.4 44.37 0.18 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -107.16 175.66 5.42 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.573 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.58 141.39 28.82 Favored Pre-proline 0 CA--C 1.555 1.137 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.02 100.29 0.08 OUTLIER 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 120.748 0.965 . . . . 0.0 112.505 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.43 95.22 0.05 OUTLIER Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.59 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 p -160.59 159.04 2.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 119.136 -1.025 . . . . 0.0 111.328 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.3 146.41 45.34 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.264 -0.974 . . . . 0.0 108.874 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.9 145.2 31.47 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.458 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 m -125.29 126.06 44.51 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.407 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.3 tt -111.46 150.15 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.164 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.13 124.9 19.63 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.815 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.01 130.27 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.594 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.09 105.35 13.1 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.625 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.37 129.69 39.41 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.353 -0.939 . . . . 0.0 109.246 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 t -135.57 130.62 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 119.115 -1.034 . . . . 0.0 112.25 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 53.6 m . . . . . 0 N--CA 1.482 1.14 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.583 179.911 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 C--O 1.217 -0.568 0 N-CA-C 111.392 -0.272 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.1 tt -149.76 128.55 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 118.934 -1.106 . . . . 0.0 109.753 179.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 99.6 p -121.04 152.04 39.08 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.769 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.77 142.57 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.339 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.92 154.65 18.07 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.598 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -164.48 131.69 3.18 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.121 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -89.69 117.26 28.42 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.172 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 116.299 -1.81 . . . . 0.0 110.597 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -161.75 171.3 18.08 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 117.942 -1.503 . . . . 0.0 112.813 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.41 129.85 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.08 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.9 t -95.59 -25.13 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.244 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.76 172.63 9.02 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.93 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.31 100.24 2.13 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.088 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.464 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -70.52 162.26 71.67 Favored Pre-proline 0 C--N 1.307 -1.271 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.563 179.858 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -53.94 -7.52 0.67 Allowed 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 121.008 1.139 . . . . 0.0 111.712 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.464 ' H ' ' C ' ' A' ' 14' ' ' THR . 7.2 m -160.29 35.99 0.17 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.412 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -167.55 120.31 0.92 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.207 179.89 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 tp -96.81 123.81 40.61 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.724 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.48 114.59 28.79 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.688 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.5 169.45 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.733 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.65 139.51 12.87 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.7 -179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 12.7 p90 . . . . . 0 N--CA 1.481 1.122 0 C-N-CA 119.649 -0.821 . . . . 0.0 110.321 179.846 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.478 0.963 0 CA-C-O 120.888 0.375 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -66.33 -57.81 6.67 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.631 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -165.45 169.02 16.07 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.539 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -122.65 148.7 44.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.902 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -126.73 108.66 11.27 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.536 -0.865 . . . . 0.0 109.531 179.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.03 128.71 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.875 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 p -128.64 139.72 52.12 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.149 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -141.95 166.7 23.99 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.725 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.02 158.68 10.25 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -51.79 158.74 0.93 Allowed 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.603 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.404 ' OG1' ' OG1' ' A' ' 69' ' ' THR . 17.8 m . . . . . 0 C--N 1.304 -1.395 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.052 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.309 0.576 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.417 ' HG2' ' H ' ' A' ' 47' ' ' GLU . 2.9 tt0 -172.78 179.8 2.28 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.339 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -164.49 158.45 18.3 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.844 -179.968 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -159.25 157.55 30.86 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.606 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -119.73 168.41 11.09 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.112 -179.868 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.566 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -147.66 158.89 42.4 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.681 179.971 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.49 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.9 Cg_endo -61.7 15.42 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.0 1.133 . . . . 0.0 112.72 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 54.19 7.98 0.98 Allowed Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.111 -1.518 . . . . 0.0 110.533 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -70.07 -34.74 73.57 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.291 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -119.33 121.68 40.12 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.837 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 m -79.66 46.63 0.78 Allowed 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.979 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.12 151.34 43.85 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.378 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.13 159.21 40.02 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.735 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.07 148.95 52.19 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.699 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.2 mt -138.21 146.89 26.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.587 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.7 m -139.43 155.42 47.62 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.231 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.46 8.71 55.99 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.928 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.23 -156.05 0.16 Allowed 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.855 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.67 103.62 0.94 Allowed Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 119.649 -0.821 . . . . 0.0 110.617 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.94 158.71 32.51 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 120.375 0.717 . . . . 0.0 111.639 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.63 35.91 5.0 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.186 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -165.22 154.68 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.943 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -72.3 113.76 9.67 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.412 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.0 148.23 30.0 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.879 -0.729 . . . . 0.0 111.247 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.404 ' OG1' ' OG1' ' A' ' 39' ' ' THR . 9.2 m -122.93 140.21 53.24 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.708 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 tt -130.84 148.63 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.394 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 65.4 m -140.5 126.03 19.01 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.249 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.3 m -117.81 129.71 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.141 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -107.59 106.86 17.41 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.617 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.52 107.85 14.62 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.182 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.39 113.7 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.526 -0.87 . . . . 0.0 111.23 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.49 1.529 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.578 179.983 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.457 -0.673 0 N-CA-C 110.429 -0.643 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.1 tp -150.12 161.31 4.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 118.493 -1.283 . . . . 0.0 111.224 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.8 p -143.73 148.95 36.42 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.595 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.87 146.23 18.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.21 160.07 17.14 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.417 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -171.95 140.45 1.24 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.994 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -87.24 112.52 22.1 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.394 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.04 0 CA-C-O 116.337 -1.792 . . . . 0.0 110.827 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 10' ' ' VAL . 1.8 tm-20 -167.63 166.72 13.84 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 117.844 -1.542 . . . . 0.0 112.897 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.475 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 97.6 t -99.62 108.55 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.618 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.3 t -70.49 -42.88 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 119.141 -1.023 . . . . 0.0 111.918 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.27 173.48 16.62 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.757 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.59 142.45 21.11 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.697 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 17' ' ' SER . 1.1 p -140.63 155.58 69.48 Favored Pre-proline 0 N--CA 1.489 1.524 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.769 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.83 -7.92 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 121.389 1.393 . . . . 0.0 112.279 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.424 ' H ' ' C ' ' A' ' 14' ' ' THR . 68.9 p -147.09 27.54 1.05 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.739 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.429 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -177.53 147.84 0.54 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.728 -179.992 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.35 134.36 47.11 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.443 179.857 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.0 tp -115.65 103.1 10.37 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.508 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.35 165.61 2.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.257 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 m -156.06 136.53 13.18 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.258 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 16.0 p90 . . . . . 0 N--CA 1.487 1.391 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.796 179.915 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.734 0.302 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -85.05 -55.4 4.07 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.486 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -157.95 163.99 37.29 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.629 -1.229 . . . . 0.0 111.924 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -119.46 160.46 22.31 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.739 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.38 98.03 3.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.808 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.554 ' N ' ' CD1' ' A' ' 34' ' ' ILE . 1.7 mp -89.58 134.01 30.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.627 -0.829 . . . . 0.0 112.247 -179.781 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -135.79 134.5 39.01 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.771 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -141.92 155.56 45.49 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.547 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.1 152.28 8.13 Favored Glycine 0 N--CA 1.479 1.558 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.697 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -48.81 175.02 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.342 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.9 m . . . . . 0 C--N 1.306 -1.325 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.906 -179.999 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.1 t . . . . . 0 N--CA 1.477 0.911 0 CA-C-O 121.231 0.539 . . . . 0.0 110.263 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.99 -169.91 0.7 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.874 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -158.1 166.97 31.14 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.95 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 13.6 p90 -162.5 153.3 17.24 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.424 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.87 160.45 16.76 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.187 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.604 ' C ' ' H ' ' A' ' 52' ' ' GLY . 22.8 m -148.66 153.08 39.06 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.265 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.504 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.3 Cg_endo -60.01 16.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 120.872 1.048 . . . . 0.0 112.758 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 53.33 6.87 0.47 Allowed Glycine 0 N--CA 1.498 2.784 0 C-N-CA 119.578 -1.296 . . . . 0.0 111.093 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -74.98 -44.41 48.39 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.503 -179.977 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.55 116.25 31.25 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.467 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.7 m -84.6 53.74 2.78 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.042 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.1 143.68 22.66 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.97 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.96 148.24 30.55 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.804 -1.159 . . . . 0.0 111.842 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.1 m -121.91 104.13 9.33 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.926 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.2 pt -109.12 136.36 45.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.209 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.8 m -118.24 -176.68 3.11 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.721 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.83 40.05 9.86 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.514 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.73 -158.35 0.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.971 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -148.58 134.93 10.02 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.209 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -56.74 107.25 0.26 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 120.489 0.793 . . . . 0.0 112.072 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.57 87.71 0.52 Allowed Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.565 -1.302 . . . . 0.0 111.286 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.6 p -161.28 135.27 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.037 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.6 120.93 8.58 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.92 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.5 118.56 26.89 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.972 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.6 m -103.73 114.74 29.22 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.08 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.9 tt -103.64 150.56 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 119.287 -0.965 . . . . 0.0 112.06 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.587 ' CG2' ' HG ' ' A' ' 89' ' ' SER . 85.5 m -139.75 116.51 10.87 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.002 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.6 m -103.22 144.17 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.768 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -112.2 128.97 56.39 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.319 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.97 86.76 2.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.728 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.01 129.81 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 119.164 -1.015 . . . . 0.0 113.113 -179.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.307 -1.266 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.859 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 C--O 1.214 -0.697 0 N-CA-C 111.413 -0.264 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 tt -149.49 147.38 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.601 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.587 ' HG ' ' CG2' ' A' ' 71' ' ' THR . 0.8 OUTLIER -135.17 155.23 51.04 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.681 -179.858 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.76 142.97 24.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.014 179.875 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.44 142.77 31.65 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.061 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -158.99 108.99 1.97 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.185 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.409 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 5.5 ptt-85 -79.04 116.81 19.57 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.887 -1.125 . . . . 0.0 109.114 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 116.367 -1.778 . . . . 0.0 110.972 -179.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -167.03 167.44 14.6 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.591 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.67 145.71 7.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.986 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.413 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -117.75 0.13 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.603 -179.853 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 11' ' ' VAL . . . 171.97 161.19 0.1 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.7 -1.2 . . . . 0.0 111.904 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.74 126.75 5.14 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.831 179.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.57 161.68 61.62 Favored Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.011 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 16' ' ' THR . 5.1 Cg_exo -49.79 104.79 0.08 OUTLIER 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 121.042 1.161 . . . . 0.0 112.051 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.463 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER 75.46 33.34 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.555 179.886 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 p -159.99 126.45 4.33 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.25 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.8 tp -130.42 140.07 50.58 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.77 -0.772 . . . . 0.0 111.347 -179.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.61 126.09 45.99 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.985 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 pt -133.66 162.15 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.286 -0.966 . . . . 0.0 112.932 -179.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -134.58 140.22 45.94 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.55 -1.205 . . . . 0.0 108.256 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 29.1 p90 . . . . . 0 N--CA 1.506 2.34 0 C-N-CA 118.712 -1.195 . . . . 0.0 113.506 -179.843 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.863 0.364 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -80.16 -41.65 24.92 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.141 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -143.09 175.06 10.14 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.79 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.12 140.5 30.88 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.746 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -123.28 107.95 12.24 Favored 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 119.118 -1.033 . . . . 0.0 109.98 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.7 mt -100.98 111.34 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.099 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 p -117.35 137.46 52.43 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.593 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -141.4 138.21 32.81 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.029 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.12 136.78 4.25 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -82.75 169.51 16.08 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.742 -179.966 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.436 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 54.9 m . . . . . 0 N--CA 1.487 1.418 0 C-N-CA 119.786 -0.766 . . . . 0.0 111.756 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 46' ' ' GLN . 4.2 t . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.417 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 1.1 mt-30 -163.3 171.93 15.42 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.509 -1.676 . . . . 0.0 112.556 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -170.6 143.28 2.17 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.127 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 4.6 p90 -147.34 141.55 26.17 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 p -98.98 156.94 16.66 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.769 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.52 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -150.07 157.88 37.19 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.321 179.942 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.41 13.61 0.09 OUTLIER 'Trans proline' 0 C--O 1.212 -0.785 0 C-N-CA 121.319 1.346 . . . . 0.0 112.234 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 57.66 27.81 59.27 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 118.886 -1.626 . . . . 0.0 109.901 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.21 -31.3 19.16 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -95.91 135.24 37.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.982 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.8 m -79.71 -15.61 57.2 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.109 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 p -139.08 -179.61 5.95 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.134 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.04 157.83 6.74 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.346 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.6 m -114.32 136.74 52.65 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.624 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.65 155.22 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.487 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 16' ' ' THR . 11.1 t -147.74 127.05 13.05 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.937 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.34 -34.15 0.38 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.672 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.48 -158.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.798 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.569 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 8.3 tttt -176.11 -43.43 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 119.334 -0.947 . . . . 0.0 112.586 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 63' ' ' LYS . 4.4 Cg_endo -78.86 -175.52 2.79 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 121.497 1.465 . . . . 0.0 112.096 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.2 80.07 0.29 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.623 ' CG2' ' H ' ' A' ' 67' ' ' ASP . 13.8 p -122.81 -174.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.241 -179.79 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.623 ' H ' ' CG2' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -65.49 95.13 0.2 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.084 179.92 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -90.88 127.95 36.56 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.109 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 m -94.05 117.92 30.78 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.94 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 tp -104.89 141.92 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.534 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.3 m -141.48 130.05 22.68 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.373 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.12 128.06 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.947 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -98.33 146.74 25.38 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.699 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.35 85.33 2.37 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.981 0.8 . . . . 0.0 109.485 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 t -81.4 128.25 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.319 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.489 1.494 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.635 -179.979 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 C--O 1.215 -0.637 0 N-CA-C 113.161 0.408 . . . . 0.0 113.161 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.1 tt -133.07 145.28 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.456 179.761 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.4 p -144.46 153.53 41.98 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.301 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.53 141.83 19.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.376 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.34 154.54 41.51 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.122 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -152.25 122.26 7.08 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.405 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.54 75.93 1.07 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.648 179.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.453 ' O ' ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 116.212 -1.851 . . . . 0.0 110.417 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.95 168.05 27.68 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 117.693 -1.603 . . . . 0.0 113.69 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.9 t -103.34 115.75 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.559 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.483 ' CG2' ' OG ' ' A' ' 21' ' ' SER . 2.3 t -72.52 -74.11 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.007 -1.077 . . . . 0.0 111.726 -179.823 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.81 179.0 6.84 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.73 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.14 100.73 3.6 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.314 -0.955 . . . . 0.0 111.499 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -65.16 164.44 23.08 Favored Pre-proline 0 C--N 1.305 -1.327 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.797 179.848 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.27 -12.52 3.97 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.213 1.275 . . . . 0.0 111.714 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 p -158.85 33.35 0.22 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.607 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.443 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.1 OUTLIER -161.45 137.96 8.33 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.124 179.989 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.6 tp -114.27 126.97 55.63 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.55 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.404 ' CD2' ' C ' ' A' ' 19' ' ' LEU . 2.8 tt -100.07 98.75 9.45 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.584 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 pp -96.61 148.8 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.394 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.483 ' OG ' ' CG2' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -145.82 134.43 22.16 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.352 -179.938 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 5.8 p90 . . . . . 0 C--N 1.308 -1.238 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.707 179.828 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.83 0.348 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.434 ' CG ' ' CE2' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -54.34 -55.67 26.17 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.149 179.955 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.434 ' CE2' ' CG ' ' A' ' 30' ' ' ARG . 2.1 p90 178.42 171.43 0.75 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.493 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -128.07 161.57 28.91 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.175 -179.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.74 104.68 4.76 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.373 179.763 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.37 120.21 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.796 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -120.35 137.09 54.47 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.663 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -142.2 157.75 44.51 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.585 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.91 170.58 42.92 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -61.4 -162.48 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.487 1.375 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.199 -179.91 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.0 t . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 120.742 0.306 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -175.17 -143.88 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.94 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -165.39 168.3 16.88 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 119.261 -0.975 . . . . 0.0 111.394 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 8.7 p90 -153.61 136.48 15.39 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.146 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.9 p -100.1 159.79 14.83 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.702 -179.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.59 ' C ' ' H ' ' A' ' 52' ' ' GLY . 34.1 m -147.9 150.53 36.08 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.666 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.95 5.75 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.725 0 C-N-CA 120.849 1.033 . . . . 0.0 112.383 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 81.72 7.49 88.01 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.324 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.44 -35.77 27.22 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.761 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -72.66 106.44 4.67 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.842 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.6 m -79.83 -18.32 51.12 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.859 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.2 p -132.67 158.82 41.35 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.273 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.11 149.25 19.24 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.549 -1.26 . . . . 0.0 111.569 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.404 ' CG2' ' HG ' ' A' ' 17' ' ' SER . 57.8 m -121.87 117.89 27.61 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.054 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 pt -108.27 149.47 11.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.406 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.9 175.76 8.1 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.522 -179.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.84 49.6 4.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.46 -168.58 1.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.614 0.721 . . . . 0.0 111.536 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -148.98 82.82 6.97 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.011 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -54.46 140.54 74.29 Favored 'Trans proline' 0 C--O 1.216 -0.578 0 C-N-CA 120.846 1.03 . . . . 0.0 111.815 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.8 31.4 2.73 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 p -162.17 169.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 119.361 -0.935 . . . . 0.0 111.255 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -82.45 126.48 32.26 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.999 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.2 133.36 56.09 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 120.144 -0.623 . . . . 0.0 110.7 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -103.46 138.4 40.23 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.444 ' CG1' ' N ' ' A' ' 71' ' ' THR . 6.1 tt -132.04 157.03 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.457 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.444 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 26.9 m -151.43 123.03 7.93 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.551 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.7 m -115.18 135.09 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -112.77 121.38 44.55 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.984 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.63 105.2 16.1 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.658 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.6 t -105.32 99.33 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.271 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.6 p . . . . . 0 N--CA 1.49 1.563 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.23 -179.995 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo . . . . . 0 C--O 1.215 -0.661 0 CA-C-O 120.769 0.237 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.2 tt -151.39 146.72 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.195 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.0 p -141.5 146.35 36.3 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.204 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pt -146.53 151.8 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.311 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.53 160.27 15.12 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.629 -0.829 . . . . 0.0 109.429 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -161.35 141.05 10.46 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.374 -1.33 . . . . 0.0 112.157 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -96.01 99.72 11.46 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.311 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 116.329 -1.796 . . . . 0.0 110.706 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 CA-C-O 120.759 0.314 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -173.44 168.29 4.57 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.881 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.1 t -96.05 117.29 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.711 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.8 t -71.49 -79.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 118.792 -1.163 . . . . 0.0 110.786 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.58 179.35 6.62 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.476 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.96 170.54 15.96 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.195 -1.002 . . . . 0.0 111.502 -179.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.635 ' HG1' ' CB ' ' A' ' 17' ' ' SER . 52.9 p -142.58 153.04 61.42 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.693 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -50.95 -5.33 0.08 OUTLIER 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 120.599 0.866 . . . . 0.0 111.98 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.544 ' H ' ' C ' ' A' ' 14' ' ' THR . 10.0 t -154.74 28.43 0.43 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.61 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.635 ' CB ' ' HG1' ' A' ' 14' ' ' THR . 0.4 OUTLIER -173.93 135.88 0.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.665 -1.214 . . . . 0.0 111.985 179.905 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 31.9 tp -112.71 146.52 38.58 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.046 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 tp -121.23 104.45 9.75 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.999 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pt -97.81 150.56 4.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.929 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 m -145.53 138.12 25.87 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 118.989 -1.085 . . . . 0.0 111.255 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 10.7 p90 . . . . . 0 C--N 1.31 -1.112 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.585 179.904 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 121.01 0.433 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -53.64 -52.34 60.23 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.729 -1.188 . . . . 0.0 108.754 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -171.78 162.89 6.32 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.294 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -109.35 171.69 7.29 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.515 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.57 108.84 6.84 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.198 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.8 mp -98.93 113.29 33.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.749 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.421 ' OG1' ' OG1' ' A' ' 71' ' ' THR . 17.6 p -117.51 135.82 53.66 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.282 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 5.6 p90 -141.17 157.61 45.02 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.138 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . -171.82 148.41 10.9 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 39' ' ' THR . 6.3 pt-20 -56.17 -163.5 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.964 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 38' ' ' GLU . 3.4 t . . . . . 0 C--N 1.303 -1.437 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.321 -179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 121.252 0.548 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -171.05 -166.91 0.5 Allowed 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.402 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -169.49 159.47 8.52 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.734 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -160.22 143.38 13.67 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.166 -1.013 . . . . 0.0 110.512 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.1 p -106.73 162.28 13.92 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.584 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -142.02 159.22 59.85 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.868 179.952 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.503 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.5 Cg_endo -63.9 14.85 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 120.99 1.126 . . . . 0.0 112.345 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 57.54 2.05 0.65 Allowed Glycine 0 N--CA 1.496 2.688 0 C-N-CA 119.432 -1.366 . . . . 0.0 111.112 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.503 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -74.3 -44.02 54.38 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.66 179.94 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 56' ' ' THR . 26.9 mttm -93.03 116.33 28.95 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.304 -0.959 . . . . 0.0 110.693 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.59 21.15 0.67 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.771 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.423 ' H ' ' C ' ' A' ' 54' ' ' LYS . 43.7 p -138.67 130.64 28.1 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.2 165.48 25.65 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.576 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 t -136.62 144.03 43.85 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.598 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.76 160.06 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.131 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.33 140.47 24.09 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.25 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.86 -15.84 5.37 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.573 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -83.56 167.0 17.76 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.324 179.992 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -134.6 128.43 19.03 Favored Pre-proline 0 CA--C 1.556 1.193 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.202 179.803 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.22 112.64 1.18 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.408 0.739 . . . . 0.0 111.8 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.22 22.4 0.26 Allowed Glycine 0 N--CA 1.498 2.788 0 C-N-CA 119.202 -1.475 . . . . 0.0 111.608 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.425 ' CG2' ' N ' ' A' ' 67' ' ' ASP . 6.9 p -151.74 158.69 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 118.689 -1.205 . . . . 0.0 112.037 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.425 ' N ' ' CG2' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -73.29 147.02 44.92 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.791 179.995 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -147.66 127.0 13.07 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.649 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.5 m -111.18 132.06 54.61 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.227 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.52 154.33 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.067 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.421 ' OG1' ' OG1' ' A' ' 35' ' ' THR . 0.1 OUTLIER -134.91 131.82 37.74 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.42 179.991 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.14 142.35 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.439 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -126.18 133.07 51.66 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.176 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.15 108.68 20.25 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.598 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 t -109.09 113.55 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.449 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.486 1.343 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.253 179.936 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo . . . . . 0 C--O 1.214 -0.69 0 N-CA-C 111.246 -0.329 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.421 ' CG1' ' N ' ' A' ' 89' ' ' SER . 6.6 tt -152.64 166.3 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.86 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.421 ' N ' ' CG1' ' A' ' 88' ' ' ILE . 88.6 p -148.97 157.72 43.63 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.864 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.01 137.85 15.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.169 -1.013 . . . . 0.0 110.819 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.83 139.8 32.34 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.5 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -162.02 148.06 13.4 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.029 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -88.61 119.81 29.42 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.536 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 116.206 -1.854 . . . . 0.0 110.377 -179.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 120.628 0.251 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 10' ' ' VAL . 1.6 tm-20 -164.85 159.85 18.83 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 118.738 -1.185 . . . . 0.0 111.772 179.922 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.405 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 2.2 t -94.56 134.83 30.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.922 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.49 -67.88 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 118.725 -1.19 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.93 172.24 13.32 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.457 179.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.41 175.46 9.76 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.815 -179.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.538 ' HG1' ' CB ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -140.63 158.43 65.77 Favored Pre-proline 0 C--N 1.307 -1.278 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.077 179.95 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.97 0.33 0.33 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.006 1.137 . . . . 0.0 111.666 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.531 ' H ' ' C ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -155.83 26.17 0.38 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.149 -1.021 . . . . 0.0 111.375 -179.95 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.538 ' CB ' ' HG1' ' A' ' 14' ' ' THR . 0.1 OUTLIER -171.64 157.3 4.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.343 -179.975 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.5 tp -129.19 147.06 51.0 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.174 -179.953 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.67 122.39 30.7 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.03 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 pt -123.58 169.85 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.861 179.944 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.47 139.32 11.68 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.449 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 13.8 p90 . . . . . 0 N--CA 1.483 1.182 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.985 179.978 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 66.8 t . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -54.45 -66.46 0.4 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.086 -179.9 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.79 160.62 39.41 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.966 -1.093 . . . . 0.0 111.076 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.49 156.15 17.98 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.916 -179.989 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -137.13 111.69 8.67 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.4 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -101.75 148.03 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.209 -179.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.4 p -138.57 133.75 32.93 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.809 179.904 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -130.12 121.73 26.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.283 179.93 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.82 137.33 5.91 Favored Glycine 0 N--CA 1.487 2.058 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.572 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -52.65 175.81 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 84.1 m . . . . . 0 N--CA 1.49 1.546 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.297 -179.923 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.796 0.332 . . . . 0.0 111.297 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -173.54 -176.89 1.36 Allowed 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.7 -179.992 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.505 ' N ' ' CD ' ' A' ' 47' ' ' GLU . 1.1 mp0 -135.02 174.91 10.08 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.759 -179.998 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -175.28 132.67 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.493 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.54 148.92 24.64 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.687 -0.805 . . . . 0.0 112.045 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 m -142.32 151.62 58.64 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.431 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.541 ' C ' ' H ' ' A' ' 53' ' ' SER . 3.9 Cg_exo -55.25 120.86 8.9 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 120.308 0.672 . . . . 0.0 110.805 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -46.87 -11.39 0.05 OUTLIER Glycine 0 N--CA 1.486 2.03 0 C-N-CA 119.305 -1.426 . . . . 0.0 110.725 179.875 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.541 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -65.32 -33.16 75.32 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.48 -179.894 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.2 mtpp -77.38 135.69 38.36 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.593 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.65 -1.74 25.96 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.4 p -132.69 162.64 30.87 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.773 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.04 161.11 36.52 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.016 -1.073 . . . . 0.0 111.583 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.2 m -137.63 123.09 19.59 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.32 156.52 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.594 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.422 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -142.48 176.82 8.72 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.504 -179.93 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.64 58.0 4.33 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.657 -1.258 . . . . 0.0 110.202 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.65 -127.83 0.2 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.068 -179.926 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.44 99.63 0.36 Allowed Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.979 -179.915 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.97 149.36 90.6 Favored 'Trans proline' 0 C--O 1.213 -0.729 0 C-N-CA 120.903 1.069 . . . . 0.0 112.237 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.82 55.17 2.73 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.926 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.4 p -168.94 150.81 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -62.52 152.04 35.82 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.503 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.09 138.85 24.28 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.982 -179.929 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.84 108.0 16.81 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.712 179.843 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -95.44 157.97 3.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.111 -179.898 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -158.98 141.57 14.17 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.432 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.15 138.87 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.83 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -119.63 104.55 10.37 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.947 -179.903 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.83 116.67 21.61 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.721 179.828 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.3 t -109.94 109.33 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.94 -179.917 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 p . . . . . 0 C--N 1.309 -1.183 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.973 179.878 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 C--O 1.214 -0.699 0 CA-C-O 120.779 0.241 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.9 tt -159.57 156.83 3.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 118.715 -1.194 . . . . 0.0 111.091 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.1 p -134.69 144.02 47.55 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.579 179.987 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -139.0 156.7 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.782 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.77 146.41 25.94 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.714 -179.968 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -153.62 144.48 22.71 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.239 -0.985 . . . . 0.0 110.737 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.05 118.79 37.59 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.134 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 116.313 -1.804 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -162.95 173.33 13.79 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 117.789 -1.564 . . . . 0.0 112.999 -179.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.27 142.25 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.875 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 1.8 p -130.95 -8.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.695 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.14 161.3 8.43 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.638 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.21 149.13 26.69 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.193 -179.94 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.463 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -136.41 161.47 61.94 Favored Pre-proline 0 N--CA 1.491 1.583 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.762 179.89 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.434 ' O ' ' OG1' ' A' ' 16' ' ' THR . 2.9 Cg_exo -50.55 -11.33 0.36 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.221 1.281 . . . . 0.0 111.795 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.463 ' H ' ' C ' ' A' ' 14' ' ' THR . 96.6 m -164.39 49.22 0.12 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.432 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.433 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER 179.63 143.62 0.16 Allowed 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.322 -179.968 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.02 140.39 50.09 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.912 -179.938 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.6 tp -113.05 113.29 25.23 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.285 179.783 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.8 167.05 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.553 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.34 134.57 16.01 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.447 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.451 ' CE3' ' O ' ' A' ' 55' ' ' SER . 5.8 p90 . . . . . 0 N--CA 1.49 1.555 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.413 179.926 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.484 0.183 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -54.56 -52.62 61.51 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.65 -1.22 . . . . 0.0 109.473 179.88 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 175.1 171.27 0.28 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.691 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -118.38 161.87 19.25 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.475 179.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -138.48 104.66 5.21 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.799 179.858 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.7 mp -96.78 105.09 16.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.94 -179.972 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.6 p -103.55 143.32 32.9 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.347 179.876 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.466 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 8.2 p90 -145.92 166.96 24.45 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 118.464 -1.295 . . . . 0.0 111.38 -179.993 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . 160.0 162.86 12.7 Favored Glycine 0 N--CA 1.482 1.719 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 37' ' ' GLY . 2.5 mt-10 -49.13 177.98 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.716 179.995 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.3 m . . . . . 0 C--N 1.303 -1.441 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.745 -179.984 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.1 t . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.852 0.358 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -175.68 -169.07 0.33 Allowed 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.329 -179.914 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.41 171.55 19.15 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.987 179.976 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.471 ' CD1' ' O ' ' A' ' 48' ' ' PHE . 23.9 p90 -159.73 130.85 5.91 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.867 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.67 163.21 13.29 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 119.391 -0.924 . . . . 0.0 112.493 -179.87 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.592 ' C ' ' H ' ' A' ' 52' ' ' GLY . 11.8 p -150.74 140.38 13.79 Favored Pre-proline 0 CA--C 1.561 1.374 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.017 -179.939 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.56 16.02 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 121.0 1.134 . . . . 0.0 113.673 -179.97 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 64.94 4.44 14.73 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.359 -1.4 . . . . 0.0 111.288 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.79 -27.32 64.81 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.042 -179.919 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.13 140.07 35.94 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.229 -179.946 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.451 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 4.6 m -96.94 -26.42 15.05 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.405 179.919 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.3 p -124.01 159.22 30.32 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.538 179.922 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.6 162.54 24.39 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.19 -1.404 . . . . 0.0 112.275 -179.92 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.6 m -107.99 134.01 51.51 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.449 179.95 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 tt -126.27 137.2 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.177 179.989 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.9 t -138.01 111.31 7.96 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.309 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.56 33.15 0.02 OUTLIER Glycine 0 N--CA 1.486 1.979 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.211 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.51 -155.67 0.71 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.63 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -147.84 162.08 32.71 Favored Pre-proline 0 C--N 1.311 -1.104 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.692 -179.903 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -74.69 159.64 42.12 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 121.586 1.524 . . . . 0.0 112.97 179.906 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 34.65 69.93 0.18 Allowed Glycine 0 N--CA 1.499 2.841 0 CA-C-N 114.957 -1.02 . . . . 0.0 113.316 179.793 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 p -159.14 143.52 6.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.745 179.688 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.82 130.54 46.23 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.073 -179.95 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -141.63 138.4 32.53 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.705 179.944 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.3 m -120.9 134.71 55.3 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.864 -0.735 . . . . 0.0 110.479 -179.953 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.97 154.87 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.138 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.458 ' OG1' ' CB ' ' A' ' 89' ' ' SER . 2.5 m -147.98 159.14 44.2 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.954 -179.957 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.4 ' N ' ' CG2' ' A' ' 71' ' ' THR . 32.9 m -139.81 129.07 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.072 -179.955 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.89 117.95 35.52 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.147 179.79 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.5 113.61 25.93 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.489 -0.885 . . . . 0.0 110.94 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.08 109.89 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.799 -179.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.484 1.232 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.022 -179.951 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 C--O 1.214 -0.704 0 N-CA-C 109.342 -1.061 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.3 tt -151.67 131.24 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 118.034 -1.466 . . . . 0.0 111.804 -179.972 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.458 ' CB ' ' OG1' ' A' ' 71' ' ' THR . 59.2 p -118.7 147.13 44.14 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.69 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -143.1 139.77 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.231 179.959 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.3 154.3 17.91 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.423 179.944 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -169.56 139.25 2.03 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.157 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.432 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 11.0 ptt-85 -88.15 115.15 25.43 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.387 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.647 -179.919 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 119.304 -0.379 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -177.25 -164.15 0.09 Allowed 'General case' 0 N--CA 1.515 2.825 0 C-N-CA 117.894 -1.522 . . . . 0.0 113.239 -179.694 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.4 151.67 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.339 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.446 ' CG1' ' O ' ' A' ' 11' ' ' VAL . 39.1 t -130.79 -8.03 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.114 179.914 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.64 157.49 3.86 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.805 179.934 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.85 157.09 44.94 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.484 -0.887 . . . . 0.0 111.089 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.481 ' HG1' ' CB ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -140.36 162.04 51.79 Favored Pre-proline 0 N--CA 1.485 1.306 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.436 179.941 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.71 -23.61 33.86 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 121.074 1.183 . . . . 0.0 111.663 -179.977 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.1 p -143.1 39.93 1.47 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.325 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.481 ' CB ' ' HG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -176.98 149.84 0.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.895 179.967 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 tp -130.43 117.24 19.38 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.758 179.94 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 tt -90.94 103.74 16.42 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.577 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 pt -97.69 158.52 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.65 179.966 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.0 127.76 15.3 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.507 -179.919 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.4 p90 . . . . . 0 C--O 1.214 -0.791 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.618 179.861 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.821 0.344 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.545 ' HE ' ' HH ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -62.71 -59.5 4.81 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.608 179.874 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.545 ' HH ' ' HE ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -173.7 168.55 4.36 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.074 -1.05 . . . . 0.0 112.027 179.929 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.82 139.58 50.89 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.85 179.856 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.71 109.58 20.78 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 119.346 -0.941 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -105.42 99.36 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.37 -179.886 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -103.59 141.35 36.18 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.914 179.92 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.532 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 4.2 p90 -143.78 163.36 33.55 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.009 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.84 149.61 5.81 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.41 144.89 24.0 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.567 -179.981 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--N 1.304 -1.395 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.131 -179.996 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.2 t . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.814 0.34 . . . . 0.0 111.42 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -171.57 -160.97 0.18 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.575 -179.899 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.502 ' N ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -164.05 158.48 19.48 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.088 -179.995 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -149.1 142.86 25.59 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.462 ' OG1' ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -92.34 166.4 12.6 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.435 -179.929 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.566 ' CG1' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -148.55 148.58 28.79 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.913 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.27 -4.17 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 121.522 1.481 . . . . 0.0 112.911 -179.821 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.566 ' H ' ' CG1' ' A' ' 50' ' ' VAL . . . 70.87 -0.87 26.69 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.646 -1.264 . . . . 0.0 111.42 179.955 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.2 -30.29 22.54 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.895 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.66 129.57 35.74 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.097 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.13 -16.04 34.52 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.582 179.976 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.1 p -134.36 152.92 52.09 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.073 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.14 163.92 39.56 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.771 -1.171 . . . . 0.0 111.611 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.3 m -117.84 112.5 20.47 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.432 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.67 137.81 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.021 -179.914 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.6 t -96.42 -156.56 0.53 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.388 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.3 83.96 0.07 OUTLIER Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.231 -1.461 . . . . 0.0 109.989 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.47 -175.43 2.94 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.3 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -172.29 85.15 0.44 Allowed Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.686 179.888 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -55.45 133.27 57.11 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 120.787 0.992 . . . . 0.0 111.923 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.43 41.61 3.89 Favored Glycine 0 N--CA 1.484 1.895 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.398 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 p -159.96 154.48 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 118.667 -1.213 . . . . 0.0 111.691 -179.977 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.53 105.88 17.62 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.446 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -89.11 118.23 28.67 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.399 -179.78 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.19 131.11 45.46 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.348 179.849 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 pp -130.15 154.54 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.184 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m -144.33 128.26 17.43 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.789 -179.998 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.9 m -110.69 137.19 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.099 -179.942 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -120.07 113.69 20.87 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.636 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.14 105.21 17.36 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.104 179.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.4 t -110.2 119.54 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.261 -179.924 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.488 1.427 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.894 179.952 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 C--O 1.214 -0.684 0 N-CA-C 110.702 -0.538 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 tt -151.68 160.35 3.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 118.332 -1.347 . . . . 0.0 111.476 -179.855 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.1 158.63 41.11 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.187 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.13 141.99 16.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.842 179.957 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.29 136.28 40.42 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.502 179.949 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -144.39 135.02 24.8 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.847 -179.981 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -83.45 107.42 15.93 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.168 179.887 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 116.306 -1.806 . . . . 0.0 110.351 -179.918 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.402 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 120.776 0.322 . . . . 0.0 110.369 . . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -155.83 153.09 29.22 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.88 -1.128 . . . . 0.0 112.054 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.8 t -87.81 129.02 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.576 179.876 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.1 t -104.63 -56.09 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.839 -179.922 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.71 161.43 37.96 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.033 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.16 87.57 1.54 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.937 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -70.64 158.33 88.13 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.068 -179.983 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.55 -5.16 1.55 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 121.054 1.17 . . . . 0.0 111.217 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 14' ' ' THR . 14.5 p -151.08 33.2 0.59 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.261 179.997 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.424 ' OG ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -173.98 122.01 0.31 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.091 179.969 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.65 127.66 43.77 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.067 179.945 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 tp -110.0 125.4 52.86 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.538 -179.875 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 pt -127.22 174.24 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.317 179.829 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.06 137.16 6.12 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.077 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 11.6 p90 . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.765 179.998 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.763 0.316 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.492 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -91.73 -79.13 0.38 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.987 179.884 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.492 ' CD1' ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -150.62 171.92 16.36 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.26 179.875 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -131.87 160.57 35.29 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.341 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.31 119.18 13.3 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 118.415 -1.314 . . . . 0.0 110.975 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.1 115.77 47.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.368 -179.876 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.2 p -111.4 138.07 48.37 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.564 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.426 ' CZ ' ' CG1' ' A' ' 45' ' ' VAL . 8.9 p90 -139.29 148.65 43.28 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.271 179.992 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.74 156.58 25.24 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.957 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -66.65 143.04 57.22 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.774 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 m . . . . . 0 C--N 1.305 -1.342 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.752 -179.95 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.426 ' CG1' ' CZ ' ' A' ' 36' ' ' TYR . 63.4 t . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.878 0.37 . . . . 0.0 111.803 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -173.26 -159.71 0.11 Allowed 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.986 -1.086 . . . . 0.0 111.036 -179.907 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -162.75 158.67 23.2 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.025 179.975 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 2.9 p90 -146.98 162.55 38.53 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.004 -179.933 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.2 p -114.99 154.82 28.08 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.351 179.968 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -136.87 157.99 73.78 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.971 -179.976 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.23 8.73 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 121.212 1.275 . . . . 0.0 112.261 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 56.27 13.63 7.44 Favored Glycine 0 N--CA 1.497 2.701 0 C-N-CA 119.484 -1.341 . . . . 0.0 111.127 -179.935 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.49 -57.34 2.91 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.433 179.984 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -64.41 123.39 19.07 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.436 -179.878 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.54 8.45 6.37 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.601 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.57 158.16 40.04 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.884 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.1 169.09 25.59 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.496 179.965 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.4 t -142.9 162.03 36.56 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.237 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 mt -139.56 143.46 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.513 179.959 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.07 143.37 31.12 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.646 -179.979 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.07 50.61 1.23 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.964 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.526 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 1.3 pt? -130.19 -171.71 2.6 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.419 -179.96 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -117.77 89.84 34.5 Favored Pre-proline 0 N--CA 1.488 1.455 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.502 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.39 146.19 95.63 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 120.892 1.062 . . . . 0.0 111.684 -179.875 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.47 43.94 5.39 Favored Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.559 -1.305 . . . . 0.0 109.958 -179.912 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -166.19 157.74 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.194 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -63.11 142.96 58.18 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.585 179.98 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.9 135.26 22.99 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.272 -0.971 . . . . 0.0 111.123 -179.953 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.33 132.59 53.57 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.173 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.1 157.96 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.251 -179.935 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.7 m -148.43 127.57 12.88 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.133 180.0 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.11 138.19 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.009 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -106.42 139.75 40.42 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.276 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -121.17 104.97 10.16 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.7 t -126.86 110.07 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.997 179.909 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 76.9 p . . . . . 0 N--CA 1.491 1.598 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.976 -179.979 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 C--O 1.216 -0.611 0 CA-C-O 121.335 0.473 . . . . 0.0 112.176 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.1 tt -142.15 137.44 29.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.204 179.912 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 p -127.73 158.55 37.33 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.298 -0.961 . . . . 0.0 112.15 -179.827 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.4 pt -153.44 148.22 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.883 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.95 156.9 16.62 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.161 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -172.38 138.49 0.93 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.64 118.62 22.36 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.32 -179.943 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.402 ' H ' ' HG1' ' A' ' 94' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 116.292 -1.813 . . . . 0.0 110.64 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 7.2 mp . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 179.06 -171.69 0.14 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 117.894 -1.523 . . . . 0.0 112.506 -179.802 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.3 t -83.75 141.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.471 179.892 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.467 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 3.4 p -99.52 -14.37 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.112 -179.983 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 11' ' ' VAL . . . 166.66 178.4 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.958 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.74 108.94 2.96 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.492 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -62.57 161.14 29.24 Favored Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.051 179.936 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.8 -3.2 1.37 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 121.031 1.154 . . . . 0.0 111.029 -179.944 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.492 ' H ' ' C ' ' A' ' 14' ' ' THR . 15.7 p -153.19 37.24 0.48 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.247 -179.891 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.8 155.48 0.57 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.451 179.948 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.6 130.78 55.28 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.704 -179.913 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.32 107.29 15.38 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.269 -179.962 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 pt -97.94 168.65 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 119.091 -1.044 . . . . 0.0 110.336 179.933 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.56 130.85 9.54 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.187 179.978 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.0 p90 . . . . . 0 C--O 1.215 -0.745 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.974 179.855 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.0 t . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.687 0.28 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -64.66 0.8 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.393 179.98 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.97 166.93 15.1 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.639 179.974 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.35 160.01 24.92 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -143.71 112.42 6.55 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.415 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.77 124.67 56.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.298 -179.956 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 71.7 p -121.53 134.09 55.03 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.767 179.915 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 5.3 p90 -137.01 162.9 32.04 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.094 -179.867 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 160.41 156.65 8.28 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.946 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -43.71 166.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.08 179.996 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.8 m . . . . . 0 N--CA 1.486 1.341 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.411 -179.898 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 120.98 0.419 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -172.13 -164.41 0.29 Allowed 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.635 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -166.86 152.83 8.14 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.236 -179.996 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 3.1 p90 -144.43 146.52 32.52 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.4 p -91.37 168.0 11.88 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.924 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -158.22 145.14 13.11 Favored Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 119.557 -0.857 . . . . 0.0 108.991 179.972 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.36 28.47 0.08 OUTLIER 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 121.037 1.158 . . . . 0.0 112.424 179.843 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 49.11 22.84 3.46 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.095 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.84 -38.29 12.42 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.047 -179.93 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -85.22 134.14 34.16 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.729 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.2 m -91.21 -15.49 29.18 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.958 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.5 p -127.37 165.95 18.78 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.232 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.69 137.36 20.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.732 -179.975 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.3 m -118.27 107.27 13.7 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.635 179.869 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.21 164.18 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.973 -179.861 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 t -146.84 177.3 9.23 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.02 179.97 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.45 8.02 50.4 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.307 -179.939 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.26 -160.97 0.74 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.019 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -148.14 112.8 3.84 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.237 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.7 156.8 40.72 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 120.555 0.837 . . . . 0.0 111.744 -179.954 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.09 52.18 1.66 Allowed Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.598 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 p -170.71 154.86 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.95 133.41 56.07 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.517 179.923 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 92' ' ' TYR . 0.2 OUTLIER -133.02 139.69 47.35 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.731 -179.87 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.9 m -122.53 136.79 54.97 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.629 179.907 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.08 161.0 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.7 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.49 146.85 30.68 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.503 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.4 m -132.52 135.59 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.264 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -117.56 131.03 56.75 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.213 -179.998 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.38 101.02 7.66 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.959 -179.997 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.45 126.46 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.813 -179.917 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.487 1.419 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.019 179.923 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 C--O 1.214 -0.707 0 CA-C-O 121.016 0.34 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.0 tt -150.08 155.13 8.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.011 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.7 p -129.31 145.77 51.31 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.481 -179.9 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -146.61 139.0 19.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.057 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -98.08 134.79 40.68 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.07 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 68' ' ' TYR . 31.9 t80 -146.96 129.75 16.16 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.558 179.999 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.6 132.32 36.97 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.796 -179.923 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 116.354 -1.784 . . . . 0.0 110.631 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 120.873 0.368 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -175.85 176.12 1.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.265 179.961 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.529 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 2.4 t -96.8 116.67 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.395 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.437 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -92.15 -4.55 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.878 179.992 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 11' ' ' VAL . . . 168.74 148.99 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.588 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.57 137.47 15.4 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.246 -179.861 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.546 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.9 OUTLIER -148.81 155.26 41.06 Favored Pre-proline 0 C--N 1.301 -1.503 0 C-N-CA 119.564 -0.855 . . . . 0.0 109.887 179.908 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.77 5.39 0.12 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.098 1.199 . . . . 0.0 112.163 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.546 ' H ' ' C ' ' A' ' 14' ' ' THR . 49.0 p -144.63 14.78 1.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.801 -179.939 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.408 ' OG ' ' OG ' ' A' ' 60' ' ' SER . 0.4 OUTLIER -178.41 139.64 0.19 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.165 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.88 121.23 24.85 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.586 -179.973 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.36 105.05 14.8 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.776 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 pt -109.09 167.29 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 118.93 -1.108 . . . . 0.0 113.561 -179.641 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.48 135.35 35.06 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.389 -1.732 . . . . 0.0 107.206 179.805 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.62 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 44.7 p90 . . . . . 0 N--CA 1.506 2.345 0 C-N-CA 118.11 -1.436 . . . . 0.0 113.657 -179.809 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.721 0.296 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.466 ' CA ' ' HE ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -77.14 -64.86 1.04 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.176 179.797 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.7 158.2 33.77 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.279 179.718 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.62 ' CE2' ' CD1' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -116.2 125.51 52.36 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.916 179.97 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.5 99.18 8.77 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.397 -179.922 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mp -96.17 135.46 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.459 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -138.96 138.34 37.22 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.749 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' TYR . . . . . 0.571 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 1.6 p90 -138.57 153.78 48.7 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.824 -1.15 . . . . 0.0 111.836 -179.958 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.86 142.7 3.81 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.99 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.34 155.05 7.37 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.962 -179.974 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.305 -1.331 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.096 179.981 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.4 t . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.688 0.28 . . . . 0.0 111.461 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -173.55 -168.25 0.43 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.445 -1.302 . . . . 0.0 112.265 -179.932 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -166.16 177.66 6.8 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.655 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -173.69 155.79 2.76 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.202 179.792 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.2 p -104.15 159.48 15.65 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.356 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.536 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -151.91 154.65 33.03 Favored Pre-proline 0 C--N 1.306 -1.311 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.712 179.769 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.48 12.94 0.09 OUTLIER 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.173 1.248 . . . . 0.0 112.132 179.944 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 59.25 23.13 57.25 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.111 -1.519 . . . . 0.0 109.849 -179.952 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.14 -47.23 13.75 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.897 -179.975 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -84.51 133.18 34.47 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.779 179.918 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.0 m -80.67 -8.12 59.54 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.223 179.989 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.3 p -134.91 -174.12 3.51 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.091 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.99 146.09 9.14 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.989 -179.997 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -108.02 110.67 22.43 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.726 -179.924 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 mt -108.97 144.48 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.024 179.974 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.408 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 48.3 m -148.28 110.04 4.49 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.224 -179.946 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.51 -11.42 0.03 OUTLIER Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.126 -1.511 . . . . 0.0 110.88 179.992 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.457 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 1.4 pt? -68.28 -164.07 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.947 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.578 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 5.1 ttpt -176.06 -42.29 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.801 -179.946 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 63' ' ' LYS . 5.6 Cg_endo -81.36 -169.22 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.457 1.438 . . . . 0.0 111.985 -179.907 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -148.29 83.62 0.18 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.646 ' CG2' ' H ' ' A' ' 67' ' ' ASP . 10.9 p -142.78 -173.88 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.534 -179.716 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.646 ' H ' ' CG2' ' A' ' 66' ' ' VAL . 0.6 OUTLIER -56.83 99.66 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.639 179.998 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -97.77 120.83 38.86 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.59 179.891 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.4 m -95.73 124.47 39.76 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.806 -179.925 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.489 ' CG1' ' N ' ' A' ' 71' ' ' THR . 3.9 tt -112.08 157.38 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.13 179.857 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.489 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -154.96 136.22 14.02 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.194 -179.955 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.4 m -131.88 117.34 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.648 179.832 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -93.5 111.66 23.38 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.152 -179.958 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.5 96.81 9.25 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.85 -1.14 . . . . 0.0 110.636 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.3 t -93.77 129.43 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.966 -179.955 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.8 p . . . . . 0 N--CA 1.489 1.512 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.039 -179.933 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo . . . . . 0 C--O 1.214 -0.696 0 N-CA-C 111.578 -0.201 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.7 tt -135.01 144.63 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.443 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.3 p -137.07 133.01 34.94 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.133 -179.957 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.37 148.52 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.14 179.954 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.539 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -98.11 152.63 19.13 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.534 179.951 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -155.28 140.56 17.62 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.372 -179.963 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.99 98.32 11.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 119.342 -0.943 . . . . 0.0 109.873 179.917 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 116.476 -1.725 . . . . 0.0 110.787 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 120.864 0.364 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.1 t -74.43 126.87 31.66 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.471 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.56 27.46 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 118.602 -1.239 . . . . 0.0 112.028 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.513 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -86.35 -43.43 0.58 Allowed Pre-proline 0 N--CA 1.491 1.575 0 C-N-CA 118.135 -1.426 . . . . 0.0 111.796 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 4' ' ' VAL . 19.7 Cg_endo -91.01 111.96 0.36 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 121.459 1.439 . . . . 0.0 111.024 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -171.5 157.79 4.95 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.415 -1.314 . . . . 0.0 112.183 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t70 67.65 33.89 4.76 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.672 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.436 ' N ' ' OE2' ' A' ' 9' ' ' GLU . 1.5 mp -88.0 105.85 17.74 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.809 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.436 ' OE2' ' N ' ' A' ' 8' ' ' LEU . 7.4 mp0 -147.87 168.47 22.12 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.526 -0.869 . . . . 0.0 111.14 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.6 t -100.41 133.01 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.767 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -88.12 -35.62 8.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 118.706 -1.197 . . . . 0.0 110.863 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 174.64 170.98 0.24 Allowed 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.162 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.66 167.68 12.65 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.534 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.28 161.64 29.13 Favored Pre-proline 0 C--N 1.3 -1.561 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.246 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.466 ' O ' ' OG1' ' A' ' 16' ' ' THR . 14.0 Cg_exo -45.41 103.86 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 120.684 0.923 . . . . 0.0 111.123 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 15' ' ' PRO . 3.1 p 59.25 49.21 9.33 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.905 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 p -171.93 137.22 0.95 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.662 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.9 tp -130.35 147.99 52.12 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.767 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.8 mp -119.47 114.13 21.82 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.54 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -110.01 147.66 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.225 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.51 137.57 28.58 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.296 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 11.8 p90 -130.76 -135.25 0.21 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.458 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.456 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 34.9 t70 -135.34 168.78 18.56 Favored 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 118.558 -1.257 . . . . 0.0 112.952 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.45 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -149.75 93.79 3.93 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.578 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -53.64 178.47 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 120.799 0.999 . . . . 0.0 112.524 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.62 -17.6 44.14 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.059 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 29' ' ' VAL . 19.3 m -58.81 127.69 18.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 118.304 -1.359 . . . . 0.0 109.816 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.44 88.75 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.195 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 27' ' ' VAL . 2.2 t -73.71 131.06 35.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.646 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -68.78 0.16 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.692 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.79 164.29 28.97 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.177 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -113.74 158.78 20.5 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.895 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.486 ' CG ' ' OE2' ' A' ' 47' ' ' GLU . 2.9 ttt180 -139.33 105.48 5.23 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.064 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.59 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 2.7 mp -96.76 120.31 45.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.169 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.0 p -126.65 137.19 53.26 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.561 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 6.9 p90 -142.16 155.95 45.33 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 118.741 -1.184 . . . . 0.0 110.427 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.72 137.41 4.75 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.421 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.35 132.97 40.07 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.681 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.5 m -50.56 123.19 8.31 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.742 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.73 -54.67 0.09 OUTLIER Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.111 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.04 -1.33 64.98 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.866 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.03 -35.91 72.18 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.665 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.8 t 177.99 136.31 0.23 Allowed Pre-proline 0 C--N 1.304 -1.384 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.19 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.8 145.85 96.93 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 120.579 0.853 . . . . 0.0 110.91 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 49.7 t -73.78 -77.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.859 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -167.6 171.86 9.9 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 117.979 -1.488 . . . . 0.0 112.499 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.486 ' OE2' ' CG ' ' A' ' 33' ' ' ARG . 0.8 OUTLIER -150.78 159.56 44.45 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.157 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 11.7 p90 -160.22 136.63 8.82 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 118.423 -1.311 . . . . 0.0 111.523 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.0 p -92.66 159.73 15.32 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.431 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -152.08 142.96 15.47 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.178 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.71 29.9 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 120.953 1.102 . . . . 0.0 112.387 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.552 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 57.42 13.56 11.2 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.251 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.44 -31.08 37.57 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.012 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -92.53 119.27 31.84 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.91 -21.73 34.1 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.373 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.4 p -119.54 -178.9 3.72 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.891 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -167.58 143.66 4.12 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.581 -1.248 . . . . 0.0 111.706 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.2 m -110.8 112.2 23.9 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.726 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.92 140.8 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.466 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -145.54 163.89 33.33 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.466 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.13 10.83 33.4 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.593 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 1.6 pt? -91.98 -177.28 4.66 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.264 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.56 110.29 40.84 Favored Pre-proline 0 N--CA 1.49 1.569 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.047 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.66 137.53 80.67 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 120.599 0.866 . . . . 0.0 111.816 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.09 60.32 1.86 Allowed Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.544 -1.312 . . . . 0.0 109.999 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 p -169.51 156.9 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.471 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -74.99 142.38 43.87 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.081 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -137.89 130.19 29.15 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.124 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.57 125.97 49.48 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.509 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 tt -115.93 148.46 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.8 m -145.5 121.48 10.69 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.338 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.6 m -108.41 122.12 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.434 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.49 101.94 11.43 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.278 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.448 ' O ' ' CB ' ' A' ' 85' ' ' SER . . . -95.06 113.28 24.95 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.403 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.7 t -107.54 128.4 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.225 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.1 p -122.66 165.2 16.89 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.58 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.82 152.53 17.68 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.011 -1.566 . . . . 0.0 110.671 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.32 -22.17 19.87 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.039 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.57 -47.11 0.04 OUTLIER Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.327 -1.416 . . . . 0.0 110.823 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -173.94 -4.69 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.281 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.545 ' C ' ' H ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -56.99 163.33 3.0 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.013 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 84' ' ' SER . 5.7 Cg_endo -68.07 30.14 0.14 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 121.605 1.537 . . . . 0.0 111.569 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.545 ' H ' ' C ' ' A' ' 81' ' ' SER . . . -49.05 91.34 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.871 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 82' ' ' PRO . 75.5 m -89.94 137.39 32.38 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.783 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 74' ' ' ALA . 3.2 t -96.6 -158.12 0.64 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.929 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -128.41 92.6 40.63 Favored Pre-proline 0 N--CA 1.485 1.317 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.19 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.91 158.19 58.42 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 120.75 0.967 . . . . 0.0 111.063 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.4 tt -147.41 150.51 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 118.654 -1.218 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.52 150.42 45.09 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.099 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 pt -152.34 141.87 14.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.674 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -93.19 145.53 24.36 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.256 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -156.25 140.71 16.77 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.218 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -84.05 118.98 24.41 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.26 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.769 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 m -102.19 162.03 13.23 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.671 -0.811 . . . . 0.0 110.616 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -153.47 69.26 0.81 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.117 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.3 t -64.96 134.72 96.15 Favored Pre-proline 0 C--N 1.306 -1.3 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.827 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -58.07 -178.95 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 120.466 0.777 . . . . 0.0 111.202 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.484 ' CZ ' ' OD2' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -172.96 170.87 4.38 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.46 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.484 ' OD2' ' CZ ' ' A' ' 6' ' ' ARG . 15.1 m-20 57.75 53.98 6.65 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.398 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.9 mp -98.77 114.78 27.47 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.533 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.441 ' OE2' ' N ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -170.12 176.89 4.45 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.362 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.0 t -95.66 129.95 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.448 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 m -101.77 -6.5 9.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.774 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.75 161.21 11.03 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.779 -1.168 . . . . 0.0 111.81 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.85 129.14 8.21 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.318 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.442 ' OG1' ' OG ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -137.88 165.12 36.15 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.476 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.461 ' O ' ' CB ' ' A' ' 16' ' ' THR . 3.2 Cg_exo -53.11 104.31 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.198 1.265 . . . . 0.0 111.94 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.7 OUTLIER 77.91 34.48 0.32 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.13 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.442 ' OG ' ' OG1' ' A' ' 14' ' ' THR . 0.8 OUTLIER -169.46 126.42 0.91 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.716 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 tp -125.58 126.9 45.53 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.1 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.4 tp -103.5 114.05 28.03 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.469 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.47 159.31 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.596 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.77 145.91 17.51 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.659 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.528 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 13.7 p90 -135.5 -155.21 0.62 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 119.189 -1.004 . . . . 0.0 111.452 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 31.2 t70 -106.95 176.42 5.18 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.509 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . -175.38 106.65 0.26 Allowed Pre-proline 0 N--CA 1.488 1.468 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.318 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.63 -171.62 0.09 OUTLIER 'Trans proline' 0 C--O 1.215 -0.659 0 CA-C-N 118.81 0.611 . . . . 0.0 111.753 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.13 -7.51 39.12 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.775 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.549 ' CG2' ' N ' ' A' ' 28' ' ' THR . 2.0 p -60.0 163.43 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 118.736 -1.185 . . . . 0.0 110.687 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.549 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 0.3 OUTLIER -74.78 109.54 8.34 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.035 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.79 139.02 36.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.137 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.523 ' NE ' ' OH ' ' A' ' 31' ' ' TYR . 2.2 mtt180 -69.93 -75.63 0.11 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.419 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.523 ' OH ' ' NE ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -153.84 167.68 28.85 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.604 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -123.85 156.04 36.93 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.146 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -140.31 110.12 6.42 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.678 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 mp -95.14 123.49 47.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.904 -1.043 . . . . 0.0 111.338 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -125.58 132.12 52.59 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.711 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.551 ' OH ' ' CE2' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -144.77 167.62 22.15 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.338 -1.345 . . . . 0.0 112.484 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.77 159.14 17.37 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.6 160.74 3.09 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.047 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 m -66.48 162.62 20.27 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.724 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.82 -57.99 0.45 Allowed Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.246 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.68 41.84 5.58 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.422 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -126.58 -5.08 6.48 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.021 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.8 p -170.43 74.23 0.6 Allowed Pre-proline 0 C--N 1.303 -1.419 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.788 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.9 144.27 99.48 Favored 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 121.106 1.204 . . . . 0.0 111.477 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 t -66.53 -74.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.509 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.587 ' NE2' ' H ' ' A' ' 47' ' ' GLU . 50.5 tp60 -171.47 162.92 6.74 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.843 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.587 ' H ' ' NE2' ' A' ' 46' ' ' GLN . 5.0 pt-20 -147.63 148.17 30.79 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.576 -0.849 . . . . 0.0 110.949 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.551 ' CE2' ' OH ' ' A' ' 36' ' ' TYR . 0.9 OUTLIER -147.84 170.97 16.47 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 118.864 -1.134 . . . . 0.0 111.421 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 50.2 p -104.89 174.26 5.95 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.883 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.598 ' C ' ' H ' ' A' ' 52' ' ' GLY . 11.3 p -165.79 137.66 3.18 Favored Pre-proline 0 CA--C 1.564 1.503 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.163 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 53' ' ' SER . 5.2 Cg_exo -56.0 14.19 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 121.216 1.277 . . . . 0.0 113.731 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 54.02 9.24 1.28 Allowed Glycine 0 N--CA 1.495 2.623 0 C-N-CA 119.36 -1.4 . . . . 0.0 111.119 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -72.42 -41.05 66.63 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.969 -1.092 . . . . 0.0 110.287 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -118.83 116.31 26.24 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.075 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 m -79.85 58.24 2.8 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.105 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 p -154.28 148.35 25.75 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.371 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.16 150.68 9.54 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 t -117.31 145.56 43.92 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.759 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -135.69 133.8 51.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.41 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.5 m -130.6 165.59 22.45 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.581 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.44 49.22 4.73 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.169 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.29 -155.19 0.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.636 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.6 99.1 17.36 Favored Pre-proline 0 N--CA 1.493 1.71 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.08 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.97 145.14 94.25 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.757 0.971 . . . . 0.0 111.593 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.92 49.97 4.83 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.668 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.3 p -159.02 152.92 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.393 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.13 151.33 31.49 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.109 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.17 121.22 8.84 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.695 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 m -105.78 121.2 43.55 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.646 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 pp -110.18 158.46 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.569 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 55.0 m -153.18 123.19 6.95 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.067 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.5 m -108.63 141.93 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.514 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -112.38 105.65 13.98 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.844 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.74 94.6 9.56 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.063 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -89.6 112.44 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.76 165.01 28.11 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.502 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.06 107.47 0.22 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.007 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -59.54 -58.49 8.35 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.252 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.99 37.68 0.02 OUTLIER Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.884 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -137.58 -103.98 0.19 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.984 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.566 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -92.56 -43.14 0.35 Allowed Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.597 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 81' ' ' SER . 5.6 Cg_exo -65.21 107.45 0.97 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 121.116 1.211 . . . . 0.0 112.086 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.44 -78.14 0.54 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.917 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.8 m -54.62 164.38 0.76 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.255 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.1 m -116.63 179.41 4.02 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -134.17 74.41 67.78 Favored Pre-proline 0 N--CA 1.484 1.273 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.12 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -54.79 168.69 1.04 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 121.841 1.694 . . . . 0.0 113.9 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.9 tt -150.43 157.59 5.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.573 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.9 p -144.83 160.69 40.87 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.563 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.97 145.57 16.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.526 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.605 ' ND2' ' N ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -91.48 144.73 25.26 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.639 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.605 ' N ' ' ND2' ' A' ' 91' ' ' ASN . 57.8 t80 -161.3 135.73 7.12 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.838 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.79 132.58 34.57 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.194 -1.003 . . . . 0.0 110.205 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 116.258 -1.83 . . . . 0.0 110.818 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.432 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 95.4 t . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 3' ' ' ASP . 8.9 p 48.15 -150.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.658 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.47 ' N ' ' OG ' ' A' ' 2' ' ' SER . 44.8 t0 -144.65 -71.65 0.27 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.589 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.46 ' O ' ' CG1' ' A' ' 4' ' ' VAL . 47.7 t -131.95 51.88 8.14 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 4' ' ' VAL . 8.8 Cg_endo -67.42 79.56 0.45 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 120.947 1.098 . . . . 0.0 110.209 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 2.3 mtm180 -147.21 -154.0 0.52 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.012 -1.075 . . . . 0.0 112.049 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 6.6 t0 72.75 14.34 5.01 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.711 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.38 134.6 56.17 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.484 -0.887 . . . . 0.0 110.27 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -169.3 146.01 3.43 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.124 -1.031 . . . . 0.0 111.112 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.0 t -85.32 116.17 28.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.736 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 t -90.27 -18.82 7.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.768 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.39 159.0 4.5 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.094 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.37 81.41 1.12 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.445 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -77.72 160.62 74.1 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.541 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.92 3.83 0.48 Allowed 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.344 1.363 . . . . 0.0 111.779 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.491 ' H ' ' C ' ' A' ' 14' ' ' THR . 1.8 m -152.91 25.3 0.56 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.895 -1.122 . . . . 0.0 111.9 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.17 131.74 0.08 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.954 -1.099 . . . . 0.0 111.287 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 tp -115.72 136.24 53.25 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.52 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.33 116.71 26.77 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.475 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.415 ' C ' ' HG ' ' A' ' 21' ' ' SER . 2.2 pt -111.28 158.59 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.174 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.415 ' HG ' ' C ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -150.13 133.52 16.47 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.92 -179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.624 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 6.3 p90 -138.07 -146.55 0.22 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.252 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.624 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 32.1 t70 -98.42 174.8 6.29 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.036 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.482 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -172.28 90.93 0.41 Allowed Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.717 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -61.33 156.18 47.55 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.915 1.077 . . . . 0.0 111.36 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.72 9.02 40.52 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.626 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.649 ' CG2' ' H ' ' A' ' 28' ' ' THR . 8.9 p -64.19 -175.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.461 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.649 ' H ' ' CG2' ' A' ' 27' ' ' VAL . 3.2 m -73.44 76.81 1.41 Allowed 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.2 t -93.1 144.77 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.684 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.537 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -87.48 -73.53 0.47 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 118.961 -1.095 . . . . 0.0 110.828 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 2.5 m-85 -146.58 167.5 23.57 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.975 -1.09 . . . . 0.0 111.976 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -131.01 145.39 52.03 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.024 -1.444 . . . . 0.0 108.65 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.1 ttm180 -132.59 121.39 23.15 Favored 'General case' 0 N--CA 1.508 2.44 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.137 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.555 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.7 mp -97.48 102.58 13.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.715 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.9 p -109.61 129.95 55.55 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 12.6 p90 -140.52 165.06 28.49 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.78 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 168.6 165.02 25.29 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.867 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -66.29 146.39 54.65 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.381 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.443 ' OG1' ' OG1' ' A' ' 69' ' ' THR . 24.4 m -75.88 0.76 17.11 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.595 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.88 54.68 0.56 Allowed Glycine 0 N--CA 1.5 2.932 0 C-N-CA 119.574 -1.298 . . . . 0.0 111.316 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.514 ' C ' ' H ' ' A' ' 43' ' ' SER . . . 173.98 131.8 1.45 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 118.749 -1.691 . . . . 0.0 111.247 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -75.16 12.8 0.82 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.127 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 41' ' ' GLY . 15.5 t -129.52 86.73 55.07 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.476 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -58.96 162.63 13.06 Favored 'Trans proline' 0 C--O 1.213 -0.726 0 C-N-CA 120.793 0.995 . . . . 0.0 112.029 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 36.4 t -49.44 -73.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.29 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -169.08 -159.06 0.22 Allowed 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.987 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -170.12 161.16 8.42 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.189 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 7.2 p90 -152.68 140.27 19.79 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.636 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 50.8 p -82.8 174.05 11.31 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.541 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 52' ' ' GLY . 5.6 p -166.21 139.23 3.3 Favored Pre-proline 0 C--N 1.305 -1.351 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.949 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.505 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.0 Cg_endo -62.5 28.3 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 121.0 1.134 . . . . 0.0 112.916 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 48.55 11.06 0.14 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.996 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -76.84 -38.92 52.88 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.57 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -93.12 131.06 38.5 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.494 -0.883 . . . . 0.0 110.622 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -84.83 -1.24 56.2 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.441 -0.904 . . . . 0.0 111.294 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.5 p -120.11 167.84 11.81 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.722 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.13 136.24 18.69 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.236 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.6 m -99.69 145.8 27.22 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.8 mt -144.32 149.19 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.616 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.4 174.45 10.91 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.75 64.64 3.55 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.784 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.01 -125.17 0.28 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.782 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.495 ' N ' ' HH ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -170.84 121.72 0.53 Allowed Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.192 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.58 142.91 73.11 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 120.566 0.844 . . . . 0.0 112.075 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.18 80.92 0.09 OUTLIER Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.387 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.446 ' CG1' ' CE2' ' A' ' 68' ' ' TYR . 7.5 p -170.4 152.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.538 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -82.48 108.65 16.05 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.495 ' HH ' ' N ' ' A' ' 63' ' ' LYS . 4.6 m-85 -105.4 130.68 53.45 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.85 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.443 ' OG1' ' OG1' ' A' ' 39' ' ' THR . 0.9 OUTLIER -97.73 119.09 35.69 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.012 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.4 HD13 ' H ' ' A' ' 71' ' ' THR . 5.2 tp -98.3 137.38 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.235 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.4 ' H ' HD13 ' A' ' 70' ' ' ILE . 82.3 m -139.35 127.77 22.87 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.073 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -118.33 151.59 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.459 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -115.89 133.32 56.15 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.009 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.53 84.36 2.19 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 123.795 0.685 . . . . 0.0 109.466 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -95.3 124.81 48.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.584 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 p -141.58 -166.18 2.14 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.876 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.0 116.9 0.45 Allowed Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.435 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.77 -3.33 19.18 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.7 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.58 61.56 1.23 Allowed Glycine 0 N--CA 1.489 2.195 0 C-N-CA 119.308 -1.425 . . . . 0.0 110.325 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.64 -43.98 0.07 Allowed 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.666 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.07 164.71 31.83 Favored Pre-proline 0 N--CA 1.487 1.393 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.979 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' A' ' 84' ' ' SER . 2.3 Cg_endo -58.01 99.4 0.1 OUTLIER 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.088 1.192 . . . . 0.0 111.248 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -52.02 -8.95 0.08 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.003 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 82' ' ' PRO . 9.3 t -67.68 74.0 0.17 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.5 ' H ' ' HG ' ' A' ' 85' ' ' SER . 0.8 OUTLIER -76.8 -150.5 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.282 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.78 153.1 31.32 Favored Pre-proline 0 C--N 1.31 -1.125 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.16 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.05 -178.98 2.3 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 121.694 1.596 . . . . 0.0 112.441 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.3 tt -158.38 139.63 4.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.611 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.3 p -149.69 166.84 28.16 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 118.216 -1.394 . . . . 0.0 113.039 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 pt -154.42 150.7 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.524 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.513 ' ND2' ' H ' ' A' ' 91' ' ' ASN . 0.0 OUTLIER -82.81 141.23 32.47 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.281 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -146.59 120.91 9.59 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.763 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -85.48 116.51 23.83 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.567 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 116.355 -1.783 . . . . 0.0 111.096 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.831 0.348 . . . . 0.0 110.071 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.44 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 3.5 p -158.93 98.0 1.44 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.318 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 2' ' ' SER . 2.5 m-20 -141.23 -25.64 0.72 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -68.04 144.49 97.07 Favored Pre-proline 0 C--N 1.299 -1.629 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.467 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 4' ' ' VAL . 2.8 Cg_exo -51.39 -178.07 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 120.621 0.881 . . . . 0.0 109.817 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -170.03 168.83 8.35 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 117.506 -1.677 . . . . 0.0 113.585 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 31.39 81.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.863 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 mp -101.54 150.18 23.34 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -169.9 168.06 8.88 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 117.499 -1.68 . . . . 0.0 112.963 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.0 t -96.23 111.52 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.374 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.454 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 24.7 t -77.82 -9.5 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.25 -0.98 . . . . 0.0 111.58 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 11' ' ' VAL . . . 169.94 168.03 0.06 Allowed 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.441 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.34 147.59 27.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.811 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.62 161.13 30.11 Favored Pre-proline 0 C--N 1.305 -1.34 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.461 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.457 ' O ' ' OG1' ' A' ' 16' ' ' THR . 3.6 Cg_exo -51.29 111.88 0.67 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 120.97 1.113 . . . . 0.0 111.083 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 15' ' ' PRO . 1.6 p 64.51 37.92 7.74 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.83 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.92 128.29 1.64 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.662 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.33 145.47 51.79 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.335 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.17 109.77 15.82 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.065 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -109.12 146.69 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.145 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.68 131.05 22.22 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.398 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.598 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 5.5 p90 -136.32 -143.66 0.19 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.497 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.598 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 15.2 t70 -141.7 162.9 34.34 Favored 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 118.419 -1.312 . . . . 0.0 112.815 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -135.63 127.45 17.54 Favored Pre-proline 0 CA--C 1.558 1.266 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.922 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -59.13 -178.48 0.14 Allowed 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 120.471 0.781 . . . . 0.0 111.679 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.32 -19.79 19.67 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.101 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.76 160.95 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 119.361 -0.935 . . . . 0.0 110.666 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.0 m -74.6 74.38 2.0 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.614 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 t -69.43 128.23 32.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.201 -0.999 . . . . 0.0 110.998 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.55 HH21 ' HH ' ' A' ' 31' ' ' TYR . 9.3 ttt180 -55.15 -60.47 3.34 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.092 -1.043 . . . . 0.0 110.037 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.55 ' HH ' HH21 ' A' ' 30' ' ' ARG . 1.1 p90 -168.95 170.16 9.19 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 118.424 -1.311 . . . . 0.0 112.746 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.05 144.32 48.98 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.189 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.34 109.53 16.4 Favored 'General case' 0 N--CA 1.509 2.494 0 C-N-CA 118.999 -1.081 . . . . 0.0 110.244 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.2 mp -96.97 113.95 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.34 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 64.2 p -113.43 142.78 45.49 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.935 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -146.71 151.77 37.74 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.753 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.88 164.92 19.03 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -53.5 155.79 2.81 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.765 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.463 ' OG1' ' OG1' ' A' ' 69' ' ' THR . 1.8 m -75.38 -13.07 60.38 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.304 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.95 -92.83 0.05 OUTLIER Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.544 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 43' ' ' SER . . . 143.91 -4.87 1.67 Allowed Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.608 -1.282 . . . . 0.0 109.947 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.61 2.99 4.37 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.455 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 41' ' ' GLY . 43.2 p -176.26 74.85 0.27 Allowed Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.834 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.64 114.44 2.39 Favored 'Trans proline' 0 C--N 1.326 -0.645 0 C-N-CA 121.23 1.287 . . . . 0.0 111.288 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.439 ' CG1' ' N ' ' A' ' 46' ' ' GLN . 50.9 t -52.77 -89.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.944 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.467 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -175.99 -166.35 0.18 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.162 -1.415 . . . . 0.0 111.753 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -160.25 169.22 23.66 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.916 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.488 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 19.0 p90 -161.03 131.08 5.0 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.674 -0.811 . . . . 0.0 109.901 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.27 166.25 11.07 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.15 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.581 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -146.72 159.16 44.72 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.936 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.47 15.84 0.05 OUTLIER 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 121.135 1.223 . . . . 0.0 112.298 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 62.29 24.21 65.22 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.208 -1.473 . . . . 0.0 110.116 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.35 -36.92 11.19 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.107 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -89.83 116.3 27.81 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.8 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.63 4.42 24.89 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.68 159.43 42.0 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.474 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.45 164.29 21.99 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.434 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.6 m -134.02 146.82 50.74 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.479 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -137.36 158.0 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.052 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.6 m -149.56 174.45 12.52 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.655 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.71 12.73 52.74 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.777 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.07 -158.77 0.67 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.626 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.02 122.19 4.18 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.598 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.71 144.3 97.1 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 120.512 0.808 . . . . 0.0 111.336 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.61 50.77 4.1 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.762 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.6 p -165.16 139.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.419 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.402 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -64.41 133.33 52.33 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.929 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -132.0 129.86 40.67 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.174 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.463 ' OG1' ' OG1' ' A' ' 39' ' ' THR . 0.1 OUTLIER -107.2 128.89 54.82 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.914 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.404 ' C ' ' HG1' ' A' ' 71' ' ' THR . 4.4 tt -119.7 145.0 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.409 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.404 ' HG1' ' C ' ' A' ' 70' ' ' ILE . 81.4 m -142.43 125.26 16.04 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.525 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.57 137.0 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 119.613 -0.835 . . . . 0.0 111.011 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -110.18 143.82 39.75 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.37 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.5 91.25 3.49 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.612 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.8 t -102.91 117.2 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.485 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.556 ' CG2' ' N ' ' A' ' 77' ' ' GLY . 14.0 t -116.57 -42.79 2.96 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.218 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.556 ' N ' ' CG2' ' A' ' 76' ' ' THR . . . -63.49 176.36 8.46 Favored Glycine 0 C--N 1.28 -2.552 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.79 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -89.47 -50.74 5.92 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.971 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -100.82 -107.75 3.0 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.62 -7.05 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.769 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.554 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -85.95 -42.55 0.61 Allowed Pre-proline 0 C--N 1.304 -1.406 0 C-N-CA 119.406 -0.917 . . . . 0.0 112.862 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 81' ' ' SER . 3.2 Cg_exo -66.71 -76.78 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 120.843 1.029 . . . . 0.0 112.167 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.02 110.21 11.47 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.738 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 85' ' ' SER . 0.1 OUTLIER -130.48 105.87 8.15 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.955 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 84' ' ' SER . 5.8 p -55.61 -162.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.089 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -128.68 123.74 22.28 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.118 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -65.4 154.82 71.88 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 120.404 0.736 . . . . 0.0 110.501 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -145.4 153.45 13.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.961 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.9 p -151.06 153.72 35.62 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.774 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.7 143.22 21.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.732 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.09 153.64 18.03 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.316 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -169.26 135.29 1.63 Allowed 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.322 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -79.86 106.71 12.08 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.312 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.887 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -176.5 161.42 2.17 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.776 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.74 84.64 0.82 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.427 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 5' ' ' PRO . 72.2 t -128.23 94.24 36.65 Favored Pre-proline 0 N--CA 1.488 1.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.095 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.401 ' O ' ' O ' ' A' ' 4' ' ' VAL . 1.2 Cg_endo -62.69 -132.86 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.698 0 C-N-CA 120.436 0.757 . . . . 0.0 110.436 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 22' ' ' TRP . 8.2 ptm180 -170.8 162.34 7.56 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 117.28 -1.768 . . . . 0.0 115.001 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -21.32 108.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 112.983 -1.917 . . . . 0.0 115.046 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -51.09 120.55 5.04 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.422 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 10' ' ' VAL . 18.5 tt0 -173.03 162.19 4.54 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.534 -1.266 . . . . 0.0 112.271 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.444 ' N ' ' CG ' ' A' ' 9' ' ' GLU . 61.5 t -91.44 114.36 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.33 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.22 -52.45 15.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 118.825 -1.15 . . . . 0.0 111.422 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -147.66 158.32 43.96 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.951 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.11 106.72 4.08 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 16' ' ' THR . 1.0 OUTLIER -104.69 155.21 37.8 Favored Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.631 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.43 3.28 0.2 Allowed 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 121.147 1.231 . . . . 0.0 112.353 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.513 ' H ' ' C ' ' A' ' 14' ' ' THR . 3.0 m -149.38 24.11 0.91 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.859 -1.136 . . . . 0.0 111.477 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.441 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.1 OUTLIER 175.96 145.17 0.08 Allowed 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.296 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.46 124.64 32.47 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.387 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 tt -95.66 102.21 13.99 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.635 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 pp -109.68 143.5 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.446 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.76 139.28 53.79 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.569 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.48 ' O ' ' O ' ' A' ' 6' ' ' ARG . 46.9 p90 -119.24 180.0 4.01 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 118.125 -1.43 . . . . 0.0 113.726 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 24' ' ' ALA . 28.6 t70 -135.73 168.62 18.95 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 113.584 -1.644 . . . . 0.0 110.906 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -179.4 179.33 0.3 Allowed Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.78 162.0 26.8 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 120.625 0.883 . . . . 0.0 111.147 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.84 2.64 48.36 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.324 -0.951 . . . . 0.0 112.227 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.0 m -63.21 160.52 2.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.593 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.1 m -70.29 100.73 1.77 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.539 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 63.5 t -87.48 140.77 15.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.82 -43.28 13.43 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.555 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -143.34 176.12 9.39 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.818 -1.153 . . . . 0.0 112.323 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -144.06 137.27 27.49 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.663 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -129.23 110.17 11.75 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.17 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -101.68 112.89 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.758 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 p -113.84 135.06 54.38 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.585 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -140.07 154.48 47.08 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 118.61 -1.236 . . . . 0.0 111.026 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.93 162.42 22.19 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 39' ' ' THR . 1.4 tm-20 -55.6 152.69 8.84 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.549 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.482 ' N ' ' CD ' ' A' ' 38' ' ' GLU . 0.9 OUTLIER -75.23 144.77 42.44 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.242 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 40.0 41.74 2.07 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 119.884 -1.151 . . . . 0.0 111.016 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.15 149.41 18.71 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.664 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -87.86 35.91 0.75 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.751 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 p 179.25 68.5 0.13 Allowed Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.042 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -57.32 139.51 90.3 Favored 'Trans proline' 0 C--N 1.322 -0.854 0 C-N-CA 121.121 1.214 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 83.7 t -49.05 -84.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.67 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -172.0 -159.0 0.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.578 -1.249 . . . . 0.0 111.678 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -165.71 156.63 13.62 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.802 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 3.5 p90 -146.72 154.76 41.79 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.569 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.4 p -115.69 155.98 26.75 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.738 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.597 ' C ' ' H ' ' A' ' 52' ' ' GLY . 32.9 m -148.77 151.43 35.35 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.661 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.92 19.89 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.06 1.173 . . . . 0.0 112.597 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 60.22 24.63 61.34 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.474 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -45.02 16.42 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.002 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -89.15 144.87 25.81 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.838 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.5 m -96.01 -12.22 25.29 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.262 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.9 p -138.35 177.3 7.98 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.399 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.11 151.61 4.01 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.824 -1.15 . . . . 0.0 111.294 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.6 m -112.65 104.05 12.11 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.982 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.37 166.82 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.262 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.4 t -142.97 -179.0 6.1 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.963 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.52 60.21 1.38 Allowed Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.528 -1.32 . . . . 0.0 109.952 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.93 -155.55 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.908 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -150.73 137.43 11.36 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.054 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.64 151.94 82.71 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 120.915 1.077 . . . . 0.0 112.672 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.97 77.91 0.08 OUTLIER Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.932 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -162.27 144.28 3.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.005 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.438 ' CG ' HD22 ' A' ' 91' ' ' ASN . 6.8 t70 -76.26 117.02 17.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.293 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -117.54 129.56 55.87 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.537 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.2 120.67 39.91 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.34 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.405 ' C ' ' HG1' ' A' ' 71' ' ' THR . 1.2 tt -111.38 146.47 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.437 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.405 ' HG1' ' C ' ' A' ' 70' ' ' ILE . 20.6 m -148.69 141.64 24.78 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.184 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.63 131.8 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.285 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -104.6 123.12 47.0 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.19 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.31 89.99 5.29 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.47 118.41 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.98 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 69.6 p -125.24 -116.03 0.28 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.032 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.524 ' N ' ' OG1' ' A' ' 76' ' ' THR . . . 85.55 170.17 46.79 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.959 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.41 -39.47 17.52 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.754 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -93.0 -96.89 1.44 Allowed Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.292 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.87 -77.65 0.57 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.002 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.502 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 1.3 m -131.04 50.13 5.65 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.562 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 81' ' ' SER . 1.6 Cg_endo -56.7 -74.83 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 120.989 1.126 . . . . 0.0 110.801 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.2 121.76 25.4 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.709 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.0 t -55.11 149.71 11.8 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.612 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.555 ' HG ' ' H ' ' A' ' 86' ' ' LYS . 1.8 p -83.29 -94.35 0.06 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.734 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.555 ' H ' ' HG ' ' A' ' 85' ' ' SER . 0.0 OUTLIER -155.54 79.41 4.36 Favored Pre-proline 0 C--N 1.296 -1.755 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.996 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -52.43 171.54 0.2 Allowed 'Trans proline' 0 C--O 1.216 -0.576 0 C-N-CA 120.898 1.065 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 10.3 tt -144.79 131.74 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 118.529 -1.268 . . . . 0.0 111.465 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.401 ' OG ' ' CG2' ' A' ' 71' ' ' THR . 31.8 m -120.38 155.74 32.8 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.657 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.86 135.46 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.534 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.438 HD22 ' CG ' ' A' ' 67' ' ' ASP . 10.5 t30 -86.13 133.66 33.86 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.59 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -140.48 132.27 27.46 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.321 -0.951 . . . . 0.0 111.174 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.04 105.82 18.03 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.091 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 116.431 -1.747 . . . . 0.0 110.868 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.978 0.418 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t -66.02 -159.97 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.03 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -151.91 48.32 0.79 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.944 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.2 t -48.9 147.08 4.9 Favored Pre-proline 0 C--N 1.304 -1.372 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.329 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -46.39 167.71 0.06 OUTLIER 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 120.769 0.98 . . . . 0.0 111.043 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.98 177.69 4.64 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.734 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' LEU . 1.8 t70 -47.4 100.24 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.89 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 7' ' ' ASP . 2.3 mm? -43.36 164.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.219 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -149.71 147.91 28.62 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.241 -1.384 . . . . 0.0 112.412 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.5 t -103.51 111.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.031 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.87 -27.35 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.693 -1.203 . . . . 0.0 111.951 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.09 151.05 27.87 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.851 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.32 121.06 7.54 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.297 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.56 ' C ' ' H ' ' A' ' 16' ' ' THR . 1.1 p -134.13 153.49 79.61 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.32 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -64.29 10.48 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 120.98 1.12 . . . . 0.0 111.648 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.56 ' H ' ' C ' ' A' ' 14' ' ' THR . 5.0 m -140.84 6.31 2.01 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.051 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 p 179.26 148.82 0.25 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.307 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.81 120.08 27.06 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.462 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.8 tt -98.07 102.42 14.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.924 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 pp -100.25 155.21 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.503 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.37 143.74 30.29 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.0 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.615 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 3.7 p90 -145.07 -148.43 0.24 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.216 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.615 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 30.4 t70 -110.36 177.94 4.54 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.559 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . -170.28 89.35 0.52 Allowed Pre-proline 0 C--N 1.303 -1.433 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.011 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -56.99 169.79 1.77 Allowed 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 120.871 1.048 . . . . 0.0 112.214 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.82 -7.4 57.31 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.683 -0.807 . . . . 0.0 112.176 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 m -59.59 161.82 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 118.525 -1.27 . . . . 0.0 110.008 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.2 m -67.33 84.68 0.16 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.885 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -83.1 116.94 28.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.008 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.414 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 4.3 mtp180 -54.51 -48.58 71.74 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.35 -1.34 . . . . 0.0 108.93 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.414 ' CG ' ' C ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER 175.93 164.58 0.37 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.849 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -114.01 155.16 26.39 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.11 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.613 ' HE ' ' CG2' ' A' ' 49' ' ' THR . 4.0 ttm180 -135.15 107.52 7.29 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.405 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.3 mt -98.96 109.07 23.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.864 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 45.1 p -113.01 134.56 54.46 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.471 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.437 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 9.7 p90 -136.9 153.37 50.76 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.262 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.88 149.41 9.21 Favored Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -86.65 139.83 30.41 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.729 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.9 m -67.68 130.12 42.02 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.889 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.7 -23.93 0.02 OUTLIER Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.392 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.62 -2.37 77.05 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.374 -1.393 . . . . 0.0 110.642 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -77.77 -69.32 0.55 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.736 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.35 130.83 0.42 Allowed Pre-proline 0 C--N 1.305 -1.349 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.434 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -61.69 151.52 79.91 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 120.482 0.788 . . . . 0.0 110.948 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.1 t -61.77 -78.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 118.947 -1.101 . . . . 0.0 110.677 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -173.34 -167.75 0.41 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.976 -1.09 . . . . 0.0 111.527 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -153.34 170.2 21.23 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.918 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -159.07 129.56 5.91 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.202 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.613 ' CG2' ' HE ' ' A' ' 33' ' ' ARG . 34.3 p -95.95 162.21 13.66 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.436 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.596 ' C ' ' H ' ' A' ' 52' ' ' GLY . 35.3 m -150.33 150.58 29.49 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.717 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.86 9.87 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 120.92 1.08 . . . . 0.0 112.225 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 72.93 13.56 78.93 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.244 -1.455 . . . . 0.0 109.949 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.25 -29.89 22.77 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.629 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -80.86 118.36 22.3 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.284 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.47 -15.37 57.89 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.371 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.0 p -144.46 176.79 9.12 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.485 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -171.79 160.52 5.63 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.219 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -121.54 143.56 49.21 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.274 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.32 163.9 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.805 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.2 m -143.21 -170.72 3.33 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.442 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.71 55.14 4.66 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.309 -1.424 . . . . 0.0 110.495 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.61 -158.52 0.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.707 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -140.28 155.05 70.41 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.295 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.28 102.55 0.39 Allowed 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.315 1.343 . . . . 0.0 112.739 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.89 95.82 0.03 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.537 -1.315 . . . . 0.0 111.474 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.9 p -157.54 137.5 4.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.826 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -50.59 116.17 1.81 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.763 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.67 130.11 52.59 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.79 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.1 m -117.67 126.47 52.56 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.564 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.57 157.19 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.419 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.08 117.09 10.51 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.448 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.1 m -111.43 126.64 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.557 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -109.16 130.3 55.49 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.157 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.33 91.48 3.67 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.217 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.1 t -91.91 123.2 43.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.081 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.489 ' HG1' ' N ' ' A' ' 77' ' ' GLY . 3.7 p -102.74 -160.98 0.81 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.994 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.489 ' N ' ' HG1' ' A' ' 76' ' ' THR . . . -101.46 -143.78 14.25 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.641 -1.266 . . . . 0.0 111.568 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.686 ' HE ' ' N ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -121.23 -165.32 1.22 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.546 0.688 . . . . 0.0 111.596 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.686 ' N ' ' HE ' ' A' ' 78' ' ' ARG . . . 170.2 -7.22 0.04 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 106.827 -2.509 . . . . 0.0 106.827 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.407 ' H ' ' H ' ' A' ' 79' ' ' GLY . 19.1 t0 178.43 -57.84 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.36 163.96 45.79 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 113.951 -1.477 . . . . 0.0 107.695 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -52.66 107.43 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 120.376 0.717 . . . . 0.0 110.362 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -79.23 47.93 0.84 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.473 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 t -74.85 130.83 40.12 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.611 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.485 ' OG ' ' N ' ' A' ' 86' ' ' LYS . 24.4 p -78.57 -141.99 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.805 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.485 ' N ' ' OG ' ' A' ' 85' ' ' SER . 8.8 tttm -130.47 121.17 19.19 Favored Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.454 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.93 157.14 40.03 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 120.51 0.807 . . . . 0.0 111.556 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.8 tt -144.42 139.62 24.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.378 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 7.2 p -128.48 160.42 32.36 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.817 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.0 pt -144.72 139.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.763 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.58 110.73 21.88 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.756 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 93' ' ' ARG . 5.9 t80 -143.05 138.82 30.21 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.616 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.436 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 10.5 mtp180 -72.16 110.59 6.72 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.597 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 116.371 -1.776 . . . . 0.0 110.984 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.991 0.424 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 m -149.36 111.01 4.51 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.67 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -141.06 33.95 1.73 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.149 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 t -92.77 127.61 47.22 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.345 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.42 172.06 3.74 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 120.457 0.771 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -175.62 -178.79 1.14 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.914 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.13 19.95 11.89 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.847 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.454 ' H ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -81.82 106.92 14.13 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.609 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -154.45 176.29 12.54 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.876 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 t -93.78 132.95 36.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.797 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.531 ' CG2' ' HG ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -111.69 -4.36 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.13 -179.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.8 144.86 2.33 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.434 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.91 102.15 3.85 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.843 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.593 ' C ' ' H ' ' A' ' 16' ' ' THR . 22.6 p -97.15 152.5 38.33 Favored Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.271 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.36 14.12 0.04 OUTLIER 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 121.305 1.337 . . . . 0.0 112.726 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.593 ' H ' ' C ' ' A' ' 14' ' ' THR . 3.2 m -159.64 21.62 0.18 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.032 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.435 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER 173.93 149.73 0.08 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.182 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.37 157.72 37.77 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.416 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.6 116.71 21.45 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.264 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pt -106.0 152.27 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.102 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.531 ' HG ' ' CG2' ' A' ' 11' ' ' VAL . 2.4 m -150.27 124.78 9.62 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.029 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.529 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 7.2 p90 -129.47 -163.77 1.33 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.419 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 30.9 t70 -103.59 173.46 6.29 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -158.81 105.91 1.6 Allowed Pre-proline 0 CA--C 1.56 1.345 0 CA-C-N 114.431 -1.258 . . . . 0.0 109.302 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -58.1 -171.06 0.04 OUTLIER 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 120.757 0.972 . . . . 0.0 112.401 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -105.34 -3.3 22.87 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.006 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' VAL . 2.3 t -58.26 159.46 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.018 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.92 89.14 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.932 -1.107 . . . . 0.0 109.748 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' VAL . 26.3 t -91.88 119.29 39.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.721 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.545 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 2.7 mmp_? -79.83 -67.86 0.72 Allowed 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 118.931 -1.107 . . . . 0.0 109.548 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.545 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 2.1 m-85 -149.35 154.37 38.85 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.646 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -110.35 165.46 11.76 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -146.87 110.76 5.0 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.319 -1.352 . . . . 0.0 110.697 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.4 mp -102.66 117.53 48.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.511 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 p -119.14 135.22 54.77 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.137 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -124.54 156.41 37.38 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.661 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.22 130.47 1.41 Allowed Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.341 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -75.53 143.71 42.32 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.635 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 m -65.23 155.55 34.74 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.778 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.508 ' C ' ' H ' ' A' ' 42' ' ' ASN . . . 152.35 2.79 0.19 Allowed Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.464 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.53 -3.49 3.54 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.191 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.508 ' H ' ' C ' ' A' ' 40' ' ' GLY . 13.1 m-80 -65.33 -88.72 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.516 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.2 163.65 10.06 Favored Pre-proline 0 C--N 1.304 -1.373 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.612 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -64.49 151.82 84.05 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.538 1.492 . . . . 0.0 111.802 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.7 t -82.0 -61.33 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.874 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -173.36 177.78 2.54 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.661 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -167.35 166.1 14.72 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.894 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -162.12 157.48 23.35 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.907 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.4 p -102.66 166.07 10.71 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.159 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.597 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -153.49 147.04 18.22 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.512 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.0 OUTLIER -59.85 17.98 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.393 1.396 . . . . 0.0 112.989 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 62.43 -2.21 1.25 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -81.0 -43.35 19.74 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.433 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HZ2' ' HG1' ' A' ' 56' ' ' THR . 0.0 OUTLIER -77.42 104.55 8.01 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.914 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 m -79.24 8.15 6.48 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.085 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.53 ' HG1' ' HZ2' ' A' ' 54' ' ' LYS . 1.9 p -137.5 159.62 41.44 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.518 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.57 144.5 3.61 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.332 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.3 m -95.33 146.33 24.46 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.308 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 tt -141.08 145.33 25.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.842 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.24 167.51 22.26 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.061 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.66 49.27 1.11 Allowed Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.796 -1.192 . . . . 0.0 110.867 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.99 -156.45 0.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.434 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -144.32 158.99 53.57 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.801 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.71 106.49 0.37 Allowed 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 121.384 1.389 . . . . 0.0 112.013 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.74 89.19 0.03 OUTLIER Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.472 -1.347 . . . . 0.0 111.05 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.2 136.68 12.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.926 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -52.75 124.05 12.9 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.009 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.32 126.84 41.57 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.445 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.2 m -107.84 110.85 22.73 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.103 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -96.19 137.35 24.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.23 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.7 m -138.31 139.17 38.97 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.286 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.44 139.08 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.066 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.462 ' CE2' ' CG ' ' A' ' 87' ' ' PRO . 1.7 m-85 -118.56 113.89 21.97 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.783 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.03 125.56 35.86 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.953 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.92 100.91 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.621 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 77' ' ' GLY . 1.6 p -95.79 -40.19 9.47 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.251 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 76' ' ' THR . . . 51.54 103.9 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.286 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.57 148.41 32.22 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.948 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.37 -106.5 2.06 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.137 -1.506 . . . . 0.0 109.984 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -149.49 -49.48 0.14 Allowed 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.101 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.8 146.25 95.07 Favored Pre-proline 0 C--N 1.306 -1.326 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.794 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.25 119.61 6.85 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.092 1.195 . . . . 0.0 111.406 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.53 80.83 1.97 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.727 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 t -63.79 148.03 50.29 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.666 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.1 m -84.9 -99.9 0.06 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -155.76 81.85 3.8 Favored Pre-proline 0 C--N 1.298 -1.662 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.821 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.462 ' CG ' ' CE2' ' A' ' 73' ' ' TYR . 12.6 Cg_exo -53.62 161.42 4.33 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 120.94 1.093 . . . . 0.0 110.687 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.42 162.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 118.491 -1.284 . . . . 0.0 111.403 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.6 p -147.74 157.66 43.65 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.085 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.7 pt -144.15 143.5 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.711 -0.795 . . . . 0.0 110.68 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -93.77 149.78 20.95 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.133 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -172.26 132.96 0.65 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.644 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.65 122.8 28.59 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.326 -0.949 . . . . 0.0 110.379 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 116.336 -1.792 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 121.034 0.445 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.8 p -150.95 41.18 0.75 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.389 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -154.42 53.17 0.67 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.429 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 t -105.21 135.91 19.26 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.664 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.77 158.09 21.63 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 120.748 0.965 . . . . 0.0 111.206 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.61 -176.0 0.83 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.327 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 45.63 62.94 1.98 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.783 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mt -101.05 120.74 40.65 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.133 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -158.27 176.45 12.46 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.418 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.24 124.2 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.937 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 t -69.5 -72.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.171 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.84 174.29 11.62 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.777 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -131.7 168.37 17.87 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.13 160.64 36.8 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.278 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 16' ' ' THR . 2.6 Cg_exo -50.54 99.64 0.04 OUTLIER 'Trans proline' 0 C--O 1.212 -0.786 0 C-N-CA 120.656 0.904 . . . . 0.0 111.092 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.463 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.6 OUTLIER 75.05 41.03 0.32 Allowed 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.304 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.48 141.05 2.9 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.12 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 tp -130.25 152.07 50.08 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.7 tp -126.11 110.55 13.64 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.157 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -101.63 157.79 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.441 -0.903 . . . . 0.0 111.228 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.64 137.57 18.13 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.552 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.485 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 8.2 p90 -135.96 -149.77 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.952 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.485 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 10.2 t70 -136.09 133.23 37.11 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.279 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.58 135.83 20.06 Favored Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.335 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.76 178.4 0.49 Allowed 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.584 0.856 . . . . 0.0 111.485 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -102.58 52.21 0.8 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.023 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.5 m -135.41 169.53 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.059 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -69.4 75.92 0.38 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.233 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.32 130.13 30.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.658 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.444 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 20.5 mmm-85 -76.32 -61.06 2.07 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.217 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 75.9 m-85 -154.16 169.56 23.3 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.297 -1.361 . . . . 0.0 112.68 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.56 133.51 38.43 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.744 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -123.27 118.88 28.59 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.889 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.5 mt -101.03 123.31 53.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.9 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 p -124.59 136.36 53.89 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.543 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 7.9 p90 -139.83 161.65 37.05 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.81 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.5 152.31 13.15 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.442 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.91 145.04 38.49 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.557 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.8 m -69.76 141.18 53.46 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.792 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.22 -39.14 0.15 Allowed Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.374 -1.394 . . . . 0.0 110.492 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.23 -108.65 0.27 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.302 -1.428 . . . . 0.0 110.504 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -126.27 67.33 1.21 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.428 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.3 t -143.45 70.43 17.67 Favored Pre-proline 0 C--N 1.307 -1.264 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.181 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.22 132.68 34.85 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.402 1.401 . . . . 0.0 111.174 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.1 t -55.57 -68.7 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 118.956 -1.098 . . . . 0.0 110.293 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -171.7 -159.22 0.14 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.012 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.31 172.15 7.42 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.315 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -161.79 138.08 8.02 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.941 -1.104 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.9 p -86.65 152.35 22.65 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.152 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.2 p -165.13 136.55 3.25 Favored Pre-proline 0 C--N 1.301 -1.522 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.44 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.513 ' C ' ' H ' ' A' ' 53' ' ' SER . 3.5 Cg_exo -51.94 134.95 50.27 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 120.295 0.663 . . . . 0.0 111.471 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.18 3.61 1.07 Allowed Glycine 0 N--CA 1.484 1.898 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.899 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.513 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -68.87 -34.62 75.75 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 118.876 -1.13 . . . . 0.0 110.285 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -79.68 119.65 22.91 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.796 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.5 -7.17 59.58 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.236 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.6 p -137.37 160.16 39.87 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.605 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.95 141.96 17.1 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.311 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.9 m -101.98 144.04 31.09 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.436 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.4 tt -141.33 149.34 20.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.204 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 16' ' ' THR . 14.2 t -149.25 124.99 10.47 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.748 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.07 14.81 0.1 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.287 -1.435 . . . . 0.0 110.541 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.31 -155.17 0.48 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.716 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -130.25 145.62 58.12 Favored Pre-proline 0 N--CA 1.493 1.703 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.4 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -71.07 121.87 8.24 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 120.863 1.042 . . . . 0.0 113.022 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.18 89.85 0.07 OUTLIER Glycine 0 N--CA 1.502 3.063 0 C-N-CA 119.989 -1.101 . . . . 0.0 112.93 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.9 p -171.89 148.86 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.176 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.15 142.02 57.19 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.792 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -144.08 151.37 39.53 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.25 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.83 125.02 46.47 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.516 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.3 tp -111.49 136.16 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.132 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 87.5 m -138.91 121.92 16.73 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.632 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.7 m -105.6 144.02 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.137 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.47 92.27 3.9 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.417 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.48 90.27 5.65 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.248 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 t -77.26 114.11 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.629 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 p -140.07 131.31 26.6 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.469 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -148.44 104.85 0.29 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 79' ' ' GLY . 2.2 ttp-105 -118.88 -94.27 0.5 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.367 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 78' ' ' ARG . . . -48.78 -103.29 0.01 OUTLIER Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.606 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -131.22 -3.5 3.9 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.102 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.61 160.44 0.46 Allowed Pre-proline 0 C--N 1.304 -1.392 0 C-N-CA 118.976 -1.089 . . . . 0.0 110.227 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.484 ' C ' ' H ' ' A' ' 84' ' ' SER . 3.0 Cg_endo -63.23 109.28 0.94 Allowed 'Trans proline' 0 C--O 1.216 -0.59 0 C-N-CA 121.203 1.269 . . . . 0.0 111.433 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.79 -14.4 0.13 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.371 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -68.66 103.0 1.61 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.41 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -43.69 167.77 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.938 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -117.06 86.41 20.13 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.31 144.6 98.65 Favored 'Trans proline' 0 C--O 1.213 -0.771 0 C-N-CA 121.067 1.178 . . . . 0.0 113.526 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 8.7 tt -143.75 129.92 16.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.854 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.0 p -129.84 165.12 22.65 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.275 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -151.45 146.86 15.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.415 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.15 149.28 28.04 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.219 -0.993 . . . . 0.0 110.194 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -158.44 134.81 9.37 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.194 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.75 114.28 26.52 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.979 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 116.27 -1.824 . . . . 0.0 110.955 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 2' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 1' ' ' VAL . 0.8 OUTLIER 57.19 113.2 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.741 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.97 -11.9 8.05 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.869 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.01 136.45 96.69 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.89 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.65 172.97 1.8 Allowed 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 120.621 0.881 . . . . 0.0 111.406 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -158.48 168.08 27.91 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.504 -0.879 . . . . 0.0 110.689 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 53.44 60.2 3.87 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.602 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -100.31 135.17 42.16 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.179 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -178.26 176.89 1.04 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 118.729 -1.189 . . . . 0.0 111.97 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.0 t -99.09 116.04 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.964 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.467 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 5.5 t -71.1 -25.43 25.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.797 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 11' ' ' VAL . . . 163.78 168.6 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.78 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -129.22 157.93 40.44 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.155 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.68 161.93 28.77 Favored Pre-proline 0 C--N 1.305 -1.334 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.767 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 16' ' ' THR . 6.1 Cg_exo -54.65 106.22 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 121.217 1.278 . . . . 0.0 111.849 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.464 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER 74.54 34.11 0.79 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.856 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 99.5 p -172.14 138.77 1.02 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.026 -1.07 . . . . 0.0 111.199 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.0 tp -131.05 122.3 26.52 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.902 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.94 113.64 25.2 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.354 -0.938 . . . . 0.0 112.156 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 pt -105.41 167.11 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.549 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -160.66 133.98 6.68 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.324 -1.35 . . . . 0.0 111.807 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.59 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 4.9 p90 -139.25 -142.46 0.15 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.053 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.59 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 5.6 t70 -140.73 159.29 42.53 Favored 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 118.634 -1.227 . . . . 0.0 113.042 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.425 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -147.12 115.59 4.32 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.945 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.34 -169.77 0.1 OUTLIER 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 120.392 0.728 . . . . 0.0 111.775 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.17 5.59 30.14 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -68.61 169.74 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 118.512 -1.275 . . . . 0.0 110.838 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.2 m -68.71 73.55 0.25 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.554 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.431 ' N ' ' O ' ' A' ' 27' ' ' VAL . 2.4 t -70.08 127.92 32.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.985 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.405 ' CG ' ' CE2' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -68.75 -50.65 48.84 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.433 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.405 ' CE2' ' CG ' ' A' ' 30' ' ' ARG . 0.7 OUTLIER 177.28 168.89 0.6 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.9 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -121.92 165.33 16.12 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.334 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -141.03 106.92 5.14 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.505 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.8 mt -98.43 111.55 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.43 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 p -124.34 133.22 53.5 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.106 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -128.27 138.88 52.62 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.13 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -154.01 137.84 5.93 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.223 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -67.2 163.79 19.59 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.596 -0.842 . . . . 0.0 111.126 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.4 t -66.67 131.02 45.09 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.54 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.46 81.76 0.06 OUTLIER Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.158 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 43' ' ' SER . . . -143.77 111.78 0.65 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.99 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -59.38 -5.29 0.74 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.424 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 41' ' ' GLY . 30.2 m -145.57 93.81 5.25 Favored Pre-proline 0 C--N 1.303 -1.438 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.227 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.56 151.58 45.58 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 120.428 0.752 . . . . 0.0 110.915 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.3 t -49.39 -75.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.987 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -171.84 169.54 5.77 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.837 -1.145 . . . . 0.0 111.466 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.76 159.47 44.11 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.298 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -168.76 134.38 1.7 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 118.941 -1.104 . . . . 0.0 111.053 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.5 162.32 14.26 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.058 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.594 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -145.96 161.56 39.29 Favored Pre-proline 0 C--N 1.307 -1.265 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.104 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.96 20.09 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 120.925 1.083 . . . . 0.0 111.858 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 55.2 22.89 31.06 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.335 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.24 -40.04 9.36 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.989 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -72.82 117.2 14.24 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.77 -23.15 42.4 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.664 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.5 p -125.01 161.65 26.24 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.0 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.83 150.89 26.53 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.75 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.2 m -123.72 108.0 12.07 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.419 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.2 pt -108.75 159.24 8.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.832 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 16' ' ' THR . 15.3 t -145.27 140.99 28.2 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.181 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 164.0 11.11 0.03 OUTLIER Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.455 -1.355 . . . . 0.0 110.872 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -131.09 150.59 52.08 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.886 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.669 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -126.24 -38.33 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.851 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.026 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.669 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 5.4 Cg_endo -80.81 -168.57 0.65 Allowed 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 121.425 1.417 . . . . 0.0 111.629 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -130.42 73.54 0.46 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.491 ' CG2' ' N ' ' A' ' 67' ' ' ASP . 14.1 p -114.14 174.5 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.573 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.491 ' N ' ' CG2' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -59.97 140.34 56.81 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.991 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.35 123.41 20.32 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.553 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.85 113.23 25.97 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.17 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -102.19 150.11 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.108 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -144.52 127.45 16.41 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.507 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.54 143.72 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.765 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -114.3 137.15 52.16 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.656 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.77 97.86 5.83 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.26 132.99 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.28 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 77' ' ' GLY . 4.0 m -137.97 -20.21 1.13 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.832 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 76' ' ' THR . . . 33.4 -110.03 0.05 OUTLIER Glycine 0 N--CA 1.503 3.132 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.817 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -58.98 158.51 8.34 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.872 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.28 -27.89 2.84 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.141 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 170.9 -58.02 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.432 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -116.65 83.96 14.6 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.448 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.63 83.77 0.08 OUTLIER 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 120.676 0.917 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 81' ' ' SER . . . -130.7 101.1 5.53 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.553 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.8 p -49.71 108.75 0.22 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.809 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.87 -168.32 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -133.25 136.29 27.04 Favored Pre-proline 0 N--CA 1.487 1.413 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.833 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.73 149.27 88.61 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 120.681 0.92 . . . . 0.0 111.64 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.3 tt -137.09 135.06 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.117 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.04 164.81 27.14 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.196 -1.002 . . . . 0.0 112.697 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -146.37 154.13 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.574 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.57 145.75 29.57 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.257 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -159.98 147.27 16.45 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.164 -1.015 . . . . 0.0 111.075 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.556 ' N ' ' CD ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -88.01 103.24 15.52 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.739 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 116.503 -1.713 . . . . 0.0 110.614 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 74.4 t . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.863 0.363 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -88.96 -75.29 0.44 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.689 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -146.32 -51.02 0.22 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.421 -0.911 . . . . 0.0 110.661 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.3 t -90.54 132.82 34.15 Favored Pre-proline 0 C--N 1.306 -1.296 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.368 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -64.3 -65.56 0.05 OUTLIER 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 120.161 0.574 . . . . 0.0 111.64 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -167.08 -166.16 0.78 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 117.628 -1.629 . . . . 0.0 113.538 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.441 ' OD2' ' OE1' ' A' ' 9' ' ' GLU . 18.2 t0 -74.84 96.01 3.03 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.762 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 tt -43.74 112.74 0.42 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.316 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.469 ' O ' ' OG ' ' A' ' 21' ' ' SER . 5.8 pt-20 -179.04 163.81 1.37 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.632 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.2 t -75.75 132.89 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.361 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.475 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 9.2 p -104.61 -23.07 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 118.601 -1.239 . . . . 0.0 112.383 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.475 ' CB ' ' O ' ' A' ' 11' ' ' VAL . . . 165.78 174.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.568 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.39 152.31 42.71 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.715 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.435 ' OG1' ' OG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -116.95 163.41 22.96 Favored Pre-proline 0 N--CA 1.486 1.356 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.282 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.47 ' O ' ' OG1' ' A' ' 16' ' ' THR . 10.2 Cg_exo -46.84 103.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 120.54 0.827 . . . . 0.0 110.477 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 15' ' ' PRO . 1.6 p 69.7 37.9 1.79 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.597 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.435 ' OG ' ' OG1' ' A' ' 14' ' ' THR . 0.4 OUTLIER -157.54 145.96 19.28 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.312 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.6 tp -123.41 122.53 38.51 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.988 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.56 121.58 38.54 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.092 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -124.36 151.88 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.469 ' OG ' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -122.97 131.73 53.84 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.132 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.522 ' NE1' ' CE2' ' A' ' 32' ' ' TYR . 25.6 p90 -119.95 -175.01 2.89 Favored 'General case' 0 N--CA 1.513 2.711 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 178.05 157.02 0.41 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 112.826 -1.988 . . . . 0.0 110.446 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' N ' ' CD ' ' A' ' 25' ' ' PRO . . . 173.78 -46.46 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.49 ' CD ' ' OH ' ' A' ' 32' ' ' TYR . 1.0 OUTLIER -68.01 148.36 75.66 Favored 'Trans proline' 0 C--O 1.211 -0.853 0 C-N-CA 121.186 1.257 . . . . 0.0 113.786 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.61 -16.74 14.44 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.543 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.53 179.44 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.932 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 p -49.59 168.33 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 118.565 -1.254 . . . . 0.0 109.095 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.71 113.24 4.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.045 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -60.39 3.42 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 118.783 -1.167 . . . . 0.0 108.143 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -154.13 161.48 41.85 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.036 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.522 ' CE2' ' NE1' ' A' ' 22' ' ' TRP . 3.2 m-85 -108.03 164.1 12.57 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.351 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -147.05 95.13 2.52 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.191 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.5 mt -91.26 135.15 27.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.399 -0.921 . . . . 0.0 111.605 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 p -138.63 137.38 36.86 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.825 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -137.88 160.2 39.94 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.797 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.21 135.77 3.17 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.405 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.86 108.36 8.67 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.466 -0.893 . . . . 0.0 110.769 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.3 m -49.38 98.88 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.768 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.54 -56.62 0.08 OUTLIER Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.128 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.59 -174.07 8.78 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 119.406 -1.378 . . . . 0.0 110.315 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.84 5.12 47.59 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.823 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.59 150.07 30.03 Favored Pre-proline 0 C--N 1.307 -1.242 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.463 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -64.23 169.42 10.82 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 121.122 1.214 . . . . 0.0 111.612 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 t -75.99 -61.45 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.071 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -173.59 -170.26 0.58 Allowed 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.8 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -168.69 176.52 5.56 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.673 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -176.13 150.24 0.94 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.336 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.5 p -111.58 153.65 25.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.05 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.529 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -143.06 150.14 51.58 Favored Pre-proline 0 C--N 1.303 -1.453 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.905 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.521 ' C ' ' H ' ' A' ' 53' ' ' SER . 3.7 Cg_endo -65.78 28.74 0.1 OUTLIER 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 120.923 1.082 . . . . 0.0 112.483 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 53.59 8.6 0.9 Allowed Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.063 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.521 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -72.27 -32.14 66.38 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.547 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -95.72 154.44 17.22 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.29 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 m -104.01 -22.79 13.4 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.135 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.0 p -122.91 -175.25 3.12 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.324 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -171.11 175.09 4.43 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.297 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.8 t -131.08 141.71 50.2 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.528 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.2 mt -132.31 111.32 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.408 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -109.05 147.54 32.2 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.585 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.19 20.66 4.33 Favored Glycine 0 N--CA 1.501 2.996 0 C-N-CA 119.841 -1.171 . . . . 0.0 110.255 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.591 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -106.46 -174.28 2.5 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.42 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -136.84 122.55 13.21 Favored Pre-proline 0 N--CA 1.487 1.422 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.883 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.08 118.8 5.73 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 120.209 0.606 . . . . 0.0 111.671 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.38 64.7 0.7 Allowed Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.607 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 p -164.69 148.37 2.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 119.156 -1.017 . . . . 0.0 111.592 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -70.31 152.45 44.15 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.893 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.63 140.83 26.32 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.711 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.2 m -117.88 107.42 14.08 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.411 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.473 ' CG1' ' N ' ' A' ' 71' ' ' THR . 5.1 tt -102.61 160.92 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.014 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.473 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 91.0 m -160.5 139.59 10.58 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.167 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 m -131.36 123.71 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.663 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.89 129.99 53.13 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.392 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.19 104.18 14.3 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.99 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.28 121.04 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 119.049 -1.061 . . . . 0.0 112.443 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -89.95 -35.56 15.49 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.585 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.41 145.09 0.04 OUTLIER Glycine 0 N--CA 1.493 2.498 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.027 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.81 -27.14 7.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.678 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.0 -10.82 0.78 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.308 -1.425 . . . . 0.0 110.779 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -168.96 -57.13 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.343 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.7 115.8 62.38 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.849 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.07 100.69 0.37 Allowed 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 120.451 0.767 . . . . 0.0 111.248 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.07 127.85 32.94 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.745 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.27 116.53 15.03 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.842 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.483 ' OG ' ' N ' ' A' ' 86' ' ' LYS . 16.4 t -85.67 -104.41 0.06 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.736 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.483 ' N ' ' OG ' ' A' ' 85' ' ' SER . 47.3 tttt -137.95 62.68 34.59 Favored Pre-proline 0 N--CA 1.486 1.332 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.397 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.08 164.48 14.34 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 121.348 1.365 . . . . 0.0 110.572 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.3 tt -151.29 135.27 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 117.983 -1.487 . . . . 0.0 111.723 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.73 139.5 52.65 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.734 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 pt -149.7 157.94 6.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 118.749 -1.18 . . . . 0.0 111.806 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.4 ' ND2' ' H ' ' A' ' 91' ' ' ASN . 0.0 OUTLIER -95.97 159.77 14.8 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.796 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -167.69 130.86 1.66 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.06 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.3 mtm-85 -88.34 119.31 28.64 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.145 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 116.337 -1.792 . . . . 0.0 110.975 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.826 0.346 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.4 m -70.05 151.69 45.24 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.673 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -157.1 -14.93 0.09 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.138 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.08 134.57 80.64 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.292 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -57.95 173.24 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 120.522 0.814 . . . . 0.0 111.087 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.6 ptt85 -175.25 -163.27 0.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.489 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 57.05 7.76 0.46 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.822 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.424 ' O ' ' OE1' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -56.9 122.44 12.24 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.209 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -157.92 158.24 34.64 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.871 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.3 t -93.56 115.22 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.576 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.487 ' CG2' ' OG ' ' A' ' 21' ' ' SER . 2.2 t -70.75 -68.71 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 118.818 -1.153 . . . . 0.0 111.197 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.12 174.82 12.76 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.522 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.54 162.87 34.34 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.411 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -135.16 161.17 65.09 Favored Pre-proline 0 N--CA 1.484 1.238 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.734 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.76 -14.38 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 120.893 1.062 . . . . 0.0 110.944 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 14' ' ' THR . 7.8 p -158.4 50.8 0.4 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.69 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.56 143.13 0.18 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.437 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.5 tp -130.16 140.83 50.72 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.111 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.91 110.19 17.43 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.42 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 pp -106.41 147.04 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.487 ' OG ' ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -145.46 136.74 24.95 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.271 -0.971 . . . . 0.0 110.609 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.633 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 4.0 p90 -138.15 -144.43 0.18 Allowed 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.523 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.633 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 12.5 t70 -148.49 168.23 23.27 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.347 -1.341 . . . . 0.0 112.994 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.45 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . -133.14 145.67 57.84 Favored Pre-proline 0 N--CA 1.486 1.364 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.991 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.93 -176.88 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 120.798 0.999 . . . . 0.0 111.333 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.47 -30.75 14.27 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.74 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.536 ' CG2' ' N ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -61.74 164.21 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.593 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.536 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 1.0 OUTLIER -73.21 111.61 8.49 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.209 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.0 t -99.82 147.27 7.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.28 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -73.0 -70.17 0.37 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.484 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -158.66 163.24 37.06 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.61 -1.236 . . . . 0.0 112.046 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -121.0 152.59 38.4 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.661 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 -131.0 115.33 16.34 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.296 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 mp -106.81 113.45 43.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.548 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -119.56 137.94 53.52 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.709 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.565 ' OH ' ' CE2' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -136.71 157.54 46.53 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.195 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.53 153.23 9.78 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -67.9 160.29 28.8 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.457 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 m -75.24 152.33 38.31 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.0 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 44.78 41.64 7.29 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.482 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.14 142.15 15.91 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.277 -1.44 . . . . 0.0 110.304 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -63.65 -18.82 64.35 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.626 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 t -158.35 131.25 4.51 Favored Pre-proline 0 C--N 1.304 -1.376 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.809 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.02 154.26 52.23 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 120.309 0.673 . . . . 0.0 111.161 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.7 t -67.34 -67.44 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.812 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -175.19 178.48 1.71 Allowed 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.129 -1.028 . . . . 0.0 111.359 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -170.8 150.35 3.22 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.363 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.565 ' CE2' ' OH ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -146.03 164.62 31.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.673 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.2 p -116.89 156.3 27.58 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.436 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.579 ' C ' ' H ' ' A' ' 52' ' ' GLY . 6.0 m -146.28 151.67 44.66 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.805 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.96 20.83 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.074 1.182 . . . . 0.0 112.586 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 66.75 4.75 27.79 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.219 -1.467 . . . . 0.0 110.211 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.71 -45.98 14.93 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.759 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.66 107.42 7.81 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.605 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.8 m -82.81 14.2 3.38 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -138.65 163.42 32.14 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.633 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.5 139.43 7.92 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.587 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.9 m -110.12 134.12 52.51 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.607 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -132.53 154.54 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.017 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t -136.45 -167.89 2.15 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.511 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 65.12 73.96 0.53 Allowed Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.309 -1.424 . . . . 0.0 109.867 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.7 mt -126.74 177.57 6.48 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.312 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.54 128.27 25.88 Favored Pre-proline 0 CA--C 1.559 1.324 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -53.76 98.01 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 120.415 0.743 . . . . 0.0 112.889 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.11 97.29 0.22 Allowed Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.124 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -167.11 138.72 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.639 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.35 109.8 0.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.882 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.8 140.39 42.31 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.962 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.57 130.39 52.6 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.548 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.67 162.57 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.618 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.6 m -150.55 116.31 5.53 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.761 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 72' ' ' VAL . 6.0 m -102.74 121.22 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.859 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -99.1 130.95 45.45 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.581 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.44 89.64 3.1 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.884 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.6 t -92.39 127.93 44.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.103 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.572 ' HG1' ' H ' ' A' ' 77' ' ' GLY . 24.2 p -128.49 -109.4 0.28 Allowed 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.567 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.572 ' H ' ' HG1' ' A' ' 76' ' ' THR . . . 59.34 154.54 0.01 OUTLIER Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.321 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.2 mtm105 -120.18 17.15 12.38 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.543 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.24 73.25 1.26 Allowed Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.466 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 179.13 -54.7 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.84 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.5 t -131.79 72.57 79.73 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.548 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.04 105.76 0.71 Allowed 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 121.267 1.311 . . . . 0.0 111.189 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.37 79.13 1.88 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.106 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.4 p -79.95 86.68 5.43 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.928 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 p -115.24 20.31 15.0 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.992 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.672 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 12.2 mtmt -114.81 0.66 0.09 OUTLIER Pre-proline 0 CA--C 1.577 2.013 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 86' ' ' LYS . 2.9 Cg_endo -61.99 149.42 90.35 Favored 'Trans proline' 0 C--N 1.355 0.897 0 CA-C-N 120.258 1.128 . . . . 0.0 110.844 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -148.29 162.16 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 118.554 -1.258 . . . . 0.0 110.732 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.88 164.71 28.96 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.086 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 pt -150.41 135.54 10.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.542 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -109.48 131.87 54.66 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.84 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -161.71 135.75 6.75 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.487 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -68.32 114.1 6.48 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.659 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 116.29 -1.814 . . . . 0.0 110.729 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.828 0.347 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.37 117.89 13.48 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.893 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.2 17.95 0.14 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.847 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.2 t -50.67 122.68 16.67 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.24 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.1 -41.15 23.44 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 120.243 0.628 . . . . 0.0 111.932 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' TRP . 17.1 tpt180 -168.71 151.55 5.18 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.435 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.31 103.31 1.23 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.409 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mt -39.17 122.78 1.29 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.093 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -175.82 157.89 2.03 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 118.719 -1.192 . . . . 0.0 112.55 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.69 113.73 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.4 t -71.72 -71.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 118.758 -1.177 . . . . 0.0 112.169 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.99 175.52 10.39 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.022 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.45 147.56 51.7 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.074 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -142.82 161.37 49.35 Favored Pre-proline 0 C--N 1.305 -1.335 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.355 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.58 106.96 0.19 Allowed 'Trans proline' 0 C--O 1.211 -0.832 0 C-N-CA 121.045 1.163 . . . . 0.0 112.156 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 72.66 -3.71 2.29 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.99 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.439 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -130.26 136.48 49.22 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.707 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 tp -130.86 154.19 48.32 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.791 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.5 tp -116.79 122.09 43.42 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 pt -124.25 160.41 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -134.18 140.52 46.58 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.963 -1.471 . . . . 0.0 107.325 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.422 ' O ' ' O ' ' A' ' 6' ' ' ARG . 14.5 p90 -123.29 -168.15 1.72 Allowed 'General case' 0 N--CA 1.505 2.31 0 C-N-CA 118.402 -1.319 . . . . 0.0 114.069 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.467 ' CG ' ' N ' ' A' ' 24' ' ' ALA . 1.5 p-10 -143.27 -155.62 0.61 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.961 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.467 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -172.1 179.18 0.64 Allowed Pre-proline 0 N--CA 1.504 2.268 0 C-N-CA 119.114 -1.035 . . . . 0.0 111.187 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HB2' ' H ' ' A' ' 26' ' ' ALA . 9.3 Cg_endo -76.44 -118.6 0.01 OUTLIER 'Trans proline' 0 CA--C 1.568 2.199 0 C-N-CA 121.136 1.224 . . . . 0.0 111.73 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.438 ' H ' ' HB2' ' A' ' 25' ' ' PRO . . . -106.6 -61.01 1.58 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 m -58.76 155.77 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 119.631 -0.828 . . . . 0.0 112.418 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -60.19 -176.05 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.073 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.545 ' N ' ' OG1' ' A' ' 28' ' ' THR . 2.0 t -135.74 107.43 7.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.747 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.414 ' CD ' ' CZ ' ' A' ' 31' ' ' TYR . 1.6 ttm-85 -57.83 -64.84 0.77 Allowed 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.668 -1.213 . . . . 0.0 109.115 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.414 ' CZ ' ' CD ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -127.26 147.51 50.22 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.117 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -110.36 130.3 55.58 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.959 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -114.04 101.43 9.22 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.3 mt -92.94 123.86 45.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.862 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.2 p -124.93 135.11 52.54 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.765 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -130.06 155.49 46.07 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.086 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -174.11 151.32 12.78 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.977 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -85.92 136.17 33.39 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.662 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 m -44.74 106.59 0.08 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -172.37 73.67 0.1 OUTLIER Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.439 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.68 -165.76 53.84 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.762 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -99.32 55.97 1.0 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.198 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.55 84.9 15.47 Favored Pre-proline 0 C--N 1.305 -1.363 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.521 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.92 168.29 9.1 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 120.752 0.968 . . . . 0.0 111.774 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 t -74.8 -72.29 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.92 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -157.28 168.7 26.64 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.076 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' OE1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -143.94 175.11 10.27 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.979 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.4 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 25.7 p90 -163.28 134.68 4.87 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.954 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.4 ' H ' ' HG1' ' A' ' 49' ' ' THR . 34.0 p -87.45 164.55 16.12 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.254 -0.979 . . . . 0.0 111.288 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.59 ' C ' ' H ' ' A' ' 52' ' ' GLY . 14.5 p -162.31 138.34 5.76 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.069 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.461 ' C ' ' H ' ' A' ' 53' ' ' SER . 3.2 Cg_exo -60.56 23.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 120.953 1.102 . . . . 0.0 113.258 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 49.67 12.31 0.39 Allowed Glycine 0 N--CA 1.495 2.625 0 C-N-CA 119.488 -1.339 . . . . 0.0 110.77 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.461 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -59.77 -24.65 64.25 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.588 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -121.07 129.78 53.48 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.465 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -79.82 -9.62 59.68 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.037 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.3 p -140.09 154.86 47.17 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.763 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.84 160.67 25.39 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.674 -1.211 . . . . 0.0 111.499 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.6 m -90.24 157.47 17.67 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.535 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.441 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 6.0 tt -150.75 128.96 2.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 119.396 -0.921 . . . . 0.0 110.416 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 t -134.66 117.29 15.91 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.699 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.69 -28.22 0.02 OUTLIER Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.607 -1.282 . . . . 0.0 110.146 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.457 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -78.85 -166.45 0.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.887 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.571 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.5 OUTLIER -165.33 -42.4 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.456 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.95 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.571 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 8.9 Cg_endo -85.56 -174.81 1.72 Allowed 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 121.358 1.372 . . . . 0.0 111.574 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.68 72.73 0.43 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.515 ' CG2' ' N ' ' A' ' 67' ' ' ASP . 5.1 p -124.31 169.52 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.239 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.515 ' N ' ' CG2' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -49.1 110.51 0.37 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.879 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.99 134.81 54.31 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.724 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.45 134.36 55.17 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.509 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.44 158.72 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.908 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.1 m -153.31 140.83 19.81 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 118.326 -1.35 . . . . 0.0 112.521 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.8 m -114.39 121.84 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -94.15 109.81 21.57 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.746 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.3 94.11 8.37 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.674 -1.211 . . . . 0.0 109.625 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.09 125.98 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.867 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 m -117.65 -77.02 0.57 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.964 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.15 136.22 3.63 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.777 -1.201 . . . . 0.0 111.227 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -97.67 165.25 12.06 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.353 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 80' ' ' ASP . . . -75.22 76.08 1.29 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.302 -1.428 . . . . 0.0 110.765 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.463 ' CG ' ' N ' ' A' ' 81' ' ' SER . 0.0 OUTLIER 169.32 -69.84 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.886 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.463 ' N ' ' CG ' ' A' ' 80' ' ' ASP . 17.3 t -117.43 101.51 52.64 Favored Pre-proline 0 N--CA 1.488 1.429 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.956 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -63.91 103.3 0.4 Allowed 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 120.534 0.823 . . . . 0.0 111.242 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -121.71 127.03 50.27 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.441 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.88 134.96 40.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.025 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.445 ' H ' ' HG ' ' A' ' 85' ' ' SER . 16.7 p -69.61 -111.13 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.404 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.9 pttt -145.1 123.13 6.48 Favored Pre-proline 0 C--N 1.306 -1.316 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.996 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -70.04 165.23 31.98 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 120.527 0.818 . . . . 0.0 111.592 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 12.5 tt -138.65 121.66 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.746 -0.782 . . . . 0.0 108.916 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -121.49 164.9 16.44 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.61 140.38 20.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.051 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -103.09 146.56 28.19 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.528 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -172.53 142.08 1.21 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.541 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -75.2 108.87 8.25 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.311 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 116.389 -1.767 . . . . 0.0 110.714 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 2' ' ' SER . 1.4 t . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.979 0.419 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 1' ' ' VAL . 0.7 OUTLIER 69.06 -166.92 0.18 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.565 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -164.59 80.74 0.38 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.621 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' PRO . 2.6 t -67.28 130.63 93.52 Favored Pre-proline 0 C--N 1.298 -1.631 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.512 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 4' ' ' VAL . 5.9 Cg_exo -57.68 -153.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 120.727 0.951 . . . . 0.0 110.239 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -163.99 163.27 23.47 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 117.431 -1.708 . . . . 0.0 113.866 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 6' ' ' ARG . 9.6 t70 12.27 87.02 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 CA-C-N 113.437 -1.711 . . . . 0.0 115.316 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mp -101.7 127.76 48.31 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -163.58 174.69 11.47 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 117.502 -1.679 . . . . 0.0 113.468 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.5 t -92.96 128.39 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.809 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.27 -2.41 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.47 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -169.19 160.42 9.65 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.914 -1.114 . . . . 0.0 111.251 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.62 150.01 27.23 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.529 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.611 ' HG1' ' CB ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -137.4 162.11 56.92 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.874 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -55.39 -6.74 0.98 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.056 1.171 . . . . 0.0 111.433 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.467 ' H ' ' C ' ' A' ' 14' ' ' THR . 0.6 OUTLIER -160.09 42.88 0.2 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.382 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.611 ' CB ' ' HG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER 179.5 146.87 0.21 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.045 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.1 tp -130.44 120.57 24.41 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.28 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.7 tt -96.8 104.68 16.7 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.502 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -104.88 153.43 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.652 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.08 144.58 24.92 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.468 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 9.9 p90 -135.25 -129.75 0.16 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.041 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 24' ' ' ALA . 9.1 t70 -153.27 172.17 17.41 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 117.954 -1.498 . . . . 0.0 112.345 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . -140.7 130.9 13.43 Favored Pre-proline 0 CA--C 1.556 1.193 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.848 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.62 171.03 3.79 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 120.528 0.819 . . . . 0.0 111.585 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.04 92.43 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.277 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.514 ' CG2' ' N ' ' A' ' 28' ' ' THR . 1.0 OUTLIER -60.97 161.62 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.5 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.514 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 10.6 p -80.01 121.65 25.76 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.066 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -91.65 129.68 41.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.509 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -65.2 0.61 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.39 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.92 159.0 36.09 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.666 -1.214 . . . . 0.0 111.789 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -119.4 146.04 45.7 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.56 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -129.56 111.21 12.5 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.4 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.8 mp -100.93 120.97 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.153 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 p -122.04 136.95 54.97 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.97 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 1.8 p90 -130.77 146.92 52.36 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.85 138.79 5.01 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.8 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -72.9 141.62 47.89 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.517 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 m -74.59 125.06 27.84 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.718 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -166.57 -82.65 0.05 OUTLIER Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.553 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 168.58 -12.04 0.06 OUTLIER Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.355 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -72.11 -83.79 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.166 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -170.81 153.38 4.0 Favored Pre-proline 0 C--N 1.302 -1.497 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.2 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.8 172.49 1.56 Allowed 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 121.07 1.18 . . . . 0.0 111.466 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.0 t -86.11 -65.29 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.403 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -172.24 -167.86 0.5 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.231 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.89 163.57 11.6 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.698 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 9.7 p90 -153.96 141.84 20.15 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.403 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -100.21 159.93 14.72 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.893 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -147.29 157.36 45.68 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.121 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.56 10.76 0.1 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.141 1.227 . . . . 0.0 112.096 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.532 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 61.07 26.86 66.32 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.062 -1.542 . . . . 0.0 109.818 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.63 -53.65 4.43 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.63 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -90.62 123.37 34.2 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.1 m -86.39 27.62 0.92 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.244 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.8 p -145.44 162.98 36.05 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.5 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.1 154.53 5.07 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.805 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.2 m -130.93 115.69 16.87 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.053 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.37 171.49 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.673 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 53.0 m -148.57 173.12 13.49 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.619 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.75 49.19 1.3 Allowed Glycine 0 N--CA 1.498 2.799 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.403 ' CD1' ' C ' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -130.51 -175.37 3.63 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.866 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -117.55 135.32 23.22 Favored Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.69 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.53 148.27 93.39 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.052 1.168 . . . . 0.0 112.799 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.18 82.91 0.03 OUTLIER Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.388 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -167.55 145.68 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 118.956 -1.098 . . . . 0.0 111.444 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -61.3 140.87 57.9 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.413 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.46 118.18 10.46 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.59 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.5 m -100.66 116.97 33.82 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.827 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 tt -107.37 149.13 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.11 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 m -141.81 120.6 12.68 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.912 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.9 m -105.91 124.63 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.596 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -102.51 94.15 5.51 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.972 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.95 132.04 36.2 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.704 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -136.09 119.43 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.969 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 85.2 m -107.37 -18.12 13.95 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.898 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.86 138.44 6.13 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.4 169.34 1.25 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.001 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.77 109.32 3.01 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -179.57 -89.63 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.116 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.553 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -107.69 -44.16 0.12 Allowed Pre-proline 0 N--CA 1.486 1.334 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.913 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 81' ' ' SER . 2.0 Cg_endo -71.27 -163.37 0.13 Allowed 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 121.081 1.188 . . . . 0.0 111.311 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.01 139.93 57.68 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.736 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.84 -177.36 4.5 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.467 -0.893 . . . . 0.0 111.663 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.7 m -89.78 132.59 35.14 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.83 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -133.46 75.25 69.94 Favored Pre-proline 0 N--CA 1.491 1.597 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.703 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.14 158.58 51.23 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 121.492 1.461 . . . . 0.0 112.248 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 tt -145.89 153.42 13.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.092 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.43 151.58 46.37 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.069 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -145.76 140.25 21.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.58 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -88.88 151.28 22.44 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.755 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -162.46 134.94 5.64 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.138 -1.025 . . . . 0.0 111.102 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.2 mtt180 -93.84 110.69 22.33 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.992 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 116.395 -1.764 . . . . 0.0 110.574 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.895 0.379 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.45 109.35 6.08 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.496 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.02 -4.24 0.49 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.881 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.6 t -99.27 124.6 44.37 Favored Pre-proline 0 C--N 1.307 -1.276 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.208 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.61 164.61 4.14 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 CA-C-N 118.894 0.641 . . . . 0.0 110.905 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -165.35 165.87 19.05 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.229 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.2 t70 46.63 70.92 0.34 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.227 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -100.9 124.21 46.25 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.397 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -170.15 170.56 7.32 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.322 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.91 149.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.969 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 7.6 p -129.98 -6.41 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.794 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.84 161.09 7.08 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.813 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.59 145.85 27.01 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.784 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -130.74 161.0 63.79 Favored Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.901 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.04 -10.08 2.54 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 121.236 1.29 . . . . 0.0 111.771 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 m -159.68 44.32 0.23 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.447 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.1 OUTLIER 177.26 149.45 0.15 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.237 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.9 tp -131.18 148.64 52.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.062 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.71 116.91 24.56 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.696 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.3 pt -104.87 170.71 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.764 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.34 135.12 13.65 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.144 -1.023 . . . . 0.0 111.126 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.567 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 8.9 p90 -141.78 -140.78 0.13 Allowed 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.46 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.567 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 22.2 t70 -113.35 171.01 7.81 Favored 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 119.489 -0.885 . . . . 0.0 113.178 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.452 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -178.13 86.96 0.23 Allowed Pre-proline 0 N--CA 1.495 1.79 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.258 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -62.34 173.6 3.26 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.669 0.913 . . . . 0.0 111.794 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.51 -1.53 55.91 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.568 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 29' ' ' VAL . 34.1 m -59.22 144.63 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 118.77 -1.172 . . . . 0.0 109.947 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.44 93.03 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.884 -1.126 . . . . 0.0 110.823 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.445 ' N ' ' O ' ' A' ' 27' ' ' VAL . 4.5 t -91.2 133.96 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.756 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.486 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 3.8 mmm180 -73.79 -78.09 0.1 Allowed 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.32 -1.352 . . . . 0.0 108.773 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -149.79 153.61 37.1 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.526 -1.27 . . . . 0.0 112.022 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.16 167.58 9.9 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.175 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -145.07 106.65 4.24 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.674 -1.21 . . . . 0.0 111.419 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 mt -100.21 106.19 18.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.364 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 43.3 p -107.45 136.66 46.88 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.494 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.419 ' H ' ' HD1' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -134.34 132.05 39.05 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.614 -0.834 . . . . 0.0 112.036 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -158.66 153.46 24.6 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 40' ' ' GLY . 2.0 mt-10 -49.57 171.43 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.62 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.427 ' O ' ' OG1' ' A' ' 39' ' ' THR . 3.6 t -75.52 21.01 0.15 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.665 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 38' ' ' GLU . . . -148.28 -102.38 0.28 Allowed Glycine 0 N--CA 1.487 2.05 0 C-N-CA 119.028 -1.558 . . . . 0.0 110.47 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -178.54 13.75 0.03 OUTLIER Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.23 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -16.73 30.82 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.3 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 p 171.86 72.22 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.507 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.82 123.09 11.99 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.322 1.348 . . . . 0.0 110.384 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.8 t -51.45 -89.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.313 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.633 ' CG ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -174.48 -140.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.305 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.633 ' H ' ' CG ' ' A' ' 46' ' ' GLN . 9.1 pt-20 -171.91 168.48 5.99 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.667 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -161.61 141.37 10.29 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.63 165.76 11.82 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.419 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.579 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -150.28 160.3 33.43 Favored Pre-proline 0 C--N 1.304 -1.411 0 C-N-CA 119.486 -0.885 . . . . 0.0 110.005 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.09 21.11 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.158 1.239 . . . . 0.0 112.254 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 42.81 32.59 1.42 Allowed Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.675 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.14 -53.29 3.69 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.554 -0.858 . . . . 0.0 111.267 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -75.86 136.22 40.16 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.08 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 m -83.83 -13.58 53.38 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.529 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.4 p -131.4 152.95 50.19 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.915 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.35 157.51 37.24 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.292 -1.363 . . . . 0.0 112.137 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 49.4 m -98.5 130.97 45.09 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.708 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.1 tp -130.43 121.64 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.433 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.9 t -117.23 -168.77 1.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.32 51.11 5.1 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.73 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.36 -160.97 1.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.701 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -136.35 139.25 29.17 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.215 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -61.94 118.13 5.0 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 120.935 1.09 . . . . 0.0 111.614 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.79 89.08 0.07 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.531 -1.318 . . . . 0.0 111.031 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.5 p -163.48 138.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.135 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.89 114.38 5.67 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.824 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -119.89 145.92 46.25 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.978 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.6 m -112.92 111.44 22.2 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.294 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.403 ' CD1' ' C ' ' A' ' 70' ' ' ILE . 0.1 OUTLIER -102.36 130.46 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.081 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.403 ' N ' ' CD1' ' A' ' 70' ' ' ILE . 2.2 m -133.41 141.83 48.05 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.398 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.18 138.22 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.275 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.36 122.95 41.91 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.733 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.425 ' O ' ' OG ' ' A' ' 85' ' ' SER . . . -101.59 116.41 32.68 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.244 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.33 108.76 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.468 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 p -120.62 -82.96 0.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.406 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.7 109.59 0.64 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.409 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.8 mtp85 -100.97 -11.81 19.41 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.169 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.07 35.17 4.6 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.759 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -141.32 -48.5 0.4 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.481 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.77 164.99 23.48 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.714 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.537 ' C ' ' H ' ' A' ' 84' ' ' SER . 2.8 Cg_exo -52.2 140.72 50.82 Favored 'Trans proline' 0 C--O 1.217 -0.575 0 C-N-CA 120.81 1.006 . . . . 0.0 111.319 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.74 -8.64 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.503 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.537 ' H ' ' C ' ' A' ' 82' ' ' PRO . 93.9 p -58.92 99.03 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.329 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.553 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 61.3 p -84.17 -3.67 58.29 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.259 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.553 ' CB ' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER 96.8 67.16 0.01 OUTLIER Pre-proline 0 N--CA 1.518 2.929 0 O-C-N 124.598 1.186 . . . . 0.0 111.536 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -58.41 157.64 25.85 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.069 1.179 . . . . 0.0 110.598 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.94 156.4 6.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 C-N-CA 118.595 -1.242 . . . . 0.0 111.17 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.3 p -142.04 144.84 33.81 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.66 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -149.54 145.76 17.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.24 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.81 141.64 28.44 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.069 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -149.02 128.36 12.96 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.623 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -78.97 106.88 11.31 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.708 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 116.142 -1.885 . . . . 0.0 111.016 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.447 ' O ' ' CG2' ' A' ' 1' ' ' VAL . 2.5 p . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.847 0.356 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.59 -60.12 2.0 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.852 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -150.4 22.43 0.83 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.896 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.88 133.34 89.58 Favored Pre-proline 0 CA--C 1.562 1.416 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.624 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.67 165.58 13.41 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 120.744 0.963 . . . . 0.0 111.13 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 -172.4 144.23 1.5 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.054 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -71.72 89.21 1.01 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.053 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.466 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.4 mp -42.63 -79.53 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.728 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -175.38 -176.72 0.94 Allowed 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.649 -1.22 . . . . 0.0 112.229 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.2 t -93.35 146.95 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.64 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -94.25 -63.47 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.472 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.49 172.4 15.03 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.173 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.8 174.8 10.18 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.428 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.51 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -148.71 160.77 35.05 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.533 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -52.98 -6.29 0.25 Allowed 'Trans proline' 0 C--O 1.216 -0.587 0 C-N-CA 121.364 1.376 . . . . 0.0 111.851 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 14' ' ' THR . 2.0 t -165.22 48.94 0.1 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.414 ' OG ' ' OG1' ' A' ' 14' ' ' THR . 0.1 OUTLIER 174.87 147.5 0.08 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.798 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 tp -127.29 133.96 50.09 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.457 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.83 111.75 24.04 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.395 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 pp -110.95 145.25 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.678 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.7 m -141.95 126.1 17.42 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.189 -1.004 . . . . 0.0 111.046 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.591 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 8.6 p90 -119.48 -144.1 0.36 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.778 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.591 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 19.7 t70 -136.07 172.09 13.51 Favored 'General case' 0 N--CA 1.514 2.729 0 C-N-CA 118.506 -1.278 . . . . 0.0 113.455 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.527 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -140.39 112.26 7.18 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.031 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.51 -176.66 0.33 Allowed 'Trans proline' 0 C--O 1.213 -0.726 0 C-N-CA 120.308 0.672 . . . . 0.0 111.647 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.76 -28.36 33.34 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.841 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.473 ' CG2' ' N ' ' A' ' 28' ' ' THR . 1.4 p -59.74 157.99 2.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 118.685 -1.206 . . . . 0.0 110.74 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.473 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -81.24 115.37 20.6 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.896 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 78.5 t -101.22 124.9 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.798 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.542 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.24 -63.68 1.11 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.126 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 9.0 m-85 -143.93 164.31 30.95 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.089 -1.045 . . . . 0.0 112.282 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.99 146.05 50.48 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.396 -1.274 . . . . 0.0 108.298 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.513 ' HE ' ' CG2' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -137.19 136.36 38.12 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.778 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.513 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 3.5 mp -121.09 119.92 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.293 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -114.19 138.06 50.96 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.593 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 8.3 p90 -135.84 154.2 51.25 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.803 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -171.16 169.61 42.61 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -76.01 -162.9 0.25 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.847 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.8 t -75.92 144.02 41.32 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.31 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 37.2 50.44 1.64 Allowed Glycine 0 N--CA 1.499 2.878 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.827 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.489 ' C ' ' H ' ' A' ' 43' ' ' SER . . . -103.15 99.16 1.74 Allowed Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.417 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -60.07 -7.42 1.81 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.663 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 41' ' ' GLY . 79.4 p -131.14 84.61 56.84 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.18 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -55.29 151.61 35.44 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 120.687 0.925 . . . . 0.0 111.858 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 50.6 t -48.78 -60.49 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.796 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -175.69 -169.79 0.37 Allowed 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.194 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -164.36 160.48 20.86 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.855 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.436 ' O ' ' CD1' ' A' ' 48' ' ' PHE . 42.3 p90 -155.51 142.46 19.08 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.726 -1.189 . . . . 0.0 111.185 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.9 140.78 29.13 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.348 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.6 155.69 80.3 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.056 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.579 ' C ' ' H ' ' A' ' 53' ' ' SER . 0.9 OUTLIER -61.66 118.23 5.09 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 120.436 0.757 . . . . 0.0 110.795 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -49.41 -6.46 0.06 OUTLIER Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.034 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.579 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -64.12 -36.45 84.06 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.25 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -83.72 157.63 22.08 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.059 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -120.65 -6.28 9.69 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.607 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.6 p -133.22 161.8 33.5 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.163 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.14 165.18 27.37 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.8 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.1 m -128.98 118.24 22.27 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.493 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.1 pt -108.4 149.23 11.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.701 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 16' ' ' THR . 8.4 t -144.88 151.27 38.46 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.971 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.19 7.6 1.71 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.585 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -130.62 -179.61 5.39 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.12 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -125.66 118.05 24.5 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.814 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.1 112.64 1.74 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 120.399 0.733 . . . . 0.0 111.346 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 94' ' ' THR . . . 158.28 30.84 0.02 OUTLIER Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.687 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.7 p -165.68 164.8 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.406 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.33 104.64 1.55 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.2 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.13 152.9 26.47 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.376 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 m -121.05 128.06 52.29 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.539 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.483 ' CD1' ' N ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -114.02 136.32 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.63 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.483 ' N ' ' CD1' ' A' ' 70' ' ' ILE . 47.2 m -132.96 145.48 50.93 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.95 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.0 m -128.57 140.54 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.383 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -118.42 141.47 48.52 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.439 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.08 105.86 12.28 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.075 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.513 ' CG2' ' HE ' ' A' ' 33' ' ' ARG . 3.5 t -108.03 130.86 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.489 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.519 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 43.1 p -131.03 -119.94 0.22 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.629 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.519 ' N ' ' OG1' ' A' ' 76' ' ' THR . . . 71.1 163.63 5.39 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.403 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -99.99 -76.8 0.54 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.212 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.04 33.17 0.15 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.356 -1.402 . . . . 0.0 110.804 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.461 ' CG ' ' N ' ' A' ' 81' ' ' SER . 14.8 t70 -130.92 -95.31 0.37 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.886 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.461 ' N ' ' CG ' ' A' ' 80' ' ' ASP . 0.8 OUTLIER -79.74 126.6 80.01 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.523 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.59 103.03 0.21 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 120.508 0.806 . . . . 0.0 111.299 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.19 123.26 39.75 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.823 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 p -110.91 123.65 50.56 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.79 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 86' ' ' LYS . 37.0 t -67.33 -118.43 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.386 -0.925 . . . . 0.0 111.008 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.507 ' N ' ' OG ' ' A' ' 85' ' ' SER . 1.3 ttpp -151.53 85.92 4.79 Favored Pre-proline 0 C--N 1.305 -1.35 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.364 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.27 154.78 55.78 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 120.932 1.088 . . . . 0.0 110.977 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.5 tt -150.65 154.09 9.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 C-N-CA 118.851 -1.14 . . . . 0.0 111.27 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.438 ' OG ' ' OG1' ' A' ' 71' ' ' THR . 14.8 m -134.94 163.07 30.66 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.412 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 pt -145.64 137.74 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.648 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.06 128.99 46.06 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.702 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.521 ' CZ ' ' O ' ' A' ' 93' ' ' ARG . 13.5 t80 -152.23 149.51 28.8 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.246 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.521 ' O ' ' CZ ' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -83.4 120.53 26.0 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.878 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 116.313 -1.803 . . . . 0.0 110.62 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -82.4 149.1 27.85 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.076 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -154.17 -5.1 0.17 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.728 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.4 t -59.79 127.02 84.68 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.485 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.33 176.55 0.19 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 120.435 0.757 . . . . 0.0 111.324 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -172.14 -168.04 0.52 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.78 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 51.25 38.37 21.11 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.381 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mt -89.45 126.22 35.48 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.266 -0.973 . . . . 0.0 111.099 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -175.32 172.92 2.63 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.308 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.61 133.97 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.69 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.602 ' CG2' ' HG ' ' A' ' 21' ' ' SER . 1.6 t -92.97 -39.44 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.266 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.37 166.33 20.81 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.876 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.63 82.71 1.46 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.746 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.407 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -65.69 160.73 58.82 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.234 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -4.84 3.63 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 121.093 1.196 . . . . 0.0 111.499 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.424 ' O ' ' OG ' ' A' ' 60' ' ' SER . 16.2 m -149.13 39.93 0.85 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.523 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 172.68 143.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.515 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.54 140.01 53.34 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.231 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.35 116.74 26.83 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.915 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 pp -112.55 150.51 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.228 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.602 ' HG ' ' CG2' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -144.12 140.36 29.38 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.652 -179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.616 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 3.6 p90 -142.9 -147.78 0.22 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.555 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.616 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 18.1 t70 -154.06 154.46 33.7 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 117.738 -1.585 . . . . 0.0 112.721 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.2 149.54 45.92 Favored Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.214 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.74 -171.66 0.09 OUTLIER 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 121.126 1.217 . . . . 0.0 111.414 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.07 -25.18 16.56 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.261 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 m -61.58 146.09 12.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.975 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.37 92.28 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.229 -0.989 . . . . 0.0 110.773 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -77.7 149.56 5.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.369 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -78.44 -70.75 0.47 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.649 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.63 161.32 41.94 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.125 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -120.51 131.97 54.96 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.957 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttp-105 -118.59 113.09 20.72 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.244 -0.983 . . . . 0.0 110.525 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.0 mt -95.84 122.91 47.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.338 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -125.69 130.87 52.41 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.212 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.0 OUTLIER -148.14 166.73 27.0 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.671 -1.212 . . . . 0.0 112.306 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.94 146.73 4.76 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.51 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 4.7 pt-20 -53.53 169.93 0.12 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.577 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 63.4 m -50.62 -62.34 1.66 Allowed 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.717 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.91 54.93 0.1 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.434 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.51 ' H ' ' CG ' ' A' ' 38' ' ' GLU . . . -75.26 -109.44 0.1 OUTLIER Glycine 0 N--CA 1.486 2.03 0 C-N-CA 119.098 -1.525 . . . . 0.0 110.614 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.431 ' O ' ' OG ' ' A' ' 43' ' ' SER . 36.1 t30 -135.2 10.05 3.51 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.485 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 42' ' ' ASN . 17.7 m -167.06 69.85 0.99 Allowed Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 118.559 -1.256 . . . . 0.0 112.232 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.34 153.63 77.37 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 121.199 1.266 . . . . 0.0 110.75 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.492 ' CG1' ' H ' ' A' ' 46' ' ' GLN . 49.3 t -74.47 -116.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.17 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.492 ' H ' ' CG1' ' A' ' 45' ' ' VAL . 4.3 pt20 -176.1 -133.12 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.361 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -171.1 161.26 6.72 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.346 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.564 ' CE2' ' OH ' ' A' ' 36' ' ' TYR . 2.7 p90 -152.56 161.22 42.88 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.0 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 p -113.75 156.85 23.08 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.534 -0.866 . . . . 0.0 112.293 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.565 ' C ' ' H ' ' A' ' 52' ' ' GLY . 2.4 m -147.42 154.29 45.06 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.956 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 53' ' ' SER . 1.1 Cg_endo -63.1 23.28 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.016 1.144 . . . . 0.0 112.931 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 52.57 13.93 2.19 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.083 -1.532 . . . . 0.0 110.693 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -74.93 -39.51 61.34 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.194 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.2 ttpt -96.72 130.47 43.96 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.119 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.9 m -87.95 24.46 1.79 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.558 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.2 164.27 30.64 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.789 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.63 141.22 17.87 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.668 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.0 m -117.19 139.33 50.9 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.401 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.0 tt -141.59 140.41 31.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.319 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 16' ' ' THR . 4.2 t -141.86 176.45 8.92 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.22 48.48 6.41 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.193 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.37 -158.83 0.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.114 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -135.41 101.52 11.0 Favored Pre-proline 0 N--CA 1.487 1.421 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.828 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -61.95 153.86 65.69 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 120.598 0.865 . . . . 0.0 111.671 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.61 47.97 4.1 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.577 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.9 p -161.87 160.31 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 C-N-CA 119.009 -1.077 . . . . 0.0 111.595 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.84 153.61 32.61 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.081 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.81 117.48 6.19 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.774 -1.171 . . . . 0.0 111.648 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.53 119.52 36.23 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.313 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.7 125.98 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.403 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 54.6 m -131.14 138.86 49.67 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.485 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.8 m -126.22 131.3 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.76 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -100.95 117.0 34.14 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.232 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.05 110.21 22.49 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.528 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.35 117.04 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.956 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.3 p -121.32 -170.05 1.96 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.586 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 169.31 158.86 13.78 Favored Glycine 0 N--CA 1.485 1.934 0 C-N-CA 117.978 -2.058 . . . . 0.0 111.753 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -113.4 -172.34 2.05 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.797 -0.702 . . . . 0.0 109.299 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 44.1 -102.15 0.03 OUTLIER Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.022 -1.561 . . . . 0.0 110.436 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -159.27 -23.41 0.07 Allowed 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.49 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.78 162.42 70.44 Favored Pre-proline 0 C--N 1.307 -1.248 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.653 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.89 154.09 63.74 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 121.398 1.398 . . . . 0.0 111.326 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.2 -139.52 0.22 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.567 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 85' ' ' SER . 0.1 OUTLIER -98.54 171.4 8.17 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.524 -0.871 . . . . 0.0 111.084 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 52.8 m -115.52 -75.51 0.58 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.806 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 85' ' ' SER . 4.2 ttmt 83.96 67.34 0.09 OUTLIER Pre-proline 0 N--CA 1.499 1.983 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.324 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -72.22 166.86 28.47 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 121.842 1.694 . . . . 0.0 112.944 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 88' ' ' ILE . 13.1 tt -152.27 127.86 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.37 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.6 p -117.17 150.88 37.99 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.592 -0.843 . . . . 0.0 112.339 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.82 133.37 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.283 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 91' ' ' ASN . 19.2 p-10 -80.57 145.41 31.77 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.1 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -160.1 132.67 6.47 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.46 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 1.4 ptp180 -90.94 123.84 34.74 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.109 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 116.343 -1.789 . . . . 0.0 110.663 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.414 ' O ' ' CG1' ' A' ' 1' ' ' VAL . 92.5 t . . . . . 0 C--O 1.214 -0.797 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.496 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 50.7 m -146.27 143.74 29.38 Favored 'General case' 0 C--O 1.203 -1.363 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.735 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.487 ' H ' ' HD2' ' A' ' 25' ' ' PRO . 4.5 t0 -141.71 -64.73 0.43 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.961 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.7 t -100.29 109.57 57.18 Favored Pre-proline 0 N--CA 1.499 2.015 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.002 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -74.41 120.52 6.27 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 120.669 0.912 . . . . 0.0 110.679 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 8' ' ' LEU . 1.8 mtm180 -105.8 -158.67 0.67 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.354 -0.939 . . . . 0.0 112.511 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -39.32 86.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.126 -0.943 . . . . 0.0 113.502 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.642 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -101.76 170.07 8.4 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.501 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -175.72 -179.02 1.15 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.392 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t -91.21 127.56 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.857 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.2 p -92.96 -21.1 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.584 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -179.86 161.8 1.0 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.478 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.81 115.66 13.94 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.219 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -96.09 162.07 25.09 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.533 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.505 ' O ' ' OG1' ' A' ' 16' ' ' THR . 7.9 Cg_exo -47.23 96.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 120.763 0.976 . . . . 0.0 110.704 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 15' ' ' PRO . 2.2 p 70.49 47.15 0.52 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.662 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.56 119.73 1.22 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.388 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 tp -105.72 137.0 44.31 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.287 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.28 103.03 8.26 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.855 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pt -97.95 173.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.505 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.57 131.28 3.03 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.242 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.426 ' CE3' ' N ' ' A' ' 22' ' ' TRP . 10.4 p90 -123.62 175.33 6.88 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 119.156 -1.017 . . . . 0.0 111.028 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' CG ' ' N ' ' A' ' 24' ' ' ALA . 31.0 t70 -104.59 171.82 7.12 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.11 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.42 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -173.12 158.95 3.41 Favored Pre-proline 0 C--N 1.306 -1.307 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.312 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.487 ' HD2' ' H ' ' A' ' 3' ' ' ASP . 11.0 Cg_endo -74.17 -169.71 0.62 Allowed 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 121.086 1.191 . . . . 0.0 111.336 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.82 12.52 28.89 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.127 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 28' ' ' THR . 2.3 p -79.29 162.33 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.202 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.547 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 7.8 p -80.28 132.07 35.77 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.574 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 2' ' ' SER . 74.3 t -133.71 157.54 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.245 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.407 ' N ' ' CG1' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -74.58 -65.43 0.86 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.047 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -160.25 -178.62 7.09 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 117.924 -1.51 . . . . 0.0 113.317 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.42 174.41 10.65 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.704 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.59 148.28 37.25 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.17 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.28 108.11 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.121 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -119.18 137.63 53.5 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.476 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -137.54 140.18 40.9 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 118.846 -1.142 . . . . 0.0 110.899 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.38 151.7 21.03 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.72 159.34 33.97 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.634 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.478 ' O ' ' CG2' ' A' ' 39' ' ' THR . 22.2 m -76.07 48.59 0.51 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.885 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 41' ' ' GLY . . . 154.5 -83.86 0.15 Allowed Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.693 -1.241 . . . . 0.0 110.128 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 40' ' ' GLY . . . 38.72 -150.17 0.07 OUTLIER Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.012 -1.089 . . . . 0.0 110.869 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.85 -14.13 14.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.476 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.88 157.53 0.45 Allowed Pre-proline 0 C--N 1.305 -1.335 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.329 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -62.32 132.04 36.83 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 121.199 1.266 . . . . 0.0 111.481 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.36 -75.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.257 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.447 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -175.71 -176.29 0.85 Allowed 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 118.525 -1.27 . . . . 0.0 111.513 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 46' ' ' GLN . 9.0 pt-20 -158.16 170.53 22.06 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.205 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -165.92 145.9 6.42 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.02 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.9 p -91.14 169.92 10.45 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.79 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.592 ' C ' ' H ' ' A' ' 52' ' ' GLY . 9.3 p -161.36 136.31 5.49 Favored Pre-proline 0 C--N 1.304 -1.399 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.25 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.533 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.6 Cg_endo -61.7 22.88 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 120.955 1.103 . . . . 0.0 112.828 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 53.26 7.86 0.63 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.491 -1.338 . . . . 0.0 110.312 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -71.62 -29.42 64.64 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.86 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.7 mttm -94.45 153.0 18.15 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.808 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.75 -12.65 17.48 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.721 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 p -130.61 170.99 13.55 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.092 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.37 132.06 9.59 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.578 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.7 m -104.13 128.75 51.82 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.205 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 10.7 mt -126.82 139.76 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.992 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.91 131.73 47.59 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.411 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.67 2.29 0.19 Allowed Glycine 0 N--CA 1.484 1.881 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 mp -91.43 178.1 6.05 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.29 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.606 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 1.0 OUTLIER -176.82 -42.38 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.733 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 63' ' ' LYS . 4.3 Cg_endo -79.81 -172.02 1.41 Allowed 'Trans proline' 0 C--O 1.217 -0.564 0 C-N-CA 121.548 1.499 . . . . 0.0 111.734 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.91 81.61 0.23 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.595 ' CG2' ' H ' ' A' ' 67' ' ' ASP . 11.8 p -132.05 -177.78 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.998 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.595 ' H ' ' CG2' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -66.93 125.38 25.75 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.142 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.09 130.96 53.31 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.318 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.81 123.81 48.56 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.721 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.447 ' C ' ' HG1' ' A' ' 71' ' ' THR . 1.9 pp -116.05 164.16 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.165 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.447 ' HG1' ' C ' ' A' ' 70' ' ' ILE . 95.9 m -152.18 143.74 23.48 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.632 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.91 139.73 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.715 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -109.07 143.26 38.64 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.536 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.13 91.48 3.55 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.812 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.2 t -94.9 107.65 19.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 119.095 -1.042 . . . . 0.0 113.277 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 77' ' ' GLY . 80.6 m -125.27 -24.22 4.01 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 76' ' ' THR . . . 53.42 127.34 0.01 OUTLIER Glycine 0 N--CA 1.497 2.715 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.587 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.417 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -104.68 136.04 44.96 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.717 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.06 -101.98 0.8 Allowed Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.824 -1.655 . . . . 0.0 109.819 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -160.53 -40.02 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.724 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.537 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -83.41 -43.91 0.83 Allowed Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.66 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' A' ' 81' ' ' SER . 3.2 Cg_exo -68.04 31.1 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.127 1.218 . . . . 0.0 112.511 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.52 ' H ' ' C ' ' A' ' 81' ' ' SER . . . -49.15 -54.3 16.97 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.487 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.2 t -52.8 115.63 1.92 Allowed 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.067 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.4 m -92.57 -148.52 0.24 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.762 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.11 86.73 57.3 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.451 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.71 167.42 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 120.866 1.044 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.4 tt -143.9 139.59 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.949 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.1 p -124.63 150.99 45.42 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -143.72 163.0 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.505 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -103.05 147.64 26.71 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.147 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -154.12 135.49 14.15 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.811 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 5.6 ptt85 -90.32 107.04 18.9 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.46 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.681 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.972 0.415 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 p -166.25 148.25 6.82 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.928 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.4 -8.29 15.08 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.956 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 5' ' ' PRO . 44.1 t -93.73 133.89 27.23 Favored Pre-proline 0 C--N 1.305 -1.338 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.837 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 4' ' ' VAL . 3.7 Cg_exo -54.56 -166.59 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.682 0 N-CA-C 110.225 -0.721 . . . . 0.0 110.225 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 7' ' ' ASP . 13.8 ptt180 -163.25 175.0 11.37 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.106 -1.438 . . . . 0.0 112.73 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 8' ' ' LEU . 57.4 m-20 -25.04 98.36 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.46 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.522 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -57.08 -163.53 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.75 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -168.65 136.44 2.05 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.026 -1.47 . . . . 0.0 112.646 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -88.46 142.4 12.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.879 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.47 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 3.6 p -130.52 1.62 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 119.074 -1.05 . . . . 0.0 112.177 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 177.79 155.61 0.34 Allowed 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.6 -1.24 . . . . 0.0 111.395 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.74 104.79 2.17 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.2 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.511 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -91.66 160.81 35.66 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.002 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.29 -0.4 0.31 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.998 1.132 . . . . 0.0 112.098 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.511 ' H ' ' C ' ' A' ' 14' ' ' THR . 25.5 p -151.39 28.97 0.64 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.699 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.47 151.05 0.57 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.69 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.6 123.98 30.71 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.975 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tp -104.14 116.66 32.59 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.803 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.0 pt -107.1 173.49 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.123 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.68 139.03 7.47 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.295 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.589 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 18.3 p90 -140.22 -154.15 0.5 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.402 -1.319 . . . . 0.0 113.052 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.589 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 36.3 t70 -99.48 -177.28 3.53 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.958 -0.697 . . . . 0.0 112.408 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.56 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . -164.6 119.98 1.04 Allowed Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.12 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.63 167.78 4.8 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 120.435 0.757 . . . . 0.0 111.757 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.83 24.51 6.06 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.731 -0.787 . . . . 0.0 111.104 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.496 ' CG1' ' H ' ' A' ' 28' ' ' THR . 44.9 t -101.79 173.48 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.473 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.496 ' H ' ' CG1' ' A' ' 27' ' ' VAL . 25.5 m -74.5 78.25 1.94 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.352 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 t -79.62 114.9 21.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.499 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.401 ' H ' ' HA ' ' A' ' 76' ' ' THR . 2.7 tpt85 -56.03 -61.46 2.36 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.315 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.74 169.33 21.66 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.611 -1.236 . . . . 0.0 112.151 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -116.55 158.32 23.85 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.96 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -138.58 112.25 8.29 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.215 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.4 mt -102.18 127.37 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.866 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' A' ' 71' ' ' THR . 0.2 OUTLIER -128.9 137.57 51.5 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.958 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.574 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 3.0 p90 -145.55 154.93 42.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 118.351 -1.339 . . . . 0.0 112.204 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -176.24 138.53 4.14 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -64.23 145.48 55.91 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 118.976 -1.09 . . . . 0.0 110.538 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 m -75.31 160.08 30.73 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.238 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.29 -44.04 3.3 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.49 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 43' ' ' SER . . . -76.82 123.59 6.69 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.596 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -75.86 18.86 0.23 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.535 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 41' ' ' GLY . 12.9 t -132.05 81.4 62.08 Favored Pre-proline 0 N--CA 1.486 1.337 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.758 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.99 150.77 82.42 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 121.015 1.144 . . . . 0.0 111.305 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 95.0 t -57.01 -81.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.475 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.49 ' CG ' ' H ' ' A' ' 47' ' ' GLU . 3.8 tp60 -171.57 -151.38 0.07 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.659 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.49 ' H ' ' CG ' ' A' ' 46' ' ' GLN . 3.2 pt-20 -170.18 161.69 8.5 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.377 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -159.02 156.6 29.63 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.869 -1.132 . . . . 0.0 111.054 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.4 p -101.67 157.97 16.44 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.754 -0.779 . . . . 0.0 111.641 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.4 p -165.61 134.14 2.51 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.462 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.537 ' C ' ' H ' ' A' ' 53' ' ' SER . 6.3 Cg_exo -56.49 124.97 17.54 Favored 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 120.274 0.649 . . . . 0.0 111.484 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.05 1.7 0.79 Allowed Glycine 0 N--CA 1.483 1.806 0 C-N-CA 119.45 -1.357 . . . . 0.0 110.694 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.537 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -59.57 -35.28 73.94 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 118.845 -1.142 . . . . 0.0 109.636 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' C ' ' H ' ' A' ' 56' ' ' THR . 46.8 mmtt -98.4 120.25 38.5 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.059 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 m -79.59 21.25 0.52 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.122 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.414 ' H ' ' C ' ' A' ' 54' ' ' LYS . 65.4 p -143.72 149.3 36.96 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.308 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.62 150.11 26.03 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.394 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.1 m -95.05 158.44 15.46 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.128 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -146.9 139.01 19.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 119.506 -0.877 . . . . 0.0 110.026 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.3 -178.08 6.2 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.061 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.32 21.65 21.76 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.779 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.06 -164.65 1.39 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.993 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -177.68 -42.39 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.355 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.295 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 63' ' ' LYS . 1.9 Cg_endo -77.16 -170.16 0.87 Allowed 'Trans proline' 0 C--O 1.214 -0.725 0 C-N-CA 121.762 1.641 . . . . 0.0 112.87 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.71 84.21 0.19 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.514 ' CG2' ' H ' ' A' ' 67' ' ' ASP . 12.2 p -130.2 177.55 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.387 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.514 ' H ' ' CG2' ' A' ' 66' ' ' VAL . 7.9 t70 -45.44 148.27 0.7 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.097 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.58 111.3 5.02 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.528 -1.269 . . . . 0.0 112.294 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.48 132.98 34.27 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.181 -1.008 . . . . 0.0 108.85 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.442 ' O ' ' CG2' ' A' ' 70' ' ' ILE . 7.2 tt -127.64 132.17 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.192 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.456 ' OG1' ' OG1' ' A' ' 35' ' ' THR . 24.1 p -125.1 121.98 35.86 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.575 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.37 129.0 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.641 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -103.72 140.81 37.1 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.406 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.97 91.22 3.5 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.135 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.0 t -93.8 124.03 46.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.717 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.401 ' HA ' ' H ' ' A' ' 30' ' ' ARG . 13.3 t -112.14 -159.0 0.67 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.062 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 156.92 109.3 0.29 Allowed Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.267 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -65.81 -46.28 79.2 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.849 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.69 -93.21 1.66 Allowed Glycine 0 N--CA 1.487 2.051 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.198 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 2.1 p-10 -156.31 -11.61 0.1 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.421 -0.911 . . . . 0.0 111.166 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.7 152.78 78.04 Favored Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 118.824 -1.151 . . . . 0.0 110.697 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.64 146.18 95.26 Favored 'Trans proline' 0 C--O 1.217 -0.57 0 C-N-CA 121.205 1.27 . . . . 0.0 111.836 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.86 108.67 10.01 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.69 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.4 t -67.01 122.11 17.03 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.377 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 86' ' ' LYS . 94.1 p -113.69 -128.74 0.29 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.538 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.434 ' N ' ' OG ' ' A' ' 85' ' ' SER . 1.4 pttt -152.08 91.96 3.61 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.86 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -57.71 -179.76 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.108 1.205 . . . . 0.0 112.227 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.435 ' O ' ' OG ' ' A' ' 89' ' ' SER . 12.4 tt -145.89 154.62 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.696 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 88' ' ' ILE . 15.2 m -161.34 147.21 14.15 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 118.446 -1.302 . . . . 0.0 112.204 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pt -150.01 164.38 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.228 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.74 136.4 34.06 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.497 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -140.88 133.55 28.74 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.371 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -87.84 108.51 19.19 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.589 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 116.502 -1.713 . . . . 0.0 110.745 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.468 ' O ' ' CG2' ' A' ' 1' ' ' VAL . 5.8 p . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 121.014 0.435 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 m 53.82 -168.21 0.06 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.171 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -133.13 32.36 3.74 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.531 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.2 t -62.26 145.2 94.2 Favored Pre-proline 0 C--N 1.303 -1.429 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.768 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -51.28 169.87 0.19 Allowed 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 120.784 0.99 . . . . 0.0 111.204 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.49 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 6.1 ptm180 -175.46 173.88 2.4 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.61 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 2.9 t70 74.72 37.99 0.5 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.371 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 mp -86.69 110.79 20.11 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.592 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -139.46 162.36 35.24 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.8 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.6 102.25 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.123 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.453 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 47.8 t -71.78 3.42 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.296 -0.961 . . . . 0.0 111.474 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 11' ' ' VAL . . . 168.81 154.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.341 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.58 93.85 2.11 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.684 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.529 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -91.27 162.27 32.63 Favored Pre-proline 0 N--CA 1.485 1.288 0 C-N-CA 119.436 -0.905 . . . . 0.0 110.613 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.72 9.55 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.428 1.419 . . . . 0.0 112.089 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.529 ' H ' ' C ' ' A' ' 14' ' ' THR . 4.4 t -168.77 28.1 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.063 -1.055 . . . . 0.0 110.806 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -173.65 141.68 0.87 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.526 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.2 tp -130.62 146.49 52.13 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.789 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.33 106.64 9.16 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.184 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.423 ' O ' ' OG ' ' A' ' 21' ' ' SER . 2.2 pt -103.35 169.7 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.461 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 20' ' ' ILE . 8.2 m -164.04 134.03 4.11 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.457 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.527 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 14.3 p90 -133.76 -157.83 0.84 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.682 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.527 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 30.4 t70 -106.42 176.31 5.21 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.514 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . -154.71 100.39 2.39 Favored Pre-proline 0 CA--C 1.558 1.258 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.77 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -57.15 175.61 0.32 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 120.788 0.992 . . . . 0.0 112.231 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -93.07 -5.22 50.91 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.5 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.75 163.32 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.132 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.4 m -62.76 98.48 0.12 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.656 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 t -95.19 129.74 44.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.345 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.14 -65.85 0.96 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.069 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -160.48 163.59 32.83 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.038 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -120.42 146.89 45.76 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.691 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -129.03 110.08 11.75 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.779 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.598 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 2.7 mp -100.81 108.48 23.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.788 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 p -104.63 147.71 27.35 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.213 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -149.39 148.36 29.39 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 117.987 -1.485 . . . . 0.0 112.088 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.26 150.85 7.92 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -78.56 -174.54 3.89 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.767 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 40' ' ' GLY . 3.5 t -51.52 176.78 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.684 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.458 ' N ' ' OG1' ' A' ' 39' ' ' THR . . . 103.35 83.28 1.7 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.089 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.28 -136.54 28.48 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.138 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.41 -66.91 0.85 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.316 -0.953 . . . . 0.0 110.606 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.423 ' C ' ' H ' ' A' ' 45' ' ' VAL . 1.5 p 175.19 71.88 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.869 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -73.07 42.52 0.63 Allowed 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.7 1.6 . . . . 0.0 111.914 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.43 ' CG1' ' N ' ' A' ' 46' ' ' GLN . 21.3 t -110.22 -86.05 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.099 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.488 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 30.7 tt0 -168.72 166.98 11.5 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 117.482 -1.687 . . . . 0.0 112.606 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.488 ' N ' ' CG ' ' A' ' 46' ' ' GLN . 3.3 pt-20 -161.17 156.42 24.3 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.445 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 1.4 p90 -139.58 167.13 22.8 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.488 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.5 p -131.27 148.66 52.71 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.606 -0.837 . . . . 0.0 111.538 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.573 ' C ' ' H ' ' A' ' 52' ' ' GLY . 10.3 m -140.72 151.78 64.09 Favored Pre-proline 0 N--CA 1.486 1.349 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.861 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.16 14.35 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 120.898 1.065 . . . . 0.0 112.173 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.573 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 70.69 16.41 74.17 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.809 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.82 -40.34 20.5 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.915 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -84.16 121.44 27.46 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.623 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 m -83.03 -9.79 59.08 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.062 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.66 168.63 11.19 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.285 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.1 136.15 6.59 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.514 -1.275 . . . . 0.0 111.947 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -105.14 136.88 43.82 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.826 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -134.13 144.56 35.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.429 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.14 135.62 20.63 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.112 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.86 -37.44 0.24 Allowed Glycine 0 N--CA 1.486 1.981 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.387 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -163.32 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.75 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.614 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -176.91 -40.79 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.604 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 63' ' ' LYS . 8.7 Cg_endo -83.4 -169.34 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.579 1.519 . . . . 0.0 111.731 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.33 74.68 0.4 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.498 ' CG2' ' N ' ' A' ' 67' ' ' ASP . 8.9 p -119.4 170.81 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.077 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.498 ' N ' ' CG2' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -64.86 97.51 0.23 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.442 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -89.59 130.26 35.92 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.631 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.41 149.2 29.06 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.793 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.492 ' C ' ' HG1' ' A' ' 71' ' ' THR . 1.5 pp -140.6 161.09 24.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.629 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.492 ' HG1' ' C ' ' A' ' 70' ' ' ILE . 20.4 m -149.61 123.32 9.22 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.68 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.03 136.92 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.355 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.47 116.25 31.06 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.294 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.66 97.64 8.88 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.256 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.0 t -99.53 116.9 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.483 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.7 p -116.72 -123.69 0.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.683 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.93 142.36 0.02 OUTLIER Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.573 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -71.0 -74.96 0.13 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.836 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.3 18.88 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.451 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 81' ' ' SER . 11.6 p-10 -137.32 -53.33 0.68 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.867 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.434 ' H ' ' CG ' ' A' ' 80' ' ' ASP . 0.3 OUTLIER -90.29 134.17 31.83 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.392 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.09 102.72 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 120.764 0.976 . . . . 0.0 111.462 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.07 70.7 1.46 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.99 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.8 t -92.46 137.04 32.7 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.746 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.1 m -82.01 -134.19 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.419 -0.912 . . . . 0.0 111.452 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -149.56 110.39 3.38 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.308 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -59.87 170.66 3.46 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 120.452 0.768 . . . . 0.0 111.231 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -155.81 156.04 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.992 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.39 156.52 46.37 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.684 -0.807 . . . . 0.0 110.942 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -145.49 152.06 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.979 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.98 146.92 34.43 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.77 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -158.66 145.86 17.63 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.682 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.465 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 1.5 ptt85 -83.85 98.79 9.93 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.254 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 t -61.86 117.35 5.77 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -161.27 -11.65 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.694 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER -49.4 133.02 18.0 Favored Pre-proline 0 N--CA 1.486 1.365 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.257 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 4' ' ' VAL . 4.6 Cg_exo -55.6 -164.07 0.01 OUTLIER 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 120.464 0.776 . . . . 0.0 111.365 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -174.61 178.82 1.85 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.617 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 52.94 43.08 32.1 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.576 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 mp -92.58 126.3 37.6 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.369 -0.933 . . . . 0.0 110.273 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -171.97 161.17 5.63 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.357 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.9 t -89.06 115.34 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.32 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.461 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 2.7 t -69.43 -26.58 31.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.565 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 11' ' ' VAL . . . 167.59 178.51 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.96 119.74 12.56 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.626 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.9 162.49 22.06 Favored Pre-proline 0 C--N 1.3 -1.584 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.708 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 16' ' ' THR . 4.5 Cg_exo -53.95 94.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 120.733 0.955 . . . . 0.0 110.673 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.489 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER 81.06 41.66 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.881 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.32 137.51 1.89 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.685 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.64 148.6 43.16 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.7 tt -129.66 105.53 8.11 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.006 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.45 168.3 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.449 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -161.82 132.21 4.93 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.591 -1.244 . . . . 0.0 111.584 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.549 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 6.8 p90 -131.21 -141.97 0.22 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.556 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.549 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 6.7 t70 -166.33 163.97 17.55 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.633 -1.627 . . . . 0.0 112.645 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.517 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . -130.79 136.17 28.5 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.588 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.17 -170.98 0.05 OUTLIER 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 120.423 0.749 . . . . 0.0 111.183 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.18 6.46 48.97 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.82 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.617 ' CG2' ' H ' ' A' ' 28' ' ' THR . 13.0 p -76.84 179.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.802 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.617 ' H ' ' CG2' ' A' ' 27' ' ' VAL . 97.3 m -66.06 123.34 19.58 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.303 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.4 t -131.03 110.6 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.319 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.03 -76.59 0.1 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.393 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -147.13 168.17 22.3 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.148 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -120.83 160.32 23.64 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.285 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -127.33 146.15 50.55 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.466 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.4 mt -137.8 99.46 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.679 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.28 137.61 43.92 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.108 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -145.28 148.03 33.01 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.242 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.58 140.75 6.66 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.58 143.42 48.25 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.09 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.9 m -74.71 107.3 6.73 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.725 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.45 -17.33 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.527 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.81 8.2 76.89 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.323 -1.418 . . . . 0.0 110.258 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -82.87 -47.28 12.02 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.725 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 170.74 108.79 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.33 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.103 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -59.51 151.71 67.02 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.214 0.61 . . . . 0.0 111.036 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.4 t -62.14 -89.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.787 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 3.8 pt20 -173.25 -152.71 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.019 -1.073 . . . . 0.0 111.404 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.484 ' N ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -159.19 173.4 16.42 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.163 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -165.08 148.24 8.34 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.517 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.21 167.22 10.73 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.339 -0.944 . . . . 0.0 112.682 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -147.21 158.18 44.74 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.667 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.16 6.26 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 121.175 1.25 . . . . 0.0 112.172 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 70.52 -1.14 22.56 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.338 -1.411 . . . . 0.0 110.275 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.39 -37.09 57.67 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.884 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -80.63 116.32 20.6 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.575 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.9 m -82.31 -2.07 51.58 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.111 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.2 p -133.09 157.56 44.97 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.513 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.03 140.67 13.36 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.579 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m -103.77 139.64 38.72 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.274 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.2 tt -135.42 149.2 28.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.843 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -141.48 -154.68 0.53 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.397 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.91 46.25 94.93 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.276 -1.44 . . . . 0.0 110.629 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.42 ' C ' ' CD1' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -130.45 -172.94 2.93 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.04 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -118.05 130.03 24.99 Favored Pre-proline 0 N--CA 1.49 1.526 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.967 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.62 140.51 87.03 Favored 'Trans proline' 0 C--O 1.217 -0.546 0 C-N-CA 120.409 0.74 . . . . 0.0 111.353 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.57 83.76 0.05 OUTLIER Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.462 -1.352 . . . . 0.0 110.553 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.1 p -165.29 148.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.153 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.92 149.49 47.74 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.616 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.37 137.09 21.59 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.846 -1.142 . . . . 0.0 111.9 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.57 119.35 35.28 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.918 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.431 ' C ' ' HG1' ' A' ' 71' ' ' THR . 3.7 tt -118.38 152.66 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.064 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 70' ' ' ILE . 50.7 m -140.51 126.15 19.12 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.656 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.18 144.84 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.782 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -119.22 125.19 48.57 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.782 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.81 86.78 4.8 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.41 118.57 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 118.962 -1.095 . . . . 0.0 112.338 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 0.5 OUTLIER -101.69 -68.3 0.83 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.906 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.569 ' N ' ' OG1' ' A' ' 76' ' ' THR . . . 98.99 116.27 3.73 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -75.23 -36.03 61.37 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.541 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.55 4.75 0.09 OUTLIER Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.193 -1.479 . . . . 0.0 111.397 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.05 -85.9 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.588 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.05 148.07 97.74 Favored Pre-proline 0 C--N 1.306 -1.296 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.733 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -62.83 128.92 24.47 Favored 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 120.778 0.985 . . . . 0.0 111.162 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.8 59.51 1.46 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.707 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.5 t -94.76 64.86 2.98 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.753 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 m -114.15 29.86 7.7 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.12 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.66 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -137.07 27.82 0.11 Allowed Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 86' ' ' LYS . 2.2 Cg_endo -58.39 138.68 87.14 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.614 0.876 . . . . 0.0 111.363 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.406 ' O ' ' CG2' ' A' ' 88' ' ' ILE . 13.1 tt -146.49 132.13 12.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.236 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 21.7 p -130.79 152.33 50.25 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.494 -0.882 . . . . 0.0 112.19 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.91 146.4 18.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.187 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -92.24 151.19 20.46 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.832 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -155.04 136.85 14.46 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.649 -1.22 . . . . 0.0 111.699 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.09 110.69 22.9 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.85 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 116.338 -1.792 . . . . 0.0 110.769 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -151.59 -147.8 0.24 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.66 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.19 -36.41 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.002 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.21 139.86 28.12 Favored Pre-proline 0 N--CA 1.498 1.926 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.039 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -55.79 169.25 1.36 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.04 1.16 . . . . 0.0 111.525 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -174.9 178.04 1.89 Allowed 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.72 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 52.68 62.35 2.73 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.78 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 mp -98.62 111.74 24.01 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.521 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 12.3 mp0 -135.38 163.88 29.02 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.776 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.9 t -89.48 116.5 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.697 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.462 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 1.9 t -82.51 -6.97 10.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.649 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 11' ' ' VAL . . . 169.23 166.3 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.526 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.38 144.77 24.81 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.164 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.72 ' HG1' ' HG ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -138.38 160.16 64.93 Favored Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.528 -179.941 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.413 ' C ' ' OG1' ' A' ' 16' ' ' THR . 5.4 Cg_exo -48.36 -8.88 0.07 OUTLIER 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.404 1.403 . . . . 0.0 112.306 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.494 ' H ' ' C ' ' A' ' 14' ' ' THR . 0.2 OUTLIER -164.29 41.7 0.09 Allowed 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.007 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.72 ' HG ' ' HG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -175.09 136.04 0.37 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.229 -179.966 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 tp -130.5 125.63 34.83 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.071 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tt -106.53 126.63 52.5 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.716 -0.793 . . . . 0.0 110.365 179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.427 ' C ' ' HG ' ' A' ' 21' ' ' SER . 9.5 pt -126.76 164.58 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.966 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.454 ' HG ' ' CG2' ' A' ' 11' ' ' VAL . 5.2 m -161.62 146.66 13.37 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.542 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.447 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 37.2 p90 -141.26 -139.87 0.13 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.975 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 24' ' ' ALA . 34.1 t70 -98.02 173.98 6.78 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.813 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.477 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . -96.73 165.53 15.8 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.731 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -62.21 169.15 8.22 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 121.244 1.296 . . . . 0.0 111.865 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.22 -79.65 0.56 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.691 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 28' ' ' THR . 3.2 m -91.64 -164.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.652 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 27' ' ' VAL . 1.5 p -39.23 151.7 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.043 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 t -138.55 147.53 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 119.026 -1.069 . . . . 0.0 112.152 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 19.8 mtp180 -108.92 -53.12 2.68 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.095 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 30' ' ' ARG . 44.3 m-85 -160.28 157.96 29.01 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.221 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.46 111.64 20.28 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.52 -1.218 . . . . 0.0 107.954 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.9 mtt-85 -100.12 145.06 28.42 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.2 mp -141.21 110.4 2.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.601 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 p -121.73 151.4 40.56 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.036 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 15.2 p90 -144.13 155.34 43.89 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 118.584 -1.246 . . . . 0.0 111.67 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.48 147.19 5.58 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.795 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -62.17 166.7 4.58 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.444 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -75.81 143.34 41.94 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.81 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 176.06 -28.84 0.07 OUTLIER Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.241 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.36 -101.86 0.21 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.122 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -135.28 62.15 1.64 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.382 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.0 t -135.39 69.51 68.1 Favored Pre-proline 0 N--CA 1.49 1.525 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.195 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.22 131.1 34.93 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.24 1.293 . . . . 0.0 111.061 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.5 t -49.74 -49.21 20.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.366 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -164.01 167.95 19.83 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.594 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -148.0 146.87 29.09 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.186 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 10.6 p90 -154.23 134.89 13.57 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 118.72 -1.192 . . . . 0.0 111.276 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 t -100.49 147.52 25.8 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.496 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.81 150.83 61.13 Favored Pre-proline 0 C--N 1.301 -1.527 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.252 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.589 ' C ' ' H ' ' A' ' 53' ' ' SER . 6.2 Cg_exo -52.77 125.17 17.23 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 120.499 0.8 . . . . 0.0 110.882 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.66 17.6 0.07 OUTLIER Glycine 0 N--CA 1.487 2.09 0 C-N-CA 119.61 -1.281 . . . . 0.0 111.726 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.589 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -73.18 -41.54 63.73 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 118.859 -1.136 . . . . 0.0 110.184 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -87.71 -172.5 3.9 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.341 -0.943 . . . . 0.0 110.63 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.37 14.06 2.38 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.441 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.0 p -126.82 174.4 8.81 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.615 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.18 122.52 0.67 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.443 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.25 146.54 24.27 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.698 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mt -136.78 147.11 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.995 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.5 t -150.57 153.97 36.72 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.419 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 62' ' ' LEU . . . 123.07 -9.27 9.0 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 61' ' ' GLY . 2.1 mt -49.79 -178.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.785 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.574 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -176.39 -43.24 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 119.416 -0.914 . . . . 0.0 112.36 179.948 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 63' ' ' LYS . 4.2 Cg_endo -79.46 -168.17 0.6 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.657 1.571 . . . . 0.0 111.776 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -154.66 87.47 0.13 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.744 -1.743 . . . . 0.0 108.744 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.618 ' CG2' ' H ' ' A' ' 67' ' ' ASP . 11.5 p -156.54 -177.2 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 118.944 -1.103 . . . . 0.0 111.715 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.618 ' H ' ' CG2' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -57.75 98.65 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.634 179.982 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -94.11 132.03 39.04 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.278 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 m -112.85 127.57 56.22 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.747 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 pp -113.86 151.2 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.203 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.3 m -143.32 120.85 11.73 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.016 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.43 141.21 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.768 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 97.15 6.52 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.343 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.29 92.2 2.74 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.533 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.54 115.67 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.696 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -119.25 -39.15 2.93 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.43 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 68.08 141.49 0.08 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.481 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 ttm-85 -81.35 -59.06 2.77 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.993 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.19 3.71 0.17 Allowed Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.428 -1.368 . . . . 0.0 110.759 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -142.23 -63.62 0.43 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.988 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.13 115.92 63.2 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.801 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -65.2 96.66 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 N-CA-C 110.266 -0.705 . . . . 0.0 110.266 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -118.97 149.5 41.51 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.322 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.41 ' H ' ' HG ' ' A' ' 84' ' ' SER . 23.2 p -64.06 127.0 29.52 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.524 -0.871 . . . . 0.0 110.824 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -65.99 -109.45 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.686 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.84 63.62 26.04 Favored Pre-proline 0 N--CA 1.486 1.365 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.948 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -55.1 158.4 11.72 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.413 1.409 . . . . 0.0 111.286 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.0 156.5 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 53.4 p -145.27 159.89 42.33 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.235 -179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -148.76 149.71 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.6 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.38 154.55 18.7 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.542 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -175.55 135.07 0.31 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.737 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -61.65 96.42 0.06 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.295 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 116.502 -1.713 . . . . 0.0 110.583 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.415 ' H1 ' ' H ' ' A' ' 2' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.929 0.395 . . . . 0.0 109.961 . . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.415 ' H ' ' H1 ' ' A' ' 1' ' ' VAL . 52.2 p -86.26 -147.53 0.12 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.846 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -113.64 -37.19 4.66 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.227 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 t -61.47 129.61 91.26 Favored Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.219 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -73.18 106.32 2.14 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 120.921 1.081 . . . . 0.0 111.386 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -175.33 -151.18 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.694 -1.202 . . . . 0.0 111.621 179.947 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 2.2 t70 74.47 22.39 2.13 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.661 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mp -52.43 144.82 12.45 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.59 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -159.73 140.84 12.55 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.869 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.83 109.64 13.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.391 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.1 t -70.17 -64.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.221 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.59 166.62 30.64 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.861 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.32 127.39 45.48 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.424 ' OG1' ' OG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -103.26 161.85 21.82 Favored Pre-proline 0 C--N 1.308 -1.206 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.299 -180.0 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.479 ' O ' ' OG1' ' A' ' 16' ' ' THR . 4.9 Cg_exo -49.28 99.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 120.547 0.831 . . . . 0.0 110.614 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 15' ' ' PRO . 1.7 p 69.14 44.59 0.97 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.52 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.424 ' OG ' ' OG1' ' A' ' 14' ' ' THR . 0.3 OUTLIER -165.33 146.92 7.52 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.274 179.937 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mt -128.31 142.94 50.99 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.759 -0.777 . . . . 0.0 111.497 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.0 tt -115.91 102.23 9.48 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.831 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.57 146.58 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.72 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -139.77 132.3 28.7 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.227 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.547 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 12.6 p90 -132.69 -144.4 0.24 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.796 -1.162 . . . . 0.0 112.447 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.547 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 22.3 t0 -99.11 162.48 13.04 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.942 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -168.38 78.76 0.81 Allowed Pre-proline 0 N--CA 1.487 1.412 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.8 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -64.79 167.53 15.39 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 121.46 1.44 . . . . 0.0 111.81 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.04 4.29 42.58 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.646 -0.821 . . . . 0.0 111.21 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.642 ' CG2' ' H ' ' A' ' 28' ' ' THR . 10.4 p -62.79 -179.21 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.624 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.642 ' H ' ' CG2' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -67.52 119.6 12.58 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.678 -179.979 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.1 t -137.13 128.31 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.341 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.523 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -87.81 -61.47 1.71 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.483 -179.984 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 46.3 m-85 -147.45 168.0 23.0 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.167 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.28 137.47 42.53 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.256 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.09 128.9 23.24 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 118.236 -1.386 . . . . 0.0 111.274 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.2 mt -111.54 135.17 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.891 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 p -128.05 135.07 49.35 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.463 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 6.7 p90 -135.91 160.6 38.08 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.653 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . 165.65 139.87 2.75 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -57.35 -161.01 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.48 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER -53.98 173.1 0.07 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.92 -179.921 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.517 ' N ' ' OG1' ' A' ' 39' ' ' THR . . . -44.68 -70.48 0.59 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.756 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.41 -130.01 37.5 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.307 -1.425 . . . . 0.0 109.964 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.24 -63.51 1.35 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.246 -0.981 . . . . 0.0 110.35 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.0 162.95 17.87 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.193 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.61 158.3 28.53 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 121.25 1.3 . . . . 0.0 111.237 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.7 t -67.57 -67.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.288 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.584 ' NE2' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -175.22 -175.5 0.84 Allowed 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.13 -179.883 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.584 ' H ' ' NE2' ' A' ' 46' ' ' GLN . 6.5 pt-20 -157.6 167.79 29.12 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.222 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -159.47 147.53 17.46 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.237 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.5 p -97.66 124.64 42.05 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.399 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.64 151.29 49.68 Favored Pre-proline 0 N--CA 1.49 1.574 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.292 179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.548 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.2 Cg_endo -61.66 126.42 19.0 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 120.678 0.918 . . . . 0.0 110.517 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.46 -9.25 0.08 OUTLIER Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.98 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.548 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -71.3 -43.18 67.62 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.496 179.983 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 mmtm -67.77 132.72 47.96 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.301 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -103.07 -5.29 23.48 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.465 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.6 p -134.8 172.93 12.28 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.46 151.84 4.6 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.102 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.5 m -121.38 117.56 27.23 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.701 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.12 157.96 9.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.929 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -145.61 178.2 8.31 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.146 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.98 53.39 2.86 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.239 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.57 -156.4 0.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.809 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -140.28 148.83 55.72 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.43 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -68.21 123.13 10.24 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 121.052 1.168 . . . . 0.0 112.439 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.22 91.75 0.04 OUTLIER Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.787 -1.197 . . . . 0.0 111.777 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.2 p -167.48 144.96 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.211 -0.996 . . . . 0.0 110.864 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.29 153.76 6.74 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.16 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.79 134.48 18.81 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.238 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.1 m -125.61 120.92 32.11 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.623 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 pp -115.63 163.12 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.92 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.443 ' OG1' ' OG ' ' A' ' 89' ' ' SER . 17.1 m -152.54 127.73 9.8 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.361 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 m -121.91 136.86 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.274 -0.971 . . . . 0.0 111.796 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -115.34 126.63 54.67 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.389 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.08 98.14 7.82 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.583 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.6 t -86.36 117.54 31.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.644 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.52 -64.21 1.16 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.732 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.434 ' H ' ' HA ' ' A' ' 83' ' ' ALA . . . 159.68 179.96 34.84 Favored Glycine 0 N--CA 1.495 2.623 0 C-N-CA 119.429 -1.367 . . . . 0.0 111.841 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -120.05 62.47 0.84 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.606 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.02 -28.58 4.38 Favored Glycine 0 N--CA 1.5 2.947 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -147.6 -51.99 0.19 Allowed 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.41 153.06 42.98 Favored Pre-proline 0 C--N 1.311 -1.066 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.485 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.43 ' C ' ' N ' ' A' ' 84' ' ' SER . 1.7 Cg_endo -60.79 123.41 12.93 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 120.846 1.03 . . . . 0.0 111.405 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HA ' ' H ' ' A' ' 77' ' ' GLY . . . -48.49 -17.3 0.15 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.953 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 85' ' ' SER . 2.9 p -86.2 69.92 10.51 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.29 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 84' ' ' SER . 39.7 m -50.89 -102.03 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.023 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -146.88 77.05 11.29 Favored Pre-proline 0 C--N 1.295 -1.768 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.691 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -52.8 162.7 2.35 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 120.616 0.877 . . . . 0.0 110.264 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.517 ' C ' ' HG ' ' A' ' 89' ' ' SER . 5.9 tt -153.57 160.12 3.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 117.961 -1.496 . . . . 0.0 112.304 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.517 ' HG ' ' C ' ' A' ' 88' ' ' ILE . 16.3 m -145.55 149.43 34.58 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.222 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 pt -147.03 154.9 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 118.956 -1.098 . . . . 0.0 111.387 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 92' ' ' TYR . 16.9 t-20 -89.77 164.15 14.78 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.554 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.447 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 22.6 t80 -172.32 129.67 0.58 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.209 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -90.39 111.06 22.15 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.082 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 116.295 -1.812 . . . . 0.0 110.666 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.424 ' H1 ' ' H ' ' A' ' 2' ' ' SER . 66.4 t . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.424 ' H ' ' H1 ' ' A' ' 1' ' ' VAL . 0.1 OUTLIER -168.85 -48.24 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.847 -1.141 . . . . 0.0 111.761 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.72 12.16 3.7 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.603 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 t -116.32 107.13 47.79 Favored Pre-proline 0 N--CA 1.495 1.821 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.009 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.41 ' HB2' ' H ' ' A' ' 6' ' ' ARG . 8.4 Cg_endo -67.88 -124.64 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.963 0 C-N-CA 120.446 0.764 . . . . 0.0 110.128 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.498 ' O ' ' O ' ' A' ' 22' ' ' TRP . 5.4 ptp180 -172.02 178.36 2.97 Favored 'General case' 0 N--CA 1.506 2.327 0 C-N-CA 117.624 -1.63 . . . . 0.0 114.158 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -33.07 102.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.839 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.456 HD11 ' H ' ' A' ' 23' ' ' ASP . 0.4 OUTLIER -53.91 125.12 17.49 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.676 179.821 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -174.14 159.16 3.17 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.89 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.1 t -91.98 135.51 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.516 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.77 -59.19 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 118.677 -1.209 . . . . 0.0 111.81 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.39 169.25 21.28 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.568 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.96 80.92 1.7 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.938 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.549 ' HG1' ' CB ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -66.92 161.18 64.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.24 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -54.36 -10.12 2.01 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.362 1.375 . . . . 0.0 111.757 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.413 ' H ' ' C ' ' A' ' 14' ' ' THR . 9.5 m -159.07 44.61 0.26 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.504 -0.879 . . . . 0.0 110.476 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.549 ' CB ' ' HG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -175.86 114.82 0.13 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.555 180.0 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.5 tp -109.81 112.15 24.03 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.336 -179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.22 122.48 31.08 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.297 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.71 148.23 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.73 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.45 136.41 46.7 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.954 179.801 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.498 ' O ' ' O ' ' A' ' 6' ' ' ARG . 45.7 p90 -118.35 -173.2 2.42 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 118.334 -1.346 . . . . 0.0 113.221 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.461 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -147.91 168.27 22.68 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.396 -179.686 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -177.15 179.56 0.36 Allowed Pre-proline 0 N--CA 1.499 1.977 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.955 179.931 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -64.12 165.15 20.13 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 C-N-CA 120.867 1.044 . . . . 0.0 111.76 -179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -92.85 42.75 1.11 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.574 -0.85 . . . . 0.0 111.592 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.595 ' CG2' ' H ' ' A' ' 28' ' ' THR . 14.0 p -103.3 177.07 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.679 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.595 ' H ' ' CG2' ' A' ' 27' ' ' VAL . 0.6 OUTLIER -80.31 105.46 11.58 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.83 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 37.1 t -103.26 123.5 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.579 -0.849 . . . . 0.0 111.035 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -65.34 -47.3 76.94 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.031 -1.068 . . . . 0.0 109.931 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -159.06 168.55 26.39 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.324 179.92 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -113.87 165.91 12.11 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.457 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -141.64 100.19 3.71 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.849 -0.741 . . . . 0.0 109.356 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.12 131.46 45.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.469 -0.892 . . . . 0.0 112.342 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 36.2 p -127.08 136.73 52.56 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.383 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 2.3 p90 -142.46 159.66 41.79 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 118.556 -1.258 . . . . 0.0 111.682 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.58 150.06 5.88 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -70.26 156.97 38.52 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.491 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.0 m -73.72 151.04 40.81 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.539 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.02 -87.13 0.09 OUTLIER Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.256 -1.45 . . . . 0.0 110.578 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.21 -5.4 0.89 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.416 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -76.51 -57.53 3.81 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.748 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 p 178.16 123.55 0.19 Allowed Pre-proline 0 C--N 1.304 -1.375 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.384 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -59.15 166.58 7.02 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 120.465 0.776 . . . . 0.0 111.188 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.5 t -63.24 -70.74 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.084 179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -174.68 -166.11 0.23 Allowed 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.827 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -162.07 174.49 12.93 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.004 -179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.582 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -170.59 153.7 4.28 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.997 179.677 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 p -113.01 157.33 21.66 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.475 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.581 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -145.44 159.88 46.9 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.493 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -64.81 22.65 0.07 OUTLIER 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 121.372 1.381 . . . . 0.0 112.179 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 48.33 20.71 1.61 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.148 -1.501 . . . . 0.0 110.394 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -45.98 16.8 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.663 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -90.55 130.4 36.59 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.274 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.4 m -81.32 -4.47 55.73 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.622 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -133.74 162.35 32.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.188 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.92 171.77 13.83 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.589 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.6 m -144.44 117.06 8.64 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.633 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.2 mt -111.39 150.02 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.559 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.3 m -136.92 -8.13 1.83 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.788 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.41 52.17 1.81 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.419 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.29 -172.97 2.92 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.998 -179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.532 ' H ' ' HH ' ' A' ' 68' ' ' TYR . 22.5 mmtt -131.91 102.15 14.93 Favored Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.911 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.29 144.22 61.5 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 120.657 0.905 . . . . 0.0 111.321 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.37 38.62 1.76 Allowed Glycine 0 N--CA 1.498 2.793 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.672 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' A' ' 67' ' ' ASP . 5.3 p -169.05 165.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.631 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.49 ' N ' ' CG2' ' A' ' 66' ' ' VAL . 4.4 t70 -60.31 145.89 46.01 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.675 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.532 ' HH ' ' H ' ' A' ' 63' ' ' LYS . 0.3 OUTLIER -145.32 119.06 9.2 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.422 -179.904 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -105.59 136.77 44.58 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.565 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.443 ' CG1' ' N ' ' A' ' 71' ' ' THR . 2.1 tt -134.36 156.54 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.876 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.616 ' HG1' ' CB ' ' A' ' 89' ' ' SER . 48.9 m -147.99 138.1 22.72 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.585 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.4 m -114.28 129.87 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.407 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -111.23 114.86 28.38 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.639 -179.765 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.07 96.52 9.7 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.172 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.34 146.24 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.161 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.626 ' CG2' ' H ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -122.26 -91.99 0.54 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.141 179.969 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.626 ' H ' ' CG2' ' A' ' 76' ' ' THR . . . 50.57 -167.25 0.46 Allowed Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.783 -1.198 . . . . 0.0 110.852 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.39 -0.04 22.62 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.247 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.41 0.9 40.69 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 119.644 -1.265 . . . . 0.0 111.256 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -130.1 -15.3 3.78 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.726 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.89 74.7 79.66 Favored Pre-proline 0 C--N 1.309 -1.16 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.545 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -63.72 112.73 1.88 Allowed 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 121.186 1.257 . . . . 0.0 111.346 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.25 119.91 39.96 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.616 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.3 m -57.59 103.01 0.11 Allowed 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.2 m -74.93 -93.46 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.603 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -140.14 67.44 33.14 Favored Pre-proline 0 C--N 1.301 -1.502 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.439 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -72.2 157.9 52.98 Favored 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 121.494 1.463 . . . . 0.0 110.351 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.3 tt -144.19 138.43 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 118.66 -1.216 . . . . 0.0 110.61 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.616 ' CB ' ' HG1' ' A' ' 71' ' ' THR . 89.4 p -119.42 122.36 41.57 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.597 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.646 ' H ' ' CD1' ' A' ' 90' ' ' ILE . 0.0 OUTLIER -120.5 145.09 27.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.681 -179.971 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -97.45 153.4 18.14 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.861 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.451 ' O ' ' O ' ' A' ' 68' ' ' TYR . 24.5 t80 -165.18 135.43 3.74 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 119.234 -0.986 . . . . 0.0 111.026 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.33 127.35 43.21 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.91 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 116.339 -1.791 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 120.812 0.339 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.81 131.65 44.12 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.213 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -162.01 -52.56 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.072 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 5' ' ' PRO . 41.9 t -62.81 136.87 96.6 Favored Pre-proline 0 C--N 1.303 -1.442 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.916 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 4' ' ' VAL . 12.4 Cg_exo -47.97 177.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 120.694 0.929 . . . . 0.0 110.792 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -172.03 166.94 6.18 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.183 -1.407 . . . . 0.0 113.041 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 41.65 86.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.599 -1.182 . . . . 0.0 113.983 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.27 149.28 24.18 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -164.75 161.65 20.69 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 117.206 -1.798 . . . . 0.0 113.78 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.9 t -103.53 135.36 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-N 114.238 -1.346 . . . . 0.0 108.502 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.49 -10.08 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.762 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 175.22 170.0 0.3 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.413 -1.315 . . . . 0.0 111.886 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.59 134.31 16.6 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.656 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -126.45 162.01 49.12 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.73 179.986 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -52.04 -12.88 1.55 Allowed 'Trans proline' 0 C--O 1.213 -0.745 0 C-N-CA 121.135 1.223 . . . . 0.0 111.865 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.14 48.99 0.39 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.03 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER 173.06 139.1 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.983 -179.998 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 tp -130.65 132.33 45.38 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.493 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.477 ' CD1' ' HG1' ' A' ' 58' ' ' THR . 2.2 tp -93.56 126.67 38.84 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.034 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 pp -128.17 156.14 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.166 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.91 145.11 29.7 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.936 -1.105 . . . . 0.0 111.61 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.613 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 7.3 p90 -144.84 -147.56 0.22 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.153 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.613 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 27.6 t70 -154.35 150.05 27.53 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 117.937 -1.505 . . . . 0.0 112.621 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.59 127.29 25.25 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.24 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.06 171.03 5.44 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 120.626 0.884 . . . . 0.0 111.62 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.67 19.26 4.07 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.119 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.531 ' CG2' ' N ' ' A' ' 28' ' ' THR . 4.1 p -84.4 165.41 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.909 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.531 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -57.64 95.35 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.606 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.5 t -108.08 137.67 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.719 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -93.4 -57.57 2.56 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.975 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -165.03 166.73 19.04 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.826 -1.149 . . . . 0.0 112.028 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.481 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 2.1 m-85 -120.0 156.0 31.74 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.439 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -135.19 104.6 5.96 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.864 179.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -96.28 122.03 47.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.682 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -120.18 141.38 49.94 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.638 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -139.16 144.38 38.56 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.898 -1.121 . . . . 0.0 111.28 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.42 153.26 18.66 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -74.31 166.83 22.8 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.006 -179.944 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.9 m -75.1 157.64 34.41 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.915 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.74 -69.67 0.42 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.288 179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.69 -134.46 3.83 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.436 ' O ' ' OG ' ' A' ' 43' ' ' SER . 48.1 t-20 -73.36 -96.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.349 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 45' ' ' VAL . 3.2 m -172.92 66.89 0.36 Allowed Pre-proline 0 C--N 1.305 -1.351 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.995 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -74.48 40.95 0.65 Allowed 'Trans proline' 0 C--N 1.327 -0.6 0 C-N-CA 121.656 1.571 . . . . 0.0 110.27 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.506 ' H ' ' C ' ' A' ' 43' ' ' SER . 61.4 t -109.57 -95.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.081 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.48 174.1 8.17 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 117.061 -1.856 . . . . 0.0 113.02 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -169.06 167.18 10.72 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.226 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -164.11 160.55 21.63 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.94 161.53 20.73 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.643 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.581 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -148.66 159.41 38.37 Favored Pre-proline 0 C--N 1.309 -1.187 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.129 179.977 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -64.99 22.25 0.08 OUTLIER 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.002 1.135 . . . . 0.0 112.107 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.581 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 49.3 17.65 1.17 Allowed Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.776 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.56 -43.33 14.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -79.09 123.33 27.24 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.951 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.7 m -81.2 -12.68 59.1 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.446 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.0 p -138.62 148.56 44.25 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.173 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.95 165.03 30.65 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.921 -1.111 . . . . 0.0 111.435 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.477 ' HG1' ' CD1' ' A' ' 19' ' ' LEU . 27.7 m -104.17 130.23 51.91 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.167 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -112.21 123.29 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.719 179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 51.6 m -129.81 157.48 42.09 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.307 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.78 -20.44 1.81 Allowed Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.576 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.452 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -79.35 -172.03 3.01 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.016 179.956 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.582 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -157.3 -43.73 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.487 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.487 179.967 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.582 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 10.3 Cg_endo -89.19 -167.65 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.517 1.478 . . . . 0.0 111.658 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -132.53 81.18 0.32 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 107.483 -2.247 . . . . 0.0 107.483 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.529 ' CG2' ' N ' ' A' ' 67' ' ' ASP . 7.5 p -133.61 175.33 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.055 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.529 ' N ' ' CG2' ' A' ' 66' ' ' VAL . 4.3 t70 -50.8 120.55 4.89 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.135 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.02 129.11 46.19 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.173 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.0 126.48 52.38 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.06 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 pp -112.23 152.66 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.847 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.411 ' OG1' ' OG ' ' A' ' 89' ' ' SER . 52.9 m -145.49 143.95 30.29 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.955 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.2 m -125.19 139.34 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.635 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -117.49 100.45 7.66 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.794 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.481 ' CB ' ' CZ ' ' A' ' 32' ' ' TYR . . . -79.44 83.35 5.46 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.86 140.03 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 118.997 -1.081 . . . . 0.0 113.544 -179.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 p -126.99 -161.03 1.04 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.134 -1.393 . . . . 0.0 108.128 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 144.46 179.39 20.86 Favored Glycine 0 N--CA 1.499 2.893 0 C-N-CA 118.549 -1.786 . . . . 0.0 111.836 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 mtt180 -91.96 -15.27 28.22 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.232 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 104.22 17.39 15.97 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.321 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -161.38 -33.23 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.762 -1.175 . . . . 0.0 111.845 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.78 139.47 21.61 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.882 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.12 113.06 1.42 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 120.711 0.941 . . . . 0.0 110.957 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.96 118.46 36.81 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.6 t -71.76 141.02 49.75 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.774 ' HG ' ' H ' ' A' ' 86' ' ' LYS . 4.8 t -115.25 -177.62 3.18 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.877 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.774 ' H ' ' HG ' ' A' ' 85' ' ' SER . 4.3 mptt -118.74 84.3 24.74 Favored Pre-proline 0 N--CA 1.494 1.745 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.952 179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -70.69 158.93 54.34 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 120.997 1.131 . . . . 0.0 112.752 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.8 tt -149.3 137.03 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.373 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.411 ' OG ' ' OG1' ' A' ' 71' ' ' THR . 4.2 m -128.2 134.63 49.06 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.902 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.7 136.01 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.104 179.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.18 145.18 26.29 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.867 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.455 ' CG ' ' N ' ' A' ' 93' ' ' ARG . 24.3 t80 -167.28 158.2 11.65 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.984 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.455 ' N ' ' CG ' ' A' ' 92' ' ' TYR . 7.2 mtm-85 -93.34 113.55 25.76 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.975 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 116.581 -1.676 . . . . 0.0 110.436 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 2' ' ' SER . 3.2 t . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 120.824 0.345 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 1' ' ' VAL . 38.0 m -56.87 -107.61 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.82 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -157.45 -20.29 0.09 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.933 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 t -90.35 135.07 30.06 Favored Pre-proline 0 N--CA 1.488 1.427 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.369 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.44 165.37 7.65 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 120.415 0.743 . . . . 0.0 111.237 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 1.8 ptp180 -175.13 171.27 3.02 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.022 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 3.3 t70 70.63 44.22 0.68 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.092 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 9.5 mp -88.08 121.76 30.86 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.543 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -171.32 166.07 7.09 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.587 -1.245 . . . . 0.0 111.933 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.6 t -92.62 143.48 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.848 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.6 p -128.92 -2.93 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.48 -179.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -179.81 147.54 0.29 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.491 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -176.57 112.17 0.1 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.631 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.64 ' O ' ' N ' ' A' ' 16' ' ' THR . 0.2 OUTLIER -148.51 -75.62 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 117.921 -1.512 . . . . 0.0 113.049 179.968 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 17' ' ' SER . 6.8 Cg_endo -53.21 78.37 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.779 0 CA-C-N 119.491 0.854 . . . . 0.0 110.863 -179.571 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 14' ' ' THR . 3.0 m 35.51 32.49 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.074 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 15' ' ' PRO . 1.6 m -139.79 148.95 42.94 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.941 -1.103 . . . . 0.0 112.447 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.6 tp -113.09 142.04 46.19 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.575 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.1 tp -117.2 107.29 14.26 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.047 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 pt -106.24 157.95 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.361 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.98 138.3 18.46 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.824 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.543 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 9.3 p90 -144.35 -156.17 0.67 Allowed 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 118.816 -1.154 . . . . 0.0 111.346 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.543 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 27.7 t70 -102.57 163.44 12.22 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -179.52 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.429 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -145.98 101.8 4.18 Favored Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.071 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -56.4 -176.66 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.615 0.876 . . . . 0.0 112.255 -179.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.95 -13.88 20.92 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.122 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.417 ' O ' ' N ' ' A' ' 29' ' ' VAL . 2.6 m -59.17 145.73 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 118.281 -1.367 . . . . 0.0 110.013 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.8 m -68.53 72.52 0.22 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.612 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.417 ' N ' ' O ' ' A' ' 27' ' ' VAL . 24.0 t -66.36 126.57 26.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.785 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.1 mmm-85 -54.61 -42.88 71.67 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.23 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -179.58 165.71 1.36 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.443 -1.303 . . . . 0.0 112.234 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -115.73 163.08 16.35 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.14 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.475 HH21 ' CG2' ' A' ' 49' ' ' THR . 21.2 ttm180 -146.56 106.16 3.95 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.39 -1.324 . . . . 0.0 111.038 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.583 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.9 mp -99.9 122.02 51.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.329 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 p -119.59 139.08 52.73 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.699 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 6.4 p90 -136.51 155.35 50.09 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.14 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.57 143.36 6.11 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.464 ' CD ' ' N ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -71.54 176.62 4.6 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.636 -0.825 . . . . 0.0 110.808 179.931 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.2 m -63.5 137.26 58.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.017 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.28 -72.42 0.25 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.648 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.21 -9.69 75.93 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.258 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -87.22 -11.57 49.39 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.4 t -173.74 78.41 0.38 Allowed Pre-proline 0 C--N 1.306 -1.286 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.752 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -60.6 163.46 15.49 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 120.996 1.131 . . . . 0.0 111.17 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.2 t -72.07 -78.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.505 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -172.11 -163.49 0.25 Allowed 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 118.476 -1.289 . . . . 0.0 111.966 -179.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.71 168.77 21.07 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.771 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -159.84 139.27 11.17 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.548 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.475 ' CG2' HH21 ' A' ' 33' ' ' ARG . 23.3 p -105.07 164.74 11.58 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.644 -0.822 . . . . 0.0 112.393 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.583 ' C ' ' H ' ' A' ' 52' ' ' GLY . 26.9 m -148.06 152.58 40.25 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.42 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -55.63 6.52 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 120.942 1.095 . . . . 0.0 112.612 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 80.86 -4.05 72.24 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.978 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.67 -27.19 45.16 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.079 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -80.45 108.74 14.33 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.01 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -81.31 -19.64 42.49 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.394 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.8 p -135.17 150.08 50.07 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.8 168.36 26.58 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.997 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -117.11 158.31 24.43 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.398 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.6 mt -143.03 155.06 17.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.396 -179.973 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.415 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -139.52 135.64 33.67 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.875 -179.999 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.4 44.37 0.18 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.5 mp -107.16 175.66 5.42 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.573 -179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.58 141.39 28.82 Favored Pre-proline 0 CA--C 1.555 1.137 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.02 100.29 0.08 OUTLIER 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 120.748 0.965 . . . . 0.0 112.505 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.43 95.22 0.05 OUTLIER Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.59 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 p -160.59 159.04 2.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 119.136 -1.025 . . . . 0.0 111.328 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.3 146.41 45.34 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.264 -0.974 . . . . 0.0 108.874 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.9 145.2 31.47 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.458 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 m -125.29 126.06 44.51 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.407 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.3 tt -111.46 150.15 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.164 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.13 124.9 19.63 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.815 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.01 130.27 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.594 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.09 105.35 13.1 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.625 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.37 129.69 39.41 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.353 -0.939 . . . . 0.0 109.246 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 t -135.57 130.62 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 119.115 -1.034 . . . . 0.0 112.25 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 77' ' ' GLY . 53.6 m -128.76 -96.31 0.4 Allowed 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.583 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 76' ' ' THR . . . 60.21 145.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.673 -1.251 . . . . 0.0 111.092 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -108.22 179.59 4.16 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.565 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.19 -105.44 1.35 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.161 -1.495 . . . . 0.0 110.394 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.467 ' CG ' ' N ' ' A' ' 81' ' ' SER . 13.1 p-10 -153.2 -52.32 0.1 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.958 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.467 ' N ' ' CG ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -51.82 127.92 35.45 Favored Pre-proline 0 CA--C 1.562 1.434 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.692 -179.998 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.53 122.84 11.37 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 120.533 0.822 . . . . 0.0 111.527 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.64 16.34 5.35 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.032 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.6 m -118.36 86.43 2.53 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.798 179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.5 m -115.24 78.12 1.14 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.315 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -136.74 61.57 36.83 Favored Pre-proline 0 N--CA 1.493 1.686 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.452 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -71.07 160.35 49.51 Favored 'Trans proline' 0 C--O 1.217 -0.568 0 C-N-CA 121.571 1.514 . . . . 0.0 111.392 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.1 tt -149.76 128.55 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 118.934 -1.106 . . . . 0.0 109.753 179.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 99.6 p -121.04 152.04 39.08 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.769 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.77 142.57 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.339 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.92 154.65 18.07 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.598 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -164.48 131.69 3.18 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.121 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -89.69 117.26 28.42 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.172 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 116.299 -1.81 . . . . 0.0 110.597 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -54.81 116.99 3.03 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.982 -179.991 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 2' ' ' SER . 69.6 m-20 -155.04 49.01 0.56 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.389 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.0 t -107.91 135.51 19.83 Favored Pre-proline 0 N--CA 1.488 1.452 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.612 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -58.16 -166.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 120.477 0.784 . . . . 0.0 110.352 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 7' ' ' ASP . 4.9 ptp180 -166.85 168.09 14.39 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 117.613 -1.635 . . . . 0.0 113.483 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 18.86 78.34 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.651 179.924 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mp -101.28 123.55 45.58 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -161.75 171.3 18.08 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 117.942 -1.503 . . . . 0.0 112.813 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.41 129.85 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.08 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.9 t -95.59 -25.13 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.244 -179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.76 172.63 9.02 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.93 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.31 100.24 2.13 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.088 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.464 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -70.52 162.26 71.67 Favored Pre-proline 0 C--N 1.307 -1.271 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.563 179.858 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -53.94 -7.52 0.67 Allowed 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 121.008 1.139 . . . . 0.0 111.712 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.464 ' H ' ' C ' ' A' ' 14' ' ' THR . 7.2 m -160.29 35.99 0.17 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.412 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -167.55 120.31 0.92 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.207 179.89 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 tp -96.81 123.81 40.61 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.724 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.48 114.59 28.79 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.688 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.5 169.45 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.733 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.65 139.51 12.87 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.7 -179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.471 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 12.7 p90 -139.39 -134.15 0.12 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.649 -0.821 . . . . 0.0 110.321 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.493 ' CG ' ' N ' ' A' ' 24' ' ' ALA . 37.2 t70 -155.95 174.83 14.77 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 117.671 -1.612 . . . . 0.0 112.594 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.493 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -142.53 126.55 9.74 Favored Pre-proline 0 CA--C 1.559 1.298 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.854 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.64 -170.85 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 120.285 0.657 . . . . 0.0 111.42 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.87 -12.72 49.99 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.346 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 29' ' ' VAL . 14.1 m -60.96 142.03 16.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.672 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.8 m -54.95 89.93 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.588 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.459 ' N ' ' O ' ' A' ' 27' ' ' VAL . 3.6 t -76.53 115.19 17.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.134 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -66.33 -57.81 6.67 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.631 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -165.45 169.02 16.07 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.539 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -122.65 148.7 44.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.902 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -126.73 108.66 11.27 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.536 -0.865 . . . . 0.0 109.531 179.782 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.03 128.71 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.875 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 p -128.64 139.72 52.12 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.149 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -141.95 166.7 23.99 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.725 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.02 158.68 10.25 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -51.79 158.74 0.93 Allowed 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.603 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.404 ' OG1' ' OG1' ' A' ' 69' ' ' THR . 17.8 m -66.56 104.5 1.28 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.052 -179.912 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.46 -41.91 0.02 OUTLIER Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.07 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.95 -12.25 50.14 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.488 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -126.88 16.32 7.4 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.566 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.5 p -148.7 70.52 10.43 Favored Pre-proline 0 N--CA 1.488 1.457 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.35 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -69.57 118.47 5.7 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 C-N-CA 121.686 1.591 . . . . 0.0 111.891 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.3 t -57.91 -57.27 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.626 179.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.417 ' HG2' ' H ' ' A' ' 47' ' ' GLU . 2.9 tt0 -172.78 179.8 2.28 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.339 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -164.49 158.45 18.3 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.844 -179.968 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -159.25 157.55 30.86 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.606 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -119.73 168.41 11.09 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.112 -179.868 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.566 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -147.66 158.89 42.4 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.681 179.971 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.49 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.9 Cg_endo -61.7 15.42 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.0 1.133 . . . . 0.0 112.72 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.566 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 54.19 7.98 0.98 Allowed Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.111 -1.518 . . . . 0.0 110.533 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.49 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -70.07 -34.74 73.57 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.291 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -119.33 121.68 40.12 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.837 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 m -79.66 46.63 0.78 Allowed 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.979 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.12 151.34 43.85 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.378 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.13 159.21 40.02 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.735 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.07 148.95 52.19 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.699 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.2 mt -138.21 146.89 26.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.587 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.7 m -139.43 155.42 47.62 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.231 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.46 8.71 55.99 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.928 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.23 -156.05 0.16 Allowed 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.855 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.67 103.62 0.94 Allowed Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 119.649 -0.821 . . . . 0.0 110.617 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.94 158.71 32.51 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 120.375 0.717 . . . . 0.0 111.639 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.63 35.91 5.0 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.186 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -165.22 154.68 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.943 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -72.3 113.76 9.67 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.412 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.0 148.23 30.0 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.879 -0.729 . . . . 0.0 111.247 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.404 ' OG1' ' OG1' ' A' ' 39' ' ' THR . 9.2 m -122.93 140.21 53.24 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.708 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 tt -130.84 148.63 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.394 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 65.4 m -140.5 126.03 19.01 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.249 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 23.3 m -117.81 129.71 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.141 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -107.59 106.86 17.41 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.617 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.448 ' O ' ' OG ' ' A' ' 85' ' ' SER . . . -81.52 107.85 14.62 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.182 -179.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.39 113.7 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.526 -0.87 . . . . 0.0 111.23 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 m -128.34 -54.47 1.27 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.578 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.75 119.25 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.617 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.66 -80.01 0.4 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.864 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.79 17.13 0.06 OUTLIER Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.459 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -144.63 -70.84 0.28 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.075 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.56 162.69 60.5 Favored Pre-proline 0 C--N 1.306 -1.304 0 C-N-CA 119.176 -1.01 . . . . 0.0 110.32 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.06 168.1 2.79 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 121.158 1.239 . . . . 0.0 111.243 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.63 -26.62 67.16 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.293 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -66.39 109.1 2.59 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.4 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.714 ' HG ' ' H ' ' A' ' 86' ' ' LYS . 20.7 p -83.27 -86.74 0.11 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.236 -179.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.714 ' H ' ' HG ' ' A' ' 85' ' ' SER . 24.1 mttp -143.99 70.1 16.54 Favored Pre-proline 0 C--N 1.299 -1.626 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.388 -179.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.58 149.38 82.65 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.002 1.135 . . . . 0.0 110.429 179.862 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.1 tp -150.12 161.31 4.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 118.493 -1.283 . . . . 0.0 111.224 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.8 p -143.73 148.95 36.42 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.595 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.87 146.23 18.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.21 160.07 17.14 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.417 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -171.95 140.45 1.24 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.994 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -87.24 112.52 22.1 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.394 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.04 0 CA-C-O 116.337 -1.792 . . . . 0.0 110.827 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 t -179.77 -73.74 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.404 -0.919 . . . . 0.0 110.787 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -151.09 45.16 0.82 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.404 -0.919 . . . . 0.0 110.777 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 5' ' ' PRO . 84.2 t -49.42 125.9 16.03 Favored Pre-proline 0 C--N 1.302 -1.487 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.447 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 4' ' ' VAL . 6.1 Cg_exo -56.96 -161.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-N 118.729 0.582 . . . . 0.0 110.619 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -104.35 -154.65 0.51 Allowed 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 118.892 -1.123 . . . . 0.0 112.67 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -42.58 99.45 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.61 -179.685 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mp -96.09 143.33 27.32 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 10' ' ' VAL . 1.8 tm-20 -167.63 166.72 13.84 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 117.844 -1.542 . . . . 0.0 112.897 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.475 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 97.6 t -99.62 108.55 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.618 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.3 t -70.49 -42.88 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 119.141 -1.023 . . . . 0.0 111.918 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.27 173.48 16.62 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.757 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.59 142.45 21.11 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.697 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 17' ' ' SER . 1.1 p -140.63 155.58 69.48 Favored Pre-proline 0 N--CA 1.489 1.524 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.769 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.83 -7.92 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 121.389 1.393 . . . . 0.0 112.279 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.424 ' H ' ' C ' ' A' ' 14' ' ' THR . 68.9 p -147.09 27.54 1.05 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.739 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.429 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -177.53 147.84 0.54 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.728 -179.992 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.35 134.36 47.11 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.443 179.857 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.0 tp -115.65 103.1 10.37 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.508 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.35 165.61 2.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.257 179.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 m -156.06 136.53 13.18 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.258 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 16.0 p90 -138.66 -140.32 0.14 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.796 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.556 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 36.9 t70 -165.1 153.79 12.15 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.52 -1.272 . . . . 0.0 112.003 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.39 134.76 20.5 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.662 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -59.28 -159.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 120.658 0.905 . . . . 0.0 111.442 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.34 -18.64 19.82 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.965 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.5 m -60.07 151.41 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.786 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.42 ' H ' ' HG1' ' A' ' 28' ' ' THR . 0.7 OUTLIER -57.93 104.07 0.17 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.247 179.925 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -94.26 118.35 40.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.494 -179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -85.05 -55.4 4.07 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.486 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -157.95 163.99 37.29 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.629 -1.229 . . . . 0.0 111.924 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -119.46 160.46 22.31 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.739 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.38 98.03 3.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.808 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.554 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.7 mp -89.58 134.01 30.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.627 -0.829 . . . . 0.0 112.247 -179.781 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -135.79 134.5 39.01 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.771 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -141.92 155.56 45.49 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.547 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.1 152.28 8.13 Favored Glycine 0 N--CA 1.479 1.558 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.697 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -48.81 175.02 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.342 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 40' ' ' GLY . 19.9 m -51.79 164.11 0.27 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.417 ' N ' ' CG2' ' A' ' 39' ' ' THR . . . 84.6 86.67 0.9 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.393 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.1 74.73 1.61 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.367 -1.397 . . . . 0.0 110.588 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.416 ' O ' ' OG ' ' A' ' 43' ' ' SER . 0.6 OUTLIER -135.12 -19.16 1.75 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.039 -179.94 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.425 ' N ' ' CD ' ' A' ' 44' ' ' PRO . 11.0 m -168.36 57.12 0.34 Allowed Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.457 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 43' ' ' SER . 3.4 Cg_exo -52.62 164.27 1.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.314 1.343 . . . . 0.0 111.927 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.1 t -50.05 -67.11 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.263 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.99 -169.91 0.7 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.874 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -158.1 166.97 31.14 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.95 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 13.6 p90 -162.5 153.3 17.24 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.424 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.87 160.45 16.76 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.187 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.604 ' C ' ' H ' ' A' ' 52' ' ' GLY . 22.8 m -148.66 153.08 39.06 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.265 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.504 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.3 Cg_endo -60.01 16.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 120.872 1.048 . . . . 0.0 112.758 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.604 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 53.33 6.87 0.47 Allowed Glycine 0 N--CA 1.498 2.784 0 C-N-CA 119.578 -1.296 . . . . 0.0 111.093 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.504 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -74.98 -44.41 48.39 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.503 -179.977 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.55 116.25 31.25 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.467 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.7 m -84.6 53.74 2.78 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.042 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.1 143.68 22.66 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.97 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.96 148.24 30.55 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.804 -1.159 . . . . 0.0 111.842 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.1 m -121.91 104.13 9.33 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.926 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.2 pt -109.12 136.36 45.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.209 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.8 m -118.24 -176.68 3.11 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.721 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.83 40.05 9.86 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.514 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.73 -158.35 0.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.971 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -148.58 134.93 10.02 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.209 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -56.74 107.25 0.26 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 120.489 0.793 . . . . 0.0 112.072 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.57 87.71 0.52 Allowed Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.565 -1.302 . . . . 0.0 111.286 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.6 p -161.28 135.27 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.037 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.6 120.93 8.58 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.92 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.5 118.56 26.89 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.972 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.6 m -103.73 114.74 29.22 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.08 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.9 tt -103.64 150.56 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 119.287 -0.965 . . . . 0.0 112.06 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.587 ' CG2' ' HG ' ' A' ' 89' ' ' SER . 85.5 m -139.75 116.51 10.87 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.002 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.6 m -103.22 144.17 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.768 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -112.2 128.97 56.39 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.319 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.97 86.76 2.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.728 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.01 129.81 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 119.164 -1.015 . . . . 0.0 113.113 -179.629 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.622 ' CG2' ' H ' ' A' ' 77' ' ' GLY . 0.7 OUTLIER -99.35 -109.39 0.19 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.859 179.835 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.622 ' H ' ' CG2' ' A' ' 76' ' ' THR . . . 132.17 127.35 2.82 Favored Glycine 0 N--CA 1.497 2.738 0 C-N-CA 119.625 -1.274 . . . . 0.0 111.116 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.29 -10.12 48.0 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.682 179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -149.68 -73.75 0.01 OUTLIER Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -172.18 -4.71 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.44 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.6 148.13 51.11 Favored Pre-proline 0 C--N 1.306 -1.294 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.811 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.59 115.3 2.45 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 121.009 1.139 . . . . 0.0 111.357 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.27 116.32 32.4 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.813 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.423 ' O ' ' OG ' ' A' ' 84' ' ' SER . 86.6 p -61.12 100.61 0.12 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.568 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.1 t -90.09 -151.47 0.24 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.019 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -118.53 93.9 46.47 Favored Pre-proline 0 N--CA 1.489 1.481 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -71.38 167.98 24.78 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 121.112 1.208 . . . . 0.0 111.413 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 tt -149.49 147.38 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.601 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.587 ' HG ' ' CG2' ' A' ' 71' ' ' THR . 0.8 OUTLIER -135.17 155.23 51.04 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.681 -179.858 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.76 142.97 24.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.014 179.875 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.44 142.77 31.65 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.061 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -158.99 108.99 1.97 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.185 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.409 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 5.5 ptt-85 -79.04 116.81 19.57 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.887 -1.125 . . . . 0.0 109.114 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 116.367 -1.778 . . . . 0.0 110.972 -179.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 1' ' ' VAL . 7.5 p . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 121.216 0.531 . . . . 0.0 109.936 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.2 p -160.84 -170.45 2.73 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.547 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.27 46.99 0.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.829 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.6 t -130.38 86.36 53.8 Favored Pre-proline 0 N--CA 1.489 1.485 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.471 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.19 -170.91 0.04 OUTLIER 'Trans proline' 0 C--O 1.215 -0.672 0 N-CA-C 109.89 -0.85 . . . . 0.0 109.89 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 22' ' ' TRP . 0.3 OUTLIER -176.43 172.77 2.18 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 117.154 -1.818 . . . . 0.0 114.71 -179.712 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' ARG . 38.5 t70 27.19 102.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 113.524 -1.671 . . . . 0.0 113.443 179.862 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.475 HD11 ' H ' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -82.13 99.54 9.28 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.142 179.747 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -167.03 167.44 14.6 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.591 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.67 145.71 7.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.986 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.413 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -117.75 0.13 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.603 -179.853 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 11' ' ' VAL . . . 171.97 161.19 0.1 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.7 -1.2 . . . . 0.0 111.904 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.74 126.75 5.14 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.831 179.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.57 161.68 61.62 Favored Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.011 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 16' ' ' THR . 5.1 Cg_exo -49.79 104.79 0.08 OUTLIER 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 121.042 1.161 . . . . 0.0 112.051 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.463 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER 75.46 33.34 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.555 179.886 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 p -159.99 126.45 4.33 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.25 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.8 tp -130.42 140.07 50.58 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.77 -0.772 . . . . 0.0 111.347 -179.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.61 126.09 45.99 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.985 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 pt -133.66 162.15 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.286 -0.966 . . . . 0.0 112.932 -179.817 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -134.58 140.22 45.94 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.55 -1.205 . . . . 0.0 108.256 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.488 ' O ' ' O ' ' A' ' 6' ' ' ARG . 29.1 p90 -119.5 176.78 5.19 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 118.712 -1.195 . . . . 0.0 113.506 -179.843 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.475 ' H ' HD11 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.51 162.02 34.24 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.496 -179.881 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . . . -172.47 -175.63 0.3 Allowed Pre-proline 0 N--CA 1.496 1.827 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.542 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.461 ' CD ' ' CB ' ' A' ' 24' ' ' ALA . 5.9 Cg_exo -67.58 152.08 78.71 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 120.625 0.883 . . . . 0.0 111.009 -179.761 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.85 44.03 0.45 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.511 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.574 ' CG2' ' H ' ' A' ' 28' ' ' THR . 13.9 p -107.57 175.36 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.008 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.574 ' H ' ' CG2' ' A' ' 27' ' ' VAL . 4.2 m -80.52 128.97 34.2 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.97 179.91 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.42 132.0 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.653 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -80.16 -41.65 24.92 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.141 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -143.09 175.06 10.14 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.79 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.12 140.5 30.88 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.746 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -123.28 107.95 12.24 Favored 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 119.118 -1.033 . . . . 0.0 109.98 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.7 mt -100.98 111.34 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.099 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 9.0 p -117.35 137.46 52.43 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.593 179.846 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -141.4 138.21 32.81 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.029 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.12 136.78 4.25 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -82.75 169.51 16.08 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.742 -179.966 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.436 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 54.9 m -70.87 162.29 29.52 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.786 -0.766 . . . . 0.0 111.756 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' A' ' 42' ' ' ASN . . . 115.3 93.02 1.86 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -51.83 94.05 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.252 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 40' ' ' GLY . 0.8 OUTLIER -135.53 -58.95 0.77 Allowed 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.757 179.902 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.66 154.89 1.95 Allowed Pre-proline 0 C--N 1.306 -1.315 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.161 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.12 137.37 61.21 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 121.078 1.185 . . . . 0.0 111.207 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 46' ' ' GLN . 4.2 t -81.15 -80.85 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.162 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.417 ' N ' ' CG1' ' A' ' 45' ' ' VAL . 1.1 mt-30 -163.3 171.93 15.42 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.509 -1.676 . . . . 0.0 112.556 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -170.6 143.28 2.17 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.127 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 4.6 p90 -147.34 141.55 26.17 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 p -98.98 156.94 16.66 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.769 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.52 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -150.07 157.88 37.19 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.321 179.942 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.41 13.61 0.09 OUTLIER 'Trans proline' 0 C--O 1.212 -0.785 0 C-N-CA 121.319 1.346 . . . . 0.0 112.234 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 57.66 27.81 59.27 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 118.886 -1.626 . . . . 0.0 109.901 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.21 -31.3 19.16 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -95.91 135.24 37.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.982 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.8 m -79.71 -15.61 57.2 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.109 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 p -139.08 -179.61 5.95 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.134 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.04 157.83 6.74 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.346 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.6 m -114.32 136.74 52.65 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.624 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.65 155.22 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.487 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 16' ' ' THR . 11.1 t -147.74 127.05 13.05 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.937 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.34 -34.15 0.38 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.672 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.48 -158.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.798 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.569 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 8.3 tttt -176.11 -43.43 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 119.334 -0.947 . . . . 0.0 112.586 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 63' ' ' LYS . 4.4 Cg_endo -78.86 -175.52 2.79 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 121.497 1.465 . . . . 0.0 112.096 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.2 80.07 0.29 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.623 ' CG2' ' H ' ' A' ' 67' ' ' ASP . 13.8 p -122.81 -174.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.241 -179.79 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.623 ' H ' ' CG2' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -65.49 95.13 0.2 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.084 179.92 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -90.88 127.95 36.56 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.109 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 m -94.05 117.92 30.78 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.94 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 tp -104.89 141.92 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.534 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 97.3 m -141.48 130.05 22.68 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.373 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.12 128.06 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.947 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -98.33 146.74 25.38 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.699 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.35 85.33 2.37 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.981 0.8 . . . . 0.0 109.485 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 t -81.4 128.25 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.319 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 m -128.84 -57.57 1.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.635 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.89 159.98 53.91 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.458 -1.353 . . . . 0.0 109.932 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.78 -162.98 0.9 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.77 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 43.3 -113.43 0.68 Allowed Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.558 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.4 -19.17 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.191 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -75.53 -41.48 3.68 Favored Pre-proline 0 C--N 1.304 -1.397 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.259 179.955 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 81' ' ' SER . 5.8 Cg_exo -66.47 -177.35 0.87 Allowed 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 120.974 1.116 . . . . 0.0 111.795 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.09 126.28 14.14 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.126 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.6 t -88.45 178.65 6.49 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.763 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.34 172.52 13.18 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.987 -179.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -132.15 75.08 75.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.897 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.39 130.43 33.82 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.666 1.577 . . . . 0.0 113.161 -179.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.1 tt -133.07 145.28 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.456 179.761 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.4 p -144.46 153.53 41.98 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.301 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.53 141.83 19.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.376 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.34 154.54 41.51 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.122 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -152.25 122.26 7.08 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.405 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.54 75.93 1.07 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.648 179.858 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.453 ' O ' ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 116.212 -1.851 . . . . 0.0 110.417 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.888 0.375 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -146.02 147.29 31.49 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.818 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.61 25.58 1.99 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.717 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 5' ' ' PRO . 17.5 t -86.0 137.1 35.56 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.305 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 4' ' ' VAL . 3.4 Cg_exo -54.17 -163.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 120.69 0.926 . . . . 0.0 110.574 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -167.54 171.47 10.31 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 117.032 -1.867 . . . . 0.0 114.223 -179.92 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 6' ' ' ARG . 4.4 m-20 2.38 95.59 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 112.859 -1.973 . . . . 0.0 115.923 -179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mp -101.49 139.46 37.11 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.487 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.95 168.05 27.68 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 117.693 -1.603 . . . . 0.0 113.69 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.9 t -103.34 115.75 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.559 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.483 ' CG2' ' OG ' ' A' ' 21' ' ' SER . 2.3 t -72.52 -74.11 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.007 -1.077 . . . . 0.0 111.726 -179.823 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.81 179.0 6.84 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.73 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.14 100.73 3.6 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.314 -0.955 . . . . 0.0 111.499 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -65.16 164.44 23.08 Favored Pre-proline 0 C--N 1.305 -1.327 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.797 179.848 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.27 -12.52 3.97 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.213 1.275 . . . . 0.0 111.714 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 p -158.85 33.35 0.22 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.607 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.443 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.1 OUTLIER -161.45 137.96 8.33 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.124 179.989 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.6 tp -114.27 126.97 55.63 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.55 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.404 ' CD2' ' C ' ' A' ' 19' ' ' LEU . 2.8 tt -100.07 98.75 9.45 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.584 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 pp -96.61 148.8 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.394 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.483 ' OG ' ' CG2' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -145.82 134.43 22.16 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.352 -179.938 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.555 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 5.8 p90 -136.42 -140.83 0.16 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.707 179.828 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.555 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 18.4 t70 -150.46 166.95 28.57 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 117.999 -1.48 . . . . 0.0 113.207 -179.754 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -142.25 136.36 14.81 Favored Pre-proline 0 CA--C 1.557 1.23 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.844 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.57 172.51 1.45 Allowed 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.754 0.969 . . . . 0.0 111.705 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.58 -26.62 37.78 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.469 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.8 t -60.0 160.59 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.53 179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 t -64.57 132.05 48.74 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.6 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.1 t -110.08 122.53 64.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.171 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.434 ' CG ' ' CE2' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -54.34 -55.67 26.17 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.149 179.955 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.434 ' CE2' ' CG ' ' A' ' 30' ' ' ARG . 2.1 p90 178.42 171.43 0.75 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.493 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -128.07 161.57 28.91 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.175 -179.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.74 104.68 4.76 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.373 179.763 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.37 120.21 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.796 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -120.35 137.09 54.47 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.663 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -142.2 157.75 44.51 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.585 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.91 170.58 42.92 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 40' ' ' GLY . 3.9 mt-10 -61.4 -162.48 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.959 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -46.73 -14.15 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.199 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' GLU . . . 80.58 98.06 0.35 Allowed Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.415 -1.374 . . . . 0.0 110.491 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 146.32 -7.96 1.39 Allowed Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.447 -1.358 . . . . 0.0 110.409 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.427 ' O ' ' OG ' ' A' ' 43' ' ' SER . 10.4 t-20 -120.32 -46.52 2.39 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.981 -0.687 . . . . 0.0 111.029 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 42' ' ' ASN . 2.8 m -175.39 78.41 0.31 Allowed Pre-proline 0 C--N 1.307 -1.279 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.298 -179.874 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -64.73 153.37 78.03 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.068 1.179 . . . . 0.0 111.252 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.0 t -77.54 -90.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.502 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -175.17 -143.88 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.94 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -165.39 168.3 16.88 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 119.261 -0.975 . . . . 0.0 111.394 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 8.7 p90 -153.61 136.48 15.39 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.146 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.9 p -100.1 159.79 14.83 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.702 -179.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.59 ' C ' ' H ' ' A' ' 52' ' ' GLY . 34.1 m -147.9 150.53 36.08 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.666 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.95 5.75 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.725 0 C-N-CA 120.849 1.033 . . . . 0.0 112.383 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.59 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 81.72 7.49 88.01 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.324 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.44 -35.77 27.22 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.761 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -72.66 106.44 4.67 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.842 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.6 m -79.83 -18.32 51.12 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.859 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.2 p -132.67 158.82 41.35 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.273 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.11 149.25 19.24 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.549 -1.26 . . . . 0.0 111.569 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.404 ' CG2' ' HG ' ' A' ' 17' ' ' SER . 57.8 m -121.87 117.89 27.61 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.054 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 pt -108.27 149.47 11.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.406 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.9 175.76 8.1 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.522 -179.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.84 49.6 4.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.46 -168.58 1.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.614 0.721 . . . . 0.0 111.536 -179.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -148.98 82.82 6.97 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.011 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -54.46 140.54 74.29 Favored 'Trans proline' 0 C--O 1.216 -0.578 0 C-N-CA 120.846 1.03 . . . . 0.0 111.815 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.8 31.4 2.73 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 p -162.17 169.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 119.361 -0.935 . . . . 0.0 111.255 179.97 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -82.45 126.48 32.26 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.999 179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.2 133.36 56.09 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 120.144 -0.623 . . . . 0.0 110.7 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -103.46 138.4 40.23 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.444 ' CG1' ' N ' ' A' ' 71' ' ' THR . 6.1 tt -132.04 157.03 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.457 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.444 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 26.9 m -151.43 123.03 7.93 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.551 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.7 m -115.18 135.09 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -112.77 121.38 44.55 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.984 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.63 105.2 16.1 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.658 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.6 t -105.32 99.33 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.271 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 34.6 p -113.73 154.06 27.96 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.23 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 169.73 155.48 10.09 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.471 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -81.56 2.49 28.93 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.681 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.01 10.59 71.6 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.556 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -131.45 -69.84 0.61 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.768 179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.12 128.74 56.61 Favored Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.508 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.2 128.49 25.29 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 120.413 0.742 . . . . 0.0 110.829 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.32 38.04 3.81 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.794 -0.763 . . . . 0.0 111.473 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.1 t -56.05 127.46 30.64 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.415 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.7 m -88.97 -110.65 0.07 Allowed 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.333 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.471 ' O ' ' CG ' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -156.2 101.78 2.08 Favored Pre-proline 0 C--N 1.303 -1.423 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.882 -179.971 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -55.74 168.02 1.9 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 120.76 0.974 . . . . 0.0 111.678 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.2 tt -151.39 146.72 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.195 179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.0 p -141.5 146.35 36.3 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.204 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pt -146.53 151.8 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.311 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.53 160.27 15.12 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.629 -0.829 . . . . 0.0 109.429 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -161.35 141.05 10.46 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.374 -1.33 . . . . 0.0 112.157 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -96.01 99.72 11.46 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.311 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 116.329 -1.796 . . . . 0.0 110.706 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.1 p -166.6 100.94 0.58 Allowed 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.513 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.39 5.69 0.95 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.462 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.86 138.34 31.28 Favored Pre-proline 0 C--N 1.304 -1.39 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.151 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.8 165.73 6.1 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 N-CA-C 109.989 -0.812 . . . . 0.0 109.989 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -170.71 168.33 7.46 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 118.121 -1.432 . . . . 0.0 112.705 179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 55.27 49.8 16.36 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.594 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.29 135.08 39.72 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.22 179.863 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -173.44 168.29 4.57 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.881 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.1 t -96.05 117.29 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.711 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.8 t -71.49 -79.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 118.792 -1.163 . . . . 0.0 110.786 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.58 179.35 6.62 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.476 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.96 170.54 15.96 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.195 -1.002 . . . . 0.0 111.502 -179.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.635 ' HG1' ' CB ' ' A' ' 17' ' ' SER . 52.9 p -142.58 153.04 61.42 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.693 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -50.95 -5.33 0.08 OUTLIER 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 120.599 0.866 . . . . 0.0 111.98 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.544 ' H ' ' C ' ' A' ' 14' ' ' THR . 10.0 t -154.74 28.43 0.43 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.61 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.635 ' CB ' ' HG1' ' A' ' 14' ' ' THR . 0.4 OUTLIER -173.93 135.88 0.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.665 -1.214 . . . . 0.0 111.985 179.905 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 31.9 tp -112.71 146.52 38.58 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.046 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 tp -121.23 104.45 9.75 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.999 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pt -97.81 150.56 4.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.929 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 m -145.53 138.12 25.87 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 118.989 -1.085 . . . . 0.0 111.255 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -144.79 -157.77 0.82 Allowed 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.585 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 24' ' ' ALA . 6.6 t70 -139.22 141.88 37.87 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.187 -1.005 . . . . 0.0 112.198 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.442 ' O ' ' OD1' ' A' ' 23' ' ' ASP . . . -96.26 155.18 38.38 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.076 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.434 ' CD ' ' HH ' ' A' ' 32' ' ' TYR . 2.2 Cg_endo -61.77 170.37 5.92 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 120.991 1.127 . . . . 0.0 111.811 -179.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.65 -38.27 83.58 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.228 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -61.78 159.24 2.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.53 179.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.29 159.09 35.22 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.506 -1.278 . . . . 0.0 108.854 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.0 t -139.55 122.07 17.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.372 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -53.64 -52.34 60.23 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.729 -1.188 . . . . 0.0 108.754 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -171.78 162.89 6.32 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.294 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' HH ' ' CD ' ' A' ' 25' ' ' PRO . 1.7 m-85 -109.35 171.69 7.29 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.515 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.57 108.84 6.84 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.198 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 34' ' ' ILE . 1.8 mp -98.93 113.29 33.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.749 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.421 ' OG1' ' OG1' ' A' ' 71' ' ' THR . 17.6 p -117.51 135.82 53.66 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.282 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 5.6 p90 -141.17 157.61 45.02 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.138 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . -171.82 148.41 10.9 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 39' ' ' THR . 6.3 pt-20 -56.17 -163.5 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.964 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.606 ' CG2' ' H ' ' A' ' 40' ' ' GLY . 3.4 t -58.38 -119.35 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.321 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.606 ' H ' ' CG2' ' A' ' 39' ' ' THR . . . -50.69 -78.05 0.11 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.098 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 40' ' ' GLY . . . 60.66 125.2 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.541 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -56.95 -19.48 18.28 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.407 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.29 162.43 21.8 Favored Pre-proline 0 C--N 1.305 -1.34 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.031 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -63.65 158.03 48.34 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 121.293 1.329 . . . . 0.0 111.596 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 4.1 t -72.95 -57.52 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 119.084 -1.046 . . . . 0.0 109.816 179.868 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -171.05 -166.91 0.5 Allowed 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.402 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -169.49 159.47 8.52 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.734 -179.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -160.22 143.38 13.67 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.166 -1.013 . . . . 0.0 110.512 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.1 p -106.73 162.28 13.92 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.584 -179.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -142.02 159.22 59.85 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.868 179.952 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.503 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.5 Cg_endo -63.9 14.85 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 120.99 1.126 . . . . 0.0 112.345 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 57.54 2.05 0.65 Allowed Glycine 0 N--CA 1.496 2.688 0 C-N-CA 119.432 -1.366 . . . . 0.0 111.112 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.503 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -74.3 -44.02 54.38 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.66 179.94 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 56' ' ' THR . 26.9 mttm -93.03 116.33 28.95 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.304 -0.959 . . . . 0.0 110.693 180.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.59 21.15 0.67 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.771 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.423 ' H ' ' C ' ' A' ' 54' ' ' LYS . 43.7 p -138.67 130.64 28.1 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.2 165.48 25.65 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.576 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 t -136.62 144.03 43.85 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.598 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.76 160.06 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.131 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.33 140.47 24.09 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.25 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.86 -15.84 5.37 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.573 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -83.56 167.0 17.76 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.324 179.992 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -134.6 128.43 19.03 Favored Pre-proline 0 CA--C 1.556 1.193 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.202 179.803 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.22 112.64 1.18 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.408 0.739 . . . . 0.0 111.8 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.22 22.4 0.26 Allowed Glycine 0 N--CA 1.498 2.788 0 C-N-CA 119.202 -1.475 . . . . 0.0 111.608 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.425 ' CG2' ' N ' ' A' ' 67' ' ' ASP . 6.9 p -151.74 158.69 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 118.689 -1.205 . . . . 0.0 112.037 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.425 ' N ' ' CG2' ' A' ' 66' ' ' VAL . 0.4 OUTLIER -73.29 147.02 44.92 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.791 179.995 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -147.66 127.0 13.07 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.649 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.5 m -111.18 132.06 54.61 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.227 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.52 154.33 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.067 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.421 ' OG1' ' OG1' ' A' ' 35' ' ' THR . 0.1 OUTLIER -134.91 131.82 37.74 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.42 179.991 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.14 142.35 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.439 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -126.18 133.07 51.66 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.176 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.15 108.68 20.25 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.598 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 t -109.09 113.55 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.449 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 m -114.32 -12.47 12.41 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.253 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -49.49 140.9 13.56 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.317 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.0 mtp85 -118.23 -27.56 6.02 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.853 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -45.39 -82.12 0.03 OUTLIER Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.249 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.43 -54.46 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.565 -179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 t -69.72 118.02 58.93 Favored Pre-proline 0 C--N 1.306 -1.319 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.824 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.37 117.52 4.39 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 120.349 0.699 . . . . 0.0 112.07 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.99 136.14 34.59 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.463 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m -70.68 96.48 1.22 Allowed 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.946 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 86' ' ' LYS . 25.6 t -64.52 -109.23 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.575 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.488 ' N ' ' OG ' ' A' ' 85' ' ' SER . 18.0 mtpp -138.06 60.34 22.6 Favored Pre-proline 0 C--N 1.305 -1.341 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.083 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -54.77 161.66 5.87 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.361 1.374 . . . . 0.0 111.246 -179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.421 ' CG1' ' N ' ' A' ' 89' ' ' SER . 6.6 tt -152.64 166.3 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.86 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.421 ' N ' ' CG1' ' A' ' 88' ' ' ILE . 88.6 p -148.97 157.72 43.63 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.864 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.01 137.85 15.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.169 -1.013 . . . . 0.0 110.819 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.83 139.8 32.34 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.5 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -162.02 148.06 13.4 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.029 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -88.61 119.81 29.42 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.536 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 116.206 -1.854 . . . . 0.0 110.377 -179.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 120.864 0.364 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.3 p -160.16 145.75 15.23 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.722 179.979 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -145.42 -20.86 0.48 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.384 -179.902 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.04 136.34 21.57 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.292 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -55.49 161.78 7.07 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 120.515 0.81 . . . . 0.0 111.176 179.926 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -172.03 174.8 3.98 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.791 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.9 t70 55.22 51.98 12.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.28 179.801 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 mp -93.44 120.91 34.28 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.53 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 10' ' ' VAL . 1.6 tm-20 -164.85 159.85 18.83 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 118.738 -1.185 . . . . 0.0 111.772 179.922 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.405 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 2.2 t -94.56 134.83 30.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.922 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.49 -67.88 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 118.725 -1.19 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.93 172.24 13.32 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.457 179.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.41 175.46 9.76 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.815 -179.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.538 ' HG1' ' CB ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -140.63 158.43 65.77 Favored Pre-proline 0 C--N 1.307 -1.278 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.077 179.95 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.97 0.33 0.33 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.006 1.137 . . . . 0.0 111.666 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.531 ' H ' ' C ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -155.83 26.17 0.38 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.149 -1.021 . . . . 0.0 111.375 -179.95 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.538 ' CB ' ' HG1' ' A' ' 14' ' ' THR . 0.1 OUTLIER -171.64 157.3 4.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.343 -179.975 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.5 tp -129.19 147.06 51.0 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.174 -179.953 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.67 122.39 30.7 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.03 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 pt -123.58 169.85 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.861 179.944 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.47 139.32 11.68 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.449 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 13.8 p90 -137.12 -138.9 0.15 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.985 179.978 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.553 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 33.0 t70 -125.69 171.81 10.3 Favored 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.875 -179.816 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.474 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -143.85 118.22 6.04 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.803 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.6 166.53 11.49 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 120.19 0.593 . . . . 0.0 111.726 -179.871 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.77 -20.04 34.02 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.044 179.987 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.5 t -60.19 163.47 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.556 179.999 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.89 90.48 5.91 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.281 -0.967 . . . . 0.0 110.408 179.96 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 66.8 t -85.86 129.03 38.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.163 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -54.45 -66.46 0.4 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.086 -179.9 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.79 160.62 39.41 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.966 -1.093 . . . . 0.0 111.076 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.49 156.15 17.98 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.916 -179.989 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -137.13 111.69 8.67 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.4 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -101.75 148.03 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.209 -179.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.4 p -138.57 133.75 32.93 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.809 179.904 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -130.12 121.73 26.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.283 179.93 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -151.82 137.33 5.91 Favored Glycine 0 N--CA 1.487 2.058 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.572 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -52.65 175.81 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 84.1 m -75.24 160.8 29.95 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.297 -179.923 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.31 -30.85 5.03 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.817 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.66 19.39 79.15 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.155 -1.498 . . . . 0.0 109.941 179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.15 -10.66 60.01 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.244 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 p -176.98 81.35 0.25 Allowed Pre-proline 0 N--CA 1.487 1.416 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.397 -179.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -63.66 130.88 29.36 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 121.016 1.144 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.1 t -58.7 -74.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.297 -179.856 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -173.54 -176.89 1.36 Allowed 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.7 -179.992 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.505 ' N ' ' CD ' ' A' ' 47' ' ' GLU . 1.1 mp0 -135.02 174.91 10.08 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.759 -179.998 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -175.28 132.67 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.493 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.54 148.92 24.64 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.687 -0.805 . . . . 0.0 112.045 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 m -142.32 151.62 58.64 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.431 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.541 ' C ' ' H ' ' A' ' 53' ' ' SER . 3.9 Cg_exo -55.25 120.86 8.9 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 120.308 0.672 . . . . 0.0 110.805 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -46.87 -11.39 0.05 OUTLIER Glycine 0 N--CA 1.486 2.03 0 C-N-CA 119.305 -1.426 . . . . 0.0 110.725 179.875 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.541 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -65.32 -33.16 75.32 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.48 -179.894 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.2 mtpp -77.38 135.69 38.36 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.593 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.65 -1.74 25.96 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.4 p -132.69 162.64 30.87 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.773 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.04 161.11 36.52 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.016 -1.073 . . . . 0.0 111.583 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.2 m -137.63 123.09 19.59 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.32 156.52 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.594 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.422 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -142.48 176.82 8.72 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.504 -179.93 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.64 58.0 4.33 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.657 -1.258 . . . . 0.0 110.202 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.65 -127.83 0.2 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.068 -179.926 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.44 99.63 0.36 Allowed Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.979 -179.915 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.97 149.36 90.6 Favored 'Trans proline' 0 C--O 1.213 -0.729 0 C-N-CA 120.903 1.069 . . . . 0.0 112.237 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.82 55.17 2.73 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.926 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.4 p -168.94 150.81 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -62.52 152.04 35.82 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.503 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.09 138.85 24.28 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.982 -179.929 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.84 108.0 16.81 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.712 179.843 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -95.44 157.97 3.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.111 -179.898 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -158.98 141.57 14.17 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.432 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.15 138.87 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.83 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -119.63 104.55 10.37 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.947 -179.903 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.83 116.67 21.61 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.721 179.828 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.3 t -109.94 109.33 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.94 -179.917 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 p -101.1 -173.9 2.48 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.973 179.878 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.41 115.18 0.4 Allowed Glycine 0 N--CA 1.491 2.334 0 C-N-CA 118.96 -1.59 . . . . 0.0 111.012 179.975 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.91 -41.37 11.19 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.354 179.97 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.21 -106.13 3.01 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -179.983 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.92 -4.73 0.54 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.085 -179.969 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.58 138.92 66.82 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 119.066 -1.053 . . . . 0.0 110.718 -179.923 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.66 99.21 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 120.72 0.947 . . . . 0.0 110.855 179.854 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.14 128.76 48.48 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.258 -179.941 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.06 126.8 43.66 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.727 179.929 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.647 ' HG ' ' H ' ' A' ' 86' ' ' LYS . 91.5 p -81.85 -125.5 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.143 -179.978 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.647 ' H ' ' HG ' ' A' ' 85' ' ' SER . 5.1 mtpm? -135.27 73.2 64.64 Favored Pre-proline 0 N--CA 1.492 1.64 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.035 -179.924 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.0 164.77 9.58 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.302 1.335 . . . . 0.0 111.577 179.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.9 tt -159.57 156.83 3.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 118.715 -1.194 . . . . 0.0 111.091 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.1 p -134.69 144.02 47.55 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.579 179.987 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -139.0 156.7 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.782 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.77 146.41 25.94 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.714 -179.968 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -153.62 144.48 22.71 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.239 -0.985 . . . . 0.0 110.737 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.05 118.79 37.59 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.134 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 116.313 -1.804 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.56 158.15 29.99 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.715 -179.997 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.57 -30.54 1.12 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.713 179.933 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 t -83.04 134.26 46.71 Favored Pre-proline 0 C--N 1.302 -1.466 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.914 179.986 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -51.9 161.61 2.22 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 N-CA-C 110.151 -0.75 . . . . 0.0 110.151 179.899 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.446 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 0.7 OUTLIER -164.1 -179.22 6.04 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 117.998 -1.481 . . . . 0.0 113.281 -179.973 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 6' ' ' ARG . 42.7 p30 19.14 74.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.078 -1.419 . . . . 0.0 114.161 179.97 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mp -99.65 132.61 44.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.81 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -162.95 173.33 13.79 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 117.789 -1.564 . . . . 0.0 112.999 -179.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.27 142.25 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.875 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 11' ' ' VAL . 1.8 p -130.95 -8.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.695 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.14 161.3 8.43 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.638 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.21 149.13 26.69 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.193 -179.94 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.463 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -136.41 161.47 61.94 Favored Pre-proline 0 N--CA 1.491 1.583 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.762 179.89 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.434 ' O ' ' OG1' ' A' ' 16' ' ' THR . 2.9 Cg_exo -50.55 -11.33 0.36 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.221 1.281 . . . . 0.0 111.795 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.463 ' H ' ' C ' ' A' ' 14' ' ' THR . 96.6 m -164.39 49.22 0.12 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.432 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.433 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER 179.63 143.62 0.16 Allowed 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.322 -179.968 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.02 140.39 50.09 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.912 -179.938 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.6 tp -113.05 113.29 25.23 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.285 179.783 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.8 167.05 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.553 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.34 134.57 16.01 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.447 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.632 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 5.8 p90 -142.23 -143.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.413 179.926 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.632 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 5.3 t70 -131.23 147.03 52.55 Favored 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.863 -179.787 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.69 126.8 24.54 Favored Pre-proline 0 N--CA 1.491 1.575 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.009 179.89 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.71 172.06 3.11 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 120.586 0.857 . . . . 0.0 111.997 -179.964 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.22 -24.51 14.54 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.54 179.95 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.9 m -60.31 166.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.229 179.861 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.39 90.64 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.004 -1.079 . . . . 0.0 110.999 -179.962 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.6 t -85.05 122.42 38.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.64 -179.979 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -54.56 -52.62 61.51 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.65 -1.22 . . . . 0.0 109.473 179.88 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 175.1 171.27 0.28 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.691 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -118.38 161.87 19.25 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.475 179.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -138.48 104.66 5.21 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.799 179.858 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.7 mp -96.78 105.09 16.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.94 -179.972 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.6 p -103.55 143.32 32.9 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.347 179.876 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.466 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 8.2 p90 -145.92 166.96 24.45 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 118.464 -1.295 . . . . 0.0 111.38 -179.993 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . 160.0 162.86 12.7 Favored Glycine 0 N--CA 1.482 1.719 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 37' ' ' GLY . 2.5 mt-10 -49.13 177.98 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.716 179.995 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.3 m -74.11 -24.34 59.44 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.745 -179.984 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 176.6 55.82 0.06 OUTLIER Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.607 179.97 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.06 -159.69 10.47 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.313 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -61.31 -25.07 66.88 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.138 -179.988 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.21 158.64 2.69 Favored Pre-proline 0 C--N 1.305 -1.368 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.89 179.877 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.09 156.35 55.52 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.885 1.057 . . . . 0.0 111.007 179.877 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.1 t -76.99 -77.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 118.864 -1.134 . . . . 0.0 110.616 -179.999 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -175.68 -169.07 0.33 Allowed 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.329 -179.914 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.41 171.55 19.15 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.987 179.976 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.471 ' O ' ' CD1' ' A' ' 48' ' ' PHE . 23.9 p90 -159.73 130.85 5.91 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.867 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.67 163.21 13.29 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 119.391 -0.924 . . . . 0.0 112.493 -179.87 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.592 ' C ' ' H ' ' A' ' 52' ' ' GLY . 11.8 p -150.74 140.38 13.79 Favored Pre-proline 0 CA--C 1.561 1.374 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.017 -179.939 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.56 16.02 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 121.0 1.134 . . . . 0.0 113.673 -179.97 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.592 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 64.94 4.44 14.73 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.359 -1.4 . . . . 0.0 111.288 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.79 -27.32 64.81 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.042 -179.919 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.13 140.07 35.94 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.229 -179.946 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.451 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 4.6 m -96.94 -26.42 15.05 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.405 179.919 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.3 p -124.01 159.22 30.32 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.538 179.922 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.6 162.54 24.39 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.19 -1.404 . . . . 0.0 112.275 -179.92 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.6 m -107.99 134.01 51.51 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.449 179.95 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 tt -126.27 137.2 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.177 179.989 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.9 t -138.01 111.31 7.96 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.309 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.56 33.15 0.02 OUTLIER Glycine 0 N--CA 1.486 1.979 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.211 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.51 -155.67 0.71 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.63 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -147.84 162.08 32.71 Favored Pre-proline 0 C--N 1.311 -1.104 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.692 -179.903 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -74.69 159.64 42.12 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 121.586 1.524 . . . . 0.0 112.97 179.906 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 34.65 69.93 0.18 Allowed Glycine 0 N--CA 1.499 2.841 0 CA-C-N 114.957 -1.02 . . . . 0.0 113.316 179.793 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 p -159.14 143.52 6.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.745 179.688 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.82 130.54 46.23 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.073 -179.95 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -141.63 138.4 32.53 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.705 179.944 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.3 m -120.9 134.71 55.3 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.864 -0.735 . . . . 0.0 110.479 -179.953 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.97 154.87 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.138 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.458 ' OG1' ' CB ' ' A' ' 89' ' ' SER . 2.5 m -147.98 159.14 44.2 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.954 -179.957 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.4 ' N ' ' CG2' ' A' ' 71' ' ' THR . 32.9 m -139.81 129.07 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.072 -179.955 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.89 117.95 35.52 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.147 179.79 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.5 113.61 25.93 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.489 -0.885 . . . . 0.0 110.94 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.08 109.89 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.799 -179.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.47 ' HG1' ' H ' ' A' ' 77' ' ' GLY . 15.8 p -106.74 -87.41 0.47 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.022 -179.951 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.47 ' H ' ' HG1' ' A' ' 76' ' ' THR . . . 102.97 72.64 0.93 Allowed Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.857 -1.164 . . . . 0.0 110.459 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -78.05 120.24 22.61 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.571 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.3 -98.1 0.42 Allowed Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.137 -1.506 . . . . 0.0 109.938 -179.9 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -145.86 -15.02 0.47 Allowed 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.769 179.937 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 t -76.91 137.16 66.05 Favored Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.507 179.977 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -62.4 137.8 67.28 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 120.668 0.912 . . . . 0.0 111.181 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.92 -9.62 3.89 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.186 -179.945 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.9 t -79.63 62.47 3.93 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.542 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.1 p -117.43 34.33 5.19 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.077 179.916 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.596 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 4.2 tptp -144.1 38.69 0.25 Allowed Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 118.674 -1.21 . . . . 0.0 114.152 -179.936 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 86' ' ' LYS . 1.4 Cg_endo -57.06 160.69 12.21 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 N-CA-C 109.342 -1.061 . . . . 0.0 109.342 179.7 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.3 tt -151.67 131.24 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 118.034 -1.466 . . . . 0.0 111.804 -179.972 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.458 ' CB ' ' OG1' ' A' ' 71' ' ' THR . 59.2 p -118.7 147.13 44.14 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.69 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -143.1 139.77 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.231 179.959 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.3 154.3 17.91 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.423 179.944 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -169.56 139.25 2.03 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.157 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.432 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 11.0 ptt-85 -88.15 115.15 25.43 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.387 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.647 -179.919 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.436 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 5.0 t -146.09 140.87 27.05 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.825 -179.941 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 2' ' ' SER . 0.5 OUTLIER -148.4 -16.49 0.33 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.637 -179.94 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.24 108.66 1.01 Allowed Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.964 -179.944 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.35 -179.64 0.93 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 120.5 0.8 . . . . 0.0 110.835 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.51 -165.94 1.96 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.497 -179.98 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -118.16 65.65 0.75 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.199 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -75.36 -155.67 0.05 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.559 -0.856 . . . . 0.0 110.342 -179.966 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -177.25 -164.15 0.09 Allowed 'General case' 0 N--CA 1.515 2.825 0 C-N-CA 117.894 -1.522 . . . . 0.0 113.239 -179.694 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 t -70.4 151.67 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.339 179.917 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.446 ' O ' ' CG1' ' A' ' 11' ' ' VAL . 39.1 t -130.79 -8.03 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.114 179.914 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.64 157.49 3.86 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.805 179.934 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.85 157.09 44.94 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.484 -0.887 . . . . 0.0 111.089 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.481 ' HG1' ' CB ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -140.36 162.04 51.79 Favored Pre-proline 0 N--CA 1.485 1.306 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.436 179.941 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.71 -23.61 33.86 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 121.074 1.183 . . . . 0.0 111.663 -179.977 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.1 p -143.1 39.93 1.47 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.325 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.481 ' CB ' ' HG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -176.98 149.84 0.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.895 179.967 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 tp -130.43 117.24 19.38 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.758 179.94 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 tt -90.94 103.74 16.42 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.577 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 pt -97.69 158.52 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.65 179.966 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.0 127.76 15.3 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.507 -179.919 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.622 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 4.4 p90 -138.43 -152.79 0.44 Allowed 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.618 179.861 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.622 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 33.1 t70 -101.55 -178.39 3.71 Favored 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.581 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.571 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . -171.24 109.3 0.4 Allowed Pre-proline 0 CA--C 1.563 1.452 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.819 -179.97 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -61.45 173.34 2.75 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 120.62 0.88 . . . . 0.0 111.93 -179.888 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.71 -23.16 16.05 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.054 -179.929 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.1 m -59.65 165.64 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.04 -1.064 . . . . 0.0 110.206 179.977 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.479 ' CG2' ' O ' ' A' ' 28' ' ' THR . 3.4 t -65.52 95.48 0.22 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.026 -1.07 . . . . 0.0 110.483 -179.994 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.54 127.56 40.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.155 -179.938 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.545 ' HE ' ' HH ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -62.71 -59.5 4.81 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.608 179.874 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.545 ' HH ' ' HE ' ' A' ' 30' ' ' ARG . 0.2 OUTLIER -173.7 168.55 4.36 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.074 -1.05 . . . . 0.0 112.027 179.929 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.82 139.58 50.89 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.85 179.856 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.71 109.58 20.78 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 119.346 -0.941 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -105.42 99.36 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.37 -179.886 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -103.59 141.35 36.18 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.914 179.92 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.532 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 4.2 p90 -143.78 163.36 33.55 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.009 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.84 149.61 5.81 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.41 144.89 24.0 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.567 -179.981 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 t -75.18 148.93 39.15 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.131 -179.996 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.27 85.63 0.08 OUTLIER Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.527 -179.999 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 43' ' ' SER . . . 171.29 123.16 0.68 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.019 -1.562 . . . . 0.0 110.665 179.977 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -75.48 38.47 0.15 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.285 179.933 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 41' ' ' GLY . 35.1 t -157.4 68.65 4.17 Favored Pre-proline 0 C--N 1.304 -1.4 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.86 -179.911 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.24 150.85 82.73 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 121.329 1.353 . . . . 0.0 111.095 -179.972 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.2 t -57.06 -83.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.42 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -171.57 -160.97 0.18 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.575 -179.899 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.502 ' N ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -164.05 158.48 19.48 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.088 -179.995 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -149.1 142.86 25.59 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.462 ' OG1' ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -92.34 166.4 12.6 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.435 -179.929 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.566 ' CG1' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -148.55 148.58 28.79 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.913 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.27 -4.17 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 121.522 1.481 . . . . 0.0 112.911 -179.821 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.566 ' H ' ' CG1' ' A' ' 50' ' ' VAL . . . 70.87 -0.87 26.69 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.646 -1.264 . . . . 0.0 111.42 179.955 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.2 -30.29 22.54 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.895 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.66 129.57 35.74 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.097 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.13 -16.04 34.52 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.582 179.976 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.1 p -134.36 152.92 52.09 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.073 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.14 163.92 39.56 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.771 -1.171 . . . . 0.0 111.611 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.3 m -117.84 112.5 20.47 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.432 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.67 137.81 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.021 -179.914 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.6 t -96.42 -156.56 0.53 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.388 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.3 83.96 0.07 OUTLIER Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.231 -1.461 . . . . 0.0 109.989 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.47 -175.43 2.94 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.3 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -172.29 85.15 0.44 Allowed Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.686 179.888 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -55.45 133.27 57.11 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 120.787 0.992 . . . . 0.0 111.923 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.43 41.61 3.89 Favored Glycine 0 N--CA 1.484 1.895 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.398 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 p -159.96 154.48 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 118.667 -1.213 . . . . 0.0 111.691 -179.977 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.53 105.88 17.62 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.446 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -89.11 118.23 28.67 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.399 -179.78 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.19 131.11 45.46 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.348 179.849 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 pp -130.15 154.54 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.184 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m -144.33 128.26 17.43 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.789 -179.998 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.9 m -110.69 137.19 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.099 -179.942 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -120.07 113.69 20.87 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.636 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.14 105.21 17.36 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.104 179.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.4 t -110.2 119.54 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.261 -179.924 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 p -105.98 -40.21 5.76 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.894 179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.12 145.49 0.26 Allowed Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.918 179.932 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -103.68 -79.29 0.54 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.543 -179.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 176.83 -0.66 0.03 OUTLIER Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.615 -179.991 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.68 -40.4 0.06 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.757 -179.992 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.8 t -115.82 87.59 18.69 Favored Pre-proline 0 N--CA 1.489 1.479 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -60.17 120.06 7.61 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 120.691 0.928 . . . . 0.0 111.044 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.59 134.09 46.71 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.06 -179.931 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 89.6 p -90.13 141.79 28.35 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.299 179.867 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.4 m -66.56 -79.34 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.998 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -167.52 77.82 0.94 Allowed Pre-proline 0 C--N 1.291 -1.969 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.433 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -57.33 156.02 27.52 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 120.963 1.109 . . . . 0.0 110.702 -179.924 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 tt -151.68 160.35 3.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 118.332 -1.347 . . . . 0.0 111.476 -179.855 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.1 158.63 41.11 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.187 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.13 141.99 16.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.842 179.957 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.29 136.28 40.42 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.502 179.949 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -144.39 135.02 24.8 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.847 -179.981 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -83.45 107.42 15.93 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.168 179.887 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 116.306 -1.806 . . . . 0.0 110.351 -179.918 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.817 0.341 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.01 171.15 1.83 Allowed 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.492 179.983 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -146.61 -16.25 0.43 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.422 179.986 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 t -86.43 133.61 39.94 Favored Pre-proline 0 C--N 1.305 -1.367 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.986 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -52.64 171.93 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 120.355 0.704 . . . . 0.0 111.062 179.938 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.9 mtt-85 -118.1 -176.18 3.0 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.055 -179.894 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -68.55 94.14 0.55 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.452 -179.916 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -45.53 174.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.369 179.969 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -155.83 153.09 29.22 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.88 -1.128 . . . . 0.0 112.054 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.8 t -87.81 129.02 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.576 179.876 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 48.1 t -104.63 -56.09 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.839 -179.922 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.71 161.43 37.96 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.033 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.16 87.57 1.54 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.937 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -70.64 158.33 88.13 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.068 -179.983 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.55 -5.16 1.55 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 121.054 1.17 . . . . 0.0 111.217 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 14' ' ' THR . 14.5 p -151.08 33.2 0.59 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.261 179.997 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.424 ' OG ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -173.98 122.01 0.31 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.091 179.969 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.65 127.66 43.77 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.067 179.945 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 tp -110.0 125.4 52.86 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.538 -179.875 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 pt -127.22 174.24 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.317 179.829 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -163.06 137.16 6.12 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.077 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.609 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 11.6 p90 -134.54 -147.6 0.29 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.765 179.998 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.609 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 24.0 t0 -99.38 177.06 5.3 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.53 -0.868 . . . . 0.0 113.333 -179.63 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.523 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . 161.96 83.97 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.401 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.331 -179.944 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.12 -177.36 0.19 Allowed 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.035 1.157 . . . . 0.0 112.284 -179.815 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.82 0.66 57.4 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.195 -179.923 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.506 ' CG2' ' N ' ' A' ' 28' ' ' THR . 7.9 p -60.39 170.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 118.928 -1.109 . . . . 0.0 110.45 -179.976 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.506 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 60.7 m -61.65 109.36 1.18 Allowed 'General case' 0 C--N 1.286 -2.173 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.589 -179.981 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.72 141.24 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.492 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -91.73 -79.13 0.38 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.987 179.884 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.492 ' CD1' ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -150.62 171.92 16.36 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.26 179.875 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -131.87 160.57 35.29 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.341 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.31 119.18 13.3 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 118.415 -1.314 . . . . 0.0 110.975 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.1 115.77 47.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.368 -179.876 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.2 p -111.4 138.07 48.37 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.564 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.426 ' CZ ' ' CG1' ' A' ' 45' ' ' VAL . 8.9 p90 -139.29 148.65 43.28 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.271 179.992 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.74 156.58 25.24 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.957 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -66.65 143.04 57.22 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.774 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 m -68.98 150.04 48.14 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.752 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.09 -5.42 10.36 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 119.967 -1.111 . . . . 0.0 110.552 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.2 37.83 82.67 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.375 -1.393 . . . . 0.0 110.204 179.995 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -92.1 -73.93 0.53 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.187 -179.986 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.8 m -139.95 88.39 11.95 Favored Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.858 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.69 134.61 55.13 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 120.598 0.866 . . . . 0.0 111.179 -179.907 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.426 ' CG1' ' CZ ' ' A' ' 36' ' ' TYR . 63.4 t -59.07 -80.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.803 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -173.26 -159.71 0.11 Allowed 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.986 -1.086 . . . . 0.0 111.036 -179.907 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -162.75 158.67 23.2 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.025 179.975 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 2.9 p90 -146.98 162.55 38.53 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.004 -179.933 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.2 p -114.99 154.82 28.08 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.351 179.968 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -136.87 157.99 73.78 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.971 -179.976 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.23 8.73 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 121.212 1.275 . . . . 0.0 112.261 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 56.27 13.63 7.44 Favored Glycine 0 N--CA 1.497 2.701 0 C-N-CA 119.484 -1.341 . . . . 0.0 111.127 -179.935 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.49 -57.34 2.91 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.433 179.984 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -64.41 123.39 19.07 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.436 -179.878 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.54 8.45 6.37 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.601 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.57 158.16 40.04 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.884 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.1 169.09 25.59 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.496 179.965 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.4 t -142.9 162.03 36.56 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.237 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 mt -139.56 143.46 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.513 179.959 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.07 143.37 31.12 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.646 -179.979 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.07 50.61 1.23 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.964 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.526 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 1.3 pt? -130.19 -171.71 2.6 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.419 -179.96 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -117.77 89.84 34.5 Favored Pre-proline 0 N--CA 1.488 1.455 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.502 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.39 146.19 95.63 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 120.892 1.062 . . . . 0.0 111.684 -179.875 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.47 43.94 5.39 Favored Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.559 -1.305 . . . . 0.0 109.958 -179.912 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -166.19 157.74 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.194 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -63.11 142.96 58.18 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.585 179.98 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.9 135.26 22.99 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.272 -0.971 . . . . 0.0 111.123 -179.953 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.33 132.59 53.57 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.173 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.1 157.96 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.251 -179.935 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.7 m -148.43 127.57 12.88 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.133 180.0 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.11 138.19 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.009 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -106.42 139.75 40.42 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.276 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -121.17 104.97 10.16 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.7 t -126.86 110.07 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.997 179.909 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 76.9 p -113.93 -115.72 0.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.976 -179.979 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.472 ' N ' ' OG1' ' A' ' 76' ' ' THR . . . 172.81 141.13 3.35 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.325 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -80.6 8.5 7.75 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.364 -0.935 . . . . 0.0 111.017 -179.932 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.65 -23.89 1.82 Allowed Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.386 -1.387 . . . . 0.0 110.553 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -173.46 -46.29 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.475 -179.945 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.0 137.47 79.38 Favored Pre-proline 0 C--N 1.306 -1.313 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.758 -179.87 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -64.87 101.89 0.4 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 120.765 0.977 . . . . 0.0 111.135 179.854 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.4 176.7 1.01 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.766 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.3 p -65.57 177.39 1.21 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.94 179.931 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.531 ' HG ' ' H ' ' A' ' 86' ' ' LYS . 3.6 p -112.4 -86.31 0.56 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.447 179.98 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.531 ' H ' ' HG ' ' A' ' 85' ' ' SER . 3.1 mmtp 75.84 70.78 0.22 Allowed Pre-proline 0 N--CA 1.501 2.123 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.209 179.943 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -68.57 171.4 13.17 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.024 1.816 . . . . 0.0 112.176 -179.878 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.1 tt -142.15 137.44 29.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.204 179.912 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 p -127.73 158.55 37.33 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.298 -0.961 . . . . 0.0 112.15 -179.827 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.4 pt -153.44 148.22 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.883 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.95 156.9 16.62 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.161 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -172.38 138.49 0.93 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.64 118.62 22.36 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.32 -179.943 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.402 ' H ' ' HG1' ' A' ' 94' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 116.292 -1.813 . . . . 0.0 110.64 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.3 t . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.86 0.362 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 t 49.97 -176.44 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.824 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -168.77 -24.97 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.18 179.987 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -101.8 131.12 23.21 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.708 -179.958 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -61.57 172.64 3.38 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 120.667 0.911 . . . . 0.0 111.25 179.972 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.84 -176.96 4.98 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.722 179.991 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -106.66 77.29 1.18 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.517 -179.901 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 7.2 mp -63.06 -116.78 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.494 179.972 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 179.06 -171.69 0.14 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 117.894 -1.523 . . . . 0.0 112.506 -179.802 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.3 t -83.75 141.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.471 179.892 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.467 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 3.4 p -99.52 -14.37 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.112 -179.983 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 11' ' ' VAL . . . 166.66 178.4 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.958 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.74 108.94 2.96 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.492 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -62.57 161.14 29.24 Favored Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.051 179.936 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.8 -3.2 1.37 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 121.031 1.154 . . . . 0.0 111.029 -179.944 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.492 ' H ' ' C ' ' A' ' 14' ' ' THR . 15.7 p -153.19 37.24 0.48 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.247 -179.891 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.8 155.48 0.57 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.451 179.948 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.6 130.78 55.28 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.704 -179.913 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.32 107.29 15.38 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.269 -179.962 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 pt -97.94 168.65 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 119.091 -1.044 . . . . 0.0 110.336 179.933 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.56 130.85 9.54 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.187 179.978 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.0 p90 -138.49 -171.25 3.01 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.974 179.855 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -113.67 136.59 52.66 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.893 -179.606 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.43 130.0 23.32 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.064 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -56.5 152.27 41.2 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 120.484 0.79 . . . . 0.0 111.387 -179.997 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.12 -37.05 72.33 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.705 -179.956 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.539 ' CG2' ' N ' ' A' ' 28' ' ' THR . 2.1 p -60.43 165.05 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 119.246 -0.981 . . . . 0.0 110.756 -179.977 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.539 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -70.34 136.43 49.73 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.922 -179.96 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.0 t -124.88 139.05 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.835 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -64.66 0.8 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.393 179.98 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.97 166.93 15.1 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.639 179.974 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.35 160.01 24.92 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -143.71 112.42 6.55 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.415 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.77 124.67 56.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.298 -179.956 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 71.7 p -121.53 134.09 55.03 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.767 179.915 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 5.3 p90 -137.01 162.9 32.04 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.094 -179.867 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 160.41 156.65 8.28 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.946 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -43.71 166.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.08 179.996 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.8 m -74.73 -22.77 58.63 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.411 -179.898 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.78 35.9 0.12 Allowed Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.137 -1.506 . . . . 0.0 110.724 -179.966 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -71.21 -157.29 2.52 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.178 -1.487 . . . . 0.0 109.968 179.943 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -56.51 -33.62 66.2 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.521 179.969 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.11 162.99 0.73 Allowed Pre-proline 0 C--N 1.307 -1.264 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.584 179.878 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.93 159.21 22.1 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 121.186 1.258 . . . . 0.0 111.128 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.1 t -85.05 -72.04 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.926 179.973 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -172.13 -164.41 0.29 Allowed 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.635 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -166.86 152.83 8.14 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.236 -179.996 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 3.1 p90 -144.43 146.52 32.52 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.4 p -91.37 168.0 11.88 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.924 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -158.22 145.14 13.11 Favored Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 119.557 -0.857 . . . . 0.0 108.991 179.972 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.36 28.47 0.08 OUTLIER 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 121.037 1.158 . . . . 0.0 112.424 179.843 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 49.11 22.84 3.46 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.095 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.84 -38.29 12.42 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.047 -179.93 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -85.22 134.14 34.16 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.729 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.2 m -91.21 -15.49 29.18 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.958 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.5 p -127.37 165.95 18.78 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.232 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -149.69 137.36 20.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.732 -179.975 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.3 m -118.27 107.27 13.7 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.635 179.869 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.21 164.18 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.973 -179.861 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 t -146.84 177.3 9.23 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.02 179.97 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.45 8.02 50.4 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.307 -179.939 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.26 -160.97 0.74 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.019 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -148.14 112.8 3.84 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.237 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.7 156.8 40.72 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 120.555 0.837 . . . . 0.0 111.744 -179.954 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.09 52.18 1.66 Allowed Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.598 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 p -170.71 154.86 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.95 133.41 56.07 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.517 179.923 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 92' ' ' TYR . 0.2 OUTLIER -133.02 139.69 47.35 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.731 -179.87 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.9 m -122.53 136.79 54.97 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.629 179.907 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.08 161.0 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.7 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.49 146.85 30.68 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.503 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.4 m -132.52 135.59 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.264 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -117.56 131.03 56.75 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.213 -179.998 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.38 101.02 7.66 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.959 -179.997 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.45 126.46 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.813 -179.917 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.519 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 30.1 p -124.1 -124.87 0.25 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.019 179.923 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.519 ' N ' ' OG1' ' A' ' 76' ' ' THR . . . 150.21 112.5 0.59 Allowed Glycine 0 N--CA 1.497 2.728 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.217 179.931 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.99 -11.32 50.83 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.262 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.64 -80.03 0.04 OUTLIER Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.449 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -156.38 -56.79 0.09 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.602 -179.975 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.531 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -85.41 -43.98 0.64 Allowed Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 119.537 -0.865 . . . . 0.0 113.247 -179.872 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 81' ' ' SER . 2.2 Cg_endo -66.66 3.59 1.4 Allowed 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 120.899 1.066 . . . . 0.0 112.425 -179.795 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.77 67.81 0.83 Allowed 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.779 179.891 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.79 143.82 35.82 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 120.009 -0.677 . . . . 0.0 109.407 179.852 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.1 m -112.6 175.21 5.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.311 -179.888 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -136.99 67.44 56.3 Favored Pre-proline 0 C--N 1.306 -1.31 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.842 179.95 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -56.77 167.86 2.72 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 121.577 1.518 . . . . 0.0 111.948 -179.816 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.0 tt -150.08 155.13 8.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.011 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.7 p -129.31 145.77 51.31 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.481 -179.9 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -146.61 139.0 19.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.057 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -98.08 134.79 40.68 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.07 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 68' ' ' TYR . 31.9 t80 -146.96 129.75 16.16 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.558 179.999 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.6 132.32 36.97 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.796 -179.923 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 116.354 -1.784 . . . . 0.0 110.631 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.442 ' O ' ' OG ' ' A' ' 2' ' ' SER . 24.4 t . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 1' ' ' VAL . 21.2 p 42.99 77.32 0.06 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.223 179.972 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -114.17 -70.1 0.82 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.602 179.97 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.649 ' H ' ' CD ' ' A' ' 5' ' ' PRO . 1.1 t -126.01 -41.18 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.637 -0.825 . . . . 0.0 112.013 179.893 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.649 ' CD ' ' H ' ' A' ' 4' ' ' VAL . 13.2 Cg_endo -84.6 -127.89 0.01 OUTLIER 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 120.909 1.073 . . . . 0.0 109.878 -179.971 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' TRP . 9.6 ptm85 -171.42 177.44 3.51 Favored 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 118.351 -1.339 . . . . 0.0 112.837 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.6 96.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.051 179.968 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tt -41.1 129.59 2.8 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.374 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -175.85 176.12 1.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.265 179.961 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.529 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 2.4 t -96.8 116.67 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.395 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.437 ' O ' ' CB ' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -92.15 -4.55 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.878 179.992 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 11' ' ' VAL . . . 168.74 148.99 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.588 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.57 137.47 15.4 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.246 -179.861 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.546 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.9 OUTLIER -148.81 155.26 41.06 Favored Pre-proline 0 C--N 1.301 -1.503 0 C-N-CA 119.564 -0.855 . . . . 0.0 109.887 179.908 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.77 5.39 0.12 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.098 1.199 . . . . 0.0 112.163 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.546 ' H ' ' C ' ' A' ' 14' ' ' THR . 49.0 p -144.63 14.78 1.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.801 -179.939 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.408 ' OG ' ' OG ' ' A' ' 60' ' ' SER . 0.4 OUTLIER -178.41 139.64 0.19 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.165 -179.993 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.88 121.23 24.85 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.586 -179.973 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.36 105.05 14.8 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.776 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 pt -109.09 167.29 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 118.93 -1.108 . . . . 0.0 113.561 -179.641 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.48 135.35 35.06 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.389 -1.732 . . . . 0.0 107.206 179.805 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.62 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 44.7 p90 -119.21 -171.39 2.1 Favored 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 118.11 -1.436 . . . . 0.0 113.657 -179.809 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.46 ' CG ' ' N ' ' A' ' 24' ' ' ALA . 27.8 t70 -136.89 171.85 13.89 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.321 -1.308 . . . . 0.0 111.276 -179.843 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.46 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -115.64 166.63 11.72 Favored Pre-proline 0 N--CA 1.493 1.681 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.44 -179.949 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.95 -99.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 121.165 1.243 . . . . 0.0 110.715 179.941 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -107.71 -83.42 0.54 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.573 -179.956 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.522 ' CG2' ' H ' ' A' ' 28' ' ' THR . 1.7 p -70.76 -170.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.979 -179.934 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.522 ' H ' ' CG2' ' A' ' 27' ' ' VAL . 37.9 p -69.64 -178.43 1.47 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.563 -179.842 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.4 t -141.11 142.15 30.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.309 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.466 ' HE ' ' CA ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -77.14 -64.86 1.04 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.176 179.797 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.7 158.2 33.77 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.279 179.718 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.62 ' CE2' ' CD1' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -116.2 125.51 52.36 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.916 179.97 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.5 99.18 8.77 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.397 -179.922 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mp -96.17 135.46 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.459 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -138.96 138.34 37.22 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.749 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 1.6 p90 -138.57 153.78 48.7 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.824 -1.15 . . . . 0.0 111.836 -179.958 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.86 142.7 3.81 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.99 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.34 155.05 7.37 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.962 -179.974 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 m -75.21 152.84 38.33 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.096 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.1 83.35 0.05 OUTLIER Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.552 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' A' ' 43' ' ' SER . . . -178.15 120.02 0.7 Allowed Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.283 -1.437 . . . . 0.0 110.505 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.02 31.69 0.17 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.352 179.973 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 41' ' ' GLY . 9.1 t -149.94 71.03 9.49 Favored Pre-proline 0 C--N 1.304 -1.37 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.668 179.978 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -61.18 152.15 73.9 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.445 1.43 . . . . 0.0 111.18 -179.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.95 -77.73 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.461 -179.91 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -173.55 -168.25 0.43 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.445 -1.302 . . . . 0.0 112.265 -179.932 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -166.16 177.66 6.8 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.655 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -173.69 155.79 2.76 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.202 179.792 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.2 p -104.15 159.48 15.65 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.356 -179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.536 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -151.91 154.65 33.03 Favored Pre-proline 0 C--N 1.306 -1.311 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.712 179.769 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.48 12.94 0.09 OUTLIER 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.173 1.248 . . . . 0.0 112.132 179.944 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 59.25 23.13 57.25 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.111 -1.519 . . . . 0.0 109.849 -179.952 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.14 -47.23 13.75 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.897 -179.975 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -84.51 133.18 34.47 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.779 179.918 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.0 m -80.67 -8.12 59.54 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.223 179.989 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.3 p -134.91 -174.12 3.51 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.091 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.99 146.09 9.14 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.989 -179.997 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -108.02 110.67 22.43 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.726 -179.924 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 mt -108.97 144.48 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.024 179.974 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.408 ' OG ' ' OG ' ' A' ' 17' ' ' SER . 48.3 m -148.28 110.04 4.49 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.224 -179.946 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.51 -11.42 0.03 OUTLIER Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.126 -1.511 . . . . 0.0 110.88 179.992 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.457 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 1.4 pt? -68.28 -164.07 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.947 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.578 ' N ' ' CD ' ' A' ' 64' ' ' PRO . 5.1 ttpt -176.06 -42.29 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.801 -179.946 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 63' ' ' LYS . 5.6 Cg_endo -81.36 -169.22 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.457 1.438 . . . . 0.0 111.985 -179.907 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -148.29 83.62 0.18 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.646 ' CG2' ' H ' ' A' ' 67' ' ' ASP . 10.9 p -142.78 -173.88 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.534 -179.716 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.646 ' H ' ' CG2' ' A' ' 66' ' ' VAL . 0.6 OUTLIER -56.83 99.66 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.639 179.998 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -97.77 120.83 38.86 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.59 179.891 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.4 m -95.73 124.47 39.76 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.806 -179.925 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.489 ' CG1' ' N ' ' A' ' 71' ' ' THR . 3.9 tt -112.08 157.38 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.13 179.857 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.489 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -154.96 136.22 14.02 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.194 -179.955 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.4 m -131.88 117.34 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.648 179.832 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -93.5 111.66 23.38 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.152 -179.958 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.5 96.81 9.25 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.85 -1.14 . . . . 0.0 110.636 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.3 t -93.77 129.43 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.966 -179.955 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 20.8 p -102.21 -138.22 0.34 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.039 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.437 ' N ' ' OG1' ' A' ' 76' ' ' THR . . . 149.02 99.6 0.21 Allowed Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.489 -1.338 . . . . 0.0 110.682 180.0 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -121.03 -44.49 2.4 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.765 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.41 -93.33 0.24 Allowed Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.194 179.999 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.54 -60.23 0.41 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.81 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.39 149.3 57.72 Favored Pre-proline 0 C--N 1.308 -1.231 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.305 -179.943 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.39 107.9 0.54 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 120.914 1.076 . . . . 0.0 111.433 179.914 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.09 105.81 16.78 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.632 179.958 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -50.72 126.61 16.14 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.449 -0.901 . . . . 0.0 110.936 -179.973 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.649 ' HG ' ' H ' ' A' ' 86' ' ' LYS . 36.7 p -93.78 -111.65 0.11 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.033 179.977 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.649 ' H ' ' HG ' ' A' ' 85' ' ' SER . 6.9 mmtt -140.61 83.64 14.63 Favored Pre-proline 0 C--N 1.306 -1.319 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.212 179.943 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.05 164.21 8.61 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 121.209 1.273 . . . . 0.0 111.578 -179.947 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.7 tt -135.01 144.63 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.443 179.938 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.3 p -137.07 133.01 34.94 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.133 -179.957 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.37 148.52 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.14 179.954 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.539 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -98.11 152.63 19.13 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.534 179.951 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -155.28 140.56 17.62 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.372 -179.963 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.99 98.32 11.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 119.342 -0.943 . . . . 0.0 109.873 179.917 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 116.476 -1.725 . . . . 0.0 110.787 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.436 ' N ' ' OE2' ' A' ' 9' ' ' GLU . 1.5 mp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.436 ' OE2' ' N ' ' A' ' 8' ' ' LEU . 7.4 mp0 -147.87 168.47 22.12 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.526 -0.869 . . . . 0.0 111.14 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.6 t -100.41 133.01 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.767 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -88.12 -35.62 8.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 118.706 -1.197 . . . . 0.0 110.863 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 174.64 170.98 0.24 Allowed 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.162 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.66 167.68 12.65 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.534 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.28 161.64 29.13 Favored Pre-proline 0 C--N 1.3 -1.561 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.246 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.488 ' C ' HG23 ' A' ' 16' ' ' THR . 14.0 Cg_exo -45.41 103.86 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 120.684 0.923 . . . . 0.0 111.123 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.488 HG23 ' C ' ' A' ' 15' ' ' PRO . 3.1 p 59.25 49.21 9.33 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.905 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 p -171.93 137.22 0.95 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.662 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.469 ' O ' HD12 ' A' ' 19' ' ' LEU . 1.9 tp -130.35 147.99 52.12 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.767 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 18' ' ' LEU . 6.8 mp -119.47 114.13 21.82 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.54 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -110.01 147.66 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.225 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.51 137.57 28.58 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.296 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 11.8 p90 . . . . . 0 N--CA 1.484 1.243 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.458 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.858 HG13 HG22 ' A' ' 76' ' ' THR . 2.2 t . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.741 0.305 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -68.78 0.16 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.692 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.79 164.29 28.97 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.177 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -113.74 158.78 20.5 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.895 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.486 ' CG ' ' OE2' ' A' ' 47' ' ' GLU . 2.9 ttt180 -139.33 105.48 5.23 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.064 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.832 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.7 mp -96.76 120.31 45.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.169 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.403 HG22 ' OE2' ' A' ' 47' ' ' GLU . 22.0 p -126.65 137.19 53.26 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.561 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.453 ' CE2' HG11 ' A' ' 45' ' ' VAL . 6.9 p90 -142.16 155.95 45.33 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 118.741 -1.184 . . . . 0.0 110.427 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.72 137.41 4.75 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.421 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.35 132.97 40.07 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.681 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.5 m . . . . . 0 C--N 1.305 -1.336 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.742 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 46' ' ' GLN . 49.7 t . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.694 0.283 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.482 ' N ' HG12 ' A' ' 45' ' ' VAL . 2.2 tt0 -167.6 171.86 9.9 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 117.979 -1.488 . . . . 0.0 112.499 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.486 ' OE2' ' CG ' ' A' ' 33' ' ' ARG . 0.8 OUTLIER -150.78 159.56 44.45 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.157 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 11.7 p90 -160.22 136.63 8.82 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 118.423 -1.311 . . . . 0.0 111.523 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.0 p -92.66 159.73 15.32 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.431 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.53 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -152.08 142.96 15.47 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.178 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.71 29.9 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 120.953 1.102 . . . . 0.0 112.387 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 57.42 13.56 11.2 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.251 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.44 -31.08 37.57 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.012 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -92.53 119.27 31.84 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.91 -21.73 34.1 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.373 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.4 p -119.54 -178.9 3.72 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.891 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -167.58 143.66 4.12 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.581 -1.248 . . . . 0.0 111.706 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.2 m -110.8 112.2 23.9 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.726 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.92 140.8 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.466 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -145.54 163.89 33.33 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.466 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.13 10.83 33.4 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.769 HD23 ' H ' ' A' ' 62' ' ' LEU . 1.6 pt? -91.98 -177.28 4.66 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.264 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.56 110.29 40.84 Favored Pre-proline 0 N--CA 1.49 1.569 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.047 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.66 137.53 80.67 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 120.599 0.866 . . . . 0.0 111.816 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.09 60.32 1.86 Allowed Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.544 -1.312 . . . . 0.0 109.999 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 p -169.51 156.9 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.471 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -74.99 142.38 43.87 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.081 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -137.89 130.19 29.15 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.124 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.57 125.97 49.48 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.509 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 tt -115.93 148.46 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.475 HG23 ' OG ' ' A' ' 89' ' ' SER . 25.8 m -145.5 121.48 10.69 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.338 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 72' ' ' VAL . 6.6 m -108.41 122.12 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.434 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.49 101.94 11.43 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.278 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.06 113.28 24.95 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.403 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.7 t -107.54 128.4 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.225 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.858 HG22 HG13 ' A' ' 29' ' ' VAL . 29.1 p . . . . . 0 N--CA 1.49 1.541 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.58 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo . . . . . 0 C--O 1.215 -0.639 0 N-CA-C 111.063 -0.399 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.4 tt -147.41 150.51 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 118.654 -1.218 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.475 ' OG ' HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -139.52 150.42 45.09 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.099 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 pt -152.34 141.87 14.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.674 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -93.19 145.53 24.36 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.256 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -156.25 140.71 16.77 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.218 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -84.05 118.98 24.41 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.26 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.769 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.441 ' OE2' ' N ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -170.12 176.89 4.45 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.362 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.0 t -95.66 129.95 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.448 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 m -101.77 -6.5 9.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.774 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.75 161.21 11.03 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.779 -1.168 . . . . 0.0 111.81 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.85 129.14 8.21 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.318 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.88 165.12 36.15 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.476 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.461 ' O ' ' CB ' ' A' ' 16' ' ' THR . 3.2 Cg_exo -53.11 104.31 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.198 1.265 . . . . 0.0 111.94 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.7 OUTLIER 77.91 34.48 0.32 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.13 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.46 126.42 0.91 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.716 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 tp -125.58 126.9 45.53 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.1 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.4 tp -103.5 114.05 28.03 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.469 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.47 159.31 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.596 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.77 145.91 17.51 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.659 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 13.7 p90 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 119.189 -1.004 . . . . 0.0 111.452 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.523 ' NE ' ' OH ' ' A' ' 31' ' ' TYR . 2.2 mtt180 -69.93 -75.63 0.11 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.419 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.523 ' OH ' ' NE ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -153.84 167.68 28.85 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.604 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -123.85 156.04 36.93 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.146 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.522 ' HE ' HG22 ' A' ' 49' ' ' THR . 38.7 ttm180 -140.31 110.12 6.42 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.678 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 mp -95.14 123.49 47.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.904 -1.043 . . . . 0.0 111.338 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -125.58 132.12 52.59 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.711 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.55 ' OH ' ' CE2' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -144.77 167.62 22.15 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.338 -1.345 . . . . 0.0 112.484 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.77 159.14 17.37 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.6 160.74 3.09 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.047 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.306 -1.299 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.724 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.56 HG12 ' N ' ' A' ' 46' ' ' GLN . 13.8 t . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.889 0.376 . . . . 0.0 111.509 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.631 ' NE2' ' H ' ' A' ' 47' ' ' GLU . 50.5 tp60 -171.47 162.92 6.74 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.843 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.631 ' H ' ' NE2' ' A' ' 46' ' ' GLN . 5.0 pt-20 -147.63 148.17 30.79 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.576 -0.849 . . . . 0.0 110.949 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.55 ' CE2' ' OH ' ' A' ' 36' ' ' TYR . 0.9 OUTLIER -147.84 170.97 16.47 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 118.864 -1.134 . . . . 0.0 111.421 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.522 HG22 ' HE ' ' A' ' 33' ' ' ARG . 50.2 p -104.89 174.26 5.95 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.883 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.571 ' C ' ' H ' ' A' ' 52' ' ' GLY . 11.3 p -165.79 137.66 3.18 Favored Pre-proline 0 CA--C 1.564 1.503 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.163 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 53' ' ' SER . 5.2 Cg_exo -56.0 14.19 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 121.216 1.277 . . . . 0.0 113.731 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 54.02 9.24 1.28 Allowed Glycine 0 N--CA 1.495 2.623 0 C-N-CA 119.36 -1.4 . . . . 0.0 111.119 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -72.42 -41.05 66.63 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.969 -1.092 . . . . 0.0 110.287 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -118.83 116.31 26.24 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.075 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 m -79.85 58.24 2.8 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.105 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 p -154.28 148.35 25.75 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.371 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.16 150.68 9.54 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 t -117.31 145.56 43.92 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.759 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -135.69 133.8 51.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.41 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.5 m -130.6 165.59 22.45 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.581 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.44 49.22 4.73 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.169 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.29 -155.19 0.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.636 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.6 99.1 17.36 Favored Pre-proline 0 N--CA 1.493 1.71 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.08 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.97 145.14 94.25 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.757 0.971 . . . . 0.0 111.593 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.92 49.97 4.83 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.668 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.3 p -159.02 152.92 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.393 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.13 151.33 31.49 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.109 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.17 121.22 8.84 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.695 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 m -105.78 121.2 43.55 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.646 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 pp -110.18 158.46 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.569 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 55.0 m -153.18 123.19 6.95 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.067 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.5 m -108.63 141.93 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.514 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -112.38 105.65 13.98 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.844 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.74 94.6 9.56 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.063 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -89.6 112.44 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.307 -1.248 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.502 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo . . . . . 0 C--O 1.215 -0.627 0 N-CA-C 113.9 0.692 . . . . 0.0 113.9 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.9 tt -150.43 157.59 5.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.573 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.9 p -144.83 160.69 40.87 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.563 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.97 145.57 16.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.526 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 92' ' ' TYR . 1.1 t30 -91.48 144.73 25.26 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.639 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.455 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 57.8 t80 -161.3 135.73 7.12 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.838 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.79 132.58 34.57 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.194 -1.003 . . . . 0.0 110.205 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 116.258 -1.83 . . . . 0.0 110.818 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.689 0.281 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -169.3 146.01 3.43 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.124 -1.031 . . . . 0.0 111.112 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.0 t -85.32 116.17 28.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.736 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 t -90.27 -18.82 7.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.768 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.39 159.0 4.5 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.094 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.37 81.41 1.12 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.445 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -77.72 160.62 74.1 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.541 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.92 3.83 0.48 Allowed 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.344 1.363 . . . . 0.0 111.779 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 14' ' ' THR . 1.8 m -152.91 25.3 0.56 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.895 -1.122 . . . . 0.0 111.9 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.17 131.74 0.08 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.954 -1.099 . . . . 0.0 111.287 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 tp -115.72 136.24 53.25 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.52 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.33 116.71 26.77 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.475 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.28 158.59 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.174 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.13 133.52 16.47 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 p90 . . . . . 0 N--CA 1.486 1.334 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.252 179.918 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.579 HG13 HG22 ' A' ' 76' ' ' THR . 13.2 t . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.743 0.306 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.537 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -87.48 -73.53 0.47 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 118.961 -1.095 . . . . 0.0 110.828 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 2.5 m-85 -146.58 167.5 23.57 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.975 -1.09 . . . . 0.0 111.976 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -131.01 145.39 52.03 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.024 -1.444 . . . . 0.0 108.65 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.486 ' C ' HD12 ' A' ' 34' ' ' ILE . 14.1 ttm180 -132.59 121.39 23.15 Favored 'General case' 0 N--CA 1.508 2.44 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.137 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.741 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.7 mp -97.48 102.58 13.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.715 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.688 HG22 ' HB2' ' A' ' 47' ' ' GLU . 69.9 p -109.61 129.95 55.55 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 12.6 p90 -140.52 165.06 28.49 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.78 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.451 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . 168.6 165.02 25.29 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -66.29 146.39 54.65 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.381 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 39' ' ' THR . 24.4 m . . . . . 0 N--CA 1.489 1.48 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.595 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 46' ' ' GLN . 36.4 t . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 121.185 0.517 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.501 ' N ' HG12 ' A' ' 45' ' ' VAL . 3.5 tt0 -169.08 -159.06 0.22 Allowed 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.987 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.688 ' HB2' HG22 ' A' ' 35' ' ' THR . 7.1 pt-20 -170.12 161.16 8.42 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.189 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 7.2 p90 -152.68 140.27 19.79 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.636 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 50.8 p -82.8 174.05 11.31 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.541 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.599 HG13 ' H ' ' A' ' 52' ' ' GLY . 5.6 p -166.21 139.23 3.3 Favored Pre-proline 0 C--N 1.305 -1.351 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.949 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 53' ' ' SER . 2.0 Cg_endo -62.5 28.3 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 121.0 1.134 . . . . 0.0 112.916 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.599 ' H ' HG13 ' A' ' 50' ' ' VAL . . . 48.55 11.06 0.14 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.996 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -76.84 -38.92 52.88 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.57 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -93.12 131.06 38.5 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.494 -0.883 . . . . 0.0 110.622 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -84.83 -1.24 56.2 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.441 -0.904 . . . . 0.0 111.294 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.5 p -120.11 167.84 11.81 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.722 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.13 136.24 18.69 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.236 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.6 m -99.69 145.8 27.22 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.8 mt -144.32 149.19 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.616 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.4 174.45 10.91 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.75 64.64 3.55 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.784 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.441 HD12 ' H ' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -120.01 -125.17 0.28 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.782 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.441 ' H ' HD12 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -170.84 121.72 0.53 Allowed Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.192 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.58 142.91 73.11 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 120.566 0.844 . . . . 0.0 112.075 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.18 80.92 0.09 OUTLIER Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.387 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.446 ' CG1' ' CE2' ' A' ' 68' ' ' TYR . 7.5 p -170.4 152.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.538 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -82.48 108.65 16.05 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.446 ' CE2' ' CG1' ' A' ' 66' ' ' VAL . 4.6 m-85 -105.4 130.68 53.45 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.85 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.73 119.09 35.69 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.012 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 tp -98.3 137.38 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.235 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.558 HG23 ' HB3' ' A' ' 89' ' ' SER . 82.3 m -139.35 127.77 22.87 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.073 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -118.33 151.59 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.459 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -115.89 133.32 56.15 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.009 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.53 84.36 2.19 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 123.795 0.685 . . . . 0.0 109.466 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -95.3 124.81 48.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.584 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.579 HG22 HG13 ' A' ' 29' ' ' VAL . 4.4 p . . . . . 0 C--N 1.302 -1.494 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.876 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 C--O 1.214 -0.706 0 CA-C-O 121.377 0.49 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.3 tt -158.38 139.63 4.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.611 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.558 ' HB3' HG23 ' A' ' 71' ' ' THR . 63.3 p -149.69 166.84 28.16 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 118.216 -1.394 . . . . 0.0 113.039 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 pt -154.42 150.7 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.524 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.81 141.23 32.47 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.281 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -146.59 120.91 9.59 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.763 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -85.48 116.51 23.83 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.567 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 116.355 -1.783 . . . . 0.0 111.096 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -169.9 168.06 8.88 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 117.499 -1.68 . . . . 0.0 112.963 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.0 t -96.23 111.52 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.374 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.648 HG23 ' OG ' ' A' ' 21' ' ' SER . 24.7 t -77.82 -9.5 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.25 -0.98 . . . . 0.0 111.58 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 169.94 168.03 0.06 Allowed 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.441 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.34 147.59 27.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.811 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.62 161.13 30.11 Favored Pre-proline 0 C--N 1.305 -1.34 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.461 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.585 ' C ' HG23 ' A' ' 16' ' ' THR . 3.6 Cg_exo -51.29 111.88 0.67 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 120.97 1.113 . . . . 0.0 111.083 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.585 HG23 ' C ' ' A' ' 15' ' ' PRO . 1.6 p 64.51 37.92 7.74 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.83 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.92 128.29 1.64 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.662 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.4 HD11 HG21 ' A' ' 94' ' ' THR . 0.4 OUTLIER -130.33 145.47 51.79 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.335 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.17 109.77 15.82 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.065 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -109.12 146.69 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.145 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.648 ' OG ' HG23 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -142.68 131.05 22.22 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.398 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 5.5 p90 . . . . . 0 N--CA 1.483 1.182 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.497 179.952 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.79 0.328 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.444 ' H ' ' HA ' ' A' ' 76' ' ' THR . 9.3 ttt180 -55.15 -60.47 3.34 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.092 -1.043 . . . . 0.0 110.037 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -168.95 170.16 9.19 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 118.424 -1.311 . . . . 0.0 112.746 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.05 144.32 48.98 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.189 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.34 109.53 16.4 Favored 'General case' 0 N--CA 1.509 2.494 0 C-N-CA 118.999 -1.081 . . . . 0.0 110.244 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.2 mp -96.97 113.95 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.34 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 64.2 p -113.43 142.78 45.49 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.935 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.682 ' CE2' HG11 ' A' ' 45' ' ' VAL . 6.0 p90 -146.71 151.77 37.74 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.753 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.88 164.92 19.03 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -53.5 155.79 2.81 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.765 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.489 1.523 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.304 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.682 HG11 ' CE2' ' A' ' 36' ' ' TYR . 50.9 t . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.336 0.112 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.643 ' N ' HG12 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -175.99 -166.35 0.18 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.162 -1.415 . . . . 0.0 111.753 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -160.25 169.22 23.66 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.916 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.488 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 19.0 p90 -161.03 131.08 5.0 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.674 -0.811 . . . . 0.0 109.901 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.27 166.25 11.07 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.15 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -146.72 159.16 44.72 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.936 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.47 15.84 0.05 OUTLIER 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 121.135 1.223 . . . . 0.0 112.298 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 62.29 24.21 65.22 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.208 -1.473 . . . . 0.0 110.116 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.35 -36.92 11.19 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.107 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -89.83 116.3 27.81 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.8 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.63 4.42 24.89 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.68 159.43 42.0 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.474 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.45 164.29 21.99 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.434 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.6 m -134.02 146.82 50.74 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.479 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.426 HD13 HG21 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -137.36 158.0 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.052 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.6 m -149.56 174.45 12.52 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.655 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.71 12.73 52.74 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.777 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.07 -158.77 0.67 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.626 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.514 ' O ' HG12 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -150.02 122.19 4.18 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.598 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.71 144.3 97.1 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 120.512 0.808 . . . . 0.0 111.336 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.61 50.77 4.1 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.762 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 63' ' ' LYS . 6.6 p -165.16 139.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.419 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.402 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -64.41 133.33 52.33 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.929 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -132.0 129.86 40.67 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.174 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.2 128.89 54.82 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.914 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 70' ' ' ILE . 4.4 tt -119.7 145.0 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.409 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 81.4 m -142.43 125.26 16.04 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.525 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.57 137.0 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 119.613 -0.835 . . . . 0.0 111.011 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -110.18 143.82 39.75 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.37 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.5 91.25 3.49 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.612 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.8 t -102.91 117.2 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.485 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.444 ' HA ' ' H ' ' A' ' 30' ' ' ARG . 14.0 t . . . . . 0 N--CA 1.486 1.371 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.218 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 C--O 1.216 -0.623 0 N-CA-C 110.501 -0.615 . . . . 0.0 110.501 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -145.4 153.45 13.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.961 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.9 p -151.06 153.72 35.62 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.774 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.7 143.22 21.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.732 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.09 153.64 18.03 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.316 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -169.26 135.29 1.63 Allowed 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.322 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -79.86 106.71 12.08 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.312 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.4 HG21 HD11 ' A' ' 18' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.887 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.535 HD22 ' HA ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.327 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 10' ' ' VAL . 18.5 tt0 -173.03 162.19 4.54 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.534 -1.266 . . . . 0.0 112.271 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.444 ' N ' ' CG ' ' A' ' 9' ' ' GLU . 61.5 t -91.44 114.36 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.33 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.439 ' H ' HG23 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -79.22 -52.45 15.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 118.825 -1.15 . . . . 0.0 111.422 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.528 ' O ' HD23 ' A' ' 18' ' ' LEU . . . -147.66 158.32 43.96 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.951 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.11 106.72 4.08 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.469 ' C ' ' H ' ' A' ' 16' ' ' THR . 1.0 OUTLIER -104.69 155.21 37.8 Favored Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.631 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.43 3.28 0.2 Allowed 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 121.147 1.231 . . . . 0.0 112.353 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 14' ' ' THR . 3.0 m -149.38 24.11 0.91 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.859 -1.136 . . . . 0.0 111.477 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.426 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.1 OUTLIER 175.96 145.17 0.08 Allowed 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.296 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -130.46 124.64 32.47 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.387 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 tt -95.66 102.21 13.99 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.635 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 pp -109.68 143.5 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.446 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.76 139.28 53.79 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.569 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.535 ' HA ' HD22 ' A' ' 8' ' ' LEU . 46.9 p90 . . . . . 0 N--CA 1.505 2.278 0 C-N-CA 118.125 -1.43 . . . . 0.0 113.726 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' ' 32' ' ' TYR . 63.5 t . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.881 0.372 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.82 -43.28 13.43 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.555 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -143.34 176.12 9.39 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.818 -1.153 . . . . 0.0 112.323 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.42 ' CE1' HG11 ' A' ' 29' ' ' VAL . 1.6 m-85 -144.06 137.27 27.49 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.663 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -129.23 110.17 11.75 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.17 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.417 HD12 ' H ' ' A' ' 34' ' ' ILE . 4.0 mp -101.68 112.89 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.758 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 p -113.84 135.06 54.38 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.585 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.627 ' CE2' HG11 ' A' ' 45' ' ' VAL . 8.9 p90 -140.07 154.48 47.08 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 118.61 -1.236 . . . . 0.0 111.026 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.93 162.42 22.19 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 39' ' ' THR . 1.4 tm-20 -55.6 152.69 8.84 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.549 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.482 ' N ' ' CD ' ' A' ' 38' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.242 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.627 HG11 ' CE2' ' A' ' 36' ' ' TYR . 83.7 t . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -172.0 -159.0 0.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.578 -1.249 . . . . 0.0 111.678 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -165.71 156.63 13.62 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.802 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 3.5 p90 -146.72 154.76 41.79 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.569 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.4 p -115.69 155.98 26.75 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.738 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 52' ' ' GLY . 32.9 m -148.77 151.43 35.35 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.661 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.92 19.89 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.06 1.173 . . . . 0.0 112.597 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.572 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 60.22 24.63 61.34 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.474 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -45.02 16.42 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.002 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -89.15 144.87 25.81 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.838 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.5 m -96.01 -12.22 25.29 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.262 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.9 p -138.35 177.3 7.98 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.399 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.11 151.61 4.01 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.824 -1.15 . . . . 0.0 111.294 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.6 m -112.65 104.05 12.11 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.982 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.37 166.82 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.262 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.4 t -142.97 -179.0 6.1 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.963 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.52 60.21 1.38 Allowed Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.528 -1.32 . . . . 0.0 109.952 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.93 -155.55 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.908 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -150.73 137.43 11.36 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.054 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.64 151.94 82.71 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 120.915 1.077 . . . . 0.0 112.672 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.97 77.91 0.08 OUTLIER Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.932 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -162.27 144.28 3.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.005 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.474 ' CG ' HD21 ' A' ' 91' ' ' ASN . 6.8 t70 -76.26 117.02 17.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.293 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -117.54 129.56 55.87 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.537 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.2 120.67 39.91 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.34 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 tt -111.38 146.47 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.437 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.401 ' CG2' ' OG ' ' A' ' 89' ' ' SER . 20.6 m -148.69 141.64 24.78 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.184 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.63 131.8 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.285 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -104.6 123.12 47.0 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.19 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.31 89.99 5.29 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.47 118.41 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.98 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 C--N 1.309 -1.192 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.032 179.929 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo . . . . . 0 C--O 1.216 -0.576 0 N-CA-C 110.859 -0.477 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 88' ' ' ILE . 10.3 tt -144.79 131.74 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 118.529 -1.268 . . . . 0.0 111.465 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.401 ' OG ' ' CG2' ' A' ' 71' ' ' THR . 31.8 m -120.38 155.74 32.8 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.657 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.86 135.46 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.534 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.474 HD21 ' CG ' ' A' ' 67' ' ' ASP . 10.5 t30 -86.13 133.66 33.86 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.59 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -140.48 132.27 27.46 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.321 -0.951 . . . . 0.0 111.174 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.04 105.82 18.03 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.091 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 116.431 -1.747 . . . . 0.0 110.868 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -149.71 147.91 28.62 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.241 -1.384 . . . . 0.0 112.412 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.5 t -103.51 111.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.031 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.87 -27.35 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.693 -1.203 . . . . 0.0 111.951 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 19' ' ' LEU . . . -155.09 151.05 27.87 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.851 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.32 121.06 7.54 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.297 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.523 ' C ' ' H ' ' A' ' 16' ' ' THR . 1.1 p -134.13 153.49 79.61 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.32 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -64.29 10.48 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 120.98 1.12 . . . . 0.0 111.648 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.523 ' H ' ' C ' ' A' ' 14' ' ' THR . 5.0 m -140.84 6.31 2.01 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.051 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 p 179.26 148.82 0.25 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.307 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.81 120.08 27.06 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.462 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 2.8 tt -98.07 102.42 14.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.924 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 pp -100.25 155.21 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.503 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.37 143.74 30.29 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.0 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.7 p90 . . . . . 0 N--CA 1.478 0.94 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.216 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 120.584 0.231 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.414 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 4.3 mtp180 -54.51 -48.58 71.74 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.35 -1.34 . . . . 0.0 108.93 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.414 ' CG ' ' C ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER 175.93 164.58 0.37 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.849 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -114.01 155.16 26.39 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.11 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.652 ' HE ' ' CG2' ' A' ' 49' ' ' THR . 4.0 ttm180 -135.15 107.52 7.29 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.405 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.3 mt -98.96 109.07 23.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.864 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.563 HG22 ' CB ' ' A' ' 47' ' ' GLU . 45.1 p -113.01 134.56 54.46 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.471 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.468 ' CE2' HG11 ' A' ' 45' ' ' VAL . 9.7 p90 -136.9 153.37 50.76 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.262 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.496 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -177.88 149.41 9.21 Favored Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.596 ' H ' ' CD ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -86.65 139.83 30.41 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.729 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.9 m . . . . . 0 N--CA 1.486 1.363 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.889 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.496 HG23 ' HA2' ' A' ' 37' ' ' GLY . 96.1 t . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.738 0.304 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -173.34 -167.75 0.41 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.976 -1.09 . . . . 0.0 111.527 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.563 ' CB ' HG22 ' A' ' 35' ' ' THR . 2.8 pm0 -153.34 170.2 21.23 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.918 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -159.07 129.56 5.91 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.202 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.652 ' CG2' ' HE ' ' A' ' 33' ' ' ARG . 34.3 p -95.95 162.21 13.66 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.436 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.548 ' C ' ' H ' ' A' ' 52' ' ' GLY . 35.3 m -150.33 150.58 29.49 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.717 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.86 9.87 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 120.92 1.08 . . . . 0.0 112.225 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 72.93 13.56 78.93 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.244 -1.455 . . . . 0.0 109.949 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.25 -29.89 22.77 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.629 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -80.86 118.36 22.3 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.284 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.47 -15.37 57.89 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.371 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.0 p -144.46 176.79 9.12 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.485 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -171.79 160.52 5.63 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.219 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -121.54 143.56 49.21 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.274 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.32 163.9 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.805 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.2 m -143.21 -170.72 3.33 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.442 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.71 55.14 4.66 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.309 -1.424 . . . . 0.0 110.495 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.61 -158.52 0.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.707 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -140.28 155.05 70.41 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.295 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.28 102.55 0.39 Allowed 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.315 1.343 . . . . 0.0 112.739 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.89 95.82 0.03 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.537 -1.315 . . . . 0.0 111.474 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 66' ' ' VAL . 9.9 p -157.54 137.5 4.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.826 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -50.59 116.17 1.81 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.763 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.67 130.11 52.59 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.79 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.1 m -117.67 126.47 52.56 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.564 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -118.57 157.19 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.419 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.406 HG23 ' CB ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -141.08 117.09 10.51 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.448 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 72' ' ' VAL . 34.1 m -111.43 126.64 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.557 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -109.16 130.3 55.49 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.157 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.33 91.48 3.67 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.217 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.1 t -91.91 123.2 43.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.081 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.482 1.144 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.994 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo . . . . . 0 C--O 1.216 -0.611 0 CA-C-O 120.818 0.258 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 88' ' ' ILE . 9.8 tt -144.42 139.62 24.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.378 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.406 ' CB ' HG23 ' A' ' 71' ' ' THR . 7.2 p -128.48 160.42 32.36 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.817 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.0 pt -144.72 139.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.763 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.58 110.73 21.88 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.756 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 93' ' ' ARG . 5.9 t80 -143.05 138.82 30.21 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.616 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.436 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 10.5 mtp180 -72.16 110.59 6.72 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.597 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 116.371 -1.776 . . . . 0.0 110.984 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.022 0.439 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -154.45 176.29 12.54 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.876 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 t -93.78 132.95 36.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.797 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.69 -4.36 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.13 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.8 144.86 2.33 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.434 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.91 102.15 3.85 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.843 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.552 ' C ' ' H ' ' A' ' 16' ' ' THR . 22.6 p -97.15 152.5 38.33 Favored Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.271 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.46 ' C ' ' HG1' ' A' ' 16' ' ' THR . 1.9 Cg_endo -59.36 14.12 0.04 OUTLIER 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 121.305 1.337 . . . . 0.0 112.726 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 14' ' ' THR . 3.2 m -159.64 21.62 0.18 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.032 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 173.93 149.73 0.08 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.182 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.37 157.72 37.77 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.416 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.6 116.71 21.45 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.264 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pt -106.0 152.27 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.102 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.426 ' HB3' HG22 ' A' ' 56' ' ' THR . 2.4 m -150.27 124.78 9.62 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.029 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 7.2 p90 . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.419 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.657 0.265 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.545 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 2.7 mmp_? -79.83 -67.86 0.72 Allowed 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 118.931 -1.107 . . . . 0.0 109.548 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.545 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 2.1 m-85 -149.35 154.37 38.85 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.646 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -110.35 165.46 11.76 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -146.87 110.76 5.0 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.319 -1.352 . . . . 0.0 110.697 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.4 mp -102.66 117.53 48.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.511 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 p -119.14 135.22 54.77 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.137 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.654 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -124.54 156.41 37.38 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.661 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.22 130.47 1.41 Allowed Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.341 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -75.53 143.71 42.32 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.635 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 m . . . . . 0 C--N 1.303 -1.435 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.778 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 46' ' ' GLN . 3.7 t . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.297 0.57 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.415 ' N ' HG12 ' A' ' 45' ' ' VAL . 4.7 tp60 -173.36 177.78 2.54 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.661 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -167.35 166.1 14.72 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.894 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -162.12 157.48 23.35 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.907 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.4 p -102.66 166.07 10.71 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.159 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.583 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -153.49 147.04 18.22 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.0 OUTLIER -59.85 17.98 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.393 1.396 . . . . 0.0 112.989 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 62.43 -2.21 1.25 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -81.0 -43.35 19.74 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.433 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 104.55 8.01 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.914 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 m -79.24 8.15 6.48 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.085 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 21' ' ' SER . 1.9 p -137.5 159.62 41.44 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.518 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.57 144.5 3.61 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.332 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.3 m -95.33 146.33 24.46 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.308 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.514 HD11 ' CD2' ' A' ' 36' ' ' TYR . 1.1 tt -141.08 145.33 25.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.842 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.24 167.51 22.26 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.061 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.66 49.27 1.11 Allowed Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.796 -1.192 . . . . 0.0 110.867 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.99 -156.45 0.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.434 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -144.32 158.99 53.57 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.801 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.71 106.49 0.37 Allowed 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 121.384 1.389 . . . . 0.0 112.013 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.74 89.19 0.03 OUTLIER Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.472 -1.347 . . . . 0.0 111.05 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.2 136.68 12.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.926 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -52.75 124.05 12.9 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.009 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.32 126.84 41.57 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.445 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.2 m -107.84 110.85 22.73 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.103 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 71' ' ' THR . 0.6 OUTLIER -96.19 137.35 24.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.23 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.548 ' N ' HD12 ' A' ' 70' ' ' ILE . 24.7 m -138.31 139.17 38.97 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.286 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.44 139.08 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.066 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.462 ' CE2' ' CG ' ' A' ' 87' ' ' PRO . 1.7 m-85 -118.56 113.89 21.97 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.783 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.03 125.56 35.86 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.953 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.92 100.91 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.621 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.306 -1.289 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.251 179.985 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.462 ' CG ' ' CE2' ' A' ' 73' ' ' TYR . 12.6 Cg_exo . . . . . 0 C--O 1.215 -0.642 0 N-CA-C 110.687 -0.544 . . . . 0.0 110.687 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.42 162.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 118.491 -1.284 . . . . 0.0 111.403 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.6 p -147.74 157.66 43.65 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.085 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.7 pt -144.15 143.5 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.711 -0.795 . . . . 0.0 110.68 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -93.77 149.78 20.95 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.133 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -172.26 132.96 0.65 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.644 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.65 122.8 28.59 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.326 -0.949 . . . . 0.0 110.379 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 116.336 -1.792 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -158.27 176.45 12.46 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.418 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.24 124.2 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.937 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 t -69.5 -72.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.171 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.84 174.29 11.62 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.777 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -131.7 168.37 17.87 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.13 160.64 36.8 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.278 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 16' ' ' THR . 2.6 Cg_exo -50.54 99.64 0.04 OUTLIER 'Trans proline' 0 C--O 1.212 -0.786 0 C-N-CA 120.656 0.904 . . . . 0.0 111.092 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.463 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.6 OUTLIER 75.05 41.03 0.32 Allowed 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.304 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.48 141.05 2.9 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.12 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 tp -130.25 152.07 50.08 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.7 tp -126.11 110.55 13.64 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.157 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -101.63 157.79 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.441 -0.903 . . . . 0.0 111.228 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.64 137.57 18.13 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.552 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.2 p90 . . . . . 0 N--CA 1.49 1.541 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.952 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.422 ' HA ' HG22 ' A' ' 76' ' ' THR . 98.4 t . . . . . 0 N--CA 1.477 0.905 0 CA-C-O 121.024 0.44 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.444 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 20.5 mmm-85 -76.32 -61.06 2.07 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.217 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 75.9 m-85 -154.16 169.56 23.3 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.297 -1.361 . . . . 0.0 112.68 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.56 133.51 38.43 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.744 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -123.27 118.88 28.59 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.889 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.5 mt -101.03 123.31 53.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.9 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 p -124.59 136.36 53.89 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.543 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.698 ' CZ ' HD11 ' A' ' 59' ' ' ILE . 7.9 p90 -139.83 161.65 37.05 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.81 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.5 152.31 13.15 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.442 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.91 145.04 38.49 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.557 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 C--N 1.303 -1.446 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.792 -179.935 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 46' ' ' GLN . 15.1 t . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 121.077 0.465 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.47 ' N ' HG12 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -171.7 -159.22 0.14 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.012 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.31 172.15 7.42 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.315 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -161.79 138.08 8.02 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.941 -1.104 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.9 p -86.65 152.35 22.65 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.152 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 50' ' ' VAL . 12.2 p -165.13 136.55 3.25 Favored Pre-proline 0 C--N 1.301 -1.522 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.44 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 53' ' ' SER . 3.5 Cg_exo -51.94 134.95 50.27 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 120.295 0.663 . . . . 0.0 111.471 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.18 3.61 1.07 Allowed Glycine 0 N--CA 1.484 1.898 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.899 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -68.87 -34.62 75.75 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 118.876 -1.13 . . . . 0.0 110.285 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -79.68 119.65 22.91 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.796 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.5 -7.17 59.58 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.236 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.6 p -137.37 160.16 39.87 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.605 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.95 141.96 17.1 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.311 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.9 m -101.98 144.04 31.09 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.436 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.698 HD11 ' CZ ' ' A' ' 36' ' ' TYR . 4.4 tt -141.33 149.34 20.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.204 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.2 t -149.25 124.99 10.47 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.748 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.07 14.81 0.1 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.287 -1.435 . . . . 0.0 110.541 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.31 -155.17 0.48 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.716 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -130.25 145.62 58.12 Favored Pre-proline 0 N--CA 1.493 1.703 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.4 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -71.07 121.87 8.24 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 120.863 1.042 . . . . 0.0 113.022 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.18 89.85 0.07 OUTLIER Glycine 0 N--CA 1.502 3.063 0 C-N-CA 119.989 -1.101 . . . . 0.0 112.93 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.9 p -171.89 148.86 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.176 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.15 142.02 57.19 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.792 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -144.08 151.37 39.53 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.25 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.83 125.02 46.47 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.516 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.405 HD12 ' H ' ' A' ' 71' ' ' THR . 3.3 tp -111.49 136.16 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.132 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.536 HG23 ' HB3' ' A' ' 89' ' ' SER . 87.5 m -138.91 121.92 16.73 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.632 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.7 m -105.6 144.02 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.137 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.47 92.27 3.9 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.417 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.48 90.27 5.65 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.248 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 t -77.26 114.11 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.629 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 29' ' ' VAL . 2.4 p . . . . . 0 N--CA 1.484 1.241 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.469 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo . . . . . 0 C--O 1.213 -0.771 0 CA-C-O 121.609 0.587 . . . . 0.0 113.526 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 88' ' ' ILE . 8.7 tt -143.75 129.92 16.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.854 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.536 ' HB3' HG23 ' A' ' 71' ' ' THR . 46.0 p -129.84 165.12 22.65 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.275 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -151.45 146.86 15.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.415 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.15 149.28 28.04 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.219 -0.993 . . . . 0.0 110.194 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -158.44 134.81 9.37 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.194 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.435 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -93.75 114.28 26.52 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.979 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 116.27 -1.824 . . . . 0.0 110.955 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -178.26 176.89 1.04 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 118.729 -1.189 . . . . 0.0 111.97 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.0 t -99.09 116.04 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.964 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.769 HG23 ' OG ' ' A' ' 21' ' ' SER . 5.5 t -71.1 -25.43 25.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.797 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 163.78 168.6 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.78 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -129.22 157.93 40.44 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.155 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.68 161.93 28.77 Favored Pre-proline 0 C--N 1.305 -1.334 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.767 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 16' ' ' THR . 6.1 Cg_exo -54.65 106.22 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 121.217 1.278 . . . . 0.0 111.849 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.464 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER 74.54 34.11 0.79 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.856 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 99.5 p -172.14 138.77 1.02 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.026 -1.07 . . . . 0.0 111.199 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.0 tp -131.05 122.3 26.52 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.902 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -96.94 113.64 25.2 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.354 -0.938 . . . . 0.0 112.156 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 pt -105.41 167.11 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.549 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.769 ' OG ' HG23 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -160.66 133.98 6.68 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.324 -1.35 . . . . 0.0 111.807 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.9 p90 . . . . . 0 N--CA 1.479 1.012 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.053 179.904 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 121.033 0.444 . . . . 0.0 111.985 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.411 ' H ' ' HA ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -68.75 -50.65 48.84 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.433 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.405 ' CE2' ' CG ' ' A' ' 30' ' ' ARG . 0.7 OUTLIER 177.28 168.89 0.6 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.9 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -121.92 165.33 16.12 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.334 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -141.03 106.92 5.14 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.505 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.8 mt -98.43 111.55 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.43 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.464 HG22 ' HB2' ' A' ' 47' ' ' GLU . 15.3 p -124.34 133.22 53.5 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.106 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -128.27 138.88 52.62 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.13 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.434 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -154.01 137.84 5.93 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.223 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -67.2 163.79 19.59 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.596 -0.842 . . . . 0.0 111.126 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 39' ' ' THR . 7.4 t . . . . . 0 C--N 1.301 -1.501 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.54 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.434 HG23 ' HA2' ' A' ' 37' ' ' GLY . 23.3 t . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 120.741 0.305 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -171.84 169.54 5.77 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.837 -1.145 . . . . 0.0 111.466 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HB2' HG22 ' A' ' 35' ' ' THR . 11.0 pt-20 -148.76 159.47 44.11 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.298 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -168.76 134.38 1.7 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 118.941 -1.104 . . . . 0.0 111.053 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.5 162.32 14.26 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.058 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -145.96 161.56 39.29 Favored Pre-proline 0 C--N 1.307 -1.265 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.104 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.96 20.09 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 120.925 1.083 . . . . 0.0 111.858 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 55.2 22.89 31.06 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.335 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.24 -40.04 9.36 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.989 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -72.82 117.2 14.24 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.77 -23.15 42.4 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.664 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.5 p -125.01 161.65 26.24 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.0 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.451 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -155.83 150.89 26.53 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.75 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.2 m -123.72 108.0 12.07 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.419 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.2 pt -108.75 159.24 8.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.832 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.3 t -145.27 140.99 28.2 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.181 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.522 ' C ' HD13 ' A' ' 62' ' ' LEU . . . 164.0 11.11 0.03 OUTLIER Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.455 -1.355 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.867 HD13 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -131.09 150.59 52.08 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.886 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.772 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -126.24 -38.33 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.851 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.026 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.772 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 5.4 Cg_endo -80.81 -168.57 0.65 Allowed 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 121.425 1.417 . . . . 0.0 111.629 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -130.42 73.54 0.46 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.68 HG22 ' N ' ' A' ' 67' ' ' ASP . 14.1 p -114.14 174.5 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.573 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.68 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -59.97 140.34 56.81 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.991 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.35 123.41 20.32 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.553 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.85 113.23 25.97 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.17 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -102.19 150.11 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.108 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.44 HG23 ' CB ' ' A' ' 89' ' ' SER . 3.9 m -144.52 127.45 16.41 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.507 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.54 143.72 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.765 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -114.3 137.15 52.16 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.656 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.77 97.86 5.83 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.26 132.99 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.28 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.411 ' HA ' ' H ' ' A' ' 30' ' ' ARG . 4.0 m . . . . . 0 C--N 1.309 -1.174 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.832 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 C--O 1.216 -0.606 0 CA-C-O 120.712 0.213 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.3 tt -137.09 135.06 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.117 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.44 ' CB ' HG23 ' A' ' 71' ' ' THR . 0.0 OUTLIER -136.04 164.81 27.14 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.196 -1.002 . . . . 0.0 112.697 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -146.37 154.13 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.574 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.57 145.75 29.57 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.257 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -159.98 147.27 16.45 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.164 -1.015 . . . . 0.0 111.075 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.556 ' N ' ' CD ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -88.01 103.24 15.52 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.739 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 116.503 -1.713 . . . . 0.0 110.614 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 tt . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.434 ' O ' ' OG ' ' A' ' 21' ' ' SER . 5.8 pt-20 -179.04 163.81 1.37 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.632 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.2 t -75.75 132.89 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.361 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.668 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 9.2 p -104.61 -23.07 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 118.601 -1.239 . . . . 0.0 112.383 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 165.78 174.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.568 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.39 152.31 42.71 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.715 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.95 163.41 22.96 Favored Pre-proline 0 N--CA 1.486 1.356 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.282 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.618 ' C ' HG23 ' A' ' 16' ' ' THR . 10.2 Cg_exo -46.84 103.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 120.54 0.827 . . . . 0.0 110.477 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.618 HG23 ' C ' ' A' ' 15' ' ' PRO . 1.6 p 69.7 37.9 1.79 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.597 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.54 145.96 19.28 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.312 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.6 tp -123.41 122.53 38.51 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.988 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.747 HD23 ' O ' ' A' ' 57' ' ' ALA . 1.2 mt -96.56 121.58 38.54 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.092 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -124.36 151.88 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -122.97 131.73 53.84 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.132 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.522 ' NE1' ' CE2' ' A' ' 32' ' ' TYR . 25.6 p90 . . . . . 0 N--CA 1.513 2.711 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -60.39 3.42 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 118.783 -1.167 . . . . 0.0 108.143 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -154.13 161.48 41.85 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.036 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.522 ' CE2' ' NE1' ' A' ' 22' ' ' TRP . 3.2 m-85 -108.03 164.1 12.57 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.351 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -147.05 95.13 2.52 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.191 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.5 mt -91.26 135.15 27.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.399 -0.921 . . . . 0.0 111.605 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 p -138.63 137.38 36.86 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.825 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.603 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -137.88 160.2 39.94 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.797 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.21 135.77 3.17 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.405 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.86 108.36 8.67 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.466 -0.893 . . . . 0.0 110.769 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.3 m . . . . . 0 C--N 1.303 -1.423 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.768 -179.996 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 46' ' ' GLN . 3.3 t . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 121.144 0.497 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.432 ' N ' HG12 ' A' ' 45' ' ' VAL . 3.6 tt0 -173.59 -170.26 0.58 Allowed 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.8 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -168.69 176.52 5.56 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.673 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -176.13 150.24 0.94 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.336 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.5 p -111.58 153.65 25.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.05 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.5 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -143.06 150.14 51.58 Favored Pre-proline 0 C--N 1.303 -1.453 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.905 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' A' ' 53' ' ' SER . 3.7 Cg_endo -65.78 28.74 0.1 OUTLIER 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 120.923 1.082 . . . . 0.0 112.483 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 53.59 8.6 0.9 Allowed Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.063 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -72.27 -32.14 66.38 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.547 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -95.72 154.44 17.22 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.29 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 m -104.01 -22.79 13.4 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.135 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.0 p -122.91 -175.25 3.12 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.324 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.747 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -171.11 175.09 4.43 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.297 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.8 t -131.08 141.71 50.2 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.528 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 59' ' ' ILE . 4.2 mt -132.31 111.32 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.408 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -109.05 147.54 32.2 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.585 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.19 20.66 4.33 Favored Glycine 0 N--CA 1.501 2.996 0 C-N-CA 119.841 -1.171 . . . . 0.0 110.255 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.688 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -106.46 -174.28 2.5 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.42 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -136.84 122.55 13.21 Favored Pre-proline 0 N--CA 1.487 1.422 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.883 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.08 118.8 5.73 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 120.209 0.606 . . . . 0.0 111.671 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.38 64.7 0.7 Allowed Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.607 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 p -164.69 148.37 2.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 119.156 -1.017 . . . . 0.0 111.592 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -70.31 152.45 44.15 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.893 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.63 140.83 26.32 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.711 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.2 m -117.88 107.42 14.08 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.411 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.473 ' CG1' ' N ' ' A' ' 71' ' ' THR . 5.1 tt -102.61 160.92 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.014 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.498 HG23 ' OG ' ' A' ' 89' ' ' SER . 91.0 m -160.5 139.59 10.58 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.167 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 m -131.36 123.71 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.663 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.89 129.99 53.13 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.392 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.19 104.18 14.3 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.99 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.28 121.04 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 119.049 -1.061 . . . . 0.0 112.443 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.487 1.377 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.585 179.849 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--O 1.216 -0.606 0 N-CA-C 110.572 -0.588 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 88' ' ' ILE . 9.3 tt -151.29 135.27 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 117.983 -1.487 . . . . 0.0 111.723 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.498 ' OG ' HG23 ' A' ' 71' ' ' THR . 1.0 OUTLIER -127.73 139.5 52.65 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.734 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 pt -149.7 157.94 6.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 118.749 -1.18 . . . . 0.0 111.806 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.97 159.77 14.8 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.796 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -167.69 130.86 1.66 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.06 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.3 mtm-85 -88.34 119.31 28.64 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.145 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 116.337 -1.792 . . . . 0.0 110.975 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.424 ' O ' ' OE1' ' A' ' 9' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -157.92 158.24 34.64 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.871 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.3 t -93.56 115.22 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.576 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.487 ' CG2' ' OG ' ' A' ' 21' ' ' SER . 2.2 t -70.75 -68.71 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 118.818 -1.153 . . . . 0.0 111.197 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.12 174.82 12.76 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.522 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.54 162.87 34.34 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.411 ' C ' ' N ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -135.16 161.17 65.09 Favored Pre-proline 0 N--CA 1.484 1.238 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.734 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' O ' HG23 ' A' ' 16' ' ' THR . 2.7 Cg_exo -50.76 -14.38 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 120.893 1.062 . . . . 0.0 110.944 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 15' ' ' PRO . 7.8 p -158.4 50.8 0.4 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.69 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.56 143.13 0.18 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.437 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.5 tp -130.16 140.83 50.72 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.111 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.91 110.19 17.43 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.42 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 pp -106.41 147.04 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.487 ' OG ' ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -145.46 136.74 24.95 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.271 -0.971 . . . . 0.0 110.609 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.0 p90 . . . . . 0 C--N 1.308 -1.201 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.523 -179.998 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.905 HG13 HG22 ' A' ' 76' ' ' THR . 5.0 t . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.664 0.268 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -73.0 -70.17 0.37 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.484 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -158.66 163.24 37.06 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.61 -1.236 . . . . 0.0 112.046 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -121.0 152.59 38.4 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.661 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 -131.0 115.33 16.34 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.296 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 mp -106.81 113.45 43.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.548 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -119.56 137.94 53.52 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.709 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.68 ' CE2' HD12 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -136.71 157.54 46.53 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.195 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.53 153.23 9.78 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -67.9 160.29 28.8 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.457 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.302 -1.46 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.0 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.499 HG12 ' N ' ' A' ' 46' ' ' GLN . 5.7 t . . . . . 0 N--CA 1.477 0.911 0 CA-C-O 120.881 0.372 . . . . 0.0 110.812 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.499 ' N ' HG12 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -175.19 178.48 1.71 Allowed 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.129 -1.028 . . . . 0.0 111.359 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -170.8 150.35 3.22 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.363 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.565 ' CE2' ' OH ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -146.03 164.62 31.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.673 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.2 p -116.89 156.3 27.58 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.436 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.695 HG23 ' H ' ' A' ' 52' ' ' GLY . 6.0 m -146.28 151.67 44.66 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.805 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.96 20.83 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.074 1.182 . . . . 0.0 112.586 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.695 ' H ' HG23 ' A' ' 50' ' ' VAL . . . 66.75 4.75 27.79 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.219 -1.467 . . . . 0.0 110.211 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.71 -45.98 14.93 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.759 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.66 107.42 7.81 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.605 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.8 m -82.81 14.2 3.38 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 21' ' ' SER . 1.3 p -138.65 163.42 32.14 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.633 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.5 139.43 7.92 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.587 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.9 m -110.12 134.12 52.51 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.607 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.68 HD12 ' CE2' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -132.53 154.54 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.017 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t -136.45 -167.89 2.15 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.511 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.499 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 65.12 73.96 0.53 Allowed Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.309 -1.424 . . . . 0.0 109.867 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 61' ' ' GLY . 10.7 mt -126.74 177.57 6.48 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.312 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.54 128.27 25.88 Favored Pre-proline 0 CA--C 1.559 1.324 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -53.76 98.01 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 120.415 0.743 . . . . 0.0 112.889 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.11 97.29 0.22 Allowed Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.124 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -167.11 138.72 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.639 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.35 109.8 0.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.882 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.8 140.39 42.31 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.962 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.57 130.39 52.6 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.548 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.67 162.57 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.618 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.6 m -150.55 116.31 5.53 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.761 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.0 m -102.74 121.22 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.859 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -99.1 130.95 45.45 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.581 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.44 89.64 3.1 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.884 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.6 t -92.39 127.93 44.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.103 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.905 HG22 HG13 ' A' ' 29' ' ' VAL . 24.2 p . . . . . 0 N--CA 1.485 1.283 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.567 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--O 1.216 -0.606 0 N-CA-C 110.844 -0.483 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -148.29 162.16 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 118.554 -1.258 . . . . 0.0 110.732 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.88 164.71 28.96 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.086 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 pt -150.41 135.54 10.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.542 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -109.48 131.87 54.66 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.84 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -161.71 135.75 6.75 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.487 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -68.32 114.1 6.48 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.659 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 116.29 -1.814 . . . . 0.0 110.729 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.501 2.089 0 N-CA-C 111.093 0.034 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -175.82 157.89 2.03 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 118.719 -1.192 . . . . 0.0 112.55 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.69 113.73 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.488 ' H ' HG23 ' A' ' 11' ' ' VAL . 1.4 t -71.72 -71.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 118.758 -1.177 . . . . 0.0 112.169 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.99 175.52 10.39 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.022 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.45 147.56 51.7 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.074 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.82 161.37 49.35 Favored Pre-proline 0 C--N 1.305 -1.335 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.355 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.58 106.96 0.19 Allowed 'Trans proline' 0 C--O 1.211 -0.832 0 C-N-CA 121.045 1.163 . . . . 0.0 112.156 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 72.66 -3.71 2.29 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.99 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.26 136.48 49.22 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.707 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 tp -130.86 154.19 48.32 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.791 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.5 tp -116.79 122.09 43.42 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 pt -124.25 160.41 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -134.18 140.52 46.58 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.963 -1.471 . . . . 0.0 107.325 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 14.5 p90 . . . . . 0 N--CA 1.505 2.31 0 C-N-CA 118.402 -1.319 . . . . 0.0 114.069 -179.773 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.414 ' CD ' ' CZ ' ' A' ' 31' ' ' TYR . 1.6 ttm-85 -57.83 -64.84 0.77 Allowed 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.668 -1.213 . . . . 0.0 109.115 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.414 ' CZ ' ' CD ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -127.26 147.51 50.22 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.117 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -110.36 130.3 55.58 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.959 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -114.04 101.43 9.22 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.3 mt -92.94 123.86 45.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.862 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.2 p -124.93 135.11 52.54 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.765 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -130.06 155.49 46.07 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.086 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.408 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -174.11 151.32 12.78 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.977 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -85.92 136.17 33.39 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.662 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.305 -1.36 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.916 179.997 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 46' ' ' GLN . 24.4 t . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.854 0.359 . . . . 0.0 111.92 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.486 ' N ' HG12 ' A' ' 45' ' ' VAL . 6.4 tt0 -157.28 168.7 26.64 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.076 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' OE1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -143.94 175.11 10.27 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.979 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.4 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 25.7 p90 -163.28 134.68 4.87 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.954 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.0 p -87.45 164.55 16.12 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.254 -0.979 . . . . 0.0 111.288 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.565 ' C ' ' H ' ' A' ' 52' ' ' GLY . 14.5 p -162.31 138.34 5.76 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.069 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 53' ' ' SER . 3.2 Cg_exo -60.56 23.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 120.953 1.102 . . . . 0.0 113.258 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 49.67 12.31 0.39 Allowed Glycine 0 N--CA 1.495 2.625 0 C-N-CA 119.488 -1.339 . . . . 0.0 110.77 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -59.77 -24.65 64.25 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.588 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -121.07 129.78 53.48 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.465 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -79.82 -9.62 59.68 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.037 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.3 p -140.09 154.86 47.17 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.763 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.84 160.67 25.39 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.674 -1.211 . . . . 0.0 111.499 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.6 m -90.24 157.47 17.67 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.535 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 59' ' ' ILE . 6.0 tt -150.75 128.96 2.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 119.396 -0.921 . . . . 0.0 110.416 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 t -134.66 117.29 15.91 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.699 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.69 -28.22 0.02 OUTLIER Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.607 -1.282 . . . . 0.0 110.146 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.534 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -78.85 -166.45 0.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.887 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.669 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.5 OUTLIER -165.33 -42.4 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.456 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.95 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.669 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 8.9 Cg_endo -85.56 -174.81 1.72 Allowed 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 121.358 1.372 . . . . 0.0 111.574 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.68 72.73 0.43 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.607 HG22 ' N ' ' A' ' 67' ' ' ASP . 5.1 p -124.31 169.52 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.239 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.607 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -49.1 110.51 0.37 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.879 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.99 134.81 54.31 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.724 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.45 134.36 55.17 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.509 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.44 158.72 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.908 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.565 HG23 ' OG ' ' A' ' 89' ' ' SER . 6.1 m -153.31 140.83 19.81 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 118.326 -1.35 . . . . 0.0 112.521 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.8 m -114.39 121.84 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -94.15 109.81 21.57 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.746 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.3 94.11 8.37 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.674 -1.211 . . . . 0.0 109.625 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.09 125.98 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.867 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.487 1.38 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.964 179.982 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 C--O 1.215 -0.639 0 CA-C-O 120.716 0.215 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 88' ' ' ILE . 12.5 tt -138.65 121.66 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.746 -0.782 . . . . 0.0 108.916 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.565 ' OG ' HG23 ' A' ' 71' ' ' THR . 0.5 OUTLIER -121.49 164.9 16.44 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.61 140.38 20.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.051 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -103.09 146.56 28.19 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.528 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -172.53 142.08 1.21 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.541 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -75.2 108.87 8.25 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.311 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 116.389 -1.767 . . . . 0.0 110.714 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -163.58 174.69 11.47 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 117.502 -1.679 . . . . 0.0 113.468 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.415 HG22 HG22 ' A' ' 20' ' ' ILE . 56.5 t -92.96 128.39 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.809 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.27 -2.41 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.47 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.556 ' HB3' ' HB3' ' A' ' 19' ' ' LEU . . . -169.19 160.42 9.65 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.914 -1.114 . . . . 0.0 111.251 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.62 150.01 27.23 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.529 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.418 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -137.4 162.11 56.92 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.874 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -55.39 -6.74 0.98 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.056 1.171 . . . . 0.0 111.433 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 14' ' ' THR . 0.6 OUTLIER -160.09 42.88 0.2 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.382 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.5 146.87 0.21 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.045 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.1 tp -130.44 120.57 24.41 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.28 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 4.7 tt -96.8 104.68 16.7 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.502 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.415 HG22 HG22 ' A' ' 10' ' ' VAL . 1.2 pp -104.88 153.43 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.652 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.08 144.58 24.92 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 9.9 p90 . . . . . 0 C--N 1.31 -1.112 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.041 179.913 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.631 HG13 ' OG1' ' A' ' 76' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.735 0.303 . . . . 0.0 110.509 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.405 ' H ' ' HA ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -54.15 -65.2 0.61 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.39 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.92 159.0 36.09 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.666 -1.214 . . . . 0.0 111.789 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 2.0 m-85 -119.4 146.04 45.7 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.56 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -129.56 111.21 12.5 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.4 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.8 mp -100.93 120.97 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.153 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 p -122.04 136.95 54.97 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.97 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 1.8 p90 -130.77 146.92 52.36 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.547 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -171.85 138.79 5.01 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.8 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -72.9 141.62 47.89 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.517 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 m . . . . . 0 C--N 1.304 -1.383 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.718 179.975 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.547 HG23 ' HA2' ' A' ' 37' ' ' GLY . 93.0 t . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 121.091 0.472 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -172.24 -167.86 0.5 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.231 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.89 163.57 11.6 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.698 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 9.7 p90 -153.96 141.84 20.15 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.403 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -100.21 159.93 14.72 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.893 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.512 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -147.29 157.36 45.68 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.121 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.56 10.76 0.1 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.141 1.227 . . . . 0.0 112.096 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 61.07 26.86 66.32 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.062 -1.542 . . . . 0.0 109.818 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.63 -53.65 4.43 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.63 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -90.62 123.37 34.2 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.1 m -86.39 27.62 0.92 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.244 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.8 p -145.44 162.98 36.05 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.5 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.1 154.53 5.07 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.805 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.2 m -130.93 115.69 16.87 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.053 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.37 171.49 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.673 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 53.0 m -148.57 173.12 13.49 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.619 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.75 49.19 1.3 Allowed Glycine 0 N--CA 1.498 2.799 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.505 HD12 ' C ' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -130.51 -175.37 3.63 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.866 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -117.55 135.32 23.22 Favored Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.69 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.53 148.27 93.39 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.052 1.168 . . . . 0.0 112.799 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.18 82.91 0.03 OUTLIER Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.388 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -167.55 145.68 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 118.956 -1.098 . . . . 0.0 111.444 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -61.3 140.87 57.9 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.413 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.46 118.18 10.46 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.59 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.5 m -100.66 116.97 33.82 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.827 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 tt -107.37 149.13 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.11 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 m -141.81 120.6 12.68 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.912 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 72' ' ' VAL . 22.9 m -105.91 124.63 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.596 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -102.51 94.15 5.51 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.972 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.605 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . . . -90.95 132.04 36.2 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.704 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -136.09 119.43 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.969 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.631 ' OG1' HG13 ' A' ' 29' ' ' VAL . 85.2 m . . . . . 0 N--CA 1.488 1.426 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.898 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 C--O 1.214 -0.68 0 CA-C-O 121.215 0.423 . . . . 0.0 112.248 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 tt -145.89 153.42 13.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.092 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.43 151.58 46.37 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.069 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -145.76 140.25 21.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.58 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -88.88 151.28 22.44 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.755 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -162.46 134.94 5.64 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.138 -1.025 . . . . 0.0 111.102 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.2 mtt180 -93.84 110.69 22.33 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.992 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 116.395 -1.764 . . . . 0.0 110.574 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -170.15 170.56 7.32 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.322 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.91 149.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.969 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 11' ' ' VAL . 7.6 p -129.98 -6.41 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.794 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.84 161.09 7.08 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.813 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.59 145.85 27.01 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.784 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.565 ' CB ' ' HG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -130.74 161.0 63.79 Favored Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.901 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.04 -10.08 2.54 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 121.236 1.29 . . . . 0.0 111.771 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 m -159.68 44.32 0.23 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.565 ' HG ' ' CB ' ' A' ' 14' ' ' THR . 0.1 OUTLIER 177.26 149.45 0.15 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.237 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.9 tp -131.18 148.64 52.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.062 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -122.71 116.91 24.56 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.696 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.3 pt -104.87 170.71 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.764 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.34 135.12 13.65 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.144 -1.023 . . . . 0.0 111.126 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.9 p90 . . . . . 0 C--N 1.311 -1.1 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.46 179.955 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.781 HG13 HG22 ' A' ' 76' ' ' THR . 4.5 t . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.486 0.184 . . . . 0.0 110.756 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.486 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 3.8 mmm180 -73.79 -78.09 0.1 Allowed 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.32 -1.352 . . . . 0.0 108.773 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -149.79 153.61 37.1 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.526 -1.27 . . . . 0.0 112.022 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.16 167.58 9.9 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.175 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -145.07 106.65 4.24 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.674 -1.21 . . . . 0.0 111.419 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 mt -100.21 106.19 18.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.364 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 47' ' ' GLU . 43.3 p -107.45 136.66 46.88 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.494 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.576 ' CZ ' HG11 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -134.34 132.05 39.05 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.614 -0.834 . . . . 0.0 112.036 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -158.66 153.46 24.6 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -49.57 171.43 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.62 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.49 1.569 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.665 -179.959 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.576 HG11 ' CZ ' ' A' ' 36' ' ' TYR . 5.8 t . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 111.313 0.116 . . . . 0.0 111.313 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.592 ' CG ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -174.48 -140.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.305 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.592 ' H ' ' CG ' ' A' ' 46' ' ' GLN . 9.1 pt-20 -171.91 168.48 5.99 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.667 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -161.61 141.37 10.29 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.63 165.76 11.82 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.419 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.567 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -150.28 160.3 33.43 Favored Pre-proline 0 C--N 1.304 -1.411 0 C-N-CA 119.486 -0.885 . . . . 0.0 110.005 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.09 21.11 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.158 1.239 . . . . 0.0 112.254 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 42.81 32.59 1.42 Allowed Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.675 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.14 -53.29 3.69 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.554 -0.858 . . . . 0.0 111.267 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -75.86 136.22 40.16 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.08 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 m -83.83 -13.58 53.38 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.529 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.4 p -131.4 152.95 50.19 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.915 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.413 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -155.35 157.51 37.24 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.292 -1.363 . . . . 0.0 112.137 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 49.4 m -98.5 130.97 45.09 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.708 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 59' ' ' ILE . 5.1 tp -130.43 121.64 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.433 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.9 t -117.23 -168.77 1.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.32 51.11 5.1 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.73 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.36 -160.97 1.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.701 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -136.35 139.25 29.17 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.215 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -61.94 118.13 5.0 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 120.935 1.09 . . . . 0.0 111.614 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.79 89.08 0.07 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.531 -1.318 . . . . 0.0 111.031 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.5 p -163.48 138.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.135 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.89 114.38 5.67 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.824 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -119.89 145.92 46.25 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.978 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.6 m -112.92 111.44 22.2 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.294 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.901 HD12 ' N ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -102.36 130.46 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.081 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.901 ' N ' HD12 ' A' ' 70' ' ' ILE . 2.2 m -133.41 141.83 48.05 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.398 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.416 HG13 HD11 ' A' ' 70' ' ' ILE . 33.1 m -130.18 138.22 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.275 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.36 122.95 41.91 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.733 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.59 116.41 32.68 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.244 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.33 108.76 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.468 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.781 HG22 HG13 ' A' ' 29' ' ' VAL . 13.0 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.406 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.455 -0.793 0 N-CA-C 110.598 -0.578 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.94 156.4 6.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 C-N-CA 118.595 -1.242 . . . . 0.0 111.17 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.3 p -142.04 144.84 33.81 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.66 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -149.54 145.76 17.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.24 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.81 141.64 28.44 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.069 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -149.02 128.36 12.96 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.623 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -78.97 106.88 11.31 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.708 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 116.142 -1.885 . . . . 0.0 111.016 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.466 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.4 mp . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.566 0.222 . . . . 0.0 110.728 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -175.38 -176.72 0.94 Allowed 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.649 -1.22 . . . . 0.0 112.229 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.2 t -93.35 146.95 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.64 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -94.25 -63.47 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.472 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.49 172.4 15.03 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.173 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.8 174.8 10.18 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.428 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -148.71 160.77 35.05 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.533 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -52.98 -6.29 0.25 Allowed 'Trans proline' 0 C--O 1.216 -0.587 0 C-N-CA 121.364 1.376 . . . . 0.0 111.851 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 14' ' ' THR . 2.0 t -165.22 48.94 0.1 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.452 ' HG ' ' CB ' ' A' ' 14' ' ' THR . 0.1 OUTLIER 174.87 147.5 0.08 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.798 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 tp -127.29 133.96 50.09 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.457 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.427 ' HA ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -98.83 111.75 24.04 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.395 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 pp -110.95 145.25 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.678 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.7 m -141.95 126.1 17.42 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.189 -1.004 . . . . 0.0 111.046 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.6 p90 . . . . . 0 N--CA 1.475 0.821 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.778 179.87 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.441 HG11 ' CD1' ' A' ' 32' ' ' TYR . 78.5 t . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.622 0.248 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.542 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.24 -63.68 1.11 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.126 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 9.0 m-85 -143.93 164.31 30.95 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.089 -1.045 . . . . 0.0 112.282 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.441 ' CD1' HG11 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -126.99 146.05 50.48 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.396 -1.274 . . . . 0.0 108.298 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.572 ' C ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -137.19 136.36 38.12 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.778 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.763 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.5 mp -121.09 119.92 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.293 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -114.19 138.06 50.96 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.593 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.475 ' CE2' HG11 ' A' ' 45' ' ' VAL . 8.3 p90 -135.84 154.2 51.25 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.803 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.448 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -171.16 169.61 42.61 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -76.01 -162.9 0.25 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.847 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.489 1.515 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.31 -179.86 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.475 HG11 ' CE2' ' A' ' 36' ' ' TYR . 50.6 t . . . . . 0 CA--C 1.502 -0.869 0 CA-C-O 121.165 0.507 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -175.69 -169.79 0.37 Allowed 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.194 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -164.36 160.48 20.86 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.855 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.436 ' O ' ' CD1' ' A' ' 48' ' ' PHE . 42.3 p90 -155.51 142.46 19.08 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.726 -1.189 . . . . 0.0 111.185 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.9 140.78 29.13 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.348 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.6 155.69 80.3 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.056 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' A' ' 53' ' ' SER . 0.9 OUTLIER -61.66 118.23 5.09 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 120.436 0.757 . . . . 0.0 110.795 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -49.41 -6.46 0.06 OUTLIER Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.034 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -64.12 -36.45 84.06 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.25 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -83.72 157.63 22.08 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.059 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -120.65 -6.28 9.69 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.607 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.6 p -133.22 161.8 33.5 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.163 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.14 165.18 27.37 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.8 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.1 m -128.98 118.24 22.27 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.493 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.1 pt -108.4 149.23 11.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.701 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.4 t -144.88 151.27 38.46 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.971 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.19 7.6 1.71 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.715 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -130.62 -179.61 5.39 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.12 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.551 ' N ' HD22 ' A' ' 62' ' ' LEU . 4.2 mptp? -125.66 118.05 24.5 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.814 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.1 112.64 1.74 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 120.399 0.733 . . . . 0.0 111.346 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 94' ' ' THR . . . 158.28 30.84 0.02 OUTLIER Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.687 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 67' ' ' ASP . 7.7 p -165.68 164.8 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.406 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.508 ' N ' HG22 ' A' ' 66' ' ' VAL . 24.0 t70 -67.33 104.64 1.55 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.2 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.13 152.9 26.47 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.376 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 m -121.05 128.06 52.29 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.539 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.979 HD12 ' N ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -114.02 136.32 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.63 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.979 ' N ' HD12 ' A' ' 70' ' ' ILE . 47.2 m -132.96 145.48 50.93 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.95 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.0 m -128.57 140.54 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.383 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -118.42 141.47 48.52 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.439 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.08 105.86 12.28 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.075 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.542 ' CG2' ' HE ' ' A' ' 33' ' ' ARG . 3.5 t -108.03 130.86 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.489 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.1 p . . . . . 0 N--CA 1.484 1.25 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.629 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo . . . . . 0 C--O 1.216 -0.603 0 N-CA-C 110.977 -0.432 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.5 tt -150.65 154.09 9.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 C-N-CA 118.851 -1.14 . . . . 0.0 111.27 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.609 ' OG ' HG23 ' A' ' 71' ' ' THR . 14.8 m -134.94 163.07 30.66 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.412 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 pt -145.64 137.74 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.648 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.06 128.99 46.06 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.702 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.521 ' CZ ' ' O ' ' A' ' 93' ' ' ARG . 13.5 t80 -152.23 149.51 28.8 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.246 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.521 ' O ' ' CZ ' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -83.4 120.53 26.0 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.878 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 116.313 -1.803 . . . . 0.0 110.62 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.716 0.293 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -175.32 172.92 2.63 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.308 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.61 133.97 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.69 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.6 t -92.97 -39.44 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.266 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.37 166.33 20.81 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.876 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.63 82.71 1.46 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.746 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.69 160.73 58.82 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.234 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -4.84 3.63 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 121.093 1.196 . . . . 0.0 111.499 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.424 ' O ' ' OG ' ' A' ' 60' ' ' SER . 16.2 m -149.13 39.93 0.85 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.523 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 172.68 143.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.515 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.54 140.01 53.34 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.231 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.35 116.74 26.83 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.915 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 pp -112.55 150.51 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.228 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.12 140.36 29.38 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.652 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.6 p90 . . . . . 0 C--N 1.304 -1.404 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.555 179.845 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.417 HG13 HG22 ' A' ' 76' ' ' THR . 2.1 t . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 120.688 0.28 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -78.44 -70.75 0.47 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.649 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.63 161.32 41.94 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.125 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -120.51 131.97 54.96 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.957 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttp-105 -118.59 113.09 20.72 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.244 -0.983 . . . . 0.0 110.525 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.0 mt -95.84 122.91 47.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.338 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -125.69 130.87 52.41 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.212 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.728 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -148.14 166.73 27.0 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.671 -1.212 . . . . 0.0 112.306 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.94 146.73 4.76 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -53.53 169.93 0.12 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.577 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 63.4 m . . . . . 0 C--N 1.304 -1.387 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.717 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.7 HG12 ' N ' ' A' ' 46' ' ' GLN . 49.3 t . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 111.17 0.063 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.7 ' N ' HG12 ' A' ' 45' ' ' VAL . 4.3 pt20 -176.1 -133.12 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.361 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -171.1 161.26 6.72 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.346 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.564 ' CE2' ' OH ' ' A' ' 36' ' ' TYR . 2.7 p90 -152.56 161.22 42.88 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.0 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 p -113.75 156.85 23.08 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.534 -0.866 . . . . 0.0 112.293 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.779 HG23 ' H ' ' A' ' 52' ' ' GLY . 2.4 m -147.42 154.29 45.06 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.956 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 53' ' ' SER . 1.1 Cg_endo -63.1 23.28 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.016 1.144 . . . . 0.0 112.931 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.779 ' H ' HG23 ' A' ' 50' ' ' VAL . . . 52.57 13.93 2.19 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.083 -1.532 . . . . 0.0 110.693 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -74.93 -39.51 61.34 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.194 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.422 ' HG2' ' H ' ' A' ' 56' ' ' THR . 3.2 ttpt -96.72 130.47 43.96 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.119 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.9 m -87.95 24.46 1.79 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.558 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.422 ' H ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -143.2 164.27 30.64 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.789 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.63 141.22 17.87 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.668 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.0 m -117.19 139.33 50.9 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.401 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.728 HD12 ' CZ ' ' A' ' 36' ' ' TYR . 11.0 tt -141.59 140.41 31.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.319 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 16' ' ' THR . 4.2 t -141.86 176.45 8.92 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.22 48.48 6.41 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.193 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.37 -158.83 0.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.114 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -135.41 101.52 11.0 Favored Pre-proline 0 N--CA 1.487 1.421 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.828 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -61.95 153.86 65.69 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 120.598 0.865 . . . . 0.0 111.671 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.61 47.97 4.1 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.577 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.468 HG22 ' N ' ' A' ' 67' ' ' ASP . 8.9 p -161.87 160.31 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 C-N-CA 119.009 -1.077 . . . . 0.0 111.595 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.468 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -62.84 153.61 32.61 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.081 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.81 117.48 6.19 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.774 -1.171 . . . . 0.0 111.648 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.53 119.52 36.23 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.313 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.736 HD12 ' N ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -112.7 125.98 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.403 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.736 ' N ' HD12 ' A' ' 70' ' ' ILE . 54.6 m -131.14 138.86 49.67 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.485 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 72' ' ' VAL . 17.8 m -126.22 131.3 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.76 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -100.95 117.0 34.14 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.232 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.05 110.21 22.49 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.528 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.35 117.04 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.956 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.417 HG22 HG13 ' A' ' 29' ' ' VAL . 1.3 p . . . . . 0 C--N 1.306 -1.289 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.586 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo . . . . . 0 C--O 1.215 -0.652 0 CA-C-O 121.361 0.484 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 88' ' ' ILE . 13.1 tt -152.27 127.86 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.37 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.6 p -117.17 150.88 37.99 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.592 -0.843 . . . . 0.0 112.339 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.82 133.37 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.283 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 91' ' ' ASN . 19.2 p-10 -80.57 145.41 31.77 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.1 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -160.1 132.67 6.47 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.46 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 1.4 ptp180 -90.94 123.84 34.74 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.109 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 116.343 -1.789 . . . . 0.0 110.663 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.959 0 CA-C-O 120.581 0.229 . . . . 0.0 110.501 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -175.72 -179.02 1.15 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.392 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t -91.21 127.56 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.857 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 4.2 p -92.96 -21.1 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.584 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . -179.86 161.8 1.0 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.478 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.81 115.66 13.94 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.219 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -96.09 162.07 25.09 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.533 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.608 ' C ' HG23 ' A' ' 16' ' ' THR . 7.9 Cg_exo -47.23 96.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 120.763 0.976 . . . . 0.0 110.704 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.608 HG23 ' C ' ' A' ' 15' ' ' PRO . 2.2 p 70.49 47.15 0.52 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.662 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.56 119.73 1.22 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.388 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 tp -105.72 137.0 44.31 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.287 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.28 103.03 8.26 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.855 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pt -97.95 173.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.505 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.57 131.28 3.03 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.242 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.426 ' CE3' ' N ' ' A' ' 22' ' ' TRP . 10.4 p90 . . . . . 0 CA--C 1.493 -1.218 0 C-N-CA 119.156 -1.017 . . . . 0.0 111.028 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 30' ' ' ARG . 74.3 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.006 0.432 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.464 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -74.58 -65.43 0.86 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.047 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.485 ' HE1' HG21 ' A' ' 75' ' ' VAL . 8.6 p90 -160.25 -178.62 7.09 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 117.924 -1.51 . . . . 0.0 113.317 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.42 174.41 10.65 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.704 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.59 148.28 37.25 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.17 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.28 108.11 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.121 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -119.18 137.63 53.5 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.476 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -137.54 140.18 40.9 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 118.846 -1.142 . . . . 0.0 110.899 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.38 151.7 21.03 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.72 159.34 33.97 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.634 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 39' ' ' THR . 22.2 m . . . . . 0 N--CA 1.485 1.315 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.885 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.985 0.422 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.444 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -175.71 -176.29 0.85 Allowed 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 118.525 -1.27 . . . . 0.0 111.513 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' A' ' 46' ' ' GLN . 9.0 pt-20 -158.16 170.53 22.06 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.205 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.485 ' HE1' HD11 ' A' ' 59' ' ' ILE . 8.8 p90 -165.92 145.9 6.42 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.02 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.9 p -91.14 169.92 10.45 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.79 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 52' ' ' GLY . 9.3 p -161.36 136.31 5.49 Favored Pre-proline 0 C--N 1.304 -1.399 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.25 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.6 Cg_endo -61.7 22.88 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 120.955 1.103 . . . . 0.0 112.828 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 53.26 7.86 0.63 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.491 -1.338 . . . . 0.0 110.312 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.493 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -71.62 -29.42 64.64 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.86 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.7 mttm -94.45 153.0 18.15 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.808 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.75 -12.65 17.48 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.721 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 p -130.61 170.99 13.55 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.092 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.37 132.06 9.59 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.578 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.7 m -104.13 128.75 51.82 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.205 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.485 HD11 ' HE1' ' A' ' 48' ' ' PHE . 10.7 mt -126.82 139.76 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.992 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.91 131.73 47.59 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.411 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.67 2.29 0.19 Allowed Glycine 0 N--CA 1.484 1.881 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 62' ' ' LEU . 7.2 mp -91.43 178.1 6.05 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.29 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.639 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 1.0 OUTLIER -176.82 -42.38 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.733 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.639 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 4.3 Cg_endo -79.81 -172.02 1.41 Allowed 'Trans proline' 0 C--O 1.217 -0.564 0 C-N-CA 121.548 1.499 . . . . 0.0 111.734 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.91 81.61 0.23 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.8 HG22 ' H ' ' A' ' 67' ' ' ASP . 11.8 p -132.05 -177.78 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.998 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.8 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -66.93 125.38 25.75 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.142 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.09 130.96 53.31 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.318 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.81 123.81 48.56 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.721 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 pp -116.05 164.16 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.165 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.9 m -152.18 143.74 23.48 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.632 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.91 139.73 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.715 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -109.07 143.26 38.64 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.536 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.13 91.48 3.55 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.812 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.485 HG21 ' HE1' ' A' ' 31' ' ' TYR . 13.2 t -94.9 107.65 19.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 119.095 -1.042 . . . . 0.0 113.277 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 m . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 179.649 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 C--O 1.214 -0.691 0 N-CA-C 110.929 -0.45 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 88' ' ' ILE . 9.4 tt -143.9 139.59 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.949 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.1 p -124.63 150.99 45.42 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -143.72 163.0 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.505 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -103.05 147.64 26.71 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.147 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -154.12 135.49 14.15 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.811 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 5.6 ptt85 -90.32 107.04 18.9 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.46 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.681 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.755 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -168.65 136.44 2.05 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.026 -1.47 . . . . 0.0 112.646 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -88.46 142.4 12.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.879 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 11' ' ' VAL . 3.6 p -130.52 1.62 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 119.074 -1.05 . . . . 0.0 112.177 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 177.79 155.61 0.34 Allowed 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.6 -1.24 . . . . 0.0 111.395 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.74 104.79 2.17 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.2 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -91.66 160.81 35.66 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.002 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.29 -0.4 0.31 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.998 1.132 . . . . 0.0 112.098 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.472 ' H ' ' C ' ' A' ' 14' ' ' THR . 25.5 p -151.39 28.97 0.64 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.699 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.47 151.05 0.57 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.69 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.6 123.98 30.71 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.975 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tp -104.14 116.66 32.59 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.803 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.0 pt -107.1 173.49 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.123 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.68 139.03 7.47 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.295 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 18.3 p90 . . . . . 0 N--CA 1.486 1.367 0 C-N-CA 118.402 -1.319 . . . . 0.0 113.052 -179.841 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.898 0.38 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.428 ' H ' ' HA ' ' A' ' 76' ' ' THR . 2.7 tpt85 -56.03 -61.46 2.36 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.315 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.74 169.33 21.66 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.611 -1.236 . . . . 0.0 112.151 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -116.55 158.32 23.85 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.96 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -138.58 112.25 8.29 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.215 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.4 mt -102.18 127.37 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.866 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.9 137.57 51.5 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.958 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.574 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 3.0 p90 -145.55 154.93 42.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 118.351 -1.339 . . . . 0.0 112.204 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -176.24 138.53 4.14 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -64.23 145.48 55.91 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 118.976 -1.09 . . . . 0.0 110.538 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.301 -1.542 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.238 -179.93 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.452 HG11 ' CE2' ' A' ' 36' ' ' TYR . 95.0 t . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 120.804 0.335 . . . . 0.0 111.475 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.462 ' CG ' ' H ' ' A' ' 47' ' ' GLU . 3.8 tp60 -171.57 -151.38 0.07 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.659 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.462 ' H ' ' CG ' ' A' ' 46' ' ' GLN . 3.2 pt-20 -170.18 161.69 8.5 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.377 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -159.02 156.6 29.63 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.869 -1.132 . . . . 0.0 111.054 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.4 p -101.67 157.97 16.44 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.754 -0.779 . . . . 0.0 111.641 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 50' ' ' VAL . 11.4 p -165.61 134.14 2.51 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 53' ' ' SER . 6.3 Cg_exo -56.49 124.97 17.54 Favored 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 120.274 0.649 . . . . 0.0 111.484 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.05 1.7 0.79 Allowed Glycine 0 N--CA 1.483 1.806 0 C-N-CA 119.45 -1.357 . . . . 0.0 110.694 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.491 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -59.57 -35.28 73.94 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 118.845 -1.142 . . . . 0.0 109.636 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -98.4 120.25 38.5 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.059 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 m -79.59 21.25 0.52 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.122 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.4 p -143.72 149.3 36.96 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.308 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.62 150.11 26.03 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.394 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.1 m -95.05 158.44 15.46 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.128 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -146.9 139.01 19.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 119.506 -0.877 . . . . 0.0 110.026 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.3 -178.08 6.2 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.061 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.32 21.65 21.76 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.779 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.06 -164.65 1.39 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.993 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.645 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -177.68 -42.39 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.355 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.295 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.645 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 1.9 Cg_endo -77.16 -170.16 0.87 Allowed 'Trans proline' 0 C--O 1.214 -0.725 0 C-N-CA 121.762 1.641 . . . . 0.0 112.87 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.71 84.21 0.19 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.688 HG22 ' N ' ' A' ' 67' ' ' ASP . 12.2 p -130.2 177.55 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.387 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.688 ' N ' HG22 ' A' ' 66' ' ' VAL . 7.9 t70 -45.44 148.27 0.7 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.097 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.58 111.3 5.02 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.528 -1.269 . . . . 0.0 112.294 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.48 132.98 34.27 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.181 -1.008 . . . . 0.0 108.85 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 70' ' ' ILE . 7.2 tt -127.64 132.17 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.192 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.586 HG22 ' CB ' ' A' ' 89' ' ' SER . 24.1 p -125.1 121.98 35.86 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.575 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.37 129.0 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.641 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -103.72 140.81 37.1 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.406 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.97 91.22 3.5 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.135 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.0 t -93.8 124.03 46.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.717 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.428 ' HA ' ' H ' ' A' ' 30' ' ' ARG . 13.3 t . . . . . 0 N--CA 1.487 1.38 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.062 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 C--O 1.215 -0.662 0 CA-C-O 120.957 0.316 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.412 ' O ' ' OG ' ' A' ' 89' ' ' SER . 12.4 tt -145.89 154.62 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.696 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.586 ' CB ' HG22 ' A' ' 71' ' ' THR . 15.2 m -161.34 147.21 14.15 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 118.446 -1.302 . . . . 0.0 112.204 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.553 HD11 ' CD2' ' A' ' 8' ' ' LEU . 1.2 pt -150.01 164.38 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.228 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.74 136.4 34.06 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.497 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -140.88 133.55 28.74 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.371 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -87.84 108.51 19.19 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.589 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 116.502 -1.713 . . . . 0.0 110.745 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.629 0.252 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -139.46 162.36 35.24 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.8 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.477 HG13 HD11 ' A' ' 18' ' ' LEU . 54.0 t -92.6 102.25 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.123 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.643 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 47.8 t -71.78 3.42 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.296 -0.961 . . . . 0.0 111.474 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 168.81 154.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.341 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.58 93.85 2.11 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.684 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -91.27 162.27 32.63 Favored Pre-proline 0 N--CA 1.485 1.288 0 C-N-CA 119.436 -0.905 . . . . 0.0 110.613 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.72 9.55 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.428 1.419 . . . . 0.0 112.089 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 14' ' ' THR . 4.4 t -168.77 28.1 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.063 -1.055 . . . . 0.0 110.806 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -173.65 141.68 0.87 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.526 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.623 HD12 ' H ' ' A' ' 19' ' ' LEU . 19.2 tp -130.62 146.49 52.13 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.789 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.623 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -128.33 106.64 9.16 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.184 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 20' ' ' ILE . 2.2 pt -103.35 169.7 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.461 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 20' ' ' ILE . 8.2 m -164.04 134.03 4.11 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.457 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 14.3 p90 . . . . . 0 N--CA 1.49 1.536 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.682 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.955 0.407 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.14 -65.85 0.96 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.069 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -160.48 163.59 32.83 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.038 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -120.42 146.89 45.76 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.691 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -129.03 110.08 11.75 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.779 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.858 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.7 mp -100.81 108.48 23.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.788 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 p -104.63 147.71 27.35 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.213 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.735 ' CD2' HD11 ' A' ' 59' ' ' ILE . 26.5 p90 -149.39 148.36 29.39 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 117.987 -1.485 . . . . 0.0 112.088 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.26 150.85 7.92 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -78.56 -174.54 3.89 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.767 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--N 1.304 -1.409 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.684 179.954 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.671 HG12 ' N ' ' A' ' 46' ' ' GLN . 21.3 t . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 119.99 -0.052 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.671 ' N ' HG12 ' A' ' 45' ' ' VAL . 30.7 tt0 -168.72 166.98 11.5 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 117.482 -1.687 . . . . 0.0 112.606 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.488 ' N ' ' CG ' ' A' ' 46' ' ' GLN . 3.3 pt-20 -161.17 156.42 24.3 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.445 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 1.4 p90 -139.58 167.13 22.8 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.488 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.5 p -131.27 148.66 52.71 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.606 -0.837 . . . . 0.0 111.538 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.688 HG23 ' H ' ' A' ' 52' ' ' GLY . 10.3 m -140.72 151.78 64.09 Favored Pre-proline 0 N--CA 1.486 1.349 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.861 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.16 14.35 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 120.898 1.065 . . . . 0.0 112.173 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.688 ' H ' HG23 ' A' ' 50' ' ' VAL . . . 70.69 16.41 74.17 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.809 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.82 -40.34 20.5 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.915 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -84.16 121.44 27.46 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.623 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 m -83.03 -9.79 59.08 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.062 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.66 168.63 11.19 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.285 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.1 136.15 6.59 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.514 -1.275 . . . . 0.0 111.947 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -105.14 136.88 43.82 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.826 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.735 HD11 ' CD2' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -134.13 144.56 35.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.429 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.14 135.62 20.63 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.112 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.86 -37.44 0.24 Allowed Glycine 0 N--CA 1.486 1.981 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.387 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -163.32 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.75 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.647 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -176.91 -40.79 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.604 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.647 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 8.7 Cg_endo -83.4 -169.34 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.579 1.519 . . . . 0.0 111.731 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.33 74.68 0.4 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.667 HG22 ' N ' ' A' ' 67' ' ' ASP . 8.9 p -119.4 170.81 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.077 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.667 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -64.86 97.51 0.23 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.442 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -89.59 130.26 35.92 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.631 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.41 149.2 29.06 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.793 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.5 pp -140.6 161.09 24.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.629 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.4 m -149.61 123.32 9.22 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.68 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.03 136.92 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.355 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.47 116.25 31.06 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.294 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.66 97.64 8.88 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.256 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.0 t -99.53 116.9 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.483 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.683 179.971 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo . . . . . 0 C--O 1.215 -0.627 0 N-CA-C 111.231 -0.334 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -155.81 156.04 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.992 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.39 156.52 46.37 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.684 -0.807 . . . . 0.0 110.942 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -145.49 152.06 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.979 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.98 146.92 34.43 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.77 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -158.66 145.86 17.63 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.682 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.465 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 1.5 ptt85 -83.85 98.79 9.93 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.254 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -171.97 161.17 5.63 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.357 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.9 t -89.06 115.34 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.32 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.663 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 2.7 t -69.43 -26.58 31.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.565 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 167.59 178.51 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.96 119.74 12.56 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.626 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.9 162.49 22.06 Favored Pre-proline 0 C--N 1.3 -1.584 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.708 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 16' ' ' THR . 4.5 Cg_exo -53.95 94.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 120.733 0.955 . . . . 0.0 110.673 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.489 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER 81.06 41.66 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.881 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.32 137.51 1.89 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.685 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.64 148.6 43.16 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 19' ' ' LEU . 1.7 tt -129.66 105.53 8.11 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.006 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.45 168.3 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.449 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -161.82 132.21 4.93 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.591 -1.244 . . . . 0.0 111.584 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.402 ' CH2' HD11 ' A' ' 34' ' ' ILE . 6.8 p90 . . . . . 0 N--CA 1.482 1.127 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.556 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.77 0.319 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.03 -76.59 0.1 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.393 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -147.13 168.17 22.3 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.148 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -120.83 160.32 23.64 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.285 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.451 ' HE ' ' HB ' ' A' ' 49' ' ' THR . 1.4 ttm180 -127.33 146.15 50.55 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.466 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 34' ' ' ILE . 17.4 mt -137.8 99.46 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.679 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.28 137.61 43.92 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.108 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.621 ' CE2' HD11 ' A' ' 59' ' ' ILE . 11.0 p90 -145.28 148.03 33.01 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.242 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.58 140.75 6.66 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.58 143.42 48.25 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.09 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.305 -1.363 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.725 -179.98 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.568 HG11 ' CZ ' ' A' ' 36' ' ' TYR . 48.4 t . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.457 0.17 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 3.8 pt20 -173.25 -152.71 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.019 -1.073 . . . . 0.0 111.404 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.484 ' N ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -159.19 173.4 16.42 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.163 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -165.08 148.24 8.34 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.517 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.451 ' HB ' ' HE ' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -113.21 167.22 10.73 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.339 -0.944 . . . . 0.0 112.682 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.493 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -147.21 158.18 44.74 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.667 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.16 6.26 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 121.175 1.25 . . . . 0.0 112.172 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 70.52 -1.14 22.56 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.338 -1.411 . . . . 0.0 110.275 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.39 -37.09 57.67 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.884 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -80.63 116.32 20.6 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.575 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.9 m -82.31 -2.07 51.58 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.111 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.2 p -133.09 157.56 44.97 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.513 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.03 140.67 13.36 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.579 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m -103.77 139.64 38.72 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.274 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.621 HD11 ' CE2' ' A' ' 36' ' ' TYR . 2.2 tt -135.42 149.2 28.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.843 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -141.48 -154.68 0.53 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.397 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.91 46.25 94.93 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.276 -1.44 . . . . 0.0 110.629 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.508 ' C ' HD12 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -130.45 -172.94 2.93 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.04 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -118.05 130.03 24.99 Favored Pre-proline 0 N--CA 1.49 1.526 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.967 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.62 140.51 87.03 Favored 'Trans proline' 0 C--O 1.217 -0.546 0 C-N-CA 120.409 0.74 . . . . 0.0 111.353 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.57 83.76 0.05 OUTLIER Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.462 -1.352 . . . . 0.0 110.553 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.1 p -165.29 148.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.153 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.92 149.49 47.74 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.616 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.37 137.09 21.59 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.846 -1.142 . . . . 0.0 111.9 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.57 119.35 35.28 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.918 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.414 ' CG1' ' N ' ' A' ' 71' ' ' THR . 3.7 tt -118.38 152.66 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.064 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.442 HG23 ' HB3' ' A' ' 89' ' ' SER . 50.7 m -140.51 126.15 19.12 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.656 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.18 144.84 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.782 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -119.22 125.19 48.57 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.782 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.81 86.78 4.8 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.427 ' H ' HG23 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -86.41 118.57 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 118.962 -1.095 . . . . 0.0 112.338 -179.728 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.308 -1.204 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.906 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 C--O 1.215 -0.626 0 N-CA-C 111.363 -0.283 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 88' ' ' ILE . 13.1 tt -146.49 132.13 12.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.236 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.442 ' HB3' HG23 ' A' ' 71' ' ' THR . 21.7 p -130.79 152.33 50.25 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.494 -0.882 . . . . 0.0 112.19 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.91 146.4 18.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.187 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -92.24 151.19 20.46 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.832 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -155.04 136.85 14.46 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.649 -1.22 . . . . 0.0 111.699 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.09 110.69 22.9 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.85 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 116.338 -1.792 . . . . 0.0 110.769 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 120.344 0.116 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.521 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 12.3 mp0 -135.38 163.88 29.02 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.776 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.9 t -89.48 116.5 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.697 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.635 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.9 t -82.51 -6.97 10.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.649 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.635 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 169.23 166.3 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.526 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.38 144.77 24.81 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.164 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -138.38 160.16 64.93 Favored Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.528 -179.941 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.413 ' C ' ' OG1' ' A' ' 16' ' ' THR . 5.4 Cg_exo -48.36 -8.88 0.07 OUTLIER 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.404 1.403 . . . . 0.0 112.306 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.2 OUTLIER -164.29 41.7 0.09 Allowed 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.007 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.09 136.04 0.37 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.229 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 62' ' ' LEU . 1.1 tp -130.5 125.63 34.83 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.071 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 20' ' ' ILE . 1.2 tt -106.53 126.63 52.5 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.716 -0.793 . . . . 0.0 110.365 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.661 ' N ' HD23 ' A' ' 19' ' ' LEU . 9.5 pt -126.76 164.58 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.966 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.421 ' OG ' HG21 ' A' ' 11' ' ' VAL . 5.2 m -161.62 146.66 13.37 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.542 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 . . . . . 0 N--CA 1.483 1.194 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.975 179.966 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.325 0.583 . . . . 0.0 112.152 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 19.8 mtp180 -108.92 -53.12 2.68 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.095 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 30' ' ' ARG . 44.3 m-85 -160.28 157.96 29.01 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.221 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.46 111.64 20.28 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.52 -1.218 . . . . 0.0 107.954 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.9 mtt-85 -100.12 145.06 28.42 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.2 mp -141.21 110.4 2.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.601 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 p -121.73 151.4 40.56 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.036 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 15.2 p90 -144.13 155.34 43.89 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 118.584 -1.246 . . . . 0.0 111.67 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.45 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . 171.48 147.19 5.58 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.795 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -62.17 166.7 4.58 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.444 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--N 1.307 -1.252 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.81 179.984 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.45 HG23 ' HA2' ' A' ' 37' ' ' GLY . 26.5 t . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.867 0.365 . . . . 0.0 110.366 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -164.01 167.95 19.83 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.594 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -148.0 146.87 29.09 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.186 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 10.6 p90 -154.23 134.89 13.57 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 118.72 -1.192 . . . . 0.0 111.276 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 t -100.49 147.52 25.8 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.496 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.81 150.83 61.13 Favored Pre-proline 0 C--N 1.301 -1.527 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.252 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.564 ' C ' ' H ' ' A' ' 53' ' ' SER . 6.2 Cg_exo -52.77 125.17 17.23 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 120.499 0.8 . . . . 0.0 110.882 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.66 17.6 0.07 OUTLIER Glycine 0 N--CA 1.487 2.09 0 C-N-CA 119.61 -1.281 . . . . 0.0 111.726 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.564 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -73.18 -41.54 63.73 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 118.859 -1.136 . . . . 0.0 110.184 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -87.71 -172.5 3.9 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.341 -0.943 . . . . 0.0 110.63 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.37 14.06 2.38 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.441 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.0 p -126.82 174.4 8.81 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.615 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.18 122.52 0.67 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.443 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.25 146.54 24.27 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.698 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mt -136.78 147.11 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.995 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.5 t -150.57 153.97 36.72 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.419 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 62' ' ' LEU . . . 123.07 -9.27 9.0 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 18' ' ' LEU . 2.1 mt -49.79 -178.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.785 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -176.39 -43.24 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 119.416 -0.914 . . . . 0.0 112.36 179.948 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.607 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 4.2 Cg_endo -79.46 -168.17 0.6 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.657 1.571 . . . . 0.0 111.776 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -154.66 87.47 0.13 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.744 -1.743 . . . . 0.0 108.744 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.848 HG22 ' H ' ' A' ' 67' ' ' ASP . 11.5 p -156.54 -177.2 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 118.944 -1.103 . . . . 0.0 111.715 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.848 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -57.75 98.65 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.634 179.982 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -94.11 132.03 39.04 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.278 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 m -112.85 127.57 56.22 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.747 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 pp -113.86 151.2 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.203 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 89' ' ' SER . 97.3 m -143.32 120.85 11.73 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.016 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.43 141.21 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.768 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 97.15 6.52 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.343 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.29 92.2 2.74 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.533 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.54 115.67 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.696 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.489 1.5 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.43 179.926 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo . . . . . 0 C--O 1.215 -0.671 0 N-CA-C 111.286 -0.313 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.0 156.5 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.404 ' HB3' HG23 ' A' ' 71' ' ' THR . 53.4 p -145.27 159.89 42.33 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.235 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -148.76 149.71 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.6 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.38 154.55 18.7 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.542 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -175.55 135.07 0.31 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.737 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 93' ' ' ARG . 2.6 ptm180 -61.65 96.42 0.06 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.295 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 116.502 -1.713 . . . . 0.0 110.583 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 120.768 0.318 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -159.73 140.84 12.55 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.869 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.83 109.64 13.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.391 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.1 t -70.17 -64.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.221 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.59 166.62 30.64 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.861 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.32 127.39 45.48 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.26 161.85 21.82 Favored Pre-proline 0 C--N 1.308 -1.206 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.299 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.617 ' C ' HG23 ' A' ' 16' ' ' THR . 4.9 Cg_exo -49.28 99.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 120.547 0.831 . . . . 0.0 110.614 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.617 HG23 ' C ' ' A' ' 15' ' ' PRO . 1.7 p 69.14 44.59 0.97 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.52 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.33 146.92 7.52 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.274 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mt -128.31 142.94 50.99 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.759 -0.777 . . . . 0.0 111.497 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 19' ' ' LEU . 2.0 tt -115.91 102.23 9.48 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.831 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.57 146.58 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.72 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -139.77 132.3 28.7 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.227 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 12.6 p90 . . . . . 0 N--CA 1.496 1.867 0 C-N-CA 118.796 -1.162 . . . . 0.0 112.447 -179.788 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.773 0.32 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.523 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -87.81 -61.47 1.71 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.483 -179.984 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 46.3 m-85 -147.45 168.0 23.0 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.167 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.28 137.47 42.53 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.256 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.09 128.9 23.24 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 118.236 -1.386 . . . . 0.0 111.274 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.2 mt -111.54 135.17 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.891 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 p -128.05 135.07 49.35 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.463 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.499 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 6.7 p90 -135.91 160.6 38.08 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.653 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . 165.65 139.87 2.75 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -57.35 -161.01 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.48 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.428 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.403 HG11 ' CE2' ' A' ' 36' ' ' TYR . 39.7 t . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 121.117 0.484 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.486 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -175.22 -175.5 0.84 Allowed 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.13 -179.883 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.486 ' H ' ' CD ' ' A' ' 46' ' ' GLN . 6.5 pt-20 -157.6 167.79 29.12 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.222 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -159.47 147.53 17.46 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.237 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.5 p -97.66 124.64 42.05 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.399 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.64 151.29 49.68 Favored Pre-proline 0 N--CA 1.49 1.574 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.292 179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 53' ' ' SER . 1.2 Cg_endo -61.66 126.42 19.0 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 120.678 0.918 . . . . 0.0 110.517 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.46 -9.25 0.08 OUTLIER Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.98 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -71.3 -43.18 67.62 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.496 179.983 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 mmtm -67.77 132.72 47.96 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.301 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -103.07 -5.29 23.48 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.465 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.6 p -134.8 172.93 12.28 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.46 151.84 4.6 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.102 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.5 m -121.38 117.56 27.23 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.701 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.12 157.96 9.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.929 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -145.61 178.2 8.31 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.146 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.98 53.39 2.86 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.239 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.57 -156.4 0.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.809 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -140.28 148.83 55.72 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.43 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -68.21 123.13 10.24 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 121.052 1.168 . . . . 0.0 112.439 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.22 91.75 0.04 OUTLIER Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.787 -1.197 . . . . 0.0 111.777 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.2 p -167.48 144.96 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.211 -0.996 . . . . 0.0 110.864 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.29 153.76 6.74 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.16 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.79 134.48 18.81 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.238 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.1 m -125.61 120.92 32.11 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.623 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 pp -115.63 163.12 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.92 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.598 HG23 ' OG ' ' A' ' 89' ' ' SER . 17.1 m -152.54 127.73 9.8 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.361 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 m -121.91 136.86 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.274 -0.971 . . . . 0.0 111.796 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -115.34 126.63 54.67 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.389 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.08 98.14 7.82 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.583 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.6 t -86.36 117.54 31.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.644 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.28 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.732 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo . . . . . 0 C--O 1.215 -0.663 0 N-CA-C 110.264 -0.706 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.9 tt -153.57 160.12 3.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 117.961 -1.496 . . . . 0.0 112.304 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.598 ' OG ' HG23 ' A' ' 71' ' ' THR . 16.3 m -145.55 149.43 34.58 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.222 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 pt -147.03 154.9 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 118.956 -1.098 . . . . 0.0 111.387 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 92' ' ' TYR . 16.9 t-20 -89.77 164.15 14.78 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.554 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.447 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 22.6 t80 -172.32 129.67 0.58 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.209 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.481 ' CD ' ' N ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -90.39 111.06 22.15 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.082 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 116.295 -1.812 . . . . 0.0 110.666 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 120.446 0.165 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -174.14 159.16 3.17 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.89 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.1 t -91.98 135.51 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.516 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.77 -59.19 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 118.677 -1.209 . . . . 0.0 111.81 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.39 169.25 21.28 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.568 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.96 80.92 1.7 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.938 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -66.92 161.18 64.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.24 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -54.36 -10.12 2.01 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.362 1.375 . . . . 0.0 111.757 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.5 m -159.07 44.61 0.26 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.504 -0.879 . . . . 0.0 110.476 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.427 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -175.86 114.82 0.13 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.555 180.0 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.444 ' HB2' HD21 ' A' ' 62' ' ' LEU . 5.5 tp -109.81 112.15 24.03 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.336 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.22 122.48 31.08 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.297 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.71 148.23 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.73 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.45 136.41 46.7 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.954 179.801 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 45.7 p90 . . . . . 0 N--CA 1.507 2.378 0 C-N-CA 118.334 -1.346 . . . . 0.0 113.221 -179.893 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.489 HG11 ' CE1' ' A' ' 32' ' ' TYR . 37.1 t . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.818 0.342 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -65.34 -47.3 76.94 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.031 -1.068 . . . . 0.0 109.931 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -159.06 168.55 26.39 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.324 179.92 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CE1' HG11 ' A' ' 29' ' ' VAL . 4.4 m-85 -113.87 165.91 12.11 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.457 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -141.64 100.19 3.71 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.849 -0.741 . . . . 0.0 109.356 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.12 131.46 45.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.469 -0.892 . . . . 0.0 112.342 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.497 HG22 ' CB ' ' A' ' 47' ' ' GLU . 36.2 p -127.08 136.73 52.56 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.383 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 2.3 p90 -142.46 159.66 41.79 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 118.556 -1.258 . . . . 0.0 111.682 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.58 150.06 5.88 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -70.26 156.97 38.52 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.491 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.0 m . . . . . 0 C--N 1.302 -1.499 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.539 -179.933 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.43 HG11 ' CE2' ' A' ' 36' ' ' TYR . 47.5 t . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 121.141 0.496 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -174.68 -166.11 0.23 Allowed 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.827 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.497 ' CB ' HG22 ' A' ' 35' ' ' THR . 8.3 pt-20 -162.07 174.49 12.93 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.004 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.582 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -170.59 153.7 4.28 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.997 179.677 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 p -113.01 157.33 21.66 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.475 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.548 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -145.44 159.88 46.9 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.493 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -64.81 22.65 0.07 OUTLIER 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 121.372 1.381 . . . . 0.0 112.179 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 48.33 20.71 1.61 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.148 -1.501 . . . . 0.0 110.394 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -45.98 16.8 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.663 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -90.55 130.4 36.59 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.274 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.4 m -81.32 -4.47 55.73 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.622 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -133.74 162.35 32.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.188 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.92 171.77 13.83 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.589 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.6 m -144.44 117.06 8.64 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.633 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 59' ' ' ILE . 12.2 mt -111.39 150.02 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.559 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.3 m -136.92 -8.13 1.83 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.788 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.41 52.17 1.81 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.419 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -130.29 -172.97 2.92 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.998 -179.976 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -131.91 102.15 14.93 Favored Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.911 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.29 144.22 61.5 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 120.657 0.905 . . . . 0.0 111.321 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.37 38.62 1.76 Allowed Glycine 0 N--CA 1.498 2.793 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.672 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.591 HG22 ' N ' ' A' ' 67' ' ' ASP . 5.3 p -169.05 165.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.631 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.591 ' N ' HG22 ' A' ' 66' ' ' VAL . 4.4 t70 -60.31 145.89 46.01 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.675 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.451 ' O ' ' O ' ' A' ' 92' ' ' TYR . 0.3 OUTLIER -145.32 119.06 9.2 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.422 -179.904 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -105.59 136.77 44.58 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.565 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.443 ' CG1' ' N ' ' A' ' 71' ' ' THR . 2.1 tt -134.36 156.54 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.876 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.443 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 48.9 m -147.99 138.1 22.72 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.585 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 72' ' ' VAL . 2.4 m -114.28 129.87 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.407 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -111.23 114.86 28.38 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.639 -179.765 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.07 96.52 9.7 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.172 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.34 146.24 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.161 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.141 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo . . . . . 0 C--O 1.216 -0.602 0 N-CA-C 110.351 -0.673 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.3 tt -144.19 138.43 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 118.66 -1.216 . . . . 0.0 110.61 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.4 p -119.42 122.36 41.57 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.597 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.063 ' H ' HD12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -120.5 145.09 27.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.681 -179.971 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -97.45 153.4 18.14 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.861 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.451 ' O ' ' O ' ' A' ' 68' ' ' TYR . 24.5 t80 -165.18 135.43 3.74 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 119.234 -0.986 . . . . 0.0 111.026 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.33 127.35 43.21 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.91 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 116.339 -1.791 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -164.75 161.65 20.69 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 117.206 -1.798 . . . . 0.0 113.78 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.9 t -103.53 135.36 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-N 114.238 -1.346 . . . . 0.0 108.502 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.547 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -112.49 -10.08 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.762 -179.811 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 175.22 170.0 0.3 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.413 -1.315 . . . . 0.0 111.886 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.59 134.31 16.6 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.656 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -126.45 162.01 49.12 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.73 179.986 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -52.04 -12.88 1.55 Allowed 'Trans proline' 0 C--O 1.213 -0.745 0 C-N-CA 121.135 1.223 . . . . 0.0 111.865 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.14 48.99 0.39 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.03 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER 173.06 139.1 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.983 -179.998 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 tp -130.65 132.33 45.38 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.493 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.438 HD23 ' HB ' ' A' ' 11' ' ' VAL . 2.2 tp -93.56 126.67 38.84 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.034 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 pp -128.17 156.14 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.166 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.91 145.11 29.7 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.936 -1.105 . . . . 0.0 111.61 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 7.3 p90 . . . . . 0 C--N 1.308 -1.236 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.153 179.761 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.627 0.251 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -93.4 -57.57 2.56 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.975 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -165.03 166.73 19.04 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.826 -1.149 . . . . 0.0 112.028 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 74' ' ' ALA . 2.1 m-85 -120.0 156.0 31.74 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.439 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -135.19 104.6 5.96 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.864 179.831 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -96.28 122.03 47.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.682 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -120.18 141.38 49.94 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.638 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.463 ' CG ' HD11 ' A' ' 59' ' ' ILE . 28.9 p90 -139.16 144.38 38.56 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.898 -1.121 . . . . 0.0 111.28 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.674 ' HA2' HG21 ' A' ' 45' ' ' VAL . . . -172.42 153.26 18.66 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -74.31 166.83 22.8 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.006 -179.944 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.9 m . . . . . 0 C--N 1.306 -1.283 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.915 179.996 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.674 HG21 ' HA2' ' A' ' 37' ' ' GLY . 61.4 t . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.008 -0.044 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -167.48 174.1 8.17 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 117.061 -1.856 . . . . 0.0 113.02 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -169.06 167.18 10.72 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.226 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -164.11 160.55 21.63 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.94 161.53 20.73 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.643 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -148.66 159.41 38.37 Favored Pre-proline 0 C--N 1.309 -1.187 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.129 179.977 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -64.99 22.25 0.08 OUTLIER 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.002 1.135 . . . . 0.0 112.107 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 49.3 17.65 1.17 Allowed Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.776 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.56 -43.33 14.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -79.09 123.33 27.24 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.951 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.7 m -81.2 -12.68 59.1 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.446 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.0 p -138.62 148.56 44.25 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.173 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.95 165.03 30.65 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.921 -1.111 . . . . 0.0 111.435 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.7 m -104.17 130.23 51.91 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.167 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.463 HD11 ' CG ' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -112.21 123.29 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.719 179.979 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 51.6 m -129.81 157.48 42.09 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.307 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.78 -20.44 1.81 Allowed Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.576 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.53 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -79.35 -172.03 3.01 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.016 179.956 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.68 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -157.3 -43.73 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.487 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.487 179.967 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.68 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 10.3 Cg_endo -89.19 -167.65 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.517 1.478 . . . . 0.0 111.658 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -132.53 81.18 0.32 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 107.483 -2.247 . . . . 0.0 107.483 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.673 HG22 ' N ' ' A' ' 67' ' ' ASP . 7.5 p -133.61 175.33 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.055 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.673 ' N ' HG22 ' A' ' 66' ' ' VAL . 4.3 t70 -50.8 120.55 4.89 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.135 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.02 129.11 46.19 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.173 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.0 126.48 52.38 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.06 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 pp -112.23 152.66 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.847 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.471 ' HG1' ' CB ' ' A' ' 89' ' ' SER . 52.9 m -145.49 143.95 30.29 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.955 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.2 m -125.19 139.34 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.635 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -117.49 100.45 7.66 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.794 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -79.44 83.35 5.46 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.86 140.03 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 118.997 -1.081 . . . . 0.0 113.544 -179.568 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 p . . . . . 0 C--N 1.308 -1.217 0 CA-C-N 114.134 -1.393 . . . . 0.0 108.128 179.772 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 C--O 1.215 -0.649 0 CA-C-O 121.283 0.451 . . . . 0.0 112.752 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 88' ' ' ILE . 13.8 tt -149.3 137.03 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.373 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.471 ' CB ' ' HG1' ' A' ' 71' ' ' THR . 4.2 m -128.2 134.63 49.06 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.902 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -116.7 136.01 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.104 179.814 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.18 145.18 26.29 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.867 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.455 ' CG ' ' N ' ' A' ' 93' ' ' ARG . 24.3 t80 -167.28 158.2 11.65 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.984 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.455 ' N ' ' CG ' ' A' ' 92' ' ' TYR . 7.2 mtm-85 -93.34 113.55 25.76 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.975 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 116.581 -1.676 . . . . 0.0 110.436 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 8' ' ' LEU . 9.5 mp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.46 0.171 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -171.32 166.07 7.09 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.587 -1.245 . . . . 0.0 111.933 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.6 t -92.62 143.48 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.848 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.6 p -128.92 -2.93 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.48 -179.859 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -179.81 147.54 0.29 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.491 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.486 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -176.57 112.17 0.1 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.631 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.64 ' O ' ' N ' ' A' ' 16' ' ' THR . 0.2 OUTLIER -148.51 -75.62 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 117.921 -1.512 . . . . 0.0 113.049 179.968 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 17' ' ' SER . 6.8 Cg_endo -53.21 78.37 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.779 0 CA-C-N 119.491 0.854 . . . . 0.0 110.863 -179.571 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 14' ' ' THR . 3.0 m 35.51 32.49 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.074 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 15' ' ' PRO . 1.6 m -139.79 148.95 42.94 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.941 -1.103 . . . . 0.0 112.447 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.53 HD13 ' CD2' ' A' ' 62' ' ' LEU . 5.6 tp -113.09 142.04 46.19 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.575 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.421 HD12 HG23 ' A' ' 58' ' ' THR . 1.1 tp -117.2 107.29 14.26 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.047 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 pt -106.24 157.95 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.361 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.98 138.3 18.46 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.824 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 9.3 p90 . . . . . 0 C--N 1.316 -0.873 0 C-N-CA 118.816 -1.154 . . . . 0.0 111.346 179.881 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.0 t . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 120.895 0.379 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.1 mmm-85 -54.61 -42.88 71.67 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.23 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -179.58 165.71 1.36 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.443 -1.303 . . . . 0.0 112.234 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -115.73 163.08 16.35 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.14 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.49 HH21 ' CG2' ' A' ' 49' ' ' THR . 21.2 ttm180 -146.56 106.16 3.95 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.39 -1.324 . . . . 0.0 111.038 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.818 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.9 mp -99.9 122.02 51.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.329 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 p -119.59 139.08 52.73 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.699 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.543 ' CE2' HG11 ' A' ' 45' ' ' VAL . 6.4 p90 -136.51 155.35 50.09 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.14 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.401 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -177.57 143.36 6.11 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.464 ' CD ' ' N ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -71.54 176.62 4.6 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.636 -0.825 . . . . 0.0 110.808 179.931 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.487 1.386 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.017 179.952 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.543 HG11 ' CE2' ' A' ' 36' ' ' TYR . 96.2 t . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.694 0.283 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -172.11 -163.49 0.25 Allowed 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 118.476 -1.289 . . . . 0.0 111.966 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.71 168.77 21.07 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.771 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -159.84 139.27 11.17 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.548 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.49 ' CG2' HH21 ' A' ' 33' ' ' ARG . 23.3 p -105.07 164.74 11.58 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.644 -0.822 . . . . 0.0 112.393 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.557 ' C ' ' H ' ' A' ' 52' ' ' GLY . 26.9 m -148.06 152.58 40.25 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.42 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -55.63 6.52 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 120.942 1.095 . . . . 0.0 112.612 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 80.86 -4.05 72.24 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.978 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.67 -27.19 45.16 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.079 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -80.45 108.74 14.33 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.01 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -81.31 -19.64 42.49 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.394 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.8 p -135.17 150.08 50.07 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.8 168.36 26.58 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.997 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.421 HG23 HD12 ' A' ' 19' ' ' LEU . 97.3 m -117.11 158.31 24.43 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.398 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 59' ' ' ILE . 5.6 mt -143.03 155.06 17.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.396 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.483 ' HG ' ' HG ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -139.52 135.64 33.67 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.875 -179.999 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.4 44.37 0.18 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.53 ' CD2' HD13 ' A' ' 18' ' ' LEU . 7.5 mp -107.16 175.66 5.42 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.573 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.58 141.39 28.82 Favored Pre-proline 0 CA--C 1.555 1.137 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.02 100.29 0.08 OUTLIER 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 120.748 0.965 . . . . 0.0 112.505 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.43 95.22 0.05 OUTLIER Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.59 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 p -160.59 159.04 2.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 119.136 -1.025 . . . . 0.0 111.328 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.3 146.41 45.34 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.264 -0.974 . . . . 0.0 108.874 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.9 145.2 31.47 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.458 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 m -125.29 126.06 44.51 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.407 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.3 tt -111.46 150.15 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.164 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.13 124.9 19.63 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.815 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.01 130.27 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.594 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.09 105.35 13.1 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.625 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.37 129.69 39.41 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.353 -0.939 . . . . 0.0 109.246 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 t -135.57 130.62 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 119.115 -1.034 . . . . 0.0 112.25 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 53.6 m . . . . . 0 N--CA 1.482 1.14 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.583 179.911 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 C--O 1.217 -0.568 0 N-CA-C 111.392 -0.272 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 88' ' ' ILE . 16.1 tt -149.76 128.55 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 118.934 -1.106 . . . . 0.0 109.753 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 99.6 p -121.04 152.04 39.08 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.769 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.77 142.57 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.339 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.92 154.65 18.07 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.598 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -164.48 131.69 3.18 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.121 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -89.69 117.26 28.42 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.172 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 116.299 -1.81 . . . . 0.0 110.597 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -161.75 171.3 18.08 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 117.942 -1.503 . . . . 0.0 112.813 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.41 129.85 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.08 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.487 HG23 ' OG ' ' A' ' 21' ' ' SER . 4.9 t -95.59 -25.13 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.244 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.76 172.63 9.02 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.93 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.31 100.24 2.13 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.088 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.53 ' CB ' ' HG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -70.52 162.26 71.67 Favored Pre-proline 0 C--N 1.307 -1.271 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.563 179.858 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -53.94 -7.52 0.67 Allowed 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 121.008 1.139 . . . . 0.0 111.712 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.434 ' H ' ' C ' ' A' ' 14' ' ' THR . 7.2 m -160.29 35.99 0.17 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.53 ' HG ' ' CB ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -167.55 120.31 0.92 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.207 179.89 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 tp -96.81 123.81 40.61 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.724 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.48 114.59 28.79 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.688 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.5 169.45 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.733 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.487 ' OG ' HG23 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -158.65 139.51 12.87 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.7 -179.91 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 12.7 p90 . . . . . 0 N--CA 1.481 1.122 0 C-N-CA 119.649 -0.821 . . . . 0.0 110.321 179.846 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.478 0.963 0 CA-C-O 120.888 0.375 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -66.33 -57.81 6.67 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.631 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -165.45 169.02 16.07 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.539 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -122.65 148.7 44.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.902 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -126.73 108.66 11.27 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.536 -0.865 . . . . 0.0 109.531 179.782 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.03 128.71 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.875 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 p -128.64 139.72 52.12 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.149 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.493 ' CE2' HG11 ' A' ' 45' ' ' VAL . 10.8 p90 -141.95 166.7 23.99 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.725 -179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.02 158.68 10.25 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -51.79 158.74 0.93 Allowed 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.603 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.8 m . . . . . 0 C--N 1.304 -1.395 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.052 -179.912 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.493 HG11 ' CE2' ' A' ' 36' ' ' TYR . 2.3 t . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.309 0.576 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.432 ' N ' HG12 ' A' ' 45' ' ' VAL . 2.9 tt0 -172.78 179.8 2.28 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.339 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -164.49 158.45 18.3 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.844 -179.968 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -159.25 157.55 30.86 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.606 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -119.73 168.41 11.09 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.112 -179.868 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -147.66 158.89 42.4 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.681 179.971 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.463 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.9 Cg_endo -61.7 15.42 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.0 1.133 . . . . 0.0 112.72 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 54.19 7.98 0.98 Allowed Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.111 -1.518 . . . . 0.0 110.533 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -70.07 -34.74 73.57 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.291 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -119.33 121.68 40.12 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.837 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 m -79.66 46.63 0.78 Allowed 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.979 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.12 151.34 43.85 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.378 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.13 159.21 40.02 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.735 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.07 148.95 52.19 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.699 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.2 mt -138.21 146.89 26.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.587 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.7 m -139.43 155.42 47.62 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.231 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.46 8.71 55.99 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.928 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.23 -156.05 0.16 Allowed 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.855 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.67 103.62 0.94 Allowed Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 119.649 -0.821 . . . . 0.0 110.617 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.94 158.71 32.51 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 120.375 0.717 . . . . 0.0 111.639 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.63 35.91 5.0 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.186 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -165.22 154.68 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.943 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.468 ' OD1' ' ND2' ' A' ' 91' ' ' ASN . 11.8 t0 -72.3 113.76 9.67 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.412 179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.0 148.23 30.0 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.879 -0.729 . . . . 0.0 111.247 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.2 m -122.93 140.21 53.24 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.708 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 tt -130.84 148.63 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.394 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 65.4 m -140.5 126.03 19.01 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.249 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' ' 72' ' ' VAL . 23.3 m -117.81 129.71 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.141 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -107.59 106.86 17.41 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.617 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.52 107.85 14.62 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.182 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.39 113.7 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.526 -0.87 . . . . 0.0 111.23 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.49 1.529 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.578 179.983 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.457 -0.673 0 N-CA-C 110.429 -0.643 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.1 tp -150.12 161.31 4.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 118.493 -1.283 . . . . 0.0 111.224 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.8 p -143.73 148.95 36.42 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.595 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.87 146.23 18.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.468 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -89.21 160.07 17.14 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.417 179.972 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -171.95 140.45 1.24 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.994 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -87.24 112.52 22.1 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.394 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.04 0 CA-C-O 116.337 -1.792 . . . . 0.0 110.827 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 10' ' ' VAL . 1.8 tm-20 -167.63 166.72 13.84 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 117.844 -1.542 . . . . 0.0 112.897 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.471 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 97.6 t -99.62 108.55 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.618 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.3 t -70.49 -42.88 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 119.141 -1.023 . . . . 0.0 111.918 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.27 173.48 16.62 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.757 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.59 142.45 21.11 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.697 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 17' ' ' SER . 1.1 p -140.63 155.58 69.48 Favored Pre-proline 0 N--CA 1.489 1.524 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.769 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.83 -7.92 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 121.389 1.393 . . . . 0.0 112.279 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.9 p -147.09 27.54 1.05 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.739 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.423 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -177.53 147.84 0.54 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.728 -179.992 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.35 134.36 47.11 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.443 179.857 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.0 tp -115.65 103.1 10.37 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.508 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.426 ' H ' HG23 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -99.35 165.61 2.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.257 179.852 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 m -156.06 136.53 13.18 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.258 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 16.0 p90 . . . . . 0 N--CA 1.487 1.391 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.796 179.915 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.734 0.302 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -85.05 -55.4 4.07 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.486 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -157.95 163.99 37.29 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.629 -1.229 . . . . 0.0 111.924 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -119.46 160.46 22.31 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.739 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.38 98.03 3.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.808 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.712 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.7 mp -89.58 134.01 30.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.627 -0.829 . . . . 0.0 112.247 -179.781 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -135.79 134.5 39.01 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.771 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -141.92 155.56 45.49 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.547 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . 171.1 152.28 8.13 Favored Glycine 0 N--CA 1.479 1.558 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.697 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -48.81 175.02 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.342 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.9 m . . . . . 0 C--N 1.306 -1.325 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.906 -179.999 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.549 HG23 ' HA2' ' A' ' 37' ' ' GLY . 86.1 t . . . . . 0 N--CA 1.477 0.911 0 CA-C-O 121.231 0.539 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.99 -169.91 0.7 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.874 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -158.1 166.97 31.14 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.95 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 13.6 p90 -162.5 153.3 17.24 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.424 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.87 160.45 16.76 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.187 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.579 ' C ' ' H ' ' A' ' 52' ' ' GLY . 22.8 m -148.66 153.08 39.06 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.265 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.3 Cg_endo -60.01 16.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 120.872 1.048 . . . . 0.0 112.758 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 53.33 6.87 0.47 Allowed Glycine 0 N--CA 1.498 2.784 0 C-N-CA 119.578 -1.296 . . . . 0.0 111.093 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -74.98 -44.41 48.39 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.503 -179.977 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.55 116.25 31.25 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.467 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.7 m -84.6 53.74 2.78 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.042 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.1 143.68 22.66 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.97 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.96 148.24 30.55 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.804 -1.159 . . . . 0.0 111.842 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.1 m -121.91 104.13 9.33 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.926 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.2 pt -109.12 136.36 45.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.209 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.8 m -118.24 -176.68 3.11 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.721 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.83 40.05 9.86 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.514 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.73 -158.35 0.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.971 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -148.58 134.93 10.02 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.209 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -56.74 107.25 0.26 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 120.489 0.793 . . . . 0.0 112.072 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.57 87.71 0.52 Allowed Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.565 -1.302 . . . . 0.0 111.286 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.6 p -161.28 135.27 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.037 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.6 120.93 8.58 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.92 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.5 118.56 26.89 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.972 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.6 m -103.73 114.74 29.22 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.08 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.9 tt -103.64 150.56 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 119.287 -0.965 . . . . 0.0 112.06 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.542 HG23 ' OG ' ' A' ' 89' ' ' SER . 85.5 m -139.75 116.51 10.87 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.002 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.6 m -103.22 144.17 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.768 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -112.2 128.97 56.39 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.319 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.97 86.76 2.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.728 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.01 129.81 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 119.164 -1.015 . . . . 0.0 113.113 -179.629 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.307 -1.266 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.859 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 C--O 1.214 -0.697 0 N-CA-C 111.413 -0.264 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 tt -149.49 147.38 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.601 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.542 ' OG ' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -135.17 155.23 51.04 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.681 -179.858 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.76 142.97 24.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.014 179.875 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.44 142.77 31.65 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.061 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -158.99 108.99 1.97 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.185 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.409 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 5.5 ptt-85 -79.04 116.81 19.57 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.887 -1.125 . . . . 0.0 109.114 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 116.367 -1.778 . . . . 0.0 110.972 -179.749 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -167.03 167.44 14.6 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.591 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.67 145.71 7.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.986 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.612 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -117.75 0.13 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.603 -179.853 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 171.97 161.19 0.1 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.7 -1.2 . . . . 0.0 111.904 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.74 126.75 5.14 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.831 179.906 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.57 161.68 61.62 Favored Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.011 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 16' ' ' THR . 5.1 Cg_exo -49.79 104.79 0.08 OUTLIER 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 121.042 1.161 . . . . 0.0 112.051 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.463 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER 75.46 33.34 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.555 179.886 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 p -159.99 126.45 4.33 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.25 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.8 tp -130.42 140.07 50.58 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.77 -0.772 . . . . 0.0 111.347 -179.869 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.61 126.09 45.99 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.985 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 pt -133.66 162.15 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.286 -0.966 . . . . 0.0 112.932 -179.817 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -134.58 140.22 45.94 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.55 -1.205 . . . . 0.0 108.256 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 29.1 p90 . . . . . 0 N--CA 1.506 2.34 0 C-N-CA 118.712 -1.195 . . . . 0.0 113.506 -179.843 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.863 0.364 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -80.16 -41.65 24.92 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.141 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -143.09 175.06 10.14 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.79 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.12 140.5 30.88 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.746 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -123.28 107.95 12.24 Favored 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 119.118 -1.033 . . . . 0.0 109.98 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.7 mt -100.98 111.34 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.099 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.402 HG22 ' OE2' ' A' ' 47' ' ' GLU . 9.0 p -117.35 137.46 52.43 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.593 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CE2' HG11 ' A' ' 45' ' ' VAL . 42.6 p90 -141.4 138.21 32.81 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.029 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.12 136.78 4.25 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -82.75 169.51 16.08 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.742 -179.966 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.436 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 54.9 m . . . . . 0 N--CA 1.487 1.418 0 C-N-CA 119.786 -0.766 . . . . 0.0 111.756 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.656 HG12 ' N ' ' A' ' 46' ' ' GLN . 4.2 t . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.656 ' N ' HG12 ' A' ' 45' ' ' VAL . 1.1 mt-30 -163.3 171.93 15.42 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.509 -1.676 . . . . 0.0 112.556 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.402 ' OE2' HG22 ' A' ' 35' ' ' THR . 2.3 tt0 -170.6 143.28 2.17 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.127 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 4.6 p90 -147.34 141.55 26.17 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 p -98.98 156.94 16.66 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.769 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.506 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -150.07 157.88 37.19 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.321 179.942 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.41 13.61 0.09 OUTLIER 'Trans proline' 0 C--O 1.212 -0.785 0 C-N-CA 121.319 1.346 . . . . 0.0 112.234 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 57.66 27.81 59.27 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 118.886 -1.626 . . . . 0.0 109.901 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.21 -31.3 19.16 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -95.91 135.24 37.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.982 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.8 m -79.71 -15.61 57.2 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.109 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 p -139.08 -179.61 5.95 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.134 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.04 157.83 6.74 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.346 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.6 m -114.32 136.74 52.65 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.624 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.65 155.22 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.487 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.1 t -147.74 127.05 13.05 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.937 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.34 -34.15 0.38 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.672 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.48 -158.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.798 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 8.3 tttt -176.11 -43.43 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 119.334 -0.947 . . . . 0.0 112.586 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.607 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 4.4 Cg_endo -78.86 -175.52 2.79 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 121.497 1.465 . . . . 0.0 112.096 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.2 80.07 0.29 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.847 HG22 ' H ' ' A' ' 67' ' ' ASP . 13.8 p -122.81 -174.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.241 -179.79 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.847 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -65.49 95.13 0.2 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.084 179.92 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -90.88 127.95 36.56 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.109 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 m -94.05 117.92 30.78 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.94 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.467 HD12 ' H ' ' A' ' 71' ' ' THR . 2.6 tp -104.89 141.92 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.534 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.467 ' H ' HD12 ' A' ' 70' ' ' ILE . 97.3 m -141.48 130.05 22.68 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.373 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.12 128.06 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.947 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -98.33 146.74 25.38 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.699 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.35 85.33 2.37 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.981 0.8 . . . . 0.0 109.485 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 t -81.4 128.25 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.319 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.489 1.494 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.635 -179.979 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 C--O 1.215 -0.637 0 N-CA-C 113.161 0.408 . . . . 0.0 113.161 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.1 tt -133.07 145.28 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.456 179.761 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.4 p -144.46 153.53 41.98 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.301 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.53 141.83 19.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.376 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.34 154.54 41.51 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.122 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -152.25 122.26 7.08 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.405 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.54 75.93 1.07 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.648 179.858 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.453 ' O ' ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 116.212 -1.851 . . . . 0.0 110.417 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.95 168.05 27.68 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 117.693 -1.603 . . . . 0.0 113.69 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.9 t -103.34 115.75 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.559 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.483 ' CG2' ' OG ' ' A' ' 21' ' ' SER . 2.3 t -72.52 -74.11 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.007 -1.077 . . . . 0.0 111.726 -179.823 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.81 179.0 6.84 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.73 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.14 100.73 3.6 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.314 -0.955 . . . . 0.0 111.499 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.16 164.44 23.08 Favored Pre-proline 0 C--N 1.305 -1.327 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.797 179.848 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.532 ' O ' HG23 ' A' ' 16' ' ' THR . 5.0 Cg_exo -54.27 -12.52 3.97 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.213 1.275 . . . . 0.0 111.714 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 15' ' ' PRO . 2.2 p -158.85 33.35 0.22 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.607 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.45 137.96 8.33 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.124 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.6 tp -114.27 126.97 55.63 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.55 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 19' ' ' LEU . 2.8 tt -100.07 98.75 9.45 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.584 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 pp -96.61 148.8 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.394 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.483 ' OG ' ' CG2' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -145.82 134.43 22.16 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.352 -179.938 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 5.8 p90 . . . . . 0 C--N 1.308 -1.238 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.707 179.828 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.797 HG13 HG22 ' A' ' 76' ' ' THR . 3.1 t . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.83 0.348 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.434 ' CG ' ' CE2' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -54.34 -55.67 26.17 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.149 179.955 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.434 ' CE2' ' CG ' ' A' ' 30' ' ' ARG . 2.1 p90 178.42 171.43 0.75 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.493 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -128.07 161.57 28.91 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.175 -179.923 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.74 104.68 4.76 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.373 179.763 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.37 120.21 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.796 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -120.35 137.09 54.47 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.663 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.69 ' CZ ' HG11 ' A' ' 45' ' ' VAL . 11.2 p90 -142.2 157.75 44.51 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.585 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.91 170.58 42.92 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -61.4 -162.48 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.487 1.375 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.199 -179.91 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.69 HG11 ' CZ ' ' A' ' 36' ' ' TYR . 86.0 t . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 120.742 0.306 . . . . 0.0 111.502 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.465 ' N ' HG12 ' A' ' 45' ' ' VAL . 9.3 tt0 -175.17 -143.88 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.94 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -165.39 168.3 16.88 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 119.261 -0.975 . . . . 0.0 111.394 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 8.7 p90 -153.61 136.48 15.39 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.146 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.9 p -100.1 159.79 14.83 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.702 -179.824 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.545 ' C ' ' H ' ' A' ' 52' ' ' GLY . 34.1 m -147.9 150.53 36.08 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.666 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.95 5.75 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.725 0 C-N-CA 120.849 1.033 . . . . 0.0 112.383 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 81.72 7.49 88.01 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.324 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.44 -35.77 27.22 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.761 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -72.66 106.44 4.67 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.842 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.6 m -79.83 -18.32 51.12 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.859 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.2 p -132.67 158.82 41.35 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.273 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.11 149.25 19.24 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.549 -1.26 . . . . 0.0 111.569 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.8 m -121.87 117.89 27.61 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.054 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 pt -108.27 149.47 11.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.406 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.9 175.76 8.1 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.522 -179.901 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.507 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 83.84 49.6 4.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.884 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.507 HD23 ' C ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -117.46 -168.58 1.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.614 0.721 . . . . 0.0 111.536 -179.881 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -148.98 82.82 6.97 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.011 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -54.46 140.54 74.29 Favored 'Trans proline' 0 C--O 1.216 -0.578 0 C-N-CA 120.846 1.03 . . . . 0.0 111.815 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.8 31.4 2.73 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 67' ' ' ASP . 2.4 p -162.17 169.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 119.361 -0.935 . . . . 0.0 111.255 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.465 ' H ' HG22 ' A' ' 66' ' ' VAL . 6.4 t0 -82.45 126.48 32.26 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.999 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.2 133.36 56.09 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 120.144 -0.623 . . . . 0.0 110.7 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -103.46 138.4 40.23 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.444 ' CG1' ' N ' ' A' ' 71' ' ' THR . 6.1 tt -132.04 157.03 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.457 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.444 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 26.9 m -151.43 123.03 7.93 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.551 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.7 m -115.18 135.09 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -112.77 121.38 44.55 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.984 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.63 105.2 16.1 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.658 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.414 HG21 ' HE1' ' A' ' 31' ' ' TYR . 10.6 t -105.32 99.33 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.271 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.797 HG22 HG13 ' A' ' 29' ' ' VAL . 34.6 p . . . . . 0 N--CA 1.49 1.563 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.23 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo . . . . . 0 C--O 1.215 -0.661 0 CA-C-O 120.769 0.237 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 88' ' ' ILE . 13.2 tt -151.39 146.72 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.195 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.0 p -141.5 146.35 36.3 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.204 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pt -146.53 151.8 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.311 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.53 160.27 15.12 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.629 -0.829 . . . . 0.0 109.429 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -161.35 141.05 10.46 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.374 -1.33 . . . . 0.0 112.157 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -96.01 99.72 11.46 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.311 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 116.329 -1.796 . . . . 0.0 110.706 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 CA-C-O 120.759 0.314 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -173.44 168.29 4.57 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.881 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.1 t -96.05 117.29 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.711 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 12' ' ' ALA . 39.8 t -71.49 -79.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 118.792 -1.163 . . . . 0.0 110.786 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.537 ' N ' HG12 ' A' ' 11' ' ' VAL . . . -139.58 179.35 6.62 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.476 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.96 170.54 15.96 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.195 -1.002 . . . . 0.0 111.502 -179.873 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 17' ' ' SER . 52.9 p -142.58 153.04 61.42 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.693 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -50.95 -5.33 0.08 OUTLIER 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 120.599 0.866 . . . . 0.0 111.98 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.504 ' H ' ' C ' ' A' ' 14' ' ' THR . 10.0 t -154.74 28.43 0.43 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.61 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.518 ' N ' ' OG1' ' A' ' 14' ' ' THR . 0.4 OUTLIER -173.93 135.88 0.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.665 -1.214 . . . . 0.0 111.985 179.905 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 31.9 tp -112.71 146.52 38.58 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.046 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 tp -121.23 104.45 9.75 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.999 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pt -97.81 150.56 4.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.929 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 m -145.53 138.12 25.87 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 118.989 -1.085 . . . . 0.0 111.255 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 10.7 p90 . . . . . 0 C--N 1.31 -1.112 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.585 179.904 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 121.01 0.433 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -53.64 -52.34 60.23 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.729 -1.188 . . . . 0.0 108.754 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -171.78 162.89 6.32 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.294 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -109.35 171.69 7.29 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.515 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.474 ' C ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -137.57 108.84 6.84 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.198 179.962 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.791 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.8 mp -98.93 113.29 33.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.749 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.514 HG22 ' HB2' ' A' ' 47' ' ' GLU . 17.6 p -117.51 135.82 53.66 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.282 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.449 ' CE2' HG11 ' A' ' 45' ' ' VAL . 5.6 p90 -141.17 157.61 45.02 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.138 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . -171.82 148.41 10.9 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 39' ' ' THR . 6.3 pt-20 -56.17 -163.5 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.964 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 38' ' ' GLU . 3.4 t . . . . . 0 C--N 1.303 -1.437 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.321 -179.866 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.449 HG11 ' CE2' ' A' ' 36' ' ' TYR . 4.1 t . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 121.252 0.548 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -171.05 -166.91 0.5 Allowed 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.402 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.514 ' HB2' HG22 ' A' ' 35' ' ' THR . 5.8 pt-20 -169.49 159.47 8.52 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.734 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -160.22 143.38 13.67 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.166 -1.013 . . . . 0.0 110.512 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.429 HG22 ' HG3' ' A' ' 33' ' ' ARG . 4.1 p -106.73 162.28 13.92 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.584 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.523 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -142.02 159.22 59.85 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.868 179.952 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.5 Cg_endo -63.9 14.85 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 120.99 1.126 . . . . 0.0 112.345 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 57.54 2.05 0.65 Allowed Glycine 0 N--CA 1.496 2.688 0 C-N-CA 119.432 -1.366 . . . . 0.0 111.112 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -74.3 -44.02 54.38 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.66 179.94 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -93.03 116.33 28.95 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.304 -0.959 . . . . 0.0 110.693 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.59 21.15 0.67 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.771 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.7 p -138.67 130.64 28.1 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.947 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.2 165.48 25.65 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.576 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 t -136.62 144.03 43.85 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.598 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.76 160.06 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.131 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.33 140.47 24.09 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.25 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.86 -15.84 5.37 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.744 ' C ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -83.56 167.0 17.76 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.324 179.992 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.425 ' N ' HD22 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -134.6 128.43 19.03 Favored Pre-proline 0 CA--C 1.556 1.193 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.202 179.803 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.22 112.64 1.18 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.408 0.739 . . . . 0.0 111.8 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.22 22.4 0.26 Allowed Glycine 0 N--CA 1.498 2.788 0 C-N-CA 119.202 -1.475 . . . . 0.0 111.608 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 67' ' ' ASP . 6.9 p -151.74 158.69 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 118.689 -1.205 . . . . 0.0 112.037 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.509 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -73.29 147.02 44.92 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.791 179.995 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -147.66 127.0 13.07 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.649 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.5 m -111.18 132.06 54.61 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.227 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.52 154.33 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.067 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 89' ' ' SER . 0.1 OUTLIER -134.91 131.82 37.74 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.42 179.991 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.14 142.35 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.439 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -126.18 133.07 51.66 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.176 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.15 108.68 20.25 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.598 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 t -109.09 113.55 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.449 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.486 1.343 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.253 179.936 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo . . . . . 0 C--O 1.214 -0.69 0 N-CA-C 111.246 -0.329 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.421 ' CG1' ' N ' ' A' ' 89' ' ' SER . 6.6 tt -152.64 166.3 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.86 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.493 ' HB3' HG22 ' A' ' 71' ' ' THR . 88.6 p -148.97 157.72 43.63 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.864 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.01 137.85 15.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.169 -1.013 . . . . 0.0 110.819 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.83 139.8 32.34 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.5 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -162.02 148.06 13.4 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.029 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -88.61 119.81 29.42 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.536 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 116.206 -1.854 . . . . 0.0 110.377 -179.971 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 120.628 0.251 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -164.85 159.85 18.83 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 118.738 -1.185 . . . . 0.0 111.772 179.922 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.56 134.83 30.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.922 179.933 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.49 -67.88 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 118.725 -1.19 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.93 172.24 13.32 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.457 179.986 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.41 175.46 9.76 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.815 -179.959 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.2 OUTLIER -140.63 158.43 65.77 Favored Pre-proline 0 C--N 1.307 -1.278 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.077 179.95 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.97 0.33 0.33 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.006 1.137 . . . . 0.0 111.666 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -155.83 26.17 0.38 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.149 -1.021 . . . . 0.0 111.375 -179.95 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.64 157.3 4.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.343 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.5 tp -129.19 147.06 51.0 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.174 -179.953 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -128.67 122.39 30.7 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.03 -179.961 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 20' ' ' ILE . 2.1 pt -123.58 169.85 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.861 179.944 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.47 139.32 11.68 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.449 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 13.8 p90 . . . . . 0 N--CA 1.483 1.182 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.985 179.978 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 66.8 t . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -54.45 -66.46 0.4 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.086 -179.9 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.79 160.62 39.41 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.966 -1.093 . . . . 0.0 111.076 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.49 156.15 17.98 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.916 -179.989 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -137.13 111.69 8.67 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.4 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -101.75 148.03 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.209 -179.951 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.4 p -138.57 133.75 32.93 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.809 179.904 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -130.12 121.73 26.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.283 179.93 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.467 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -151.82 137.33 5.91 Favored Glycine 0 N--CA 1.487 2.058 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.572 -179.851 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -52.65 175.81 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 84.1 m . . . . . 0 N--CA 1.49 1.546 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.297 -179.923 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.467 HG23 ' HA2' ' A' ' 37' ' ' GLY . 5.1 t . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.796 0.332 . . . . 0.0 111.297 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -173.54 -176.89 1.36 Allowed 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.7 -179.992 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.505 ' N ' ' CD ' ' A' ' 47' ' ' GLU . 1.1 mp0 -135.02 174.91 10.08 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.759 -179.998 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -175.28 132.67 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.493 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.54 148.92 24.64 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.687 -0.805 . . . . 0.0 112.045 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 m -142.32 151.62 58.64 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.431 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 53' ' ' SER . 3.9 Cg_exo -55.25 120.86 8.9 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 120.308 0.672 . . . . 0.0 110.805 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -46.87 -11.39 0.05 OUTLIER Glycine 0 N--CA 1.486 2.03 0 C-N-CA 119.305 -1.426 . . . . 0.0 110.725 179.875 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -65.32 -33.16 75.32 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.48 -179.894 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.2 mtpp -77.38 135.69 38.36 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.593 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.65 -1.74 25.96 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.4 p -132.69 162.64 30.87 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.773 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.466 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -159.04 161.11 36.52 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.016 -1.073 . . . . 0.0 111.583 179.972 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.2 m -137.63 123.09 19.59 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.32 156.52 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.594 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 16' ' ' THR . 0.2 OUTLIER -142.48 176.82 8.72 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.504 -179.93 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.64 58.0 4.33 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.657 -1.258 . . . . 0.0 110.202 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.511 HD12 ' H ' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -130.65 -127.83 0.2 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.068 -179.926 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.511 ' H ' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -172.44 99.63 0.36 Allowed Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.979 -179.915 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.97 149.36 90.6 Favored 'Trans proline' 0 C--O 1.213 -0.729 0 C-N-CA 120.903 1.069 . . . . 0.0 112.237 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.82 55.17 2.73 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.926 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.4 p -168.94 150.81 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -62.52 152.04 35.82 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.503 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.09 138.85 24.28 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.982 -179.929 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.84 108.0 16.81 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.712 179.843 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -95.44 157.97 3.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.111 -179.898 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -158.98 141.57 14.17 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.432 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.15 138.87 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.83 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -119.63 104.55 10.37 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.947 -179.903 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.83 116.67 21.61 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.721 179.828 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.3 t -109.94 109.33 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.94 -179.917 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 p . . . . . 0 C--N 1.309 -1.183 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.973 179.878 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 C--O 1.214 -0.699 0 CA-C-O 120.779 0.241 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 88' ' ' ILE . 7.9 tt -159.57 156.83 3.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 118.715 -1.194 . . . . 0.0 111.091 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.1 p -134.69 144.02 47.55 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.579 179.987 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -139.0 156.7 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.782 179.945 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.77 146.41 25.94 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.714 -179.968 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -153.62 144.48 22.71 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.239 -0.985 . . . . 0.0 110.737 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.05 118.79 37.59 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.134 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 116.313 -1.804 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -162.95 173.33 13.79 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 117.789 -1.564 . . . . 0.0 112.999 -179.832 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.524 HG13 HD21 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -87.27 142.25 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.875 179.9 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 11' ' ' VAL . 1.8 p -130.95 -8.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.695 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 19' ' ' LEU . . . -170.14 161.3 8.43 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.638 -179.977 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.21 149.13 26.69 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.193 -179.94 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.434 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -136.41 161.47 61.94 Favored Pre-proline 0 N--CA 1.491 1.583 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.762 179.89 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.434 ' O ' ' OG1' ' A' ' 16' ' ' THR . 2.9 Cg_exo -50.55 -11.33 0.36 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.221 1.281 . . . . 0.0 111.795 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 16' ' ' THR . 96.6 m -164.39 49.22 0.12 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.432 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.63 143.62 0.16 Allowed 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.322 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.524 HD21 HG13 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -131.02 140.39 50.09 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.912 -179.938 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 8.6 tp -113.05 113.29 25.23 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.285 179.783 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.8 167.05 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.553 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.34 134.57 16.01 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.447 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.451 ' CE3' ' O ' ' A' ' 55' ' ' SER . 5.8 p90 . . . . . 0 N--CA 1.49 1.555 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.413 179.926 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.834 HG13 HG22 ' A' ' 76' ' ' THR . 1.6 t . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.484 0.183 . . . . 0.0 110.64 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -54.56 -52.62 61.51 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.65 -1.22 . . . . 0.0 109.473 179.88 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 175.1 171.27 0.28 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.691 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -118.38 161.87 19.25 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.475 179.882 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -138.48 104.66 5.21 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.799 179.858 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.547 HD13 ' CE1' ' A' ' 48' ' ' PHE . 4.7 mp -96.78 105.09 16.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.94 -179.972 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.6 p -103.55 143.32 32.9 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.347 179.876 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.469 ' CE2' HG11 ' A' ' 45' ' ' VAL . 8.2 p90 -145.92 166.96 24.45 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 118.464 -1.295 . . . . 0.0 111.38 -179.993 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . 160.0 162.86 12.7 Favored Glycine 0 N--CA 1.482 1.719 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 37' ' ' GLY . 2.5 mt-10 -49.13 177.98 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.716 179.995 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.3 m . . . . . 0 C--N 1.303 -1.441 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.745 -179.984 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 46' ' ' GLN . 24.1 t . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.852 0.358 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.567 ' N ' HG12 ' A' ' 45' ' ' VAL . 1.2 tt0 -175.68 -169.07 0.33 Allowed 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.329 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.41 171.55 19.15 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.987 179.976 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.547 ' CE1' HD13 ' A' ' 34' ' ' ILE . 23.9 p90 -159.73 130.85 5.91 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.867 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -95.67 163.21 13.29 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 119.391 -0.924 . . . . 0.0 112.493 -179.87 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.575 ' C ' ' H ' ' A' ' 52' ' ' GLY . 11.8 p -150.74 140.38 13.79 Favored Pre-proline 0 CA--C 1.561 1.374 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.017 -179.939 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.56 16.02 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 121.0 1.134 . . . . 0.0 113.673 -179.97 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 64.94 4.44 14.73 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.359 -1.4 . . . . 0.0 111.288 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.79 -27.32 64.81 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.042 -179.919 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.13 140.07 35.94 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.229 -179.946 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.451 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 4.6 m -96.94 -26.42 15.05 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.405 179.919 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.3 p -124.01 159.22 30.32 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.538 179.922 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.6 162.54 24.39 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.19 -1.404 . . . . 0.0 112.275 -179.92 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.6 m -107.99 134.01 51.51 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.449 179.95 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 tt -126.27 137.2 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.177 179.989 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.9 t -138.01 111.31 7.96 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.309 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.56 33.15 0.02 OUTLIER Glycine 0 N--CA 1.486 1.979 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.211 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.51 -155.67 0.71 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.63 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -147.84 162.08 32.71 Favored Pre-proline 0 C--N 1.311 -1.104 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.692 -179.903 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -74.69 159.64 42.12 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 121.586 1.524 . . . . 0.0 112.97 179.906 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 34.65 69.93 0.18 Allowed Glycine 0 N--CA 1.499 2.841 0 CA-C-N 114.957 -1.02 . . . . 0.0 113.316 179.793 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 p -159.14 143.52 6.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.745 179.688 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.82 130.54 46.23 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.073 -179.95 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -141.63 138.4 32.53 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.705 179.944 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.3 m -120.9 134.71 55.3 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.864 -0.735 . . . . 0.0 110.479 -179.953 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.97 154.87 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.138 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.458 ' OG1' ' CB ' ' A' ' 89' ' ' SER . 2.5 m -147.98 159.14 44.2 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.954 -179.957 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 72' ' ' VAL . 32.9 m -139.81 129.07 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.072 -179.955 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.89 117.95 35.52 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.147 179.79 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.5 113.61 25.93 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.489 -0.885 . . . . 0.0 110.94 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.08 109.89 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.799 -179.943 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.834 HG22 HG13 ' A' ' 29' ' ' VAL . 15.8 p . . . . . 0 N--CA 1.484 1.232 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.022 -179.951 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 C--O 1.214 -0.704 0 N-CA-C 109.342 -1.061 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.3 tt -151.67 131.24 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 118.034 -1.466 . . . . 0.0 111.804 -179.972 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.458 ' CB ' ' OG1' ' A' ' 71' ' ' THR . 59.2 p -118.7 147.13 44.14 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.69 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -143.1 139.77 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.231 179.959 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.3 154.3 17.91 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.423 179.944 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -169.56 139.25 2.03 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.157 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.432 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 11.0 ptt-85 -88.15 115.15 25.43 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.387 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.421 HG21 HD11 ' A' ' 18' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.647 -179.919 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 119.304 -0.379 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -177.25 -164.15 0.09 Allowed 'General case' 0 N--CA 1.515 2.825 0 C-N-CA 117.894 -1.522 . . . . 0.0 113.239 -179.694 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.426 ' H ' HG23 ' A' ' 10' ' ' VAL . 2.8 t -70.4 151.67 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.339 179.917 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 11' ' ' VAL . 39.1 t -130.79 -8.03 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.114 179.914 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.64 157.49 3.86 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.805 179.934 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.85 157.09 44.94 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.484 -0.887 . . . . 0.0 111.089 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.36 162.04 51.79 Favored Pre-proline 0 N--CA 1.485 1.306 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.436 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.71 -23.61 33.86 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 121.074 1.183 . . . . 0.0 111.663 -179.977 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.1 p -143.1 39.93 1.47 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.325 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.98 149.84 0.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.895 179.967 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 tp -130.43 117.24 19.38 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.758 179.94 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 tt -90.94 103.74 16.42 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.577 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 pt -97.69 158.52 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.65 179.966 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.0 127.76 15.3 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.507 -179.919 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.4 p90 . . . . . 0 C--O 1.214 -0.791 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.618 179.861 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.821 0.344 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -59.5 4.81 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.608 179.874 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.7 168.55 4.36 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.074 -1.05 . . . . 0.0 112.027 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.82 139.58 50.89 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.85 179.856 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.71 109.58 20.78 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 119.346 -0.941 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -105.42 99.36 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.37 -179.886 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -103.59 141.35 36.18 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.914 179.92 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.532 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 4.2 p90 -143.78 163.36 33.55 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.009 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.84 149.61 5.81 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.41 144.89 24.0 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.567 -179.981 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--N 1.304 -1.395 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.131 -179.996 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 46' ' ' GLN . 55.2 t . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.814 0.34 . . . . 0.0 111.42 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.546 ' N ' HG12 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -171.57 -160.97 0.18 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.575 -179.899 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.502 ' N ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -164.05 158.48 19.48 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.088 -179.995 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -149.1 142.86 25.59 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.462 ' OG1' ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -92.34 166.4 12.6 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.435 -179.929 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.641 ' CG1' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -148.55 148.58 28.79 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.913 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.27 -4.17 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 121.522 1.481 . . . . 0.0 112.911 -179.821 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.641 ' H ' ' CG1' ' A' ' 50' ' ' VAL . . . 70.87 -0.87 26.69 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.646 -1.264 . . . . 0.0 111.42 179.955 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.2 -30.29 22.54 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.895 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.66 129.57 35.74 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.097 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.13 -16.04 34.52 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.582 179.976 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.1 p -134.36 152.92 52.09 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.073 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.14 163.92 39.56 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.771 -1.171 . . . . 0.0 111.611 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.3 m -117.84 112.5 20.47 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.432 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.67 137.81 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.021 -179.914 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.6 t -96.42 -156.56 0.53 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.388 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.3 83.96 0.07 OUTLIER Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.231 -1.461 . . . . 0.0 109.989 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.47 -175.43 2.94 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.3 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -172.29 85.15 0.44 Allowed Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.686 179.888 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -55.45 133.27 57.11 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 120.787 0.992 . . . . 0.0 111.923 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.43 41.61 3.89 Favored Glycine 0 N--CA 1.484 1.895 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.398 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 p -159.96 154.48 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 118.667 -1.213 . . . . 0.0 111.691 -179.977 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.53 105.88 17.62 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.446 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -89.11 118.23 28.67 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.399 -179.78 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.19 131.11 45.46 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.348 179.849 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 pp -130.15 154.54 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.184 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m -144.33 128.26 17.43 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.789 -179.998 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.9 m -110.69 137.19 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.099 -179.942 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -120.07 113.69 20.87 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.636 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.14 105.21 17.36 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.104 179.965 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.4 t -110.2 119.54 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.261 -179.924 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.488 1.427 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.894 179.952 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 C--O 1.214 -0.684 0 N-CA-C 110.702 -0.538 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 tt -151.68 160.35 3.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 118.332 -1.347 . . . . 0.0 111.476 -179.855 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.1 158.63 41.11 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.187 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.13 141.99 16.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.842 179.957 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.29 136.28 40.42 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.502 179.949 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -144.39 135.02 24.8 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.847 -179.981 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -83.45 107.42 15.93 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.168 179.887 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 116.306 -1.806 . . . . 0.0 110.351 -179.918 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.462 ' N ' HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 120.776 0.322 . . . . 0.0 110.369 . . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -155.83 153.09 29.22 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.88 -1.128 . . . . 0.0 112.054 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.8 t -87.81 129.02 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.576 179.876 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.423 HG23 ' OG ' ' A' ' 21' ' ' SER . 48.1 t -104.63 -56.09 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.839 -179.922 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.71 161.43 37.96 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.033 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.16 87.57 1.54 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.937 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.442 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -70.64 158.33 88.13 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.068 -179.983 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.55 -5.16 1.55 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 121.054 1.17 . . . . 0.0 111.217 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.442 ' H ' ' C ' ' A' ' 14' ' ' THR . 14.5 p -151.08 33.2 0.59 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.261 179.997 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.98 122.01 0.31 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.091 179.969 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -97.65 127.66 43.77 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.067 179.945 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 tp -110.0 125.4 52.86 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.538 -179.875 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 20' ' ' ILE . 4.2 pt -127.22 174.24 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.317 179.829 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.561 ' HB3' HG22 ' A' ' 56' ' ' THR . 1.0 OUTLIER -163.06 137.16 6.12 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.077 179.978 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 11.6 p90 . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.765 179.998 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.763 0.316 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.492 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -91.73 -79.13 0.38 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.987 179.884 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.492 ' CD1' ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -150.62 171.92 16.36 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.26 179.875 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -131.87 160.57 35.29 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.341 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.31 119.18 13.3 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 118.415 -1.314 . . . . 0.0 110.975 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.1 115.77 47.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.368 -179.876 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.2 p -111.4 138.07 48.37 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.564 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.689 ' CZ ' HG11 ' A' ' 45' ' ' VAL . 8.9 p90 -139.29 148.65 43.28 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.271 179.992 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.74 156.58 25.24 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.957 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -66.65 143.04 57.22 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.774 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 m . . . . . 0 C--N 1.305 -1.342 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.752 -179.95 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.689 HG11 ' CZ ' ' A' ' 36' ' ' TYR . 63.4 t . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.878 0.37 . . . . 0.0 111.803 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -173.26 -159.71 0.11 Allowed 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.986 -1.086 . . . . 0.0 111.036 -179.907 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -162.75 158.67 23.2 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.025 179.975 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 2.9 p90 -146.98 162.55 38.53 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.004 -179.933 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.2 p -114.99 154.82 28.08 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.351 179.968 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.524 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -136.87 157.99 73.78 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.971 -179.976 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.23 8.73 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 121.212 1.275 . . . . 0.0 112.261 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 56.27 13.63 7.44 Favored Glycine 0 N--CA 1.497 2.701 0 C-N-CA 119.484 -1.341 . . . . 0.0 111.127 -179.935 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.49 -57.34 2.91 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.433 179.984 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -64.41 123.39 19.07 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.436 -179.878 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.54 8.45 6.37 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.601 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.561 HG22 ' HB3' ' A' ' 21' ' ' SER . 0.8 OUTLIER -129.57 158.16 40.04 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.884 -179.947 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.1 169.09 25.59 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.496 179.965 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.4 t -142.9 162.03 36.56 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.237 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 mt -139.56 143.46 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.513 179.959 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.07 143.37 31.12 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.646 -179.979 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.07 50.61 1.23 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.964 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.911 HD23 ' H ' ' A' ' 62' ' ' LEU . 1.3 pt? -130.19 -171.71 2.6 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.419 -179.96 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -117.77 89.84 34.5 Favored Pre-proline 0 N--CA 1.488 1.455 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.502 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.39 146.19 95.63 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 120.892 1.062 . . . . 0.0 111.684 -179.875 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.47 43.94 5.39 Favored Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.559 -1.305 . . . . 0.0 109.958 -179.912 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -166.19 157.74 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.194 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -63.11 142.96 58.18 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.585 179.98 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.9 135.26 22.99 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.272 -0.971 . . . . 0.0 111.123 -179.953 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.33 132.59 53.57 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.173 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.1 157.96 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.251 -179.935 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.7 m -148.43 127.57 12.88 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.133 180.0 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.11 138.19 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.009 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -106.42 139.75 40.42 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.276 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -121.17 104.97 10.16 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.7 t -126.86 110.07 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.997 179.909 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 76.9 p . . . . . 0 N--CA 1.491 1.598 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.976 -179.979 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 C--O 1.216 -0.611 0 CA-C-O 121.335 0.473 . . . . 0.0 112.176 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 88' ' ' ILE . 14.1 tt -142.15 137.44 29.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.204 179.912 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 p -127.73 158.55 37.33 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.298 -0.961 . . . . 0.0 112.15 -179.827 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 90' ' ' ILE . 10.4 pt -153.44 148.22 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.883 -179.978 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.95 156.9 16.62 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.161 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -172.38 138.49 0.93 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.444 ' H ' ' NE ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -80.64 118.62 22.36 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.32 -179.943 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 116.292 -1.813 . . . . 0.0 110.64 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.669 HD22 ' HA ' ' A' ' 22' ' ' TRP . 7.2 mp . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 179.06 -171.69 0.14 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 117.894 -1.523 . . . . 0.0 112.506 -179.802 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.3 t -83.75 141.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.471 179.892 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.66 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 3.4 p -99.52 -14.37 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.112 -179.983 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 166.66 178.4 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.958 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.74 108.94 2.96 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -62.57 161.14 29.24 Favored Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.051 179.936 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.8 -3.2 1.37 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 121.031 1.154 . . . . 0.0 111.029 -179.944 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 14' ' ' THR . 15.7 p -153.19 37.24 0.48 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.247 -179.891 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.8 155.48 0.57 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.451 179.948 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.6 130.78 55.28 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.704 -179.913 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -114.32 107.29 15.38 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.269 -179.962 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.442 HG21 HD13 ' A' ' 20' ' ' ILE . 5.0 pt -97.94 168.65 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 119.091 -1.044 . . . . 0.0 110.336 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.56 130.85 9.54 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.187 179.978 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.669 ' HA ' HD22 ' A' ' 8' ' ' LEU . 6.0 p90 . . . . . 0 C--O 1.215 -0.745 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.974 179.855 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.486 HG13 HG22 ' A' ' 76' ' ' THR . 87.0 t . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.687 0.28 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -64.66 0.8 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.393 179.98 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.97 166.93 15.1 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.639 179.974 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.35 160.01 24.92 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -143.71 112.42 6.55 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.415 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.3 mp -102.77 124.67 56.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.298 -179.956 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.559 HG22 ' CB ' ' A' ' 47' ' ' GLU . 71.7 p -121.53 134.09 55.03 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.767 179.915 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.568 ' CE2' HG11 ' A' ' 45' ' ' VAL . 5.3 p90 -137.01 162.9 32.04 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.094 -179.867 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 160.41 156.65 8.28 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.946 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -43.71 166.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.08 179.996 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.8 m . . . . . 0 N--CA 1.486 1.341 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.411 -179.898 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.568 HG11 ' CE2' ' A' ' 36' ' ' TYR . 39.1 t . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 120.98 0.419 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.459 ' N ' HG12 ' A' ' 45' ' ' VAL . 2.4 tt0 -172.13 -164.41 0.29 Allowed 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.635 -179.948 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.559 ' CB ' HG22 ' A' ' 35' ' ' THR . 2.4 pt-20 -166.86 152.83 8.14 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.236 -179.996 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 3.1 p90 -144.43 146.52 32.52 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.4 p -91.37 168.0 11.88 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.924 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -158.22 145.14 13.11 Favored Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 119.557 -0.857 . . . . 0.0 108.991 179.972 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.36 28.47 0.08 OUTLIER 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 121.037 1.158 . . . . 0.0 112.424 179.843 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 49.11 22.84 3.46 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.095 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.84 -38.29 12.42 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.047 -179.93 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -85.22 134.14 34.16 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.729 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.2 m -91.21 -15.49 29.18 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.958 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.5 p -127.37 165.95 18.78 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.232 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.459 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -149.69 137.36 20.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.732 -179.975 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.3 m -118.27 107.27 13.7 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.635 179.869 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.21 164.18 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.973 -179.861 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 t -146.84 177.3 9.23 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.02 179.97 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.45 8.02 50.4 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.307 -179.939 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.26 -160.97 0.74 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.019 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -148.14 112.8 3.84 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.237 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.7 156.8 40.72 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 120.555 0.837 . . . . 0.0 111.744 -179.954 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.09 52.18 1.66 Allowed Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.598 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 p -170.71 154.86 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.95 133.41 56.07 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.517 179.923 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 92' ' ' TYR . 0.2 OUTLIER -133.02 139.69 47.35 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.731 -179.87 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.9 m -122.53 136.79 54.97 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.629 179.907 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.08 161.0 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.7 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.49 146.85 30.68 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.503 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.4 m -132.52 135.59 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.264 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -117.56 131.03 56.75 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.213 -179.998 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.38 101.02 7.66 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.959 -179.997 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.45 126.46 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.813 -179.917 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.486 HG22 HG13 ' A' ' 29' ' ' VAL . 30.1 p . . . . . 0 N--CA 1.487 1.419 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.019 179.923 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 C--O 1.214 -0.707 0 CA-C-O 121.016 0.34 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.0 tt -150.08 155.13 8.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.011 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.7 p -129.31 145.77 51.31 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.481 -179.9 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -146.61 139.0 19.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.057 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -98.08 134.79 40.68 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.07 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 68' ' ' TYR . 31.9 t80 -146.96 129.75 16.16 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.558 179.999 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.6 132.32 36.97 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.796 -179.923 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 116.354 -1.784 . . . . 0.0 110.631 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 120.873 0.368 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -175.85 176.12 1.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.265 179.961 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.523 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 2.4 t -96.8 116.67 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.395 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.652 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -92.15 -4.55 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.878 179.992 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 168.74 148.99 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.588 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.57 137.47 15.4 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.246 -179.861 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.515 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.9 OUTLIER -148.81 155.26 41.06 Favored Pre-proline 0 C--N 1.301 -1.503 0 C-N-CA 119.564 -0.855 . . . . 0.0 109.887 179.908 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.77 5.39 0.12 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.098 1.199 . . . . 0.0 112.163 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.515 ' H ' ' C ' ' A' ' 14' ' ' THR . 49.0 p -144.63 14.78 1.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.801 -179.939 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.41 139.64 0.19 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.165 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.88 121.23 24.85 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.586 -179.973 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.36 105.05 14.8 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.776 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 20' ' ' ILE . 1.4 pt -109.09 167.29 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 118.93 -1.108 . . . . 0.0 113.561 -179.641 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.48 135.35 35.06 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.389 -1.732 . . . . 0.0 107.206 179.805 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.62 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 44.7 p90 . . . . . 0 N--CA 1.506 2.345 0 C-N-CA 118.11 -1.436 . . . . 0.0 113.657 -179.809 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.721 0.296 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.497 ' HE ' ' CA ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -77.14 -64.86 1.04 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.176 179.797 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.7 158.2 33.77 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.279 179.718 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.62 ' CE2' ' CD1' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -116.2 125.51 52.36 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.916 179.97 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.578 ' NH1' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -106.5 99.18 8.77 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.397 -179.922 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mp -96.17 135.46 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.459 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -138.96 138.34 37.22 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.749 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 1.6 p90 -138.57 153.78 48.7 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.824 -1.15 . . . . 0.0 111.836 -179.958 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.462 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . 171.86 142.7 3.81 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.34 155.05 7.37 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.962 -179.974 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.305 -1.331 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.096 179.981 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.462 HG23 ' HA2' ' A' ' 37' ' ' GLY . 62.4 t . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.688 0.28 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -173.55 -168.25 0.43 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.445 -1.302 . . . . 0.0 112.265 -179.932 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -166.16 177.66 6.8 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.655 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -173.69 155.79 2.76 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.202 179.792 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.456 HG22 ' CD ' ' A' ' 33' ' ' ARG . 33.2 p -104.15 159.48 15.65 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.356 -179.983 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.504 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -151.91 154.65 33.03 Favored Pre-proline 0 C--N 1.306 -1.311 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.712 179.769 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.48 12.94 0.09 OUTLIER 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.173 1.248 . . . . 0.0 112.132 179.944 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 59.25 23.13 57.25 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.111 -1.519 . . . . 0.0 109.849 -179.952 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.14 -47.23 13.75 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.897 -179.975 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -84.51 133.18 34.47 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.779 179.918 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.0 m -80.67 -8.12 59.54 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.223 179.989 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.3 p -134.91 -174.12 3.51 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.091 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.99 146.09 9.14 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.989 -179.997 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -108.02 110.67 22.43 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.726 -179.924 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 mt -108.97 144.48 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.024 179.974 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.3 m -148.28 110.04 4.49 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.224 -179.946 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.51 -11.42 0.03 OUTLIER Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.126 -1.511 . . . . 0.0 110.88 179.992 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.603 HD23 ' N ' ' A' ' 62' ' ' LEU . 1.4 pt? -68.28 -164.07 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.947 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.626 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 5.1 ttpt -176.06 -42.29 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.801 -179.946 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.626 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 5.6 Cg_endo -81.36 -169.22 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.457 1.438 . . . . 0.0 111.985 -179.907 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -148.29 83.62 0.18 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.91 HG22 ' H ' ' A' ' 67' ' ' ASP . 10.9 p -142.78 -173.88 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.534 -179.716 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.91 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -56.83 99.66 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.639 179.998 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -97.77 120.83 38.86 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.59 179.891 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.4 m -95.73 124.47 39.76 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.806 -179.925 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.489 ' CG1' ' N ' ' A' ' 71' ' ' THR . 3.9 tt -112.08 157.38 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.13 179.857 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.489 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -154.96 136.22 14.02 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.194 -179.955 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.4 m -131.88 117.34 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.648 179.832 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -93.5 111.66 23.38 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.152 -179.958 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.5 96.81 9.25 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.85 -1.14 . . . . 0.0 110.636 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.578 HG21 ' NH1' ' A' ' 33' ' ' ARG . 9.3 t -93.77 129.43 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.966 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.8 p . . . . . 0 N--CA 1.489 1.512 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.039 -179.933 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo . . . . . 0 C--O 1.214 -0.696 0 N-CA-C 111.578 -0.201 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 88' ' ' ILE . 7.7 tt -135.01 144.63 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.443 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.3 p -137.07 133.01 34.94 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.133 -179.957 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.37 148.52 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.14 179.954 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.539 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -98.11 152.63 19.13 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.534 179.951 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -155.28 140.56 17.62 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.372 -179.963 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.99 98.32 11.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 119.342 -0.943 . . . . 0.0 109.873 179.917 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 116.476 -1.725 . . . . 0.0 110.787 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 120.864 0.364 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.1 t -74.43 126.87 31.66 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.471 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.56 27.46 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 118.602 -1.239 . . . . 0.0 112.028 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.513 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -86.35 -43.43 0.58 Allowed Pre-proline 0 N--CA 1.491 1.575 0 C-N-CA 118.135 -1.426 . . . . 0.0 111.796 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 4' ' ' VAL . 19.7 Cg_endo -91.01 111.96 0.36 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 121.459 1.439 . . . . 0.0 111.024 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -171.5 157.79 4.95 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.415 -1.314 . . . . 0.0 112.183 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t70 67.65 33.89 4.76 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.672 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.436 ' N ' ' OE2' ' A' ' 9' ' ' GLU . 1.5 mp -88.0 105.85 17.74 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.809 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.436 ' OE2' ' N ' ' A' ' 8' ' ' LEU . 7.4 mp0 -147.87 168.47 22.12 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.526 -0.869 . . . . 0.0 111.14 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.6 t -100.41 133.01 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.767 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -88.12 -35.62 8.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 118.706 -1.197 . . . . 0.0 110.863 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 174.64 170.98 0.24 Allowed 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.162 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.66 167.68 12.65 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.534 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.28 161.64 29.13 Favored Pre-proline 0 C--N 1.3 -1.561 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.246 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.488 ' C ' HG23 ' A' ' 16' ' ' THR . 14.0 Cg_exo -45.41 103.86 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 120.684 0.923 . . . . 0.0 111.123 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.488 HG23 ' C ' ' A' ' 15' ' ' PRO . 3.1 p 59.25 49.21 9.33 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.905 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 p -171.93 137.22 0.95 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.662 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.469 ' O ' HD12 ' A' ' 19' ' ' LEU . 1.9 tp -130.35 147.99 52.12 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.767 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 18' ' ' LEU . 6.8 mp -119.47 114.13 21.82 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.54 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -110.01 147.66 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.225 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.51 137.57 28.58 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.296 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 11.8 p90 -130.76 -135.25 0.21 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.458 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.456 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 34.9 t70 -135.34 168.78 18.56 Favored 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 118.558 -1.257 . . . . 0.0 112.952 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.45 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -149.75 93.79 3.93 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.578 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.588 ' HB2' HG22 ' A' ' 27' ' ' VAL . 10.9 Cg_exo -53.64 178.47 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 120.799 0.999 . . . . 0.0 112.524 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.62 -17.6 44.14 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.059 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.588 HG22 ' HB2' ' A' ' 25' ' ' PRO . 19.3 m -58.81 127.69 18.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 118.304 -1.359 . . . . 0.0 109.816 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.44 88.75 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.195 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.858 HG13 HG22 ' A' ' 76' ' ' THR . 2.2 t -73.71 131.06 35.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.646 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -68.78 0.16 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.692 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.79 164.29 28.97 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.177 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -113.74 158.78 20.5 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.895 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.486 ' CG ' ' OE2' ' A' ' 47' ' ' GLU . 2.9 ttt180 -139.33 105.48 5.23 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.064 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.832 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.7 mp -96.76 120.31 45.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.169 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.403 HG22 ' OE2' ' A' ' 47' ' ' GLU . 22.0 p -126.65 137.19 53.26 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.561 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.453 ' CE2' HG11 ' A' ' 45' ' ' VAL . 6.9 p90 -142.16 155.95 45.33 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 118.741 -1.184 . . . . 0.0 110.427 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.72 137.41 4.75 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.421 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.35 132.97 40.07 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.681 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.5 m -50.56 123.19 8.31 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.742 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.73 -54.67 0.09 OUTLIER Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.111 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.04 -1.33 64.98 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.866 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.03 -35.91 72.18 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.665 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.8 t 177.99 136.31 0.23 Allowed Pre-proline 0 C--N 1.304 -1.384 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.19 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.8 145.85 96.93 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 120.579 0.853 . . . . 0.0 110.91 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 46' ' ' GLN . 49.7 t -73.78 -77.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.859 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.482 ' N ' HG12 ' A' ' 45' ' ' VAL . 2.2 tt0 -167.6 171.86 9.9 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 117.979 -1.488 . . . . 0.0 112.499 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.486 ' OE2' ' CG ' ' A' ' 33' ' ' ARG . 0.8 OUTLIER -150.78 159.56 44.45 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.157 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 11.7 p90 -160.22 136.63 8.82 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 118.423 -1.311 . . . . 0.0 111.523 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.0 p -92.66 159.73 15.32 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.431 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.53 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -152.08 142.96 15.47 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.178 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.71 29.9 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 120.953 1.102 . . . . 0.0 112.387 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 57.42 13.56 11.2 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.251 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.44 -31.08 37.57 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.012 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -92.53 119.27 31.84 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.91 -21.73 34.1 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.373 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.4 p -119.54 -178.9 3.72 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.891 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -167.58 143.66 4.12 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.581 -1.248 . . . . 0.0 111.706 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.2 m -110.8 112.2 23.9 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.726 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.92 140.8 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.466 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -145.54 163.89 33.33 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.466 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.13 10.83 33.4 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.769 HD23 ' H ' ' A' ' 62' ' ' LEU . 1.6 pt? -91.98 -177.28 4.66 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.264 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.56 110.29 40.84 Favored Pre-proline 0 N--CA 1.49 1.569 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.047 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.66 137.53 80.67 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 120.599 0.866 . . . . 0.0 111.816 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.09 60.32 1.86 Allowed Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.544 -1.312 . . . . 0.0 109.999 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 p -169.51 156.9 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.471 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -74.99 142.38 43.87 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.081 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -137.89 130.19 29.15 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.124 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.57 125.97 49.48 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.509 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 tt -115.93 148.46 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.475 HG23 ' OG ' ' A' ' 89' ' ' SER . 25.8 m -145.5 121.48 10.69 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.338 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 72' ' ' VAL . 6.6 m -108.41 122.12 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.434 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.49 101.94 11.43 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.278 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.448 ' O ' ' CB ' ' A' ' 85' ' ' SER . . . -95.06 113.28 24.95 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.403 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.7 t -107.54 128.4 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.225 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.858 HG22 HG13 ' A' ' 29' ' ' VAL . 29.1 p -122.66 165.2 16.89 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.58 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.82 152.53 17.68 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.011 -1.566 . . . . 0.0 110.671 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.32 -22.17 19.87 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.039 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.57 -47.11 0.04 OUTLIER Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.327 -1.416 . . . . 0.0 110.823 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.435 ' H ' ' H ' ' A' ' 81' ' ' SER . 4.7 p-10 -173.94 -4.69 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.281 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -56.99 163.33 3.0 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.013 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 84' ' ' SER . 5.7 Cg_endo -68.07 30.14 0.14 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 121.605 1.537 . . . . 0.0 111.569 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 81' ' ' SER . . . -49.05 91.34 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.871 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 82' ' ' PRO . 75.5 m -89.94 137.39 32.38 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.783 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 74' ' ' ALA . 3.2 t -96.6 -158.12 0.64 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.929 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -128.41 92.6 40.63 Favored Pre-proline 0 N--CA 1.485 1.317 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.19 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.91 158.19 58.42 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 120.75 0.967 . . . . 0.0 111.063 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.4 tt -147.41 150.51 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 118.654 -1.218 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.475 ' OG ' HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -139.52 150.42 45.09 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.099 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 pt -152.34 141.87 14.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.674 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -93.19 145.53 24.36 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.256 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -156.25 140.71 16.77 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.218 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -84.05 118.98 24.41 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.26 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.769 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 m -102.19 162.03 13.23 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.671 -0.811 . . . . 0.0 110.616 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -153.47 69.26 0.81 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.117 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.3 t -64.96 134.72 96.15 Favored Pre-proline 0 C--N 1.306 -1.3 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.827 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -58.07 -178.95 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 120.466 0.777 . . . . 0.0 111.202 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.484 ' CZ ' ' OD2' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -172.96 170.87 4.38 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.46 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.484 ' OD2' ' CZ ' ' A' ' 6' ' ' ARG . 15.1 m-20 57.75 53.98 6.65 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.398 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.9 mp -98.77 114.78 27.47 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.533 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.441 ' OE2' ' N ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -170.12 176.89 4.45 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.362 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.0 t -95.66 129.95 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.448 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 m -101.77 -6.5 9.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.774 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.75 161.21 11.03 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.779 -1.168 . . . . 0.0 111.81 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.85 129.14 8.21 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.318 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.88 165.12 36.15 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.476 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.461 ' O ' ' CB ' ' A' ' 16' ' ' THR . 3.2 Cg_exo -53.11 104.31 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.198 1.265 . . . . 0.0 111.94 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.7 OUTLIER 77.91 34.48 0.32 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.13 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.46 126.42 0.91 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.716 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 tp -125.58 126.9 45.53 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.1 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.4 tp -103.5 114.05 28.03 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.469 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.47 159.31 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.596 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.77 145.91 17.51 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.659 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.528 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 13.7 p90 -135.5 -155.21 0.62 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 119.189 -1.004 . . . . 0.0 111.452 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 31.2 t70 -106.95 176.42 5.18 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.777 ' HB2' ' OG ' ' A' ' 55' ' ' SER . . . -175.38 106.65 0.26 Allowed Pre-proline 0 N--CA 1.488 1.468 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.318 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.493 ' HB2' HG12 ' A' ' 27' ' ' VAL . 3.3 Cg_exo -61.63 -171.62 0.09 OUTLIER 'Trans proline' 0 C--O 1.215 -0.659 0 CA-C-N 118.81 0.611 . . . . 0.0 111.753 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.13 -7.51 39.12 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.775 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.549 ' CG2' ' N ' ' A' ' 28' ' ' THR . 2.0 p -60.0 163.43 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 118.736 -1.185 . . . . 0.0 110.687 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.549 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 0.3 OUTLIER -74.78 109.54 8.34 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.035 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.79 139.02 36.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.137 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.523 ' NE ' ' OH ' ' A' ' 31' ' ' TYR . 2.2 mtt180 -69.93 -75.63 0.11 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.419 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.523 ' OH ' ' NE ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -153.84 167.68 28.85 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.604 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -123.85 156.04 36.93 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.146 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.522 ' HE ' HG22 ' A' ' 49' ' ' THR . 38.7 ttm180 -140.31 110.12 6.42 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.678 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 mp -95.14 123.49 47.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.904 -1.043 . . . . 0.0 111.338 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -125.58 132.12 52.59 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.711 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.55 ' OH ' ' CE2' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -144.77 167.62 22.15 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.338 -1.345 . . . . 0.0 112.484 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.77 159.14 17.37 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.6 160.74 3.09 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.047 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 m -66.48 162.62 20.27 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.724 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.82 -57.99 0.45 Allowed Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.246 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.68 41.84 5.58 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.422 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -126.58 -5.08 6.48 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.021 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.8 p -170.43 74.23 0.6 Allowed Pre-proline 0 C--N 1.303 -1.419 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.788 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.9 144.27 99.48 Favored 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 121.106 1.204 . . . . 0.0 111.477 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.56 HG12 ' N ' ' A' ' 46' ' ' GLN . 13.8 t -66.53 -74.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.509 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.631 ' NE2' ' H ' ' A' ' 47' ' ' GLU . 50.5 tp60 -171.47 162.92 6.74 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.843 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.631 ' H ' ' NE2' ' A' ' 46' ' ' GLN . 5.0 pt-20 -147.63 148.17 30.79 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.576 -0.849 . . . . 0.0 110.949 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.55 ' CE2' ' OH ' ' A' ' 36' ' ' TYR . 0.9 OUTLIER -147.84 170.97 16.47 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 118.864 -1.134 . . . . 0.0 111.421 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.522 HG22 ' HE ' ' A' ' 33' ' ' ARG . 50.2 p -104.89 174.26 5.95 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.883 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.571 ' C ' ' H ' ' A' ' 52' ' ' GLY . 11.3 p -165.79 137.66 3.18 Favored Pre-proline 0 CA--C 1.564 1.503 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.163 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 53' ' ' SER . 5.2 Cg_exo -56.0 14.19 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 121.216 1.277 . . . . 0.0 113.731 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 54.02 9.24 1.28 Allowed Glycine 0 N--CA 1.495 2.623 0 C-N-CA 119.36 -1.4 . . . . 0.0 111.119 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -72.42 -41.05 66.63 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.969 -1.092 . . . . 0.0 110.287 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -118.83 116.31 26.24 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.075 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.777 ' OG ' ' HB2' ' A' ' 24' ' ' ALA . 2.1 m -79.85 58.24 2.8 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.105 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 p -154.28 148.35 25.75 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.371 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.16 150.68 9.54 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 t -117.31 145.56 43.92 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.759 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -135.69 133.8 51.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.41 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.5 m -130.6 165.59 22.45 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.581 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.44 49.22 4.73 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.169 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.29 -155.19 0.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.636 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.6 99.1 17.36 Favored Pre-proline 0 N--CA 1.493 1.71 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.08 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.97 145.14 94.25 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.757 0.971 . . . . 0.0 111.593 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.92 49.97 4.83 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.668 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.3 p -159.02 152.92 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.393 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.13 151.33 31.49 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.109 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.17 121.22 8.84 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.695 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 m -105.78 121.2 43.55 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.646 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 pp -110.18 158.46 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.569 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 55.0 m -153.18 123.19 6.95 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.067 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.5 m -108.63 141.93 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.514 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -112.38 105.65 13.98 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.844 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.74 94.6 9.56 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.063 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -89.6 112.44 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.76 165.01 28.11 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.502 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.06 107.47 0.22 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.007 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -59.54 -58.49 8.35 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.252 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.99 37.68 0.02 OUTLIER Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.884 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -137.58 -103.98 0.19 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.984 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.566 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -92.56 -43.14 0.35 Allowed Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.597 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 81' ' ' SER . 5.6 Cg_exo -65.21 107.45 0.97 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 121.116 1.211 . . . . 0.0 112.086 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.44 -78.14 0.54 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.917 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.8 m -54.62 164.38 0.76 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.255 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.1 m -116.63 179.41 4.02 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -134.17 74.41 67.78 Favored Pre-proline 0 N--CA 1.484 1.273 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.12 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -54.79 168.69 1.04 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 121.841 1.694 . . . . 0.0 113.9 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.9 tt -150.43 157.59 5.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.573 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.9 p -144.83 160.69 40.87 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.563 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.97 145.57 16.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.526 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 92' ' ' TYR . 1.1 t30 -91.48 144.73 25.26 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.639 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.455 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 57.8 t80 -161.3 135.73 7.12 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.838 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.79 132.58 34.57 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.194 -1.003 . . . . 0.0 110.205 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 116.258 -1.83 . . . . 0.0 110.818 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.63 ' O ' HG12 ' A' ' 1' ' ' VAL . 95.4 t . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 3' ' ' ASP . 8.9 p 48.15 -150.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.658 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.47 ' N ' ' OG ' ' A' ' 2' ' ' SER . 44.8 t0 -144.65 -71.65 0.27 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.589 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 4' ' ' VAL . 47.7 t -131.95 51.88 8.14 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 8.8 Cg_endo -67.42 79.56 0.45 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 120.947 1.098 . . . . 0.0 110.209 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 2.3 mtm180 -147.21 -154.0 0.52 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.012 -1.075 . . . . 0.0 112.049 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 6.6 t0 72.75 14.34 5.01 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.711 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.38 134.6 56.17 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.484 -0.887 . . . . 0.0 110.27 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -169.3 146.01 3.43 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.124 -1.031 . . . . 0.0 111.112 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.0 t -85.32 116.17 28.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.736 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 t -90.27 -18.82 7.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.768 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.39 159.0 4.5 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.094 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.37 81.41 1.12 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.445 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -77.72 160.62 74.1 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.541 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.92 3.83 0.48 Allowed 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.344 1.363 . . . . 0.0 111.779 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 14' ' ' THR . 1.8 m -152.91 25.3 0.56 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.895 -1.122 . . . . 0.0 111.9 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.17 131.74 0.08 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.954 -1.099 . . . . 0.0 111.287 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 tp -115.72 136.24 53.25 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.52 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.33 116.71 26.77 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.475 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.28 158.59 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.174 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.13 133.52 16.47 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.624 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 6.3 p90 -138.07 -146.55 0.22 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.252 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.624 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 32.1 t70 -98.42 174.8 6.29 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.036 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.482 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -172.28 90.93 0.41 Allowed Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.717 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -61.33 156.18 47.55 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.915 1.077 . . . . 0.0 111.36 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.72 9.02 40.52 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.626 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.906 HG22 ' H ' ' A' ' 28' ' ' THR . 8.9 p -64.19 -175.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.461 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.906 ' H ' HG22 ' A' ' 27' ' ' VAL . 3.2 m -73.44 76.81 1.41 Allowed 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.579 HG13 HG22 ' A' ' 76' ' ' THR . 13.2 t -93.1 144.77 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.684 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.537 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -87.48 -73.53 0.47 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 118.961 -1.095 . . . . 0.0 110.828 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 2.5 m-85 -146.58 167.5 23.57 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.975 -1.09 . . . . 0.0 111.976 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -131.01 145.39 52.03 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.024 -1.444 . . . . 0.0 108.65 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.486 ' C ' HD12 ' A' ' 34' ' ' ILE . 14.1 ttm180 -132.59 121.39 23.15 Favored 'General case' 0 N--CA 1.508 2.44 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.137 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.741 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.7 mp -97.48 102.58 13.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.715 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.688 HG22 ' HB2' ' A' ' 47' ' ' GLU . 69.9 p -109.61 129.95 55.55 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 12.6 p90 -140.52 165.06 28.49 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.78 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.451 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . 168.6 165.02 25.29 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -66.29 146.39 54.65 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.381 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 39' ' ' THR . 24.4 m -75.88 0.76 17.11 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.595 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.88 54.68 0.56 Allowed Glycine 0 N--CA 1.5 2.932 0 C-N-CA 119.574 -1.298 . . . . 0.0 111.316 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 43' ' ' SER . . . 173.98 131.8 1.45 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 118.749 -1.691 . . . . 0.0 111.247 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -75.16 12.8 0.82 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.127 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 41' ' ' GLY . 15.5 t -129.52 86.73 55.07 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.476 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -58.96 162.63 13.06 Favored 'Trans proline' 0 C--O 1.213 -0.726 0 C-N-CA 120.793 0.995 . . . . 0.0 112.029 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 46' ' ' GLN . 36.4 t -49.44 -73.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.29 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.501 ' N ' HG12 ' A' ' 45' ' ' VAL . 3.5 tt0 -169.08 -159.06 0.22 Allowed 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.987 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.688 ' HB2' HG22 ' A' ' 35' ' ' THR . 7.1 pt-20 -170.12 161.16 8.42 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.189 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 7.2 p90 -152.68 140.27 19.79 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.636 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 50.8 p -82.8 174.05 11.31 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.541 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.599 HG13 ' H ' ' A' ' 52' ' ' GLY . 5.6 p -166.21 139.23 3.3 Favored Pre-proline 0 C--N 1.305 -1.351 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.949 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 53' ' ' SER . 2.0 Cg_endo -62.5 28.3 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 121.0 1.134 . . . . 0.0 112.916 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.599 ' H ' HG13 ' A' ' 50' ' ' VAL . . . 48.55 11.06 0.14 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.996 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -76.84 -38.92 52.88 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.57 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -93.12 131.06 38.5 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.494 -0.883 . . . . 0.0 110.622 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -84.83 -1.24 56.2 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.441 -0.904 . . . . 0.0 111.294 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.5 p -120.11 167.84 11.81 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.722 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.13 136.24 18.69 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.236 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.6 m -99.69 145.8 27.22 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.8 mt -144.32 149.19 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.616 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.4 174.45 10.91 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.75 64.64 3.55 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.784 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.441 HD12 ' H ' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -120.01 -125.17 0.28 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.782 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.441 ' H ' HD12 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -170.84 121.72 0.53 Allowed Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.192 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.58 142.91 73.11 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 120.566 0.844 . . . . 0.0 112.075 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.18 80.92 0.09 OUTLIER Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.387 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.446 ' CG1' ' CE2' ' A' ' 68' ' ' TYR . 7.5 p -170.4 152.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.538 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -82.48 108.65 16.05 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.446 ' CE2' ' CG1' ' A' ' 66' ' ' VAL . 4.6 m-85 -105.4 130.68 53.45 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.85 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.73 119.09 35.69 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.012 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 tp -98.3 137.38 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.235 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.558 HG23 ' HB3' ' A' ' 89' ' ' SER . 82.3 m -139.35 127.77 22.87 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.073 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -118.33 151.59 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.459 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -115.89 133.32 56.15 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.009 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.53 84.36 2.19 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 123.795 0.685 . . . . 0.0 109.466 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -95.3 124.81 48.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.584 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.579 HG22 HG13 ' A' ' 29' ' ' VAL . 4.4 p -141.58 -166.18 2.14 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.876 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.0 116.9 0.45 Allowed Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.435 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.77 -3.33 19.18 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.7 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.58 61.56 1.23 Allowed Glycine 0 N--CA 1.489 2.195 0 C-N-CA 119.308 -1.425 . . . . 0.0 110.325 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.64 -43.98 0.07 Allowed 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.666 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.07 164.71 31.83 Favored Pre-proline 0 N--CA 1.487 1.393 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.979 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 84' ' ' SER . 2.3 Cg_endo -58.01 99.4 0.1 OUTLIER 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.088 1.192 . . . . 0.0 111.248 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 85' ' ' SER . . . -52.02 -8.95 0.08 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.003 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 82' ' ' PRO . 9.3 t -67.68 74.0 0.17 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -76.8 -150.5 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.282 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.78 153.1 31.32 Favored Pre-proline 0 C--N 1.31 -1.125 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.16 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.05 -178.98 2.3 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 121.694 1.596 . . . . 0.0 112.441 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.3 tt -158.38 139.63 4.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.611 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.558 ' HB3' HG23 ' A' ' 71' ' ' THR . 63.3 p -149.69 166.84 28.16 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 118.216 -1.394 . . . . 0.0 113.039 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 pt -154.42 150.7 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.524 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -82.81 141.23 32.47 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.281 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -146.59 120.91 9.59 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.763 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -85.48 116.51 23.83 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.567 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 116.355 -1.783 . . . . 0.0 111.096 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 1' ' ' VAL . 1.4 p . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.831 0.348 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.44 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 3.5 p -158.93 98.0 1.44 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.318 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 2' ' ' SER . 2.5 m-20 -141.23 -25.64 0.72 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -68.04 144.49 97.07 Favored Pre-proline 0 C--N 1.299 -1.629 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.467 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 4' ' ' VAL . 2.8 Cg_exo -51.39 -178.07 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 120.621 0.881 . . . . 0.0 109.817 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -170.03 168.83 8.35 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 117.506 -1.677 . . . . 0.0 113.585 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 31.39 81.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.863 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 mp -101.54 150.18 23.34 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -169.9 168.06 8.88 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 117.499 -1.68 . . . . 0.0 112.963 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.0 t -96.23 111.52 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.374 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.648 HG23 ' OG ' ' A' ' 21' ' ' SER . 24.7 t -77.82 -9.5 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.25 -0.98 . . . . 0.0 111.58 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 169.94 168.03 0.06 Allowed 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.441 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.34 147.59 27.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.811 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.62 161.13 30.11 Favored Pre-proline 0 C--N 1.305 -1.34 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.461 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.585 ' C ' HG23 ' A' ' 16' ' ' THR . 3.6 Cg_exo -51.29 111.88 0.67 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 120.97 1.113 . . . . 0.0 111.083 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.585 HG23 ' C ' ' A' ' 15' ' ' PRO . 1.6 p 64.51 37.92 7.74 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.83 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.92 128.29 1.64 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.662 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.4 HD11 HG21 ' A' ' 94' ' ' THR . 0.4 OUTLIER -130.33 145.47 51.79 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.335 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.17 109.77 15.82 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.065 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -109.12 146.69 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.145 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.648 ' OG ' HG23 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -142.68 131.05 22.22 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.398 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.598 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 5.5 p90 -136.32 -143.66 0.19 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.497 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.598 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 15.2 t70 -141.7 162.9 34.34 Favored 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 118.419 -1.312 . . . . 0.0 112.815 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -135.63 127.45 17.54 Favored Pre-proline 0 CA--C 1.558 1.266 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.922 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -59.13 -178.48 0.14 Allowed 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 120.471 0.781 . . . . 0.0 111.679 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.32 -19.79 19.67 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.101 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.76 160.95 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 119.361 -0.935 . . . . 0.0 110.666 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.0 m -74.6 74.38 2.0 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.614 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 t -69.43 128.23 32.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.201 -0.999 . . . . 0.0 110.998 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.444 ' H ' ' HA ' ' A' ' 76' ' ' THR . 9.3 ttt180 -55.15 -60.47 3.34 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.092 -1.043 . . . . 0.0 110.037 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -168.95 170.16 9.19 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 118.424 -1.311 . . . . 0.0 112.746 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.05 144.32 48.98 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.189 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.34 109.53 16.4 Favored 'General case' 0 N--CA 1.509 2.494 0 C-N-CA 118.999 -1.081 . . . . 0.0 110.244 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.2 mp -96.97 113.95 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.34 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 64.2 p -113.43 142.78 45.49 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.935 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.682 ' CE2' HG11 ' A' ' 45' ' ' VAL . 6.0 p90 -146.71 151.77 37.74 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.753 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.88 164.92 19.03 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -53.5 155.79 2.81 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.765 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 m -75.38 -13.07 60.38 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.304 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.95 -92.83 0.05 OUTLIER Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.544 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 143.91 -4.87 1.67 Allowed Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.608 -1.282 . . . . 0.0 109.947 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.61 2.99 4.37 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.455 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.2 p -176.26 74.85 0.27 Allowed Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.834 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.64 114.44 2.39 Favored 'Trans proline' 0 C--N 1.326 -0.645 0 C-N-CA 121.23 1.287 . . . . 0.0 111.288 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.682 HG11 ' CE2' ' A' ' 36' ' ' TYR . 50.9 t -52.77 -89.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.944 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.643 ' N ' HG12 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -175.99 -166.35 0.18 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.162 -1.415 . . . . 0.0 111.753 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -160.25 169.22 23.66 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.916 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.488 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 19.0 p90 -161.03 131.08 5.0 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.674 -0.811 . . . . 0.0 109.901 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.27 166.25 11.07 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.15 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -146.72 159.16 44.72 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.936 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.47 15.84 0.05 OUTLIER 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 121.135 1.223 . . . . 0.0 112.298 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 62.29 24.21 65.22 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.208 -1.473 . . . . 0.0 110.116 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.35 -36.92 11.19 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.107 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -89.83 116.3 27.81 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.8 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.63 4.42 24.89 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.68 159.43 42.0 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.474 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.45 164.29 21.99 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.434 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.6 m -134.02 146.82 50.74 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.479 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.426 HG21 HD13 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -137.36 158.0 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.052 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.6 m -149.56 174.45 12.52 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.655 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.71 12.73 52.74 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.777 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.07 -158.77 0.67 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.626 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' O ' HG12 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -150.02 122.19 4.18 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.598 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.71 144.3 97.1 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 120.512 0.808 . . . . 0.0 111.336 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.61 50.77 4.1 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.762 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 63' ' ' LYS . 6.6 p -165.16 139.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.419 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.402 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -64.41 133.33 52.33 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.929 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -132.0 129.86 40.67 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.174 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.2 128.89 54.82 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.914 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 70' ' ' ILE . 4.4 tt -119.7 145.0 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.409 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 81.4 m -142.43 125.26 16.04 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.525 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.57 137.0 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 119.613 -0.835 . . . . 0.0 111.011 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -110.18 143.82 39.75 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.37 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.5 91.25 3.49 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.612 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.8 t -102.91 117.2 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.485 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.556 ' CG2' ' N ' ' A' ' 77' ' ' GLY . 14.0 t -116.57 -42.79 2.96 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.218 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.556 ' N ' ' CG2' ' A' ' 76' ' ' THR . . . -63.49 176.36 8.46 Favored Glycine 0 C--N 1.28 -2.552 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.79 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -89.47 -50.74 5.92 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.971 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -100.82 -107.75 3.0 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.62 -7.05 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.769 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.554 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -85.95 -42.55 0.61 Allowed Pre-proline 0 C--N 1.304 -1.406 0 C-N-CA 119.406 -0.917 . . . . 0.0 112.862 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 81' ' ' SER . 3.2 Cg_exo -66.71 -76.78 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 120.843 1.029 . . . . 0.0 112.167 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.02 110.21 11.47 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.738 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 85' ' ' SER . 0.1 OUTLIER -130.48 105.87 8.15 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.955 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 84' ' ' SER . 5.8 p -55.61 -162.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.089 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -128.68 123.74 22.28 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.118 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -65.4 154.82 71.88 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 120.404 0.736 . . . . 0.0 110.501 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -145.4 153.45 13.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.961 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.9 p -151.06 153.72 35.62 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.774 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.7 143.22 21.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.732 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.09 153.64 18.03 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.316 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -169.26 135.29 1.63 Allowed 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.322 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -79.86 106.71 12.08 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.312 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.4 HG21 HD11 ' A' ' 18' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.887 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -176.5 161.42 2.17 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.776 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.74 84.64 0.82 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.427 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 5' ' ' PRO . 72.2 t -128.23 94.24 36.65 Favored Pre-proline 0 N--CA 1.488 1.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.095 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HB2' ' H ' ' A' ' 6' ' ' ARG . 1.2 Cg_endo -62.69 -132.86 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.698 0 C-N-CA 120.436 0.757 . . . . 0.0 110.436 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 22' ' ' TRP . 8.2 ptm180 -170.8 162.34 7.56 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 117.28 -1.768 . . . . 0.0 115.001 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -21.32 108.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 112.983 -1.917 . . . . 0.0 115.046 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.535 HD22 ' HA ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -51.09 120.55 5.04 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.422 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 10' ' ' VAL . 18.5 tt0 -173.03 162.19 4.54 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.534 -1.266 . . . . 0.0 112.271 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.444 ' N ' ' CG ' ' A' ' 9' ' ' GLU . 61.5 t -91.44 114.36 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.33 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.439 ' H ' HG23 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -79.22 -52.45 15.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 118.825 -1.15 . . . . 0.0 111.422 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.528 ' O ' HD23 ' A' ' 18' ' ' LEU . . . -147.66 158.32 43.96 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.951 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.11 106.72 4.08 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.469 ' C ' ' H ' ' A' ' 16' ' ' THR . 1.0 OUTLIER -104.69 155.21 37.8 Favored Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.631 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.43 3.28 0.2 Allowed 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 121.147 1.231 . . . . 0.0 112.353 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 14' ' ' THR . 3.0 m -149.38 24.11 0.91 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.859 -1.136 . . . . 0.0 111.477 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.426 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.1 OUTLIER 175.96 145.17 0.08 Allowed 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.296 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -130.46 124.64 32.47 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.387 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 tt -95.66 102.21 13.99 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.635 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 pp -109.68 143.5 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.446 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.76 139.28 53.79 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.569 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.535 ' HA ' HD22 ' A' ' 8' ' ' LEU . 46.9 p90 -119.24 180.0 4.01 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 118.125 -1.43 . . . . 0.0 113.726 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 24' ' ' ALA . 28.6 t70 -135.73 168.62 18.95 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 113.584 -1.644 . . . . 0.0 110.906 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -179.4 179.33 0.3 Allowed Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 2.8 Cg_exo -62.78 162.0 26.8 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 120.625 0.883 . . . . 0.0 111.147 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.84 2.64 48.36 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.324 -0.951 . . . . 0.0 112.227 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.0 m -63.21 160.52 2.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.593 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.1 m -70.29 100.73 1.77 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.539 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' ' 32' ' ' TYR . 63.5 t -87.48 140.77 15.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.82 -43.28 13.43 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.555 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -143.34 176.12 9.39 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.818 -1.153 . . . . 0.0 112.323 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.463 ' OH ' ' HB3' ' A' ' 24' ' ' ALA . 1.6 m-85 -144.06 137.27 27.49 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.663 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -129.23 110.17 11.75 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.17 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.417 HD12 ' H ' ' A' ' 34' ' ' ILE . 4.0 mp -101.68 112.89 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.758 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 p -113.84 135.06 54.38 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.585 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.627 ' CE2' HG11 ' A' ' 45' ' ' VAL . 8.9 p90 -140.07 154.48 47.08 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 118.61 -1.236 . . . . 0.0 111.026 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.93 162.42 22.19 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 39' ' ' THR . 1.4 tm-20 -55.6 152.69 8.84 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.549 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.482 ' N ' ' CD ' ' A' ' 38' ' ' GLU . 0.9 OUTLIER -75.23 144.77 42.44 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.242 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 40.0 41.74 2.07 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 119.884 -1.151 . . . . 0.0 111.016 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.15 149.41 18.71 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.664 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -87.86 35.91 0.75 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.751 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 p 179.25 68.5 0.13 Allowed Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.042 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -57.32 139.51 90.3 Favored 'Trans proline' 0 C--N 1.322 -0.854 0 C-N-CA 121.121 1.214 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.627 HG11 ' CE2' ' A' ' 36' ' ' TYR . 83.7 t -49.05 -84.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.67 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -172.0 -159.0 0.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.578 -1.249 . . . . 0.0 111.678 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -165.71 156.63 13.62 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.802 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 3.5 p90 -146.72 154.76 41.79 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.569 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.4 p -115.69 155.98 26.75 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.738 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 52' ' ' GLY . 32.9 m -148.77 151.43 35.35 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.661 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.92 19.89 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.06 1.173 . . . . 0.0 112.597 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.572 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 60.22 24.63 61.34 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.474 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -45.02 16.42 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.002 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -89.15 144.87 25.81 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.838 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.5 m -96.01 -12.22 25.29 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.262 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.9 p -138.35 177.3 7.98 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.399 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.11 151.61 4.01 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.824 -1.15 . . . . 0.0 111.294 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.6 m -112.65 104.05 12.11 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.982 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.37 166.82 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.262 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.4 t -142.97 -179.0 6.1 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.963 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.52 60.21 1.38 Allowed Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.528 -1.32 . . . . 0.0 109.952 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.93 -155.55 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.908 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -150.73 137.43 11.36 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.054 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.64 151.94 82.71 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 120.915 1.077 . . . . 0.0 112.672 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.97 77.91 0.08 OUTLIER Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.932 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -162.27 144.28 3.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.005 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.474 ' CG ' HD21 ' A' ' 91' ' ' ASN . 6.8 t70 -76.26 117.02 17.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.293 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -117.54 129.56 55.87 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.537 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.2 120.67 39.91 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.34 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 tt -111.38 146.47 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.437 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.401 ' CG2' ' OG ' ' A' ' 89' ' ' SER . 20.6 m -148.69 141.64 24.78 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.184 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.63 131.8 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.285 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -104.6 123.12 47.0 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.19 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.31 89.99 5.29 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.47 118.41 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.98 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 69.6 p -125.24 -116.03 0.28 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.032 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.524 ' N ' ' OG1' ' A' ' 76' ' ' THR . . . 85.55 170.17 46.79 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.959 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.41 -39.47 17.52 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.754 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -93.0 -96.89 1.44 Allowed Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.292 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.87 -77.65 0.57 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.002 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.502 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 1.3 m -131.04 50.13 5.65 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.562 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 81' ' ' SER . 1.6 Cg_endo -56.7 -74.83 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 120.989 1.126 . . . . 0.0 110.801 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.2 121.76 25.4 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.709 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.0 t -55.11 149.71 11.8 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.612 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 p -83.29 -94.35 0.06 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.734 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.54 79.41 4.36 Favored Pre-proline 0 C--N 1.296 -1.755 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.996 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -52.43 171.54 0.2 Allowed 'Trans proline' 0 C--O 1.216 -0.576 0 C-N-CA 120.898 1.065 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 88' ' ' ILE . 10.3 tt -144.79 131.74 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 118.529 -1.268 . . . . 0.0 111.465 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.401 ' OG ' ' CG2' ' A' ' 71' ' ' THR . 31.8 m -120.38 155.74 32.8 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.657 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.86 135.46 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.534 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.474 HD21 ' CG ' ' A' ' 67' ' ' ASP . 10.5 t30 -86.13 133.66 33.86 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.59 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -140.48 132.27 27.46 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.321 -0.951 . . . . 0.0 111.174 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.04 105.82 18.03 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.091 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 116.431 -1.747 . . . . 0.0 110.868 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.978 0.418 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t -66.02 -159.97 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.03 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -151.91 48.32 0.79 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.944 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.2 t -48.9 147.08 4.9 Favored Pre-proline 0 C--N 1.304 -1.372 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.329 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -46.39 167.71 0.06 OUTLIER 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 120.769 0.98 . . . . 0.0 111.043 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.98 177.69 4.64 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.734 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' LEU . 1.8 t70 -47.4 100.24 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.89 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 7' ' ' ASP . 2.3 mm? -43.36 164.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.219 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -149.71 147.91 28.62 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.241 -1.384 . . . . 0.0 112.412 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.5 t -103.51 111.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.031 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.87 -27.35 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.693 -1.203 . . . . 0.0 111.951 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 19' ' ' LEU . . . -155.09 151.05 27.87 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.851 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.32 121.06 7.54 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.297 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.523 ' C ' ' H ' ' A' ' 16' ' ' THR . 1.1 p -134.13 153.49 79.61 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.32 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -64.29 10.48 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 120.98 1.12 . . . . 0.0 111.648 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.523 ' H ' ' C ' ' A' ' 14' ' ' THR . 5.0 m -140.84 6.31 2.01 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.051 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 p 179.26 148.82 0.25 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.307 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.81 120.08 27.06 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.462 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 2.8 tt -98.07 102.42 14.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.924 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 pp -100.25 155.21 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.503 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.37 143.74 30.29 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.0 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.615 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 3.7 p90 -145.07 -148.43 0.24 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.216 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.615 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 30.4 t70 -110.36 177.94 4.54 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.528 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . -170.28 89.35 0.52 Allowed Pre-proline 0 C--N 1.303 -1.433 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.011 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -56.99 169.79 1.77 Allowed 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 120.871 1.048 . . . . 0.0 112.214 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.82 -7.4 57.31 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.683 -0.807 . . . . 0.0 112.176 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 m -59.59 161.82 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 118.525 -1.27 . . . . 0.0 110.008 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.464 ' O ' HG22 ' A' ' 28' ' ' THR . 4.2 m -67.33 84.68 0.16 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.885 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -83.1 116.94 28.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.008 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.414 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 4.3 mtp180 -54.51 -48.58 71.74 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.35 -1.34 . . . . 0.0 108.93 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.414 ' CG ' ' C ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER 175.93 164.58 0.37 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.849 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -114.01 155.16 26.39 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.11 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.652 ' HE ' ' CG2' ' A' ' 49' ' ' THR . 4.0 ttm180 -135.15 107.52 7.29 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.405 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.3 mt -98.96 109.07 23.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.864 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.563 HG22 ' CB ' ' A' ' 47' ' ' GLU . 45.1 p -113.01 134.56 54.46 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.471 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.468 ' CE2' HG11 ' A' ' 45' ' ' VAL . 9.7 p90 -136.9 153.37 50.76 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.262 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.496 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -177.88 149.41 9.21 Favored Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.596 ' CD ' ' H ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -86.65 139.83 30.41 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.729 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.9 m -67.68 130.12 42.02 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.889 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.7 -23.93 0.02 OUTLIER Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.392 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.62 -2.37 77.05 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.374 -1.393 . . . . 0.0 110.642 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -77.77 -69.32 0.55 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.736 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.35 130.83 0.42 Allowed Pre-proline 0 C--N 1.305 -1.349 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.434 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -61.69 151.52 79.91 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 120.482 0.788 . . . . 0.0 110.948 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.496 HG23 ' HA2' ' A' ' 37' ' ' GLY . 96.1 t -61.77 -78.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 118.947 -1.101 . . . . 0.0 110.677 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -173.34 -167.75 0.41 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.976 -1.09 . . . . 0.0 111.527 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.563 ' CB ' HG22 ' A' ' 35' ' ' THR . 2.8 pm0 -153.34 170.2 21.23 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.918 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -159.07 129.56 5.91 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.202 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.652 ' CG2' ' HE ' ' A' ' 33' ' ' ARG . 34.3 p -95.95 162.21 13.66 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.436 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.548 ' C ' ' H ' ' A' ' 52' ' ' GLY . 35.3 m -150.33 150.58 29.49 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.717 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.86 9.87 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 120.92 1.08 . . . . 0.0 112.225 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 72.93 13.56 78.93 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.244 -1.455 . . . . 0.0 109.949 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.25 -29.89 22.77 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.629 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -80.86 118.36 22.3 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.284 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.47 -15.37 57.89 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.371 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.0 p -144.46 176.79 9.12 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.485 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -171.79 160.52 5.63 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.219 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -121.54 143.56 49.21 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.274 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.32 163.9 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.805 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.2 m -143.21 -170.72 3.33 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.442 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.71 55.14 4.66 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.309 -1.424 . . . . 0.0 110.495 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.61 -158.52 0.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.707 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -140.28 155.05 70.41 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.295 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.28 102.55 0.39 Allowed 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.315 1.343 . . . . 0.0 112.739 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.89 95.82 0.03 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.537 -1.315 . . . . 0.0 111.474 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 66' ' ' VAL . 9.9 p -157.54 137.5 4.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.826 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -50.59 116.17 1.81 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.763 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.67 130.11 52.59 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.79 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.1 m -117.67 126.47 52.56 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.564 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -118.57 157.19 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.419 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.406 HG23 ' CB ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -141.08 117.09 10.51 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.448 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 72' ' ' VAL . 34.1 m -111.43 126.64 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.557 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -109.16 130.3 55.49 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.157 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.33 91.48 3.67 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.217 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.1 t -91.91 123.2 43.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.081 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.7 p -102.74 -160.98 0.81 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.994 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.46 -143.78 14.25 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.641 -1.266 . . . . 0.0 111.568 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.726 ' HE ' ' N ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -121.23 -165.32 1.22 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.546 0.688 . . . . 0.0 111.596 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.726 ' N ' ' HE ' ' A' ' 78' ' ' ARG . . . 170.2 -7.22 0.04 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 106.827 -2.509 . . . . 0.0 106.827 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.449 ' H ' ' H ' ' A' ' 79' ' ' GLY . 19.1 t0 178.43 -57.84 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.36 163.96 45.79 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 113.951 -1.477 . . . . 0.0 107.695 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -52.66 107.43 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 120.376 0.717 . . . . 0.0 110.362 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.23 47.93 0.84 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.473 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 t -74.85 130.83 40.12 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.611 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.485 ' OG ' ' N ' ' A' ' 86' ' ' LYS . 24.4 p -78.57 -141.99 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.805 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.485 ' N ' ' OG ' ' A' ' 85' ' ' SER . 8.8 tttm -130.47 121.17 19.19 Favored Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.454 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.93 157.14 40.03 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 120.51 0.807 . . . . 0.0 111.556 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 88' ' ' ILE . 9.8 tt -144.42 139.62 24.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.378 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.406 ' CB ' HG23 ' A' ' 71' ' ' THR . 7.2 p -128.48 160.42 32.36 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.817 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.0 pt -144.72 139.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.763 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.58 110.73 21.88 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.756 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 93' ' ' ARG . 5.9 t80 -143.05 138.82 30.21 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.616 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.436 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 10.5 mtp180 -72.16 110.59 6.72 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.597 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 116.371 -1.776 . . . . 0.0 110.984 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.991 0.424 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 m -149.36 111.01 4.51 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.67 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -141.06 33.95 1.73 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.149 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 t -92.77 127.61 47.22 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.345 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.42 172.06 3.74 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 120.457 0.771 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -175.62 -178.79 1.14 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.914 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.13 19.95 11.89 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.847 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.591 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -81.82 106.92 14.13 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.609 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -154.45 176.29 12.54 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.876 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 t -93.78 132.95 36.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.797 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.69 -4.36 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.13 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.8 144.86 2.33 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.434 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.91 102.15 3.85 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.843 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.552 ' C ' ' H ' ' A' ' 16' ' ' THR . 22.6 p -97.15 152.5 38.33 Favored Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.271 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.46 ' C ' ' HG1' ' A' ' 16' ' ' THR . 1.9 Cg_endo -59.36 14.12 0.04 OUTLIER 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 121.305 1.337 . . . . 0.0 112.726 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 14' ' ' THR . 3.2 m -159.64 21.62 0.18 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.032 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 173.93 149.73 0.08 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.182 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.37 157.72 37.77 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.416 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.6 116.71 21.45 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.264 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pt -106.0 152.27 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.102 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.426 ' HB3' HG22 ' A' ' 56' ' ' THR . 2.4 m -150.27 124.78 9.62 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.029 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.529 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 7.2 p90 -129.47 -163.77 1.33 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.419 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 30.9 t70 -103.59 173.46 6.29 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -158.81 105.91 1.6 Allowed Pre-proline 0 CA--C 1.56 1.345 0 CA-C-N 114.431 -1.258 . . . . 0.0 109.302 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -58.1 -171.06 0.04 OUTLIER 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 120.757 0.972 . . . . 0.0 112.401 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -105.34 -3.3 22.87 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.006 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' VAL . 2.3 t -58.26 159.46 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.018 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.92 89.14 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.932 -1.107 . . . . 0.0 109.748 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' VAL . 26.3 t -91.88 119.29 39.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.721 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.545 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 2.7 mmp_? -79.83 -67.86 0.72 Allowed 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 118.931 -1.107 . . . . 0.0 109.548 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.545 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 2.1 m-85 -149.35 154.37 38.85 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.646 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -110.35 165.46 11.76 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -146.87 110.76 5.0 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.319 -1.352 . . . . 0.0 110.697 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.4 mp -102.66 117.53 48.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.511 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 p -119.14 135.22 54.77 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.137 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -124.54 156.41 37.38 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.661 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.22 130.47 1.41 Allowed Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.341 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -75.53 143.71 42.32 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.635 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 m -65.23 155.55 34.74 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.778 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 42' ' ' ASN . . . 152.35 2.79 0.19 Allowed Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.464 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.53 -3.49 3.54 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.191 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 40' ' ' GLY . 13.1 m-80 -65.33 -88.72 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.516 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.2 163.65 10.06 Favored Pre-proline 0 C--N 1.304 -1.373 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.612 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -64.49 151.82 84.05 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.538 1.492 . . . . 0.0 111.802 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 46' ' ' GLN . 3.7 t -82.0 -61.33 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.874 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.415 ' N ' HG12 ' A' ' 45' ' ' VAL . 4.7 tp60 -173.36 177.78 2.54 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.661 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -167.35 166.1 14.72 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.894 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -162.12 157.48 23.35 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.907 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.4 p -102.66 166.07 10.71 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.159 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.583 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -153.49 147.04 18.22 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.0 OUTLIER -59.85 17.98 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.393 1.396 . . . . 0.0 112.989 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 62.43 -2.21 1.25 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -81.0 -43.35 19.74 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.433 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 104.55 8.01 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.914 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 m -79.24 8.15 6.48 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.085 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 21' ' ' SER . 1.9 p -137.5 159.62 41.44 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.518 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.57 144.5 3.61 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.332 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.3 m -95.33 146.33 24.46 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.308 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.514 HD11 ' CD2' ' A' ' 36' ' ' TYR . 1.1 tt -141.08 145.33 25.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.842 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.24 167.51 22.26 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.061 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.66 49.27 1.11 Allowed Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.796 -1.192 . . . . 0.0 110.867 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.99 -156.45 0.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.434 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -144.32 158.99 53.57 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.801 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.71 106.49 0.37 Allowed 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 121.384 1.389 . . . . 0.0 112.013 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.74 89.19 0.03 OUTLIER Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.472 -1.347 . . . . 0.0 111.05 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.2 136.68 12.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.926 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -52.75 124.05 12.9 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.009 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.32 126.84 41.57 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.445 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.2 m -107.84 110.85 22.73 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.103 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 71' ' ' THR . 0.6 OUTLIER -96.19 137.35 24.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.23 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.548 ' N ' HD12 ' A' ' 70' ' ' ILE . 24.7 m -138.31 139.17 38.97 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.286 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.44 139.08 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.066 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.462 ' CE2' ' CG ' ' A' ' 87' ' ' PRO . 1.7 m-85 -118.56 113.89 21.97 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.783 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.03 125.56 35.86 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.953 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.92 100.91 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.621 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 77' ' ' GLY . 1.6 p -95.79 -40.19 9.47 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.251 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 76' ' ' THR . . . 51.54 103.9 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.286 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.57 148.41 32.22 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.948 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.37 -106.5 2.06 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.137 -1.506 . . . . 0.0 109.984 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -149.49 -49.48 0.14 Allowed 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.101 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.8 146.25 95.07 Favored Pre-proline 0 C--N 1.306 -1.326 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.794 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.25 119.61 6.85 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.092 1.195 . . . . 0.0 111.406 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.53 80.83 1.97 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.727 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 t -63.79 148.03 50.29 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.666 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.1 m -84.9 -99.9 0.06 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -155.76 81.85 3.8 Favored Pre-proline 0 C--N 1.298 -1.662 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.821 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.462 ' CG ' ' CE2' ' A' ' 73' ' ' TYR . 12.6 Cg_exo -53.62 161.42 4.33 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 120.94 1.093 . . . . 0.0 110.687 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.42 162.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 118.491 -1.284 . . . . 0.0 111.403 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.6 p -147.74 157.66 43.65 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.085 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.7 pt -144.15 143.5 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.711 -0.795 . . . . 0.0 110.68 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -93.77 149.78 20.95 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.133 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -172.26 132.96 0.65 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.644 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.65 122.8 28.59 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.326 -0.949 . . . . 0.0 110.379 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 116.336 -1.792 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 121.034 0.445 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.8 p -150.95 41.18 0.75 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.389 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -154.42 53.17 0.67 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.429 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 t -105.21 135.91 19.26 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.664 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.77 158.09 21.63 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 120.748 0.965 . . . . 0.0 111.206 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.61 -176.0 0.83 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.327 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 45.63 62.94 1.98 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.783 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mt -101.05 120.74 40.65 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.133 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -158.27 176.45 12.46 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.418 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.24 124.2 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.937 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 t -69.5 -72.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.171 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.84 174.29 11.62 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.777 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -131.7 168.37 17.87 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.13 160.64 36.8 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.278 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 16' ' ' THR . 2.6 Cg_exo -50.54 99.64 0.04 OUTLIER 'Trans proline' 0 C--O 1.212 -0.786 0 C-N-CA 120.656 0.904 . . . . 0.0 111.092 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.463 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.6 OUTLIER 75.05 41.03 0.32 Allowed 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.304 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.48 141.05 2.9 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.12 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 tp -130.25 152.07 50.08 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.7 tp -126.11 110.55 13.64 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.157 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -101.63 157.79 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.441 -0.903 . . . . 0.0 111.228 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.64 137.57 18.13 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.552 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.485 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 8.2 p90 -135.96 -149.77 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.952 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.485 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 10.2 t70 -136.09 133.23 37.11 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.279 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.58 135.83 20.06 Favored Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.335 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.453 ' HB2' HG22 ' A' ' 27' ' ' VAL . 2.0 Cg_endo -60.76 178.4 0.49 Allowed 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.584 0.856 . . . . 0.0 111.485 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -102.58 52.21 0.8 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.023 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 25' ' ' PRO . 30.5 m -135.41 169.53 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.059 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -69.4 75.92 0.38 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.233 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.422 ' HA ' HG22 ' A' ' 76' ' ' THR . 98.4 t -65.32 130.13 30.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.658 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.444 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 20.5 mmm-85 -76.32 -61.06 2.07 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.217 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 75.9 m-85 -154.16 169.56 23.3 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.297 -1.361 . . . . 0.0 112.68 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.56 133.51 38.43 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.744 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -123.27 118.88 28.59 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.889 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.5 mt -101.03 123.31 53.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.9 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 p -124.59 136.36 53.89 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.543 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.698 ' CZ ' HD11 ' A' ' 59' ' ' ILE . 7.9 p90 -139.83 161.65 37.05 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.81 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.5 152.31 13.15 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.442 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.91 145.04 38.49 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.557 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.8 m -69.76 141.18 53.46 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.792 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.22 -39.14 0.15 Allowed Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.374 -1.394 . . . . 0.0 110.492 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.23 -108.65 0.27 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.302 -1.428 . . . . 0.0 110.504 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -126.27 67.33 1.21 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.428 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.3 t -143.45 70.43 17.67 Favored Pre-proline 0 C--N 1.307 -1.264 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.181 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.22 132.68 34.85 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.402 1.401 . . . . 0.0 111.174 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 46' ' ' GLN . 15.1 t -55.57 -68.7 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 118.956 -1.098 . . . . 0.0 110.293 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.47 ' N ' HG12 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -171.7 -159.22 0.14 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.012 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.31 172.15 7.42 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.315 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -161.79 138.08 8.02 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.941 -1.104 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.9 p -86.65 152.35 22.65 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.152 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 50' ' ' VAL . 12.2 p -165.13 136.55 3.25 Favored Pre-proline 0 C--N 1.301 -1.522 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.44 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 53' ' ' SER . 3.5 Cg_exo -51.94 134.95 50.27 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 120.295 0.663 . . . . 0.0 111.471 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.18 3.61 1.07 Allowed Glycine 0 N--CA 1.484 1.898 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.899 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -68.87 -34.62 75.75 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 118.876 -1.13 . . . . 0.0 110.285 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -79.68 119.65 22.91 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.796 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.5 -7.17 59.58 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.236 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.6 p -137.37 160.16 39.87 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.605 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.95 141.96 17.1 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.311 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.9 m -101.98 144.04 31.09 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.436 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.698 HD11 ' CZ ' ' A' ' 36' ' ' TYR . 4.4 tt -141.33 149.34 20.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.204 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.2 t -149.25 124.99 10.47 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.748 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.07 14.81 0.1 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.287 -1.435 . . . . 0.0 110.541 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.31 -155.17 0.48 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.716 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -130.25 145.62 58.12 Favored Pre-proline 0 N--CA 1.493 1.703 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.4 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -71.07 121.87 8.24 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 120.863 1.042 . . . . 0.0 113.022 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.18 89.85 0.07 OUTLIER Glycine 0 N--CA 1.502 3.063 0 C-N-CA 119.989 -1.101 . . . . 0.0 112.93 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.9 p -171.89 148.86 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.176 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.15 142.02 57.19 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.792 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -144.08 151.37 39.53 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.25 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.83 125.02 46.47 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.516 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.405 HD12 ' H ' ' A' ' 71' ' ' THR . 3.3 tp -111.49 136.16 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.132 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.536 HG23 ' HB3' ' A' ' 89' ' ' SER . 87.5 m -138.91 121.92 16.73 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.632 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.7 m -105.6 144.02 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.137 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.47 92.27 3.9 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.417 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.48 90.27 5.65 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.248 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.452 HG22 ' OG ' ' A' ' 85' ' ' SER . 17.9 t -77.26 114.11 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.629 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 29' ' ' VAL . 2.4 p -140.07 131.31 26.6 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.469 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -148.44 104.85 0.29 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 79' ' ' GLY . 2.2 ttp-105 -118.88 -94.27 0.5 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.367 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 78' ' ' ARG . . . -48.78 -103.29 0.01 OUTLIER Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.606 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -131.22 -3.5 3.9 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.102 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.61 160.44 0.46 Allowed Pre-proline 0 C--N 1.304 -1.392 0 C-N-CA 118.976 -1.089 . . . . 0.0 110.227 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.483 ' C ' ' N ' ' A' ' 84' ' ' SER . 3.0 Cg_endo -63.23 109.28 0.94 Allowed 'Trans proline' 0 C--O 1.216 -0.59 0 C-N-CA 121.203 1.269 . . . . 0.0 111.433 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.79 -14.4 0.13 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.371 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.483 ' N ' ' C ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -68.66 103.0 1.61 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.41 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.452 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -43.69 167.77 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.938 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -117.06 86.41 20.13 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.31 144.6 98.65 Favored 'Trans proline' 0 C--O 1.213 -0.771 0 C-N-CA 121.067 1.178 . . . . 0.0 113.526 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 88' ' ' ILE . 8.7 tt -143.75 129.92 16.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.854 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.536 ' HB3' HG23 ' A' ' 71' ' ' THR . 46.0 p -129.84 165.12 22.65 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.275 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -151.45 146.86 15.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.415 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.15 149.28 28.04 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.219 -0.993 . . . . 0.0 110.194 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -158.44 134.81 9.37 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.194 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.435 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -93.75 114.28 26.52 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.979 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 116.27 -1.824 . . . . 0.0 110.955 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 2' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 1' ' ' VAL . 0.8 OUTLIER 57.19 113.2 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.741 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.97 -11.9 8.05 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.869 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.01 136.45 96.69 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.89 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.65 172.97 1.8 Allowed 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 120.621 0.881 . . . . 0.0 111.406 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -158.48 168.08 27.91 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.504 -0.879 . . . . 0.0 110.689 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 53.44 60.2 3.87 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.602 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -100.31 135.17 42.16 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.179 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -178.26 176.89 1.04 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 118.729 -1.189 . . . . 0.0 111.97 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.0 t -99.09 116.04 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.964 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.769 HG23 ' OG ' ' A' ' 21' ' ' SER . 5.5 t -71.1 -25.43 25.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.797 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 163.78 168.6 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.78 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -129.22 157.93 40.44 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.155 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.68 161.93 28.77 Favored Pre-proline 0 C--N 1.305 -1.334 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.767 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 16' ' ' THR . 6.1 Cg_exo -54.65 106.22 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 121.217 1.278 . . . . 0.0 111.849 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.464 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER 74.54 34.11 0.79 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.856 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 99.5 p -172.14 138.77 1.02 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.026 -1.07 . . . . 0.0 111.199 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.0 tp -131.05 122.3 26.52 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.902 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -96.94 113.64 25.2 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.354 -0.938 . . . . 0.0 112.156 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 pt -105.41 167.11 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.549 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.769 ' OG ' HG23 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -160.66 133.98 6.68 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.324 -1.35 . . . . 0.0 111.807 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.59 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 4.9 p90 -139.25 -142.46 0.15 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.053 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.59 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 5.6 t70 -140.73 159.29 42.53 Favored 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 118.634 -1.227 . . . . 0.0 113.042 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.425 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -147.12 115.59 4.32 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.945 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.34 -169.77 0.1 OUTLIER 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 120.392 0.728 . . . . 0.0 111.775 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.17 5.59 30.14 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.651 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -68.61 169.74 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 118.512 -1.275 . . . . 0.0 110.838 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.2 m -68.71 73.55 0.25 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.554 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 27' ' ' VAL . 2.4 t -70.08 127.92 32.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.985 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.411 ' H ' ' HA ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -68.75 -50.65 48.84 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.433 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.405 ' CE2' ' CG ' ' A' ' 30' ' ' ARG . 0.7 OUTLIER 177.28 168.89 0.6 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.9 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -121.92 165.33 16.12 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.334 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -141.03 106.92 5.14 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.505 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.8 mt -98.43 111.55 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.43 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.464 HG22 ' HB2' ' A' ' 47' ' ' GLU . 15.3 p -124.34 133.22 53.5 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.106 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -128.27 138.88 52.62 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.13 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.434 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -154.01 137.84 5.93 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.223 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -67.2 163.79 19.59 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.596 -0.842 . . . . 0.0 111.126 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 39' ' ' THR . 7.4 t -66.67 131.02 45.09 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.54 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.46 81.76 0.06 OUTLIER Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.158 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 43' ' ' SER . . . -143.77 111.78 0.65 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.99 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -59.38 -5.29 0.74 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.424 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.458 ' H ' ' C ' ' A' ' 41' ' ' GLY . 30.2 m -145.57 93.81 5.25 Favored Pre-proline 0 C--N 1.303 -1.438 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.227 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.56 151.58 45.58 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 120.428 0.752 . . . . 0.0 110.915 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.434 HG23 ' HA2' ' A' ' 37' ' ' GLY . 23.3 t -49.39 -75.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.987 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -171.84 169.54 5.77 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.837 -1.145 . . . . 0.0 111.466 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HB2' HG22 ' A' ' 35' ' ' THR . 11.0 pt-20 -148.76 159.47 44.11 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.298 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -168.76 134.38 1.7 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 118.941 -1.104 . . . . 0.0 111.053 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.5 162.32 14.26 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.058 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -145.96 161.56 39.29 Favored Pre-proline 0 C--N 1.307 -1.265 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.104 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.96 20.09 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 120.925 1.083 . . . . 0.0 111.858 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 55.2 22.89 31.06 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.335 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.24 -40.04 9.36 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.989 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -72.82 117.2 14.24 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.77 -23.15 42.4 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.664 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.5 p -125.01 161.65 26.24 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.0 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.451 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -155.83 150.89 26.53 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.75 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.2 m -123.72 108.0 12.07 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.419 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.2 pt -108.75 159.24 8.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.832 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.3 t -145.27 140.99 28.2 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.181 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.522 ' C ' HD13 ' A' ' 62' ' ' LEU . . . 164.0 11.11 0.03 OUTLIER Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.455 -1.355 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.867 HD13 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -131.09 150.59 52.08 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.886 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.772 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -126.24 -38.33 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.851 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.026 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.772 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 5.4 Cg_endo -80.81 -168.57 0.65 Allowed 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 121.425 1.417 . . . . 0.0 111.629 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -130.42 73.54 0.46 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.68 HG22 ' N ' ' A' ' 67' ' ' ASP . 14.1 p -114.14 174.5 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.573 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.68 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -59.97 140.34 56.81 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.991 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.35 123.41 20.32 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.553 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.85 113.23 25.97 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.17 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -102.19 150.11 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.108 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.44 HG23 ' CB ' ' A' ' 89' ' ' SER . 3.9 m -144.52 127.45 16.41 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.507 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.54 143.72 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.765 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -114.3 137.15 52.16 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.656 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.77 97.86 5.83 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.26 132.99 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.28 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 77' ' ' GLY . 4.0 m -137.97 -20.21 1.13 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.832 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 76' ' ' THR . . . 33.4 -110.03 0.05 OUTLIER Glycine 0 N--CA 1.503 3.132 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.817 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -58.98 158.51 8.34 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.872 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.28 -27.89 2.84 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.141 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 170.9 -58.02 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.432 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -116.65 83.96 14.6 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.448 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.63 83.77 0.08 OUTLIER 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 120.676 0.917 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 81' ' ' SER . . . -130.7 101.1 5.53 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.553 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.8 p -49.71 108.75 0.22 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.809 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.87 -168.32 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -133.25 136.29 27.04 Favored Pre-proline 0 N--CA 1.487 1.413 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.833 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.73 149.27 88.61 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 120.681 0.92 . . . . 0.0 111.64 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.3 tt -137.09 135.06 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.117 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.44 ' CB ' HG23 ' A' ' 71' ' ' THR . 0.0 OUTLIER -136.04 164.81 27.14 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.196 -1.002 . . . . 0.0 112.697 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -146.37 154.13 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.574 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.57 145.75 29.57 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.257 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -159.98 147.27 16.45 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.164 -1.015 . . . . 0.0 111.075 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.556 ' N ' ' CD ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -88.01 103.24 15.52 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.739 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 116.503 -1.713 . . . . 0.0 110.614 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 74.4 t . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.863 0.363 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -88.96 -75.29 0.44 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.689 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -146.32 -51.02 0.22 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.421 -0.911 . . . . 0.0 110.661 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.3 t -90.54 132.82 34.15 Favored Pre-proline 0 C--N 1.306 -1.296 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.368 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -64.3 -65.56 0.05 OUTLIER 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 120.161 0.574 . . . . 0.0 111.64 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -167.08 -166.16 0.78 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 117.628 -1.629 . . . . 0.0 113.538 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.441 ' OD2' ' OE1' ' A' ' 9' ' ' GLU . 18.2 t0 -74.84 96.01 3.03 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.762 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 23' ' ' ASP . 5.3 tt -43.74 112.74 0.42 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.316 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.441 ' OE1' ' OD2' ' A' ' 7' ' ' ASP . 5.8 pt-20 -179.04 163.81 1.37 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.632 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.2 t -75.75 132.89 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.361 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.668 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 9.2 p -104.61 -23.07 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 118.601 -1.239 . . . . 0.0 112.383 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 165.78 174.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.568 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.39 152.31 42.71 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.715 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.95 163.41 22.96 Favored Pre-proline 0 N--CA 1.486 1.356 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.282 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.618 ' C ' HG23 ' A' ' 16' ' ' THR . 10.2 Cg_exo -46.84 103.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 120.54 0.827 . . . . 0.0 110.477 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.618 HG23 ' C ' ' A' ' 15' ' ' PRO . 1.6 p 69.7 37.9 1.79 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.597 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.54 145.96 19.28 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.312 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.6 tp -123.41 122.53 38.51 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.988 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.747 HD23 ' O ' ' A' ' 57' ' ' ALA . 1.2 mt -96.56 121.58 38.54 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.092 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -124.36 151.88 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -122.97 131.73 53.84 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.132 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.522 ' NE1' ' CE2' ' A' ' 32' ' ' TYR . 25.6 p90 -119.95 -175.01 2.89 Favored 'General case' 0 N--CA 1.513 2.711 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.557 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER 178.05 157.02 0.41 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 112.826 -1.988 . . . . 0.0 110.446 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.6 ' HB3' ' HD3' ' A' ' 25' ' ' PRO . . . 173.78 -46.46 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -68.01 148.36 75.66 Favored 'Trans proline' 0 C--O 1.211 -0.853 0 C-N-CA 121.186 1.257 . . . . 0.0 113.786 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.61 -16.74 14.44 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.543 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.53 179.44 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.932 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 p -49.59 168.33 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 118.565 -1.254 . . . . 0.0 109.095 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.71 113.24 4.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.045 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -60.39 3.42 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 118.783 -1.167 . . . . 0.0 108.143 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -154.13 161.48 41.85 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.036 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.522 ' CE2' ' NE1' ' A' ' 22' ' ' TRP . 3.2 m-85 -108.03 164.1 12.57 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.351 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -147.05 95.13 2.52 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.191 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.5 mt -91.26 135.15 27.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.399 -0.921 . . . . 0.0 111.605 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 p -138.63 137.38 36.86 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.825 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -137.88 160.2 39.94 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.797 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.21 135.77 3.17 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.405 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.86 108.36 8.67 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.466 -0.893 . . . . 0.0 110.769 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.3 m -49.38 98.88 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.768 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.54 -56.62 0.08 OUTLIER Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.128 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.59 -174.07 8.78 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 119.406 -1.378 . . . . 0.0 110.315 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.84 5.12 47.59 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.823 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.59 150.07 30.03 Favored Pre-proline 0 C--N 1.307 -1.242 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.463 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -64.23 169.42 10.82 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 121.122 1.214 . . . . 0.0 111.612 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 46' ' ' GLN . 3.3 t -75.99 -61.45 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.071 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.432 ' N ' HG12 ' A' ' 45' ' ' VAL . 3.6 tt0 -173.59 -170.26 0.58 Allowed 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.8 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -168.69 176.52 5.56 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.673 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -176.13 150.24 0.94 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.336 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.5 p -111.58 153.65 25.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.05 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.5 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -143.06 150.14 51.58 Favored Pre-proline 0 C--N 1.303 -1.453 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.905 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' A' ' 53' ' ' SER . 3.7 Cg_endo -65.78 28.74 0.1 OUTLIER 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 120.923 1.082 . . . . 0.0 112.483 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 53.59 8.6 0.9 Allowed Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.063 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -72.27 -32.14 66.38 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.547 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -95.72 154.44 17.22 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.29 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 m -104.01 -22.79 13.4 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.135 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.0 p -122.91 -175.25 3.12 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.324 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.747 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -171.11 175.09 4.43 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.297 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.8 t -131.08 141.71 50.2 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.528 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 59' ' ' ILE . 4.2 mt -132.31 111.32 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.408 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -109.05 147.54 32.2 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.585 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.19 20.66 4.33 Favored Glycine 0 N--CA 1.501 2.996 0 C-N-CA 119.841 -1.171 . . . . 0.0 110.255 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.688 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -106.46 -174.28 2.5 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.42 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -136.84 122.55 13.21 Favored Pre-proline 0 N--CA 1.487 1.422 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.883 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.08 118.8 5.73 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 120.209 0.606 . . . . 0.0 111.671 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.38 64.7 0.7 Allowed Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.607 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 p -164.69 148.37 2.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 119.156 -1.017 . . . . 0.0 111.592 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -70.31 152.45 44.15 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.893 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.63 140.83 26.32 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.711 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.2 m -117.88 107.42 14.08 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.411 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.473 ' CG1' ' N ' ' A' ' 71' ' ' THR . 5.1 tt -102.61 160.92 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.014 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.498 HG23 ' OG ' ' A' ' 89' ' ' SER . 91.0 m -160.5 139.59 10.58 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.167 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 m -131.36 123.71 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.663 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.89 129.99 53.13 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.392 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.19 104.18 14.3 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.99 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.28 121.04 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 119.049 -1.061 . . . . 0.0 112.443 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -89.95 -35.56 15.49 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.585 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.41 145.09 0.04 OUTLIER Glycine 0 N--CA 1.493 2.498 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.027 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.81 -27.14 7.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.678 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.0 -10.82 0.78 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.308 -1.425 . . . . 0.0 110.779 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -168.96 -57.13 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.343 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.7 115.8 62.38 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.849 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.07 100.69 0.37 Allowed 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 120.451 0.767 . . . . 0.0 111.248 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.07 127.85 32.94 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.745 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.27 116.53 15.03 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.842 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.483 ' OG ' ' N ' ' A' ' 86' ' ' LYS . 16.4 t -85.67 -104.41 0.06 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.736 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.483 ' N ' ' OG ' ' A' ' 85' ' ' SER . 47.3 tttt -137.95 62.68 34.59 Favored Pre-proline 0 N--CA 1.486 1.332 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.397 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.08 164.48 14.34 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 121.348 1.365 . . . . 0.0 110.572 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 88' ' ' ILE . 9.3 tt -151.29 135.27 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 117.983 -1.487 . . . . 0.0 111.723 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.498 ' OG ' HG23 ' A' ' 71' ' ' THR . 1.0 OUTLIER -127.73 139.5 52.65 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.734 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 pt -149.7 157.94 6.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 118.749 -1.18 . . . . 0.0 111.806 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.97 159.77 14.8 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.796 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -167.69 130.86 1.66 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.06 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.3 mtm-85 -88.34 119.31 28.64 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.145 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 116.337 -1.792 . . . . 0.0 110.975 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.826 0.346 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.4 m -70.05 151.69 45.24 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.673 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -157.1 -14.93 0.09 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.138 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -73.08 134.57 80.64 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.292 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -57.95 173.24 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 120.522 0.814 . . . . 0.0 111.087 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.6 ptt85 -175.25 -163.27 0.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.489 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 57.05 7.76 0.46 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.822 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.424 ' O ' ' OE1' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -56.9 122.44 12.24 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.209 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -157.92 158.24 34.64 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.871 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.3 t -93.56 115.22 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.576 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.487 ' CG2' ' OG ' ' A' ' 21' ' ' SER . 2.2 t -70.75 -68.71 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 118.818 -1.153 . . . . 0.0 111.197 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.12 174.82 12.76 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.522 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.54 162.87 34.34 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.411 ' C ' ' N ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -135.16 161.17 65.09 Favored Pre-proline 0 N--CA 1.484 1.238 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.734 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' O ' HG23 ' A' ' 16' ' ' THR . 2.7 Cg_exo -50.76 -14.38 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 120.893 1.062 . . . . 0.0 110.944 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 15' ' ' PRO . 7.8 p -158.4 50.8 0.4 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.69 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.56 143.13 0.18 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.437 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.5 tp -130.16 140.83 50.72 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.111 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.91 110.19 17.43 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.42 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 pp -106.41 147.04 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.487 ' OG ' ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -145.46 136.74 24.95 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.271 -0.971 . . . . 0.0 110.609 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.633 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 4.0 p90 -138.15 -144.43 0.18 Allowed 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.523 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.633 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 12.5 t70 -148.49 168.23 23.27 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.347 -1.341 . . . . 0.0 112.994 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.45 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . -133.14 145.67 57.84 Favored Pre-proline 0 N--CA 1.486 1.364 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.991 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.93 -176.88 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 120.798 0.999 . . . . 0.0 111.333 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.47 -30.75 14.27 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.74 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.536 ' CG2' ' N ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -61.74 164.21 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.593 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.536 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 1.0 OUTLIER -73.21 111.61 8.49 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.209 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.905 HG13 HG22 ' A' ' 76' ' ' THR . 5.0 t -99.82 147.27 7.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.28 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -73.0 -70.17 0.37 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.484 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -158.66 163.24 37.06 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.61 -1.236 . . . . 0.0 112.046 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -121.0 152.59 38.4 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.661 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 -131.0 115.33 16.34 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.296 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 mp -106.81 113.45 43.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.548 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -119.56 137.94 53.52 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.709 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.68 ' CE2' HD12 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -136.71 157.54 46.53 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.195 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.53 153.23 9.78 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -67.9 160.29 28.8 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.457 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 m -75.24 152.33 38.31 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.0 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 44.78 41.64 7.29 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.482 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.14 142.15 15.91 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.277 -1.44 . . . . 0.0 110.304 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -63.65 -18.82 64.35 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.626 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 t -158.35 131.25 4.51 Favored Pre-proline 0 C--N 1.304 -1.376 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.809 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.02 154.26 52.23 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 120.309 0.673 . . . . 0.0 111.161 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.499 HG12 ' N ' ' A' ' 46' ' ' GLN . 5.7 t -67.34 -67.44 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.812 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.499 ' N ' HG12 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -175.19 178.48 1.71 Allowed 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.129 -1.028 . . . . 0.0 111.359 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -170.8 150.35 3.22 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.363 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.565 ' CE2' ' OH ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -146.03 164.62 31.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.673 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.2 p -116.89 156.3 27.58 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.436 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.695 HG23 ' H ' ' A' ' 52' ' ' GLY . 6.0 m -146.28 151.67 44.66 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.805 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.96 20.83 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.074 1.182 . . . . 0.0 112.586 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.695 ' H ' HG23 ' A' ' 50' ' ' VAL . . . 66.75 4.75 27.79 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.219 -1.467 . . . . 0.0 110.211 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.71 -45.98 14.93 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.759 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.66 107.42 7.81 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.605 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.8 m -82.81 14.2 3.38 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 21' ' ' SER . 1.3 p -138.65 163.42 32.14 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.633 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.5 139.43 7.92 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.587 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.9 m -110.12 134.12 52.51 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.607 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.68 HD12 ' CE2' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -132.53 154.54 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.017 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t -136.45 -167.89 2.15 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.511 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.499 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 65.12 73.96 0.53 Allowed Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.309 -1.424 . . . . 0.0 109.867 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 61' ' ' GLY . 10.7 mt -126.74 177.57 6.48 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.312 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.54 128.27 25.88 Favored Pre-proline 0 CA--C 1.559 1.324 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -53.76 98.01 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 120.415 0.743 . . . . 0.0 112.889 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.11 97.29 0.22 Allowed Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.124 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -167.11 138.72 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.639 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.35 109.8 0.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.882 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.8 140.39 42.31 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.962 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.57 130.39 52.6 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.548 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.67 162.57 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.618 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.6 m -150.55 116.31 5.53 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.761 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 72' ' ' VAL . 6.0 m -102.74 121.22 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.859 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -99.1 130.95 45.45 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.581 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.44 89.64 3.1 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.884 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.6 t -92.39 127.93 44.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.103 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.905 HG22 HG13 ' A' ' 29' ' ' VAL . 24.2 p -128.49 -109.4 0.28 Allowed 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.567 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 76' ' ' THR . . . 59.34 154.54 0.01 OUTLIER Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.321 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.2 mtm105 -120.18 17.15 12.38 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.543 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.24 73.25 1.26 Allowed Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.466 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 179.13 -54.7 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.84 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.5 t -131.79 72.57 79.73 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.548 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.04 105.76 0.71 Allowed 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 121.267 1.311 . . . . 0.0 111.189 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.37 79.13 1.88 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.106 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.4 p -79.95 86.68 5.43 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.928 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 p -115.24 20.31 15.0 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.992 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.672 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 12.2 mtmt -114.81 0.66 0.09 OUTLIER Pre-proline 0 CA--C 1.577 2.013 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 86' ' ' LYS . 2.9 Cg_endo -61.99 149.42 90.35 Favored 'Trans proline' 0 C--N 1.355 0.897 0 CA-C-N 120.258 1.128 . . . . 0.0 110.844 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -148.29 162.16 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 118.554 -1.258 . . . . 0.0 110.732 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.88 164.71 28.96 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.086 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 pt -150.41 135.54 10.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.542 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -109.48 131.87 54.66 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.84 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -161.71 135.75 6.75 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.487 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -68.32 114.1 6.48 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.659 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 116.29 -1.814 . . . . 0.0 110.729 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.828 0.347 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.37 117.89 13.48 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.893 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.2 17.95 0.14 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.847 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.2 t -50.67 122.68 16.67 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.24 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.1 -41.15 23.44 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 120.243 0.628 . . . . 0.0 111.932 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' TRP . 17.1 tpt180 -168.71 151.55 5.18 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.435 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.31 103.31 1.23 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.409 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mt -39.17 122.78 1.29 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.093 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -175.82 157.89 2.03 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 118.719 -1.192 . . . . 0.0 112.55 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.69 113.73 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.488 ' H ' HG23 ' A' ' 11' ' ' VAL . 1.4 t -71.72 -71.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 118.758 -1.177 . . . . 0.0 112.169 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.99 175.52 10.39 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.022 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.45 147.56 51.7 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.074 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.82 161.37 49.35 Favored Pre-proline 0 C--N 1.305 -1.335 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.355 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.58 106.96 0.19 Allowed 'Trans proline' 0 C--O 1.211 -0.832 0 C-N-CA 121.045 1.163 . . . . 0.0 112.156 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 72.66 -3.71 2.29 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.99 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.26 136.48 49.22 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.707 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 tp -130.86 154.19 48.32 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.791 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.5 tp -116.79 122.09 43.42 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 pt -124.25 160.41 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -134.18 140.52 46.58 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.963 -1.471 . . . . 0.0 107.325 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.422 ' O ' ' O ' ' A' ' 6' ' ' ARG . 14.5 p90 -123.29 -168.15 1.72 Allowed 'General case' 0 N--CA 1.505 2.31 0 C-N-CA 118.402 -1.319 . . . . 0.0 114.069 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.467 ' CG ' ' N ' ' A' ' 24' ' ' ALA . 1.5 p-10 -143.27 -155.62 0.61 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.961 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.807 ' HB2' ' OH ' ' A' ' 32' ' ' TYR . . . -172.1 179.18 0.64 Allowed Pre-proline 0 N--CA 1.504 2.268 0 C-N-CA 119.114 -1.035 . . . . 0.0 111.187 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.76 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 9.3 Cg_endo -76.44 -118.6 0.01 OUTLIER 'Trans proline' 0 CA--C 1.568 2.199 0 C-N-CA 121.136 1.224 . . . . 0.0 111.73 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.408 ' H ' ' HB2' ' A' ' 25' ' ' PRO . . . -106.6 -61.01 1.58 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 28' ' ' THR . 2.9 m -58.76 155.77 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 119.631 -0.828 . . . . 0.0 112.418 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -60.19 -176.05 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.073 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.545 ' N ' ' OG1' ' A' ' 28' ' ' THR . 2.0 t -135.74 107.43 7.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.747 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.414 ' CD ' ' CZ ' ' A' ' 31' ' ' TYR . 1.6 ttm-85 -57.83 -64.84 0.77 Allowed 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.668 -1.213 . . . . 0.0 109.115 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.414 ' CZ ' ' CD ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -127.26 147.51 50.22 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.117 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.807 ' OH ' ' HB2' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -110.36 130.3 55.58 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.959 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -114.04 101.43 9.22 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.3 mt -92.94 123.86 45.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.862 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.2 p -124.93 135.11 52.54 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.765 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -130.06 155.49 46.07 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.086 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -174.11 151.32 12.78 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.977 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -85.92 136.17 33.39 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.662 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 m -44.74 106.59 0.08 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -172.37 73.67 0.1 OUTLIER Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.439 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.68 -165.76 53.84 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.762 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -99.32 55.97 1.0 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.198 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.55 84.9 15.47 Favored Pre-proline 0 C--N 1.305 -1.363 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.521 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.92 168.29 9.1 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 120.752 0.968 . . . . 0.0 111.774 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 46' ' ' GLN . 24.4 t -74.8 -72.29 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.92 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.486 ' N ' HG12 ' A' ' 45' ' ' VAL . 6.4 tt0 -157.28 168.7 26.64 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.076 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' OE1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -143.94 175.11 10.27 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.979 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.4 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 25.7 p90 -163.28 134.68 4.87 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.954 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.0 p -87.45 164.55 16.12 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.254 -0.979 . . . . 0.0 111.288 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.565 ' C ' ' H ' ' A' ' 52' ' ' GLY . 14.5 p -162.31 138.34 5.76 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.069 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 53' ' ' SER . 3.2 Cg_exo -60.56 23.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 120.953 1.102 . . . . 0.0 113.258 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 49.67 12.31 0.39 Allowed Glycine 0 N--CA 1.495 2.625 0 C-N-CA 119.488 -1.339 . . . . 0.0 110.77 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -59.77 -24.65 64.25 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.588 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -121.07 129.78 53.48 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.465 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -79.82 -9.62 59.68 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.037 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.3 p -140.09 154.86 47.17 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.763 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.84 160.67 25.39 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.674 -1.211 . . . . 0.0 111.499 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.6 m -90.24 157.47 17.67 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.535 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 59' ' ' ILE . 6.0 tt -150.75 128.96 2.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 119.396 -0.921 . . . . 0.0 110.416 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 t -134.66 117.29 15.91 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.699 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.69 -28.22 0.02 OUTLIER Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.607 -1.282 . . . . 0.0 110.146 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.534 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -78.85 -166.45 0.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.887 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.669 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.5 OUTLIER -165.33 -42.4 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.456 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.95 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.669 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 8.9 Cg_endo -85.56 -174.81 1.72 Allowed 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 121.358 1.372 . . . . 0.0 111.574 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.68 72.73 0.43 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.607 HG22 ' N ' ' A' ' 67' ' ' ASP . 5.1 p -124.31 169.52 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.239 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.607 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -49.1 110.51 0.37 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.879 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.99 134.81 54.31 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.724 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.45 134.36 55.17 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.509 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.44 158.72 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.908 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.565 HG23 ' OG ' ' A' ' 89' ' ' SER . 6.1 m -153.31 140.83 19.81 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 118.326 -1.35 . . . . 0.0 112.521 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.8 m -114.39 121.84 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -94.15 109.81 21.57 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.746 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.3 94.11 8.37 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.674 -1.211 . . . . 0.0 109.625 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.09 125.98 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.867 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 m -117.65 -77.02 0.57 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.964 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.15 136.22 3.63 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.777 -1.201 . . . . 0.0 111.227 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -97.67 165.25 12.06 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.353 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 80' ' ' ASP . . . -75.22 76.08 1.29 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.302 -1.428 . . . . 0.0 110.765 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.463 ' CG ' ' N ' ' A' ' 81' ' ' SER . 0.0 OUTLIER 169.32 -69.84 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.886 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.463 ' N ' ' CG ' ' A' ' 80' ' ' ASP . 17.3 t -117.43 101.51 52.64 Favored Pre-proline 0 N--CA 1.488 1.429 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.956 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -63.91 103.3 0.4 Allowed 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 120.534 0.823 . . . . 0.0 111.242 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -121.71 127.03 50.27 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.441 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.88 134.96 40.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.025 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 p -69.61 -111.13 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.404 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.9 pttt -145.1 123.13 6.48 Favored Pre-proline 0 C--N 1.306 -1.316 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.996 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -70.04 165.23 31.98 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 120.527 0.818 . . . . 0.0 111.592 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 88' ' ' ILE . 12.5 tt -138.65 121.66 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.746 -0.782 . . . . 0.0 108.916 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.565 ' OG ' HG23 ' A' ' 71' ' ' THR . 0.5 OUTLIER -121.49 164.9 16.44 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.61 140.38 20.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.051 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -103.09 146.56 28.19 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.528 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -172.53 142.08 1.21 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.541 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -75.2 108.87 8.25 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.311 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 116.389 -1.767 . . . . 0.0 110.714 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 2' ' ' SER . 1.4 t . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.979 0.419 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 1' ' ' VAL . 0.7 OUTLIER 69.06 -166.92 0.18 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.565 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -164.59 80.74 0.38 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.621 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' PRO . 2.6 t -67.28 130.63 93.52 Favored Pre-proline 0 C--N 1.298 -1.631 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.512 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 4' ' ' VAL . 5.9 Cg_exo -57.68 -153.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 120.727 0.951 . . . . 0.0 110.239 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -163.99 163.27 23.47 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 117.431 -1.708 . . . . 0.0 113.866 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 6' ' ' ARG . 9.6 t70 12.27 87.02 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 CA-C-N 113.437 -1.711 . . . . 0.0 115.316 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mp -101.7 127.76 48.31 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -163.58 174.69 11.47 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 117.502 -1.679 . . . . 0.0 113.468 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.415 HG22 HG22 ' A' ' 20' ' ' ILE . 56.5 t -92.96 128.39 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.809 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.27 -2.41 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.47 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.556 ' HB3' ' HB3' ' A' ' 19' ' ' LEU . . . -169.19 160.42 9.65 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.914 -1.114 . . . . 0.0 111.251 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.62 150.01 27.23 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.529 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.418 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -137.4 162.11 56.92 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.874 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -55.39 -6.74 0.98 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.056 1.171 . . . . 0.0 111.433 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 14' ' ' THR . 0.6 OUTLIER -160.09 42.88 0.2 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.382 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.5 146.87 0.21 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.045 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.1 tp -130.44 120.57 24.41 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.28 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 4.7 tt -96.8 104.68 16.7 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.502 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.415 HG22 HG22 ' A' ' 10' ' ' VAL . 1.2 pp -104.88 153.43 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.652 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.08 144.58 24.92 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.468 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 9.9 p90 -135.25 -129.75 0.16 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.041 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 24' ' ' ALA . 9.1 t70 -153.27 172.17 17.41 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 117.954 -1.498 . . . . 0.0 112.345 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . -140.7 130.9 13.43 Favored Pre-proline 0 CA--C 1.556 1.193 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.848 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.62 171.03 3.79 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 120.528 0.819 . . . . 0.0 111.585 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.04 92.43 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.277 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.514 ' CG2' ' N ' ' A' ' 28' ' ' THR . 1.0 OUTLIER -60.97 161.62 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.5 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.514 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 10.6 p -80.01 121.65 25.76 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.066 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.631 HG13 ' OG1' ' A' ' 76' ' ' THR . 0.6 OUTLIER -91.65 129.68 41.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.509 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.405 ' H ' ' HA ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -54.15 -65.2 0.61 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.39 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.92 159.0 36.09 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.666 -1.214 . . . . 0.0 111.789 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 2.0 m-85 -119.4 146.04 45.7 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.56 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -129.56 111.21 12.5 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.4 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.8 mp -100.93 120.97 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.153 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 p -122.04 136.95 54.97 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.97 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 1.8 p90 -130.77 146.92 52.36 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.547 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -171.85 138.79 5.01 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.8 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -72.9 141.62 47.89 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.517 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 m -74.59 125.06 27.84 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.718 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -166.57 -82.65 0.05 OUTLIER Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.553 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 168.58 -12.04 0.06 OUTLIER Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.355 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -72.11 -83.79 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.166 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -170.81 153.38 4.0 Favored Pre-proline 0 C--N 1.302 -1.497 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.2 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.8 172.49 1.56 Allowed 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 121.07 1.18 . . . . 0.0 111.466 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.547 HG23 ' HA2' ' A' ' 37' ' ' GLY . 93.0 t -86.11 -65.29 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.403 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -172.24 -167.86 0.5 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.231 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.89 163.57 11.6 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.698 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 9.7 p90 -153.96 141.84 20.15 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.403 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -100.21 159.93 14.72 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.893 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.512 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -147.29 157.36 45.68 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.121 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.56 10.76 0.1 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.141 1.227 . . . . 0.0 112.096 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 61.07 26.86 66.32 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.062 -1.542 . . . . 0.0 109.818 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.63 -53.65 4.43 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.63 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -90.62 123.37 34.2 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.1 m -86.39 27.62 0.92 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.244 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.8 p -145.44 162.98 36.05 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.5 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.1 154.53 5.07 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.805 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.2 m -130.93 115.69 16.87 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.053 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.37 171.49 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.673 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 53.0 m -148.57 173.12 13.49 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.619 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.75 49.19 1.3 Allowed Glycine 0 N--CA 1.498 2.799 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.505 ' C ' HD12 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -130.51 -175.37 3.63 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.866 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -117.55 135.32 23.22 Favored Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.69 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.53 148.27 93.39 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.052 1.168 . . . . 0.0 112.799 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.18 82.91 0.03 OUTLIER Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.388 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -167.55 145.68 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 118.956 -1.098 . . . . 0.0 111.444 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -61.3 140.87 57.9 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.413 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.46 118.18 10.46 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.59 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.5 m -100.66 116.97 33.82 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.827 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 tt -107.37 149.13 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.11 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 m -141.81 120.6 12.68 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.912 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 72' ' ' VAL . 22.9 m -105.91 124.63 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.596 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -102.51 94.15 5.51 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.972 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.605 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . . . -90.95 132.04 36.2 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.704 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -136.09 119.43 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.969 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.631 ' OG1' HG13 ' A' ' 29' ' ' VAL . 85.2 m -107.37 -18.12 13.95 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.898 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.86 138.44 6.13 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.4 169.34 1.25 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.001 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.77 109.32 3.01 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -179.57 -89.63 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.116 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.588 ' H ' ' CD ' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -107.69 -44.16 0.12 Allowed Pre-proline 0 N--CA 1.486 1.334 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.913 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.588 ' CD ' ' H ' ' A' ' 81' ' ' SER . 2.0 Cg_endo -71.27 -163.37 0.13 Allowed 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 121.081 1.188 . . . . 0.0 111.311 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.01 139.93 57.68 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.736 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.84 -177.36 4.5 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.467 -0.893 . . . . 0.0 111.663 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.7 m -89.78 132.59 35.14 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.83 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -133.46 75.25 69.94 Favored Pre-proline 0 N--CA 1.491 1.597 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.703 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.14 158.58 51.23 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 121.492 1.461 . . . . 0.0 112.248 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 tt -145.89 153.42 13.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.092 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.43 151.58 46.37 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.069 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -145.76 140.25 21.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.58 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -88.88 151.28 22.44 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.755 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -162.46 134.94 5.64 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.138 -1.025 . . . . 0.0 111.102 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.2 mtt180 -93.84 110.69 22.33 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.992 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 116.395 -1.764 . . . . 0.0 110.574 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.895 0.379 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.45 109.35 6.08 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.496 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.02 -4.24 0.49 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.881 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.6 t -99.27 124.6 44.37 Favored Pre-proline 0 C--N 1.307 -1.276 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.208 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.61 164.61 4.14 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 CA-C-N 118.894 0.641 . . . . 0.0 110.905 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -165.35 165.87 19.05 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.229 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.2 t70 46.63 70.92 0.34 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.227 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -100.9 124.21 46.25 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.397 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -170.15 170.56 7.32 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.322 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.91 149.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.969 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 11' ' ' VAL . 7.6 p -129.98 -6.41 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.794 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.84 161.09 7.08 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.813 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.59 145.85 27.01 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.784 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.565 ' CB ' ' HG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -130.74 161.0 63.79 Favored Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.901 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.04 -10.08 2.54 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 121.236 1.29 . . . . 0.0 111.771 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 m -159.68 44.32 0.23 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.565 ' HG ' ' CB ' ' A' ' 14' ' ' THR . 0.1 OUTLIER 177.26 149.45 0.15 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.237 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.9 tp -131.18 148.64 52.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.062 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -122.71 116.91 24.56 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.696 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.3 pt -104.87 170.71 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.764 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.34 135.12 13.65 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.144 -1.023 . . . . 0.0 111.126 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.567 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 8.9 p90 -141.78 -140.78 0.13 Allowed 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.46 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.567 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 22.2 t70 -113.35 171.01 7.81 Favored 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 119.489 -0.885 . . . . 0.0 113.178 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.452 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -178.13 86.96 0.23 Allowed Pre-proline 0 N--CA 1.495 1.79 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.258 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -62.34 173.6 3.26 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.669 0.913 . . . . 0.0 111.794 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.51 -1.53 55.91 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.568 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.678 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.1 m -59.22 144.63 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 118.77 -1.172 . . . . 0.0 109.947 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.44 93.03 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.884 -1.126 . . . . 0.0 110.823 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.781 HG13 HG22 ' A' ' 76' ' ' THR . 4.5 t -91.2 133.96 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.756 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.486 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 3.8 mmm180 -73.79 -78.09 0.1 Allowed 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.32 -1.352 . . . . 0.0 108.773 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -149.79 153.61 37.1 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.526 -1.27 . . . . 0.0 112.022 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.16 167.58 9.9 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.175 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -145.07 106.65 4.24 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.674 -1.21 . . . . 0.0 111.419 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 mt -100.21 106.19 18.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.364 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 47' ' ' GLU . 43.3 p -107.45 136.66 46.88 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.494 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.576 ' CZ ' HG11 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -134.34 132.05 39.05 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.614 -0.834 . . . . 0.0 112.036 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -158.66 153.46 24.6 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.416 ' C ' ' H ' ' A' ' 40' ' ' GLY . 2.0 mt-10 -49.57 171.43 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.62 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -75.52 21.01 0.15 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.665 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 38' ' ' GLU . . . -148.28 -102.38 0.28 Allowed Glycine 0 N--CA 1.487 2.05 0 C-N-CA 119.028 -1.558 . . . . 0.0 110.47 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' A' ' 42' ' ' ASN . . . -178.54 13.75 0.03 OUTLIER Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.23 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.41 ' H ' ' H ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -59.83 -16.73 30.82 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.3 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 p 171.86 72.22 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.507 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.82 123.09 11.99 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.322 1.348 . . . . 0.0 110.384 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.576 HG11 ' CZ ' ' A' ' 36' ' ' TYR . 5.8 t -51.45 -89.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.313 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.592 ' CG ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -174.48 -140.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.305 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.592 ' H ' ' CG ' ' A' ' 46' ' ' GLN . 9.1 pt-20 -171.91 168.48 5.99 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.667 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -161.61 141.37 10.29 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.63 165.76 11.82 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.419 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.567 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -150.28 160.3 33.43 Favored Pre-proline 0 C--N 1.304 -1.411 0 C-N-CA 119.486 -0.885 . . . . 0.0 110.005 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.09 21.11 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.158 1.239 . . . . 0.0 112.254 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 42.81 32.59 1.42 Allowed Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.675 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.14 -53.29 3.69 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.554 -0.858 . . . . 0.0 111.267 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -75.86 136.22 40.16 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.08 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 m -83.83 -13.58 53.38 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.529 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.4 p -131.4 152.95 50.19 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.915 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.413 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -155.35 157.51 37.24 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.292 -1.363 . . . . 0.0 112.137 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 49.4 m -98.5 130.97 45.09 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.708 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 59' ' ' ILE . 5.1 tp -130.43 121.64 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.433 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.9 t -117.23 -168.77 1.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.32 51.11 5.1 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.73 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.36 -160.97 1.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.701 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -136.35 139.25 29.17 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.215 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -61.94 118.13 5.0 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 120.935 1.09 . . . . 0.0 111.614 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.79 89.08 0.07 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.531 -1.318 . . . . 0.0 111.031 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.5 p -163.48 138.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.135 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.89 114.38 5.67 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.824 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -119.89 145.92 46.25 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.978 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.6 m -112.92 111.44 22.2 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.294 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.901 HD12 ' N ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -102.36 130.46 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.081 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.901 ' N ' HD12 ' A' ' 70' ' ' ILE . 2.2 m -133.41 141.83 48.05 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.398 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.416 HG13 HD11 ' A' ' 70' ' ' ILE . 33.1 m -130.18 138.22 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.275 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.36 122.95 41.91 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.733 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.792 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -101.59 116.41 32.68 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.244 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.33 108.76 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.468 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.781 HG22 HG13 ' A' ' 29' ' ' VAL . 13.0 p -120.62 -82.96 0.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.7 109.59 0.64 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.409 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.8 mtp85 -100.97 -11.81 19.41 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.169 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.07 35.17 4.6 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.759 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -141.32 -48.5 0.4 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.481 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.77 164.99 23.48 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.714 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 84' ' ' SER . 2.8 Cg_exo -52.2 140.72 50.82 Favored 'Trans proline' 0 C--O 1.217 -0.575 0 C-N-CA 120.81 1.006 . . . . 0.0 111.319 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.74 -8.64 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.503 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 82' ' ' PRO . 93.9 p -58.92 99.03 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.329 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.792 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 61.3 p -84.17 -3.67 58.29 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.259 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.553 ' CB ' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER 96.8 67.16 0.01 OUTLIER Pre-proline 0 N--CA 1.518 2.929 0 O-C-N 124.598 1.186 . . . . 0.0 111.536 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.441 ' HD3' ' H ' ' A' ' 86' ' ' LYS . 2.9 Cg_exo -58.41 157.64 25.85 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.069 1.179 . . . . 0.0 110.598 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.94 156.4 6.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 C-N-CA 118.595 -1.242 . . . . 0.0 111.17 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.3 p -142.04 144.84 33.81 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.66 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -149.54 145.76 17.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.24 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.81 141.64 28.44 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.069 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -149.02 128.36 12.96 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.623 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -78.97 106.88 11.31 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.708 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 116.142 -1.885 . . . . 0.0 111.016 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 1' ' ' VAL . 2.5 p . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.847 0.356 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.59 -60.12 2.0 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.852 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -150.4 22.43 0.83 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.896 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.88 133.34 89.58 Favored Pre-proline 0 CA--C 1.562 1.416 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.624 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.67 165.58 13.41 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 120.744 0.963 . . . . 0.0 111.13 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 -172.4 144.23 1.5 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.054 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -71.72 89.21 1.01 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.053 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.466 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.4 mp -42.63 -79.53 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.728 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -175.38 -176.72 0.94 Allowed 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.649 -1.22 . . . . 0.0 112.229 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.2 t -93.35 146.95 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.64 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -94.25 -63.47 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.472 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.49 172.4 15.03 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.173 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.8 174.8 10.18 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.428 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -148.71 160.77 35.05 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.533 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -52.98 -6.29 0.25 Allowed 'Trans proline' 0 C--O 1.216 -0.587 0 C-N-CA 121.364 1.376 . . . . 0.0 111.851 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 14' ' ' THR . 2.0 t -165.22 48.94 0.1 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.452 ' HG ' ' CB ' ' A' ' 14' ' ' THR . 0.1 OUTLIER 174.87 147.5 0.08 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.798 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 tp -127.29 133.96 50.09 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.457 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.427 ' HA ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -98.83 111.75 24.04 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.395 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 pp -110.95 145.25 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.678 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.7 m -141.95 126.1 17.42 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.189 -1.004 . . . . 0.0 111.046 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.591 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 8.6 p90 -119.48 -144.1 0.36 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.778 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.591 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 19.7 t70 -136.07 172.09 13.51 Favored 'General case' 0 N--CA 1.514 2.729 0 C-N-CA 118.506 -1.278 . . . . 0.0 113.455 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.527 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -140.39 112.26 7.18 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.031 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HB2' HG12 ' A' ' 27' ' ' VAL . 1.0 OUTLIER -63.51 -176.66 0.33 Allowed 'Trans proline' 0 C--O 1.213 -0.726 0 C-N-CA 120.308 0.672 . . . . 0.0 111.647 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.76 -28.36 33.34 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.841 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.473 ' CG2' ' N ' ' A' ' 28' ' ' THR . 1.4 p -59.74 157.99 2.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 118.685 -1.206 . . . . 0.0 110.74 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.473 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -81.24 115.37 20.6 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.896 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.441 HG11 ' CD1' ' A' ' 32' ' ' TYR . 78.5 t -101.22 124.9 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.798 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.542 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.24 -63.68 1.11 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.126 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 9.0 m-85 -143.93 164.31 30.95 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.089 -1.045 . . . . 0.0 112.282 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.441 ' CD1' HG11 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -126.99 146.05 50.48 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.396 -1.274 . . . . 0.0 108.298 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.572 ' C ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -137.19 136.36 38.12 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.778 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.763 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.5 mp -121.09 119.92 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.293 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -114.19 138.06 50.96 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.593 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.475 ' CE2' HG11 ' A' ' 45' ' ' VAL . 8.3 p90 -135.84 154.2 51.25 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.803 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.448 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -171.16 169.61 42.61 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -76.01 -162.9 0.25 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.847 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.8 t -75.92 144.02 41.32 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.31 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 37.2 50.44 1.64 Allowed Glycine 0 N--CA 1.499 2.878 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.827 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 43' ' ' SER . . . -103.15 99.16 1.74 Allowed Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.417 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -60.07 -7.42 1.81 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.663 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 41' ' ' GLY . 79.4 p -131.14 84.61 56.84 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.18 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -55.29 151.61 35.44 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 120.687 0.925 . . . . 0.0 111.858 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.475 HG11 ' CE2' ' A' ' 36' ' ' TYR . 50.6 t -48.78 -60.49 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.796 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -175.69 -169.79 0.37 Allowed 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.194 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -164.36 160.48 20.86 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.855 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.436 ' O ' ' CD1' ' A' ' 48' ' ' PHE . 42.3 p90 -155.51 142.46 19.08 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.726 -1.189 . . . . 0.0 111.185 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.9 140.78 29.13 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.348 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.6 155.69 80.3 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.056 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' A' ' 53' ' ' SER . 0.9 OUTLIER -61.66 118.23 5.09 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 120.436 0.757 . . . . 0.0 110.795 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -49.41 -6.46 0.06 OUTLIER Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.034 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -64.12 -36.45 84.06 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.25 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -83.72 157.63 22.08 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.059 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -120.65 -6.28 9.69 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.607 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.6 p -133.22 161.8 33.5 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.163 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.14 165.18 27.37 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.8 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.1 m -128.98 118.24 22.27 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.493 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.1 pt -108.4 149.23 11.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.701 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.4 t -144.88 151.27 38.46 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.971 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.19 7.6 1.71 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.715 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -130.62 -179.61 5.39 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.12 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.551 ' N ' HD22 ' A' ' 62' ' ' LEU . 4.2 mptp? -125.66 118.05 24.5 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.814 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.1 112.64 1.74 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 120.399 0.733 . . . . 0.0 111.346 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 94' ' ' THR . . . 158.28 30.84 0.02 OUTLIER Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.687 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 67' ' ' ASP . 7.7 p -165.68 164.8 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.406 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.508 ' N ' HG22 ' A' ' 66' ' ' VAL . 24.0 t70 -67.33 104.64 1.55 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.2 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.13 152.9 26.47 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.376 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 m -121.05 128.06 52.29 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.539 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.979 HD12 ' N ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -114.02 136.32 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.63 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.979 ' N ' HD12 ' A' ' 70' ' ' ILE . 47.2 m -132.96 145.48 50.93 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.95 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.0 m -128.57 140.54 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.383 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -118.42 141.47 48.52 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.439 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.08 105.86 12.28 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.075 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.542 ' CG2' ' HE ' ' A' ' 33' ' ' ARG . 3.5 t -108.03 130.86 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.489 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.519 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 43.1 p -131.03 -119.94 0.22 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.629 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.519 ' N ' ' OG1' ' A' ' 76' ' ' THR . . . 71.1 163.63 5.39 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.403 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -99.99 -76.8 0.54 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.212 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.04 33.17 0.15 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.356 -1.402 . . . . 0.0 110.804 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.461 ' CG ' ' N ' ' A' ' 81' ' ' SER . 14.8 t70 -130.92 -95.31 0.37 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.886 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.461 ' N ' ' CG ' ' A' ' 80' ' ' ASP . 0.8 OUTLIER -79.74 126.6 80.01 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.523 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.59 103.03 0.21 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 120.508 0.806 . . . . 0.0 111.299 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.19 123.26 39.75 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.823 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 p -110.91 123.65 50.56 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.79 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 86' ' ' LYS . 37.0 t -67.33 -118.43 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.386 -0.925 . . . . 0.0 111.008 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.507 ' N ' ' OG ' ' A' ' 85' ' ' SER . 1.3 ttpp -151.53 85.92 4.79 Favored Pre-proline 0 C--N 1.305 -1.35 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.364 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.27 154.78 55.78 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 120.932 1.088 . . . . 0.0 110.977 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.5 tt -150.65 154.09 9.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 C-N-CA 118.851 -1.14 . . . . 0.0 111.27 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.609 ' OG ' HG23 ' A' ' 71' ' ' THR . 14.8 m -134.94 163.07 30.66 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.412 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 pt -145.64 137.74 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.648 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.06 128.99 46.06 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.702 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.521 ' CZ ' ' O ' ' A' ' 93' ' ' ARG . 13.5 t80 -152.23 149.51 28.8 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.246 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.521 ' O ' ' CZ ' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -83.4 120.53 26.0 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.878 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 116.313 -1.803 . . . . 0.0 110.62 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -82.4 149.1 27.85 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.076 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -154.17 -5.1 0.17 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.728 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.4 t -59.79 127.02 84.68 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.485 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.33 176.55 0.19 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 120.435 0.757 . . . . 0.0 111.324 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -172.14 -168.04 0.52 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.78 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 51.25 38.37 21.11 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.381 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mt -89.45 126.22 35.48 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.266 -0.973 . . . . 0.0 111.099 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -175.32 172.92 2.63 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.308 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.61 133.97 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.69 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.6 t -92.97 -39.44 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.266 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.37 166.33 20.81 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.876 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.63 82.71 1.46 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.746 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.69 160.73 58.82 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.234 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -4.84 3.63 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 121.093 1.196 . . . . 0.0 111.499 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.424 ' O ' ' OG ' ' A' ' 60' ' ' SER . 16.2 m -149.13 39.93 0.85 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.523 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 172.68 143.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.515 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.54 140.01 53.34 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.231 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.35 116.74 26.83 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.915 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 pp -112.55 150.51 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.228 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.12 140.36 29.38 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.652 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.616 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 3.6 p90 -142.9 -147.78 0.22 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.555 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.616 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 18.1 t70 -154.06 154.46 33.7 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 117.738 -1.585 . . . . 0.0 112.721 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.2 149.54 45.92 Favored Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.214 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.74 -171.66 0.09 OUTLIER 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 121.126 1.217 . . . . 0.0 111.414 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.07 -25.18 16.56 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.261 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 m -61.58 146.09 12.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.975 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.37 92.28 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.229 -0.989 . . . . 0.0 110.773 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.441 ' H ' HG23 ' A' ' 29' ' ' VAL . 2.1 t -77.7 149.56 5.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.369 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -78.44 -70.75 0.47 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.649 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.63 161.32 41.94 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.125 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -120.51 131.97 54.96 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.957 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttp-105 -118.59 113.09 20.72 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.244 -0.983 . . . . 0.0 110.525 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.0 mt -95.84 122.91 47.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.338 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -125.69 130.87 52.41 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.212 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.728 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -148.14 166.73 27.0 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.671 -1.212 . . . . 0.0 112.306 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.94 146.73 4.76 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.55 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 4.7 pt-20 -53.53 169.93 0.12 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.577 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 63.4 m -50.62 -62.34 1.66 Allowed 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.717 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.91 54.93 0.1 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.434 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.55 ' H ' ' CG ' ' A' ' 38' ' ' GLU . . . -75.26 -109.44 0.1 OUTLIER Glycine 0 N--CA 1.486 2.03 0 C-N-CA 119.098 -1.525 . . . . 0.0 110.614 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -135.2 10.05 3.51 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.485 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.7 m -167.06 69.85 0.99 Allowed Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 118.559 -1.256 . . . . 0.0 112.232 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.34 153.63 77.37 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 121.199 1.266 . . . . 0.0 110.75 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.7 HG12 ' N ' ' A' ' 46' ' ' GLN . 49.3 t -74.47 -116.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.17 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.7 ' N ' HG12 ' A' ' 45' ' ' VAL . 4.3 pt20 -176.1 -133.12 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.361 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -171.1 161.26 6.72 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.346 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.564 ' CE2' ' OH ' ' A' ' 36' ' ' TYR . 2.7 p90 -152.56 161.22 42.88 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.0 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 p -113.75 156.85 23.08 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.534 -0.866 . . . . 0.0 112.293 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.779 HG23 ' H ' ' A' ' 52' ' ' GLY . 2.4 m -147.42 154.29 45.06 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.956 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 53' ' ' SER . 1.1 Cg_endo -63.1 23.28 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.016 1.144 . . . . 0.0 112.931 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.779 ' H ' HG23 ' A' ' 50' ' ' VAL . . . 52.57 13.93 2.19 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.083 -1.532 . . . . 0.0 110.693 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -74.93 -39.51 61.34 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.194 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.422 ' HG2' ' H ' ' A' ' 56' ' ' THR . 3.2 ttpt -96.72 130.47 43.96 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.119 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.9 m -87.95 24.46 1.79 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.558 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.422 ' H ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -143.2 164.27 30.64 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.789 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.63 141.22 17.87 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.668 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.0 m -117.19 139.33 50.9 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.401 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.728 HD12 ' CZ ' ' A' ' 36' ' ' TYR . 11.0 tt -141.59 140.41 31.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.319 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 16' ' ' THR . 4.2 t -141.86 176.45 8.92 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.22 48.48 6.41 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.193 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.37 -158.83 0.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.114 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -135.41 101.52 11.0 Favored Pre-proline 0 N--CA 1.487 1.421 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.828 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -61.95 153.86 65.69 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 120.598 0.865 . . . . 0.0 111.671 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.61 47.97 4.1 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.577 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.468 HG22 ' N ' ' A' ' 67' ' ' ASP . 8.9 p -161.87 160.31 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 C-N-CA 119.009 -1.077 . . . . 0.0 111.595 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.468 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -62.84 153.61 32.61 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.081 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.81 117.48 6.19 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.774 -1.171 . . . . 0.0 111.648 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.53 119.52 36.23 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.313 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.736 HD12 ' N ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -112.7 125.98 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.403 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.736 ' N ' HD12 ' A' ' 70' ' ' ILE . 54.6 m -131.14 138.86 49.67 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.485 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 72' ' ' VAL . 17.8 m -126.22 131.3 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.76 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -100.95 117.0 34.14 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.232 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.05 110.21 22.49 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.528 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.35 117.04 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.956 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.417 HG22 HG13 ' A' ' 29' ' ' VAL . 1.3 p -121.32 -170.05 1.96 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.586 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 169.31 158.86 13.78 Favored Glycine 0 N--CA 1.485 1.934 0 C-N-CA 117.978 -2.058 . . . . 0.0 111.753 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -113.4 -172.34 2.05 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.797 -0.702 . . . . 0.0 109.299 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 44.1 -102.15 0.03 OUTLIER Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.022 -1.561 . . . . 0.0 110.436 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -159.27 -23.41 0.07 Allowed 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.49 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.78 162.42 70.44 Favored Pre-proline 0 C--N 1.307 -1.248 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.653 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.89 154.09 63.74 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 121.398 1.398 . . . . 0.0 111.326 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.2 -139.52 0.22 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.567 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 85' ' ' SER . 0.1 OUTLIER -98.54 171.4 8.17 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.524 -0.871 . . . . 0.0 111.084 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 52.8 m -115.52 -75.51 0.58 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.806 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 85' ' ' SER . 4.2 ttmt 83.96 67.34 0.09 OUTLIER Pre-proline 0 N--CA 1.499 1.983 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.324 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.428 ' HD3' ' H ' ' A' ' 86' ' ' LYS . 5.5 Cg_endo -72.22 166.86 28.47 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 121.842 1.694 . . . . 0.0 112.944 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 88' ' ' ILE . 13.1 tt -152.27 127.86 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.37 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.6 p -117.17 150.88 37.99 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.592 -0.843 . . . . 0.0 112.339 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.82 133.37 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.283 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 91' ' ' ASN . 19.2 p-10 -80.57 145.41 31.77 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.1 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -160.1 132.67 6.47 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.46 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 1.4 ptp180 -90.94 123.84 34.74 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.109 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 116.343 -1.789 . . . . 0.0 110.663 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.617 ' O ' HG12 ' A' ' 1' ' ' VAL . 92.5 t . . . . . 0 C--O 1.214 -0.797 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.762 ' O ' HG21 ' A' ' 29' ' ' VAL . 50.7 m -146.27 143.74 29.38 Favored 'General case' 0 C--O 1.203 -1.363 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.735 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.591 ' H ' ' HD2' ' A' ' 25' ' ' PRO . 4.5 t0 -141.71 -64.73 0.43 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.961 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.7 t -100.29 109.57 57.18 Favored Pre-proline 0 N--CA 1.499 2.015 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.002 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -74.41 120.52 6.27 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 120.669 0.912 . . . . 0.0 110.679 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 8' ' ' LEU . 1.8 mtm180 -105.8 -158.67 0.67 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.354 -0.939 . . . . 0.0 112.511 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -39.32 86.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.126 -0.943 . . . . 0.0 113.502 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.841 HD23 ' H ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -101.76 170.07 8.4 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.501 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -175.72 -179.02 1.15 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.392 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t -91.21 127.56 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.857 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 4.2 p -92.96 -21.1 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.584 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . -179.86 161.8 1.0 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.478 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.81 115.66 13.94 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.219 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -96.09 162.07 25.09 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.533 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.608 ' C ' HG23 ' A' ' 16' ' ' THR . 7.9 Cg_exo -47.23 96.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 120.763 0.976 . . . . 0.0 110.704 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.608 HG23 ' C ' ' A' ' 15' ' ' PRO . 2.2 p 70.49 47.15 0.52 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.662 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.56 119.73 1.22 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.388 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 tp -105.72 137.0 44.31 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.287 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.28 103.03 8.26 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.855 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pt -97.95 173.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.505 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.57 131.28 3.03 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.242 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.426 ' CE3' ' N ' ' A' ' 22' ' ' TRP . 10.4 p90 -123.62 175.33 6.88 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 119.156 -1.017 . . . . 0.0 111.028 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' CG ' ' N ' ' A' ' 24' ' ' ALA . 31.0 t70 -104.59 171.82 7.12 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.11 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' A' ' 2' ' ' SER . . . -173.12 158.95 3.41 Favored Pre-proline 0 C--N 1.306 -1.307 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.312 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.591 ' HD2' ' H ' ' A' ' 3' ' ' ASP . 11.0 Cg_endo -74.17 -169.71 0.62 Allowed 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 121.086 1.191 . . . . 0.0 111.336 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.82 12.52 28.89 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.127 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 28' ' ' THR . 2.3 p -79.29 162.33 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.202 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.547 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 7.8 p -80.28 132.07 35.77 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.574 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.762 HG21 ' O ' ' A' ' 2' ' ' SER . 74.3 t -133.71 157.54 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.245 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.464 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -74.58 -65.43 0.86 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.047 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.485 ' HE1' HG21 ' A' ' 75' ' ' VAL . 8.6 p90 -160.25 -178.62 7.09 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 117.924 -1.51 . . . . 0.0 113.317 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.42 174.41 10.65 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.704 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.59 148.28 37.25 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.17 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.28 108.11 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.121 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -119.18 137.63 53.5 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.476 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -137.54 140.18 40.9 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 118.846 -1.142 . . . . 0.0 110.899 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.38 151.7 21.03 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.72 159.34 33.97 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.634 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 39' ' ' THR . 22.2 m -76.07 48.59 0.51 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.885 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 41' ' ' GLY . . . 154.5 -83.86 0.15 Allowed Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.693 -1.241 . . . . 0.0 110.128 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 40' ' ' GLY . . . 38.72 -150.17 0.07 OUTLIER Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.012 -1.089 . . . . 0.0 110.869 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.85 -14.13 14.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.476 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.88 157.53 0.45 Allowed Pre-proline 0 C--N 1.305 -1.335 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.329 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -62.32 132.04 36.83 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 121.199 1.266 . . . . 0.0 111.481 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.36 -75.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.257 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.444 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -175.71 -176.29 0.85 Allowed 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 118.525 -1.27 . . . . 0.0 111.513 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' A' ' 46' ' ' GLN . 9.0 pt-20 -158.16 170.53 22.06 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.205 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.485 ' HE1' HD11 ' A' ' 59' ' ' ILE . 8.8 p90 -165.92 145.9 6.42 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.02 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.9 p -91.14 169.92 10.45 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.79 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 52' ' ' GLY . 9.3 p -161.36 136.31 5.49 Favored Pre-proline 0 C--N 1.304 -1.399 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.25 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.6 Cg_endo -61.7 22.88 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 120.955 1.103 . . . . 0.0 112.828 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 53.26 7.86 0.63 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.491 -1.338 . . . . 0.0 110.312 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.493 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -71.62 -29.42 64.64 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.86 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.7 mttm -94.45 153.0 18.15 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.808 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.75 -12.65 17.48 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.721 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 p -130.61 170.99 13.55 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.092 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.37 132.06 9.59 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.578 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.7 m -104.13 128.75 51.82 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.205 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.485 HD11 ' HE1' ' A' ' 48' ' ' PHE . 10.7 mt -126.82 139.76 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.992 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.91 131.73 47.59 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.411 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.67 2.29 0.19 Allowed Glycine 0 N--CA 1.484 1.881 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 62' ' ' LEU . 7.2 mp -91.43 178.1 6.05 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.29 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.639 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 1.0 OUTLIER -176.82 -42.38 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.733 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.639 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 4.3 Cg_endo -79.81 -172.02 1.41 Allowed 'Trans proline' 0 C--O 1.217 -0.564 0 C-N-CA 121.548 1.499 . . . . 0.0 111.734 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.91 81.61 0.23 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.8 HG22 ' H ' ' A' ' 67' ' ' ASP . 11.8 p -132.05 -177.78 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.998 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.8 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -66.93 125.38 25.75 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.142 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.09 130.96 53.31 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.318 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.81 123.81 48.56 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.721 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 pp -116.05 164.16 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.165 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.9 m -152.18 143.74 23.48 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.632 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.91 139.73 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.715 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -109.07 143.26 38.64 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.536 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 3' ' ' ASP . . . -120.13 91.48 3.55 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.812 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.485 HG21 ' HE1' ' A' ' 31' ' ' TYR . 13.2 t -94.9 107.65 19.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 119.095 -1.042 . . . . 0.0 113.277 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 77' ' ' GLY . 80.6 m -125.27 -24.22 4.01 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 76' ' ' THR . . . 53.42 127.34 0.01 OUTLIER Glycine 0 N--CA 1.497 2.715 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.587 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.417 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -104.68 136.04 44.96 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.717 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.06 -101.98 0.8 Allowed Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.824 -1.655 . . . . 0.0 109.819 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.436 ' H ' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -160.53 -40.02 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.724 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.537 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -83.41 -43.91 0.83 Allowed Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.66 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' A' ' 81' ' ' SER . 3.2 Cg_exo -68.04 31.1 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.127 1.218 . . . . 0.0 112.511 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 81' ' ' SER . . . -49.15 -54.3 16.97 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.487 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.2 t -52.8 115.63 1.92 Allowed 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.067 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.4 m -92.57 -148.52 0.24 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.762 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.11 86.73 57.3 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.451 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.71 167.42 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 120.866 1.044 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 88' ' ' ILE . 9.4 tt -143.9 139.59 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.949 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.1 p -124.63 150.99 45.42 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -143.72 163.0 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.505 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -103.05 147.64 26.71 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.147 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -154.12 135.49 14.15 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.811 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 5.6 ptt85 -90.32 107.04 18.9 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.46 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.681 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.972 0.415 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 p -166.25 148.25 6.82 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.928 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.4 -8.29 15.08 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.956 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 5' ' ' PRO . 44.1 t -93.73 133.89 27.23 Favored Pre-proline 0 C--N 1.305 -1.338 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.837 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 4' ' ' VAL . 3.7 Cg_exo -54.56 -166.59 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.682 0 N-CA-C 110.225 -0.721 . . . . 0.0 110.225 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.575 ' O ' HD13 ' A' ' 8' ' ' LEU . 13.8 ptt180 -163.25 175.0 11.37 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.106 -1.438 . . . . 0.0 112.73 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 8' ' ' LEU . 57.4 m-20 -25.04 98.36 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.46 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.799 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -57.08 -163.53 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.75 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -168.65 136.44 2.05 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.026 -1.47 . . . . 0.0 112.646 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -88.46 142.4 12.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.879 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 11' ' ' VAL . 3.6 p -130.52 1.62 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 119.074 -1.05 . . . . 0.0 112.177 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 177.79 155.61 0.34 Allowed 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.6 -1.24 . . . . 0.0 111.395 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.74 104.79 2.17 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.2 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -91.66 160.81 35.66 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.002 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.29 -0.4 0.31 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.998 1.132 . . . . 0.0 112.098 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.472 ' H ' ' C ' ' A' ' 14' ' ' THR . 25.5 p -151.39 28.97 0.64 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.699 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.47 151.05 0.57 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.69 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.6 123.98 30.71 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.975 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tp -104.14 116.66 32.59 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.803 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.0 pt -107.1 173.49 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.123 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.68 139.03 7.47 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.295 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.589 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 18.3 p90 -140.22 -154.15 0.5 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.402 -1.319 . . . . 0.0 113.052 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.589 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 36.3 t70 -99.48 -177.28 3.53 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.958 -0.697 . . . . 0.0 112.408 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.548 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . -164.6 119.98 1.04 Allowed Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.12 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.63 167.78 4.8 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 120.435 0.757 . . . . 0.0 111.757 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.83 24.51 6.06 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.731 -0.787 . . . . 0.0 111.104 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.694 HG12 ' N ' ' A' ' 28' ' ' THR . 44.9 t -101.79 173.48 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.473 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.694 ' N ' HG12 ' A' ' 27' ' ' VAL . 25.5 m -74.5 78.25 1.94 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.352 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 27' ' ' VAL . 2.2 t -79.62 114.9 21.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.499 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.428 ' H ' ' HA ' ' A' ' 76' ' ' THR . 2.7 tpt85 -56.03 -61.46 2.36 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.315 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.74 169.33 21.66 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.611 -1.236 . . . . 0.0 112.151 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -116.55 158.32 23.85 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.96 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -138.58 112.25 8.29 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.215 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.4 mt -102.18 127.37 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.866 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.9 137.57 51.5 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.958 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.574 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 3.0 p90 -145.55 154.93 42.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 118.351 -1.339 . . . . 0.0 112.204 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -176.24 138.53 4.14 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -64.23 145.48 55.91 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 118.976 -1.09 . . . . 0.0 110.538 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 m -75.31 160.08 30.73 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.238 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.29 -44.04 3.3 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.49 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 43' ' ' SER . . . -76.82 123.59 6.69 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.596 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -75.86 18.86 0.23 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.535 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 41' ' ' GLY . 12.9 t -132.05 81.4 62.08 Favored Pre-proline 0 N--CA 1.486 1.337 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.758 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.99 150.77 82.42 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 121.015 1.144 . . . . 0.0 111.305 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.452 HG11 ' CE2' ' A' ' 36' ' ' TYR . 95.0 t -57.01 -81.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.475 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.462 ' CG ' ' H ' ' A' ' 47' ' ' GLU . 3.8 tp60 -171.57 -151.38 0.07 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.659 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.462 ' H ' ' CG ' ' A' ' 46' ' ' GLN . 3.2 pt-20 -170.18 161.69 8.5 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.377 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -159.02 156.6 29.63 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.869 -1.132 . . . . 0.0 111.054 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.4 p -101.67 157.97 16.44 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.754 -0.779 . . . . 0.0 111.641 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 50' ' ' VAL . 11.4 p -165.61 134.14 2.51 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 53' ' ' SER . 6.3 Cg_exo -56.49 124.97 17.54 Favored 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 120.274 0.649 . . . . 0.0 111.484 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.05 1.7 0.79 Allowed Glycine 0 N--CA 1.483 1.806 0 C-N-CA 119.45 -1.357 . . . . 0.0 110.694 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.491 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -59.57 -35.28 73.94 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 118.845 -1.142 . . . . 0.0 109.636 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -98.4 120.25 38.5 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.059 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 m -79.59 21.25 0.52 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.122 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.4 p -143.72 149.3 36.96 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.308 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.62 150.11 26.03 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.394 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.1 m -95.05 158.44 15.46 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.128 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -146.9 139.01 19.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 119.506 -0.877 . . . . 0.0 110.026 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.3 -178.08 6.2 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.061 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.32 21.65 21.76 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.779 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.06 -164.65 1.39 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.993 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.645 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -177.68 -42.39 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.355 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.295 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.645 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 1.9 Cg_endo -77.16 -170.16 0.87 Allowed 'Trans proline' 0 C--O 1.214 -0.725 0 C-N-CA 121.762 1.641 . . . . 0.0 112.87 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.71 84.21 0.19 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.688 HG22 ' N ' ' A' ' 67' ' ' ASP . 12.2 p -130.2 177.55 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.387 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.688 ' N ' HG22 ' A' ' 66' ' ' VAL . 7.9 t70 -45.44 148.27 0.7 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.097 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.58 111.3 5.02 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.528 -1.269 . . . . 0.0 112.294 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.48 132.98 34.27 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.181 -1.008 . . . . 0.0 108.85 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 70' ' ' ILE . 7.2 tt -127.64 132.17 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.192 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.586 HG22 ' CB ' ' A' ' 89' ' ' SER . 24.1 p -125.1 121.98 35.86 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.575 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.37 129.0 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.641 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -103.72 140.81 37.1 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.406 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.97 91.22 3.5 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.135 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.0 t -93.8 124.03 46.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.717 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.574 HG23 ' N ' ' A' ' 77' ' ' GLY . 13.3 t -112.14 -159.0 0.67 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.062 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.574 ' N ' HG23 ' A' ' 76' ' ' THR . . . 156.92 109.3 0.29 Allowed Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.267 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -65.81 -46.28 79.2 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.849 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.69 -93.21 1.66 Allowed Glycine 0 N--CA 1.487 2.051 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.198 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 2.1 p-10 -156.31 -11.61 0.1 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.421 -0.911 . . . . 0.0 111.166 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.7 152.78 78.04 Favored Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 118.824 -1.151 . . . . 0.0 110.697 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.64 146.18 95.26 Favored 'Trans proline' 0 C--O 1.217 -0.57 0 C-N-CA 121.205 1.27 . . . . 0.0 111.836 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.86 108.67 10.01 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.69 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.4 t -67.01 122.11 17.03 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.377 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 86' ' ' LYS . 94.1 p -113.69 -128.74 0.29 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.538 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.434 ' N ' ' OG ' ' A' ' 85' ' ' SER . 1.4 pttt -152.08 91.96 3.61 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.86 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -57.71 -179.76 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.108 1.205 . . . . 0.0 112.227 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.412 ' O ' ' OG ' ' A' ' 89' ' ' SER . 12.4 tt -145.89 154.62 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.696 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.586 ' CB ' HG22 ' A' ' 71' ' ' THR . 15.2 m -161.34 147.21 14.15 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 118.446 -1.302 . . . . 0.0 112.204 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.553 HD11 ' CD2' ' A' ' 8' ' ' LEU . 1.2 pt -150.01 164.38 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.228 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.74 136.4 34.06 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.497 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -140.88 133.55 28.74 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.371 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -87.84 108.51 19.19 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.589 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 116.502 -1.713 . . . . 0.0 110.745 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.661 ' O ' HG22 ' A' ' 1' ' ' VAL . 5.8 p . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 121.014 0.435 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 m 53.82 -168.21 0.06 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.171 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -133.13 32.36 3.74 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.531 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.2 t -62.26 145.2 94.2 Favored Pre-proline 0 C--N 1.303 -1.429 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.768 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -51.28 169.87 0.19 Allowed 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 120.784 0.99 . . . . 0.0 111.204 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.49 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 6.1 ptm180 -175.46 173.88 2.4 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.61 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 2.9 t70 74.72 37.99 0.5 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.371 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 mp -86.69 110.79 20.11 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.592 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -139.46 162.36 35.24 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.8 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.477 HG13 HD11 ' A' ' 18' ' ' LEU . 54.0 t -92.6 102.25 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.123 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.643 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 47.8 t -71.78 3.42 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.296 -0.961 . . . . 0.0 111.474 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 168.81 154.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.341 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.58 93.85 2.11 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.684 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -91.27 162.27 32.63 Favored Pre-proline 0 N--CA 1.485 1.288 0 C-N-CA 119.436 -0.905 . . . . 0.0 110.613 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.72 9.55 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.428 1.419 . . . . 0.0 112.089 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 14' ' ' THR . 4.4 t -168.77 28.1 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.063 -1.055 . . . . 0.0 110.806 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -173.65 141.68 0.87 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.526 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.623 HD12 ' H ' ' A' ' 19' ' ' LEU . 19.2 tp -130.62 146.49 52.13 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.789 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.623 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -128.33 106.64 9.16 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.184 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 20' ' ' ILE . 2.2 pt -103.35 169.7 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.461 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 20' ' ' ILE . 8.2 m -164.04 134.03 4.11 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.457 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.527 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 14.3 p90 -133.76 -157.83 0.84 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.682 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.527 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 30.4 t70 -106.42 176.31 5.21 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.493 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -154.71 100.39 2.39 Favored Pre-proline 0 CA--C 1.558 1.258 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.77 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -57.15 175.61 0.32 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 120.788 0.992 . . . . 0.0 112.231 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -93.07 -5.22 50.91 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.5 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.421 ' H ' HG23 ' A' ' 27' ' ' VAL . 3.2 t -60.75 163.32 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.132 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.4 m -62.76 98.48 0.12 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.656 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 t -95.19 129.74 44.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.345 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.14 -65.85 0.96 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.069 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -160.48 163.59 32.83 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.038 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -120.42 146.89 45.76 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.691 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -129.03 110.08 11.75 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.779 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.858 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.7 mp -100.81 108.48 23.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.788 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 p -104.63 147.71 27.35 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.213 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.735 ' CD2' HD11 ' A' ' 59' ' ' ILE . 26.5 p90 -149.39 148.36 29.39 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 117.987 -1.485 . . . . 0.0 112.088 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.26 150.85 7.92 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -78.56 -174.54 3.89 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.767 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 40' ' ' GLY . 3.5 t -51.52 176.78 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.684 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.458 ' N ' ' OG1' ' A' ' 39' ' ' THR . . . 103.35 83.28 1.7 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.089 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.28 -136.54 28.48 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.138 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.41 -66.91 0.85 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.316 -0.953 . . . . 0.0 110.606 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 p 175.19 71.88 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -73.07 42.52 0.63 Allowed 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.7 1.6 . . . . 0.0 111.914 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.671 HG12 ' N ' ' A' ' 46' ' ' GLN . 21.3 t -110.22 -86.05 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.099 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.671 ' N ' HG12 ' A' ' 45' ' ' VAL . 30.7 tt0 -168.72 166.98 11.5 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 117.482 -1.687 . . . . 0.0 112.606 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.488 ' N ' ' CG ' ' A' ' 46' ' ' GLN . 3.3 pt-20 -161.17 156.42 24.3 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.445 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 1.4 p90 -139.58 167.13 22.8 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.488 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.5 p -131.27 148.66 52.71 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.606 -0.837 . . . . 0.0 111.538 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.688 HG23 ' H ' ' A' ' 52' ' ' GLY . 10.3 m -140.72 151.78 64.09 Favored Pre-proline 0 N--CA 1.486 1.349 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.861 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.16 14.35 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 120.898 1.065 . . . . 0.0 112.173 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.688 ' H ' HG23 ' A' ' 50' ' ' VAL . . . 70.69 16.41 74.17 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.809 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.82 -40.34 20.5 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.915 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -84.16 121.44 27.46 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.623 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 m -83.03 -9.79 59.08 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.062 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.66 168.63 11.19 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.285 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.1 136.15 6.59 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.514 -1.275 . . . . 0.0 111.947 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -105.14 136.88 43.82 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.826 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.735 HD11 ' CD2' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -134.13 144.56 35.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.429 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.14 135.62 20.63 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.112 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.86 -37.44 0.24 Allowed Glycine 0 N--CA 1.486 1.981 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.387 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -163.32 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.75 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.647 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -176.91 -40.79 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.604 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.647 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 8.7 Cg_endo -83.4 -169.34 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.579 1.519 . . . . 0.0 111.731 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.33 74.68 0.4 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.667 HG22 ' N ' ' A' ' 67' ' ' ASP . 8.9 p -119.4 170.81 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.077 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.667 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -64.86 97.51 0.23 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.442 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -89.59 130.26 35.92 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.631 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.41 149.2 29.06 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.793 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.5 pp -140.6 161.09 24.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.629 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.4 m -149.61 123.32 9.22 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.68 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.03 136.92 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.355 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.47 116.25 31.06 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.294 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.66 97.64 8.88 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.256 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.0 t -99.53 116.9 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.483 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.7 p -116.72 -123.69 0.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.683 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.93 142.36 0.02 OUTLIER Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.573 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -71.0 -74.96 0.13 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.836 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.3 18.88 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.451 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 11.6 p-10 -137.32 -53.33 0.68 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.867 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.29 134.17 31.83 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.392 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.09 102.72 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 120.764 0.976 . . . . 0.0 111.462 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.07 70.7 1.46 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.99 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.8 t -92.46 137.04 32.7 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.746 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.1 m -82.01 -134.19 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.419 -0.912 . . . . 0.0 111.452 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -149.56 110.39 3.38 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.308 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -59.87 170.66 3.46 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 120.452 0.768 . . . . 0.0 111.231 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -155.81 156.04 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.992 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.39 156.52 46.37 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.684 -0.807 . . . . 0.0 110.942 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -145.49 152.06 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.979 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.98 146.92 34.43 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.77 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -158.66 145.86 17.63 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.682 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.465 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 1.5 ptt85 -83.85 98.79 9.93 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.254 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 t -61.86 117.35 5.77 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.423 ' H ' ' H ' ' A' ' 4' ' ' VAL . 1.2 m-20 -161.27 -11.65 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.694 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.439 ' H ' HG23 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -49.4 133.02 18.0 Favored Pre-proline 0 N--CA 1.486 1.365 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.257 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 4' ' ' VAL . 4.6 Cg_exo -55.6 -164.07 0.01 OUTLIER 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 120.464 0.776 . . . . 0.0 111.365 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -174.61 178.82 1.85 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.617 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 52.94 43.08 32.1 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.576 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 mp -92.58 126.3 37.6 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.369 -0.933 . . . . 0.0 110.273 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -171.97 161.17 5.63 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.357 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.9 t -89.06 115.34 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.32 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.663 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 2.7 t -69.43 -26.58 31.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.565 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 167.59 178.51 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.96 119.74 12.56 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.626 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.9 162.49 22.06 Favored Pre-proline 0 C--N 1.3 -1.584 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.708 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 16' ' ' THR . 4.5 Cg_exo -53.95 94.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 120.733 0.955 . . . . 0.0 110.673 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.489 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER 81.06 41.66 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.881 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.32 137.51 1.89 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.685 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.64 148.6 43.16 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 19' ' ' LEU . 1.7 tt -129.66 105.53 8.11 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.006 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.45 168.3 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.449 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -161.82 132.21 4.93 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.591 -1.244 . . . . 0.0 111.584 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.549 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 6.8 p90 -131.21 -141.97 0.22 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.556 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.549 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 6.7 t70 -166.33 163.97 17.55 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.633 -1.627 . . . . 0.0 112.645 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.517 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . -130.79 136.17 28.5 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.588 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.17 -170.98 0.05 OUTLIER 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 120.423 0.749 . . . . 0.0 111.183 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.18 6.46 48.97 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.82 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.764 HG22 ' H ' ' A' ' 28' ' ' THR . 13.0 p -76.84 179.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.802 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.764 ' H ' HG22 ' A' ' 27' ' ' VAL . 97.3 m -66.06 123.34 19.58 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.303 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.4 t -131.03 110.6 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.319 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.03 -76.59 0.1 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.393 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -147.13 168.17 22.3 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.148 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -120.83 160.32 23.64 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.285 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.451 ' HE ' ' HB ' ' A' ' 49' ' ' THR . 1.4 ttm180 -127.33 146.15 50.55 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.466 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 34' ' ' ILE . 17.4 mt -137.8 99.46 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.679 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.28 137.61 43.92 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.108 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.621 ' CE2' HD11 ' A' ' 59' ' ' ILE . 11.0 p90 -145.28 148.03 33.01 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.242 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.58 140.75 6.66 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.58 143.42 48.25 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.09 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.9 m -74.71 107.3 6.73 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.725 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.45 -17.33 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.527 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.81 8.2 76.89 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.323 -1.418 . . . . 0.0 110.258 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -82.87 -47.28 12.02 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.725 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 170.74 108.79 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.33 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.103 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -59.51 151.71 67.02 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.214 0.61 . . . . 0.0 111.036 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.568 HG11 ' CZ ' ' A' ' 36' ' ' TYR . 48.4 t -62.14 -89.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.787 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 3.8 pt20 -173.25 -152.71 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.019 -1.073 . . . . 0.0 111.404 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.484 ' N ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -159.19 173.4 16.42 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.163 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -165.08 148.24 8.34 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.517 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.451 ' HB ' ' HE ' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -113.21 167.22 10.73 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.339 -0.944 . . . . 0.0 112.682 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.493 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -147.21 158.18 44.74 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.667 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.16 6.26 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 121.175 1.25 . . . . 0.0 112.172 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 70.52 -1.14 22.56 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.338 -1.411 . . . . 0.0 110.275 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.39 -37.09 57.67 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.884 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -80.63 116.32 20.6 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.575 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.9 m -82.31 -2.07 51.58 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.111 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.2 p -133.09 157.56 44.97 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.513 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.03 140.67 13.36 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.579 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m -103.77 139.64 38.72 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.274 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.621 HD11 ' CE2' ' A' ' 36' ' ' TYR . 2.2 tt -135.42 149.2 28.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.843 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -141.48 -154.68 0.53 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.397 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.91 46.25 94.93 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.276 -1.44 . . . . 0.0 110.629 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.508 ' C ' HD12 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -130.45 -172.94 2.93 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.04 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -118.05 130.03 24.99 Favored Pre-proline 0 N--CA 1.49 1.526 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.967 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.62 140.51 87.03 Favored 'Trans proline' 0 C--O 1.217 -0.546 0 C-N-CA 120.409 0.74 . . . . 0.0 111.353 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.57 83.76 0.05 OUTLIER Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.462 -1.352 . . . . 0.0 110.553 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.1 p -165.29 148.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.153 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.92 149.49 47.74 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.616 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.37 137.09 21.59 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.846 -1.142 . . . . 0.0 111.9 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.57 119.35 35.28 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.918 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.414 ' CG1' ' N ' ' A' ' 71' ' ' THR . 3.7 tt -118.38 152.66 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.064 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.442 HG23 ' HB3' ' A' ' 89' ' ' SER . 50.7 m -140.51 126.15 19.12 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.656 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.18 144.84 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.782 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -119.22 125.19 48.57 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.782 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.81 86.78 4.8 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.427 ' H ' HG23 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -86.41 118.57 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 118.962 -1.095 . . . . 0.0 112.338 -179.728 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 0.5 OUTLIER -101.69 -68.3 0.83 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.906 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.569 ' N ' ' OG1' ' A' ' 76' ' ' THR . . . 98.99 116.27 3.73 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -75.23 -36.03 61.37 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.541 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.55 4.75 0.09 OUTLIER Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.193 -1.479 . . . . 0.0 111.397 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.05 -85.9 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.588 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.05 148.07 97.74 Favored Pre-proline 0 C--N 1.306 -1.296 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.733 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -62.83 128.92 24.47 Favored 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 120.778 0.985 . . . . 0.0 111.162 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.8 59.51 1.46 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.707 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.5 t -94.76 64.86 2.98 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.753 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 m -114.15 29.86 7.7 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.12 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.66 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -137.07 27.82 0.11 Allowed Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 86' ' ' LYS . 2.2 Cg_endo -58.39 138.68 87.14 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.614 0.876 . . . . 0.0 111.363 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 88' ' ' ILE . 13.1 tt -146.49 132.13 12.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.236 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.442 ' HB3' HG23 ' A' ' 71' ' ' THR . 21.7 p -130.79 152.33 50.25 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.494 -0.882 . . . . 0.0 112.19 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.91 146.4 18.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.187 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -92.24 151.19 20.46 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.832 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -155.04 136.85 14.46 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.649 -1.22 . . . . 0.0 111.699 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.09 110.69 22.9 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.85 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 116.338 -1.792 . . . . 0.0 110.769 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -151.59 -147.8 0.24 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.66 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.19 -36.41 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.002 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.21 139.86 28.12 Favored Pre-proline 0 N--CA 1.498 1.926 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.039 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -55.79 169.25 1.36 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.04 1.16 . . . . 0.0 111.525 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -174.9 178.04 1.89 Allowed 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.72 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 52.68 62.35 2.73 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.78 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 mp -98.62 111.74 24.01 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.521 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 12.3 mp0 -135.38 163.88 29.02 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.776 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.9 t -89.48 116.5 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.697 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.635 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.9 t -82.51 -6.97 10.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.649 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.635 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 169.23 166.3 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.526 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.38 144.77 24.81 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.164 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -138.38 160.16 64.93 Favored Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.528 -179.941 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.413 ' C ' ' OG1' ' A' ' 16' ' ' THR . 5.4 Cg_exo -48.36 -8.88 0.07 OUTLIER 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.404 1.403 . . . . 0.0 112.306 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.2 OUTLIER -164.29 41.7 0.09 Allowed 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.007 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.09 136.04 0.37 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.229 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 62' ' ' LEU . 1.1 tp -130.5 125.63 34.83 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.071 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 20' ' ' ILE . 1.2 tt -106.53 126.63 52.5 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.716 -0.793 . . . . 0.0 110.365 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.661 ' N ' HD23 ' A' ' 19' ' ' LEU . 9.5 pt -126.76 164.58 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.966 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.421 ' OG ' HG21 ' A' ' 11' ' ' VAL . 5.2 m -161.62 146.66 13.37 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.542 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.447 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 37.2 p90 -141.26 -139.87 0.13 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.975 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 24' ' ' ALA . 34.1 t70 -98.02 173.98 6.78 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.813 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.611 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -96.73 165.53 15.8 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.731 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.611 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -62.21 169.15 8.22 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 121.244 1.296 . . . . 0.0 111.865 179.938 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.22 -79.65 0.56 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.691 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.444 HG23 ' N ' ' A' ' 28' ' ' THR . 3.2 m -91.64 -164.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.652 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.444 ' N ' HG23 ' A' ' 27' ' ' VAL . 1.5 p -39.23 151.7 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.043 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 t -138.55 147.53 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 119.026 -1.069 . . . . 0.0 112.152 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 19.8 mtp180 -108.92 -53.12 2.68 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.095 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 30' ' ' ARG . 44.3 m-85 -160.28 157.96 29.01 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.221 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.46 111.64 20.28 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.52 -1.218 . . . . 0.0 107.954 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.9 mtt-85 -100.12 145.06 28.42 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.2 mp -141.21 110.4 2.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.601 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 p -121.73 151.4 40.56 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.036 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 15.2 p90 -144.13 155.34 43.89 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 118.584 -1.246 . . . . 0.0 111.67 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.45 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . 171.48 147.19 5.58 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.795 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -62.17 166.7 4.58 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.444 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -75.81 143.34 41.94 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.81 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 176.06 -28.84 0.07 OUTLIER Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.241 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.36 -101.86 0.21 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.122 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -135.28 62.15 1.64 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.382 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.0 t -135.39 69.51 68.1 Favored Pre-proline 0 N--CA 1.49 1.525 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.195 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.22 131.1 34.93 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.24 1.293 . . . . 0.0 111.061 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.45 HG23 ' HA2' ' A' ' 37' ' ' GLY . 26.5 t -49.74 -49.21 20.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.366 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -164.01 167.95 19.83 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.594 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -148.0 146.87 29.09 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.186 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 10.6 p90 -154.23 134.89 13.57 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 118.72 -1.192 . . . . 0.0 111.276 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 t -100.49 147.52 25.8 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.496 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.81 150.83 61.13 Favored Pre-proline 0 C--N 1.301 -1.527 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.252 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.564 ' C ' ' H ' ' A' ' 53' ' ' SER . 6.2 Cg_exo -52.77 125.17 17.23 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 120.499 0.8 . . . . 0.0 110.882 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.66 17.6 0.07 OUTLIER Glycine 0 N--CA 1.487 2.09 0 C-N-CA 119.61 -1.281 . . . . 0.0 111.726 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.564 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -73.18 -41.54 63.73 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 118.859 -1.136 . . . . 0.0 110.184 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -87.71 -172.5 3.9 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.341 -0.943 . . . . 0.0 110.63 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.37 14.06 2.38 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.441 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.0 p -126.82 174.4 8.81 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.615 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.18 122.52 0.67 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.443 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.25 146.54 24.27 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.698 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mt -136.78 147.11 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.995 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.5 t -150.57 153.97 36.72 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.419 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 62' ' ' LEU . . . 123.07 -9.27 9.0 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 18' ' ' LEU . 2.1 mt -49.79 -178.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.785 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -176.39 -43.24 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 119.416 -0.914 . . . . 0.0 112.36 179.948 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.607 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 4.2 Cg_endo -79.46 -168.17 0.6 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.657 1.571 . . . . 0.0 111.776 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -154.66 87.47 0.13 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.744 -1.743 . . . . 0.0 108.744 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.848 HG22 ' H ' ' A' ' 67' ' ' ASP . 11.5 p -156.54 -177.2 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 118.944 -1.103 . . . . 0.0 111.715 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.848 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -57.75 98.65 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.634 179.982 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -94.11 132.03 39.04 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.278 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 m -112.85 127.57 56.22 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.747 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 pp -113.86 151.2 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.203 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 89' ' ' SER . 97.3 m -143.32 120.85 11.73 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.016 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.43 141.21 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.768 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 97.15 6.52 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.343 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.29 92.2 2.74 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.533 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.54 115.67 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.696 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -119.25 -39.15 2.93 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.43 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 68.08 141.49 0.08 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.481 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 ttm-85 -81.35 -59.06 2.77 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.993 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.19 3.71 0.17 Allowed Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.428 -1.368 . . . . 0.0 110.759 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -142.23 -63.62 0.43 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.988 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.13 115.92 63.2 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.801 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -65.2 96.66 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 N-CA-C 110.266 -0.705 . . . . 0.0 110.266 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -118.97 149.5 41.51 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.322 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 p -64.06 127.0 29.52 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.524 -0.871 . . . . 0.0 110.824 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -65.99 -109.45 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.686 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.84 63.62 26.04 Favored Pre-proline 0 N--CA 1.486 1.365 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.948 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -55.1 158.4 11.72 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.413 1.409 . . . . 0.0 111.286 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.0 156.5 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.404 ' HB3' HG23 ' A' ' 71' ' ' THR . 53.4 p -145.27 159.89 42.33 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.235 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -148.76 149.71 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.6 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.38 154.55 18.7 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.542 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -175.55 135.07 0.31 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.737 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 93' ' ' ARG . 2.6 ptm180 -61.65 96.42 0.06 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.295 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 116.502 -1.713 . . . . 0.0 110.583 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.929 0.395 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.2 p -86.26 -147.53 0.12 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.846 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -113.64 -37.19 4.66 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.227 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 t -61.47 129.61 91.26 Favored Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.219 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -73.18 106.32 2.14 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 120.921 1.081 . . . . 0.0 111.386 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -175.33 -151.18 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.694 -1.202 . . . . 0.0 111.621 179.947 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 2.2 t70 74.47 22.39 2.13 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.661 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mp -52.43 144.82 12.45 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.59 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -159.73 140.84 12.55 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.869 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.83 109.64 13.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.391 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.1 t -70.17 -64.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.221 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.59 166.62 30.64 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.861 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.32 127.39 45.48 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.26 161.85 21.82 Favored Pre-proline 0 C--N 1.308 -1.206 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.299 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.617 ' C ' HG23 ' A' ' 16' ' ' THR . 4.9 Cg_exo -49.28 99.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 120.547 0.831 . . . . 0.0 110.614 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.617 HG23 ' C ' ' A' ' 15' ' ' PRO . 1.7 p 69.14 44.59 0.97 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.52 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.33 146.92 7.52 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.274 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mt -128.31 142.94 50.99 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.759 -0.777 . . . . 0.0 111.497 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 19' ' ' LEU . 2.0 tt -115.91 102.23 9.48 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.831 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.57 146.58 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.72 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -139.77 132.3 28.7 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.227 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.547 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 12.6 p90 -132.69 -144.4 0.24 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.796 -1.162 . . . . 0.0 112.447 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.547 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 22.3 t0 -99.11 162.48 13.04 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.942 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -168.38 78.76 0.81 Allowed Pre-proline 0 N--CA 1.487 1.412 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.8 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -64.79 167.53 15.39 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 121.46 1.44 . . . . 0.0 111.81 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.04 4.29 42.58 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.646 -0.821 . . . . 0.0 111.21 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.83 HG22 ' H ' ' A' ' 28' ' ' THR . 10.4 p -62.79 -179.21 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.624 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.83 ' H ' HG22 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -67.52 119.6 12.58 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.678 -179.979 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.1 t -137.13 128.31 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.341 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.523 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -87.81 -61.47 1.71 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.483 -179.984 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 46.3 m-85 -147.45 168.0 23.0 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.167 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.28 137.47 42.53 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.256 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.09 128.9 23.24 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 118.236 -1.386 . . . . 0.0 111.274 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.2 mt -111.54 135.17 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.891 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 p -128.05 135.07 49.35 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.463 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 6.7 p90 -135.91 160.6 38.08 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.653 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . 165.65 139.87 2.75 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -57.35 -161.01 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.48 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER -53.98 173.1 0.07 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.92 -179.921 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.517 ' N ' ' OG1' ' A' ' 39' ' ' THR . . . -44.68 -70.48 0.59 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.756 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.41 -130.01 37.5 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.307 -1.425 . . . . 0.0 109.964 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.24 -63.51 1.35 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.246 -0.981 . . . . 0.0 110.35 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.0 162.95 17.87 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.193 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.61 158.3 28.53 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 121.25 1.3 . . . . 0.0 111.237 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.403 HG11 ' CE2' ' A' ' 36' ' ' TYR . 39.7 t -67.57 -67.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.288 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.486 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -175.22 -175.5 0.84 Allowed 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.13 -179.883 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.486 ' H ' ' CD ' ' A' ' 46' ' ' GLN . 6.5 pt-20 -157.6 167.79 29.12 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.222 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -159.47 147.53 17.46 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.237 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.5 p -97.66 124.64 42.05 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.399 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.64 151.29 49.68 Favored Pre-proline 0 N--CA 1.49 1.574 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.292 179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 53' ' ' SER . 1.2 Cg_endo -61.66 126.42 19.0 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 120.678 0.918 . . . . 0.0 110.517 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.46 -9.25 0.08 OUTLIER Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.98 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -71.3 -43.18 67.62 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.496 179.983 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 mmtm -67.77 132.72 47.96 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.301 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -103.07 -5.29 23.48 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.465 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.6 p -134.8 172.93 12.28 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.46 151.84 4.6 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.102 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.5 m -121.38 117.56 27.23 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.701 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.12 157.96 9.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.929 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -145.61 178.2 8.31 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.146 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.98 53.39 2.86 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.239 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.57 -156.4 0.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.809 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -140.28 148.83 55.72 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.43 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -68.21 123.13 10.24 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 121.052 1.168 . . . . 0.0 112.439 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.22 91.75 0.04 OUTLIER Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.787 -1.197 . . . . 0.0 111.777 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.2 p -167.48 144.96 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.211 -0.996 . . . . 0.0 110.864 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.29 153.76 6.74 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.16 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.79 134.48 18.81 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.238 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.1 m -125.61 120.92 32.11 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.623 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 pp -115.63 163.12 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.92 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.598 HG23 ' OG ' ' A' ' 89' ' ' SER . 17.1 m -152.54 127.73 9.8 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.361 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 m -121.91 136.86 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.274 -0.971 . . . . 0.0 111.796 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -115.34 126.63 54.67 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.389 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.08 98.14 7.82 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.583 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.429 HG12 ' HB1' ' A' ' 83' ' ' ALA . 1.6 t -86.36 117.54 31.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.644 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.52 -64.21 1.16 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.732 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.505 ' H ' ' HA ' ' A' ' 83' ' ' ALA . . . 159.68 179.96 34.84 Favored Glycine 0 N--CA 1.495 2.623 0 C-N-CA 119.429 -1.367 . . . . 0.0 111.841 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -120.05 62.47 0.84 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.606 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.02 -28.58 4.38 Favored Glycine 0 N--CA 1.5 2.947 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -147.6 -51.99 0.19 Allowed 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.41 153.06 42.98 Favored Pre-proline 0 C--N 1.311 -1.066 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.485 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.43 ' C ' ' N ' ' A' ' 84' ' ' SER . 1.7 Cg_endo -60.79 123.41 12.93 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 120.846 1.03 . . . . 0.0 111.405 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.505 ' HA ' ' H ' ' A' ' 77' ' ' GLY . . . -48.49 -17.3 0.15 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.953 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 85' ' ' SER . 2.9 p -86.2 69.92 10.51 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.29 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 84' ' ' SER . 39.7 m -50.89 -102.03 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.023 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -146.88 77.05 11.29 Favored Pre-proline 0 C--N 1.295 -1.768 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.691 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -52.8 162.7 2.35 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 120.616 0.877 . . . . 0.0 110.264 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.9 tt -153.57 160.12 3.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 117.961 -1.496 . . . . 0.0 112.304 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.598 ' OG ' HG23 ' A' ' 71' ' ' THR . 16.3 m -145.55 149.43 34.58 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.222 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 pt -147.03 154.9 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 118.956 -1.098 . . . . 0.0 111.387 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 92' ' ' TYR . 16.9 t-20 -89.77 164.15 14.78 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.554 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.447 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 22.6 t80 -172.32 129.67 0.58 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.209 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -90.39 111.06 22.15 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.082 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 116.295 -1.812 . . . . 0.0 110.666 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.85 -48.24 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.847 -1.141 . . . . 0.0 111.761 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.72 12.16 3.7 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.603 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 t -116.32 107.13 47.79 Favored Pre-proline 0 N--CA 1.495 1.821 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.009 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -67.88 -124.64 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.963 0 C-N-CA 120.446 0.764 . . . . 0.0 110.128 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.498 ' O ' ' O ' ' A' ' 22' ' ' TRP . 5.4 ptp180 -172.02 178.36 2.97 Favored 'General case' 0 N--CA 1.506 2.327 0 C-N-CA 117.624 -1.63 . . . . 0.0 114.158 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -33.07 102.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.839 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.518 HD12 ' H ' ' A' ' 23' ' ' ASP . 0.4 OUTLIER -53.91 125.12 17.49 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.676 179.821 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -174.14 159.16 3.17 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.89 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.1 t -91.98 135.51 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.516 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.77 -59.19 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 118.677 -1.209 . . . . 0.0 111.81 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.39 169.25 21.28 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.568 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.96 80.92 1.7 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.938 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -66.92 161.18 64.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.24 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -54.36 -10.12 2.01 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.362 1.375 . . . . 0.0 111.757 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.5 m -159.07 44.61 0.26 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.504 -0.879 . . . . 0.0 110.476 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.427 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -175.86 114.82 0.13 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.555 180.0 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.444 ' HB2' HD21 ' A' ' 62' ' ' LEU . 5.5 tp -109.81 112.15 24.03 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.336 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.22 122.48 31.08 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.297 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.71 148.23 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.73 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.45 136.41 46.7 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.954 179.801 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.498 ' O ' ' O ' ' A' ' 6' ' ' ARG . 45.7 p90 -118.35 -173.2 2.42 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 118.334 -1.346 . . . . 0.0 113.221 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -147.91 168.27 22.68 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.396 -179.686 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -177.15 179.56 0.36 Allowed Pre-proline 0 N--CA 1.499 1.977 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.955 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 3.0 Cg_exo -64.12 165.15 20.13 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 C-N-CA 120.867 1.044 . . . . 0.0 111.76 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -92.85 42.75 1.11 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.574 -0.85 . . . . 0.0 111.592 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.71 HG22 ' N ' ' A' ' 28' ' ' THR . 14.0 p -103.3 177.07 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.679 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.71 ' N ' HG22 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -80.31 105.46 11.58 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.83 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.489 HG11 ' CE1' ' A' ' 32' ' ' TYR . 37.1 t -103.26 123.5 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.579 -0.849 . . . . 0.0 111.035 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -65.34 -47.3 76.94 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.031 -1.068 . . . . 0.0 109.931 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -159.06 168.55 26.39 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.324 179.92 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.503 ' OH ' ' HB3' ' A' ' 24' ' ' ALA . 4.4 m-85 -113.87 165.91 12.11 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.457 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -141.64 100.19 3.71 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.849 -0.741 . . . . 0.0 109.356 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.12 131.46 45.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.469 -0.892 . . . . 0.0 112.342 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.497 HG22 ' CB ' ' A' ' 47' ' ' GLU . 36.2 p -127.08 136.73 52.56 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.383 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 2.3 p90 -142.46 159.66 41.79 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 118.556 -1.258 . . . . 0.0 111.682 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.58 150.06 5.88 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -70.26 156.97 38.52 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.491 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.0 m -73.72 151.04 40.81 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.539 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.02 -87.13 0.09 OUTLIER Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.256 -1.45 . . . . 0.0 110.578 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.21 -5.4 0.89 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.416 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -76.51 -57.53 3.81 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.748 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 p 178.16 123.55 0.19 Allowed Pre-proline 0 C--N 1.304 -1.375 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.384 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -59.15 166.58 7.02 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 120.465 0.776 . . . . 0.0 111.188 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.43 HG11 ' CE2' ' A' ' 36' ' ' TYR . 47.5 t -63.24 -70.74 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.084 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -174.68 -166.11 0.23 Allowed 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.827 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.497 ' CB ' HG22 ' A' ' 35' ' ' THR . 8.3 pt-20 -162.07 174.49 12.93 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.004 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.582 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -170.59 153.7 4.28 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.997 179.677 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 p -113.01 157.33 21.66 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.475 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.548 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -145.44 159.88 46.9 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.493 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -64.81 22.65 0.07 OUTLIER 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 121.372 1.381 . . . . 0.0 112.179 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 48.33 20.71 1.61 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.148 -1.501 . . . . 0.0 110.394 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -45.98 16.8 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.663 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -90.55 130.4 36.59 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.274 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.4 m -81.32 -4.47 55.73 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.622 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -133.74 162.35 32.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.188 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.92 171.77 13.83 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.589 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.6 m -144.44 117.06 8.64 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.633 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 59' ' ' ILE . 12.2 mt -111.39 150.02 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.559 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.3 m -136.92 -8.13 1.83 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.788 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.41 52.17 1.81 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.419 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -130.29 -172.97 2.92 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.998 -179.976 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -131.91 102.15 14.93 Favored Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.911 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.29 144.22 61.5 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 120.657 0.905 . . . . 0.0 111.321 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.37 38.62 1.76 Allowed Glycine 0 N--CA 1.498 2.793 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.672 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.591 HG22 ' N ' ' A' ' 67' ' ' ASP . 5.3 p -169.05 165.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.631 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.591 ' N ' HG22 ' A' ' 66' ' ' VAL . 4.4 t70 -60.31 145.89 46.01 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.675 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.451 ' O ' ' O ' ' A' ' 92' ' ' TYR . 0.3 OUTLIER -145.32 119.06 9.2 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.422 -179.904 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -105.59 136.77 44.58 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.565 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.443 ' CG1' ' N ' ' A' ' 71' ' ' THR . 2.1 tt -134.36 156.54 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.876 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.443 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 48.9 m -147.99 138.1 22.72 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.585 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 72' ' ' VAL . 2.4 m -114.28 129.87 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.407 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -111.23 114.86 28.38 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.639 -179.765 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.07 96.52 9.7 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.172 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.34 146.24 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.161 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.843 HG23 ' H ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -122.26 -91.99 0.54 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.141 179.969 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.843 ' H ' HG23 ' A' ' 76' ' ' THR . . . 50.57 -167.25 0.46 Allowed Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.783 -1.198 . . . . 0.0 110.852 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.39 -0.04 22.62 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.247 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.41 0.9 40.69 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 119.644 -1.265 . . . . 0.0 111.256 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -130.1 -15.3 3.78 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.726 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.89 74.7 79.66 Favored Pre-proline 0 C--N 1.309 -1.16 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.545 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -63.72 112.73 1.88 Allowed 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 121.186 1.257 . . . . 0.0 111.346 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.25 119.91 39.96 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.616 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.3 m -57.59 103.01 0.11 Allowed 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.2 m -74.93 -93.46 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.603 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -140.14 67.44 33.14 Favored Pre-proline 0 C--N 1.301 -1.502 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.439 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -72.2 157.9 52.98 Favored 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 121.494 1.463 . . . . 0.0 110.351 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.3 tt -144.19 138.43 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 118.66 -1.216 . . . . 0.0 110.61 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.4 p -119.42 122.36 41.57 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.597 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.063 ' H ' HD12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -120.5 145.09 27.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.681 -179.971 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -97.45 153.4 18.14 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.861 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.451 ' O ' ' O ' ' A' ' 68' ' ' TYR . 24.5 t80 -165.18 135.43 3.74 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 119.234 -0.986 . . . . 0.0 111.026 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.33 127.35 43.21 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.91 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 116.339 -1.791 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 120.812 0.339 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.81 131.65 44.12 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.213 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -162.01 -52.56 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.072 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 5' ' ' PRO . 41.9 t -62.81 136.87 96.6 Favored Pre-proline 0 C--N 1.303 -1.442 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.916 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 4' ' ' VAL . 12.4 Cg_exo -47.97 177.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 120.694 0.929 . . . . 0.0 110.792 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -172.03 166.94 6.18 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.183 -1.407 . . . . 0.0 113.041 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 41.65 86.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.599 -1.182 . . . . 0.0 113.983 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.27 149.28 24.18 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -164.75 161.65 20.69 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 117.206 -1.798 . . . . 0.0 113.78 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.9 t -103.53 135.36 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-N 114.238 -1.346 . . . . 0.0 108.502 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.547 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -112.49 -10.08 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.762 -179.811 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 175.22 170.0 0.3 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.413 -1.315 . . . . 0.0 111.886 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.59 134.31 16.6 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.656 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -126.45 162.01 49.12 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.73 179.986 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -52.04 -12.88 1.55 Allowed 'Trans proline' 0 C--O 1.213 -0.745 0 C-N-CA 121.135 1.223 . . . . 0.0 111.865 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.14 48.99 0.39 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.03 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER 173.06 139.1 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.983 -179.998 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 tp -130.65 132.33 45.38 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.493 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.438 HD23 ' HB ' ' A' ' 11' ' ' VAL . 2.2 tp -93.56 126.67 38.84 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.034 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 pp -128.17 156.14 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.166 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.91 145.11 29.7 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.936 -1.105 . . . . 0.0 111.61 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.613 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 7.3 p90 -144.84 -147.56 0.22 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.153 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.613 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 27.6 t70 -154.35 150.05 27.53 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 117.937 -1.505 . . . . 0.0 112.621 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.59 127.29 25.25 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.24 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.53 ' HB2' HG12 ' A' ' 27' ' ' VAL . 1.7 Cg_endo -62.06 171.03 5.44 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 120.626 0.884 . . . . 0.0 111.62 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.67 19.26 4.07 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.119 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.609 HG22 ' N ' ' A' ' 28' ' ' THR . 4.1 p -84.4 165.41 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.909 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.609 ' N ' HG22 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -57.64 95.35 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.606 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.5 t -108.08 137.67 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.719 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -93.4 -57.57 2.56 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.975 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -165.03 166.73 19.04 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.826 -1.149 . . . . 0.0 112.028 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 74' ' ' ALA . 2.1 m-85 -120.0 156.0 31.74 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.439 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -135.19 104.6 5.96 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.864 179.831 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -96.28 122.03 47.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.682 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -120.18 141.38 49.94 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.638 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.463 ' CG ' HD11 ' A' ' 59' ' ' ILE . 28.9 p90 -139.16 144.38 38.56 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.898 -1.121 . . . . 0.0 111.28 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.674 ' HA2' HG21 ' A' ' 45' ' ' VAL . . . -172.42 153.26 18.66 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -74.31 166.83 22.8 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.006 -179.944 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.415 HG22 ' N ' ' A' ' 40' ' ' GLY . 39.9 m -75.1 157.64 34.41 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.915 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.415 ' N ' HG22 ' A' ' 39' ' ' THR . . . 142.74 -69.67 0.42 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.288 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.69 -134.46 3.83 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -73.36 -96.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.349 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 45' ' ' VAL . 3.2 m -172.92 66.89 0.36 Allowed Pre-proline 0 C--N 1.305 -1.351 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.995 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -74.48 40.95 0.65 Allowed 'Trans proline' 0 C--N 1.327 -0.6 0 C-N-CA 121.656 1.571 . . . . 0.0 110.27 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.674 HG21 ' HA2' ' A' ' 37' ' ' GLY . 61.4 t -109.57 -95.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.081 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -167.48 174.1 8.17 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 117.061 -1.856 . . . . 0.0 113.02 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -169.06 167.18 10.72 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.226 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -164.11 160.55 21.63 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.94 161.53 20.73 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.643 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -148.66 159.41 38.37 Favored Pre-proline 0 C--N 1.309 -1.187 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.129 179.977 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -64.99 22.25 0.08 OUTLIER 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.002 1.135 . . . . 0.0 112.107 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 49.3 17.65 1.17 Allowed Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.776 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.56 -43.33 14.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -79.09 123.33 27.24 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.951 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.7 m -81.2 -12.68 59.1 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.446 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.0 p -138.62 148.56 44.25 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.173 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.95 165.03 30.65 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.921 -1.111 . . . . 0.0 111.435 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.7 m -104.17 130.23 51.91 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.167 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.463 HD11 ' CG ' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -112.21 123.29 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.719 179.979 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 51.6 m -129.81 157.48 42.09 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.307 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.78 -20.44 1.81 Allowed Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.576 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.53 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -79.35 -172.03 3.01 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.016 179.956 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.68 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -157.3 -43.73 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.487 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.487 179.967 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.68 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 10.3 Cg_endo -89.19 -167.65 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.517 1.478 . . . . 0.0 111.658 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -132.53 81.18 0.32 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 107.483 -2.247 . . . . 0.0 107.483 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.673 HG22 ' N ' ' A' ' 67' ' ' ASP . 7.5 p -133.61 175.33 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.055 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.673 ' N ' HG22 ' A' ' 66' ' ' VAL . 4.3 t70 -50.8 120.55 4.89 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.135 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.02 129.11 46.19 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.173 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.0 126.48 52.38 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.06 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 pp -112.23 152.66 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.847 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.471 ' HG1' ' CB ' ' A' ' 89' ' ' SER . 52.9 m -145.49 143.95 30.29 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.955 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.2 m -125.19 139.34 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.635 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -117.49 100.45 7.66 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.794 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -79.44 83.35 5.46 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.86 140.03 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 118.997 -1.081 . . . . 0.0 113.544 -179.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 p -126.99 -161.03 1.04 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.134 -1.393 . . . . 0.0 108.128 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 144.46 179.39 20.86 Favored Glycine 0 N--CA 1.499 2.893 0 C-N-CA 118.549 -1.786 . . . . 0.0 111.836 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 mtt180 -91.96 -15.27 28.22 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.232 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 104.22 17.39 15.97 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.321 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -161.38 -33.23 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.762 -1.175 . . . . 0.0 111.845 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.78 139.47 21.61 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.882 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.12 113.06 1.42 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 120.711 0.941 . . . . 0.0 110.957 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.96 118.46 36.81 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.6 t -71.76 141.02 49.75 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 74' ' ' ALA . 4.8 t -115.25 -177.62 3.18 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.877 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -118.74 84.3 24.74 Favored Pre-proline 0 N--CA 1.494 1.745 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.952 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -70.69 158.93 54.34 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 120.997 1.131 . . . . 0.0 112.752 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 88' ' ' ILE . 13.8 tt -149.3 137.03 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.373 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.471 ' CB ' ' HG1' ' A' ' 71' ' ' THR . 4.2 m -128.2 134.63 49.06 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.902 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -116.7 136.01 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.104 179.814 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.18 145.18 26.29 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.867 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.455 ' CG ' ' N ' ' A' ' 93' ' ' ARG . 24.3 t80 -167.28 158.2 11.65 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.984 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.455 ' N ' ' CG ' ' A' ' 92' ' ' TYR . 7.2 mtm-85 -93.34 113.55 25.76 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.975 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 116.581 -1.676 . . . . 0.0 110.436 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 2' ' ' SER . 3.2 t . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 120.824 0.345 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 1' ' ' VAL . 38.0 m -56.87 -107.61 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.82 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -157.45 -20.29 0.09 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.933 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 t -90.35 135.07 30.06 Favored Pre-proline 0 N--CA 1.488 1.427 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.369 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.44 165.37 7.65 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 120.415 0.743 . . . . 0.0 111.237 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.43 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 1.8 ptp180 -175.13 171.27 3.02 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.022 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 3.3 t70 70.63 44.22 0.68 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.092 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 8' ' ' LEU . 9.5 mp -88.08 121.76 30.86 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.543 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -171.32 166.07 7.09 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.587 -1.245 . . . . 0.0 111.933 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.6 t -92.62 143.48 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.848 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.6 p -128.92 -2.93 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.48 -179.859 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -179.81 147.54 0.29 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.491 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.486 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -176.57 112.17 0.1 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.631 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.64 ' O ' ' N ' ' A' ' 16' ' ' THR . 0.2 OUTLIER -148.51 -75.62 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 117.921 -1.512 . . . . 0.0 113.049 179.968 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 17' ' ' SER . 6.8 Cg_endo -53.21 78.37 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.779 0 CA-C-N 119.491 0.854 . . . . 0.0 110.863 -179.571 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 14' ' ' THR . 3.0 m 35.51 32.49 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.074 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 15' ' ' PRO . 1.6 m -139.79 148.95 42.94 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.941 -1.103 . . . . 0.0 112.447 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.53 HD13 ' CD2' ' A' ' 62' ' ' LEU . 5.6 tp -113.09 142.04 46.19 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.575 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.421 HD12 HG23 ' A' ' 58' ' ' THR . 1.1 tp -117.2 107.29 14.26 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.047 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 pt -106.24 157.95 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.361 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.98 138.3 18.46 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.824 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.543 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 9.3 p90 -144.35 -156.17 0.67 Allowed 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 118.816 -1.154 . . . . 0.0 111.346 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.543 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 27.7 t70 -102.57 163.44 12.22 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -179.52 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.429 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -145.98 101.8 4.18 Favored Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.071 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.503 ' HB2' HG22 ' A' ' 27' ' ' VAL . 7.4 Cg_exo -56.4 -176.66 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.615 0.876 . . . . 0.0 112.255 -179.783 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.95 -13.88 20.92 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.122 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 25' ' ' PRO . 2.6 m -59.17 145.73 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 118.281 -1.367 . . . . 0.0 110.013 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.8 m -68.53 72.52 0.22 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.612 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 27' ' ' VAL . 24.0 t -66.36 126.57 26.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.785 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.1 mmm-85 -54.61 -42.88 71.67 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.23 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -179.58 165.71 1.36 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.443 -1.303 . . . . 0.0 112.234 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -115.73 163.08 16.35 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.14 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.49 HH21 ' CG2' ' A' ' 49' ' ' THR . 21.2 ttm180 -146.56 106.16 3.95 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.39 -1.324 . . . . 0.0 111.038 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.818 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.9 mp -99.9 122.02 51.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.329 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 p -119.59 139.08 52.73 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.699 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.543 ' CE2' HG11 ' A' ' 45' ' ' VAL . 6.4 p90 -136.51 155.35 50.09 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.14 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.401 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -177.57 143.36 6.11 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.464 ' CD ' ' N ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -71.54 176.62 4.6 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.636 -0.825 . . . . 0.0 110.808 179.931 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.2 m -63.5 137.26 58.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.017 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.28 -72.42 0.25 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.648 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.21 -9.69 75.93 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.258 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -87.22 -11.57 49.39 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.4 t -173.74 78.41 0.38 Allowed Pre-proline 0 C--N 1.306 -1.286 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.752 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -60.6 163.46 15.49 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 120.996 1.131 . . . . 0.0 111.17 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.543 HG11 ' CE2' ' A' ' 36' ' ' TYR . 96.2 t -72.07 -78.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.505 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -172.11 -163.49 0.25 Allowed 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 118.476 -1.289 . . . . 0.0 111.966 -179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.71 168.77 21.07 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.771 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -159.84 139.27 11.17 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.548 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.49 ' CG2' HH21 ' A' ' 33' ' ' ARG . 23.3 p -105.07 164.74 11.58 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.644 -0.822 . . . . 0.0 112.393 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.557 ' C ' ' H ' ' A' ' 52' ' ' GLY . 26.9 m -148.06 152.58 40.25 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.42 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -55.63 6.52 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 120.942 1.095 . . . . 0.0 112.612 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 80.86 -4.05 72.24 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.978 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.67 -27.19 45.16 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.079 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -80.45 108.74 14.33 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.01 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -81.31 -19.64 42.49 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.394 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.8 p -135.17 150.08 50.07 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.8 168.36 26.58 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.997 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.421 HG23 HD12 ' A' ' 19' ' ' LEU . 97.3 m -117.11 158.31 24.43 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.398 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 59' ' ' ILE . 5.6 mt -143.03 155.06 17.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.396 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.483 ' HG ' ' HG ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -139.52 135.64 33.67 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.875 -179.999 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.4 44.37 0.18 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.53 ' CD2' HD13 ' A' ' 18' ' ' LEU . 7.5 mp -107.16 175.66 5.42 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.573 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.58 141.39 28.82 Favored Pre-proline 0 CA--C 1.555 1.137 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.02 100.29 0.08 OUTLIER 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 120.748 0.965 . . . . 0.0 112.505 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.43 95.22 0.05 OUTLIER Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.59 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 p -160.59 159.04 2.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 119.136 -1.025 . . . . 0.0 111.328 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.3 146.41 45.34 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.264 -0.974 . . . . 0.0 108.874 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.9 145.2 31.47 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.458 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 m -125.29 126.06 44.51 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.407 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.3 tt -111.46 150.15 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.164 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.13 124.9 19.63 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.815 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.01 130.27 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.594 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.09 105.35 13.1 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.625 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.37 129.69 39.41 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.353 -0.939 . . . . 0.0 109.246 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 t -135.57 130.62 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 119.115 -1.034 . . . . 0.0 112.25 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.445 ' H ' ' CB ' ' A' ' 84' ' ' SER . 53.6 m -128.76 -96.31 0.4 Allowed 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.583 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 76' ' ' THR . . . 60.21 145.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.673 -1.251 . . . . 0.0 111.092 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -108.22 179.59 4.16 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.565 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.19 -105.44 1.35 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.161 -1.495 . . . . 0.0 110.394 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.467 ' CG ' ' N ' ' A' ' 81' ' ' SER . 13.1 p-10 -153.2 -52.32 0.1 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.958 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.467 ' N ' ' CG ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -51.82 127.92 35.45 Favored Pre-proline 0 CA--C 1.562 1.434 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.692 -179.998 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.53 122.84 11.37 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 120.533 0.822 . . . . 0.0 111.527 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.64 16.34 5.35 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.032 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.445 ' CB ' ' H ' ' A' ' 76' ' ' THR . 8.6 m -118.36 86.43 2.53 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.798 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.5 m -115.24 78.12 1.14 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.315 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -136.74 61.57 36.83 Favored Pre-proline 0 N--CA 1.493 1.686 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.452 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -71.07 160.35 49.51 Favored 'Trans proline' 0 C--O 1.217 -0.568 0 C-N-CA 121.571 1.514 . . . . 0.0 111.392 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 88' ' ' ILE . 16.1 tt -149.76 128.55 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 118.934 -1.106 . . . . 0.0 109.753 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 99.6 p -121.04 152.04 39.08 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.769 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.77 142.57 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.339 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.92 154.65 18.07 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.598 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -164.48 131.69 3.18 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.121 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -89.69 117.26 28.42 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.172 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 116.299 -1.81 . . . . 0.0 110.597 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -54.81 116.99 3.03 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.982 -179.991 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 2' ' ' SER . 69.6 m-20 -155.04 49.01 0.56 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.389 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.0 t -107.91 135.51 19.83 Favored Pre-proline 0 N--CA 1.488 1.452 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.612 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -58.16 -166.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 120.477 0.784 . . . . 0.0 110.352 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 7' ' ' ASP . 4.9 ptp180 -166.85 168.09 14.39 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 117.613 -1.635 . . . . 0.0 113.483 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 18.86 78.34 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.651 179.924 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mp -101.28 123.55 45.58 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.598 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -161.75 171.3 18.08 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 117.942 -1.503 . . . . 0.0 112.813 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.41 129.85 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.08 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.487 HG23 ' OG ' ' A' ' 21' ' ' SER . 4.9 t -95.59 -25.13 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.244 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.76 172.63 9.02 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.93 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.31 100.24 2.13 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.088 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.53 ' CB ' ' HG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -70.52 162.26 71.67 Favored Pre-proline 0 C--N 1.307 -1.271 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.563 179.858 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -53.94 -7.52 0.67 Allowed 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 121.008 1.139 . . . . 0.0 111.712 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.434 ' H ' ' C ' ' A' ' 14' ' ' THR . 7.2 m -160.29 35.99 0.17 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.53 ' HG ' ' CB ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -167.55 120.31 0.92 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.207 179.89 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 tp -96.81 123.81 40.61 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.724 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.48 114.59 28.79 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.688 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.5 169.45 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.733 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.487 ' OG ' HG23 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -158.65 139.51 12.87 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.7 -179.91 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.471 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 12.7 p90 -139.39 -134.15 0.12 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.649 -0.821 . . . . 0.0 110.321 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.493 ' CG ' ' N ' ' A' ' 24' ' ' ALA . 37.2 t70 -155.95 174.83 14.77 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 117.671 -1.612 . . . . 0.0 112.594 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.493 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -142.53 126.55 9.74 Favored Pre-proline 0 CA--C 1.559 1.298 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.854 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.64 -170.85 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 120.285 0.657 . . . . 0.0 111.42 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.87 -12.72 49.99 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.346 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.539 ' O ' HG23 ' A' ' 29' ' ' VAL . 14.1 m -60.96 142.03 16.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.672 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.8 m -54.95 89.93 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.588 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 27' ' ' VAL . 3.6 t -76.53 115.19 17.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.134 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -66.33 -57.81 6.67 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.631 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -165.45 169.02 16.07 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.539 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -122.65 148.7 44.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.902 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -126.73 108.66 11.27 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.536 -0.865 . . . . 0.0 109.531 179.782 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.03 128.71 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.875 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 p -128.64 139.72 52.12 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.149 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.493 ' CE2' HG11 ' A' ' 45' ' ' VAL . 10.8 p90 -141.95 166.7 23.99 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.725 -179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.02 158.68 10.25 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -51.79 158.74 0.93 Allowed 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.603 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.8 m -66.56 104.5 1.28 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.052 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.46 -41.91 0.02 OUTLIER Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.07 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.95 -12.25 50.14 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.488 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -126.88 16.32 7.4 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.566 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.5 p -148.7 70.52 10.43 Favored Pre-proline 0 N--CA 1.488 1.457 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.35 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -69.57 118.47 5.7 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 C-N-CA 121.686 1.591 . . . . 0.0 111.891 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.493 HG11 ' CE2' ' A' ' 36' ' ' TYR . 2.3 t -57.91 -57.27 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.626 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.432 ' N ' HG12 ' A' ' 45' ' ' VAL . 2.9 tt0 -172.78 179.8 2.28 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.339 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -164.49 158.45 18.3 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.844 -179.968 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -159.25 157.55 30.86 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.606 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -119.73 168.41 11.09 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.112 -179.868 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -147.66 158.89 42.4 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.681 179.971 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.463 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.9 Cg_endo -61.7 15.42 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.0 1.133 . . . . 0.0 112.72 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 54.19 7.98 0.98 Allowed Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.111 -1.518 . . . . 0.0 110.533 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -70.07 -34.74 73.57 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.291 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -119.33 121.68 40.12 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.837 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 m -79.66 46.63 0.78 Allowed 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.979 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.12 151.34 43.85 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.378 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.13 159.21 40.02 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.735 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.07 148.95 52.19 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.699 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.2 mt -138.21 146.89 26.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.587 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.7 m -139.43 155.42 47.62 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.231 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.46 8.71 55.99 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.928 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.23 -156.05 0.16 Allowed 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.855 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.67 103.62 0.94 Allowed Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 119.649 -0.821 . . . . 0.0 110.617 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.94 158.71 32.51 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 120.375 0.717 . . . . 0.0 111.639 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.63 35.91 5.0 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.186 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -165.22 154.68 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.943 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.468 ' OD1' ' ND2' ' A' ' 91' ' ' ASN . 11.8 t0 -72.3 113.76 9.67 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.412 179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.0 148.23 30.0 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.879 -0.729 . . . . 0.0 111.247 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.2 m -122.93 140.21 53.24 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.708 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 tt -130.84 148.63 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.394 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 65.4 m -140.5 126.03 19.01 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.249 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' ' 72' ' ' VAL . 23.3 m -117.81 129.71 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.141 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -107.59 106.86 17.41 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.617 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.52 107.85 14.62 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.182 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.39 113.7 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.526 -0.87 . . . . 0.0 111.23 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 m -128.34 -54.47 1.27 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.578 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.75 119.25 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.617 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.66 -80.01 0.4 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.864 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.79 17.13 0.06 OUTLIER Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.459 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -144.63 -70.84 0.28 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.075 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.56 162.69 60.5 Favored Pre-proline 0 C--N 1.306 -1.304 0 C-N-CA 119.176 -1.01 . . . . 0.0 110.32 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.06 168.1 2.79 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 121.158 1.239 . . . . 0.0 111.243 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.63 -26.62 67.16 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.293 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -66.39 109.1 2.59 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.4 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.7 p -83.27 -86.74 0.11 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.236 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -143.99 70.1 16.54 Favored Pre-proline 0 C--N 1.299 -1.626 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.388 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.58 149.38 82.65 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.002 1.135 . . . . 0.0 110.429 179.862 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.1 tp -150.12 161.31 4.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 118.493 -1.283 . . . . 0.0 111.224 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.8 p -143.73 148.95 36.42 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.595 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.87 146.23 18.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.468 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -89.21 160.07 17.14 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.417 179.972 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -171.95 140.45 1.24 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.994 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -87.24 112.52 22.1 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.394 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.04 0 CA-C-O 116.337 -1.792 . . . . 0.0 110.827 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 t -179.77 -73.74 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.404 -0.919 . . . . 0.0 110.787 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -151.09 45.16 0.82 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.404 -0.919 . . . . 0.0 110.777 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 5' ' ' PRO . 84.2 t -49.42 125.9 16.03 Favored Pre-proline 0 C--N 1.302 -1.487 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.447 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 4' ' ' VAL . 6.1 Cg_exo -56.96 -161.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-N 118.729 0.582 . . . . 0.0 110.619 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -104.35 -154.65 0.51 Allowed 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 118.892 -1.123 . . . . 0.0 112.67 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -42.58 99.45 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.61 -179.685 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mp -96.09 143.33 27.32 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 10' ' ' VAL . 1.8 tm-20 -167.63 166.72 13.84 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 117.844 -1.542 . . . . 0.0 112.897 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.471 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 97.6 t -99.62 108.55 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.618 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.3 t -70.49 -42.88 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 119.141 -1.023 . . . . 0.0 111.918 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.27 173.48 16.62 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.757 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.59 142.45 21.11 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.697 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 17' ' ' SER . 1.1 p -140.63 155.58 69.48 Favored Pre-proline 0 N--CA 1.489 1.524 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.769 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.83 -7.92 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 121.389 1.393 . . . . 0.0 112.279 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.9 p -147.09 27.54 1.05 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.739 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.423 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -177.53 147.84 0.54 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.728 -179.992 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.35 134.36 47.11 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.443 179.857 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.0 tp -115.65 103.1 10.37 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.508 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.426 ' H ' HG23 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -99.35 165.61 2.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.257 179.852 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 m -156.06 136.53 13.18 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.258 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 16.0 p90 -138.66 -140.32 0.14 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.796 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.556 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 36.9 t70 -165.1 153.79 12.15 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.52 -1.272 . . . . 0.0 112.003 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.39 134.76 20.5 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.662 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -59.28 -159.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 120.658 0.905 . . . . 0.0 111.442 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.34 -18.64 19.82 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.965 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.5 m -60.07 151.41 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.786 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.93 104.07 0.17 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.247 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 27' ' ' VAL . 2.9 t -94.26 118.35 40.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.494 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -85.05 -55.4 4.07 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.486 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -157.95 163.99 37.29 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.629 -1.229 . . . . 0.0 111.924 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -119.46 160.46 22.31 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.739 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.38 98.03 3.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.808 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.712 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.7 mp -89.58 134.01 30.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.627 -0.829 . . . . 0.0 112.247 -179.781 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -135.79 134.5 39.01 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.771 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -141.92 155.56 45.49 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.547 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . 171.1 152.28 8.13 Favored Glycine 0 N--CA 1.479 1.558 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.697 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -48.81 175.02 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.342 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.527 HG22 ' N ' ' A' ' 40' ' ' GLY . 19.9 m -51.79 164.11 0.27 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.527 ' N ' HG22 ' A' ' 39' ' ' THR . . . 84.6 86.67 0.9 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.393 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.1 74.73 1.61 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.367 -1.397 . . . . 0.0 110.588 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.12 -19.16 1.75 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.039 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.425 ' N ' ' CD ' ' A' ' 44' ' ' PRO . 11.0 m -168.36 57.12 0.34 Allowed Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.457 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 43' ' ' SER . 3.4 Cg_exo -52.62 164.27 1.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.314 1.343 . . . . 0.0 111.927 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.549 HG23 ' HA2' ' A' ' 37' ' ' GLY . 86.1 t -50.05 -67.11 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.263 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.99 -169.91 0.7 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.874 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -158.1 166.97 31.14 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.95 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 13.6 p90 -162.5 153.3 17.24 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.424 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.87 160.45 16.76 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.187 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.579 ' C ' ' H ' ' A' ' 52' ' ' GLY . 22.8 m -148.66 153.08 39.06 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.265 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.3 Cg_endo -60.01 16.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 120.872 1.048 . . . . 0.0 112.758 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 53.33 6.87 0.47 Allowed Glycine 0 N--CA 1.498 2.784 0 C-N-CA 119.578 -1.296 . . . . 0.0 111.093 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -74.98 -44.41 48.39 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.503 -179.977 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.55 116.25 31.25 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.467 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.7 m -84.6 53.74 2.78 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.042 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.1 143.68 22.66 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.97 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.96 148.24 30.55 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.804 -1.159 . . . . 0.0 111.842 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.1 m -121.91 104.13 9.33 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.926 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.2 pt -109.12 136.36 45.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.209 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.8 m -118.24 -176.68 3.11 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.721 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.83 40.05 9.86 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.514 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.73 -158.35 0.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.971 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -148.58 134.93 10.02 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.209 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -56.74 107.25 0.26 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 120.489 0.793 . . . . 0.0 112.072 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.57 87.71 0.52 Allowed Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.565 -1.302 . . . . 0.0 111.286 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.6 p -161.28 135.27 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.037 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.6 120.93 8.58 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.92 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.5 118.56 26.89 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.972 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.6 m -103.73 114.74 29.22 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.08 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.9 tt -103.64 150.56 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 119.287 -0.965 . . . . 0.0 112.06 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.542 HG23 ' OG ' ' A' ' 89' ' ' SER . 85.5 m -139.75 116.51 10.87 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.002 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.6 m -103.22 144.17 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.768 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -112.2 128.97 56.39 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.319 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.97 86.76 2.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.728 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.01 129.81 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 119.164 -1.015 . . . . 0.0 113.113 -179.629 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.769 HG23 ' H ' ' A' ' 77' ' ' GLY . 0.7 OUTLIER -99.35 -109.39 0.19 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.859 179.835 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.769 ' H ' HG23 ' A' ' 76' ' ' THR . . . 132.17 127.35 2.82 Favored Glycine 0 N--CA 1.497 2.738 0 C-N-CA 119.625 -1.274 . . . . 0.0 111.116 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.435 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -89.29 -10.12 48.0 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.682 179.844 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -149.68 -73.75 0.01 OUTLIER Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -172.18 -4.71 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.44 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.6 148.13 51.11 Favored Pre-proline 0 C--N 1.306 -1.294 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.811 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.59 115.3 2.45 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 121.009 1.139 . . . . 0.0 111.357 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.27 116.32 32.4 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.813 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 84' ' ' SER . 86.6 p -61.12 100.61 0.12 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.568 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.1 t -90.09 -151.47 0.24 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.019 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -118.53 93.9 46.47 Favored Pre-proline 0 N--CA 1.489 1.481 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -71.38 167.98 24.78 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 121.112 1.208 . . . . 0.0 111.413 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 tt -149.49 147.38 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.601 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.542 ' OG ' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -135.17 155.23 51.04 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.681 -179.858 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.76 142.97 24.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.014 179.875 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.44 142.77 31.65 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.061 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -158.99 108.99 1.97 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.185 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.409 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 5.5 ptt-85 -79.04 116.81 19.57 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.887 -1.125 . . . . 0.0 109.114 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 116.367 -1.778 . . . . 0.0 110.972 -179.749 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.739 ' O ' HG22 ' A' ' 1' ' ' VAL . 7.5 p . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 121.216 0.531 . . . . 0.0 109.936 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.2 p -160.84 -170.45 2.73 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.547 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.27 46.99 0.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.829 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.6 t -130.38 86.36 53.8 Favored Pre-proline 0 N--CA 1.489 1.485 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.471 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.19 -170.91 0.04 OUTLIER 'Trans proline' 0 C--O 1.215 -0.672 0 N-CA-C 109.89 -0.85 . . . . 0.0 109.89 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 22' ' ' TRP . 0.3 OUTLIER -176.43 172.77 2.18 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 117.154 -1.818 . . . . 0.0 114.71 -179.712 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' ARG . 38.5 t70 27.19 102.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 113.524 -1.671 . . . . 0.0 113.443 179.862 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -82.13 99.54 9.28 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.142 179.747 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -167.03 167.44 14.6 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.591 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.67 145.71 7.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.986 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.612 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -117.75 0.13 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.603 -179.853 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 171.97 161.19 0.1 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.7 -1.2 . . . . 0.0 111.904 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.74 126.75 5.14 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.831 179.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.57 161.68 61.62 Favored Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.011 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 16' ' ' THR . 5.1 Cg_exo -49.79 104.79 0.08 OUTLIER 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 121.042 1.161 . . . . 0.0 112.051 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.463 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER 75.46 33.34 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.555 179.886 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 p -159.99 126.45 4.33 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.25 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.8 tp -130.42 140.07 50.58 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.77 -0.772 . . . . 0.0 111.347 -179.869 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.61 126.09 45.99 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.985 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 pt -133.66 162.15 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.286 -0.966 . . . . 0.0 112.932 -179.817 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -134.58 140.22 45.94 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.55 -1.205 . . . . 0.0 108.256 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.488 ' O ' ' O ' ' A' ' 6' ' ' ARG . 29.1 p90 -119.5 176.78 5.19 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 118.712 -1.195 . . . . 0.0 113.506 -179.843 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.48 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.51 162.02 34.24 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.496 -179.881 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.768 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -172.47 -175.63 0.3 Allowed Pre-proline 0 N--CA 1.496 1.827 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.542 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.768 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 5.9 Cg_exo -67.58 152.08 78.71 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 120.625 0.883 . . . . 0.0 111.009 -179.761 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.85 44.03 0.45 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.511 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.713 HG22 ' N ' ' A' ' 28' ' ' THR . 13.9 p -107.57 175.36 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.008 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.713 ' N ' HG22 ' A' ' 27' ' ' VAL . 4.2 m -80.52 128.97 34.2 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.97 179.91 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.42 132.0 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.653 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -80.16 -41.65 24.92 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.141 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -143.09 175.06 10.14 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.79 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.12 140.5 30.88 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.746 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -123.28 107.95 12.24 Favored 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 119.118 -1.033 . . . . 0.0 109.98 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.7 mt -100.98 111.34 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.099 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.402 HG22 ' OE2' ' A' ' 47' ' ' GLU . 9.0 p -117.35 137.46 52.43 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.593 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CE2' HG11 ' A' ' 45' ' ' VAL . 42.6 p90 -141.4 138.21 32.81 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.029 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.12 136.78 4.25 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -82.75 169.51 16.08 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.742 -179.966 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.523 HG22 ' N ' ' A' ' 40' ' ' GLY . 54.9 m -70.87 162.29 29.52 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.786 -0.766 . . . . 0.0 111.756 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 39' ' ' THR . . . 115.3 93.02 1.86 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -51.83 94.05 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.252 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 40' ' ' GLY . 0.8 OUTLIER -135.53 -58.95 0.77 Allowed 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.757 179.902 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.66 154.89 1.95 Allowed Pre-proline 0 C--N 1.306 -1.315 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.161 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.12 137.37 61.21 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 121.078 1.185 . . . . 0.0 111.207 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.656 HG12 ' N ' ' A' ' 46' ' ' GLN . 4.2 t -81.15 -80.85 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.162 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.656 ' N ' HG12 ' A' ' 45' ' ' VAL . 1.1 mt-30 -163.3 171.93 15.42 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.509 -1.676 . . . . 0.0 112.556 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' OE2' HG22 ' A' ' 35' ' ' THR . 2.3 tt0 -170.6 143.28 2.17 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.127 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 4.6 p90 -147.34 141.55 26.17 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 p -98.98 156.94 16.66 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.769 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.506 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -150.07 157.88 37.19 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.321 179.942 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.41 13.61 0.09 OUTLIER 'Trans proline' 0 C--O 1.212 -0.785 0 C-N-CA 121.319 1.346 . . . . 0.0 112.234 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 57.66 27.81 59.27 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 118.886 -1.626 . . . . 0.0 109.901 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.21 -31.3 19.16 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -95.91 135.24 37.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.982 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.8 m -79.71 -15.61 57.2 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.109 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 p -139.08 -179.61 5.95 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.134 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.04 157.83 6.74 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.346 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.6 m -114.32 136.74 52.65 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.624 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.65 155.22 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.487 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.1 t -147.74 127.05 13.05 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.937 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.34 -34.15 0.38 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.672 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.48 -158.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.798 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 8.3 tttt -176.11 -43.43 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 119.334 -0.947 . . . . 0.0 112.586 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.607 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 4.4 Cg_endo -78.86 -175.52 2.79 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 121.497 1.465 . . . . 0.0 112.096 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.2 80.07 0.29 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.847 HG22 ' H ' ' A' ' 67' ' ' ASP . 13.8 p -122.81 -174.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.241 -179.79 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.847 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -65.49 95.13 0.2 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.084 179.92 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -90.88 127.95 36.56 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.109 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 m -94.05 117.92 30.78 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.94 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.467 HD12 ' H ' ' A' ' 71' ' ' THR . 2.6 tp -104.89 141.92 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.534 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.467 ' H ' HD12 ' A' ' 70' ' ' ILE . 97.3 m -141.48 130.05 22.68 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.373 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.12 128.06 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.947 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -98.33 146.74 25.38 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.699 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.35 85.33 2.37 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.981 0.8 . . . . 0.0 109.485 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.413 HG22 ' OG ' ' A' ' 85' ' ' SER . 18.6 t -81.4 128.25 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.319 -179.823 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 m -128.84 -57.57 1.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.635 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.89 159.98 53.91 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.458 -1.353 . . . . 0.0 109.932 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.78 -162.98 0.9 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.77 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 43.3 -113.43 0.68 Allowed Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.558 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.4 -19.17 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.191 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -75.53 -41.48 3.68 Favored Pre-proline 0 C--N 1.304 -1.397 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.259 179.955 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 81' ' ' SER . 5.8 Cg_exo -66.47 -177.35 0.87 Allowed 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 120.974 1.116 . . . . 0.0 111.795 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.09 126.28 14.14 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.126 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.6 t -88.45 178.65 6.49 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.763 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.413 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -77.34 172.52 13.18 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.987 -179.976 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -132.15 75.08 75.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.897 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.39 130.43 33.82 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.666 1.577 . . . . 0.0 113.161 -179.772 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.1 tt -133.07 145.28 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.456 179.761 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.4 p -144.46 153.53 41.98 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.301 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.53 141.83 19.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.376 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.34 154.54 41.51 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.122 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -152.25 122.26 7.08 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.405 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.54 75.93 1.07 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.648 179.858 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.453 ' O ' ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 116.212 -1.851 . . . . 0.0 110.417 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.888 0.375 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -146.02 147.29 31.49 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.818 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.61 25.58 1.99 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.717 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 5' ' ' PRO . 17.5 t -86.0 137.1 35.56 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.305 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 4' ' ' VAL . 3.4 Cg_exo -54.17 -163.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 120.69 0.926 . . . . 0.0 110.574 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -167.54 171.47 10.31 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 117.032 -1.867 . . . . 0.0 114.223 -179.92 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 6' ' ' ARG . 4.4 m-20 2.38 95.59 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 112.859 -1.973 . . . . 0.0 115.923 -179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mp -101.49 139.46 37.11 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.487 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.95 168.05 27.68 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 117.693 -1.603 . . . . 0.0 113.69 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.9 t -103.34 115.75 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.559 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.483 ' CG2' ' OG ' ' A' ' 21' ' ' SER . 2.3 t -72.52 -74.11 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.007 -1.077 . . . . 0.0 111.726 -179.823 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.81 179.0 6.84 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.73 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.14 100.73 3.6 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.314 -0.955 . . . . 0.0 111.499 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.16 164.44 23.08 Favored Pre-proline 0 C--N 1.305 -1.327 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.797 179.848 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.532 ' O ' HG23 ' A' ' 16' ' ' THR . 5.0 Cg_exo -54.27 -12.52 3.97 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.213 1.275 . . . . 0.0 111.714 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 15' ' ' PRO . 2.2 p -158.85 33.35 0.22 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.607 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.45 137.96 8.33 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.124 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.6 tp -114.27 126.97 55.63 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.55 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 19' ' ' LEU . 2.8 tt -100.07 98.75 9.45 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.584 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 pp -96.61 148.8 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.394 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.483 ' OG ' ' CG2' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -145.82 134.43 22.16 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.352 -179.938 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.555 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 5.8 p90 -136.42 -140.83 0.16 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.707 179.828 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.555 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 18.4 t70 -150.46 166.95 28.57 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 117.999 -1.48 . . . . 0.0 113.207 -179.754 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -142.25 136.36 14.81 Favored Pre-proline 0 CA--C 1.557 1.23 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.844 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.57 172.51 1.45 Allowed 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.754 0.969 . . . . 0.0 111.705 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.58 -26.62 37.78 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.469 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 27' ' ' VAL . 1.8 t -60.0 160.59 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.53 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 t -64.57 132.05 48.74 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.6 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.797 HG13 HG22 ' A' ' 76' ' ' THR . 3.1 t -110.08 122.53 64.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.171 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.434 ' CG ' ' CE2' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -54.34 -55.67 26.17 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.149 179.955 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.434 ' CE2' ' CG ' ' A' ' 30' ' ' ARG . 2.1 p90 178.42 171.43 0.75 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.493 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -128.07 161.57 28.91 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.175 -179.923 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.74 104.68 4.76 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.373 179.763 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.37 120.21 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.796 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -120.35 137.09 54.47 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.663 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.69 ' CZ ' HG11 ' A' ' 45' ' ' VAL . 11.2 p90 -142.2 157.75 44.51 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.585 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.91 170.58 42.92 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 40' ' ' GLY . 3.9 mt-10 -61.4 -162.48 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.959 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -46.73 -14.15 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.199 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' GLU . . . 80.58 98.06 0.35 Allowed Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.415 -1.374 . . . . 0.0 110.491 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 146.32 -7.96 1.39 Allowed Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.447 -1.358 . . . . 0.0 110.409 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -120.32 -46.52 2.39 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.981 -0.687 . . . . 0.0 111.029 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 m -175.39 78.41 0.31 Allowed Pre-proline 0 C--N 1.307 -1.279 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.298 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -64.73 153.37 78.03 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.068 1.179 . . . . 0.0 111.252 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.69 HG11 ' CZ ' ' A' ' 36' ' ' TYR . 86.0 t -77.54 -90.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.502 -179.984 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' N ' HG12 ' A' ' 45' ' ' VAL . 9.3 tt0 -175.17 -143.88 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.94 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -165.39 168.3 16.88 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 119.261 -0.975 . . . . 0.0 111.394 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 8.7 p90 -153.61 136.48 15.39 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.146 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.9 p -100.1 159.79 14.83 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.702 -179.824 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.545 ' C ' ' H ' ' A' ' 52' ' ' GLY . 34.1 m -147.9 150.53 36.08 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.666 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.95 5.75 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.725 0 C-N-CA 120.849 1.033 . . . . 0.0 112.383 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 81.72 7.49 88.01 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.324 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.44 -35.77 27.22 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.761 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -72.66 106.44 4.67 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.842 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.6 m -79.83 -18.32 51.12 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.859 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.2 p -132.67 158.82 41.35 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.273 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.11 149.25 19.24 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.549 -1.26 . . . . 0.0 111.569 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.8 m -121.87 117.89 27.61 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.054 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 pt -108.27 149.47 11.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.406 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.9 175.76 8.1 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.522 -179.901 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.507 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 83.84 49.6 4.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.884 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.507 HD23 ' C ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -117.46 -168.58 1.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.614 0.721 . . . . 0.0 111.536 -179.881 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -148.98 82.82 6.97 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.011 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -54.46 140.54 74.29 Favored 'Trans proline' 0 C--O 1.216 -0.578 0 C-N-CA 120.846 1.03 . . . . 0.0 111.815 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.8 31.4 2.73 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 67' ' ' ASP . 2.4 p -162.17 169.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 119.361 -0.935 . . . . 0.0 111.255 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.465 ' H ' HG22 ' A' ' 66' ' ' VAL . 6.4 t0 -82.45 126.48 32.26 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.999 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.2 133.36 56.09 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 120.144 -0.623 . . . . 0.0 110.7 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -103.46 138.4 40.23 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.444 ' CG1' ' N ' ' A' ' 71' ' ' THR . 6.1 tt -132.04 157.03 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.457 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.444 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 26.9 m -151.43 123.03 7.93 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.551 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.7 m -115.18 135.09 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -112.77 121.38 44.55 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.984 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.63 105.2 16.1 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.658 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.414 HG21 ' HE1' ' A' ' 31' ' ' TYR . 10.6 t -105.32 99.33 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.271 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.797 HG22 HG13 ' A' ' 29' ' ' VAL . 34.6 p -113.73 154.06 27.96 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.23 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 169.73 155.48 10.09 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.471 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -81.56 2.49 28.93 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.681 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.01 10.59 71.6 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.556 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -131.45 -69.84 0.61 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.768 179.992 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.12 128.74 56.61 Favored Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.508 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.2 128.49 25.29 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 120.413 0.742 . . . . 0.0 110.829 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.32 38.04 3.81 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.794 -0.763 . . . . 0.0 111.473 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.1 t -56.05 127.46 30.64 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.415 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.7 m -88.97 -110.65 0.07 Allowed 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.333 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.471 ' CG ' ' O ' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -156.2 101.78 2.08 Favored Pre-proline 0 C--N 1.303 -1.423 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.882 -179.971 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -55.74 168.02 1.9 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 120.76 0.974 . . . . 0.0 111.678 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 88' ' ' ILE . 13.2 tt -151.39 146.72 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.195 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.0 p -141.5 146.35 36.3 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.204 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pt -146.53 151.8 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.311 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.53 160.27 15.12 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.629 -0.829 . . . . 0.0 109.429 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -161.35 141.05 10.46 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.374 -1.33 . . . . 0.0 112.157 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -96.01 99.72 11.46 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.311 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 116.329 -1.796 . . . . 0.0 110.706 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.1 p -166.6 100.94 0.58 Allowed 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.513 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.39 5.69 0.95 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.462 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.86 138.34 31.28 Favored Pre-proline 0 C--N 1.304 -1.39 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.151 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.8 165.73 6.1 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 N-CA-C 109.989 -0.812 . . . . 0.0 109.989 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.429 ' O ' HD23 ' A' ' 8' ' ' LEU . 5.0 ptm180 -170.71 168.33 7.46 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 118.121 -1.432 . . . . 0.0 112.705 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 55.27 49.8 16.36 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.594 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 6' ' ' ARG . 0.1 OUTLIER -97.29 135.08 39.72 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.22 179.863 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -173.44 168.29 4.57 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.881 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.1 t -96.05 117.29 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.711 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 12' ' ' ALA . 39.8 t -71.49 -79.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 118.792 -1.163 . . . . 0.0 110.786 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.537 ' N ' HG12 ' A' ' 11' ' ' VAL . . . -139.58 179.35 6.62 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.476 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.96 170.54 15.96 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.195 -1.002 . . . . 0.0 111.502 -179.873 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 17' ' ' SER . 52.9 p -142.58 153.04 61.42 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.693 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -50.95 -5.33 0.08 OUTLIER 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 120.599 0.866 . . . . 0.0 111.98 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.504 ' H ' ' C ' ' A' ' 14' ' ' THR . 10.0 t -154.74 28.43 0.43 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.61 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.518 ' N ' ' OG1' ' A' ' 14' ' ' THR . 0.4 OUTLIER -173.93 135.88 0.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.665 -1.214 . . . . 0.0 111.985 179.905 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 31.9 tp -112.71 146.52 38.58 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.046 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 tp -121.23 104.45 9.75 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.999 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pt -97.81 150.56 4.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.929 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 m -145.53 138.12 25.87 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 118.989 -1.085 . . . . 0.0 111.255 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -144.79 -157.77 0.82 Allowed 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.585 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 24' ' ' ALA . 6.6 t70 -139.22 141.88 37.87 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.187 -1.005 . . . . 0.0 112.198 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.442 ' O ' ' OD1' ' A' ' 23' ' ' ASP . . . -96.26 155.18 38.38 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.076 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.77 170.37 5.92 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 120.991 1.127 . . . . 0.0 111.811 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.65 -38.27 83.58 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.228 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.468 ' H ' HG23 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -61.78 159.24 2.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.53 179.973 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.29 159.09 35.22 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.506 -1.278 . . . . 0.0 108.854 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.0 t -139.55 122.07 17.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.372 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -53.64 -52.34 60.23 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.729 -1.188 . . . . 0.0 108.754 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -171.78 162.89 6.32 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.294 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -109.35 171.69 7.29 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.515 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.474 ' C ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -137.57 108.84 6.84 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.198 179.962 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.791 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.8 mp -98.93 113.29 33.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.749 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.514 HG22 ' HB2' ' A' ' 47' ' ' GLU . 17.6 p -117.51 135.82 53.66 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.282 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.449 ' CE2' HG11 ' A' ' 45' ' ' VAL . 5.6 p90 -141.17 157.61 45.02 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.138 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . -171.82 148.41 10.9 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 39' ' ' THR . 6.3 pt-20 -56.17 -163.5 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.964 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.723 HG23 ' H ' ' A' ' 40' ' ' GLY . 3.4 t -58.38 -119.35 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.321 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.723 ' H ' HG23 ' A' ' 39' ' ' THR . . . -50.69 -78.05 0.11 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.098 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 40' ' ' GLY . . . 60.66 125.2 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.541 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -56.95 -19.48 18.28 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.407 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.29 162.43 21.8 Favored Pre-proline 0 C--N 1.305 -1.34 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.031 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -63.65 158.03 48.34 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 121.293 1.329 . . . . 0.0 111.596 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.449 HG11 ' CE2' ' A' ' 36' ' ' TYR . 4.1 t -72.95 -57.52 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 119.084 -1.046 . . . . 0.0 109.816 179.868 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -171.05 -166.91 0.5 Allowed 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.402 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.514 ' HB2' HG22 ' A' ' 35' ' ' THR . 5.8 pt-20 -169.49 159.47 8.52 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.734 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -160.22 143.38 13.67 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.166 -1.013 . . . . 0.0 110.512 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.429 HG22 ' HG3' ' A' ' 33' ' ' ARG . 4.1 p -106.73 162.28 13.92 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.584 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.523 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -142.02 159.22 59.85 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.868 179.952 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.5 Cg_endo -63.9 14.85 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 120.99 1.126 . . . . 0.0 112.345 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 57.54 2.05 0.65 Allowed Glycine 0 N--CA 1.496 2.688 0 C-N-CA 119.432 -1.366 . . . . 0.0 111.112 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -74.3 -44.02 54.38 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.66 179.94 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -93.03 116.33 28.95 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.304 -0.959 . . . . 0.0 110.693 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.59 21.15 0.67 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.771 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.7 p -138.67 130.64 28.1 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.947 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.2 165.48 25.65 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.576 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 t -136.62 144.03 43.85 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.598 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.76 160.06 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.131 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.33 140.47 24.09 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.25 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.86 -15.84 5.37 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.744 ' C ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -83.56 167.0 17.76 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.324 179.992 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.425 ' N ' HD22 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -134.6 128.43 19.03 Favored Pre-proline 0 CA--C 1.556 1.193 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.202 179.803 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.22 112.64 1.18 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.408 0.739 . . . . 0.0 111.8 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.22 22.4 0.26 Allowed Glycine 0 N--CA 1.498 2.788 0 C-N-CA 119.202 -1.475 . . . . 0.0 111.608 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 67' ' ' ASP . 6.9 p -151.74 158.69 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 118.689 -1.205 . . . . 0.0 112.037 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.509 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -73.29 147.02 44.92 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.791 179.995 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -147.66 127.0 13.07 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.649 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.5 m -111.18 132.06 54.61 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.227 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.52 154.33 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.067 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 89' ' ' SER . 0.1 OUTLIER -134.91 131.82 37.74 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.42 179.991 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.14 142.35 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.439 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -126.18 133.07 51.66 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.176 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.15 108.68 20.25 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.598 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 t -109.09 113.55 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.449 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 m -114.32 -12.47 12.41 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.253 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -49.49 140.9 13.56 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.317 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.0 mtp85 -118.23 -27.56 6.02 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.853 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -45.39 -82.12 0.03 OUTLIER Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.249 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.43 -54.46 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.565 -179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 t -69.72 118.02 58.93 Favored Pre-proline 0 C--N 1.306 -1.319 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.824 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.37 117.52 4.39 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 120.349 0.699 . . . . 0.0 112.07 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.99 136.14 34.59 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.463 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m -70.68 96.48 1.22 Allowed 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.946 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 86' ' ' LYS . 25.6 t -64.52 -109.23 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.575 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.488 ' N ' ' OG ' ' A' ' 85' ' ' SER . 18.0 mtpp -138.06 60.34 22.6 Favored Pre-proline 0 C--N 1.305 -1.341 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.083 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -54.77 161.66 5.87 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.361 1.374 . . . . 0.0 111.246 -179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.421 ' CG1' ' N ' ' A' ' 89' ' ' SER . 6.6 tt -152.64 166.3 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.86 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.493 ' HB3' HG22 ' A' ' 71' ' ' THR . 88.6 p -148.97 157.72 43.63 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.864 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.01 137.85 15.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.169 -1.013 . . . . 0.0 110.819 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.83 139.8 32.34 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.5 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -162.02 148.06 13.4 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.029 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -88.61 119.81 29.42 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.536 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 116.206 -1.854 . . . . 0.0 110.377 -179.971 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 1' ' ' VAL . 3.3 m . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 120.864 0.364 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.3 p -160.16 145.75 15.23 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.722 179.979 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -145.42 -20.86 0.48 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.384 -179.902 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.04 136.34 21.57 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.292 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -55.49 161.78 7.07 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 120.515 0.81 . . . . 0.0 111.176 179.926 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -172.03 174.8 3.98 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.791 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.9 t70 55.22 51.98 12.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.28 179.801 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 mp -93.44 120.91 34.28 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.53 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -164.85 159.85 18.83 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 118.738 -1.185 . . . . 0.0 111.772 179.922 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.56 134.83 30.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.922 179.933 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.49 -67.88 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 118.725 -1.19 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.93 172.24 13.32 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.457 179.986 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.41 175.46 9.76 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.815 -179.959 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.2 OUTLIER -140.63 158.43 65.77 Favored Pre-proline 0 C--N 1.307 -1.278 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.077 179.95 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.97 0.33 0.33 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.006 1.137 . . . . 0.0 111.666 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -155.83 26.17 0.38 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.149 -1.021 . . . . 0.0 111.375 -179.95 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.64 157.3 4.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.343 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.5 tp -129.19 147.06 51.0 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.174 -179.953 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -128.67 122.39 30.7 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.03 -179.961 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 20' ' ' ILE . 2.1 pt -123.58 169.85 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.861 179.944 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.47 139.32 11.68 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.449 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 13.8 p90 -137.12 -138.9 0.15 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.985 179.978 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.553 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 33.0 t70 -125.69 171.81 10.3 Favored 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.875 -179.816 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.474 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -143.85 118.22 6.04 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.803 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.6 166.53 11.49 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 120.19 0.593 . . . . 0.0 111.726 -179.871 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.77 -20.04 34.02 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.044 179.987 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 28' ' ' THR . 4.5 t -60.19 163.47 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.556 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.444 ' N ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -80.89 90.48 5.91 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.281 -0.967 . . . . 0.0 110.408 179.96 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 66.8 t -85.86 129.03 38.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.163 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -54.45 -66.46 0.4 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.086 -179.9 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.79 160.62 39.41 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.966 -1.093 . . . . 0.0 111.076 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.49 156.15 17.98 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.916 -179.989 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -137.13 111.69 8.67 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.4 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -101.75 148.03 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.209 -179.951 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.4 p -138.57 133.75 32.93 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.809 179.904 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -130.12 121.73 26.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.283 179.93 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.467 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -151.82 137.33 5.91 Favored Glycine 0 N--CA 1.487 2.058 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.572 -179.851 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -52.65 175.81 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 40' ' ' GLY . 84.1 m -75.24 160.8 29.95 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.297 -179.923 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 39' ' ' THR . . . 88.31 -30.85 5.03 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.817 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.66 19.39 79.15 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.155 -1.498 . . . . 0.0 109.941 179.996 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.15 -10.66 60.01 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.244 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 p -176.98 81.35 0.25 Allowed Pre-proline 0 N--CA 1.487 1.416 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.397 -179.915 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -63.66 130.88 29.36 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 121.016 1.144 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.467 HG23 ' HA2' ' A' ' 37' ' ' GLY . 5.1 t -58.7 -74.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.297 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -173.54 -176.89 1.36 Allowed 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.7 -179.992 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.505 ' N ' ' CD ' ' A' ' 47' ' ' GLU . 1.1 mp0 -135.02 174.91 10.08 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.759 -179.998 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -175.28 132.67 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.493 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.54 148.92 24.64 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.687 -0.805 . . . . 0.0 112.045 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 m -142.32 151.62 58.64 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.431 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 53' ' ' SER . 3.9 Cg_exo -55.25 120.86 8.9 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 120.308 0.672 . . . . 0.0 110.805 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -46.87 -11.39 0.05 OUTLIER Glycine 0 N--CA 1.486 2.03 0 C-N-CA 119.305 -1.426 . . . . 0.0 110.725 179.875 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -65.32 -33.16 75.32 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.48 -179.894 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.2 mtpp -77.38 135.69 38.36 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.593 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.65 -1.74 25.96 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.4 p -132.69 162.64 30.87 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.773 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.466 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -159.04 161.11 36.52 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.016 -1.073 . . . . 0.0 111.583 179.972 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.2 m -137.63 123.09 19.59 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.32 156.52 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.594 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 16' ' ' THR . 0.2 OUTLIER -142.48 176.82 8.72 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.504 -179.93 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.64 58.0 4.33 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.657 -1.258 . . . . 0.0 110.202 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.511 HD12 ' H ' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -130.65 -127.83 0.2 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.068 -179.926 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.511 ' H ' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -172.44 99.63 0.36 Allowed Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.979 -179.915 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.97 149.36 90.6 Favored 'Trans proline' 0 C--O 1.213 -0.729 0 C-N-CA 120.903 1.069 . . . . 0.0 112.237 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.82 55.17 2.73 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.926 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.4 p -168.94 150.81 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -62.52 152.04 35.82 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.503 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.09 138.85 24.28 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.982 -179.929 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.84 108.0 16.81 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.712 179.843 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -95.44 157.97 3.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.111 -179.898 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -158.98 141.57 14.17 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.432 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.15 138.87 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.83 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -119.63 104.55 10.37 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.947 -179.903 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.83 116.67 21.61 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.721 179.828 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.3 t -109.94 109.33 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.94 -179.917 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 p -101.1 -173.9 2.48 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.973 179.878 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.41 115.18 0.4 Allowed Glycine 0 N--CA 1.491 2.334 0 C-N-CA 118.96 -1.59 . . . . 0.0 111.012 179.975 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.91 -41.37 11.19 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.354 179.97 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.21 -106.13 3.01 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -179.983 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.92 -4.73 0.54 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.085 -179.969 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.58 138.92 66.82 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 119.066 -1.053 . . . . 0.0 110.718 -179.923 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.66 99.21 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 120.72 0.947 . . . . 0.0 110.855 179.854 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.14 128.76 48.48 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.258 -179.941 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.06 126.8 43.66 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.727 179.929 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 86' ' ' LYS . 91.5 p -81.85 -125.5 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.143 -179.978 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.402 ' N ' ' OG ' ' A' ' 85' ' ' SER . 5.1 mtpm? -135.27 73.2 64.64 Favored Pre-proline 0 N--CA 1.492 1.64 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.035 -179.924 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.0 164.77 9.58 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.302 1.335 . . . . 0.0 111.577 179.965 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 88' ' ' ILE . 7.9 tt -159.57 156.83 3.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 118.715 -1.194 . . . . 0.0 111.091 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.1 p -134.69 144.02 47.55 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.579 179.987 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -139.0 156.7 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.782 179.945 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.77 146.41 25.94 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.714 -179.968 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -153.62 144.48 22.71 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.239 -0.985 . . . . 0.0 110.737 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.05 118.79 37.59 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.134 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 116.313 -1.804 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.56 158.15 29.99 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.715 -179.997 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.57 -30.54 1.12 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.713 179.933 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 t -83.04 134.26 46.71 Favored Pre-proline 0 C--N 1.302 -1.466 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.914 179.986 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -51.9 161.61 2.22 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 N-CA-C 110.151 -0.75 . . . . 0.0 110.151 179.899 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.446 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 0.7 OUTLIER -164.1 -179.22 6.04 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 117.998 -1.481 . . . . 0.0 113.281 -179.973 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 6' ' ' ARG . 42.7 p30 19.14 74.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.078 -1.419 . . . . 0.0 114.161 179.97 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mp -99.65 132.61 44.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.81 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -162.95 173.33 13.79 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 117.789 -1.564 . . . . 0.0 112.999 -179.832 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.524 HG13 HD21 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -87.27 142.25 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.875 179.9 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 11' ' ' VAL . 1.8 p -130.95 -8.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.695 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 19' ' ' LEU . . . -170.14 161.3 8.43 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.638 -179.977 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.21 149.13 26.69 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.193 -179.94 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.434 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -136.41 161.47 61.94 Favored Pre-proline 0 N--CA 1.491 1.583 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.762 179.89 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.434 ' O ' ' OG1' ' A' ' 16' ' ' THR . 2.9 Cg_exo -50.55 -11.33 0.36 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.221 1.281 . . . . 0.0 111.795 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 16' ' ' THR . 96.6 m -164.39 49.22 0.12 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.432 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.63 143.62 0.16 Allowed 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.322 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.524 HD21 HG13 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -131.02 140.39 50.09 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.912 -179.938 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 8.6 tp -113.05 113.29 25.23 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.285 179.783 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.8 167.05 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.553 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.34 134.57 16.01 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.447 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.632 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 5.8 p90 -142.23 -143.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.413 179.926 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.632 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 5.3 t70 -131.23 147.03 52.55 Favored 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.863 -179.787 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.69 126.8 24.54 Favored Pre-proline 0 N--CA 1.491 1.575 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.009 179.89 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.71 172.06 3.11 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 120.586 0.857 . . . . 0.0 111.997 -179.964 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.22 -24.51 14.54 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.54 179.95 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 29' ' ' VAL . 2.9 m -60.31 166.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.229 179.861 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.39 90.64 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.004 -1.079 . . . . 0.0 110.999 -179.962 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.834 HG13 HG22 ' A' ' 76' ' ' THR . 1.6 t -85.05 122.42 38.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.64 -179.979 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -54.56 -52.62 61.51 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.65 -1.22 . . . . 0.0 109.473 179.88 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 175.1 171.27 0.28 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.691 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -118.38 161.87 19.25 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.475 179.882 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -138.48 104.66 5.21 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.799 179.858 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.547 HD13 ' CE1' ' A' ' 48' ' ' PHE . 4.7 mp -96.78 105.09 16.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.94 -179.972 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.6 p -103.55 143.32 32.9 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.347 179.876 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.469 ' CE2' HG11 ' A' ' 45' ' ' VAL . 8.2 p90 -145.92 166.96 24.45 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 118.464 -1.295 . . . . 0.0 111.38 -179.993 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . 160.0 162.86 12.7 Favored Glycine 0 N--CA 1.482 1.719 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 37' ' ' GLY . 2.5 mt-10 -49.13 177.98 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.716 179.995 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.3 m -74.11 -24.34 59.44 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.745 -179.984 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 176.6 55.82 0.06 OUTLIER Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.607 179.97 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.06 -159.69 10.47 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.313 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -61.31 -25.07 66.88 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.138 -179.988 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.21 158.64 2.69 Favored Pre-proline 0 C--N 1.305 -1.368 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.89 179.877 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.09 156.35 55.52 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.885 1.057 . . . . 0.0 111.007 179.877 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 46' ' ' GLN . 24.1 t -76.99 -77.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 118.864 -1.134 . . . . 0.0 110.616 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.567 ' N ' HG12 ' A' ' 45' ' ' VAL . 1.2 tt0 -175.68 -169.07 0.33 Allowed 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.329 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.41 171.55 19.15 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.987 179.976 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.547 ' CE1' HD13 ' A' ' 34' ' ' ILE . 23.9 p90 -159.73 130.85 5.91 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.867 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -95.67 163.21 13.29 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 119.391 -0.924 . . . . 0.0 112.493 -179.87 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.575 ' C ' ' H ' ' A' ' 52' ' ' GLY . 11.8 p -150.74 140.38 13.79 Favored Pre-proline 0 CA--C 1.561 1.374 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.017 -179.939 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.56 16.02 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 121.0 1.134 . . . . 0.0 113.673 -179.97 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 64.94 4.44 14.73 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.359 -1.4 . . . . 0.0 111.288 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.79 -27.32 64.81 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.042 -179.919 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.13 140.07 35.94 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.229 -179.946 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.451 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 4.6 m -96.94 -26.42 15.05 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.405 179.919 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.3 p -124.01 159.22 30.32 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.538 179.922 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.6 162.54 24.39 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.19 -1.404 . . . . 0.0 112.275 -179.92 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.6 m -107.99 134.01 51.51 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.449 179.95 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 tt -126.27 137.2 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.177 179.989 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.9 t -138.01 111.31 7.96 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.309 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.56 33.15 0.02 OUTLIER Glycine 0 N--CA 1.486 1.979 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.211 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.51 -155.67 0.71 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.63 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -147.84 162.08 32.71 Favored Pre-proline 0 C--N 1.311 -1.104 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.692 -179.903 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -74.69 159.64 42.12 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 121.586 1.524 . . . . 0.0 112.97 179.906 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 34.65 69.93 0.18 Allowed Glycine 0 N--CA 1.499 2.841 0 CA-C-N 114.957 -1.02 . . . . 0.0 113.316 179.793 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 p -159.14 143.52 6.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.745 179.688 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.82 130.54 46.23 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.073 -179.95 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -141.63 138.4 32.53 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.705 179.944 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.3 m -120.9 134.71 55.3 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.864 -0.735 . . . . 0.0 110.479 -179.953 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.97 154.87 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.138 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.458 ' OG1' ' CB ' ' A' ' 89' ' ' SER . 2.5 m -147.98 159.14 44.2 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.954 -179.957 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 72' ' ' VAL . 32.9 m -139.81 129.07 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.072 -179.955 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.89 117.95 35.52 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.147 179.79 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.5 113.61 25.93 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.489 -0.885 . . . . 0.0 110.94 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.08 109.89 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.799 -179.943 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.834 HG22 HG13 ' A' ' 29' ' ' VAL . 15.8 p -106.74 -87.41 0.47 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.022 -179.951 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.97 72.64 0.93 Allowed Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.857 -1.164 . . . . 0.0 110.459 179.977 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -78.05 120.24 22.61 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.571 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.3 -98.1 0.42 Allowed Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.137 -1.506 . . . . 0.0 109.938 -179.9 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -145.86 -15.02 0.47 Allowed 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.769 179.937 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 t -76.91 137.16 66.05 Favored Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.507 179.977 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -62.4 137.8 67.28 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 120.668 0.912 . . . . 0.0 111.181 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.92 -9.62 3.89 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.186 -179.945 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.9 t -79.63 62.47 3.93 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.542 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.1 p -117.43 34.33 5.19 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.077 179.916 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.596 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 4.2 tptp -144.1 38.69 0.25 Allowed Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 118.674 -1.21 . . . . 0.0 114.152 -179.936 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 86' ' ' LYS . 1.4 Cg_endo -57.06 160.69 12.21 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 N-CA-C 109.342 -1.061 . . . . 0.0 109.342 179.7 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.3 tt -151.67 131.24 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 118.034 -1.466 . . . . 0.0 111.804 -179.972 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.458 ' CB ' ' OG1' ' A' ' 71' ' ' THR . 59.2 p -118.7 147.13 44.14 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.69 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -143.1 139.77 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.231 179.959 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.3 154.3 17.91 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.423 179.944 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -169.56 139.25 2.03 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.157 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.432 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 11.0 ptt-85 -88.15 115.15 25.43 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.387 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.421 HG21 HD11 ' A' ' 18' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.647 -179.919 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.436 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 5.0 t -146.09 140.87 27.05 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.825 -179.941 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 2' ' ' SER . 0.5 OUTLIER -148.4 -16.49 0.33 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.637 -179.94 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.24 108.66 1.01 Allowed Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.964 -179.944 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.35 -179.64 0.93 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 120.5 0.8 . . . . 0.0 110.835 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.51 -165.94 1.96 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.497 -179.98 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -118.16 65.65 0.75 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.199 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -75.36 -155.67 0.05 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.559 -0.856 . . . . 0.0 110.342 -179.966 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -177.25 -164.15 0.09 Allowed 'General case' 0 N--CA 1.515 2.825 0 C-N-CA 117.894 -1.522 . . . . 0.0 113.239 -179.694 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.426 ' H ' HG23 ' A' ' 10' ' ' VAL . 2.8 t -70.4 151.67 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.339 179.917 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 11' ' ' VAL . 39.1 t -130.79 -8.03 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.114 179.914 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.64 157.49 3.86 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.805 179.934 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.85 157.09 44.94 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.484 -0.887 . . . . 0.0 111.089 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.36 162.04 51.79 Favored Pre-proline 0 N--CA 1.485 1.306 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.436 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.71 -23.61 33.86 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 121.074 1.183 . . . . 0.0 111.663 -179.977 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.1 p -143.1 39.93 1.47 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.325 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.98 149.84 0.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.895 179.967 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 tp -130.43 117.24 19.38 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.758 179.94 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 tt -90.94 103.74 16.42 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.577 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 pt -97.69 158.52 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.65 179.966 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.0 127.76 15.3 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.507 -179.919 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.622 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 4.4 p90 -138.43 -152.79 0.44 Allowed 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.618 179.861 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.622 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 33.1 t70 -101.55 -178.39 3.71 Favored 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.581 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.537 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . -171.24 109.3 0.4 Allowed Pre-proline 0 CA--C 1.563 1.452 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.819 -179.97 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -61.45 173.34 2.75 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 120.62 0.88 . . . . 0.0 111.93 -179.888 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.71 -23.16 16.05 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.054 -179.929 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.48 HG13 ' H ' ' A' ' 27' ' ' VAL . 2.1 m -59.65 165.64 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.04 -1.064 . . . . 0.0 110.206 179.977 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.743 HG23 ' O ' ' A' ' 28' ' ' THR . 3.4 t -65.52 95.48 0.22 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.026 -1.07 . . . . 0.0 110.483 -179.994 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -87.54 127.56 40.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.155 -179.938 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -59.5 4.81 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.608 179.874 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.7 168.55 4.36 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.074 -1.05 . . . . 0.0 112.027 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.82 139.58 50.89 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.85 179.856 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.71 109.58 20.78 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 119.346 -0.941 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -105.42 99.36 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.37 -179.886 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -103.59 141.35 36.18 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.914 179.92 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.532 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 4.2 p90 -143.78 163.36 33.55 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.009 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.84 149.61 5.81 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.41 144.89 24.0 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.567 -179.981 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 t -75.18 148.93 39.15 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.131 -179.996 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.27 85.63 0.08 OUTLIER Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.527 -179.999 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 43' ' ' SER . . . 171.29 123.16 0.68 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.019 -1.562 . . . . 0.0 110.665 179.977 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -75.48 38.47 0.15 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.285 179.933 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 41' ' ' GLY . 35.1 t -157.4 68.65 4.17 Favored Pre-proline 0 C--N 1.304 -1.4 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.86 -179.911 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.24 150.85 82.73 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 121.329 1.353 . . . . 0.0 111.095 -179.972 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 46' ' ' GLN . 55.2 t -57.06 -83.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.42 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.546 ' N ' HG12 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -171.57 -160.97 0.18 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.575 -179.899 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.502 ' N ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -164.05 158.48 19.48 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.088 -179.995 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -149.1 142.86 25.59 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.462 ' OG1' ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -92.34 166.4 12.6 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.435 -179.929 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.641 ' CG1' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -148.55 148.58 28.79 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.913 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.27 -4.17 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 121.522 1.481 . . . . 0.0 112.911 -179.821 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.641 ' H ' ' CG1' ' A' ' 50' ' ' VAL . . . 70.87 -0.87 26.69 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.646 -1.264 . . . . 0.0 111.42 179.955 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.2 -30.29 22.54 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.895 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.66 129.57 35.74 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.097 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.13 -16.04 34.52 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.582 179.976 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.1 p -134.36 152.92 52.09 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.073 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.14 163.92 39.56 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.771 -1.171 . . . . 0.0 111.611 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.3 m -117.84 112.5 20.47 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.432 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.67 137.81 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.021 -179.914 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.6 t -96.42 -156.56 0.53 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.388 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.3 83.96 0.07 OUTLIER Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.231 -1.461 . . . . 0.0 109.989 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.47 -175.43 2.94 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.3 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -172.29 85.15 0.44 Allowed Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.686 179.888 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -55.45 133.27 57.11 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 120.787 0.992 . . . . 0.0 111.923 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.43 41.61 3.89 Favored Glycine 0 N--CA 1.484 1.895 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.398 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 p -159.96 154.48 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 118.667 -1.213 . . . . 0.0 111.691 -179.977 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.53 105.88 17.62 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.446 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -89.11 118.23 28.67 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.399 -179.78 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.19 131.11 45.46 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.348 179.849 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 pp -130.15 154.54 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.184 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m -144.33 128.26 17.43 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.789 -179.998 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.9 m -110.69 137.19 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.099 -179.942 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -120.07 113.69 20.87 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.636 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.14 105.21 17.36 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.104 179.965 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.4 t -110.2 119.54 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.261 -179.924 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 p -105.98 -40.21 5.76 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.894 179.952 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.12 145.49 0.26 Allowed Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.918 179.932 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -103.68 -79.29 0.54 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.543 -179.979 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 176.83 -0.66 0.03 OUTLIER Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.615 -179.991 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.68 -40.4 0.06 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.757 -179.992 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.8 t -115.82 87.59 18.69 Favored Pre-proline 0 N--CA 1.489 1.479 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -60.17 120.06 7.61 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 120.691 0.928 . . . . 0.0 111.044 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.59 134.09 46.71 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.06 -179.931 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 89.6 p -90.13 141.79 28.35 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.299 179.867 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.4 m -66.56 -79.34 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.998 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -167.52 77.82 0.94 Allowed Pre-proline 0 C--N 1.291 -1.969 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.433 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -57.33 156.02 27.52 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 120.963 1.109 . . . . 0.0 110.702 -179.924 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 tt -151.68 160.35 3.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 118.332 -1.347 . . . . 0.0 111.476 -179.855 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.1 158.63 41.11 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.187 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.13 141.99 16.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.842 179.957 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.29 136.28 40.42 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.502 179.949 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -144.39 135.02 24.8 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.847 -179.981 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -83.45 107.42 15.93 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.168 179.887 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 116.306 -1.806 . . . . 0.0 110.351 -179.918 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.817 0.341 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.01 171.15 1.83 Allowed 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.492 179.983 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -146.61 -16.25 0.43 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.422 179.986 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 t -86.43 133.61 39.94 Favored Pre-proline 0 C--N 1.305 -1.367 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.986 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -52.64 171.93 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 120.355 0.704 . . . . 0.0 111.062 179.938 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.485 ' O ' HD23 ' A' ' 8' ' ' LEU . 14.9 mtt-85 -118.1 -176.18 3.0 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.055 -179.894 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -68.55 94.14 0.55 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.452 -179.916 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 6' ' ' ARG . 0.1 OUTLIER -45.53 174.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.369 179.969 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -155.83 153.09 29.22 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.88 -1.128 . . . . 0.0 112.054 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.8 t -87.81 129.02 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.576 179.876 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.423 HG23 ' OG ' ' A' ' 21' ' ' SER . 48.1 t -104.63 -56.09 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.839 -179.922 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.71 161.43 37.96 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.033 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.16 87.57 1.54 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.937 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.442 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -70.64 158.33 88.13 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.068 -179.983 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.55 -5.16 1.55 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 121.054 1.17 . . . . 0.0 111.217 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.442 ' H ' ' C ' ' A' ' 14' ' ' THR . 14.5 p -151.08 33.2 0.59 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.261 179.997 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.98 122.01 0.31 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.091 179.969 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -97.65 127.66 43.77 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.067 179.945 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 tp -110.0 125.4 52.86 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.538 -179.875 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 20' ' ' ILE . 4.2 pt -127.22 174.24 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.317 179.829 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.561 ' HB3' HG22 ' A' ' 56' ' ' THR . 1.0 OUTLIER -163.06 137.16 6.12 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.077 179.978 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.609 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 11.6 p90 -134.54 -147.6 0.29 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.765 179.998 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.669 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 24.0 t0 -99.38 177.06 5.3 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.53 -0.868 . . . . 0.0 113.333 -179.63 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 23' ' ' ASP . . . 161.96 83.97 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.401 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.331 -179.944 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.12 -177.36 0.19 Allowed 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.035 1.157 . . . . 0.0 112.284 -179.815 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.82 0.66 57.4 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.195 -179.923 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.654 HG22 ' N ' ' A' ' 28' ' ' THR . 7.9 p -60.39 170.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 118.928 -1.109 . . . . 0.0 110.45 -179.976 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.654 ' N ' HG22 ' A' ' 27' ' ' VAL . 60.7 m -61.65 109.36 1.18 Allowed 'General case' 0 C--N 1.286 -2.173 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.589 -179.981 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.72 141.24 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.492 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -91.73 -79.13 0.38 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.987 179.884 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.492 ' CD1' ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -150.62 171.92 16.36 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.26 179.875 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -131.87 160.57 35.29 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.341 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.31 119.18 13.3 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 118.415 -1.314 . . . . 0.0 110.975 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.1 115.77 47.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.368 -179.876 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.2 p -111.4 138.07 48.37 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.564 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.689 ' CZ ' HG11 ' A' ' 45' ' ' VAL . 8.9 p90 -139.29 148.65 43.28 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.271 179.992 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.74 156.58 25.24 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.957 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -66.65 143.04 57.22 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.774 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 m -68.98 150.04 48.14 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.752 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.09 -5.42 10.36 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 119.967 -1.111 . . . . 0.0 110.552 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.2 37.83 82.67 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.375 -1.393 . . . . 0.0 110.204 179.995 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -92.1 -73.93 0.53 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.187 -179.986 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.8 m -139.95 88.39 11.95 Favored Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.858 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.69 134.61 55.13 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 120.598 0.866 . . . . 0.0 111.179 -179.907 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.689 HG11 ' CZ ' ' A' ' 36' ' ' TYR . 63.4 t -59.07 -80.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.803 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -173.26 -159.71 0.11 Allowed 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.986 -1.086 . . . . 0.0 111.036 -179.907 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -162.75 158.67 23.2 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.025 179.975 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 2.9 p90 -146.98 162.55 38.53 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.004 -179.933 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.2 p -114.99 154.82 28.08 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.351 179.968 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.524 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -136.87 157.99 73.78 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.971 -179.976 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.23 8.73 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 121.212 1.275 . . . . 0.0 112.261 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 56.27 13.63 7.44 Favored Glycine 0 N--CA 1.497 2.701 0 C-N-CA 119.484 -1.341 . . . . 0.0 111.127 -179.935 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.49 -57.34 2.91 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.433 179.984 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -64.41 123.39 19.07 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.436 -179.878 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.54 8.45 6.37 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.601 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.561 HG22 ' HB3' ' A' ' 21' ' ' SER . 0.8 OUTLIER -129.57 158.16 40.04 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.884 -179.947 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.1 169.09 25.59 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.496 179.965 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.4 t -142.9 162.03 36.56 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.237 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 mt -139.56 143.46 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.513 179.959 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.07 143.37 31.12 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.646 -179.979 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.07 50.61 1.23 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.964 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.911 HD23 ' H ' ' A' ' 62' ' ' LEU . 1.3 pt? -130.19 -171.71 2.6 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.419 -179.96 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -117.77 89.84 34.5 Favored Pre-proline 0 N--CA 1.488 1.455 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.502 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.39 146.19 95.63 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 120.892 1.062 . . . . 0.0 111.684 -179.875 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.47 43.94 5.39 Favored Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.559 -1.305 . . . . 0.0 109.958 -179.912 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -166.19 157.74 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.194 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -63.11 142.96 58.18 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.585 179.98 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.9 135.26 22.99 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.272 -0.971 . . . . 0.0 111.123 -179.953 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.33 132.59 53.57 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.173 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.1 157.96 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.251 -179.935 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.7 m -148.43 127.57 12.88 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.133 180.0 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.11 138.19 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.009 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -106.42 139.75 40.42 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.276 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -121.17 104.97 10.16 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.7 t -126.86 110.07 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.997 179.909 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 76.9 p -113.93 -115.72 0.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.976 -179.979 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.472 ' N ' ' OG1' ' A' ' 76' ' ' THR . . . 172.81 141.13 3.35 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.325 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -80.6 8.5 7.75 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.364 -0.935 . . . . 0.0 111.017 -179.932 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.65 -23.89 1.82 Allowed Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.386 -1.387 . . . . 0.0 110.553 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -173.46 -46.29 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.475 -179.945 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.0 137.47 79.38 Favored Pre-proline 0 C--N 1.306 -1.313 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.758 -179.87 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -64.87 101.89 0.4 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 120.765 0.977 . . . . 0.0 111.135 179.854 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.4 176.7 1.01 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.766 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.3 p -65.57 177.39 1.21 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.94 179.931 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.6 p -112.4 -86.31 0.56 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.447 179.98 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp 75.84 70.78 0.22 Allowed Pre-proline 0 N--CA 1.501 2.123 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.209 179.943 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -68.57 171.4 13.17 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.024 1.816 . . . . 0.0 112.176 -179.878 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 88' ' ' ILE . 14.1 tt -142.15 137.44 29.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.204 179.912 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 p -127.73 158.55 37.33 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.298 -0.961 . . . . 0.0 112.15 -179.827 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 90' ' ' ILE . 10.4 pt -153.44 148.22 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.883 -179.978 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.95 156.9 16.62 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.161 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -172.38 138.49 0.93 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.444 ' NE ' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -80.64 118.62 22.36 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.32 -179.943 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 116.292 -1.813 . . . . 0.0 110.64 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.3 t . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.86 0.362 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 t 49.97 -176.44 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.824 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -168.77 -24.97 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.18 179.987 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.421 ' H ' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -101.8 131.12 23.21 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.708 -179.958 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -61.57 172.64 3.38 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 120.667 0.911 . . . . 0.0 111.25 179.972 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.84 -176.96 4.98 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.722 179.991 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.593 ' OD2' HD13 ' A' ' 88' ' ' ILE . 3.2 m-20 -106.66 77.29 1.18 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.517 -179.901 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.669 HD22 ' HA ' ' A' ' 22' ' ' TRP . 7.2 mp -63.06 -116.78 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.494 179.972 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 179.06 -171.69 0.14 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 117.894 -1.523 . . . . 0.0 112.506 -179.802 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.3 t -83.75 141.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.471 179.892 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.66 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 3.4 p -99.52 -14.37 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.112 -179.983 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 166.66 178.4 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.958 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.74 108.94 2.96 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -62.57 161.14 29.24 Favored Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.051 179.936 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.8 -3.2 1.37 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 121.031 1.154 . . . . 0.0 111.029 -179.944 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 14' ' ' THR . 15.7 p -153.19 37.24 0.48 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.247 -179.891 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.8 155.48 0.57 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.451 179.948 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.6 130.78 55.28 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.704 -179.913 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -114.32 107.29 15.38 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.269 -179.962 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.442 HG21 HD13 ' A' ' 20' ' ' ILE . 5.0 pt -97.94 168.65 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 119.091 -1.044 . . . . 0.0 110.336 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.56 130.85 9.54 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.187 179.978 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.669 ' HA ' HD22 ' A' ' 8' ' ' LEU . 6.0 p90 -138.49 -171.25 3.01 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.974 179.855 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -113.67 136.59 52.66 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.893 -179.606 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.43 130.0 23.32 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.064 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -56.5 152.27 41.2 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 120.484 0.79 . . . . 0.0 111.387 -179.997 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.12 -37.05 72.33 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.705 -179.956 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.545 HG22 ' N ' ' A' ' 28' ' ' THR . 2.1 p -60.43 165.05 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 119.246 -0.981 . . . . 0.0 110.756 -179.977 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.545 ' N ' HG22 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -70.34 136.43 49.73 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.922 -179.96 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.486 HG13 HG22 ' A' ' 76' ' ' THR . 87.0 t -124.88 139.05 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.835 179.999 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -64.66 0.8 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.393 179.98 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.97 166.93 15.1 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.639 179.974 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.35 160.01 24.92 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -143.71 112.42 6.55 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.415 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.3 mp -102.77 124.67 56.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.298 -179.956 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.559 HG22 ' CB ' ' A' ' 47' ' ' GLU . 71.7 p -121.53 134.09 55.03 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.767 179.915 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.568 ' CE2' HG11 ' A' ' 45' ' ' VAL . 5.3 p90 -137.01 162.9 32.04 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.094 -179.867 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 160.41 156.65 8.28 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.946 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.412 ' HB2' ' H ' ' A' ' 41' ' ' GLY . 3.3 mt-10 -43.71 166.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.08 179.996 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.8 m -74.73 -22.77 58.63 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.411 -179.898 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.78 35.9 0.12 Allowed Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.137 -1.506 . . . . 0.0 110.724 -179.966 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' A' ' 38' ' ' GLU . . . -71.21 -157.29 2.52 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.178 -1.487 . . . . 0.0 109.968 179.943 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -56.51 -33.62 66.2 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.521 179.969 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.11 162.99 0.73 Allowed Pre-proline 0 C--N 1.307 -1.264 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.584 179.878 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.93 159.21 22.1 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 121.186 1.258 . . . . 0.0 111.128 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.568 HG11 ' CE2' ' A' ' 36' ' ' TYR . 39.1 t -85.05 -72.04 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.459 ' N ' HG12 ' A' ' 45' ' ' VAL . 2.4 tt0 -172.13 -164.41 0.29 Allowed 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.635 -179.948 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.559 ' CB ' HG22 ' A' ' 35' ' ' THR . 2.4 pt-20 -166.86 152.83 8.14 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.236 -179.996 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 3.1 p90 -144.43 146.52 32.52 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.4 p -91.37 168.0 11.88 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.924 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -158.22 145.14 13.11 Favored Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 119.557 -0.857 . . . . 0.0 108.991 179.972 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.36 28.47 0.08 OUTLIER 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 121.037 1.158 . . . . 0.0 112.424 179.843 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 49.11 22.84 3.46 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.095 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.84 -38.29 12.42 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.047 -179.93 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -85.22 134.14 34.16 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.729 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.2 m -91.21 -15.49 29.18 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.958 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.5 p -127.37 165.95 18.78 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.232 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.459 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -149.69 137.36 20.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.732 -179.975 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.3 m -118.27 107.27 13.7 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.635 179.869 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.21 164.18 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.973 -179.861 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 t -146.84 177.3 9.23 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.02 179.97 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.45 8.02 50.4 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.307 -179.939 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.26 -160.97 0.74 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.019 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -148.14 112.8 3.84 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.237 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.7 156.8 40.72 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 120.555 0.837 . . . . 0.0 111.744 -179.954 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.09 52.18 1.66 Allowed Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.598 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 p -170.71 154.86 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.95 133.41 56.07 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.517 179.923 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 92' ' ' TYR . 0.2 OUTLIER -133.02 139.69 47.35 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.731 -179.87 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.9 m -122.53 136.79 54.97 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.629 179.907 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.08 161.0 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.7 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.49 146.85 30.68 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.503 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.4 m -132.52 135.59 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.264 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -117.56 131.03 56.75 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.213 -179.998 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.38 101.02 7.66 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.959 -179.997 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.45 126.46 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.813 -179.917 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.519 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 30.1 p -124.1 -124.87 0.25 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.019 179.923 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.519 ' N ' ' OG1' ' A' ' 76' ' ' THR . . . 150.21 112.5 0.59 Allowed Glycine 0 N--CA 1.497 2.728 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.217 179.931 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.99 -11.32 50.83 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.262 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.64 -80.03 0.04 OUTLIER Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.449 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.461 ' H ' ' HD2' ' A' ' 82' ' ' PRO . 5.6 m-20 -156.38 -56.79 0.09 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.602 -179.975 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.531 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -85.41 -43.98 0.64 Allowed Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 119.537 -0.865 . . . . 0.0 113.247 -179.872 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 81' ' ' SER . 2.2 Cg_endo -66.66 3.59 1.4 Allowed 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 120.899 1.066 . . . . 0.0 112.425 -179.795 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.77 67.81 0.83 Allowed 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.779 179.891 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.79 143.82 35.82 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 120.009 -0.677 . . . . 0.0 109.407 179.852 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.1 m -112.6 175.21 5.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.311 -179.888 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -136.99 67.44 56.3 Favored Pre-proline 0 C--N 1.306 -1.31 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.842 179.95 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -56.77 167.86 2.72 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 121.577 1.518 . . . . 0.0 111.948 -179.816 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.593 HD13 ' OD2' ' A' ' 7' ' ' ASP . 4.0 tt -150.08 155.13 8.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.011 179.945 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.7 p -129.31 145.77 51.31 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.481 -179.9 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -146.61 139.0 19.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.057 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -98.08 134.79 40.68 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.07 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 68' ' ' TYR . 31.9 t80 -146.96 129.75 16.16 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.558 179.999 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.6 132.32 36.97 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.796 -179.923 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 116.354 -1.784 . . . . 0.0 110.631 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.427 ' O ' ' OG ' ' A' ' 2' ' ' SER . 24.4 t . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 1' ' ' VAL . 21.2 p 42.99 77.32 0.06 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.223 179.972 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -114.17 -70.1 0.82 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.602 179.97 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.75 ' H ' ' CD ' ' A' ' 5' ' ' PRO . 1.1 t -126.01 -41.18 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.637 -0.825 . . . . 0.0 112.013 179.893 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.75 ' CD ' ' H ' ' A' ' 4' ' ' VAL . 13.2 Cg_endo -84.6 -127.89 0.01 OUTLIER 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 120.909 1.073 . . . . 0.0 109.878 -179.971 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' TRP . 9.6 ptm85 -171.42 177.44 3.51 Favored 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 118.351 -1.339 . . . . 0.0 112.837 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.6 96.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.051 179.968 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tt -41.1 129.59 2.8 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.374 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -175.85 176.12 1.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.265 179.961 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.523 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 2.4 t -96.8 116.67 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.395 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.652 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -92.15 -4.55 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.878 179.992 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 168.74 148.99 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.588 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.57 137.47 15.4 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.246 -179.861 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.515 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.9 OUTLIER -148.81 155.26 41.06 Favored Pre-proline 0 C--N 1.301 -1.503 0 C-N-CA 119.564 -0.855 . . . . 0.0 109.887 179.908 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.77 5.39 0.12 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.098 1.199 . . . . 0.0 112.163 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.515 ' H ' ' C ' ' A' ' 14' ' ' THR . 49.0 p -144.63 14.78 1.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.801 -179.939 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.41 139.64 0.19 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.165 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.88 121.23 24.85 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.586 -179.973 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.36 105.05 14.8 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.776 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 20' ' ' ILE . 1.4 pt -109.09 167.29 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 118.93 -1.108 . . . . 0.0 113.561 -179.641 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.48 135.35 35.06 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.389 -1.732 . . . . 0.0 107.206 179.805 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.62 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 44.7 p90 -119.21 -171.39 2.1 Favored 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 118.11 -1.436 . . . . 0.0 113.657 -179.809 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.46 ' CG ' ' N ' ' A' ' 24' ' ' ALA . 27.8 t70 -136.89 171.85 13.89 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.321 -1.308 . . . . 0.0 111.276 -179.843 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.618 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -115.64 166.63 11.72 Favored Pre-proline 0 N--CA 1.493 1.681 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.44 -179.949 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.618 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 19.2 Cg_endo -71.95 -99.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 121.165 1.243 . . . . 0.0 110.715 179.941 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -107.71 -83.42 0.54 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.573 -179.956 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.837 HG22 ' H ' ' A' ' 28' ' ' THR . 1.7 p -70.76 -170.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.979 -179.934 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.837 ' H ' HG22 ' A' ' 27' ' ' VAL . 37.9 p -69.64 -178.43 1.47 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.563 -179.842 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.4 t -141.11 142.15 30.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.309 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.497 ' HE ' ' CA ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -77.14 -64.86 1.04 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.176 179.797 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.7 158.2 33.77 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.279 179.718 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.62 ' CE2' ' CD1' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -116.2 125.51 52.36 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.916 179.97 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.578 ' NH1' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -106.5 99.18 8.77 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.397 -179.922 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mp -96.17 135.46 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.459 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -138.96 138.34 37.22 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.749 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 1.6 p90 -138.57 153.78 48.7 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.824 -1.15 . . . . 0.0 111.836 -179.958 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . 171.86 142.7 3.81 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.34 155.05 7.37 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.962 -179.974 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 m -75.21 152.84 38.33 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.096 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.1 83.35 0.05 OUTLIER Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.552 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 43' ' ' SER . . . -178.15 120.02 0.7 Allowed Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.283 -1.437 . . . . 0.0 110.505 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.02 31.69 0.17 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.352 179.973 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 41' ' ' GLY . 9.1 t -149.94 71.03 9.49 Favored Pre-proline 0 C--N 1.304 -1.37 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.668 179.978 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -61.18 152.15 73.9 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.445 1.43 . . . . 0.0 111.18 -179.849 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.462 HG23 ' HA2' ' A' ' 37' ' ' GLY . 62.4 t -62.95 -77.73 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.461 -179.91 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -173.55 -168.25 0.43 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.445 -1.302 . . . . 0.0 112.265 -179.932 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -166.16 177.66 6.8 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.655 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -173.69 155.79 2.76 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.202 179.792 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.456 HG22 ' CD ' ' A' ' 33' ' ' ARG . 33.2 p -104.15 159.48 15.65 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.356 -179.983 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.504 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -151.91 154.65 33.03 Favored Pre-proline 0 C--N 1.306 -1.311 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.712 179.769 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.48 12.94 0.09 OUTLIER 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.173 1.248 . . . . 0.0 112.132 179.944 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 59.25 23.13 57.25 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.111 -1.519 . . . . 0.0 109.849 -179.952 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.14 -47.23 13.75 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.897 -179.975 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -84.51 133.18 34.47 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.779 179.918 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.0 m -80.67 -8.12 59.54 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.223 179.989 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.3 p -134.91 -174.12 3.51 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.091 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.99 146.09 9.14 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.989 -179.997 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -108.02 110.67 22.43 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.726 -179.924 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 mt -108.97 144.48 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.024 179.974 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.3 m -148.28 110.04 4.49 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.224 -179.946 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.51 -11.42 0.03 OUTLIER Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.126 -1.511 . . . . 0.0 110.88 179.992 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.603 HD23 ' N ' ' A' ' 62' ' ' LEU . 1.4 pt? -68.28 -164.07 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.947 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.626 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 5.1 ttpt -176.06 -42.29 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.801 -179.946 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.626 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 5.6 Cg_endo -81.36 -169.22 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.457 1.438 . . . . 0.0 111.985 -179.907 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -148.29 83.62 0.18 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.91 HG22 ' H ' ' A' ' 67' ' ' ASP . 10.9 p -142.78 -173.88 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.534 -179.716 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.91 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -56.83 99.66 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.639 179.998 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -97.77 120.83 38.86 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.59 179.891 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.4 m -95.73 124.47 39.76 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.806 -179.925 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.489 ' CG1' ' N ' ' A' ' 71' ' ' THR . 3.9 tt -112.08 157.38 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.13 179.857 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.489 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -154.96 136.22 14.02 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.194 -179.955 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.4 m -131.88 117.34 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.648 179.832 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -93.5 111.66 23.38 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.152 -179.958 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.5 96.81 9.25 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.85 -1.14 . . . . 0.0 110.636 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.578 HG21 ' NH1' ' A' ' 33' ' ' ARG . 9.3 t -93.77 129.43 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.966 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 20.8 p -102.21 -138.22 0.34 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.039 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.437 ' N ' ' OG1' ' A' ' 76' ' ' THR . . . 149.02 99.6 0.21 Allowed Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.489 -1.338 . . . . 0.0 110.682 180.0 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -121.03 -44.49 2.4 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.765 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.41 -93.33 0.24 Allowed Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.194 179.999 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.54 -60.23 0.41 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.81 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.39 149.3 57.72 Favored Pre-proline 0 C--N 1.308 -1.231 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.305 -179.943 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.39 107.9 0.54 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 120.914 1.076 . . . . 0.0 111.433 179.914 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.09 105.81 16.78 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.632 179.958 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -50.72 126.61 16.14 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.449 -0.901 . . . . 0.0 110.936 -179.973 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.7 p -93.78 -111.65 0.11 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.033 179.977 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -140.61 83.64 14.63 Favored Pre-proline 0 C--N 1.306 -1.319 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.212 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.05 164.21 8.61 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 121.209 1.273 . . . . 0.0 111.578 -179.947 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 88' ' ' ILE . 7.7 tt -135.01 144.63 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.443 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.3 p -137.07 133.01 34.94 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.133 -179.957 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.37 148.52 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.14 179.954 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.539 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -98.11 152.63 19.13 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.534 179.951 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -155.28 140.56 17.62 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.372 -179.963 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.99 98.32 11.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 119.342 -0.943 . . . . 0.0 109.873 179.917 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 116.476 -1.725 . . . . 0.0 110.787 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.436 ' N ' ' OE2' ' A' ' 9' ' ' GLU . 1.5 mp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 111.809 0.299 . . . . 0.0 111.809 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.436 ' OE2' ' N ' ' A' ' 8' ' ' LEU . 7.4 mp0 -147.87 168.47 22.12 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.526 -0.869 . . . . 0.0 111.14 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.6 t -100.41 133.01 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.767 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -88.12 -35.62 8.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 118.706 -1.197 . . . . 0.0 110.863 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 174.64 170.98 0.24 Allowed 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.162 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.66 167.68 12.65 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.534 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.28 161.64 29.13 Favored Pre-proline 0 C--N 1.3 -1.561 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.246 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.488 ' C ' HG23 ' A' ' 16' ' ' THR . 14.0 Cg_exo -45.41 103.86 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 120.684 0.923 . . . . 0.0 111.123 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.488 HG23 ' C ' ' A' ' 15' ' ' PRO . 3.1 p 59.25 49.21 9.33 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.905 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 p -171.93 137.22 0.95 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.662 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.469 ' O ' HD12 ' A' ' 19' ' ' LEU . 1.9 tp -130.35 147.99 52.12 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.767 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 18' ' ' LEU . 6.8 mp -119.47 114.13 21.82 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.54 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -110.01 147.66 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.225 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.51 137.57 28.58 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.296 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 11.8 p90 . . . . . 0 N--CA 1.484 1.243 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.458 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.858 HG13 HG22 ' A' ' 76' ' ' THR . 2.2 t . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.741 0.305 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -68.78 0.16 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.692 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.79 164.29 28.97 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.177 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -113.74 158.78 20.5 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.895 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.486 ' CG ' ' OE2' ' A' ' 47' ' ' GLU . 2.9 ttt180 -139.33 105.48 5.23 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.064 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.832 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.7 mp -96.76 120.31 45.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.169 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.403 HG22 ' OE2' ' A' ' 47' ' ' GLU . 22.0 p -126.65 137.19 53.26 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.561 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.453 ' CE2' HG11 ' A' ' 45' ' ' VAL . 6.9 p90 -142.16 155.95 45.33 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 118.741 -1.184 . . . . 0.0 110.427 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.72 137.41 4.75 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.421 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.35 132.97 40.07 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.681 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.5 m . . . . . 0 C--N 1.305 -1.336 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.742 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 46' ' ' GLN . 49.7 t . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.694 0.283 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.482 ' N ' HG12 ' A' ' 45' ' ' VAL . 2.2 tt0 -167.6 171.86 9.9 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 117.979 -1.488 . . . . 0.0 112.499 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.486 ' OE2' ' CG ' ' A' ' 33' ' ' ARG . 0.8 OUTLIER -150.78 159.56 44.45 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.157 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 11.7 p90 -160.22 136.63 8.82 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 118.423 -1.311 . . . . 0.0 111.523 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.0 p -92.66 159.73 15.32 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.431 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.53 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -152.08 142.96 15.47 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.178 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.71 29.9 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 120.953 1.102 . . . . 0.0 112.387 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 57.42 13.56 11.2 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.251 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.44 -31.08 37.57 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.012 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -92.53 119.27 31.84 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.91 -21.73 34.1 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.373 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.4 p -119.54 -178.9 3.72 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.891 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -167.58 143.66 4.12 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.581 -1.248 . . . . 0.0 111.706 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.2 m -110.8 112.2 23.9 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.726 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.92 140.8 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.466 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -145.54 163.89 33.33 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.466 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.13 10.83 33.4 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.769 HD23 ' H ' ' A' ' 62' ' ' LEU . 1.6 pt? -91.98 -177.28 4.66 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.264 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.56 110.29 40.84 Favored Pre-proline 0 N--CA 1.49 1.569 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.047 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.66 137.53 80.67 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 120.599 0.866 . . . . 0.0 111.816 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.09 60.32 1.86 Allowed Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.544 -1.312 . . . . 0.0 109.999 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 p -169.51 156.9 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.471 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -74.99 142.38 43.87 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.081 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -137.89 130.19 29.15 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.124 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.57 125.97 49.48 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.509 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 tt -115.93 148.46 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.475 HG23 ' OG ' ' A' ' 89' ' ' SER . 25.8 m -145.5 121.48 10.69 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.338 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 72' ' ' VAL . 6.6 m -108.41 122.12 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.434 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.49 101.94 11.43 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.278 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.06 113.28 24.95 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.403 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.7 t -107.54 128.4 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.225 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.858 HG22 HG13 ' A' ' 29' ' ' VAL . 29.1 p . . . . . 0 N--CA 1.49 1.541 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.58 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo . . . . . 0 C--O 1.215 -0.639 0 N-CA-C 111.063 -0.399 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.4 tt -147.41 150.51 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 118.654 -1.218 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.475 ' OG ' HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -139.52 150.42 45.09 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.099 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 pt -152.34 141.87 14.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.674 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -93.19 145.53 24.36 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.256 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -156.25 140.71 16.77 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.218 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -84.05 118.98 24.41 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.26 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.769 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.441 ' OE2' ' N ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -170.12 176.89 4.45 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.362 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.0 t -95.66 129.95 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.448 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 m -101.77 -6.5 9.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.774 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.75 161.21 11.03 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.779 -1.168 . . . . 0.0 111.81 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.85 129.14 8.21 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.318 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.88 165.12 36.15 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.476 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.461 ' O ' ' CB ' ' A' ' 16' ' ' THR . 3.2 Cg_exo -53.11 104.31 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.198 1.265 . . . . 0.0 111.94 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.7 OUTLIER 77.91 34.48 0.32 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.13 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.46 126.42 0.91 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.716 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 tp -125.58 126.9 45.53 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.1 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.4 tp -103.5 114.05 28.03 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.469 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.47 159.31 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.596 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.77 145.91 17.51 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.659 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 13.7 p90 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 119.189 -1.004 . . . . 0.0 111.452 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.523 ' NE ' ' OH ' ' A' ' 31' ' ' TYR . 2.2 mtt180 -69.93 -75.63 0.11 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.419 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.523 ' OH ' ' NE ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -153.84 167.68 28.85 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.604 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -123.85 156.04 36.93 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.146 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.522 ' HE ' HG22 ' A' ' 49' ' ' THR . 38.7 ttm180 -140.31 110.12 6.42 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.678 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 mp -95.14 123.49 47.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.904 -1.043 . . . . 0.0 111.338 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -125.58 132.12 52.59 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.711 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.55 ' OH ' ' CE2' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -144.77 167.62 22.15 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.338 -1.345 . . . . 0.0 112.484 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.77 159.14 17.37 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.6 160.74 3.09 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.047 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.306 -1.299 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.724 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.56 HG12 ' N ' ' A' ' 46' ' ' GLN . 13.8 t . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.889 0.376 . . . . 0.0 111.509 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.631 ' NE2' ' H ' ' A' ' 47' ' ' GLU . 50.5 tp60 -171.47 162.92 6.74 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.843 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.631 ' H ' ' NE2' ' A' ' 46' ' ' GLN . 5.0 pt-20 -147.63 148.17 30.79 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.576 -0.849 . . . . 0.0 110.949 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.55 ' CE2' ' OH ' ' A' ' 36' ' ' TYR . 0.9 OUTLIER -147.84 170.97 16.47 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 118.864 -1.134 . . . . 0.0 111.421 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.522 HG22 ' HE ' ' A' ' 33' ' ' ARG . 50.2 p -104.89 174.26 5.95 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.883 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.571 ' C ' ' H ' ' A' ' 52' ' ' GLY . 11.3 p -165.79 137.66 3.18 Favored Pre-proline 0 CA--C 1.564 1.503 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.163 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 53' ' ' SER . 5.2 Cg_exo -56.0 14.19 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 121.216 1.277 . . . . 0.0 113.731 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 54.02 9.24 1.28 Allowed Glycine 0 N--CA 1.495 2.623 0 C-N-CA 119.36 -1.4 . . . . 0.0 111.119 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -72.42 -41.05 66.63 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.969 -1.092 . . . . 0.0 110.287 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -118.83 116.31 26.24 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.075 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.1 m -79.85 58.24 2.8 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.105 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 p -154.28 148.35 25.75 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.371 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.16 150.68 9.54 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 t -117.31 145.56 43.92 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.759 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -135.69 133.8 51.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.41 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.5 m -130.6 165.59 22.45 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.581 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.44 49.22 4.73 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.169 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.29 -155.19 0.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.636 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.6 99.1 17.36 Favored Pre-proline 0 N--CA 1.493 1.71 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.08 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.97 145.14 94.25 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.757 0.971 . . . . 0.0 111.593 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.92 49.97 4.83 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.668 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.3 p -159.02 152.92 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.393 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.13 151.33 31.49 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.109 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.17 121.22 8.84 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.695 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 m -105.78 121.2 43.55 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.646 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 pp -110.18 158.46 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.569 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 55.0 m -153.18 123.19 6.95 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.067 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.5 m -108.63 141.93 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.514 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -112.38 105.65 13.98 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.844 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.74 94.6 9.56 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.063 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -89.6 112.44 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.307 -1.248 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.502 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo . . . . . 0 C--O 1.215 -0.627 0 N-CA-C 113.9 0.692 . . . . 0.0 113.9 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.9 tt -150.43 157.59 5.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.573 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.9 p -144.83 160.69 40.87 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.563 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.97 145.57 16.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.526 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.605 ' ND2' ' N ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -91.48 144.73 25.26 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.639 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.605 ' N ' ' ND2' ' A' ' 91' ' ' ASN . 57.8 t80 -161.3 135.73 7.12 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.838 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.79 132.58 34.57 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.194 -1.003 . . . . 0.0 110.205 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 116.258 -1.83 . . . . 0.0 110.818 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.689 0.281 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -169.3 146.01 3.43 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.124 -1.031 . . . . 0.0 111.112 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.0 t -85.32 116.17 28.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.736 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 t -90.27 -18.82 7.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.768 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.39 159.0 4.5 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.094 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.37 81.41 1.12 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.445 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -77.72 160.62 74.1 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.541 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.92 3.83 0.48 Allowed 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.344 1.363 . . . . 0.0 111.779 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 14' ' ' THR . 1.8 m -152.91 25.3 0.56 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.895 -1.122 . . . . 0.0 111.9 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.17 131.74 0.08 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.954 -1.099 . . . . 0.0 111.287 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 tp -115.72 136.24 53.25 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.52 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.33 116.71 26.77 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.475 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.28 158.59 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.174 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.13 133.52 16.47 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 p90 . . . . . 0 N--CA 1.486 1.334 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.252 179.918 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.579 HG13 HG22 ' A' ' 76' ' ' THR . 13.2 t . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.743 0.306 . . . . 0.0 110.684 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.537 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -87.48 -73.53 0.47 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 118.961 -1.095 . . . . 0.0 110.828 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 2.5 m-85 -146.58 167.5 23.57 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.975 -1.09 . . . . 0.0 111.976 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -131.01 145.39 52.03 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.024 -1.444 . . . . 0.0 108.65 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.486 ' C ' HD12 ' A' ' 34' ' ' ILE . 14.1 ttm180 -132.59 121.39 23.15 Favored 'General case' 0 N--CA 1.508 2.44 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.137 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.741 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.7 mp -97.48 102.58 13.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.715 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.688 HG22 ' HB2' ' A' ' 47' ' ' GLU . 69.9 p -109.61 129.95 55.55 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 12.6 p90 -140.52 165.06 28.49 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.78 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.451 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . 168.6 165.02 25.29 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -66.29 146.39 54.65 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.381 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 39' ' ' THR . 24.4 m . . . . . 0 N--CA 1.489 1.48 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.595 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 46' ' ' GLN . 36.4 t . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 121.185 0.517 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.501 ' N ' HG12 ' A' ' 45' ' ' VAL . 3.5 tt0 -169.08 -159.06 0.22 Allowed 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.987 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.688 ' HB2' HG22 ' A' ' 35' ' ' THR . 7.1 pt-20 -170.12 161.16 8.42 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.189 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 7.2 p90 -152.68 140.27 19.79 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.636 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 50.8 p -82.8 174.05 11.31 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.541 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.599 HG13 ' H ' ' A' ' 52' ' ' GLY . 5.6 p -166.21 139.23 3.3 Favored Pre-proline 0 C--N 1.305 -1.351 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.949 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 53' ' ' SER . 2.0 Cg_endo -62.5 28.3 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 121.0 1.134 . . . . 0.0 112.916 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.599 ' H ' HG13 ' A' ' 50' ' ' VAL . . . 48.55 11.06 0.14 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.996 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -76.84 -38.92 52.88 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.57 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -93.12 131.06 38.5 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.494 -0.883 . . . . 0.0 110.622 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -84.83 -1.24 56.2 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.441 -0.904 . . . . 0.0 111.294 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.5 p -120.11 167.84 11.81 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.722 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.13 136.24 18.69 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.236 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.6 m -99.69 145.8 27.22 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.8 mt -144.32 149.19 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.616 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.4 174.45 10.91 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.75 64.64 3.55 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.784 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.441 HD12 ' H ' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -120.01 -125.17 0.28 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.782 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.441 ' H ' HD12 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -170.84 121.72 0.53 Allowed Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.192 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.58 142.91 73.11 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 120.566 0.844 . . . . 0.0 112.075 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.18 80.92 0.09 OUTLIER Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.387 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.446 ' CG1' ' CE2' ' A' ' 68' ' ' TYR . 7.5 p -170.4 152.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.538 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -82.48 108.65 16.05 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.446 ' CE2' ' CG1' ' A' ' 66' ' ' VAL . 4.6 m-85 -105.4 130.68 53.45 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.85 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.73 119.09 35.69 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.012 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 tp -98.3 137.38 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.235 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.558 HG23 ' HB3' ' A' ' 89' ' ' SER . 82.3 m -139.35 127.77 22.87 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.073 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -118.33 151.59 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.459 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -115.89 133.32 56.15 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.009 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.53 84.36 2.19 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 123.795 0.685 . . . . 0.0 109.466 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -95.3 124.81 48.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.584 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.579 HG22 HG13 ' A' ' 29' ' ' VAL . 4.4 p . . . . . 0 C--N 1.302 -1.494 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.876 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo . . . . . 0 C--O 1.214 -0.706 0 CA-C-O 121.377 0.49 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.3 tt -158.38 139.63 4.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.611 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.558 ' HB3' HG23 ' A' ' 71' ' ' THR . 63.3 p -149.69 166.84 28.16 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 118.216 -1.394 . . . . 0.0 113.039 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 pt -154.42 150.7 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.524 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.602 ' ND2' ' H ' ' A' ' 91' ' ' ASN . 0.0 OUTLIER -82.81 141.23 32.47 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.281 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -146.59 120.91 9.59 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.763 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -85.48 116.51 23.83 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.567 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 116.355 -1.783 . . . . 0.0 111.096 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 mp . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -169.9 168.06 8.88 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 117.499 -1.68 . . . . 0.0 112.963 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.0 t -96.23 111.52 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.374 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.648 HG23 ' OG ' ' A' ' 21' ' ' SER . 24.7 t -77.82 -9.5 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.25 -0.98 . . . . 0.0 111.58 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 169.94 168.03 0.06 Allowed 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.441 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.34 147.59 27.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.811 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.62 161.13 30.11 Favored Pre-proline 0 C--N 1.305 -1.34 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.461 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.585 ' C ' HG23 ' A' ' 16' ' ' THR . 3.6 Cg_exo -51.29 111.88 0.67 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 120.97 1.113 . . . . 0.0 111.083 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.585 HG23 ' C ' ' A' ' 15' ' ' PRO . 1.6 p 64.51 37.92 7.74 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.83 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.92 128.29 1.64 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.662 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.4 HD11 HG21 ' A' ' 94' ' ' THR . 0.4 OUTLIER -130.33 145.47 51.79 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.335 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.17 109.77 15.82 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.065 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -109.12 146.69 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.145 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.648 ' OG ' HG23 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -142.68 131.05 22.22 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.398 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 5.5 p90 . . . . . 0 N--CA 1.483 1.182 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.497 179.952 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 t . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.79 0.328 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.444 ' H ' ' HA ' ' A' ' 76' ' ' THR . 9.3 ttt180 -55.15 -60.47 3.34 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.092 -1.043 . . . . 0.0 110.037 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -168.95 170.16 9.19 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 118.424 -1.311 . . . . 0.0 112.746 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.05 144.32 48.98 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.189 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.34 109.53 16.4 Favored 'General case' 0 N--CA 1.509 2.494 0 C-N-CA 118.999 -1.081 . . . . 0.0 110.244 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.2 mp -96.97 113.95 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.34 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 64.2 p -113.43 142.78 45.49 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.935 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.682 ' CE2' HG11 ' A' ' 45' ' ' VAL . 6.0 p90 -146.71 151.77 37.74 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.753 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.88 164.92 19.03 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -53.5 155.79 2.81 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.765 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.489 1.523 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.304 -179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.682 HG11 ' CE2' ' A' ' 36' ' ' TYR . 50.9 t . . . . . 0 N--CA 1.477 0.914 0 CA-C-O 120.336 0.112 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.643 ' N ' HG12 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -175.99 -166.35 0.18 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.162 -1.415 . . . . 0.0 111.753 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -160.25 169.22 23.66 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.916 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.488 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 19.0 p90 -161.03 131.08 5.0 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.674 -0.811 . . . . 0.0 109.901 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.27 166.25 11.07 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.15 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -146.72 159.16 44.72 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.936 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.47 15.84 0.05 OUTLIER 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 121.135 1.223 . . . . 0.0 112.298 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 62.29 24.21 65.22 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.208 -1.473 . . . . 0.0 110.116 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.35 -36.92 11.19 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.107 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -89.83 116.3 27.81 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.8 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.63 4.42 24.89 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.68 159.43 42.0 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.474 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.45 164.29 21.99 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.434 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.6 m -134.02 146.82 50.74 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.479 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.426 HD13 HG21 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -137.36 158.0 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.052 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.6 m -149.56 174.45 12.52 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.655 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.71 12.73 52.74 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.777 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.07 -158.77 0.67 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.626 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.514 ' O ' HG12 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -150.02 122.19 4.18 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.598 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.71 144.3 97.1 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 120.512 0.808 . . . . 0.0 111.336 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.61 50.77 4.1 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.762 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 63' ' ' LYS . 6.6 p -165.16 139.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.419 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.402 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -64.41 133.33 52.33 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.929 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -132.0 129.86 40.67 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.174 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.2 128.89 54.82 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.914 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 70' ' ' ILE . 4.4 tt -119.7 145.0 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.409 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 81.4 m -142.43 125.26 16.04 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.525 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.57 137.0 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 119.613 -0.835 . . . . 0.0 111.011 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -110.18 143.82 39.75 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.37 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.5 91.25 3.49 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.612 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.8 t -102.91 117.2 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.485 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.444 ' HA ' ' H ' ' A' ' 30' ' ' ARG . 14.0 t . . . . . 0 N--CA 1.486 1.371 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.218 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 C--O 1.216 -0.623 0 N-CA-C 110.501 -0.615 . . . . 0.0 110.501 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -145.4 153.45 13.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.961 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.9 p -151.06 153.72 35.62 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.774 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.7 143.22 21.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.732 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.09 153.64 18.03 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.316 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -169.26 135.29 1.63 Allowed 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.322 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -79.86 106.71 12.08 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.312 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.4 HG21 HD11 ' A' ' 18' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.887 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.535 HD22 ' HA ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.506 2.327 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 10' ' ' VAL . 18.5 tt0 -173.03 162.19 4.54 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.534 -1.266 . . . . 0.0 112.271 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.444 ' N ' ' CG ' ' A' ' 9' ' ' GLU . 61.5 t -91.44 114.36 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.33 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.439 ' H ' HG23 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -79.22 -52.45 15.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 118.825 -1.15 . . . . 0.0 111.422 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.528 ' O ' HD23 ' A' ' 18' ' ' LEU . . . -147.66 158.32 43.96 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.951 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.11 106.72 4.08 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.469 ' C ' ' H ' ' A' ' 16' ' ' THR . 1.0 OUTLIER -104.69 155.21 37.8 Favored Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.631 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.43 3.28 0.2 Allowed 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 121.147 1.231 . . . . 0.0 112.353 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 14' ' ' THR . 3.0 m -149.38 24.11 0.91 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.859 -1.136 . . . . 0.0 111.477 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.426 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.1 OUTLIER 175.96 145.17 0.08 Allowed 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.296 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -130.46 124.64 32.47 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.387 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 tt -95.66 102.21 13.99 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.635 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 pp -109.68 143.5 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.446 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.76 139.28 53.79 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.569 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.535 ' HA ' HD22 ' A' ' 8' ' ' LEU . 46.9 p90 . . . . . 0 N--CA 1.505 2.278 0 C-N-CA 118.125 -1.43 . . . . 0.0 113.726 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' ' 32' ' ' TYR . 63.5 t . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.881 0.372 . . . . 0.0 110.864 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.82 -43.28 13.43 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.555 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -143.34 176.12 9.39 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.818 -1.153 . . . . 0.0 112.323 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.42 ' CE1' HG11 ' A' ' 29' ' ' VAL . 1.6 m-85 -144.06 137.27 27.49 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.663 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -129.23 110.17 11.75 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.17 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.417 HD12 ' H ' ' A' ' 34' ' ' ILE . 4.0 mp -101.68 112.89 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.758 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 p -113.84 135.06 54.38 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.585 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.627 ' CE2' HG11 ' A' ' 45' ' ' VAL . 8.9 p90 -140.07 154.48 47.08 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 118.61 -1.236 . . . . 0.0 111.026 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.93 162.42 22.19 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 39' ' ' THR . 1.4 tm-20 -55.6 152.69 8.84 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.549 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.482 ' N ' ' CD ' ' A' ' 38' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.313 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.242 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.627 HG11 ' CE2' ' A' ' 36' ' ' TYR . 83.7 t . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -172.0 -159.0 0.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.578 -1.249 . . . . 0.0 111.678 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -165.71 156.63 13.62 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.802 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 3.5 p90 -146.72 154.76 41.79 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.569 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.4 p -115.69 155.98 26.75 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.738 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 52' ' ' GLY . 32.9 m -148.77 151.43 35.35 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.661 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.92 19.89 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.06 1.173 . . . . 0.0 112.597 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.572 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 60.22 24.63 61.34 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.474 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -45.02 16.42 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.002 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -89.15 144.87 25.81 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.838 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.5 m -96.01 -12.22 25.29 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.262 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.9 p -138.35 177.3 7.98 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.399 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.11 151.61 4.01 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.824 -1.15 . . . . 0.0 111.294 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.6 m -112.65 104.05 12.11 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.982 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.37 166.82 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.262 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.4 t -142.97 -179.0 6.1 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.963 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.52 60.21 1.38 Allowed Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.528 -1.32 . . . . 0.0 109.952 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.93 -155.55 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.908 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -150.73 137.43 11.36 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.054 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.64 151.94 82.71 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 120.915 1.077 . . . . 0.0 112.672 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.97 77.91 0.08 OUTLIER Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.932 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -162.27 144.28 3.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.005 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.474 ' CG ' HD21 ' A' ' 91' ' ' ASN . 6.8 t70 -76.26 117.02 17.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.293 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -117.54 129.56 55.87 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.537 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.2 120.67 39.91 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.34 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 tt -111.38 146.47 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.437 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.401 ' CG2' ' OG ' ' A' ' 89' ' ' SER . 20.6 m -148.69 141.64 24.78 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.184 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.63 131.8 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.285 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -104.6 123.12 47.0 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.19 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.31 89.99 5.29 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.47 118.41 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.98 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.6 p . . . . . 0 C--N 1.309 -1.192 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.032 179.929 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo . . . . . 0 C--O 1.216 -0.576 0 N-CA-C 110.859 -0.477 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 88' ' ' ILE . 10.3 tt -144.79 131.74 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 118.529 -1.268 . . . . 0.0 111.465 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.401 ' OG ' ' CG2' ' A' ' 71' ' ' THR . 31.8 m -120.38 155.74 32.8 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.657 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.86 135.46 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.534 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.474 HD21 ' CG ' ' A' ' 67' ' ' ASP . 10.5 t30 -86.13 133.66 33.86 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.59 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -140.48 132.27 27.46 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.321 -0.951 . . . . 0.0 111.174 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.04 105.82 18.03 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.091 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 116.431 -1.747 . . . . 0.0 110.868 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -149.71 147.91 28.62 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.241 -1.384 . . . . 0.0 112.412 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.5 t -103.51 111.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.031 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.87 -27.35 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.693 -1.203 . . . . 0.0 111.951 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 19' ' ' LEU . . . -155.09 151.05 27.87 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.851 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.32 121.06 7.54 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.297 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.523 ' C ' ' H ' ' A' ' 16' ' ' THR . 1.1 p -134.13 153.49 79.61 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.32 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -64.29 10.48 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 120.98 1.12 . . . . 0.0 111.648 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.523 ' H ' ' C ' ' A' ' 14' ' ' THR . 5.0 m -140.84 6.31 2.01 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.051 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 p 179.26 148.82 0.25 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.307 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.81 120.08 27.06 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.462 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 2.8 tt -98.07 102.42 14.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.924 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 pp -100.25 155.21 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.503 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.37 143.74 30.29 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.0 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.7 p90 . . . . . 0 N--CA 1.478 0.94 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.216 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.129 0 CA-C-O 120.584 0.231 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.414 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 4.3 mtp180 -54.51 -48.58 71.74 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.35 -1.34 . . . . 0.0 108.93 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.414 ' CG ' ' C ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER 175.93 164.58 0.37 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.849 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -114.01 155.16 26.39 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.11 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.652 ' HE ' ' CG2' ' A' ' 49' ' ' THR . 4.0 ttm180 -135.15 107.52 7.29 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.405 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.3 mt -98.96 109.07 23.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.864 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.563 HG22 ' CB ' ' A' ' 47' ' ' GLU . 45.1 p -113.01 134.56 54.46 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.471 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.468 ' CE2' HG11 ' A' ' 45' ' ' VAL . 9.7 p90 -136.9 153.37 50.76 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.262 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.496 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -177.88 149.41 9.21 Favored Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.596 ' H ' ' CD ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -86.65 139.83 30.41 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.729 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.9 m . . . . . 0 N--CA 1.486 1.363 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.889 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.496 HG23 ' HA2' ' A' ' 37' ' ' GLY . 96.1 t . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.738 0.304 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -173.34 -167.75 0.41 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.976 -1.09 . . . . 0.0 111.527 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.563 ' CB ' HG22 ' A' ' 35' ' ' THR . 2.8 pm0 -153.34 170.2 21.23 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.918 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -159.07 129.56 5.91 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.202 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.652 ' CG2' ' HE ' ' A' ' 33' ' ' ARG . 34.3 p -95.95 162.21 13.66 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.436 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.548 ' C ' ' H ' ' A' ' 52' ' ' GLY . 35.3 m -150.33 150.58 29.49 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.717 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.86 9.87 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 120.92 1.08 . . . . 0.0 112.225 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 72.93 13.56 78.93 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.244 -1.455 . . . . 0.0 109.949 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.25 -29.89 22.77 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.629 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -80.86 118.36 22.3 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.284 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.47 -15.37 57.89 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.371 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.0 p -144.46 176.79 9.12 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.485 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -171.79 160.52 5.63 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.219 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -121.54 143.56 49.21 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.274 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.32 163.9 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.805 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.2 m -143.21 -170.72 3.33 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.442 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.71 55.14 4.66 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.309 -1.424 . . . . 0.0 110.495 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.61 -158.52 0.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.707 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -140.28 155.05 70.41 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.295 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.28 102.55 0.39 Allowed 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.315 1.343 . . . . 0.0 112.739 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.89 95.82 0.03 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.537 -1.315 . . . . 0.0 111.474 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 66' ' ' VAL . 9.9 p -157.54 137.5 4.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.826 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -50.59 116.17 1.81 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.763 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.67 130.11 52.59 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.79 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.1 m -117.67 126.47 52.56 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.564 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -118.57 157.19 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.419 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.406 HG23 ' CB ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -141.08 117.09 10.51 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.448 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 72' ' ' VAL . 34.1 m -111.43 126.64 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.557 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -109.16 130.3 55.49 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.157 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.33 91.48 3.67 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.217 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.1 t -91.91 123.2 43.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.081 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.482 1.144 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.994 179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo . . . . . 0 C--O 1.216 -0.611 0 CA-C-O 120.818 0.258 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 88' ' ' ILE . 9.8 tt -144.42 139.62 24.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.378 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.406 ' CB ' HG23 ' A' ' 71' ' ' THR . 7.2 p -128.48 160.42 32.36 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.817 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.0 pt -144.72 139.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.763 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.58 110.73 21.88 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.756 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 93' ' ' ARG . 5.9 t80 -143.05 138.82 30.21 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.616 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.436 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 10.5 mtp180 -72.16 110.59 6.72 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.597 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 116.371 -1.776 . . . . 0.0 110.984 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.022 0.439 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -154.45 176.29 12.54 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.876 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 t -93.78 132.95 36.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.797 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.69 -4.36 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.13 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.8 144.86 2.33 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.434 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.91 102.15 3.85 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.843 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.552 ' C ' ' H ' ' A' ' 16' ' ' THR . 22.6 p -97.15 152.5 38.33 Favored Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.271 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.46 ' C ' ' HG1' ' A' ' 16' ' ' THR . 1.9 Cg_endo -59.36 14.12 0.04 OUTLIER 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 121.305 1.337 . . . . 0.0 112.726 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 14' ' ' THR . 3.2 m -159.64 21.62 0.18 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.032 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 173.93 149.73 0.08 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.182 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.37 157.72 37.77 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.416 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.6 116.71 21.45 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.264 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pt -106.0 152.27 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.102 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.426 ' HB3' HG22 ' A' ' 56' ' ' THR . 2.4 m -150.27 124.78 9.62 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.029 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 7.2 p90 . . . . . 0 N--CA 1.489 1.484 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.419 179.994 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.3 t . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 120.657 0.265 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.545 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 2.7 mmp_? -79.83 -67.86 0.72 Allowed 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 118.931 -1.107 . . . . 0.0 109.548 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.545 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 2.1 m-85 -149.35 154.37 38.85 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.646 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -110.35 165.46 11.76 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -146.87 110.76 5.0 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.319 -1.352 . . . . 0.0 110.697 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.4 mp -102.66 117.53 48.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.511 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 p -119.14 135.22 54.77 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.137 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.654 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -124.54 156.41 37.38 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.661 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.22 130.47 1.41 Allowed Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.341 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -75.53 143.71 42.32 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.635 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 m . . . . . 0 C--N 1.303 -1.435 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.778 -179.996 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 46' ' ' GLN . 3.7 t . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.297 0.57 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.415 ' N ' HG12 ' A' ' 45' ' ' VAL . 4.7 tp60 -173.36 177.78 2.54 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.661 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -167.35 166.1 14.72 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.894 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -162.12 157.48 23.35 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.907 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.4 p -102.66 166.07 10.71 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.159 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.583 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -153.49 147.04 18.22 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.0 OUTLIER -59.85 17.98 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.393 1.396 . . . . 0.0 112.989 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 62.43 -2.21 1.25 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -81.0 -43.35 19.74 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.433 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 104.55 8.01 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.914 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 m -79.24 8.15 6.48 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.085 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 21' ' ' SER . 1.9 p -137.5 159.62 41.44 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.518 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.57 144.5 3.61 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.332 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.3 m -95.33 146.33 24.46 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.308 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.514 HD11 ' CD2' ' A' ' 36' ' ' TYR . 1.1 tt -141.08 145.33 25.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.842 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.24 167.51 22.26 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.061 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.66 49.27 1.11 Allowed Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.796 -1.192 . . . . 0.0 110.867 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.99 -156.45 0.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.434 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -144.32 158.99 53.57 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.801 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.71 106.49 0.37 Allowed 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 121.384 1.389 . . . . 0.0 112.013 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.74 89.19 0.03 OUTLIER Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.472 -1.347 . . . . 0.0 111.05 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.2 136.68 12.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.926 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -52.75 124.05 12.9 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.009 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.32 126.84 41.57 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.445 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.2 m -107.84 110.85 22.73 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.103 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 71' ' ' THR . 0.6 OUTLIER -96.19 137.35 24.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.23 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.548 ' N ' HD12 ' A' ' 70' ' ' ILE . 24.7 m -138.31 139.17 38.97 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.286 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.44 139.08 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.066 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.462 ' CE2' ' CG ' ' A' ' 87' ' ' PRO . 1.7 m-85 -118.56 113.89 21.97 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.783 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.03 125.56 35.86 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.953 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.92 100.91 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.621 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 C--N 1.306 -1.289 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.251 179.985 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.462 ' CG ' ' CE2' ' A' ' 73' ' ' TYR . 12.6 Cg_exo . . . . . 0 C--O 1.215 -0.642 0 N-CA-C 110.687 -0.544 . . . . 0.0 110.687 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.42 162.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 118.491 -1.284 . . . . 0.0 111.403 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.6 p -147.74 157.66 43.65 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.085 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.7 pt -144.15 143.5 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.711 -0.795 . . . . 0.0 110.68 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -93.77 149.78 20.95 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.133 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -172.26 132.96 0.65 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.644 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.65 122.8 28.59 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.326 -0.949 . . . . 0.0 110.379 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 116.336 -1.792 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -158.27 176.45 12.46 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.418 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.24 124.2 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.937 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 t -69.5 -72.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.171 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.84 174.29 11.62 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.777 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -131.7 168.37 17.87 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.13 160.64 36.8 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.278 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 16' ' ' THR . 2.6 Cg_exo -50.54 99.64 0.04 OUTLIER 'Trans proline' 0 C--O 1.212 -0.786 0 C-N-CA 120.656 0.904 . . . . 0.0 111.092 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.463 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.6 OUTLIER 75.05 41.03 0.32 Allowed 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.304 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.48 141.05 2.9 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.12 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 tp -130.25 152.07 50.08 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.7 tp -126.11 110.55 13.64 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.157 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -101.63 157.79 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.441 -0.903 . . . . 0.0 111.228 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.64 137.57 18.13 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.552 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.2 p90 . . . . . 0 N--CA 1.49 1.541 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.952 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.422 ' HA ' HG22 ' A' ' 76' ' ' THR . 98.4 t . . . . . 0 N--CA 1.477 0.905 0 CA-C-O 121.024 0.44 . . . . 0.0 111.658 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.444 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 20.5 mmm-85 -76.32 -61.06 2.07 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.217 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 75.9 m-85 -154.16 169.56 23.3 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.297 -1.361 . . . . 0.0 112.68 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.56 133.51 38.43 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.744 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -123.27 118.88 28.59 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.889 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.5 mt -101.03 123.31 53.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.9 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 p -124.59 136.36 53.89 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.543 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.698 ' CZ ' HD11 ' A' ' 59' ' ' ILE . 7.9 p90 -139.83 161.65 37.05 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.81 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.5 152.31 13.15 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.442 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.91 145.04 38.49 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.557 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 C--N 1.303 -1.446 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.792 -179.935 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 46' ' ' GLN . 15.1 t . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 121.077 0.465 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.47 ' N ' HG12 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -171.7 -159.22 0.14 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.012 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.31 172.15 7.42 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.315 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -161.79 138.08 8.02 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.941 -1.104 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.9 p -86.65 152.35 22.65 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.152 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 50' ' ' VAL . 12.2 p -165.13 136.55 3.25 Favored Pre-proline 0 C--N 1.301 -1.522 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.44 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 53' ' ' SER . 3.5 Cg_exo -51.94 134.95 50.27 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 120.295 0.663 . . . . 0.0 111.471 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.18 3.61 1.07 Allowed Glycine 0 N--CA 1.484 1.898 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.899 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -68.87 -34.62 75.75 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 118.876 -1.13 . . . . 0.0 110.285 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -79.68 119.65 22.91 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.796 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.5 -7.17 59.58 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.236 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.6 p -137.37 160.16 39.87 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.605 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.95 141.96 17.1 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.311 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.9 m -101.98 144.04 31.09 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.436 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.698 HD11 ' CZ ' ' A' ' 36' ' ' TYR . 4.4 tt -141.33 149.34 20.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.204 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.2 t -149.25 124.99 10.47 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.748 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.07 14.81 0.1 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.287 -1.435 . . . . 0.0 110.541 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.31 -155.17 0.48 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.716 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -130.25 145.62 58.12 Favored Pre-proline 0 N--CA 1.493 1.703 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.4 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -71.07 121.87 8.24 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 120.863 1.042 . . . . 0.0 113.022 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.18 89.85 0.07 OUTLIER Glycine 0 N--CA 1.502 3.063 0 C-N-CA 119.989 -1.101 . . . . 0.0 112.93 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.9 p -171.89 148.86 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.176 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.15 142.02 57.19 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.792 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -144.08 151.37 39.53 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.25 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.83 125.02 46.47 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.516 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.405 HD12 ' H ' ' A' ' 71' ' ' THR . 3.3 tp -111.49 136.16 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.132 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.536 HG23 ' HB3' ' A' ' 89' ' ' SER . 87.5 m -138.91 121.92 16.73 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.632 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.7 m -105.6 144.02 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.137 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.47 92.27 3.9 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.417 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.48 90.27 5.65 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.248 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 t -77.26 114.11 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.629 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 29' ' ' VAL . 2.4 p . . . . . 0 N--CA 1.484 1.241 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.469 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo . . . . . 0 C--O 1.213 -0.771 0 CA-C-O 121.609 0.587 . . . . 0.0 113.526 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 88' ' ' ILE . 8.7 tt -143.75 129.92 16.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.854 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.536 ' HB3' HG23 ' A' ' 71' ' ' THR . 46.0 p -129.84 165.12 22.65 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.275 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -151.45 146.86 15.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.415 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.15 149.28 28.04 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.219 -0.993 . . . . 0.0 110.194 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -158.44 134.81 9.37 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.194 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.435 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -93.75 114.28 26.52 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.979 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 116.27 -1.824 . . . . 0.0 110.955 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -178.26 176.89 1.04 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 118.729 -1.189 . . . . 0.0 111.97 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.0 t -99.09 116.04 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.964 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.769 HG23 ' OG ' ' A' ' 21' ' ' SER . 5.5 t -71.1 -25.43 25.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.797 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 163.78 168.6 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.78 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -129.22 157.93 40.44 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.155 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.68 161.93 28.77 Favored Pre-proline 0 C--N 1.305 -1.334 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.767 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 16' ' ' THR . 6.1 Cg_exo -54.65 106.22 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 121.217 1.278 . . . . 0.0 111.849 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.464 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER 74.54 34.11 0.79 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.856 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 99.5 p -172.14 138.77 1.02 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.026 -1.07 . . . . 0.0 111.199 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.0 tp -131.05 122.3 26.52 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.902 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -96.94 113.64 25.2 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.354 -0.938 . . . . 0.0 112.156 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 pt -105.41 167.11 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.549 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.769 ' OG ' HG23 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -160.66 133.98 6.68 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.324 -1.35 . . . . 0.0 111.807 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.9 p90 . . . . . 0 N--CA 1.479 1.012 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.053 179.904 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 N--CA 1.48 1.041 0 CA-C-O 121.033 0.444 . . . . 0.0 111.985 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.411 ' H ' ' HA ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -68.75 -50.65 48.84 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.433 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.405 ' CE2' ' CG ' ' A' ' 30' ' ' ARG . 0.7 OUTLIER 177.28 168.89 0.6 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.9 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -121.92 165.33 16.12 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.334 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -141.03 106.92 5.14 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.505 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.8 mt -98.43 111.55 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.43 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.464 HG22 ' HB2' ' A' ' 47' ' ' GLU . 15.3 p -124.34 133.22 53.5 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.106 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -128.27 138.88 52.62 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.13 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.434 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -154.01 137.84 5.93 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.223 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -67.2 163.79 19.59 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.596 -0.842 . . . . 0.0 111.126 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 39' ' ' THR . 7.4 t . . . . . 0 C--N 1.301 -1.501 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.54 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.434 HG23 ' HA2' ' A' ' 37' ' ' GLY . 23.3 t . . . . . 0 N--CA 1.476 0.875 0 CA-C-O 120.741 0.305 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -171.84 169.54 5.77 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.837 -1.145 . . . . 0.0 111.466 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HB2' HG22 ' A' ' 35' ' ' THR . 11.0 pt-20 -148.76 159.47 44.11 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.298 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -168.76 134.38 1.7 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 118.941 -1.104 . . . . 0.0 111.053 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.5 162.32 14.26 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.058 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -145.96 161.56 39.29 Favored Pre-proline 0 C--N 1.307 -1.265 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.104 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.96 20.09 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 120.925 1.083 . . . . 0.0 111.858 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 55.2 22.89 31.06 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.335 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.24 -40.04 9.36 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.989 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -72.82 117.2 14.24 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.77 -23.15 42.4 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.664 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.5 p -125.01 161.65 26.24 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.0 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.451 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -155.83 150.89 26.53 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.75 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.2 m -123.72 108.0 12.07 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.419 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.2 pt -108.75 159.24 8.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.832 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.3 t -145.27 140.99 28.2 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.181 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.522 ' C ' HD13 ' A' ' 62' ' ' LEU . . . 164.0 11.11 0.03 OUTLIER Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.455 -1.355 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.867 HD13 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -131.09 150.59 52.08 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.886 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.772 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -126.24 -38.33 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.851 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.026 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.772 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 5.4 Cg_endo -80.81 -168.57 0.65 Allowed 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 121.425 1.417 . . . . 0.0 111.629 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -130.42 73.54 0.46 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.68 HG22 ' N ' ' A' ' 67' ' ' ASP . 14.1 p -114.14 174.5 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.573 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.68 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -59.97 140.34 56.81 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.991 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.35 123.41 20.32 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.553 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.85 113.23 25.97 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.17 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -102.19 150.11 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.108 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.44 HG23 ' CB ' ' A' ' 89' ' ' SER . 3.9 m -144.52 127.45 16.41 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.507 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.54 143.72 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.765 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -114.3 137.15 52.16 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.656 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.77 97.86 5.83 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.26 132.99 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.28 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.411 ' HA ' ' H ' ' A' ' 30' ' ' ARG . 4.0 m . . . . . 0 C--N 1.309 -1.174 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.832 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo . . . . . 0 C--O 1.216 -0.606 0 CA-C-O 120.712 0.213 . . . . 0.0 111.64 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.3 tt -137.09 135.06 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.117 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.44 ' CB ' HG23 ' A' ' 71' ' ' THR . 0.0 OUTLIER -136.04 164.81 27.14 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.196 -1.002 . . . . 0.0 112.697 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -146.37 154.13 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.574 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.57 145.75 29.57 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.257 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -159.98 147.27 16.45 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.164 -1.015 . . . . 0.0 111.075 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.556 ' N ' ' CD ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -88.01 103.24 15.52 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.739 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 116.503 -1.713 . . . . 0.0 110.614 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 tt . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.434 ' O ' ' OG ' ' A' ' 21' ' ' SER . 5.8 pt-20 -179.04 163.81 1.37 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.632 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.2 t -75.75 132.89 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.361 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.668 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 9.2 p -104.61 -23.07 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 118.601 -1.239 . . . . 0.0 112.383 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 165.78 174.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.568 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.39 152.31 42.71 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.715 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.95 163.41 22.96 Favored Pre-proline 0 N--CA 1.486 1.356 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.282 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.618 ' C ' HG23 ' A' ' 16' ' ' THR . 10.2 Cg_exo -46.84 103.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 120.54 0.827 . . . . 0.0 110.477 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.618 HG23 ' C ' ' A' ' 15' ' ' PRO . 1.6 p 69.7 37.9 1.79 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.597 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.54 145.96 19.28 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.312 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.6 tp -123.41 122.53 38.51 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.988 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.747 HD23 ' O ' ' A' ' 57' ' ' ALA . 1.2 mt -96.56 121.58 38.54 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.092 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -124.36 151.88 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -122.97 131.73 53.84 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.132 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.522 ' NE1' ' CE2' ' A' ' 32' ' ' TYR . 25.6 p90 . . . . . 0 N--CA 1.513 2.711 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -60.39 3.42 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 118.783 -1.167 . . . . 0.0 108.143 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -154.13 161.48 41.85 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.036 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.522 ' CE2' ' NE1' ' A' ' 22' ' ' TRP . 3.2 m-85 -108.03 164.1 12.57 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.351 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -147.05 95.13 2.52 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.191 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.5 mt -91.26 135.15 27.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.399 -0.921 . . . . 0.0 111.605 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 p -138.63 137.38 36.86 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.825 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -137.88 160.2 39.94 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.797 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.21 135.77 3.17 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.405 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.86 108.36 8.67 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.466 -0.893 . . . . 0.0 110.769 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.3 m . . . . . 0 C--N 1.303 -1.423 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.768 -179.996 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 46' ' ' GLN . 3.3 t . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 121.144 0.497 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.432 ' N ' HG12 ' A' ' 45' ' ' VAL . 3.6 tt0 -173.59 -170.26 0.58 Allowed 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.8 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -168.69 176.52 5.56 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.673 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -176.13 150.24 0.94 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.336 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.5 p -111.58 153.65 25.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.05 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.5 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -143.06 150.14 51.58 Favored Pre-proline 0 C--N 1.303 -1.453 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.905 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' A' ' 53' ' ' SER . 3.7 Cg_endo -65.78 28.74 0.1 OUTLIER 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 120.923 1.082 . . . . 0.0 112.483 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 53.59 8.6 0.9 Allowed Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.063 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -72.27 -32.14 66.38 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.547 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -95.72 154.44 17.22 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.29 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 m -104.01 -22.79 13.4 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.135 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.0 p -122.91 -175.25 3.12 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.324 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.747 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -171.11 175.09 4.43 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.297 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.8 t -131.08 141.71 50.2 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.528 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 59' ' ' ILE . 4.2 mt -132.31 111.32 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.408 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -109.05 147.54 32.2 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.585 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.19 20.66 4.33 Favored Glycine 0 N--CA 1.501 2.996 0 C-N-CA 119.841 -1.171 . . . . 0.0 110.255 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.688 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -106.46 -174.28 2.5 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.42 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -136.84 122.55 13.21 Favored Pre-proline 0 N--CA 1.487 1.422 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.883 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.08 118.8 5.73 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 120.209 0.606 . . . . 0.0 111.671 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.38 64.7 0.7 Allowed Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.607 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 p -164.69 148.37 2.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 119.156 -1.017 . . . . 0.0 111.592 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -70.31 152.45 44.15 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.893 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.63 140.83 26.32 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.711 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.2 m -117.88 107.42 14.08 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.411 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.473 ' CG1' ' N ' ' A' ' 71' ' ' THR . 5.1 tt -102.61 160.92 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.014 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.498 HG23 ' OG ' ' A' ' 89' ' ' SER . 91.0 m -160.5 139.59 10.58 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.167 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 m -131.36 123.71 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.663 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.89 129.99 53.13 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.392 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.19 104.18 14.3 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.99 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.28 121.04 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 119.049 -1.061 . . . . 0.0 112.443 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.487 1.377 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.585 179.849 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 C--O 1.216 -0.606 0 N-CA-C 110.572 -0.588 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 88' ' ' ILE . 9.3 tt -151.29 135.27 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 117.983 -1.487 . . . . 0.0 111.723 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.498 ' OG ' HG23 ' A' ' 71' ' ' THR . 1.0 OUTLIER -127.73 139.5 52.65 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.734 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 pt -149.7 157.94 6.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 118.749 -1.18 . . . . 0.0 111.806 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.479 ' ND2' ' H ' ' A' ' 91' ' ' ASN . 0.0 OUTLIER -95.97 159.77 14.8 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.796 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -167.69 130.86 1.66 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.06 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.3 mtm-85 -88.34 119.31 28.64 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.145 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 116.337 -1.792 . . . . 0.0 110.975 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.424 ' O ' ' OE1' ' A' ' 9' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -157.92 158.24 34.64 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.871 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.3 t -93.56 115.22 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.576 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.487 ' CG2' ' OG ' ' A' ' 21' ' ' SER . 2.2 t -70.75 -68.71 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 118.818 -1.153 . . . . 0.0 111.197 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.12 174.82 12.76 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.522 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.54 162.87 34.34 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.411 ' C ' ' N ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -135.16 161.17 65.09 Favored Pre-proline 0 N--CA 1.484 1.238 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.734 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' O ' HG23 ' A' ' 16' ' ' THR . 2.7 Cg_exo -50.76 -14.38 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 120.893 1.062 . . . . 0.0 110.944 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 15' ' ' PRO . 7.8 p -158.4 50.8 0.4 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.69 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.56 143.13 0.18 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.437 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.5 tp -130.16 140.83 50.72 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.111 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.91 110.19 17.43 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.42 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 pp -106.41 147.04 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.487 ' OG ' ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -145.46 136.74 24.95 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.271 -0.971 . . . . 0.0 110.609 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.0 p90 . . . . . 0 C--N 1.308 -1.201 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.523 -179.998 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.905 HG13 HG22 ' A' ' 76' ' ' THR . 5.0 t . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 120.664 0.268 . . . . 0.0 110.28 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -73.0 -70.17 0.37 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.484 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -158.66 163.24 37.06 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.61 -1.236 . . . . 0.0 112.046 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -121.0 152.59 38.4 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.661 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 -131.0 115.33 16.34 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.296 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 mp -106.81 113.45 43.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.548 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -119.56 137.94 53.52 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.709 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.68 ' CE2' HD12 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -136.71 157.54 46.53 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.195 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.53 153.23 9.78 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -67.9 160.29 28.8 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.457 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 m . . . . . 0 C--N 1.302 -1.46 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.0 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.499 HG12 ' N ' ' A' ' 46' ' ' GLN . 5.7 t . . . . . 0 N--CA 1.477 0.911 0 CA-C-O 120.881 0.372 . . . . 0.0 110.812 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.499 ' N ' HG12 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -175.19 178.48 1.71 Allowed 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.129 -1.028 . . . . 0.0 111.359 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -170.8 150.35 3.22 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.363 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.565 ' CE2' ' OH ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -146.03 164.62 31.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.673 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.2 p -116.89 156.3 27.58 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.436 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.695 HG23 ' H ' ' A' ' 52' ' ' GLY . 6.0 m -146.28 151.67 44.66 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.805 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.96 20.83 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.074 1.182 . . . . 0.0 112.586 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.695 ' H ' HG23 ' A' ' 50' ' ' VAL . . . 66.75 4.75 27.79 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.219 -1.467 . . . . 0.0 110.211 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.71 -45.98 14.93 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.759 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.66 107.42 7.81 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.605 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.8 m -82.81 14.2 3.38 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 21' ' ' SER . 1.3 p -138.65 163.42 32.14 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.633 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.5 139.43 7.92 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.587 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.9 m -110.12 134.12 52.51 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.607 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.68 HD12 ' CE2' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -132.53 154.54 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.017 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t -136.45 -167.89 2.15 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.511 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.499 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 65.12 73.96 0.53 Allowed Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.309 -1.424 . . . . 0.0 109.867 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 61' ' ' GLY . 10.7 mt -126.74 177.57 6.48 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.312 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.54 128.27 25.88 Favored Pre-proline 0 CA--C 1.559 1.324 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -53.76 98.01 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 120.415 0.743 . . . . 0.0 112.889 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.11 97.29 0.22 Allowed Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.124 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -167.11 138.72 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.639 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.35 109.8 0.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.882 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.8 140.39 42.31 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.962 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.57 130.39 52.6 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.548 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.67 162.57 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.618 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.6 m -150.55 116.31 5.53 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.761 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.595 ' O ' HG23 ' A' ' 72' ' ' VAL . 6.0 m -102.74 121.22 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.859 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -99.1 130.95 45.45 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.581 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.44 89.64 3.1 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.884 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.6 t -92.39 127.93 44.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.103 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.905 HG22 HG13 ' A' ' 29' ' ' VAL . 24.2 p . . . . . 0 N--CA 1.485 1.283 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.567 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 C--O 1.216 -0.606 0 N-CA-C 110.844 -0.483 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -148.29 162.16 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 118.554 -1.258 . . . . 0.0 110.732 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.88 164.71 28.96 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.086 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 pt -150.41 135.54 10.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.542 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -109.48 131.87 54.66 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.84 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -161.71 135.75 6.75 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.487 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -68.32 114.1 6.48 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.659 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 116.29 -1.814 . . . . 0.0 110.729 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.501 2.089 0 N-CA-C 111.093 0.034 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -175.82 157.89 2.03 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 118.719 -1.192 . . . . 0.0 112.55 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.69 113.73 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.488 ' H ' HG23 ' A' ' 11' ' ' VAL . 1.4 t -71.72 -71.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 118.758 -1.177 . . . . 0.0 112.169 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.99 175.52 10.39 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.022 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.45 147.56 51.7 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.074 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.82 161.37 49.35 Favored Pre-proline 0 C--N 1.305 -1.335 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.355 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.58 106.96 0.19 Allowed 'Trans proline' 0 C--O 1.211 -0.832 0 C-N-CA 121.045 1.163 . . . . 0.0 112.156 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 72.66 -3.71 2.29 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.99 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.26 136.48 49.22 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.707 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 tp -130.86 154.19 48.32 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.791 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.5 tp -116.79 122.09 43.42 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 pt -124.25 160.41 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -134.18 140.52 46.58 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.963 -1.471 . . . . 0.0 107.325 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 14.5 p90 . . . . . 0 N--CA 1.505 2.31 0 C-N-CA 118.402 -1.319 . . . . 0.0 114.069 -179.773 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.414 ' CD ' ' CZ ' ' A' ' 31' ' ' TYR . 1.6 ttm-85 -57.83 -64.84 0.77 Allowed 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.668 -1.213 . . . . 0.0 109.115 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.414 ' CZ ' ' CD ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -127.26 147.51 50.22 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.117 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -110.36 130.3 55.58 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.959 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -114.04 101.43 9.22 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.3 mt -92.94 123.86 45.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.862 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.2 p -124.93 135.11 52.54 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.765 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -130.06 155.49 46.07 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.086 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.408 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -174.11 151.32 12.78 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.977 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -85.92 136.17 33.39 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.662 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.305 -1.36 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.916 179.997 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 46' ' ' GLN . 24.4 t . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.854 0.359 . . . . 0.0 111.92 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.486 ' N ' HG12 ' A' ' 45' ' ' VAL . 6.4 tt0 -157.28 168.7 26.64 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.076 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' OE1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -143.94 175.11 10.27 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.979 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.4 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 25.7 p90 -163.28 134.68 4.87 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.954 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.0 p -87.45 164.55 16.12 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.254 -0.979 . . . . 0.0 111.288 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.565 ' C ' ' H ' ' A' ' 52' ' ' GLY . 14.5 p -162.31 138.34 5.76 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.069 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 53' ' ' SER . 3.2 Cg_exo -60.56 23.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 120.953 1.102 . . . . 0.0 113.258 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 49.67 12.31 0.39 Allowed Glycine 0 N--CA 1.495 2.625 0 C-N-CA 119.488 -1.339 . . . . 0.0 110.77 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -59.77 -24.65 64.25 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.588 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -121.07 129.78 53.48 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.465 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -79.82 -9.62 59.68 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.037 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.3 p -140.09 154.86 47.17 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.763 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.84 160.67 25.39 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.674 -1.211 . . . . 0.0 111.499 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.6 m -90.24 157.47 17.67 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.535 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 59' ' ' ILE . 6.0 tt -150.75 128.96 2.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 119.396 -0.921 . . . . 0.0 110.416 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 t -134.66 117.29 15.91 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.699 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.69 -28.22 0.02 OUTLIER Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.607 -1.282 . . . . 0.0 110.146 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.534 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -78.85 -166.45 0.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.887 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.669 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.5 OUTLIER -165.33 -42.4 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.456 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.95 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.669 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 8.9 Cg_endo -85.56 -174.81 1.72 Allowed 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 121.358 1.372 . . . . 0.0 111.574 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.68 72.73 0.43 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.607 HG22 ' N ' ' A' ' 67' ' ' ASP . 5.1 p -124.31 169.52 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.239 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.607 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -49.1 110.51 0.37 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.879 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.99 134.81 54.31 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.724 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.45 134.36 55.17 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.509 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.44 158.72 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.908 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.565 HG23 ' OG ' ' A' ' 89' ' ' SER . 6.1 m -153.31 140.83 19.81 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 118.326 -1.35 . . . . 0.0 112.521 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.8 m -114.39 121.84 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -94.15 109.81 21.57 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.746 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.3 94.11 8.37 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.674 -1.211 . . . . 0.0 109.625 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.09 125.98 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.867 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 N--CA 1.487 1.38 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.964 179.982 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo . . . . . 0 C--O 1.215 -0.639 0 CA-C-O 120.716 0.215 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 88' ' ' ILE . 12.5 tt -138.65 121.66 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.746 -0.782 . . . . 0.0 108.916 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.565 ' OG ' HG23 ' A' ' 71' ' ' THR . 0.5 OUTLIER -121.49 164.9 16.44 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.61 140.38 20.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.051 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -103.09 146.56 28.19 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.528 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -172.53 142.08 1.21 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.541 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -75.2 108.87 8.25 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.311 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 116.389 -1.767 . . . . 0.0 110.714 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -163.58 174.69 11.47 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 117.502 -1.679 . . . . 0.0 113.468 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.415 HG22 HG22 ' A' ' 20' ' ' ILE . 56.5 t -92.96 128.39 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.809 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.27 -2.41 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.47 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.556 ' HB3' ' HB3' ' A' ' 19' ' ' LEU . . . -169.19 160.42 9.65 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.914 -1.114 . . . . 0.0 111.251 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.62 150.01 27.23 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.529 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.418 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -137.4 162.11 56.92 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.874 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -55.39 -6.74 0.98 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.056 1.171 . . . . 0.0 111.433 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 14' ' ' THR . 0.6 OUTLIER -160.09 42.88 0.2 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.382 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.5 146.87 0.21 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.045 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.1 tp -130.44 120.57 24.41 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.28 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 4.7 tt -96.8 104.68 16.7 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.502 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.415 HG22 HG22 ' A' ' 10' ' ' VAL . 1.2 pp -104.88 153.43 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.652 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.08 144.58 24.92 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 9.9 p90 . . . . . 0 C--N 1.31 -1.112 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.041 179.913 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.631 HG13 ' OG1' ' A' ' 76' ' ' THR . 0.6 OUTLIER . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.735 0.303 . . . . 0.0 110.509 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.405 ' H ' ' HA ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -54.15 -65.2 0.61 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.39 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.92 159.0 36.09 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.666 -1.214 . . . . 0.0 111.789 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 2.0 m-85 -119.4 146.04 45.7 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.56 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -129.56 111.21 12.5 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.4 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.8 mp -100.93 120.97 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.153 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 p -122.04 136.95 54.97 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.97 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.551 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 1.8 p90 -130.77 146.92 52.36 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.547 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -171.85 138.79 5.01 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.8 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -72.9 141.62 47.89 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.517 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 m . . . . . 0 C--N 1.304 -1.383 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.718 179.975 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.547 HG23 ' HA2' ' A' ' 37' ' ' GLY . 93.0 t . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 121.091 0.472 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -172.24 -167.86 0.5 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.231 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.89 163.57 11.6 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.698 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 9.7 p90 -153.96 141.84 20.15 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.403 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -100.21 159.93 14.72 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.893 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.512 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -147.29 157.36 45.68 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.121 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.56 10.76 0.1 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.141 1.227 . . . . 0.0 112.096 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 61.07 26.86 66.32 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.062 -1.542 . . . . 0.0 109.818 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.63 -53.65 4.43 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.63 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -90.62 123.37 34.2 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.1 m -86.39 27.62 0.92 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.244 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.8 p -145.44 162.98 36.05 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.5 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.1 154.53 5.07 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.805 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.2 m -130.93 115.69 16.87 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.053 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.37 171.49 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.673 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 53.0 m -148.57 173.12 13.49 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.619 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.75 49.19 1.3 Allowed Glycine 0 N--CA 1.498 2.799 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.505 HD12 ' C ' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -130.51 -175.37 3.63 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.866 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -117.55 135.32 23.22 Favored Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.69 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.53 148.27 93.39 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.052 1.168 . . . . 0.0 112.799 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.18 82.91 0.03 OUTLIER Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.388 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -167.55 145.68 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 118.956 -1.098 . . . . 0.0 111.444 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -61.3 140.87 57.9 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.413 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.46 118.18 10.46 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.59 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.5 m -100.66 116.97 33.82 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.827 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 tt -107.37 149.13 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.11 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 m -141.81 120.6 12.68 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.912 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 72' ' ' VAL . 22.9 m -105.91 124.63 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.596 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -102.51 94.15 5.51 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.972 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.605 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . . . -90.95 132.04 36.2 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.704 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -136.09 119.43 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.969 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.631 ' OG1' HG13 ' A' ' 29' ' ' VAL . 85.2 m . . . . . 0 N--CA 1.488 1.426 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.898 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo . . . . . 0 C--O 1.214 -0.68 0 CA-C-O 121.215 0.423 . . . . 0.0 112.248 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 tt -145.89 153.42 13.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.092 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.43 151.58 46.37 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.069 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -145.76 140.25 21.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.58 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -88.88 151.28 22.44 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.755 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -162.46 134.94 5.64 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.138 -1.025 . . . . 0.0 111.102 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.2 mtt180 -93.84 110.69 22.33 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.992 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 116.395 -1.764 . . . . 0.0 110.574 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -170.15 170.56 7.32 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.322 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.91 149.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.969 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 11' ' ' VAL . 7.6 p -129.98 -6.41 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.794 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.84 161.09 7.08 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.813 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.59 145.85 27.01 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.784 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.565 ' CB ' ' HG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -130.74 161.0 63.79 Favored Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.901 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.04 -10.08 2.54 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 121.236 1.29 . . . . 0.0 111.771 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 m -159.68 44.32 0.23 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.565 ' HG ' ' CB ' ' A' ' 14' ' ' THR . 0.1 OUTLIER 177.26 149.45 0.15 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.237 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.9 tp -131.18 148.64 52.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.062 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -122.71 116.91 24.56 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.696 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.3 pt -104.87 170.71 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.764 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.34 135.12 13.65 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.144 -1.023 . . . . 0.0 111.126 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.9 p90 . . . . . 0 C--N 1.311 -1.1 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.46 179.955 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.781 HG13 HG22 ' A' ' 76' ' ' THR . 4.5 t . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.486 0.184 . . . . 0.0 110.756 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.486 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 3.8 mmm180 -73.79 -78.09 0.1 Allowed 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.32 -1.352 . . . . 0.0 108.773 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -149.79 153.61 37.1 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.526 -1.27 . . . . 0.0 112.022 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.16 167.58 9.9 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.175 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -145.07 106.65 4.24 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.674 -1.21 . . . . 0.0 111.419 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 mt -100.21 106.19 18.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.364 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 47' ' ' GLU . 43.3 p -107.45 136.66 46.88 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.494 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.576 ' CZ ' HG11 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -134.34 132.05 39.05 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.614 -0.834 . . . . 0.0 112.036 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -158.66 153.46 24.6 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -49.57 171.43 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.62 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.49 1.569 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.665 -179.959 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.576 HG11 ' CZ ' ' A' ' 36' ' ' TYR . 5.8 t . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 111.313 0.116 . . . . 0.0 111.313 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.592 ' CG ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -174.48 -140.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.305 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.592 ' H ' ' CG ' ' A' ' 46' ' ' GLN . 9.1 pt-20 -171.91 168.48 5.99 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.667 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -161.61 141.37 10.29 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.63 165.76 11.82 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.419 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.567 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -150.28 160.3 33.43 Favored Pre-proline 0 C--N 1.304 -1.411 0 C-N-CA 119.486 -0.885 . . . . 0.0 110.005 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.09 21.11 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.158 1.239 . . . . 0.0 112.254 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 42.81 32.59 1.42 Allowed Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.675 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.14 -53.29 3.69 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.554 -0.858 . . . . 0.0 111.267 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -75.86 136.22 40.16 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.08 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 m -83.83 -13.58 53.38 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.529 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.4 p -131.4 152.95 50.19 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.915 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.413 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -155.35 157.51 37.24 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.292 -1.363 . . . . 0.0 112.137 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 49.4 m -98.5 130.97 45.09 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.708 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 59' ' ' ILE . 5.1 tp -130.43 121.64 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.433 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.9 t -117.23 -168.77 1.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.32 51.11 5.1 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.73 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.36 -160.97 1.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.701 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -136.35 139.25 29.17 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.215 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -61.94 118.13 5.0 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 120.935 1.09 . . . . 0.0 111.614 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.79 89.08 0.07 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.531 -1.318 . . . . 0.0 111.031 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.5 p -163.48 138.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.135 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.89 114.38 5.67 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.824 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -119.89 145.92 46.25 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.978 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.6 m -112.92 111.44 22.2 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.294 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.901 HD12 ' N ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -102.36 130.46 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.081 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.901 ' N ' HD12 ' A' ' 70' ' ' ILE . 2.2 m -133.41 141.83 48.05 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.398 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.416 HG13 HD11 ' A' ' 70' ' ' ILE . 33.1 m -130.18 138.22 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.275 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.36 122.95 41.91 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.733 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.59 116.41 32.68 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.244 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.33 108.76 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.468 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.781 HG22 HG13 ' A' ' 29' ' ' VAL . 13.0 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.406 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.455 -0.793 0 N-CA-C 110.598 -0.578 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.94 156.4 6.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 C-N-CA 118.595 -1.242 . . . . 0.0 111.17 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.3 p -142.04 144.84 33.81 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.66 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -149.54 145.76 17.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.24 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.81 141.64 28.44 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.069 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -149.02 128.36 12.96 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.623 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -78.97 106.88 11.31 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.708 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 116.142 -1.885 . . . . 0.0 111.016 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.466 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.4 mp . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.566 0.222 . . . . 0.0 110.728 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -175.38 -176.72 0.94 Allowed 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.649 -1.22 . . . . 0.0 112.229 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.2 t -93.35 146.95 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.64 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -94.25 -63.47 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.472 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.49 172.4 15.03 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.173 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.8 174.8 10.18 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.428 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -148.71 160.77 35.05 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.533 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -52.98 -6.29 0.25 Allowed 'Trans proline' 0 C--O 1.216 -0.587 0 C-N-CA 121.364 1.376 . . . . 0.0 111.851 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 14' ' ' THR . 2.0 t -165.22 48.94 0.1 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.452 ' HG ' ' CB ' ' A' ' 14' ' ' THR . 0.1 OUTLIER 174.87 147.5 0.08 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.798 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 tp -127.29 133.96 50.09 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.457 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.427 ' HA ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -98.83 111.75 24.04 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.395 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 pp -110.95 145.25 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.678 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.7 m -141.95 126.1 17.42 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.189 -1.004 . . . . 0.0 111.046 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 8.6 p90 . . . . . 0 N--CA 1.475 0.821 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.778 179.87 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.441 HG11 ' CD1' ' A' ' 32' ' ' TYR . 78.5 t . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.622 0.248 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.542 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.24 -63.68 1.11 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.126 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 9.0 m-85 -143.93 164.31 30.95 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.089 -1.045 . . . . 0.0 112.282 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.441 ' CD1' HG11 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -126.99 146.05 50.48 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.396 -1.274 . . . . 0.0 108.298 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.572 ' C ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -137.19 136.36 38.12 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.778 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.763 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.5 mp -121.09 119.92 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.293 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -114.19 138.06 50.96 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.593 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.475 ' CE2' HG11 ' A' ' 45' ' ' VAL . 8.3 p90 -135.84 154.2 51.25 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.803 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.448 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -171.16 169.61 42.61 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -76.01 -162.9 0.25 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.847 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.489 1.515 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.31 -179.86 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.475 HG11 ' CE2' ' A' ' 36' ' ' TYR . 50.6 t . . . . . 0 CA--C 1.502 -0.869 0 CA-C-O 121.165 0.507 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -175.69 -169.79 0.37 Allowed 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.194 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -164.36 160.48 20.86 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.855 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.436 ' O ' ' CD1' ' A' ' 48' ' ' PHE . 42.3 p90 -155.51 142.46 19.08 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.726 -1.189 . . . . 0.0 111.185 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.9 140.78 29.13 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.348 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.6 155.69 80.3 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.056 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' A' ' 53' ' ' SER . 0.9 OUTLIER -61.66 118.23 5.09 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 120.436 0.757 . . . . 0.0 110.795 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -49.41 -6.46 0.06 OUTLIER Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.034 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -64.12 -36.45 84.06 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.25 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -83.72 157.63 22.08 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.059 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -120.65 -6.28 9.69 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.607 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.6 p -133.22 161.8 33.5 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.163 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.14 165.18 27.37 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.8 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.1 m -128.98 118.24 22.27 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.493 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.1 pt -108.4 149.23 11.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.701 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.4 t -144.88 151.27 38.46 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.971 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.19 7.6 1.71 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.715 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -130.62 -179.61 5.39 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.12 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.551 ' N ' HD22 ' A' ' 62' ' ' LEU . 4.2 mptp? -125.66 118.05 24.5 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.814 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.1 112.64 1.74 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 120.399 0.733 . . . . 0.0 111.346 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 94' ' ' THR . . . 158.28 30.84 0.02 OUTLIER Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.687 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 67' ' ' ASP . 7.7 p -165.68 164.8 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.406 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.508 ' N ' HG22 ' A' ' 66' ' ' VAL . 24.0 t70 -67.33 104.64 1.55 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.2 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.13 152.9 26.47 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.376 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 m -121.05 128.06 52.29 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.539 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.979 HD12 ' N ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -114.02 136.32 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.63 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.979 ' N ' HD12 ' A' ' 70' ' ' ILE . 47.2 m -132.96 145.48 50.93 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.95 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.0 m -128.57 140.54 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.383 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -118.42 141.47 48.52 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.439 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.08 105.86 12.28 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.075 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.542 ' CG2' ' HE ' ' A' ' 33' ' ' ARG . 3.5 t -108.03 130.86 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.489 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 43.1 p . . . . . 0 N--CA 1.484 1.25 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.629 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo . . . . . 0 C--O 1.216 -0.603 0 N-CA-C 110.977 -0.432 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.5 tt -150.65 154.09 9.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 C-N-CA 118.851 -1.14 . . . . 0.0 111.27 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.609 ' OG ' HG23 ' A' ' 71' ' ' THR . 14.8 m -134.94 163.07 30.66 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.412 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 pt -145.64 137.74 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.648 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.06 128.99 46.06 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.702 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.521 ' CZ ' ' O ' ' A' ' 93' ' ' ARG . 13.5 t80 -152.23 149.51 28.8 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.246 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.521 ' O ' ' CZ ' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -83.4 120.53 26.0 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.878 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 116.313 -1.803 . . . . 0.0 110.62 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.716 0.293 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -175.32 172.92 2.63 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.308 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.61 133.97 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.69 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.6 t -92.97 -39.44 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.266 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.37 166.33 20.81 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.876 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.63 82.71 1.46 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.746 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.69 160.73 58.82 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.234 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -4.84 3.63 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 121.093 1.196 . . . . 0.0 111.499 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.424 ' O ' ' OG ' ' A' ' 60' ' ' SER . 16.2 m -149.13 39.93 0.85 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.523 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 172.68 143.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.515 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.54 140.01 53.34 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.231 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.35 116.74 26.83 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.915 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 pp -112.55 150.51 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.228 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.12 140.36 29.38 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.652 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.6 p90 . . . . . 0 C--N 1.304 -1.404 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.555 179.845 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.417 HG13 HG22 ' A' ' 76' ' ' THR . 2.1 t . . . . . 0 N--CA 1.478 0.953 0 CA-C-O 120.688 0.28 . . . . 0.0 110.369 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -78.44 -70.75 0.47 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.649 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.63 161.32 41.94 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.125 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -120.51 131.97 54.96 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.957 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttp-105 -118.59 113.09 20.72 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.244 -0.983 . . . . 0.0 110.525 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.0 mt -95.84 122.91 47.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.338 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -125.69 130.87 52.41 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.212 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.728 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -148.14 166.73 27.0 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.671 -1.212 . . . . 0.0 112.306 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.94 146.73 4.76 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -53.53 169.93 0.12 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.577 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 63.4 m . . . . . 0 C--N 1.304 -1.387 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.717 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.7 HG12 ' N ' ' A' ' 46' ' ' GLN . 49.3 t . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 111.17 0.063 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.7 ' N ' HG12 ' A' ' 45' ' ' VAL . 4.3 pt20 -176.1 -133.12 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.361 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -171.1 161.26 6.72 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.346 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.564 ' CE2' ' OH ' ' A' ' 36' ' ' TYR . 2.7 p90 -152.56 161.22 42.88 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.0 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 p -113.75 156.85 23.08 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.534 -0.866 . . . . 0.0 112.293 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.779 HG23 ' H ' ' A' ' 52' ' ' GLY . 2.4 m -147.42 154.29 45.06 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.956 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 53' ' ' SER . 1.1 Cg_endo -63.1 23.28 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.016 1.144 . . . . 0.0 112.931 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.779 ' H ' HG23 ' A' ' 50' ' ' VAL . . . 52.57 13.93 2.19 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.083 -1.532 . . . . 0.0 110.693 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -74.93 -39.51 61.34 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.194 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.422 ' HG2' ' H ' ' A' ' 56' ' ' THR . 3.2 ttpt -96.72 130.47 43.96 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.119 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.9 m -87.95 24.46 1.79 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.558 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.422 ' H ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -143.2 164.27 30.64 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.789 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.63 141.22 17.87 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.668 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.0 m -117.19 139.33 50.9 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.401 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.728 HD12 ' CZ ' ' A' ' 36' ' ' TYR . 11.0 tt -141.59 140.41 31.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.319 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 16' ' ' THR . 4.2 t -141.86 176.45 8.92 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.22 48.48 6.41 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.193 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.37 -158.83 0.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.114 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -135.41 101.52 11.0 Favored Pre-proline 0 N--CA 1.487 1.421 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.828 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -61.95 153.86 65.69 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 120.598 0.865 . . . . 0.0 111.671 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.61 47.97 4.1 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.577 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.468 HG22 ' N ' ' A' ' 67' ' ' ASP . 8.9 p -161.87 160.31 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 C-N-CA 119.009 -1.077 . . . . 0.0 111.595 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.468 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -62.84 153.61 32.61 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.081 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.81 117.48 6.19 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.774 -1.171 . . . . 0.0 111.648 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.53 119.52 36.23 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.313 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.736 HD12 ' N ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -112.7 125.98 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.403 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.736 ' N ' HD12 ' A' ' 70' ' ' ILE . 54.6 m -131.14 138.86 49.67 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.485 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 72' ' ' VAL . 17.8 m -126.22 131.3 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.76 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -100.95 117.0 34.14 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.232 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.05 110.21 22.49 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.528 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.35 117.04 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.956 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.417 HG22 HG13 ' A' ' 29' ' ' VAL . 1.3 p . . . . . 0 C--N 1.306 -1.289 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.586 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo . . . . . 0 C--O 1.215 -0.652 0 CA-C-O 121.361 0.484 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 88' ' ' ILE . 13.1 tt -152.27 127.86 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.37 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.6 p -117.17 150.88 37.99 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.592 -0.843 . . . . 0.0 112.339 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.82 133.37 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.283 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 91' ' ' ASN . 19.2 p-10 -80.57 145.41 31.77 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.1 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -160.1 132.67 6.47 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.46 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 1.4 ptp180 -90.94 123.84 34.74 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.109 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 116.343 -1.789 . . . . 0.0 110.663 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.498 1.959 0 CA-C-O 120.581 0.229 . . . . 0.0 110.501 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -175.72 -179.02 1.15 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.392 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t -91.21 127.56 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.857 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 4.2 p -92.96 -21.1 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.584 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . -179.86 161.8 1.0 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.478 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.81 115.66 13.94 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.219 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -96.09 162.07 25.09 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.533 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.608 ' C ' HG23 ' A' ' 16' ' ' THR . 7.9 Cg_exo -47.23 96.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 120.763 0.976 . . . . 0.0 110.704 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.608 HG23 ' C ' ' A' ' 15' ' ' PRO . 2.2 p 70.49 47.15 0.52 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.662 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.56 119.73 1.22 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.388 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 tp -105.72 137.0 44.31 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.287 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.28 103.03 8.26 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.855 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pt -97.95 173.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.505 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.57 131.28 3.03 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.242 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.426 ' CE3' ' N ' ' A' ' 22' ' ' TRP . 10.4 p90 . . . . . 0 CA--C 1.493 -1.218 0 C-N-CA 119.156 -1.017 . . . . 0.0 111.028 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 30' ' ' ARG . 74.3 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.006 0.432 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.464 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -74.58 -65.43 0.86 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.047 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.485 ' HE1' HG21 ' A' ' 75' ' ' VAL . 8.6 p90 -160.25 -178.62 7.09 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 117.924 -1.51 . . . . 0.0 113.317 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.42 174.41 10.65 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.704 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.59 148.28 37.25 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.17 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.28 108.11 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.121 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -119.18 137.63 53.5 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.476 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -137.54 140.18 40.9 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 118.846 -1.142 . . . . 0.0 110.899 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.38 151.7 21.03 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.72 159.34 33.97 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.634 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 39' ' ' THR . 22.2 m . . . . . 0 N--CA 1.485 1.315 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.885 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 120.985 0.422 . . . . 0.0 110.257 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.444 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -175.71 -176.29 0.85 Allowed 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 118.525 -1.27 . . . . 0.0 111.513 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' A' ' 46' ' ' GLN . 9.0 pt-20 -158.16 170.53 22.06 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.205 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.485 ' HE1' HD11 ' A' ' 59' ' ' ILE . 8.8 p90 -165.92 145.9 6.42 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.02 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.9 p -91.14 169.92 10.45 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.79 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 52' ' ' GLY . 9.3 p -161.36 136.31 5.49 Favored Pre-proline 0 C--N 1.304 -1.399 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.25 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.6 Cg_endo -61.7 22.88 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 120.955 1.103 . . . . 0.0 112.828 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 53.26 7.86 0.63 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.491 -1.338 . . . . 0.0 110.312 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.493 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -71.62 -29.42 64.64 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.86 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.7 mttm -94.45 153.0 18.15 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.808 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.75 -12.65 17.48 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.721 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 p -130.61 170.99 13.55 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.092 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.37 132.06 9.59 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.578 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.7 m -104.13 128.75 51.82 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.205 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.485 HD11 ' HE1' ' A' ' 48' ' ' PHE . 10.7 mt -126.82 139.76 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.992 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.91 131.73 47.59 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.411 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.67 2.29 0.19 Allowed Glycine 0 N--CA 1.484 1.881 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 62' ' ' LEU . 7.2 mp -91.43 178.1 6.05 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.29 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.639 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 1.0 OUTLIER -176.82 -42.38 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.733 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.639 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 4.3 Cg_endo -79.81 -172.02 1.41 Allowed 'Trans proline' 0 C--O 1.217 -0.564 0 C-N-CA 121.548 1.499 . . . . 0.0 111.734 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.91 81.61 0.23 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.8 HG22 ' H ' ' A' ' 67' ' ' ASP . 11.8 p -132.05 -177.78 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.998 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.8 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -66.93 125.38 25.75 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.142 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.09 130.96 53.31 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.318 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.81 123.81 48.56 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.721 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 pp -116.05 164.16 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.165 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.9 m -152.18 143.74 23.48 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.632 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.91 139.73 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.715 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -109.07 143.26 38.64 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.536 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.13 91.48 3.55 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.812 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.485 HG21 ' HE1' ' A' ' 31' ' ' TYR . 13.2 t -94.9 107.65 19.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 119.095 -1.042 . . . . 0.0 113.277 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 m . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 179.649 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 C--O 1.214 -0.691 0 N-CA-C 110.929 -0.45 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 88' ' ' ILE . 9.4 tt -143.9 139.59 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.949 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.1 p -124.63 150.99 45.42 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -143.72 163.0 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.505 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -103.05 147.64 26.71 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.147 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -154.12 135.49 14.15 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.811 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 5.6 ptt85 -90.32 107.04 18.9 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.46 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.681 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.755 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -168.65 136.44 2.05 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.026 -1.47 . . . . 0.0 112.646 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -88.46 142.4 12.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.879 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 11' ' ' VAL . 3.6 p -130.52 1.62 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 119.074 -1.05 . . . . 0.0 112.177 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 177.79 155.61 0.34 Allowed 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.6 -1.24 . . . . 0.0 111.395 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.74 104.79 2.17 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.2 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -91.66 160.81 35.66 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.002 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.29 -0.4 0.31 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.998 1.132 . . . . 0.0 112.098 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.472 ' H ' ' C ' ' A' ' 14' ' ' THR . 25.5 p -151.39 28.97 0.64 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.699 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.47 151.05 0.57 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.69 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.6 123.98 30.71 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.975 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tp -104.14 116.66 32.59 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.803 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.0 pt -107.1 173.49 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.123 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.68 139.03 7.47 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.295 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 18.3 p90 . . . . . 0 N--CA 1.486 1.367 0 C-N-CA 118.402 -1.319 . . . . 0.0 113.052 -179.841 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 120.898 0.38 . . . . 0.0 111.499 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.428 ' H ' ' HA ' ' A' ' 76' ' ' THR . 2.7 tpt85 -56.03 -61.46 2.36 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.315 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.74 169.33 21.66 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.611 -1.236 . . . . 0.0 112.151 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -116.55 158.32 23.85 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.96 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -138.58 112.25 8.29 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.215 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.4 mt -102.18 127.37 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.866 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.9 137.57 51.5 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.958 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.574 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 3.0 p90 -145.55 154.93 42.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 118.351 -1.339 . . . . 0.0 112.204 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -176.24 138.53 4.14 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -64.23 145.48 55.91 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 118.976 -1.09 . . . . 0.0 110.538 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 C--N 1.301 -1.542 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.238 -179.93 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.452 HG11 ' CE2' ' A' ' 36' ' ' TYR . 95.0 t . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 120.804 0.335 . . . . 0.0 111.475 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.462 ' CG ' ' H ' ' A' ' 47' ' ' GLU . 3.8 tp60 -171.57 -151.38 0.07 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.659 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.462 ' H ' ' CG ' ' A' ' 46' ' ' GLN . 3.2 pt-20 -170.18 161.69 8.5 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.377 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -159.02 156.6 29.63 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.869 -1.132 . . . . 0.0 111.054 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.4 p -101.67 157.97 16.44 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.754 -0.779 . . . . 0.0 111.641 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 50' ' ' VAL . 11.4 p -165.61 134.14 2.51 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 53' ' ' SER . 6.3 Cg_exo -56.49 124.97 17.54 Favored 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 120.274 0.649 . . . . 0.0 111.484 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.05 1.7 0.79 Allowed Glycine 0 N--CA 1.483 1.806 0 C-N-CA 119.45 -1.357 . . . . 0.0 110.694 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.491 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -59.57 -35.28 73.94 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 118.845 -1.142 . . . . 0.0 109.636 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -98.4 120.25 38.5 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.059 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 m -79.59 21.25 0.52 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.122 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.4 p -143.72 149.3 36.96 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.308 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.62 150.11 26.03 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.394 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.1 m -95.05 158.44 15.46 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.128 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -146.9 139.01 19.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 119.506 -0.877 . . . . 0.0 110.026 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.3 -178.08 6.2 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.061 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.32 21.65 21.76 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.779 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.06 -164.65 1.39 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.993 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.645 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -177.68 -42.39 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.355 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.295 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.645 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 1.9 Cg_endo -77.16 -170.16 0.87 Allowed 'Trans proline' 0 C--O 1.214 -0.725 0 C-N-CA 121.762 1.641 . . . . 0.0 112.87 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.71 84.21 0.19 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.688 HG22 ' N ' ' A' ' 67' ' ' ASP . 12.2 p -130.2 177.55 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.387 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.688 ' N ' HG22 ' A' ' 66' ' ' VAL . 7.9 t70 -45.44 148.27 0.7 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.097 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.58 111.3 5.02 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.528 -1.269 . . . . 0.0 112.294 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.48 132.98 34.27 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.181 -1.008 . . . . 0.0 108.85 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 70' ' ' ILE . 7.2 tt -127.64 132.17 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.192 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.586 HG22 ' CB ' ' A' ' 89' ' ' SER . 24.1 p -125.1 121.98 35.86 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.575 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.37 129.0 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.641 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -103.72 140.81 37.1 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.406 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.97 91.22 3.5 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.135 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.0 t -93.8 124.03 46.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.717 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.428 ' HA ' ' H ' ' A' ' 30' ' ' ARG . 13.3 t . . . . . 0 N--CA 1.487 1.38 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.062 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 C--O 1.215 -0.662 0 CA-C-O 120.957 0.316 . . . . 0.0 112.227 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.412 ' O ' ' OG ' ' A' ' 89' ' ' SER . 12.4 tt -145.89 154.62 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.696 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.586 ' CB ' HG22 ' A' ' 71' ' ' THR . 15.2 m -161.34 147.21 14.15 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 118.446 -1.302 . . . . 0.0 112.204 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.553 HD11 ' CD2' ' A' ' 8' ' ' LEU . 1.2 pt -150.01 164.38 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.228 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.74 136.4 34.06 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.497 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -140.88 133.55 28.74 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.371 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -87.84 108.51 19.19 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.589 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 116.502 -1.713 . . . . 0.0 110.745 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 120.629 0.252 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -139.46 162.36 35.24 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.8 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.477 HG13 HD11 ' A' ' 18' ' ' LEU . 54.0 t -92.6 102.25 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.123 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.643 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 47.8 t -71.78 3.42 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.296 -0.961 . . . . 0.0 111.474 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 168.81 154.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.341 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.58 93.85 2.11 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.684 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -91.27 162.27 32.63 Favored Pre-proline 0 N--CA 1.485 1.288 0 C-N-CA 119.436 -0.905 . . . . 0.0 110.613 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.72 9.55 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.428 1.419 . . . . 0.0 112.089 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 14' ' ' THR . 4.4 t -168.77 28.1 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.063 -1.055 . . . . 0.0 110.806 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -173.65 141.68 0.87 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.526 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.623 HD12 ' H ' ' A' ' 19' ' ' LEU . 19.2 tp -130.62 146.49 52.13 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.789 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.623 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -128.33 106.64 9.16 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.184 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 20' ' ' ILE . 2.2 pt -103.35 169.7 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.461 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 20' ' ' ILE . 8.2 m -164.04 134.03 4.11 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.457 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 14.3 p90 . . . . . 0 N--CA 1.49 1.536 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.682 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.482 1.165 0 CA-C-O 120.955 0.407 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.14 -65.85 0.96 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.069 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -160.48 163.59 32.83 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.038 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -120.42 146.89 45.76 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.691 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -129.03 110.08 11.75 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.779 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.858 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.7 mp -100.81 108.48 23.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.788 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 p -104.63 147.71 27.35 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.213 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.735 ' CD2' HD11 ' A' ' 59' ' ' ILE . 26.5 p90 -149.39 148.36 29.39 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 117.987 -1.485 . . . . 0.0 112.088 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.26 150.85 7.92 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -78.56 -174.54 3.89 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.767 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--N 1.304 -1.409 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.684 179.954 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.671 HG12 ' N ' ' A' ' 46' ' ' GLN . 21.3 t . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 119.99 -0.052 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.671 ' N ' HG12 ' A' ' 45' ' ' VAL . 30.7 tt0 -168.72 166.98 11.5 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 117.482 -1.687 . . . . 0.0 112.606 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.488 ' N ' ' CG ' ' A' ' 46' ' ' GLN . 3.3 pt-20 -161.17 156.42 24.3 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.445 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 1.4 p90 -139.58 167.13 22.8 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.488 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.5 p -131.27 148.66 52.71 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.606 -0.837 . . . . 0.0 111.538 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.688 HG23 ' H ' ' A' ' 52' ' ' GLY . 10.3 m -140.72 151.78 64.09 Favored Pre-proline 0 N--CA 1.486 1.349 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.861 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.16 14.35 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 120.898 1.065 . . . . 0.0 112.173 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.688 ' H ' HG23 ' A' ' 50' ' ' VAL . . . 70.69 16.41 74.17 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.809 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.82 -40.34 20.5 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.915 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -84.16 121.44 27.46 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.623 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 m -83.03 -9.79 59.08 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.062 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.66 168.63 11.19 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.285 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.1 136.15 6.59 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.514 -1.275 . . . . 0.0 111.947 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -105.14 136.88 43.82 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.826 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.735 HD11 ' CD2' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -134.13 144.56 35.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.429 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.14 135.62 20.63 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.112 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.86 -37.44 0.24 Allowed Glycine 0 N--CA 1.486 1.981 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.387 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -163.32 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.75 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.647 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -176.91 -40.79 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.604 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.647 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 8.7 Cg_endo -83.4 -169.34 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.579 1.519 . . . . 0.0 111.731 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.33 74.68 0.4 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.667 HG22 ' N ' ' A' ' 67' ' ' ASP . 8.9 p -119.4 170.81 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.077 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.667 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -64.86 97.51 0.23 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.442 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -89.59 130.26 35.92 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.631 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.41 149.2 29.06 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.793 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.5 pp -140.6 161.09 24.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.629 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.4 m -149.61 123.32 9.22 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.68 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.03 136.92 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.355 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.47 116.25 31.06 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.294 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.66 97.64 8.88 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.256 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.0 t -99.53 116.9 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.483 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.683 179.971 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo . . . . . 0 C--O 1.215 -0.627 0 N-CA-C 111.231 -0.334 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -155.81 156.04 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.992 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.39 156.52 46.37 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.684 -0.807 . . . . 0.0 110.942 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -145.49 152.06 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.979 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.98 146.92 34.43 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.77 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -158.66 145.86 17.63 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.682 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.465 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 1.5 ptt85 -83.85 98.79 9.93 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.254 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 mp . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 110.273 -0.269 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -171.97 161.17 5.63 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.357 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.9 t -89.06 115.34 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.32 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.663 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 2.7 t -69.43 -26.58 31.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.565 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 167.59 178.51 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.96 119.74 12.56 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.626 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.9 162.49 22.06 Favored Pre-proline 0 C--N 1.3 -1.584 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.708 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 16' ' ' THR . 4.5 Cg_exo -53.95 94.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 120.733 0.955 . . . . 0.0 110.673 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.489 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER 81.06 41.66 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.881 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.32 137.51 1.89 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.685 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.64 148.6 43.16 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 19' ' ' LEU . 1.7 tt -129.66 105.53 8.11 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.006 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.45 168.3 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.449 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -161.82 132.21 4.93 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.591 -1.244 . . . . 0.0 111.584 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.402 ' CH2' HD11 ' A' ' 34' ' ' ILE . 6.8 p90 . . . . . 0 N--CA 1.482 1.127 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.556 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.77 0.319 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.03 -76.59 0.1 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.393 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -147.13 168.17 22.3 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.148 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -120.83 160.32 23.64 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.285 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.451 ' HE ' ' HB ' ' A' ' 49' ' ' THR . 1.4 ttm180 -127.33 146.15 50.55 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.466 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 34' ' ' ILE . 17.4 mt -137.8 99.46 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.679 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.28 137.61 43.92 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.108 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.621 ' CE2' HD11 ' A' ' 59' ' ' ILE . 11.0 p90 -145.28 148.03 33.01 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.242 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.58 140.75 6.66 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.58 143.42 48.25 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.09 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.305 -1.363 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.725 -179.98 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.568 HG11 ' CZ ' ' A' ' 36' ' ' TYR . 48.4 t . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 120.457 0.17 . . . . 0.0 110.787 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 3.8 pt20 -173.25 -152.71 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.019 -1.073 . . . . 0.0 111.404 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.484 ' N ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -159.19 173.4 16.42 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.163 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -165.08 148.24 8.34 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.517 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.451 ' HB ' ' HE ' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -113.21 167.22 10.73 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.339 -0.944 . . . . 0.0 112.682 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.493 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -147.21 158.18 44.74 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.667 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.16 6.26 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 121.175 1.25 . . . . 0.0 112.172 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 70.52 -1.14 22.56 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.338 -1.411 . . . . 0.0 110.275 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.39 -37.09 57.67 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.884 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -80.63 116.32 20.6 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.575 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.9 m -82.31 -2.07 51.58 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.111 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.2 p -133.09 157.56 44.97 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.513 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.03 140.67 13.36 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.579 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m -103.77 139.64 38.72 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.274 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.621 HD11 ' CE2' ' A' ' 36' ' ' TYR . 2.2 tt -135.42 149.2 28.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.843 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -141.48 -154.68 0.53 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.397 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.91 46.25 94.93 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.276 -1.44 . . . . 0.0 110.629 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.508 ' C ' HD12 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -130.45 -172.94 2.93 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.04 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -118.05 130.03 24.99 Favored Pre-proline 0 N--CA 1.49 1.526 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.967 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.62 140.51 87.03 Favored 'Trans proline' 0 C--O 1.217 -0.546 0 C-N-CA 120.409 0.74 . . . . 0.0 111.353 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.57 83.76 0.05 OUTLIER Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.462 -1.352 . . . . 0.0 110.553 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.1 p -165.29 148.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.153 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.92 149.49 47.74 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.616 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.37 137.09 21.59 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.846 -1.142 . . . . 0.0 111.9 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.57 119.35 35.28 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.918 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.414 ' CG1' ' N ' ' A' ' 71' ' ' THR . 3.7 tt -118.38 152.66 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.064 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.442 HG23 ' HB3' ' A' ' 89' ' ' SER . 50.7 m -140.51 126.15 19.12 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.656 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.18 144.84 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.782 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -119.22 125.19 48.57 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.782 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.81 86.78 4.8 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.427 ' H ' HG23 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -86.41 118.57 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 118.962 -1.095 . . . . 0.0 112.338 -179.728 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.308 -1.204 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.906 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 C--O 1.215 -0.626 0 N-CA-C 111.363 -0.283 . . . . 0.0 111.363 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 88' ' ' ILE . 13.1 tt -146.49 132.13 12.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.236 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.442 ' HB3' HG23 ' A' ' 71' ' ' THR . 21.7 p -130.79 152.33 50.25 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.494 -0.882 . . . . 0.0 112.19 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.91 146.4 18.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.187 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -92.24 151.19 20.46 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.832 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -155.04 136.85 14.46 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.649 -1.22 . . . . 0.0 111.699 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.09 110.69 22.9 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.85 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 116.338 -1.792 . . . . 0.0 110.769 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 120.344 0.116 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.521 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 12.3 mp0 -135.38 163.88 29.02 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.776 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.9 t -89.48 116.5 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.697 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.635 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.9 t -82.51 -6.97 10.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.649 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.635 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 169.23 166.3 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.526 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.38 144.77 24.81 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.164 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -138.38 160.16 64.93 Favored Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.528 -179.941 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.413 ' C ' ' OG1' ' A' ' 16' ' ' THR . 5.4 Cg_exo -48.36 -8.88 0.07 OUTLIER 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.404 1.403 . . . . 0.0 112.306 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.2 OUTLIER -164.29 41.7 0.09 Allowed 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.007 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.09 136.04 0.37 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.229 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 62' ' ' LEU . 1.1 tp -130.5 125.63 34.83 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.071 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 20' ' ' ILE . 1.2 tt -106.53 126.63 52.5 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.716 -0.793 . . . . 0.0 110.365 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.661 ' N ' HD23 ' A' ' 19' ' ' LEU . 9.5 pt -126.76 164.58 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.966 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.421 ' OG ' HG21 ' A' ' 11' ' ' VAL . 5.2 m -161.62 146.66 13.37 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.542 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 37.2 p90 . . . . . 0 N--CA 1.483 1.194 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.975 179.966 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.325 0.583 . . . . 0.0 112.152 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 19.8 mtp180 -108.92 -53.12 2.68 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.095 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 30' ' ' ARG . 44.3 m-85 -160.28 157.96 29.01 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.221 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.46 111.64 20.28 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.52 -1.218 . . . . 0.0 107.954 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.9 mtt-85 -100.12 145.06 28.42 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.2 mp -141.21 110.4 2.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.601 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 p -121.73 151.4 40.56 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.036 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 15.2 p90 -144.13 155.34 43.89 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 118.584 -1.246 . . . . 0.0 111.67 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.45 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . 171.48 147.19 5.58 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.795 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -62.17 166.7 4.58 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.444 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 C--N 1.307 -1.252 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.81 179.984 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.45 HG23 ' HA2' ' A' ' 37' ' ' GLY . 26.5 t . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.867 0.365 . . . . 0.0 110.366 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -164.01 167.95 19.83 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.594 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -148.0 146.87 29.09 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.186 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 10.6 p90 -154.23 134.89 13.57 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 118.72 -1.192 . . . . 0.0 111.276 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 t -100.49 147.52 25.8 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.496 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.81 150.83 61.13 Favored Pre-proline 0 C--N 1.301 -1.527 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.252 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.564 ' C ' ' H ' ' A' ' 53' ' ' SER . 6.2 Cg_exo -52.77 125.17 17.23 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 120.499 0.8 . . . . 0.0 110.882 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.66 17.6 0.07 OUTLIER Glycine 0 N--CA 1.487 2.09 0 C-N-CA 119.61 -1.281 . . . . 0.0 111.726 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.564 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -73.18 -41.54 63.73 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 118.859 -1.136 . . . . 0.0 110.184 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -87.71 -172.5 3.9 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.341 -0.943 . . . . 0.0 110.63 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.37 14.06 2.38 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.441 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.0 p -126.82 174.4 8.81 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.615 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.18 122.52 0.67 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.443 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.25 146.54 24.27 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.698 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mt -136.78 147.11 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.995 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.5 t -150.57 153.97 36.72 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.419 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 62' ' ' LEU . . . 123.07 -9.27 9.0 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 18' ' ' LEU . 2.1 mt -49.79 -178.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.785 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -176.39 -43.24 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 119.416 -0.914 . . . . 0.0 112.36 179.948 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.607 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 4.2 Cg_endo -79.46 -168.17 0.6 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.657 1.571 . . . . 0.0 111.776 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -154.66 87.47 0.13 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.744 -1.743 . . . . 0.0 108.744 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.848 HG22 ' H ' ' A' ' 67' ' ' ASP . 11.5 p -156.54 -177.2 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 118.944 -1.103 . . . . 0.0 111.715 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.848 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -57.75 98.65 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.634 179.982 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -94.11 132.03 39.04 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.278 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 m -112.85 127.57 56.22 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.747 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 pp -113.86 151.2 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.203 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 89' ' ' SER . 97.3 m -143.32 120.85 11.73 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.016 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.43 141.21 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.768 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 97.15 6.52 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.343 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.29 92.2 2.74 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.533 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.54 115.67 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.696 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.489 1.5 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.43 179.926 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo . . . . . 0 C--O 1.215 -0.671 0 N-CA-C 111.286 -0.313 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.0 156.5 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.404 ' HB3' HG23 ' A' ' 71' ' ' THR . 53.4 p -145.27 159.89 42.33 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.235 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -148.76 149.71 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.6 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.38 154.55 18.7 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.542 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -175.55 135.07 0.31 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.737 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 93' ' ' ARG . 2.6 ptm180 -61.65 96.42 0.06 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.295 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 116.502 -1.713 . . . . 0.0 110.583 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 120.768 0.318 . . . . 0.0 110.59 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -159.73 140.84 12.55 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.869 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.83 109.64 13.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.391 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.1 t -70.17 -64.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.221 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.59 166.62 30.64 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.861 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.32 127.39 45.48 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.26 161.85 21.82 Favored Pre-proline 0 C--N 1.308 -1.206 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.299 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.617 ' C ' HG23 ' A' ' 16' ' ' THR . 4.9 Cg_exo -49.28 99.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 120.547 0.831 . . . . 0.0 110.614 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.617 HG23 ' C ' ' A' ' 15' ' ' PRO . 1.7 p 69.14 44.59 0.97 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.52 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.33 146.92 7.52 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.274 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mt -128.31 142.94 50.99 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.759 -0.777 . . . . 0.0 111.497 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 19' ' ' LEU . 2.0 tt -115.91 102.23 9.48 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.831 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.57 146.58 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.72 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -139.77 132.3 28.7 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.227 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 12.6 p90 . . . . . 0 N--CA 1.496 1.867 0 C-N-CA 118.796 -1.162 . . . . 0.0 112.447 -179.788 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.1 t . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.773 0.32 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.523 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -87.81 -61.47 1.71 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.483 -179.984 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 46.3 m-85 -147.45 168.0 23.0 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.167 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.28 137.47 42.53 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.256 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.09 128.9 23.24 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 118.236 -1.386 . . . . 0.0 111.274 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.2 mt -111.54 135.17 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.891 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 p -128.05 135.07 49.35 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.463 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.499 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 6.7 p90 -135.91 160.6 38.08 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.653 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . 165.65 139.87 2.75 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -57.35 -161.01 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.48 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.428 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.403 HG11 ' CE2' ' A' ' 36' ' ' TYR . 39.7 t . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 121.117 0.484 . . . . 0.0 110.288 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.614 ' NE2' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -175.22 -175.5 0.84 Allowed 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.13 -179.883 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.614 ' H ' ' NE2' ' A' ' 46' ' ' GLN . 6.5 pt-20 -157.6 167.79 29.12 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.222 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -159.47 147.53 17.46 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.237 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.5 p -97.66 124.64 42.05 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.399 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.64 151.29 49.68 Favored Pre-proline 0 N--CA 1.49 1.574 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.292 179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 53' ' ' SER . 1.2 Cg_endo -61.66 126.42 19.0 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 120.678 0.918 . . . . 0.0 110.517 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.46 -9.25 0.08 OUTLIER Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.98 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -71.3 -43.18 67.62 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.496 179.983 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 mmtm -67.77 132.72 47.96 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.301 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -103.07 -5.29 23.48 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.465 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.6 p -134.8 172.93 12.28 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.46 151.84 4.6 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.102 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.5 m -121.38 117.56 27.23 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.701 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.12 157.96 9.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.929 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -145.61 178.2 8.31 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.146 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.98 53.39 2.86 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.239 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.57 -156.4 0.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.809 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -140.28 148.83 55.72 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.43 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -68.21 123.13 10.24 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 121.052 1.168 . . . . 0.0 112.439 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.22 91.75 0.04 OUTLIER Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.787 -1.197 . . . . 0.0 111.777 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.2 p -167.48 144.96 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.211 -0.996 . . . . 0.0 110.864 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.29 153.76 6.74 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.16 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.79 134.48 18.81 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.238 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.1 m -125.61 120.92 32.11 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.623 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 pp -115.63 163.12 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.92 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.598 HG23 ' OG ' ' A' ' 89' ' ' SER . 17.1 m -152.54 127.73 9.8 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.361 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 m -121.91 136.86 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.274 -0.971 . . . . 0.0 111.796 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -115.34 126.63 54.67 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.389 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.08 98.14 7.82 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.583 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.6 t -86.36 117.54 31.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.644 -179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.28 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.732 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo . . . . . 0 C--O 1.215 -0.663 0 N-CA-C 110.264 -0.706 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.9 tt -153.57 160.12 3.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 117.961 -1.496 . . . . 0.0 112.304 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.598 ' OG ' HG23 ' A' ' 71' ' ' THR . 16.3 m -145.55 149.43 34.58 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.222 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 pt -147.03 154.9 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 118.956 -1.098 . . . . 0.0 111.387 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 92' ' ' TYR . 16.9 t-20 -89.77 164.15 14.78 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.554 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.447 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 22.6 t80 -172.32 129.67 0.58 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.209 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.481 ' CD ' ' N ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -90.39 111.06 22.15 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.082 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 116.295 -1.812 . . . . 0.0 110.666 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 120.446 0.165 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -174.14 159.16 3.17 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.89 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.1 t -91.98 135.51 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.516 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.77 -59.19 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 118.677 -1.209 . . . . 0.0 111.81 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.39 169.25 21.28 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.568 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.96 80.92 1.7 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.938 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -66.92 161.18 64.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.24 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -54.36 -10.12 2.01 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.362 1.375 . . . . 0.0 111.757 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.5 m -159.07 44.61 0.26 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.504 -0.879 . . . . 0.0 110.476 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.427 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -175.86 114.82 0.13 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.555 180.0 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.444 ' HB2' HD21 ' A' ' 62' ' ' LEU . 5.5 tp -109.81 112.15 24.03 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.336 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.22 122.48 31.08 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.297 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.71 148.23 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.73 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.45 136.41 46.7 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.954 179.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 45.7 p90 . . . . . 0 N--CA 1.507 2.378 0 C-N-CA 118.334 -1.346 . . . . 0.0 113.221 -179.893 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.489 HG11 ' CE1' ' A' ' 32' ' ' TYR . 37.1 t . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.818 0.342 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -65.34 -47.3 76.94 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.031 -1.068 . . . . 0.0 109.931 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -159.06 168.55 26.39 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.324 179.92 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CE1' HG11 ' A' ' 29' ' ' VAL . 4.4 m-85 -113.87 165.91 12.11 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.457 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -141.64 100.19 3.71 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.849 -0.741 . . . . 0.0 109.356 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.12 131.46 45.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.469 -0.892 . . . . 0.0 112.342 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.497 HG22 ' CB ' ' A' ' 47' ' ' GLU . 36.2 p -127.08 136.73 52.56 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.383 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.567 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 2.3 p90 -142.46 159.66 41.79 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 118.556 -1.258 . . . . 0.0 111.682 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.58 150.06 5.88 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -70.26 156.97 38.52 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.491 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.0 m . . . . . 0 C--N 1.302 -1.499 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.539 -179.933 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.43 HG11 ' CE2' ' A' ' 36' ' ' TYR . 47.5 t . . . . . 0 N--CA 1.483 1.175 0 CA-C-O 121.141 0.496 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -174.68 -166.11 0.23 Allowed 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.827 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.497 ' CB ' HG22 ' A' ' 35' ' ' THR . 8.3 pt-20 -162.07 174.49 12.93 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.004 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.582 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -170.59 153.7 4.28 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.997 179.677 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 p -113.01 157.33 21.66 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.475 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.548 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -145.44 159.88 46.9 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.493 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -64.81 22.65 0.07 OUTLIER 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 121.372 1.381 . . . . 0.0 112.179 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 48.33 20.71 1.61 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.148 -1.501 . . . . 0.0 110.394 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -45.98 16.8 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.663 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -90.55 130.4 36.59 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.274 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.4 m -81.32 -4.47 55.73 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.622 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -133.74 162.35 32.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.188 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.92 171.77 13.83 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.589 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.6 m -144.44 117.06 8.64 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.633 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 59' ' ' ILE . 12.2 mt -111.39 150.02 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.559 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.3 m -136.92 -8.13 1.83 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.788 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.41 52.17 1.81 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.419 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -130.29 -172.97 2.92 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.998 -179.976 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -131.91 102.15 14.93 Favored Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.911 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.29 144.22 61.5 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 120.657 0.905 . . . . 0.0 111.321 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.37 38.62 1.76 Allowed Glycine 0 N--CA 1.498 2.793 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.672 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.591 HG22 ' N ' ' A' ' 67' ' ' ASP . 5.3 p -169.05 165.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.631 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.591 ' N ' HG22 ' A' ' 66' ' ' VAL . 4.4 t70 -60.31 145.89 46.01 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.675 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.451 ' O ' ' O ' ' A' ' 92' ' ' TYR . 0.3 OUTLIER -145.32 119.06 9.2 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.422 -179.904 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -105.59 136.77 44.58 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.565 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.443 ' CG1' ' N ' ' A' ' 71' ' ' THR . 2.1 tt -134.36 156.54 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.876 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.443 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 48.9 m -147.99 138.1 22.72 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.585 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 72' ' ' VAL . 2.4 m -114.28 129.87 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.407 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -111.23 114.86 28.38 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.639 -179.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.07 96.52 9.7 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.172 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.34 146.24 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.161 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.141 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo . . . . . 0 C--O 1.216 -0.602 0 N-CA-C 110.351 -0.673 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.3 tt -144.19 138.43 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 118.66 -1.216 . . . . 0.0 110.61 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.4 p -119.42 122.36 41.57 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.597 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.063 ' H ' HD12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -120.5 145.09 27.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.681 -179.971 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -97.45 153.4 18.14 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.861 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.451 ' O ' ' O ' ' A' ' 68' ' ' TYR . 24.5 t80 -165.18 135.43 3.74 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 119.234 -0.986 . . . . 0.0 111.026 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.33 127.35 43.21 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.91 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 116.339 -1.791 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mm? . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -164.75 161.65 20.69 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 117.206 -1.798 . . . . 0.0 113.78 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.9 t -103.53 135.36 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-N 114.238 -1.346 . . . . 0.0 108.502 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.547 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -112.49 -10.08 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.762 -179.811 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 175.22 170.0 0.3 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.413 -1.315 . . . . 0.0 111.886 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.59 134.31 16.6 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.656 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -126.45 162.01 49.12 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.73 179.986 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -52.04 -12.88 1.55 Allowed 'Trans proline' 0 C--O 1.213 -0.745 0 C-N-CA 121.135 1.223 . . . . 0.0 111.865 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.14 48.99 0.39 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.03 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER 173.06 139.1 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.983 -179.998 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 tp -130.65 132.33 45.38 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.493 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.438 HD23 ' HB ' ' A' ' 11' ' ' VAL . 2.2 tp -93.56 126.67 38.84 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.034 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 pp -128.17 156.14 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.166 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.91 145.11 29.7 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.936 -1.105 . . . . 0.0 111.61 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 7.3 p90 . . . . . 0 C--N 1.308 -1.236 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.153 179.761 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.627 0.251 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -93.4 -57.57 2.56 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.975 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -165.03 166.73 19.04 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.826 -1.149 . . . . 0.0 112.028 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 74' ' ' ALA . 2.1 m-85 -120.0 156.0 31.74 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.439 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -135.19 104.6 5.96 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.864 179.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -96.28 122.03 47.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.682 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -120.18 141.38 49.94 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.638 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.463 ' CG ' HD11 ' A' ' 59' ' ' ILE . 28.9 p90 -139.16 144.38 38.56 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.898 -1.121 . . . . 0.0 111.28 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.674 ' HA2' HG21 ' A' ' 45' ' ' VAL . . . -172.42 153.26 18.66 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -74.31 166.83 22.8 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.006 -179.944 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.9 m . . . . . 0 C--N 1.306 -1.283 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.915 179.996 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.674 HG21 ' HA2' ' A' ' 37' ' ' GLY . 61.4 t . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.008 -0.044 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.48 174.1 8.17 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 117.061 -1.856 . . . . 0.0 113.02 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -169.06 167.18 10.72 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.226 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -164.11 160.55 21.63 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.94 161.53 20.73 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.643 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -148.66 159.41 38.37 Favored Pre-proline 0 C--N 1.309 -1.187 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.129 179.977 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -64.99 22.25 0.08 OUTLIER 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.002 1.135 . . . . 0.0 112.107 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 49.3 17.65 1.17 Allowed Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.776 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.56 -43.33 14.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -79.09 123.33 27.24 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.951 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.7 m -81.2 -12.68 59.1 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.446 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.0 p -138.62 148.56 44.25 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.173 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.95 165.03 30.65 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.921 -1.111 . . . . 0.0 111.435 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.7 m -104.17 130.23 51.91 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.167 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.463 HD11 ' CG ' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -112.21 123.29 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.719 179.979 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 51.6 m -129.81 157.48 42.09 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.307 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.78 -20.44 1.81 Allowed Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.576 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.53 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -79.35 -172.03 3.01 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.016 179.956 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.68 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -157.3 -43.73 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.487 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.487 179.967 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.68 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 10.3 Cg_endo -89.19 -167.65 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.517 1.478 . . . . 0.0 111.658 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -132.53 81.18 0.32 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 107.483 -2.247 . . . . 0.0 107.483 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.673 HG22 ' N ' ' A' ' 67' ' ' ASP . 7.5 p -133.61 175.33 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.055 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.673 ' N ' HG22 ' A' ' 66' ' ' VAL . 4.3 t70 -50.8 120.55 4.89 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.135 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.02 129.11 46.19 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.173 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.0 126.48 52.38 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.06 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 pp -112.23 152.66 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.847 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.471 ' HG1' ' CB ' ' A' ' 89' ' ' SER . 52.9 m -145.49 143.95 30.29 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.955 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.2 m -125.19 139.34 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.635 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -117.49 100.45 7.66 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.794 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -79.44 83.35 5.46 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.86 140.03 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 118.997 -1.081 . . . . 0.0 113.544 -179.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 p . . . . . 0 C--N 1.308 -1.217 0 CA-C-N 114.134 -1.393 . . . . 0.0 108.128 179.772 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 C--O 1.215 -0.649 0 CA-C-O 121.283 0.451 . . . . 0.0 112.752 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 88' ' ' ILE . 13.8 tt -149.3 137.03 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.373 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.471 ' CB ' ' HG1' ' A' ' 71' ' ' THR . 4.2 m -128.2 134.63 49.06 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.902 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -116.7 136.01 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.104 179.814 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.18 145.18 26.29 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.867 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.455 ' CG ' ' N ' ' A' ' 93' ' ' ARG . 24.3 t80 -167.28 158.2 11.65 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.984 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.455 ' N ' ' CG ' ' A' ' 92' ' ' TYR . 7.2 mtm-85 -93.34 113.55 25.76 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.975 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 116.581 -1.676 . . . . 0.0 110.436 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 8' ' ' LEU . 9.5 mp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 120.46 0.171 . . . . 0.0 110.543 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -171.32 166.07 7.09 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.587 -1.245 . . . . 0.0 111.933 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.6 t -92.62 143.48 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.848 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.6 p -128.92 -2.93 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.48 -179.859 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -179.81 147.54 0.29 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.491 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.486 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -176.57 112.17 0.1 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.631 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.64 ' O ' ' N ' ' A' ' 16' ' ' THR . 0.2 OUTLIER -148.51 -75.62 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 117.921 -1.512 . . . . 0.0 113.049 179.968 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 17' ' ' SER . 6.8 Cg_endo -53.21 78.37 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.779 0 CA-C-N 119.491 0.854 . . . . 0.0 110.863 -179.571 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 14' ' ' THR . 3.0 m 35.51 32.49 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.074 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 15' ' ' PRO . 1.6 m -139.79 148.95 42.94 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.941 -1.103 . . . . 0.0 112.447 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.53 HD13 ' CD2' ' A' ' 62' ' ' LEU . 5.6 tp -113.09 142.04 46.19 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.575 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.421 HD12 HG23 ' A' ' 58' ' ' THR . 1.1 tp -117.2 107.29 14.26 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.047 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 pt -106.24 157.95 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.361 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.98 138.3 18.46 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.824 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 9.3 p90 . . . . . 0 C--N 1.316 -0.873 0 C-N-CA 118.816 -1.154 . . . . 0.0 111.346 179.881 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.0 t . . . . . 0 N--CA 1.474 0.758 0 CA-C-O 120.895 0.379 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.1 mmm-85 -54.61 -42.88 71.67 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.23 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -179.58 165.71 1.36 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.443 -1.303 . . . . 0.0 112.234 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -115.73 163.08 16.35 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.14 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.49 HH21 ' CG2' ' A' ' 49' ' ' THR . 21.2 ttm180 -146.56 106.16 3.95 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.39 -1.324 . . . . 0.0 111.038 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.818 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.9 mp -99.9 122.02 51.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.329 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 p -119.59 139.08 52.73 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.699 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.543 ' CE2' HG11 ' A' ' 45' ' ' VAL . 6.4 p90 -136.51 155.35 50.09 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.14 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.401 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -177.57 143.36 6.11 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.464 ' CD ' ' N ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -71.54 176.62 4.6 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.636 -0.825 . . . . 0.0 110.808 179.931 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.487 1.386 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.017 179.952 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.543 HG11 ' CE2' ' A' ' 36' ' ' TYR . 96.2 t . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 120.694 0.283 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -172.11 -163.49 0.25 Allowed 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 118.476 -1.289 . . . . 0.0 111.966 -179.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.71 168.77 21.07 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.771 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -159.84 139.27 11.17 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.548 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.49 ' CG2' HH21 ' A' ' 33' ' ' ARG . 23.3 p -105.07 164.74 11.58 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.644 -0.822 . . . . 0.0 112.393 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.557 ' C ' ' H ' ' A' ' 52' ' ' GLY . 26.9 m -148.06 152.58 40.25 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.42 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -55.63 6.52 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 120.942 1.095 . . . . 0.0 112.612 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 80.86 -4.05 72.24 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.978 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.67 -27.19 45.16 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.079 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -80.45 108.74 14.33 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.01 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -81.31 -19.64 42.49 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.394 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.8 p -135.17 150.08 50.07 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.8 168.36 26.58 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.997 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.421 HG23 HD12 ' A' ' 19' ' ' LEU . 97.3 m -117.11 158.31 24.43 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.398 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 59' ' ' ILE . 5.6 mt -143.03 155.06 17.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.396 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.483 ' HG ' ' HG ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -139.52 135.64 33.67 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.875 -179.999 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.4 44.37 0.18 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.53 ' CD2' HD13 ' A' ' 18' ' ' LEU . 7.5 mp -107.16 175.66 5.42 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.573 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.58 141.39 28.82 Favored Pre-proline 0 CA--C 1.555 1.137 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.02 100.29 0.08 OUTLIER 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 120.748 0.965 . . . . 0.0 112.505 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.43 95.22 0.05 OUTLIER Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.59 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 p -160.59 159.04 2.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 119.136 -1.025 . . . . 0.0 111.328 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.3 146.41 45.34 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.264 -0.974 . . . . 0.0 108.874 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.9 145.2 31.47 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.458 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 m -125.29 126.06 44.51 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.407 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.3 tt -111.46 150.15 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.164 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.13 124.9 19.63 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.815 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.01 130.27 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.594 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.09 105.35 13.1 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.625 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.37 129.69 39.41 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.353 -0.939 . . . . 0.0 109.246 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 t -135.57 130.62 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 119.115 -1.034 . . . . 0.0 112.25 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 53.6 m . . . . . 0 N--CA 1.482 1.14 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.583 179.911 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 C--O 1.217 -0.568 0 N-CA-C 111.392 -0.272 . . . . 0.0 111.392 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 88' ' ' ILE . 16.1 tt -149.76 128.55 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 118.934 -1.106 . . . . 0.0 109.753 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 99.6 p -121.04 152.04 39.08 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.769 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.77 142.57 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.339 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.92 154.65 18.07 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.598 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -164.48 131.69 3.18 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.121 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -89.69 117.26 28.42 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.172 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 116.299 -1.81 . . . . 0.0 110.597 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -161.75 171.3 18.08 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 117.942 -1.503 . . . . 0.0 112.813 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.41 129.85 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.08 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.487 HG23 ' OG ' ' A' ' 21' ' ' SER . 4.9 t -95.59 -25.13 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.244 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.76 172.63 9.02 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.93 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.31 100.24 2.13 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.088 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.53 ' CB ' ' HG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -70.52 162.26 71.67 Favored Pre-proline 0 C--N 1.307 -1.271 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.563 179.858 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -53.94 -7.52 0.67 Allowed 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 121.008 1.139 . . . . 0.0 111.712 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.434 ' H ' ' C ' ' A' ' 14' ' ' THR . 7.2 m -160.29 35.99 0.17 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.53 ' HG ' ' CB ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -167.55 120.31 0.92 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.207 179.89 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 tp -96.81 123.81 40.61 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.724 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.48 114.59 28.79 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.688 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.5 169.45 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.733 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.487 ' OG ' HG23 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -158.65 139.51 12.87 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.7 -179.91 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 12.7 p90 . . . . . 0 N--CA 1.481 1.122 0 C-N-CA 119.649 -0.821 . . . . 0.0 110.321 179.846 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.478 0.963 0 CA-C-O 120.888 0.375 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -66.33 -57.81 6.67 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.631 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -165.45 169.02 16.07 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.539 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -122.65 148.7 44.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.902 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -126.73 108.66 11.27 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.536 -0.865 . . . . 0.0 109.531 179.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.03 128.71 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.875 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 p -128.64 139.72 52.12 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.149 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.493 ' CE2' HG11 ' A' ' 45' ' ' VAL . 10.8 p90 -141.95 166.7 23.99 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.725 -179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.02 158.68 10.25 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -51.79 158.74 0.93 Allowed 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.603 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.8 m . . . . . 0 C--N 1.304 -1.395 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.052 -179.912 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.493 HG11 ' CE2' ' A' ' 36' ' ' TYR . 2.3 t . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.309 0.576 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.432 ' N ' HG12 ' A' ' 45' ' ' VAL . 2.9 tt0 -172.78 179.8 2.28 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.339 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -164.49 158.45 18.3 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.844 -179.968 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -159.25 157.55 30.86 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.606 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -119.73 168.41 11.09 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.112 -179.868 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -147.66 158.89 42.4 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.681 179.971 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.463 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.9 Cg_endo -61.7 15.42 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.0 1.133 . . . . 0.0 112.72 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 54.19 7.98 0.98 Allowed Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.111 -1.518 . . . . 0.0 110.533 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -70.07 -34.74 73.57 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.291 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -119.33 121.68 40.12 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.837 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 m -79.66 46.63 0.78 Allowed 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.979 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.12 151.34 43.85 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.378 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.13 159.21 40.02 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.735 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.07 148.95 52.19 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.699 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.2 mt -138.21 146.89 26.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.587 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.7 m -139.43 155.42 47.62 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.231 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.46 8.71 55.99 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.928 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.23 -156.05 0.16 Allowed 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.855 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.67 103.62 0.94 Allowed Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 119.649 -0.821 . . . . 0.0 110.617 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.94 158.71 32.51 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 120.375 0.717 . . . . 0.0 111.639 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.63 35.91 5.0 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.186 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -165.22 154.68 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.943 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -72.3 113.76 9.67 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.412 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.0 148.23 30.0 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.879 -0.729 . . . . 0.0 111.247 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.2 m -122.93 140.21 53.24 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.708 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 tt -130.84 148.63 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.394 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 65.4 m -140.5 126.03 19.01 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.249 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' ' 72' ' ' VAL . 23.3 m -117.81 129.71 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.141 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -107.59 106.86 17.41 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.617 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.52 107.85 14.62 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.182 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.39 113.7 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.526 -0.87 . . . . 0.0 111.23 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.49 1.529 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.578 179.983 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.457 -0.673 0 N-CA-C 110.429 -0.643 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.1 tp -150.12 161.31 4.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 118.493 -1.283 . . . . 0.0 111.224 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.8 p -143.73 148.95 36.42 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.595 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.87 146.23 18.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.21 160.07 17.14 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.417 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -171.95 140.45 1.24 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.994 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -87.24 112.52 22.1 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.394 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.04 0 CA-C-O 116.337 -1.792 . . . . 0.0 110.827 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 10' ' ' VAL . 1.8 tm-20 -167.63 166.72 13.84 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 117.844 -1.542 . . . . 0.0 112.897 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.471 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 97.6 t -99.62 108.55 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.618 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.3 t -70.49 -42.88 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 119.141 -1.023 . . . . 0.0 111.918 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.27 173.48 16.62 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.757 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.59 142.45 21.11 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.697 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 17' ' ' SER . 1.1 p -140.63 155.58 69.48 Favored Pre-proline 0 N--CA 1.489 1.524 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.769 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.83 -7.92 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 121.389 1.393 . . . . 0.0 112.279 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.9 p -147.09 27.54 1.05 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.739 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.423 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -177.53 147.84 0.54 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.728 -179.992 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.35 134.36 47.11 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.443 179.857 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.0 tp -115.65 103.1 10.37 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.508 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.426 ' H ' HG23 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -99.35 165.61 2.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.257 179.852 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 m -156.06 136.53 13.18 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.258 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 16.0 p90 . . . . . 0 N--CA 1.487 1.391 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.796 179.915 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.734 0.302 . . . . 0.0 111.494 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -85.05 -55.4 4.07 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.486 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -157.95 163.99 37.29 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.629 -1.229 . . . . 0.0 111.924 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -119.46 160.46 22.31 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.739 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.38 98.03 3.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.808 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.712 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.7 mp -89.58 134.01 30.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.627 -0.829 . . . . 0.0 112.247 -179.781 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -135.79 134.5 39.01 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.771 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -141.92 155.56 45.49 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.547 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . 171.1 152.28 8.13 Favored Glycine 0 N--CA 1.479 1.558 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.697 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -48.81 175.02 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.342 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.9 m . . . . . 0 C--N 1.306 -1.325 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.906 -179.999 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.549 HG23 ' HA2' ' A' ' 37' ' ' GLY . 86.1 t . . . . . 0 N--CA 1.477 0.911 0 CA-C-O 121.231 0.539 . . . . 0.0 110.263 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.99 -169.91 0.7 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.874 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -158.1 166.97 31.14 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.95 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 13.6 p90 -162.5 153.3 17.24 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.424 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.87 160.45 16.76 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.187 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.579 ' C ' ' H ' ' A' ' 52' ' ' GLY . 22.8 m -148.66 153.08 39.06 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.265 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.3 Cg_endo -60.01 16.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 120.872 1.048 . . . . 0.0 112.758 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 53.33 6.87 0.47 Allowed Glycine 0 N--CA 1.498 2.784 0 C-N-CA 119.578 -1.296 . . . . 0.0 111.093 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -74.98 -44.41 48.39 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.503 -179.977 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.55 116.25 31.25 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.467 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.7 m -84.6 53.74 2.78 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.042 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.1 143.68 22.66 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.97 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.96 148.24 30.55 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.804 -1.159 . . . . 0.0 111.842 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.1 m -121.91 104.13 9.33 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.926 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.2 pt -109.12 136.36 45.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.209 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.8 m -118.24 -176.68 3.11 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.721 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.83 40.05 9.86 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.514 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.73 -158.35 0.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.971 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -148.58 134.93 10.02 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.209 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -56.74 107.25 0.26 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 120.489 0.793 . . . . 0.0 112.072 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.57 87.71 0.52 Allowed Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.565 -1.302 . . . . 0.0 111.286 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.6 p -161.28 135.27 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.037 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.6 120.93 8.58 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.92 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.5 118.56 26.89 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.972 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.6 m -103.73 114.74 29.22 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.08 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.9 tt -103.64 150.56 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 119.287 -0.965 . . . . 0.0 112.06 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.542 HG23 ' OG ' ' A' ' 89' ' ' SER . 85.5 m -139.75 116.51 10.87 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.002 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.6 m -103.22 144.17 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.768 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -112.2 128.97 56.39 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.319 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.97 86.76 2.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.728 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.01 129.81 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 119.164 -1.015 . . . . 0.0 113.113 -179.629 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.307 -1.266 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.859 179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo . . . . . 0 C--O 1.214 -0.697 0 N-CA-C 111.413 -0.264 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 tt -149.49 147.38 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.601 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.542 ' OG ' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -135.17 155.23 51.04 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.681 -179.858 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.76 142.97 24.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.014 179.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.44 142.77 31.65 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.061 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -158.99 108.99 1.97 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.185 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.409 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 5.5 ptt-85 -79.04 116.81 19.57 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.887 -1.125 . . . . 0.0 109.114 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 116.367 -1.778 . . . . 0.0 110.972 -179.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -167.03 167.44 14.6 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.591 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.67 145.71 7.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.986 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.612 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -117.75 0.13 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.603 -179.853 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 171.97 161.19 0.1 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.7 -1.2 . . . . 0.0 111.904 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.74 126.75 5.14 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.831 179.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.57 161.68 61.62 Favored Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.011 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 16' ' ' THR . 5.1 Cg_exo -49.79 104.79 0.08 OUTLIER 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 121.042 1.161 . . . . 0.0 112.051 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.463 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER 75.46 33.34 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.555 179.886 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 p -159.99 126.45 4.33 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.25 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.8 tp -130.42 140.07 50.58 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.77 -0.772 . . . . 0.0 111.347 -179.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.61 126.09 45.99 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.985 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 pt -133.66 162.15 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.286 -0.966 . . . . 0.0 112.932 -179.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -134.58 140.22 45.94 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.55 -1.205 . . . . 0.0 108.256 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 29.1 p90 . . . . . 0 N--CA 1.506 2.34 0 C-N-CA 118.712 -1.195 . . . . 0.0 113.506 -179.843 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.863 0.364 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -80.16 -41.65 24.92 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.141 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -143.09 175.06 10.14 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.79 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.12 140.5 30.88 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.746 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -123.28 107.95 12.24 Favored 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 119.118 -1.033 . . . . 0.0 109.98 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.7 mt -100.98 111.34 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.099 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.402 HG22 ' OE2' ' A' ' 47' ' ' GLU . 9.0 p -117.35 137.46 52.43 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.593 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CE2' HG11 ' A' ' 45' ' ' VAL . 42.6 p90 -141.4 138.21 32.81 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.029 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.12 136.78 4.25 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -82.75 169.51 16.08 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.742 -179.966 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.436 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 54.9 m . . . . . 0 N--CA 1.487 1.418 0 C-N-CA 119.786 -0.766 . . . . 0.0 111.756 -179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.656 HG12 ' N ' ' A' ' 46' ' ' GLN . 4.2 t . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.656 ' N ' HG12 ' A' ' 45' ' ' VAL . 1.1 mt-30 -163.3 171.93 15.42 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.509 -1.676 . . . . 0.0 112.556 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.402 ' OE2' HG22 ' A' ' 35' ' ' THR . 2.3 tt0 -170.6 143.28 2.17 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.127 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 4.6 p90 -147.34 141.55 26.17 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 p -98.98 156.94 16.66 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.769 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.506 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -150.07 157.88 37.19 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.321 179.942 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.41 13.61 0.09 OUTLIER 'Trans proline' 0 C--O 1.212 -0.785 0 C-N-CA 121.319 1.346 . . . . 0.0 112.234 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 57.66 27.81 59.27 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 118.886 -1.626 . . . . 0.0 109.901 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.21 -31.3 19.16 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -95.91 135.24 37.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.982 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.8 m -79.71 -15.61 57.2 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.109 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 p -139.08 -179.61 5.95 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.134 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.04 157.83 6.74 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.346 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.6 m -114.32 136.74 52.65 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.624 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.65 155.22 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.487 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.1 t -147.74 127.05 13.05 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.937 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.34 -34.15 0.38 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.672 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.48 -158.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.798 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 8.3 tttt -176.11 -43.43 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 119.334 -0.947 . . . . 0.0 112.586 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.607 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 4.4 Cg_endo -78.86 -175.52 2.79 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 121.497 1.465 . . . . 0.0 112.096 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.2 80.07 0.29 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.847 HG22 ' H ' ' A' ' 67' ' ' ASP . 13.8 p -122.81 -174.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.241 -179.79 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.847 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -65.49 95.13 0.2 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.084 179.92 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -90.88 127.95 36.56 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.109 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 m -94.05 117.92 30.78 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.94 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.467 HD12 ' H ' ' A' ' 71' ' ' THR . 2.6 tp -104.89 141.92 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.534 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.467 ' H ' HD12 ' A' ' 70' ' ' ILE . 97.3 m -141.48 130.05 22.68 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.373 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.12 128.06 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.947 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -98.33 146.74 25.38 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.699 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.35 85.33 2.37 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.981 0.8 . . . . 0.0 109.485 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.6 t -81.4 128.25 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.319 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.489 1.494 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.635 -179.979 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 C--O 1.215 -0.637 0 N-CA-C 113.161 0.408 . . . . 0.0 113.161 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.1 tt -133.07 145.28 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.456 179.761 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.4 p -144.46 153.53 41.98 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.301 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.53 141.83 19.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.376 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.34 154.54 41.51 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.122 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -152.25 122.26 7.08 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.405 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.54 75.93 1.07 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.648 179.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.453 ' O ' ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 116.212 -1.851 . . . . 0.0 110.417 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.493 1.703 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.95 168.05 27.68 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 117.693 -1.603 . . . . 0.0 113.69 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.9 t -103.34 115.75 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.559 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.483 ' CG2' ' OG ' ' A' ' 21' ' ' SER . 2.3 t -72.52 -74.11 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.007 -1.077 . . . . 0.0 111.726 -179.823 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.81 179.0 6.84 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.73 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.14 100.73 3.6 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.314 -0.955 . . . . 0.0 111.499 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.16 164.44 23.08 Favored Pre-proline 0 C--N 1.305 -1.327 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.797 179.848 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.532 ' O ' HG23 ' A' ' 16' ' ' THR . 5.0 Cg_exo -54.27 -12.52 3.97 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.213 1.275 . . . . 0.0 111.714 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 15' ' ' PRO . 2.2 p -158.85 33.35 0.22 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.607 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.45 137.96 8.33 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.124 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.6 tp -114.27 126.97 55.63 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.55 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 19' ' ' LEU . 2.8 tt -100.07 98.75 9.45 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.584 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 pp -96.61 148.8 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.394 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.483 ' OG ' ' CG2' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -145.82 134.43 22.16 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.352 -179.938 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 5.8 p90 . . . . . 0 C--N 1.308 -1.238 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.707 179.828 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.797 HG13 HG22 ' A' ' 76' ' ' THR . 3.1 t . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.83 0.348 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.434 ' CG ' ' CE2' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -54.34 -55.67 26.17 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.149 179.955 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.434 ' CE2' ' CG ' ' A' ' 30' ' ' ARG . 2.1 p90 178.42 171.43 0.75 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.493 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -128.07 161.57 28.91 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.175 -179.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.74 104.68 4.76 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.373 179.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.37 120.21 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.796 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -120.35 137.09 54.47 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.663 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.69 ' CZ ' HG11 ' A' ' 45' ' ' VAL . 11.2 p90 -142.2 157.75 44.51 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.585 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.91 170.58 42.92 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -61.4 -162.48 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.959 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.487 1.375 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.199 -179.91 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.69 HG11 ' CZ ' ' A' ' 36' ' ' TYR . 86.0 t . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 120.742 0.306 . . . . 0.0 111.502 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.465 ' N ' HG12 ' A' ' 45' ' ' VAL . 9.3 tt0 -175.17 -143.88 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.94 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -165.39 168.3 16.88 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 119.261 -0.975 . . . . 0.0 111.394 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 8.7 p90 -153.61 136.48 15.39 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.146 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.9 p -100.1 159.79 14.83 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.702 -179.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.545 ' C ' ' H ' ' A' ' 52' ' ' GLY . 34.1 m -147.9 150.53 36.08 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.666 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.95 5.75 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.725 0 C-N-CA 120.849 1.033 . . . . 0.0 112.383 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 81.72 7.49 88.01 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.324 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.44 -35.77 27.22 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.761 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -72.66 106.44 4.67 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.842 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.6 m -79.83 -18.32 51.12 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.859 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.2 p -132.67 158.82 41.35 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.273 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.11 149.25 19.24 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.549 -1.26 . . . . 0.0 111.569 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.8 m -121.87 117.89 27.61 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.054 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 pt -108.27 149.47 11.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.406 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.9 175.76 8.1 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.522 -179.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.507 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 83.84 49.6 4.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.884 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.507 HD23 ' C ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -117.46 -168.58 1.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.614 0.721 . . . . 0.0 111.536 -179.881 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -148.98 82.82 6.97 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.011 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -54.46 140.54 74.29 Favored 'Trans proline' 0 C--O 1.216 -0.578 0 C-N-CA 120.846 1.03 . . . . 0.0 111.815 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.8 31.4 2.73 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 67' ' ' ASP . 2.4 p -162.17 169.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 119.361 -0.935 . . . . 0.0 111.255 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.465 ' H ' HG22 ' A' ' 66' ' ' VAL . 6.4 t0 -82.45 126.48 32.26 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.999 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.2 133.36 56.09 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 120.144 -0.623 . . . . 0.0 110.7 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -103.46 138.4 40.23 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.444 ' CG1' ' N ' ' A' ' 71' ' ' THR . 6.1 tt -132.04 157.03 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.457 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.444 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 26.9 m -151.43 123.03 7.93 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.551 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.7 m -115.18 135.09 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -112.77 121.38 44.55 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.984 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.63 105.2 16.1 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.658 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.414 HG21 ' HE1' ' A' ' 31' ' ' TYR . 10.6 t -105.32 99.33 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.271 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.797 HG22 HG13 ' A' ' 29' ' ' VAL . 34.6 p . . . . . 0 N--CA 1.49 1.563 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.23 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo . . . . . 0 C--O 1.215 -0.661 0 CA-C-O 120.769 0.237 . . . . 0.0 111.678 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 88' ' ' ILE . 13.2 tt -151.39 146.72 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.195 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.0 p -141.5 146.35 36.3 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.204 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pt -146.53 151.8 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.311 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.53 160.27 15.12 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.629 -0.829 . . . . 0.0 109.429 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -161.35 141.05 10.46 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.374 -1.33 . . . . 0.0 112.157 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -96.01 99.72 11.46 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.311 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 116.329 -1.796 . . . . 0.0 110.706 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.5 2.042 0 CA-C-O 120.759 0.314 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -173.44 168.29 4.57 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.881 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.1 t -96.05 117.29 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.711 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 12' ' ' ALA . 39.8 t -71.49 -79.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 118.792 -1.163 . . . . 0.0 110.786 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.537 ' N ' HG12 ' A' ' 11' ' ' VAL . . . -139.58 179.35 6.62 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.476 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.96 170.54 15.96 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.195 -1.002 . . . . 0.0 111.502 -179.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 17' ' ' SER . 52.9 p -142.58 153.04 61.42 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.693 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -50.95 -5.33 0.08 OUTLIER 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 120.599 0.866 . . . . 0.0 111.98 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.504 ' H ' ' C ' ' A' ' 14' ' ' THR . 10.0 t -154.74 28.43 0.43 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.61 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.518 ' N ' ' OG1' ' A' ' 14' ' ' THR . 0.4 OUTLIER -173.93 135.88 0.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.665 -1.214 . . . . 0.0 111.985 179.905 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 31.9 tp -112.71 146.52 38.58 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.046 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 tp -121.23 104.45 9.75 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.999 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pt -97.81 150.56 4.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.929 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 m -145.53 138.12 25.87 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 118.989 -1.085 . . . . 0.0 111.255 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 10.7 p90 . . . . . 0 C--N 1.31 -1.112 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.585 179.904 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.0 t . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 121.01 0.433 . . . . 0.0 110.372 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -53.64 -52.34 60.23 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.729 -1.188 . . . . 0.0 108.754 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -171.78 162.89 6.32 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.294 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -109.35 171.69 7.29 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.515 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.474 ' C ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -137.57 108.84 6.84 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.198 179.962 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.791 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.8 mp -98.93 113.29 33.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.749 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.514 HG22 ' HB2' ' A' ' 47' ' ' GLU . 17.6 p -117.51 135.82 53.66 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.282 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.449 ' CE2' HG11 ' A' ' 45' ' ' VAL . 5.6 p90 -141.17 157.61 45.02 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.138 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . -171.82 148.41 10.9 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 39' ' ' THR . 6.3 pt-20 -56.17 -163.5 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.964 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 38' ' ' GLU . 3.4 t . . . . . 0 C--N 1.303 -1.437 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.321 -179.866 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.449 HG11 ' CE2' ' A' ' 36' ' ' TYR . 4.1 t . . . . . 0 N--CA 1.485 1.294 0 CA-C-O 121.252 0.548 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -171.05 -166.91 0.5 Allowed 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.402 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.514 ' HB2' HG22 ' A' ' 35' ' ' THR . 5.8 pt-20 -169.49 159.47 8.52 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.734 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -160.22 143.38 13.67 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.166 -1.013 . . . . 0.0 110.512 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.429 HG22 ' HG3' ' A' ' 33' ' ' ARG . 4.1 p -106.73 162.28 13.92 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.584 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.523 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -142.02 159.22 59.85 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.868 179.952 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.5 Cg_endo -63.9 14.85 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 120.99 1.126 . . . . 0.0 112.345 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 57.54 2.05 0.65 Allowed Glycine 0 N--CA 1.496 2.688 0 C-N-CA 119.432 -1.366 . . . . 0.0 111.112 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -74.3 -44.02 54.38 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.66 179.94 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -93.03 116.33 28.95 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.304 -0.959 . . . . 0.0 110.693 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.59 21.15 0.67 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.771 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.7 p -138.67 130.64 28.1 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.947 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.2 165.48 25.65 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.576 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 t -136.62 144.03 43.85 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.598 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.76 160.06 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.131 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.33 140.47 24.09 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.25 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.86 -15.84 5.37 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.744 ' C ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -83.56 167.0 17.76 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.324 179.992 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.425 ' N ' HD22 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -134.6 128.43 19.03 Favored Pre-proline 0 CA--C 1.556 1.193 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.202 179.803 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.22 112.64 1.18 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.408 0.739 . . . . 0.0 111.8 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.22 22.4 0.26 Allowed Glycine 0 N--CA 1.498 2.788 0 C-N-CA 119.202 -1.475 . . . . 0.0 111.608 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 67' ' ' ASP . 6.9 p -151.74 158.69 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 118.689 -1.205 . . . . 0.0 112.037 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.509 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -73.29 147.02 44.92 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.791 179.995 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -147.66 127.0 13.07 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.649 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.5 m -111.18 132.06 54.61 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.227 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.52 154.33 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.067 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 89' ' ' SER . 0.1 OUTLIER -134.91 131.82 37.74 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.42 179.991 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.14 142.35 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.439 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -126.18 133.07 51.66 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.176 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.15 108.68 20.25 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.598 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 t -109.09 113.55 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.449 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.486 1.343 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.253 179.936 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo . . . . . 0 C--O 1.214 -0.69 0 N-CA-C 111.246 -0.329 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.421 ' CG1' ' N ' ' A' ' 89' ' ' SER . 6.6 tt -152.64 166.3 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.86 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.493 ' HB3' HG22 ' A' ' 71' ' ' THR . 88.6 p -148.97 157.72 43.63 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.864 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.01 137.85 15.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.169 -1.013 . . . . 0.0 110.819 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.83 139.8 32.34 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.5 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -162.02 148.06 13.4 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.029 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -88.61 119.81 29.42 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.536 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 116.206 -1.854 . . . . 0.0 110.377 -179.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.488 1.468 0 CA-C-O 120.628 0.251 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -164.85 159.85 18.83 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 118.738 -1.185 . . . . 0.0 111.772 179.922 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.56 134.83 30.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.922 179.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.49 -67.88 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 118.725 -1.19 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.93 172.24 13.32 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.457 179.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.41 175.46 9.76 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.815 -179.959 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.2 OUTLIER -140.63 158.43 65.77 Favored Pre-proline 0 C--N 1.307 -1.278 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.077 179.95 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.97 0.33 0.33 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.006 1.137 . . . . 0.0 111.666 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -155.83 26.17 0.38 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.149 -1.021 . . . . 0.0 111.375 -179.95 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.64 157.3 4.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.343 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.5 tp -129.19 147.06 51.0 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.174 -179.953 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -128.67 122.39 30.7 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.03 -179.961 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 20' ' ' ILE . 2.1 pt -123.58 169.85 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.861 179.944 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.47 139.32 11.68 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.449 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 13.8 p90 . . . . . 0 N--CA 1.483 1.182 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.985 179.978 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 66.8 t . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -54.45 -66.46 0.4 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.086 -179.9 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.79 160.62 39.41 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.966 -1.093 . . . . 0.0 111.076 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.49 156.15 17.98 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.916 -179.989 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -137.13 111.69 8.67 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.4 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -101.75 148.03 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.209 -179.951 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.4 p -138.57 133.75 32.93 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.809 179.904 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -130.12 121.73 26.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.283 179.93 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.467 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -151.82 137.33 5.91 Favored Glycine 0 N--CA 1.487 2.058 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.572 -179.851 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -52.65 175.81 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 84.1 m . . . . . 0 N--CA 1.49 1.546 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.297 -179.923 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.467 HG23 ' HA2' ' A' ' 37' ' ' GLY . 5.1 t . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.796 0.332 . . . . 0.0 111.297 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -173.54 -176.89 1.36 Allowed 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.7 -179.992 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.505 ' N ' ' CD ' ' A' ' 47' ' ' GLU . 1.1 mp0 -135.02 174.91 10.08 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.759 -179.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -175.28 132.67 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.493 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.54 148.92 24.64 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.687 -0.805 . . . . 0.0 112.045 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 m -142.32 151.62 58.64 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.431 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 53' ' ' SER . 3.9 Cg_exo -55.25 120.86 8.9 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 120.308 0.672 . . . . 0.0 110.805 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -46.87 -11.39 0.05 OUTLIER Glycine 0 N--CA 1.486 2.03 0 C-N-CA 119.305 -1.426 . . . . 0.0 110.725 179.875 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -65.32 -33.16 75.32 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.48 -179.894 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.2 mtpp -77.38 135.69 38.36 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.593 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.65 -1.74 25.96 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.4 p -132.69 162.64 30.87 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.773 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.466 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -159.04 161.11 36.52 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.016 -1.073 . . . . 0.0 111.583 179.972 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.2 m -137.63 123.09 19.59 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.32 156.52 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.594 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 16' ' ' THR . 0.2 OUTLIER -142.48 176.82 8.72 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.504 -179.93 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.64 58.0 4.33 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.657 -1.258 . . . . 0.0 110.202 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.511 HD12 ' H ' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -130.65 -127.83 0.2 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.068 -179.926 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.511 ' H ' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -172.44 99.63 0.36 Allowed Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.979 -179.915 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.97 149.36 90.6 Favored 'Trans proline' 0 C--O 1.213 -0.729 0 C-N-CA 120.903 1.069 . . . . 0.0 112.237 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.82 55.17 2.73 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.926 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.4 p -168.94 150.81 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -62.52 152.04 35.82 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.503 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.09 138.85 24.28 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.982 -179.929 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.84 108.0 16.81 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.712 179.843 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -95.44 157.97 3.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.111 -179.898 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -158.98 141.57 14.17 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.432 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.15 138.87 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.83 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -119.63 104.55 10.37 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.947 -179.903 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.83 116.67 21.61 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.721 179.828 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.3 t -109.94 109.33 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.94 -179.917 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 p . . . . . 0 C--N 1.309 -1.183 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.973 179.878 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo . . . . . 0 C--O 1.214 -0.699 0 CA-C-O 120.779 0.241 . . . . 0.0 111.577 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 88' ' ' ILE . 7.9 tt -159.57 156.83 3.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 118.715 -1.194 . . . . 0.0 111.091 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.1 p -134.69 144.02 47.55 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.579 179.987 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -139.0 156.7 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.782 179.945 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.77 146.41 25.94 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.714 -179.968 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -153.62 144.48 22.71 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.239 -0.985 . . . . 0.0 110.737 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.05 118.79 37.59 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.134 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 116.313 -1.804 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -162.95 173.33 13.79 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 117.789 -1.564 . . . . 0.0 112.999 -179.832 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.524 HG13 HD21 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -87.27 142.25 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.875 179.9 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 11' ' ' VAL . 1.8 p -130.95 -8.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.695 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 19' ' ' LEU . . . -170.14 161.3 8.43 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.638 -179.977 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.21 149.13 26.69 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.193 -179.94 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.434 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -136.41 161.47 61.94 Favored Pre-proline 0 N--CA 1.491 1.583 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.762 179.89 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.434 ' O ' ' OG1' ' A' ' 16' ' ' THR . 2.9 Cg_exo -50.55 -11.33 0.36 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.221 1.281 . . . . 0.0 111.795 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 16' ' ' THR . 96.6 m -164.39 49.22 0.12 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.432 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.63 143.62 0.16 Allowed 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.322 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.524 HD21 HG13 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -131.02 140.39 50.09 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.912 -179.938 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 8.6 tp -113.05 113.29 25.23 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.285 179.783 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.8 167.05 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.553 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.34 134.57 16.01 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.447 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.451 ' CE3' ' O ' ' A' ' 55' ' ' SER . 5.8 p90 . . . . . 0 N--CA 1.49 1.555 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.413 179.926 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.834 HG13 HG22 ' A' ' 76' ' ' THR . 1.6 t . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.484 0.183 . . . . 0.0 110.64 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -54.56 -52.62 61.51 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.65 -1.22 . . . . 0.0 109.473 179.88 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 175.1 171.27 0.28 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.691 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -118.38 161.87 19.25 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.475 179.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -138.48 104.66 5.21 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.799 179.858 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.547 HD13 ' CE1' ' A' ' 48' ' ' PHE . 4.7 mp -96.78 105.09 16.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.94 -179.972 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.6 p -103.55 143.32 32.9 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.347 179.876 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.469 ' CE2' HG11 ' A' ' 45' ' ' VAL . 8.2 p90 -145.92 166.96 24.45 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 118.464 -1.295 . . . . 0.0 111.38 -179.993 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . 160.0 162.86 12.7 Favored Glycine 0 N--CA 1.482 1.719 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 37' ' ' GLY . 2.5 mt-10 -49.13 177.98 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.716 179.995 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.3 m . . . . . 0 C--N 1.303 -1.441 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.745 -179.984 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 46' ' ' GLN . 24.1 t . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.852 0.358 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.567 ' N ' HG12 ' A' ' 45' ' ' VAL . 1.2 tt0 -175.68 -169.07 0.33 Allowed 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.329 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.41 171.55 19.15 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.987 179.976 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.547 ' CE1' HD13 ' A' ' 34' ' ' ILE . 23.9 p90 -159.73 130.85 5.91 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.867 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -95.67 163.21 13.29 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 119.391 -0.924 . . . . 0.0 112.493 -179.87 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.575 ' C ' ' H ' ' A' ' 52' ' ' GLY . 11.8 p -150.74 140.38 13.79 Favored Pre-proline 0 CA--C 1.561 1.374 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.017 -179.939 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.56 16.02 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 121.0 1.134 . . . . 0.0 113.673 -179.97 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 64.94 4.44 14.73 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.359 -1.4 . . . . 0.0 111.288 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.79 -27.32 64.81 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.042 -179.919 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.13 140.07 35.94 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.229 -179.946 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.451 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 4.6 m -96.94 -26.42 15.05 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.405 179.919 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.3 p -124.01 159.22 30.32 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.538 179.922 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.6 162.54 24.39 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.19 -1.404 . . . . 0.0 112.275 -179.92 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.6 m -107.99 134.01 51.51 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.449 179.95 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 tt -126.27 137.2 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.177 179.989 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.9 t -138.01 111.31 7.96 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.309 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.56 33.15 0.02 OUTLIER Glycine 0 N--CA 1.486 1.979 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.211 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.51 -155.67 0.71 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.63 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -147.84 162.08 32.71 Favored Pre-proline 0 C--N 1.311 -1.104 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.692 -179.903 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -74.69 159.64 42.12 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 121.586 1.524 . . . . 0.0 112.97 179.906 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 34.65 69.93 0.18 Allowed Glycine 0 N--CA 1.499 2.841 0 CA-C-N 114.957 -1.02 . . . . 0.0 113.316 179.793 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 p -159.14 143.52 6.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.745 179.688 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.82 130.54 46.23 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.073 -179.95 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -141.63 138.4 32.53 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.705 179.944 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.3 m -120.9 134.71 55.3 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.864 -0.735 . . . . 0.0 110.479 -179.953 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.97 154.87 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.138 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.458 ' OG1' ' CB ' ' A' ' 89' ' ' SER . 2.5 m -147.98 159.14 44.2 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.954 -179.957 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 72' ' ' VAL . 32.9 m -139.81 129.07 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.072 -179.955 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.89 117.95 35.52 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.147 179.79 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.5 113.61 25.93 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.489 -0.885 . . . . 0.0 110.94 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.08 109.89 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.799 -179.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.834 HG22 HG13 ' A' ' 29' ' ' VAL . 15.8 p . . . . . 0 N--CA 1.484 1.232 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.022 -179.951 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 C--O 1.214 -0.704 0 N-CA-C 109.342 -1.061 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.3 tt -151.67 131.24 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 118.034 -1.466 . . . . 0.0 111.804 -179.972 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.458 ' CB ' ' OG1' ' A' ' 71' ' ' THR . 59.2 p -118.7 147.13 44.14 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.69 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -143.1 139.77 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.231 179.959 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.3 154.3 17.91 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.423 179.944 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -169.56 139.25 2.03 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.157 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.432 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 11.0 ptt-85 -88.15 115.15 25.43 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.387 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.421 HG21 HD11 ' A' ' 18' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.647 -179.919 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 119.304 -0.379 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -177.25 -164.15 0.09 Allowed 'General case' 0 N--CA 1.515 2.825 0 C-N-CA 117.894 -1.522 . . . . 0.0 113.239 -179.694 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.426 ' H ' HG23 ' A' ' 10' ' ' VAL . 2.8 t -70.4 151.67 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.339 179.917 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 11' ' ' VAL . 39.1 t -130.79 -8.03 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.114 179.914 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.64 157.49 3.86 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.805 179.934 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.85 157.09 44.94 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.484 -0.887 . . . . 0.0 111.089 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.36 162.04 51.79 Favored Pre-proline 0 N--CA 1.485 1.306 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.436 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.71 -23.61 33.86 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 121.074 1.183 . . . . 0.0 111.663 -179.977 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.1 p -143.1 39.93 1.47 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.325 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.98 149.84 0.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.895 179.967 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 tp -130.43 117.24 19.38 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.758 179.94 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 tt -90.94 103.74 16.42 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.577 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 pt -97.69 158.52 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.65 179.966 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.0 127.76 15.3 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.507 -179.919 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.4 p90 . . . . . 0 C--O 1.214 -0.791 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.618 179.861 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.821 0.344 . . . . 0.0 111.155 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -59.5 4.81 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.608 179.874 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.7 168.55 4.36 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.074 -1.05 . . . . 0.0 112.027 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.82 139.58 50.89 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.85 179.856 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.71 109.58 20.78 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 119.346 -0.941 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -105.42 99.36 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.37 -179.886 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -103.59 141.35 36.18 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.914 179.92 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.532 ' N ' ' CD1' ' A' ' 36' ' ' TYR . 4.2 p90 -143.78 163.36 33.55 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.009 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.84 149.61 5.81 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.41 144.89 24.0 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.567 -179.981 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 t . . . . . 0 C--N 1.304 -1.395 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.131 -179.996 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 46' ' ' GLN . 55.2 t . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.814 0.34 . . . . 0.0 111.42 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.546 ' N ' HG12 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -171.57 -160.97 0.18 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.575 -179.899 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.502 ' N ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -164.05 158.48 19.48 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.088 -179.995 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -149.1 142.86 25.59 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.462 ' OG1' ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -92.34 166.4 12.6 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.435 -179.929 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.641 ' CG1' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -148.55 148.58 28.79 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.913 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.27 -4.17 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 121.522 1.481 . . . . 0.0 112.911 -179.821 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.641 ' H ' ' CG1' ' A' ' 50' ' ' VAL . . . 70.87 -0.87 26.69 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.646 -1.264 . . . . 0.0 111.42 179.955 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.2 -30.29 22.54 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.895 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.66 129.57 35.74 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.097 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.13 -16.04 34.52 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.582 179.976 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.1 p -134.36 152.92 52.09 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.073 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.14 163.92 39.56 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.771 -1.171 . . . . 0.0 111.611 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.3 m -117.84 112.5 20.47 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.432 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.67 137.81 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.021 -179.914 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.6 t -96.42 -156.56 0.53 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.388 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.3 83.96 0.07 OUTLIER Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.231 -1.461 . . . . 0.0 109.989 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.47 -175.43 2.94 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.3 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -172.29 85.15 0.44 Allowed Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.686 179.888 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -55.45 133.27 57.11 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 120.787 0.992 . . . . 0.0 111.923 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.43 41.61 3.89 Favored Glycine 0 N--CA 1.484 1.895 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.398 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 p -159.96 154.48 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 118.667 -1.213 . . . . 0.0 111.691 -179.977 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.53 105.88 17.62 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.446 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -89.11 118.23 28.67 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.399 -179.78 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.19 131.11 45.46 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.348 179.849 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 pp -130.15 154.54 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.184 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m -144.33 128.26 17.43 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.789 -179.998 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.9 m -110.69 137.19 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.099 -179.942 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -120.07 113.69 20.87 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.636 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.14 105.21 17.36 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.104 179.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.4 t -110.2 119.54 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.261 -179.924 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.488 1.427 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.894 179.952 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 C--O 1.214 -0.684 0 N-CA-C 110.702 -0.538 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 tt -151.68 160.35 3.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 118.332 -1.347 . . . . 0.0 111.476 -179.855 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.1 158.63 41.11 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.187 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.13 141.99 16.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.842 179.957 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.29 136.28 40.42 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.502 179.949 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -144.39 135.02 24.8 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.847 -179.981 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -83.45 107.42 15.93 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.168 179.887 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 116.306 -1.806 . . . . 0.0 110.351 -179.918 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.462 ' N ' HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 120.776 0.322 . . . . 0.0 110.369 . . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -155.83 153.09 29.22 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.88 -1.128 . . . . 0.0 112.054 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.8 t -87.81 129.02 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.576 179.876 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.423 HG23 ' OG ' ' A' ' 21' ' ' SER . 48.1 t -104.63 -56.09 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.839 -179.922 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.71 161.43 37.96 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.033 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.16 87.57 1.54 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.937 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.442 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -70.64 158.33 88.13 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.068 -179.983 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.55 -5.16 1.55 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 121.054 1.17 . . . . 0.0 111.217 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.442 ' H ' ' C ' ' A' ' 14' ' ' THR . 14.5 p -151.08 33.2 0.59 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.261 179.997 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.98 122.01 0.31 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.091 179.969 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -97.65 127.66 43.77 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.067 179.945 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 tp -110.0 125.4 52.86 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.538 -179.875 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 20' ' ' ILE . 4.2 pt -127.22 174.24 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.317 179.829 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.561 ' HB3' HG22 ' A' ' 56' ' ' THR . 1.0 OUTLIER -163.06 137.16 6.12 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.077 179.978 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 11.6 p90 . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.765 179.998 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.763 0.316 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.492 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -91.73 -79.13 0.38 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.987 179.884 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.492 ' CD1' ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -150.62 171.92 16.36 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.26 179.875 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -131.87 160.57 35.29 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.341 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.31 119.18 13.3 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 118.415 -1.314 . . . . 0.0 110.975 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.1 115.77 47.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.368 -179.876 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.2 p -111.4 138.07 48.37 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.564 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.689 ' CZ ' HG11 ' A' ' 45' ' ' VAL . 8.9 p90 -139.29 148.65 43.28 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.271 179.992 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.74 156.58 25.24 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.957 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -66.65 143.04 57.22 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.774 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 m . . . . . 0 C--N 1.305 -1.342 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.752 -179.95 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.689 HG11 ' CZ ' ' A' ' 36' ' ' TYR . 63.4 t . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.878 0.37 . . . . 0.0 111.803 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -173.26 -159.71 0.11 Allowed 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.986 -1.086 . . . . 0.0 111.036 -179.907 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -162.75 158.67 23.2 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.025 179.975 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 2.9 p90 -146.98 162.55 38.53 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.004 -179.933 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.2 p -114.99 154.82 28.08 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.351 179.968 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.524 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -136.87 157.99 73.78 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.971 -179.976 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.23 8.73 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 121.212 1.275 . . . . 0.0 112.261 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 56.27 13.63 7.44 Favored Glycine 0 N--CA 1.497 2.701 0 C-N-CA 119.484 -1.341 . . . . 0.0 111.127 -179.935 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.49 -57.34 2.91 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.433 179.984 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -64.41 123.39 19.07 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.436 -179.878 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.54 8.45 6.37 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.601 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.561 HG22 ' HB3' ' A' ' 21' ' ' SER . 0.8 OUTLIER -129.57 158.16 40.04 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.884 -179.947 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.1 169.09 25.59 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.496 179.965 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.4 t -142.9 162.03 36.56 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.237 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 mt -139.56 143.46 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.513 179.959 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.07 143.37 31.12 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.646 -179.979 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.07 50.61 1.23 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.964 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.911 HD23 ' H ' ' A' ' 62' ' ' LEU . 1.3 pt? -130.19 -171.71 2.6 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.419 -179.96 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -117.77 89.84 34.5 Favored Pre-proline 0 N--CA 1.488 1.455 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.502 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.39 146.19 95.63 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 120.892 1.062 . . . . 0.0 111.684 -179.875 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.47 43.94 5.39 Favored Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.559 -1.305 . . . . 0.0 109.958 -179.912 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -166.19 157.74 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.194 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -63.11 142.96 58.18 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.585 179.98 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.9 135.26 22.99 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.272 -0.971 . . . . 0.0 111.123 -179.953 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.33 132.59 53.57 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.173 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.1 157.96 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.251 -179.935 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.7 m -148.43 127.57 12.88 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.133 180.0 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.11 138.19 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.009 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -106.42 139.75 40.42 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.276 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -121.17 104.97 10.16 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.7 t -126.86 110.07 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.997 179.909 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 76.9 p . . . . . 0 N--CA 1.491 1.598 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.976 -179.979 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 C--O 1.216 -0.611 0 CA-C-O 121.335 0.473 . . . . 0.0 112.176 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 88' ' ' ILE . 14.1 tt -142.15 137.44 29.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.204 179.912 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 p -127.73 158.55 37.33 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.298 -0.961 . . . . 0.0 112.15 -179.827 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 90' ' ' ILE . 10.4 pt -153.44 148.22 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.883 -179.978 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.95 156.9 16.62 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.161 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -172.38 138.49 0.93 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.444 ' H ' ' NE ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -80.64 118.62 22.36 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.32 -179.943 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 116.292 -1.813 . . . . 0.0 110.64 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.669 HD22 ' HA ' ' A' ' 22' ' ' TRP . 7.2 mp . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 110.494 -0.187 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 179.06 -171.69 0.14 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 117.894 -1.523 . . . . 0.0 112.506 -179.802 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.3 t -83.75 141.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.471 179.892 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.66 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 3.4 p -99.52 -14.37 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.112 -179.983 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 166.66 178.4 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.958 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.74 108.94 2.96 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -62.57 161.14 29.24 Favored Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.051 179.936 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.8 -3.2 1.37 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 121.031 1.154 . . . . 0.0 111.029 -179.944 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 14' ' ' THR . 15.7 p -153.19 37.24 0.48 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.247 -179.891 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.8 155.48 0.57 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.451 179.948 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.6 130.78 55.28 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.704 -179.913 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -114.32 107.29 15.38 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.269 -179.962 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.442 HG21 HD13 ' A' ' 20' ' ' ILE . 5.0 pt -97.94 168.65 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 119.091 -1.044 . . . . 0.0 110.336 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.56 130.85 9.54 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.187 179.978 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.669 ' HA ' HD22 ' A' ' 8' ' ' LEU . 6.0 p90 . . . . . 0 C--O 1.215 -0.745 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.974 179.855 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.486 HG13 HG22 ' A' ' 76' ' ' THR . 87.0 t . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 120.687 0.28 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -64.66 0.8 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.393 179.98 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.97 166.93 15.1 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.639 179.974 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.35 160.01 24.92 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -143.71 112.42 6.55 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.415 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.3 mp -102.77 124.67 56.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.298 -179.956 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.559 HG22 ' CB ' ' A' ' 47' ' ' GLU . 71.7 p -121.53 134.09 55.03 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.767 179.915 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.568 ' CE2' HG11 ' A' ' 45' ' ' VAL . 5.3 p90 -137.01 162.9 32.04 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.094 -179.867 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 160.41 156.65 8.28 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.946 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -43.71 166.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.08 179.996 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.8 m . . . . . 0 N--CA 1.486 1.341 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.411 -179.898 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.568 HG11 ' CE2' ' A' ' 36' ' ' TYR . 39.1 t . . . . . 0 N--CA 1.478 0.929 0 CA-C-O 120.98 0.419 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.459 ' N ' HG12 ' A' ' 45' ' ' VAL . 2.4 tt0 -172.13 -164.41 0.29 Allowed 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.635 -179.948 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.559 ' CB ' HG22 ' A' ' 35' ' ' THR . 2.4 pt-20 -166.86 152.83 8.14 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.236 -179.996 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 3.1 p90 -144.43 146.52 32.52 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.4 p -91.37 168.0 11.88 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.924 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -158.22 145.14 13.11 Favored Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 119.557 -0.857 . . . . 0.0 108.991 179.972 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.36 28.47 0.08 OUTLIER 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 121.037 1.158 . . . . 0.0 112.424 179.843 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 49.11 22.84 3.46 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.095 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.84 -38.29 12.42 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.047 -179.93 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -85.22 134.14 34.16 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.729 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.2 m -91.21 -15.49 29.18 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.958 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.5 p -127.37 165.95 18.78 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.232 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.459 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -149.69 137.36 20.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.732 -179.975 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.3 m -118.27 107.27 13.7 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.635 179.869 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.21 164.18 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.973 -179.861 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 t -146.84 177.3 9.23 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.02 179.97 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.45 8.02 50.4 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.307 -179.939 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.26 -160.97 0.74 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.019 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -148.14 112.8 3.84 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.237 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.7 156.8 40.72 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 120.555 0.837 . . . . 0.0 111.744 -179.954 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.09 52.18 1.66 Allowed Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.598 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 p -170.71 154.86 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.95 133.41 56.07 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.517 179.923 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 92' ' ' TYR . 0.2 OUTLIER -133.02 139.69 47.35 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.731 -179.87 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.9 m -122.53 136.79 54.97 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.629 179.907 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.08 161.0 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.7 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.49 146.85 30.68 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.503 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.4 m -132.52 135.59 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.264 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -117.56 131.03 56.75 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.213 -179.998 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.38 101.02 7.66 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.959 -179.997 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.45 126.46 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.813 -179.917 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.486 HG22 HG13 ' A' ' 29' ' ' VAL . 30.1 p . . . . . 0 N--CA 1.487 1.419 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.019 179.923 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo . . . . . 0 C--O 1.214 -0.707 0 CA-C-O 121.016 0.34 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.0 tt -150.08 155.13 8.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.011 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.7 p -129.31 145.77 51.31 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.481 -179.9 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -146.61 139.0 19.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.057 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -98.08 134.79 40.68 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.07 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 68' ' ' TYR . 31.9 t80 -146.96 129.75 16.16 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.558 179.999 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.6 132.32 36.97 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.796 -179.923 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 116.354 -1.784 . . . . 0.0 110.631 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 120.873 0.368 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -175.85 176.12 1.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.265 179.961 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.523 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 2.4 t -96.8 116.67 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.395 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.652 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -92.15 -4.55 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.878 179.992 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 168.74 148.99 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.588 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.57 137.47 15.4 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.246 -179.861 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.515 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.9 OUTLIER -148.81 155.26 41.06 Favored Pre-proline 0 C--N 1.301 -1.503 0 C-N-CA 119.564 -0.855 . . . . 0.0 109.887 179.908 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.77 5.39 0.12 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.098 1.199 . . . . 0.0 112.163 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.515 ' H ' ' C ' ' A' ' 14' ' ' THR . 49.0 p -144.63 14.78 1.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.801 -179.939 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.41 139.64 0.19 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.165 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.88 121.23 24.85 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.586 -179.973 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.36 105.05 14.8 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.776 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 20' ' ' ILE . 1.4 pt -109.09 167.29 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 118.93 -1.108 . . . . 0.0 113.561 -179.641 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.48 135.35 35.06 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.389 -1.732 . . . . 0.0 107.206 179.805 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.62 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 44.7 p90 . . . . . 0 N--CA 1.506 2.345 0 C-N-CA 118.11 -1.436 . . . . 0.0 113.657 -179.809 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.721 0.296 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.497 ' HE ' ' CA ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -77.14 -64.86 1.04 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.176 179.797 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.7 158.2 33.77 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.279 179.718 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.62 ' CE2' ' CD1' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -116.2 125.51 52.36 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.916 179.97 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.578 ' NH1' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -106.5 99.18 8.77 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.397 -179.922 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mp -96.17 135.46 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.459 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -138.96 138.34 37.22 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.749 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 1.6 p90 -138.57 153.78 48.7 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.824 -1.15 . . . . 0.0 111.836 -179.958 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.462 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . 171.86 142.7 3.81 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.34 155.05 7.37 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.962 -179.974 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.305 -1.331 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.096 179.981 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.462 HG23 ' HA2' ' A' ' 37' ' ' GLY . 62.4 t . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.688 0.28 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -173.55 -168.25 0.43 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.445 -1.302 . . . . 0.0 112.265 -179.932 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -166.16 177.66 6.8 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.655 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -173.69 155.79 2.76 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.202 179.792 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.456 HG22 ' CD ' ' A' ' 33' ' ' ARG . 33.2 p -104.15 159.48 15.65 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.356 -179.983 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.504 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -151.91 154.65 33.03 Favored Pre-proline 0 C--N 1.306 -1.311 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.712 179.769 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.48 12.94 0.09 OUTLIER 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.173 1.248 . . . . 0.0 112.132 179.944 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 59.25 23.13 57.25 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.111 -1.519 . . . . 0.0 109.849 -179.952 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.14 -47.23 13.75 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.897 -179.975 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -84.51 133.18 34.47 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.779 179.918 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.0 m -80.67 -8.12 59.54 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.223 179.989 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.3 p -134.91 -174.12 3.51 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.091 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.99 146.09 9.14 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.989 -179.997 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -108.02 110.67 22.43 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.726 -179.924 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 mt -108.97 144.48 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.024 179.974 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.3 m -148.28 110.04 4.49 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.224 -179.946 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.51 -11.42 0.03 OUTLIER Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.126 -1.511 . . . . 0.0 110.88 179.992 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.603 HD23 ' N ' ' A' ' 62' ' ' LEU . 1.4 pt? -68.28 -164.07 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.947 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.626 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 5.1 ttpt -176.06 -42.29 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.801 -179.946 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.626 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 5.6 Cg_endo -81.36 -169.22 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.457 1.438 . . . . 0.0 111.985 -179.907 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -148.29 83.62 0.18 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.91 HG22 ' H ' ' A' ' 67' ' ' ASP . 10.9 p -142.78 -173.88 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.534 -179.716 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.91 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -56.83 99.66 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.639 179.998 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -97.77 120.83 38.86 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.59 179.891 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.4 m -95.73 124.47 39.76 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.806 -179.925 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.489 ' CG1' ' N ' ' A' ' 71' ' ' THR . 3.9 tt -112.08 157.38 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.13 179.857 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.489 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -154.96 136.22 14.02 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.194 -179.955 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.4 m -131.88 117.34 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.648 179.832 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -93.5 111.66 23.38 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.152 -179.958 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.5 96.81 9.25 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.85 -1.14 . . . . 0.0 110.636 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.578 HG21 ' NH1' ' A' ' 33' ' ' ARG . 9.3 t -93.77 129.43 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.966 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 20.8 p . . . . . 0 N--CA 1.489 1.512 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.039 -179.933 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo . . . . . 0 C--O 1.214 -0.696 0 N-CA-C 111.578 -0.201 . . . . 0.0 111.578 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 88' ' ' ILE . 7.7 tt -135.01 144.63 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.443 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.3 p -137.07 133.01 34.94 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.133 -179.957 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.37 148.52 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.14 179.954 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.539 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -98.11 152.63 19.13 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.534 179.951 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -155.28 140.56 17.62 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.372 -179.963 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.99 98.32 11.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 119.342 -0.943 . . . . 0.0 109.873 179.917 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 116.476 -1.725 . . . . 0.0 110.787 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 120.864 0.364 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.1 t -74.43 126.87 31.66 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.471 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -170.56 27.46 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 118.602 -1.239 . . . . 0.0 112.028 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.513 ' N ' ' CD ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -86.35 -43.43 0.58 Allowed Pre-proline 0 N--CA 1.491 1.575 0 C-N-CA 118.135 -1.426 . . . . 0.0 111.796 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 4' ' ' VAL . 19.7 Cg_endo -91.01 111.96 0.36 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 121.459 1.439 . . . . 0.0 111.024 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -171.5 157.79 4.95 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 118.415 -1.314 . . . . 0.0 112.183 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 t70 67.65 33.89 4.76 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.672 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.436 ' N ' ' OE2' ' A' ' 9' ' ' GLU . 1.5 mp -88.0 105.85 17.74 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.809 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.436 ' OE2' ' N ' ' A' ' 8' ' ' LEU . 7.4 mp0 -147.87 168.47 22.12 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.526 -0.869 . . . . 0.0 111.14 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 74.6 t -100.41 133.01 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.767 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -88.12 -35.62 8.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 118.706 -1.197 . . . . 0.0 110.863 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 174.64 170.98 0.24 Allowed 'General case' 0 C--N 1.295 -1.769 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.162 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.66 167.68 12.65 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.534 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.28 161.64 29.13 Favored Pre-proline 0 C--N 1.3 -1.561 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.246 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.488 ' C ' HG23 ' A' ' 16' ' ' THR . 14.0 Cg_exo -45.41 103.86 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 120.684 0.923 . . . . 0.0 111.123 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.488 HG23 ' C ' ' A' ' 15' ' ' PRO . 3.1 p 59.25 49.21 9.33 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.905 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.8 p -171.93 137.22 0.95 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.662 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.469 ' O ' HD12 ' A' ' 19' ' ' LEU . 1.9 tp -130.35 147.99 52.12 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.767 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 18' ' ' LEU . 6.8 mp -119.47 114.13 21.82 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.54 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -110.01 147.66 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.225 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.51 137.57 28.58 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.046 -1.062 . . . . 0.0 111.296 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.456 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 11.8 p90 -130.76 -135.25 0.21 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.458 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.456 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 34.9 t70 -135.34 168.78 18.56 Favored 'General case' 0 N--CA 1.504 2.264 0 C-N-CA 118.558 -1.257 . . . . 0.0 112.952 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.45 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -149.75 93.79 3.93 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.578 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.588 ' HB2' HG22 ' A' ' 27' ' ' VAL . 10.9 Cg_exo -53.64 178.47 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 120.799 0.999 . . . . 0.0 112.524 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.62 -17.6 44.14 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.059 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.588 HG22 ' HB2' ' A' ' 25' ' ' PRO . 19.3 m -58.81 127.69 18.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 118.304 -1.359 . . . . 0.0 109.816 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.44 88.75 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 C-N-CA 118.874 -1.13 . . . . 0.0 110.195 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.858 HG13 HG22 ' A' ' 76' ' ' THR . 2.2 t -73.71 131.06 35.5 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.552 -0.859 . . . . 0.0 110.646 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -68.78 0.16 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.692 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.79 164.29 28.97 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.177 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -113.74 158.78 20.5 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.895 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.486 ' CG ' ' OE2' ' A' ' 47' ' ' GLU . 2.9 ttt180 -139.33 105.48 5.23 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.064 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.832 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.7 mp -96.76 120.31 45.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.169 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.403 HG22 ' OE2' ' A' ' 47' ' ' GLU . 22.0 p -126.65 137.19 53.26 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.561 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.453 ' CE2' HG11 ' A' ' 45' ' ' VAL . 6.9 p90 -142.16 155.95 45.33 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 118.741 -1.184 . . . . 0.0 110.427 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.72 137.41 4.75 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.421 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.35 132.97 40.07 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.681 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.5 m -50.56 123.19 8.31 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.742 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.73 -54.67 0.09 OUTLIER Glycine 0 N--CA 1.488 2.123 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.111 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.04 -1.33 64.98 Favored Glycine 0 N--CA 1.489 2.206 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.866 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.03 -35.91 72.18 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.665 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.8 t 177.99 136.31 0.23 Allowed Pre-proline 0 C--N 1.304 -1.384 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.19 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.8 145.85 96.93 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 120.579 0.853 . . . . 0.0 110.91 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 46' ' ' GLN . 49.7 t -73.78 -77.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 118.738 -1.185 . . . . 0.0 110.859 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.482 ' N ' HG12 ' A' ' 45' ' ' VAL . 2.2 tt0 -167.6 171.86 9.9 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 117.979 -1.488 . . . . 0.0 112.499 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.486 ' OE2' ' CG ' ' A' ' 33' ' ' ARG . 0.8 OUTLIER -150.78 159.56 44.45 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.157 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 11.7 p90 -160.22 136.63 8.82 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 118.423 -1.311 . . . . 0.0 111.523 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.0 p -92.66 159.73 15.32 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.431 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.53 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -152.08 142.96 15.47 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.178 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.71 29.9 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 120.953 1.102 . . . . 0.0 112.387 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 57.42 13.56 11.2 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.251 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.44 -31.08 37.57 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.012 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -92.53 119.27 31.84 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.9 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.91 -21.73 34.1 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.373 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.4 p -119.54 -178.9 3.72 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.891 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -167.58 143.66 4.12 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.581 -1.248 . . . . 0.0 111.706 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.2 m -110.8 112.2 23.9 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.726 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.92 140.8 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.466 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.9 m -145.54 163.89 33.33 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.466 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.13 10.83 33.4 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.769 HD23 ' H ' ' A' ' 62' ' ' LEU . 1.6 pt? -91.98 -177.28 4.66 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.885 -0.726 . . . . 0.0 111.264 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.56 110.29 40.84 Favored Pre-proline 0 N--CA 1.49 1.569 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.047 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.66 137.53 80.67 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 120.599 0.866 . . . . 0.0 111.816 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.09 60.32 1.86 Allowed Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.544 -1.312 . . . . 0.0 109.999 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 p -169.51 156.9 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.471 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -74.99 142.38 43.87 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.081 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -137.89 130.19 29.15 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.124 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.57 125.97 49.48 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.509 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 tt -115.93 148.46 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.475 HG23 ' OG ' ' A' ' 89' ' ' SER . 25.8 m -145.5 121.48 10.69 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.338 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 72' ' ' VAL . 6.6 m -108.41 122.12 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.434 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.49 101.94 11.43 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.278 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.448 ' O ' ' CB ' ' A' ' 85' ' ' SER . . . -95.06 113.28 24.95 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.403 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.7 t -107.54 128.4 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.225 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.858 HG22 HG13 ' A' ' 29' ' ' VAL . 29.1 p -122.66 165.2 16.89 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.58 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -171.82 152.53 17.68 Favored Glycine 0 N--CA 1.489 2.197 0 C-N-CA 119.011 -1.566 . . . . 0.0 110.671 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.32 -22.17 19.87 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.039 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -172.57 -47.11 0.04 OUTLIER Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.327 -1.416 . . . . 0.0 110.823 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.435 ' H ' ' H ' ' A' ' 81' ' ' SER . 4.7 p-10 -173.94 -4.69 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.281 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -56.99 163.33 3.0 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 119.106 -1.038 . . . . 0.0 111.013 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 84' ' ' SER . 5.7 Cg_endo -68.07 30.14 0.14 Allowed 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 121.605 1.537 . . . . 0.0 111.569 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 81' ' ' SER . . . -49.05 91.34 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.871 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 82' ' ' PRO . 75.5 m -89.94 137.39 32.38 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.5 -0.88 . . . . 0.0 109.783 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 74' ' ' ALA . 3.2 t -96.6 -158.12 0.64 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.929 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -128.41 92.6 40.63 Favored Pre-proline 0 N--CA 1.485 1.317 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.19 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.91 158.19 58.42 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 120.75 0.967 . . . . 0.0 111.063 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 15.4 tt -147.41 150.51 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 118.654 -1.218 . . . . 0.0 110.896 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.475 ' OG ' HG23 ' A' ' 71' ' ' THR . 0.7 OUTLIER -139.52 150.42 45.09 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.099 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 pt -152.34 141.87 14.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.674 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -93.19 145.53 24.36 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.256 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -156.25 140.71 16.77 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.843 -1.143 . . . . 0.0 111.218 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -84.05 118.98 24.41 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.691 -0.804 . . . . 0.0 110.26 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.769 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.181 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 m -102.19 162.03 13.23 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.671 -0.811 . . . . 0.0 110.616 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -153.47 69.26 0.81 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.117 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.3 t -64.96 134.72 96.15 Favored Pre-proline 0 C--N 1.306 -1.3 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.827 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -58.07 -178.95 0.11 Allowed 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 120.466 0.777 . . . . 0.0 111.202 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.484 ' CZ ' ' OD2' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -172.96 170.87 4.38 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.46 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.484 ' OD2' ' CZ ' ' A' ' 6' ' ' ARG . 15.1 m-20 57.75 53.98 6.65 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.398 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.9 mp -98.77 114.78 27.47 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.533 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.441 ' OE2' ' N ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -170.12 176.89 4.45 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.26 -1.376 . . . . 0.0 112.362 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.0 t -95.66 129.95 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.448 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.2 m -101.77 -6.5 9.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.774 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.75 161.21 11.03 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.779 -1.168 . . . . 0.0 111.81 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.85 129.14 8.21 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.318 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.88 165.12 36.15 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.476 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.461 ' O ' ' CB ' ' A' ' 16' ' ' THR . 3.2 Cg_exo -53.11 104.31 0.1 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.198 1.265 . . . . 0.0 111.94 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.7 OUTLIER 77.91 34.48 0.32 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.13 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -169.46 126.42 0.91 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.672 -1.211 . . . . 0.0 111.716 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 tp -125.58 126.9 45.53 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.1 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 16.4 tp -103.5 114.05 28.03 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.469 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.47 159.31 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.596 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.77 145.91 17.51 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.659 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.528 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 13.7 p90 -135.5 -155.21 0.62 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 119.189 -1.004 . . . . 0.0 111.452 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.528 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 31.2 t70 -106.95 176.42 5.18 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.777 ' HB2' ' OG ' ' A' ' 55' ' ' SER . . . -175.38 106.65 0.26 Allowed Pre-proline 0 N--CA 1.488 1.468 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.318 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.493 ' HB2' HG12 ' A' ' 27' ' ' VAL . 3.3 Cg_exo -61.63 -171.62 0.09 OUTLIER 'Trans proline' 0 C--O 1.215 -0.659 0 CA-C-N 118.81 0.611 . . . . 0.0 111.753 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.13 -7.51 39.12 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.775 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.549 ' CG2' ' N ' ' A' ' 28' ' ' THR . 2.0 p -60.0 163.43 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 118.736 -1.185 . . . . 0.0 110.687 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.549 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 0.3 OUTLIER -74.78 109.54 8.34 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.035 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.79 139.02 36.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.137 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.523 ' NE ' ' OH ' ' A' ' 31' ' ' TYR . 2.2 mtt180 -69.93 -75.63 0.11 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.795 -1.162 . . . . 0.0 110.419 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.523 ' OH ' ' NE ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -153.84 167.68 28.85 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.931 -1.108 . . . . 0.0 111.604 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -123.85 156.04 36.93 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.146 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.522 ' HE ' HG22 ' A' ' 49' ' ' THR . 38.7 ttm180 -140.31 110.12 6.42 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.678 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.1 mp -95.14 123.49 47.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.904 -1.043 . . . . 0.0 111.338 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 p -125.58 132.12 52.59 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.711 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.55 ' OH ' ' CE2' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -144.77 167.62 22.15 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.338 -1.345 . . . . 0.0 112.484 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.77 159.14 17.37 Favored Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -56.6 160.74 3.09 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.047 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 m -66.48 162.62 20.27 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.724 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.82 -57.99 0.45 Allowed Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.891 -1.147 . . . . 0.0 110.246 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.68 41.84 5.58 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.266 -1.445 . . . . 0.0 110.422 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -126.58 -5.08 6.48 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.021 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.8 p -170.43 74.23 0.6 Allowed Pre-proline 0 C--N 1.303 -1.419 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.788 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.9 144.27 99.48 Favored 'Trans proline' 0 C--N 1.322 -0.848 0 C-N-CA 121.106 1.204 . . . . 0.0 111.477 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.56 HG12 ' N ' ' A' ' 46' ' ' GLN . 13.8 t -66.53 -74.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.509 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.631 ' NE2' ' H ' ' A' ' 47' ' ' GLU . 50.5 tp60 -171.47 162.92 6.74 Favored 'General case' 0 C--N 1.292 -1.907 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.843 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.631 ' H ' ' NE2' ' A' ' 46' ' ' GLN . 5.0 pt-20 -147.63 148.17 30.79 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.576 -0.849 . . . . 0.0 110.949 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.55 ' CE2' ' OH ' ' A' ' 36' ' ' TYR . 0.9 OUTLIER -147.84 170.97 16.47 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 118.864 -1.134 . . . . 0.0 111.421 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.522 HG22 ' HE ' ' A' ' 33' ' ' ARG . 50.2 p -104.89 174.26 5.95 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.883 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.571 ' C ' ' H ' ' A' ' 52' ' ' GLY . 11.3 p -165.79 137.66 3.18 Favored Pre-proline 0 CA--C 1.564 1.503 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.163 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 53' ' ' SER . 5.2 Cg_exo -56.0 14.19 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 121.216 1.277 . . . . 0.0 113.731 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.571 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 54.02 9.24 1.28 Allowed Glycine 0 N--CA 1.495 2.623 0 C-N-CA 119.36 -1.4 . . . . 0.0 111.119 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -72.42 -41.05 66.63 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 118.969 -1.092 . . . . 0.0 110.287 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -118.83 116.31 26.24 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.075 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.777 ' OG ' ' HB2' ' A' ' 24' ' ' ALA . 2.1 m -79.85 58.24 2.8 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.172 -1.011 . . . . 0.0 111.105 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.6 p -154.28 148.35 25.75 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.371 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -165.16 150.68 9.54 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.1 t -117.31 145.56 43.92 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.759 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -135.69 133.8 51.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.41 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.5 m -130.6 165.59 22.45 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.581 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 84.44 49.22 4.73 Favored Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.169 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.29 -155.19 0.63 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.636 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.6 99.1 17.36 Favored Pre-proline 0 N--CA 1.493 1.71 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.08 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.97 145.14 94.25 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.757 0.971 . . . . 0.0 111.593 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.92 49.97 4.83 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.668 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.3 p -159.02 152.92 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 119.17 -1.012 . . . . 0.0 111.393 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.13 151.33 31.49 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.109 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.17 121.22 8.84 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.933 -1.107 . . . . 0.0 111.695 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 m -105.78 121.2 43.55 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.646 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.6 pp -110.18 158.46 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.569 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 55.0 m -153.18 123.19 6.95 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.067 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.5 m -108.63 141.93 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.514 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -112.38 105.65 13.98 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.844 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -86.74 94.6 9.56 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.063 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -89.6 112.44 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.872 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.76 165.01 28.11 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.502 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.06 107.47 0.22 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.007 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 -59.54 -58.49 8.35 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.252 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.99 37.68 0.02 OUTLIER Glycine 0 N--CA 1.487 2.069 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.884 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -137.58 -103.98 0.19 Allowed 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.984 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.566 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -92.56 -43.14 0.35 Allowed Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 119.518 -0.873 . . . . 0.0 112.597 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.566 ' CD ' ' N ' ' A' ' 81' ' ' SER . 5.6 Cg_exo -65.21 107.45 0.97 Allowed 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 121.116 1.211 . . . . 0.0 112.086 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.44 -78.14 0.54 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.917 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.8 m -54.62 164.38 0.76 Allowed 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.255 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.1 m -116.63 179.41 4.02 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 113.247 0.832 . . . . 0.0 113.247 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -134.17 74.41 67.78 Favored Pre-proline 0 N--CA 1.484 1.273 0 CA-C-N 114.174 -1.375 . . . . 0.0 108.12 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -54.79 168.69 1.04 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 121.841 1.694 . . . . 0.0 113.9 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.9 tt -150.43 157.59 5.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.573 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.9 p -144.83 160.69 40.87 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.563 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.97 145.57 16.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.526 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.605 ' ND2' ' N ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -91.48 144.73 25.26 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.639 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.605 ' N ' ' ND2' ' A' ' 91' ' ' ASN . 57.8 t80 -161.3 135.73 7.12 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.838 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -88.79 132.58 34.57 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.194 -1.003 . . . . 0.0 110.205 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 116.258 -1.83 . . . . 0.0 110.818 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.63 ' O ' HG12 ' A' ' 1' ' ' VAL . 95.4 t . . . . . 0 N--CA 1.483 1.197 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 3' ' ' ASP . 8.9 p 48.15 -150.4 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.658 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.47 ' N ' ' OG ' ' A' ' 2' ' ' SER . 44.8 t0 -144.65 -71.65 0.27 Allowed 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.589 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 4' ' ' VAL . 47.7 t -131.95 51.88 8.14 Favored Pre-proline 0 N--CA 1.49 1.55 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 4' ' ' VAL . 8.8 Cg_endo -67.42 79.56 0.45 Allowed 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 120.947 1.098 . . . . 0.0 110.209 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.435 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 2.3 mtm180 -147.21 -154.0 0.52 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.012 -1.075 . . . . 0.0 112.049 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 6.6 t0 72.75 14.34 5.01 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.711 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 mt -57.38 134.6 56.17 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.484 -0.887 . . . . 0.0 110.27 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -169.3 146.01 3.43 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.124 -1.031 . . . . 0.0 111.112 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 73.0 t -85.32 116.17 28.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.736 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 14.8 t -90.27 -18.82 7.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.768 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.39 159.0 4.5 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.094 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.37 81.41 1.12 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.445 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -77.72 160.62 74.1 Favored Pre-proline 0 N--CA 1.485 1.297 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.541 -179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -62.92 3.83 0.48 Allowed 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.344 1.363 . . . . 0.0 111.779 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.441 ' H ' ' C ' ' A' ' 14' ' ' THR . 1.8 m -152.91 25.3 0.56 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 118.895 -1.122 . . . . 0.0 111.9 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.17 131.74 0.08 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.954 -1.099 . . . . 0.0 111.287 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.7 tp -115.72 136.24 53.25 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.52 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.33 116.71 26.77 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.475 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.2 pt -111.28 158.59 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 119.93 -0.708 . . . . 0.0 111.174 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.13 133.52 16.47 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.92 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.624 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 6.3 p90 -138.07 -146.55 0.22 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.252 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.624 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 32.1 t70 -98.42 174.8 6.29 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.036 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.482 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -172.28 90.93 0.41 Allowed Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 119.709 -0.796 . . . . 0.0 110.717 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -61.33 156.18 47.55 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.915 1.077 . . . . 0.0 111.36 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.72 9.02 40.52 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.626 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.906 HG22 ' H ' ' A' ' 28' ' ' THR . 8.9 p -64.19 -175.0 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.461 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.906 ' H ' HG22 ' A' ' 27' ' ' VAL . 3.2 m -73.44 76.81 1.41 Allowed 'General case' 0 C--N 1.286 -2.192 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.933 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.579 HG13 HG22 ' A' ' 76' ' ' THR . 13.2 t -93.1 144.77 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.684 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.537 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -87.48 -73.53 0.47 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 118.961 -1.095 . . . . 0.0 110.828 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.537 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 2.5 m-85 -146.58 167.5 23.57 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.975 -1.09 . . . . 0.0 111.976 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -131.01 145.39 52.03 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 114.024 -1.444 . . . . 0.0 108.65 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.486 ' C ' HD12 ' A' ' 34' ' ' ILE . 14.1 ttm180 -132.59 121.39 23.15 Favored 'General case' 0 N--CA 1.508 2.44 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.137 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.741 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.7 mp -97.48 102.58 13.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.715 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.688 HG22 ' HB2' ' A' ' 47' ' ' GLU . 69.9 p -109.61 129.95 55.55 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 12.6 p90 -140.52 165.06 28.49 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.78 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.451 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . 168.6 165.02 25.29 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.867 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -66.29 146.39 54.65 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.381 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 39' ' ' THR . 24.4 m -75.88 0.76 17.11 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.595 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.88 54.68 0.56 Allowed Glycine 0 N--CA 1.5 2.932 0 C-N-CA 119.574 -1.298 . . . . 0.0 111.316 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 43' ' ' SER . . . 173.98 131.8 1.45 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 118.749 -1.691 . . . . 0.0 111.247 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -75.16 12.8 0.82 Allowed 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.127 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.478 ' H ' ' C ' ' A' ' 41' ' ' GLY . 15.5 t -129.52 86.73 55.07 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.476 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -58.96 162.63 13.06 Favored 'Trans proline' 0 C--O 1.213 -0.726 0 C-N-CA 120.793 0.995 . . . . 0.0 112.029 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 46' ' ' GLN . 36.4 t -49.44 -73.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.29 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.501 ' N ' HG12 ' A' ' 45' ' ' VAL . 3.5 tt0 -169.08 -159.06 0.22 Allowed 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.987 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.688 ' HB2' HG22 ' A' ' 35' ' ' THR . 7.1 pt-20 -170.12 161.16 8.42 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.189 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 7.2 p90 -152.68 140.27 19.79 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.636 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 50.8 p -82.8 174.05 11.31 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.541 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.599 HG13 ' H ' ' A' ' 52' ' ' GLY . 5.6 p -166.21 139.23 3.3 Favored Pre-proline 0 C--N 1.305 -1.351 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.949 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 53' ' ' SER . 2.0 Cg_endo -62.5 28.3 0.06 OUTLIER 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 121.0 1.134 . . . . 0.0 112.916 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.599 ' H ' HG13 ' A' ' 50' ' ' VAL . . . 48.55 11.06 0.14 Allowed Glycine 0 N--CA 1.493 2.485 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.996 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.491 ' N ' ' O ' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -76.84 -38.92 52.88 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.57 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -93.12 131.06 38.5 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.494 -0.883 . . . . 0.0 110.622 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -84.83 -1.24 56.2 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.441 -0.904 . . . . 0.0 111.294 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 61.5 p -120.11 167.84 11.81 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.722 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -150.13 136.24 18.69 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.236 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.6 m -99.69 145.8 27.22 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.904 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.8 mt -144.32 149.19 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.616 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.4 174.45 10.91 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.75 64.64 3.55 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.605 -1.283 . . . . 0.0 110.784 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.441 HD12 ' H ' ' A' ' 63' ' ' LYS . 0.4 OUTLIER -120.01 -125.17 0.28 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.782 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.441 ' H ' HD12 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -170.84 121.72 0.53 Allowed Pre-proline 0 CA--C 1.56 1.334 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.192 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -65.58 142.91 73.11 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 120.566 0.844 . . . . 0.0 112.075 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.18 80.92 0.09 OUTLIER Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.966 -1.111 . . . . 0.0 111.387 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.446 ' CG1' ' CE2' ' A' ' 68' ' ' TYR . 7.5 p -170.4 152.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.538 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -82.48 108.65 16.05 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.879 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.446 ' CE2' ' CG1' ' A' ' 66' ' ' VAL . 4.6 m-85 -105.4 130.68 53.45 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.85 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.73 119.09 35.69 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.012 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 5.2 tp -98.3 137.38 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.235 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.558 HG23 ' HB3' ' A' ' 89' ' ' SER . 82.3 m -139.35 127.77 22.87 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.073 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.2 m -118.33 151.59 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.459 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -115.89 133.32 56.15 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.009 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.53 84.36 2.19 Favored 'General case' 0 N--CA 1.485 1.306 0 O-C-N 123.795 0.685 . . . . 0.0 109.466 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.2 t -95.3 124.81 48.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.584 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.579 HG22 HG13 ' A' ' 29' ' ' VAL . 4.4 p -141.58 -166.18 2.14 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.876 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 160.0 116.9 0.45 Allowed Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.435 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.77 -3.33 19.18 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.7 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.58 61.56 1.23 Allowed Glycine 0 N--CA 1.489 2.195 0 C-N-CA 119.308 -1.425 . . . . 0.0 110.325 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -157.64 -43.98 0.07 Allowed 'General case' 0 C--N 1.29 -2.006 0 C-N-CA 119.594 -0.842 . . . . 0.0 110.666 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.07 164.71 31.83 Favored Pre-proline 0 N--CA 1.487 1.393 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.979 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 84' ' ' SER . 2.3 Cg_endo -58.01 99.4 0.1 OUTLIER 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 121.088 1.192 . . . . 0.0 111.248 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' A' ' 85' ' ' SER . . . -52.02 -8.95 0.08 Allowed 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.003 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 82' ' ' PRO . 9.3 t -67.68 74.0 0.17 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.919 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 83' ' ' ALA . 0.8 OUTLIER -76.8 -150.5 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.282 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.78 153.1 31.32 Favored Pre-proline 0 C--N 1.31 -1.125 0 C-N-CA 118.755 -1.178 . . . . 0.0 111.16 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -69.05 -178.98 2.3 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 121.694 1.596 . . . . 0.0 112.441 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.3 tt -158.38 139.63 4.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.611 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.558 ' HB3' HG23 ' A' ' 71' ' ' THR . 63.3 p -149.69 166.84 28.16 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 118.216 -1.394 . . . . 0.0 113.039 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 pt -154.42 150.7 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 CA-C-N 114.503 -1.226 . . . . 0.0 109.524 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.602 ' ND2' ' H ' ' A' ' 91' ' ' ASN . 0.0 OUTLIER -82.81 141.23 32.47 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.281 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -146.59 120.91 9.59 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.763 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -85.48 116.51 23.83 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.567 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 116.355 -1.783 . . . . 0.0 111.096 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 1' ' ' VAL . 1.4 p . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.831 0.348 . . . . 0.0 110.071 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.44 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 3.5 p -158.93 98.0 1.44 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.049 -1.06 . . . . 0.0 111.318 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 2' ' ' SER . 2.5 m-20 -141.23 -25.64 0.72 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.264 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.425 ' O ' ' O ' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -68.04 144.49 97.07 Favored Pre-proline 0 C--N 1.299 -1.629 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.467 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 4' ' ' VAL . 2.8 Cg_exo -51.39 -178.07 0.02 OUTLIER 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 120.621 0.881 . . . . 0.0 109.817 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -170.03 168.83 8.35 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 117.506 -1.677 . . . . 0.0 113.585 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 31.39 81.21 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.157 -1.383 . . . . 0.0 113.863 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 mp -101.54 150.18 23.34 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -169.9 168.06 8.88 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 117.499 -1.68 . . . . 0.0 112.963 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.0 t -96.23 111.52 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.374 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.648 HG23 ' OG ' ' A' ' 21' ' ' SER . 24.7 t -77.82 -9.5 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.25 -0.98 . . . . 0.0 111.58 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.639 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 169.94 168.03 0.06 Allowed 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 118.811 -1.156 . . . . 0.0 111.441 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.34 147.59 27.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.811 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.62 161.13 30.11 Favored Pre-proline 0 C--N 1.305 -1.34 0 C-N-CA 118.895 -1.122 . . . . 0.0 110.461 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.585 ' C ' HG23 ' A' ' 16' ' ' THR . 3.6 Cg_exo -51.29 111.88 0.67 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 120.97 1.113 . . . . 0.0 111.083 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.585 HG23 ' C ' ' A' ' 15' ' ' PRO . 1.6 p 64.51 37.92 7.74 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.83 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.92 128.29 1.64 Allowed 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.662 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.4 HD11 HG21 ' A' ' 94' ' ' THR . 0.4 OUTLIER -130.33 145.47 51.79 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.335 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.17 109.77 15.82 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.065 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -109.12 146.69 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.145 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.648 ' OG ' HG23 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -142.68 131.05 22.22 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.693 -0.803 . . . . 0.0 110.398 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.598 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 5.5 p90 -136.32 -143.66 0.19 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.497 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.598 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 15.2 t70 -141.7 162.9 34.34 Favored 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 118.419 -1.312 . . . . 0.0 112.815 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.449 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -135.63 127.45 17.54 Favored Pre-proline 0 CA--C 1.558 1.266 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.922 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -59.13 -178.48 0.14 Allowed 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 120.471 0.781 . . . . 0.0 111.679 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.32 -19.79 19.67 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.101 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -59.76 160.95 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 119.361 -0.935 . . . . 0.0 110.666 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.0 m -74.6 74.38 2.0 Allowed 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.614 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 t -69.43 128.23 32.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.201 -0.999 . . . . 0.0 110.998 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.444 ' H ' ' HA ' ' A' ' 76' ' ' THR . 9.3 ttt180 -55.15 -60.47 3.34 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.092 -1.043 . . . . 0.0 110.037 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -168.95 170.16 9.19 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 118.424 -1.311 . . . . 0.0 112.746 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.05 144.32 48.98 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.189 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -118.34 109.53 16.4 Favored 'General case' 0 N--CA 1.509 2.494 0 C-N-CA 118.999 -1.081 . . . . 0.0 110.244 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.2 mp -96.97 113.95 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.34 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 64.2 p -113.43 142.78 45.49 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.935 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.682 ' CE2' HG11 ' A' ' 45' ' ' VAL . 6.0 p90 -146.71 151.77 37.74 Favored 'General case' 0 C--N 1.313 -0.996 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.753 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.88 164.92 19.03 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -53.5 155.79 2.81 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.765 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 m -75.38 -13.07 60.38 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.304 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.95 -92.83 0.05 OUTLIER Glycine 0 N--CA 1.491 2.326 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.544 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 143.91 -4.87 1.67 Allowed Glycine 0 N--CA 1.488 2.124 0 C-N-CA 119.608 -1.282 . . . . 0.0 109.947 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.61 2.99 4.37 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.455 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 43.2 p -176.26 74.85 0.27 Allowed Pre-proline 0 N--CA 1.485 1.294 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.834 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.64 114.44 2.39 Favored 'Trans proline' 0 C--N 1.326 -0.645 0 C-N-CA 121.23 1.287 . . . . 0.0 111.288 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.682 HG11 ' CE2' ' A' ' 36' ' ' TYR . 50.9 t -52.77 -89.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.944 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.643 ' N ' HG12 ' A' ' 45' ' ' VAL . 0.2 OUTLIER -175.99 -166.35 0.18 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.162 -1.415 . . . . 0.0 111.753 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -160.25 169.22 23.66 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.916 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.488 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 19.0 p90 -161.03 131.08 5.0 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.674 -0.811 . . . . 0.0 109.901 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.27 166.25 11.07 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.15 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -146.72 159.16 44.72 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.936 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.47 15.84 0.05 OUTLIER 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 121.135 1.223 . . . . 0.0 112.298 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 62.29 24.21 65.22 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.208 -1.473 . . . . 0.0 110.116 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.35 -36.92 11.19 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.107 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -89.83 116.3 27.81 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.8 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.63 4.42 24.89 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.167 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.68 159.43 42.0 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.474 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -164.45 164.29 21.99 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.434 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.6 m -134.02 146.82 50.74 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.479 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.426 HG21 HD13 ' A' ' 59' ' ' ILE . 0.6 OUTLIER -137.36 158.0 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.052 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 43.6 m -149.56 174.45 12.52 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.655 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 95.71 12.73 52.74 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.36 -1.4 . . . . 0.0 110.777 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.07 -158.77 0.67 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.626 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.514 ' O ' HG12 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -150.02 122.19 4.18 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.598 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -61.71 144.3 97.1 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 120.512 0.808 . . . . 0.0 111.336 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.61 50.77 4.1 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.762 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 63' ' ' LYS . 6.6 p -165.16 139.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 118.996 -1.082 . . . . 0.0 111.419 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.402 ' O ' ' OE1' ' A' ' 38' ' ' GLU . 0.2 OUTLIER -64.41 133.33 52.33 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.929 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -132.0 129.86 40.67 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.174 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.2 128.89 54.82 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.914 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 70' ' ' ILE . 4.4 tt -119.7 145.0 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.409 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 81.4 m -142.43 125.26 16.04 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.525 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -117.57 137.0 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 119.613 -0.835 . . . . 0.0 111.011 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -110.18 143.82 39.75 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.37 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.5 91.25 3.49 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.612 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 20.8 t -102.91 117.2 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.485 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.556 ' CG2' ' N ' ' A' ' 77' ' ' GLY . 14.0 t -116.57 -42.79 2.96 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.218 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.556 ' N ' ' CG2' ' A' ' 76' ' ' THR . . . -63.49 176.36 8.46 Favored Glycine 0 C--N 1.28 -2.552 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.79 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.1 mtp85 -89.47 -50.74 5.92 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.971 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -100.82 -107.75 3.0 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -163.62 -7.05 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.769 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.554 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -85.95 -42.55 0.61 Allowed Pre-proline 0 C--N 1.304 -1.406 0 C-N-CA 119.406 -0.917 . . . . 0.0 112.862 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 81' ' ' SER . 3.2 Cg_exo -66.71 -76.78 0.01 OUTLIER 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 120.843 1.029 . . . . 0.0 112.167 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.02 110.21 11.47 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.738 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 85' ' ' SER . 0.1 OUTLIER -130.48 105.87 8.15 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.955 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.435 ' O ' ' O ' ' A' ' 84' ' ' SER . 5.8 p -55.61 -162.06 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.089 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -128.68 123.74 22.28 Favored Pre-proline 0 N--CA 1.485 1.281 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.118 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -65.4 154.82 71.88 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 120.404 0.736 . . . . 0.0 110.501 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -145.4 153.45 13.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.961 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 59.9 p -151.06 153.72 35.62 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.774 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.7 143.22 21.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.732 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.09 153.64 18.03 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.316 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -169.26 135.29 1.63 Allowed 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.786 -1.166 . . . . 0.0 111.322 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -79.86 106.71 12.08 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.312 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.4 HG21 HD11 ' A' ' 18' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.887 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -176.5 161.42 2.17 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.776 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.74 84.64 0.82 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.427 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.401 ' O ' ' O ' ' A' ' 5' ' ' PRO . 72.2 t -128.23 94.24 36.65 Favored Pre-proline 0 N--CA 1.488 1.466 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.095 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HB2' ' H ' ' A' ' 6' ' ' ARG . 1.2 Cg_endo -62.69 -132.86 0.0 OUTLIER 'Trans proline' 0 CA--C 1.558 1.698 0 C-N-CA 120.436 0.757 . . . . 0.0 110.436 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.48 ' O ' ' O ' ' A' ' 22' ' ' TRP . 8.2 ptm180 -170.8 162.34 7.56 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 117.28 -1.768 . . . . 0.0 115.001 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -21.32 108.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 112.983 -1.917 . . . . 0.0 115.046 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.535 HD22 ' HA ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -51.09 120.55 5.04 Favored 'General case' 0 N--CA 1.506 2.327 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.422 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.444 ' CG ' ' N ' ' A' ' 10' ' ' VAL . 18.5 tt0 -173.03 162.19 4.54 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.534 -1.266 . . . . 0.0 112.271 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.444 ' N ' ' CG ' ' A' ' 9' ' ' GLU . 61.5 t -91.44 114.36 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.33 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.439 ' H ' HG23 ' A' ' 11' ' ' VAL . 0.5 OUTLIER -79.22 -52.45 15.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 118.825 -1.15 . . . . 0.0 111.422 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.528 ' O ' HD23 ' A' ' 18' ' ' LEU . . . -147.66 158.32 43.96 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.951 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.11 106.72 4.08 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.85 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.469 ' C ' ' H ' ' A' ' 16' ' ' THR . 1.0 OUTLIER -104.69 155.21 37.8 Favored Pre-proline 0 N--CA 1.49 1.557 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.631 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.43 3.28 0.2 Allowed 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 121.147 1.231 . . . . 0.0 112.353 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 14' ' ' THR . 3.0 m -149.38 24.11 0.91 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.859 -1.136 . . . . 0.0 111.477 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.426 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.1 OUTLIER 175.96 145.17 0.08 Allowed 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.296 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -130.46 124.64 32.47 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.387 -179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 tt -95.66 102.21 13.99 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.635 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 pp -109.68 143.5 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.649 -0.82 . . . . 0.0 112.446 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.76 139.28 53.79 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.569 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.535 ' HA ' HD22 ' A' ' 8' ' ' LEU . 46.9 p90 -119.24 180.0 4.01 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 118.125 -1.43 . . . . 0.0 113.726 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.444 ' CG ' ' N ' ' A' ' 24' ' ' ALA . 28.6 t70 -135.73 168.62 18.95 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 113.584 -1.644 . . . . 0.0 110.906 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -179.4 179.33 0.3 Allowed Pre-proline 0 N--CA 1.497 1.896 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 2.8 Cg_exo -62.78 162.0 26.8 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 120.625 0.883 . . . . 0.0 111.147 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.84 2.64 48.36 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.324 -0.951 . . . . 0.0 112.227 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.0 m -63.21 160.52 2.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.593 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 85.1 m -70.29 100.73 1.77 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.539 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.42 HG11 ' CE1' ' A' ' 32' ' ' TYR . 63.5 t -87.48 140.77 15.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.864 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.82 -43.28 13.43 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.555 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -143.34 176.12 9.39 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.818 -1.153 . . . . 0.0 112.323 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.463 ' OH ' ' HB3' ' A' ' 24' ' ' ALA . 1.6 m-85 -144.06 137.27 27.49 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.663 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -129.23 110.17 11.75 Favored 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.17 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.417 HD12 ' H ' ' A' ' 34' ' ' ILE . 4.0 mp -101.68 112.89 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.758 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.3 p -113.84 135.06 54.38 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.585 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.627 ' CE2' HG11 ' A' ' 45' ' ' VAL . 8.9 p90 -140.07 154.48 47.08 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 118.61 -1.236 . . . . 0.0 111.026 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 169.93 162.42 22.19 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 39' ' ' THR . 1.4 tm-20 -55.6 152.69 8.84 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.549 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.482 ' N ' ' CD ' ' A' ' 38' ' ' GLU . 0.9 OUTLIER -75.23 144.77 42.44 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.242 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 40.0 41.74 2.07 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 119.884 -1.151 . . . . 0.0 111.016 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -100.15 149.41 18.71 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.664 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -87.86 35.91 0.75 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.751 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 p 179.25 68.5 0.13 Allowed Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.042 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -57.32 139.51 90.3 Favored 'Trans proline' 0 C--N 1.322 -0.854 0 C-N-CA 121.121 1.214 . . . . 0.0 110.881 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.627 HG11 ' CE2' ' A' ' 36' ' ' TYR . 83.7 t -49.05 -84.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.178 -1.009 . . . . 0.0 111.67 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -172.0 -159.0 0.13 Allowed 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.578 -1.249 . . . . 0.0 111.678 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -165.71 156.63 13.62 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.802 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 3.5 p90 -146.72 154.76 41.79 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.569 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.4 p -115.69 155.98 26.75 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.738 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 52' ' ' GLY . 32.9 m -148.77 151.43 35.35 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.661 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.92 19.89 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 121.06 1.173 . . . . 0.0 112.597 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.572 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 60.22 24.63 61.34 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.474 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.61 -45.02 16.42 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.273 -0.971 . . . . 0.0 111.002 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -89.15 144.87 25.81 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.838 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 27.5 m -96.01 -12.22 25.29 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.262 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.9 p -138.35 177.3 7.98 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.399 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.11 151.61 4.01 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.824 -1.15 . . . . 0.0 111.294 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.6 m -112.65 104.05 12.11 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.982 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.37 166.82 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.262 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 9.4 t -142.97 -179.0 6.1 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.963 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.52 60.21 1.38 Allowed Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.528 -1.32 . . . . 0.0 109.952 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.93 -155.55 0.7 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.908 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -150.73 137.43 11.36 Favored Pre-proline 0 CA--C 1.562 1.432 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.054 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.64 151.94 82.71 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 120.915 1.077 . . . . 0.0 112.672 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 43.97 77.91 0.08 OUTLIER Glycine 0 N--CA 1.493 2.485 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.932 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -162.27 144.28 3.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.005 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.474 ' CG ' HD21 ' A' ' 91' ' ' ASN . 6.8 t70 -76.26 117.02 17.51 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.293 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -117.54 129.56 55.87 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.537 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.2 120.67 39.91 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.34 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 tt -111.38 146.47 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 119.866 -0.733 . . . . 0.0 110.437 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.401 ' CG2' ' OG ' ' A' ' 89' ' ' SER . 20.6 m -148.69 141.64 24.78 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.184 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -127.63 131.8 69.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.285 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -104.6 123.12 47.0 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.19 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.31 89.99 5.29 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.47 118.41 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 118.787 -1.165 . . . . 0.0 111.98 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 69.6 p -125.24 -116.03 0.28 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.032 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.524 ' N ' ' OG1' ' A' ' 76' ' ' THR . . . 85.55 170.17 46.79 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.959 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.41 -39.47 17.52 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.754 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -93.0 -96.89 1.44 Allowed Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.292 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.87 -77.65 0.57 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.002 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.502 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 1.3 m -131.04 50.13 5.65 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 119.791 -0.763 . . . . 0.0 111.562 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 81' ' ' SER . 1.6 Cg_endo -56.7 -74.83 0.02 OUTLIER 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 120.989 1.126 . . . . 0.0 110.801 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.2 121.76 25.4 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.709 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.0 t -55.11 149.71 11.8 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.612 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.8 p -83.29 -94.35 0.06 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.734 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.54 79.41 4.36 Favored Pre-proline 0 C--N 1.296 -1.755 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.996 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -52.43 171.54 0.2 Allowed 'Trans proline' 0 C--O 1.216 -0.576 0 C-N-CA 120.898 1.065 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 88' ' ' ILE . 10.3 tt -144.79 131.74 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 C-N-CA 118.529 -1.268 . . . . 0.0 111.465 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.401 ' OG ' ' CG2' ' A' ' 71' ' ' THR . 31.8 m -120.38 155.74 32.8 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.657 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.86 135.46 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.534 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.474 HD21 ' CG ' ' A' ' 67' ' ' ASP . 10.5 t30 -86.13 133.66 33.86 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.59 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -140.48 132.27 27.46 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.321 -0.951 . . . . 0.0 111.174 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.04 105.82 18.03 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.091 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 116.431 -1.747 . . . . 0.0 110.868 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.978 0.418 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t -66.02 -159.97 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.03 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -151.91 48.32 0.79 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.944 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.2 t -48.9 147.08 4.9 Favored Pre-proline 0 C--N 1.304 -1.372 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.329 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -46.39 167.71 0.06 OUTLIER 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 120.769 0.98 . . . . 0.0 111.043 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.98 177.69 4.64 Favored 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.734 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 8' ' ' LEU . 1.8 t70 -47.4 100.24 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.89 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' A' ' 7' ' ' ASP . 2.3 mm? -43.36 164.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.603 -0.839 . . . . 0.0 109.219 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -149.71 147.91 28.62 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.241 -1.384 . . . . 0.0 112.412 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.5 t -103.51 111.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.031 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.87 -27.35 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.693 -1.203 . . . . 0.0 111.951 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 19' ' ' LEU . . . -155.09 151.05 27.87 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.851 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.32 121.06 7.54 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.297 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.523 ' C ' ' H ' ' A' ' 16' ' ' THR . 1.1 p -134.13 153.49 79.61 Favored Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.32 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -64.29 10.48 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 120.98 1.12 . . . . 0.0 111.648 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.523 ' H ' ' C ' ' A' ' 14' ' ' THR . 5.0 m -140.84 6.31 2.01 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.051 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.6 p 179.26 148.82 0.25 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.307 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.81 120.08 27.06 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.462 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.567 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 2.8 tt -98.07 102.42 14.17 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.924 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 pp -100.25 155.21 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.503 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.37 143.74 30.29 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.384 -0.926 . . . . 0.0 111.0 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.615 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 3.7 p90 -145.07 -148.43 0.24 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 119.038 -1.065 . . . . 0.0 111.216 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.615 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 30.4 t70 -110.36 177.94 4.54 Favored 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.528 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . -170.28 89.35 0.52 Allowed Pre-proline 0 C--N 1.303 -1.433 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.011 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -56.99 169.79 1.77 Allowed 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 120.871 1.048 . . . . 0.0 112.214 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.82 -7.4 57.31 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.683 -0.807 . . . . 0.0 112.176 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.7 m -59.59 161.82 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 118.525 -1.27 . . . . 0.0 110.008 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.464 ' O ' HG22 ' A' ' 28' ' ' THR . 4.2 m -67.33 84.68 0.16 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.885 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.402 ' H ' HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -83.1 116.94 28.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 C-N-CA 119.254 -0.978 . . . . 0.0 111.008 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.414 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 4.3 mtp180 -54.51 -48.58 71.74 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 118.35 -1.34 . . . . 0.0 108.93 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.414 ' CG ' ' C ' ' A' ' 30' ' ' ARG . 0.3 OUTLIER 175.93 164.58 0.37 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.849 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -114.01 155.16 26.39 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.197 -1.365 . . . . 0.0 108.11 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.652 ' HE ' ' CG2' ' A' ' 49' ' ' THR . 4.0 ttm180 -135.15 107.52 7.29 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.405 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.3 mt -98.96 109.07 23.44 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.864 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.563 HG22 ' CB ' ' A' ' 47' ' ' GLU . 45.1 p -113.01 134.56 54.46 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.471 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.468 ' CE2' HG11 ' A' ' 45' ' ' VAL . 9.7 p90 -136.9 153.37 50.76 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.262 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.496 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -177.88 149.41 9.21 Favored Glycine 0 N--CA 1.483 1.814 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.596 ' CD ' ' H ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -86.65 139.83 30.41 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.729 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 74.9 m -67.68 130.12 42.02 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.889 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.7 -23.93 0.02 OUTLIER Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.392 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.62 -2.37 77.05 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.374 -1.393 . . . . 0.0 110.642 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 30.2 t-20 -77.77 -69.32 0.55 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.736 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.35 130.83 0.42 Allowed Pre-proline 0 C--N 1.305 -1.349 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.434 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -61.69 151.52 79.91 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 120.482 0.788 . . . . 0.0 110.948 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.496 HG23 ' HA2' ' A' ' 37' ' ' GLY . 96.1 t -61.77 -78.63 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 118.947 -1.101 . . . . 0.0 110.677 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -173.34 -167.75 0.41 Allowed 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.976 -1.09 . . . . 0.0 111.527 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.563 ' CB ' HG22 ' A' ' 35' ' ' THR . 2.8 pm0 -153.34 170.2 21.23 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.918 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -159.07 129.56 5.91 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.202 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.652 ' CG2' ' HE ' ' A' ' 33' ' ' ARG . 34.3 p -95.95 162.21 13.66 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.436 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.548 ' C ' ' H ' ' A' ' 52' ' ' GLY . 35.3 m -150.33 150.58 29.49 Favored Pre-proline 0 C--N 1.309 -1.176 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.717 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.86 9.87 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 120.92 1.08 . . . . 0.0 112.225 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 72.93 13.56 78.93 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.244 -1.455 . . . . 0.0 109.949 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.25 -29.89 22.77 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.629 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -80.86 118.36 22.3 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.284 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.47 -15.37 57.89 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.371 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.0 p -144.46 176.79 9.12 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.485 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -171.79 160.52 5.63 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.219 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.3 m -121.54 143.56 49.21 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.274 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.32 163.9 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.805 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.2 m -143.21 -170.72 3.33 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.442 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.71 55.14 4.66 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.309 -1.424 . . . . 0.0 110.495 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.61 -158.52 0.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.707 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -140.28 155.05 70.41 Favored Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.295 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.28 102.55 0.39 Allowed 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 121.315 1.343 . . . . 0.0 112.739 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 65.89 95.82 0.03 OUTLIER Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.537 -1.315 . . . . 0.0 111.474 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.405 ' O ' HG13 ' A' ' 66' ' ' VAL . 9.9 p -157.54 137.5 4.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.826 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -50.59 116.17 1.81 Allowed 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.763 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.67 130.11 52.59 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.79 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.1 m -117.67 126.47 52.56 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.564 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -118.57 157.19 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.419 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.406 HG23 ' CB ' ' A' ' 89' ' ' SER . 0.2 OUTLIER -141.08 117.09 10.51 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.448 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 72' ' ' VAL . 34.1 m -111.43 126.64 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.557 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -109.16 130.3 55.49 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.157 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -108.33 91.48 3.67 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.217 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 83.1 t -91.91 123.2 43.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.082 -1.047 . . . . 0.0 111.081 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.7 p -102.74 -160.98 0.81 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.994 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.46 -143.78 14.25 Favored Glycine 0 N--CA 1.494 2.509 0 C-N-CA 119.641 -1.266 . . . . 0.0 111.568 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.726 ' HE ' ' N ' ' A' ' 79' ' ' GLY . 0.1 OUTLIER -121.23 -165.32 1.22 Allowed 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.546 0.688 . . . . 0.0 111.596 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.726 ' N ' ' HE ' ' A' ' 78' ' ' ARG . . . 170.2 -7.22 0.04 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 106.827 -2.509 . . . . 0.0 106.827 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.449 ' H ' ' H ' ' A' ' 79' ' ' GLY . 19.1 t0 178.43 -57.84 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.36 163.96 45.79 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 113.951 -1.477 . . . . 0.0 107.695 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -52.66 107.43 0.19 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 120.376 0.717 . . . . 0.0 110.362 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.23 47.93 0.84 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.473 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 15.0 t -74.85 130.83 40.12 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.611 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.485 ' OG ' ' N ' ' A' ' 86' ' ' LYS . 24.4 p -78.57 -141.99 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.805 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.485 ' N ' ' OG ' ' A' ' 85' ' ' SER . 8.8 tttm -130.47 121.17 19.19 Favored Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.454 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.93 157.14 40.03 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 120.51 0.807 . . . . 0.0 111.556 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 88' ' ' ILE . 9.8 tt -144.42 139.62 24.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.378 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.406 ' CB ' HG23 ' A' ' 71' ' ' THR . 7.2 p -128.48 160.42 32.36 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.817 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.0 pt -144.72 139.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.763 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.58 110.73 21.88 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.756 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 93' ' ' ARG . 5.9 t80 -143.05 138.82 30.21 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.616 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.436 ' N ' ' CD1' ' A' ' 92' ' ' TYR . 10.5 mtp180 -72.16 110.59 6.72 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.597 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 116.371 -1.776 . . . . 0.0 110.984 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.482 1.166 0 CA-C-O 120.991 0.424 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 m -149.36 111.01 4.51 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.67 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -141.06 33.95 1.73 Allowed 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.511 -0.876 . . . . 0.0 111.149 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.1 t -92.77 127.61 47.22 Favored Pre-proline 0 C--N 1.306 -1.303 0 C-N-CA 119.114 -1.034 . . . . 0.0 110.345 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.42 172.06 3.74 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 120.457 0.771 . . . . 0.0 110.911 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -175.62 -178.79 1.14 Allowed 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.914 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 65.13 19.95 11.89 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.847 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.591 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -81.82 106.92 14.13 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.609 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -154.45 176.29 12.54 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.876 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 t -93.78 132.95 36.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.797 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.69 -4.36 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 120.037 -0.665 . . . . 0.0 111.13 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.8 144.86 2.33 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.434 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -143.91 102.15 3.85 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.843 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.552 ' C ' ' H ' ' A' ' 16' ' ' THR . 22.6 p -97.15 152.5 38.33 Favored Pre-proline 0 N--CA 1.485 1.309 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.271 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.46 ' C ' ' HG1' ' A' ' 16' ' ' THR . 1.9 Cg_endo -59.36 14.12 0.04 OUTLIER 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 121.305 1.337 . . . . 0.0 112.726 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.552 ' H ' ' C ' ' A' ' 14' ' ' THR . 3.2 m -159.64 21.62 0.18 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.032 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 173.93 149.73 0.08 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.182 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.37 157.72 37.77 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.416 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.6 116.71 21.45 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.264 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pt -106.0 152.27 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.102 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.426 ' HB3' HG22 ' A' ' 56' ' ' THR . 2.4 m -150.27 124.78 9.62 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.029 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.529 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 7.2 p90 -129.47 -163.77 1.33 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.419 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.529 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 30.9 t70 -103.59 173.46 6.29 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -158.81 105.91 1.6 Allowed Pre-proline 0 CA--C 1.56 1.345 0 CA-C-N 114.431 -1.258 . . . . 0.0 109.302 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -58.1 -171.06 0.04 OUTLIER 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 120.757 0.972 . . . . 0.0 112.401 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -105.34 -3.3 22.87 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.006 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.532 ' O ' ' N ' ' A' ' 29' ' ' VAL . 2.3 t -58.26 159.46 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 118.587 -1.245 . . . . 0.0 110.018 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.92 89.14 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.932 -1.107 . . . . 0.0 109.748 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 27' ' ' VAL . 26.3 t -91.88 119.29 39.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.721 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.545 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 2.7 mmp_? -79.83 -67.86 0.72 Allowed 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 118.931 -1.107 . . . . 0.0 109.548 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.545 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 2.1 m-85 -149.35 154.37 38.85 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 118.91 -1.116 . . . . 0.0 111.646 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -110.35 165.46 11.76 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -146.87 110.76 5.0 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.319 -1.352 . . . . 0.0 110.697 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.507 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.4 mp -102.66 117.53 48.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.511 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.7 p -119.14 135.22 54.77 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.137 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.654 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -124.54 156.41 37.38 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.661 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 178.22 130.47 1.41 Allowed Glycine 0 N--CA 1.489 2.179 0 C-N-CA 119.667 -1.254 . . . . 0.0 110.341 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.426 ' OE2' ' O ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -75.53 143.71 42.32 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.635 179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.8 m -65.23 155.55 34.74 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.778 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.482 ' C ' ' H ' ' A' ' 42' ' ' ASN . . . 152.35 2.79 0.19 Allowed Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.464 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.53 -3.49 3.54 Favored Glycine 0 N--CA 1.487 2.09 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.191 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 40' ' ' GLY . 13.1 m-80 -65.33 -88.72 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.516 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -167.2 163.65 10.06 Favored Pre-proline 0 C--N 1.304 -1.373 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.612 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -64.49 151.82 84.05 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 121.538 1.492 . . . . 0.0 111.802 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 46' ' ' GLN . 3.7 t -82.0 -61.33 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.874 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.415 ' N ' HG12 ' A' ' 45' ' ' VAL . 4.7 tp60 -173.36 177.78 2.54 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.661 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -167.35 166.1 14.72 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.894 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -162.12 157.48 23.35 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 118.982 -1.087 . . . . 0.0 110.907 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 43.4 p -102.66 166.07 10.71 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.159 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.583 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -153.49 147.04 18.22 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.0 OUTLIER -59.85 17.98 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 121.393 1.396 . . . . 0.0 112.989 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 62.43 -2.21 1.25 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -81.0 -43.35 19.74 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.433 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 104.55 8.01 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.914 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 m -79.24 8.15 6.48 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.085 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 21' ' ' SER . 1.9 p -137.5 159.62 41.44 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.518 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -168.57 144.5 3.61 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.332 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 59.3 m -95.33 146.33 24.46 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.308 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.514 HD11 ' CD2' ' A' ' 36' ' ' TYR . 1.1 tt -141.08 145.33 25.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.842 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.24 167.51 22.26 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.061 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.66 49.27 1.11 Allowed Glycine 0 N--CA 1.494 2.552 0 C-N-CA 119.796 -1.192 . . . . 0.0 110.867 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.99 -156.45 0.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.944 -0.703 . . . . 0.0 110.434 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.3 mttp -144.32 158.99 53.57 Favored Pre-proline 0 N--CA 1.488 1.447 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.801 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.71 106.49 0.37 Allowed 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 121.384 1.389 . . . . 0.0 112.013 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 62.74 89.19 0.03 OUTLIER Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.472 -1.347 . . . . 0.0 111.05 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.0 p -150.2 136.68 12.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.926 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -52.75 124.05 12.9 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.344 -0.943 . . . . 0.0 110.009 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.32 126.84 41.57 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.705 -0.798 . . . . 0.0 111.445 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.2 m -107.84 110.85 22.73 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.103 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 71' ' ' THR . 0.6 OUTLIER -96.19 137.35 24.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.23 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.548 ' N ' HD12 ' A' ' 70' ' ' ILE . 24.7 m -138.31 139.17 38.97 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.649 -0.82 . . . . 0.0 111.286 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -125.44 139.08 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.066 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.462 ' CE2' ' CG ' ' A' ' 87' ' ' PRO . 1.7 m-85 -118.56 113.89 21.97 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.783 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.03 125.56 35.86 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.554 -0.858 . . . . 0.0 110.953 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.92 100.91 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.621 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 77' ' ' GLY . 1.6 p -95.79 -40.19 9.47 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.251 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 76' ' ' THR . . . 51.54 103.9 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 C-N-CA 120.026 -1.083 . . . . 0.0 111.286 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -110.57 148.41 32.22 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.948 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.37 -106.5 2.06 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.137 -1.506 . . . . 0.0 109.984 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -149.49 -49.48 0.14 Allowed 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.134 -1.026 . . . . 0.0 111.101 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.8 146.25 95.07 Favored Pre-proline 0 C--N 1.306 -1.326 0 C-N-CA 119.131 -1.028 . . . . 0.0 110.794 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.25 119.61 6.85 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.092 1.195 . . . . 0.0 111.406 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.53 80.83 1.97 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.727 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 t -63.79 148.03 50.29 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.666 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.1 m -84.9 -99.9 0.06 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -155.76 81.85 3.8 Favored Pre-proline 0 C--N 1.298 -1.662 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.821 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.462 ' CG ' ' CE2' ' A' ' 73' ' ' TYR . 12.6 Cg_exo -53.62 161.42 4.33 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 120.94 1.093 . . . . 0.0 110.687 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -152.42 162.26 2.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 118.491 -1.284 . . . . 0.0 111.403 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 94.6 p -147.74 157.66 43.65 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.085 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.7 pt -144.15 143.5 23.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 C-N-CA 119.711 -0.795 . . . . 0.0 110.68 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -93.77 149.78 20.95 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.449 -0.9 . . . . 0.0 111.133 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -172.26 132.96 0.65 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.644 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.65 122.8 28.59 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.326 -0.949 . . . . 0.0 110.379 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 116.336 -1.792 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.482 1.167 0 CA-C-O 121.034 0.445 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.8 p -150.95 41.18 0.75 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.389 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -154.42 53.17 0.67 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.429 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.9 t -105.21 135.91 19.26 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 119.924 -0.71 . . . . 0.0 110.664 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -57.77 158.09 21.63 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 120.748 0.965 . . . . 0.0 111.206 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.61 -176.0 0.83 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.327 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 45.63 62.94 1.98 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.948 -1.023 . . . . 0.0 112.783 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mt -101.05 120.74 40.65 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.133 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -158.27 176.45 12.46 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.418 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.8 t -109.24 124.2 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.937 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 9.2 t -69.5 -72.4 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 119.27 -0.972 . . . . 0.0 111.171 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.84 174.29 11.62 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.777 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -131.7 168.37 17.87 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.13 160.64 36.8 Favored Pre-proline 0 C--N 1.301 -1.507 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.278 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 16' ' ' THR . 2.6 Cg_exo -50.54 99.64 0.04 OUTLIER 'Trans proline' 0 C--O 1.212 -0.786 0 C-N-CA 120.656 0.904 . . . . 0.0 111.092 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.463 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.6 OUTLIER 75.05 41.03 0.32 Allowed 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.304 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.48 141.05 2.9 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.247 -0.981 . . . . 0.0 111.12 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 tp -130.25 152.07 50.08 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 13.7 tp -126.11 110.55 13.64 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.157 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -101.63 157.79 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.441 -0.903 . . . . 0.0 111.228 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.64 137.57 18.13 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.552 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.485 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 8.2 p90 -135.96 -149.77 0.35 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.952 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.485 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 10.2 t70 -136.09 133.23 37.11 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.279 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.58 135.83 20.06 Favored Pre-proline 0 N--CA 1.485 1.307 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.335 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.453 ' HB2' HG22 ' A' ' 27' ' ' VAL . 2.0 Cg_endo -60.76 178.4 0.49 Allowed 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.584 0.856 . . . . 0.0 111.485 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -102.58 52.21 0.8 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.023 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.453 HG22 ' HB2' ' A' ' 25' ' ' PRO . 30.5 m -135.41 169.53 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.059 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -69.4 75.92 0.38 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.233 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.422 ' HA ' HG22 ' A' ' 76' ' ' THR . 98.4 t -65.32 130.13 30.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.658 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.444 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 20.5 mmm-85 -76.32 -61.06 2.07 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.217 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.444 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 75.9 m-85 -154.16 169.56 23.3 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.297 -1.361 . . . . 0.0 112.68 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.56 133.51 38.43 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.746 -1.57 . . . . 0.0 108.744 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -123.27 118.88 28.59 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.889 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.5 mt -101.03 123.31 53.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.9 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 p -124.59 136.36 53.89 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.543 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.698 ' CZ ' HD11 ' A' ' 59' ' ' ILE . 7.9 p90 -139.83 161.65 37.05 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.81 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.5 152.31 13.15 Favored Glycine 0 N--CA 1.488 2.142 0 C-N-CA 119.551 -1.309 . . . . 0.0 110.442 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.91 145.04 38.49 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.435 -0.906 . . . . 0.0 110.557 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.8 m -69.76 141.18 53.46 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.792 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.22 -39.14 0.15 Allowed Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.374 -1.394 . . . . 0.0 110.492 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 175.23 -108.65 0.27 Allowed Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.302 -1.428 . . . . 0.0 110.504 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -126.27 67.33 1.21 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.428 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.3 t -143.45 70.43 17.67 Favored Pre-proline 0 C--N 1.307 -1.264 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.181 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -64.22 132.68 34.85 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.402 1.401 . . . . 0.0 111.174 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 46' ' ' GLN . 15.1 t -55.57 -68.7 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 C-N-CA 118.956 -1.098 . . . . 0.0 110.293 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.47 ' N ' HG12 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -171.7 -159.22 0.14 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.012 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.31 172.15 7.42 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.315 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -161.79 138.08 8.02 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.941 -1.104 . . . . 0.0 110.897 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.9 p -86.65 152.35 22.65 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.152 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 50' ' ' VAL . 12.2 p -165.13 136.55 3.25 Favored Pre-proline 0 C--N 1.301 -1.522 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.44 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 53' ' ' SER . 3.5 Cg_exo -51.94 134.95 50.27 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 120.295 0.663 . . . . 0.0 111.471 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.18 3.61 1.07 Allowed Glycine 0 N--CA 1.484 1.898 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.899 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -68.87 -34.62 75.75 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 118.876 -1.13 . . . . 0.0 110.285 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.0 mmtt -79.68 119.65 22.91 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.796 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.5 -7.17 59.58 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.236 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 52.6 p -137.37 160.16 39.87 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.605 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.95 141.96 17.1 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.311 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.9 m -101.98 144.04 31.09 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.436 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.698 HD11 ' CZ ' ' A' ' 36' ' ' TYR . 4.4 tt -141.33 149.34 20.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.399 -0.92 . . . . 0.0 111.204 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 14.2 t -149.25 124.99 10.47 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.748 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 149.07 14.81 0.1 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.287 -1.435 . . . . 0.0 110.541 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.31 -155.17 0.48 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.716 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.5 mmtt -130.25 145.62 58.12 Favored Pre-proline 0 N--CA 1.493 1.703 0 C-N-CA 119.877 -0.729 . . . . 0.0 110.4 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -71.07 121.87 8.24 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 120.863 1.042 . . . . 0.0 113.022 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.18 89.85 0.07 OUTLIER Glycine 0 N--CA 1.502 3.063 0 C-N-CA 119.989 -1.101 . . . . 0.0 112.93 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.9 p -171.89 148.86 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 119.663 -0.815 . . . . 0.0 111.176 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -67.15 142.02 57.19 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.792 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -144.08 151.37 39.53 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.25 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.83 125.02 46.47 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.516 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.405 HD12 ' H ' ' A' ' 71' ' ' THR . 3.3 tp -111.49 136.16 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 C-N-CA 119.916 -0.713 . . . . 0.0 111.132 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.536 HG23 ' HB3' ' A' ' 89' ' ' SER . 87.5 m -138.91 121.92 16.73 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.632 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.7 m -105.6 144.02 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.137 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.47 92.27 3.9 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.417 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.48 90.27 5.65 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.143 -1.023 . . . . 0.0 111.248 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.452 HG22 ' OG ' ' A' ' 85' ' ' SER . 17.9 t -77.26 114.11 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.287 -0.965 . . . . 0.0 111.629 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 29' ' ' VAL . 2.4 p -140.07 131.31 26.6 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.469 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -148.44 104.85 0.29 Allowed Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' A' ' 79' ' ' GLY . 2.2 ttp-105 -118.88 -94.27 0.5 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 120.134 -0.626 . . . . 0.0 111.367 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 78' ' ' ARG . . . -48.78 -103.29 0.01 OUTLIER Glycine 0 N--CA 1.493 2.45 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.606 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -131.22 -3.5 3.9 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.102 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.61 160.44 0.46 Allowed Pre-proline 0 C--N 1.304 -1.392 0 C-N-CA 118.976 -1.089 . . . . 0.0 110.227 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.483 ' C ' ' N ' ' A' ' 84' ' ' SER . 3.0 Cg_endo -63.23 109.28 0.94 Allowed 'Trans proline' 0 C--O 1.216 -0.59 0 C-N-CA 121.203 1.269 . . . . 0.0 111.433 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.79 -14.4 0.13 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.371 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.483 ' N ' ' C ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -68.66 103.0 1.61 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.41 179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.452 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -43.69 167.77 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.938 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.6 tptt -117.06 86.41 20.13 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -61.31 144.6 98.65 Favored 'Trans proline' 0 C--O 1.213 -0.771 0 C-N-CA 121.067 1.178 . . . . 0.0 113.526 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 88' ' ' ILE . 8.7 tt -143.75 129.92 16.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.854 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.536 ' HB3' HG23 ' A' ' 71' ' ' THR . 46.0 p -129.84 165.12 22.65 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.333 -0.947 . . . . 0.0 112.275 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -151.45 146.86 15.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.415 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.15 149.28 28.04 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.219 -0.993 . . . . 0.0 110.194 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -158.44 134.81 9.37 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.194 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.435 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -93.75 114.28 26.52 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.979 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 116.27 -1.824 . . . . 0.0 110.955 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 2' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.286 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 1' ' ' VAL . 0.8 OUTLIER 57.19 113.2 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.538 -0.865 . . . . 0.0 110.741 179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.97 -11.9 8.05 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.869 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.01 136.45 96.69 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.89 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.65 172.97 1.8 Allowed 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 120.621 0.881 . . . . 0.0 111.406 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.3 ptm180 -158.48 168.08 27.91 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.504 -0.879 . . . . 0.0 110.689 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 53.44 60.2 3.87 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.602 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -100.31 135.17 42.16 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.179 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -178.26 176.89 1.04 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 118.729 -1.189 . . . . 0.0 111.97 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 76.0 t -99.09 116.04 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.964 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.769 HG23 ' OG ' ' A' ' 21' ' ' SER . 5.5 t -71.1 -25.43 25.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.797 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 163.78 168.6 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.78 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -129.22 157.93 40.44 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.155 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.68 161.93 28.77 Favored Pre-proline 0 C--N 1.305 -1.334 0 C-N-CA 118.995 -1.082 . . . . 0.0 110.767 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 16' ' ' THR . 6.1 Cg_exo -54.65 106.22 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 121.217 1.278 . . . . 0.0 111.849 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.464 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER 74.54 34.11 0.79 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 120.017 -0.673 . . . . 0.0 111.856 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 99.5 p -172.14 138.77 1.02 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.026 -1.07 . . . . 0.0 111.199 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 45.0 tp -131.05 122.3 26.52 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.961 -0.696 . . . . 0.0 109.902 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 57' ' ' ALA . 0.6 OUTLIER -96.94 113.64 25.2 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.354 -0.938 . . . . 0.0 112.156 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 pt -105.41 167.11 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.549 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.769 ' OG ' HG23 ' A' ' 11' ' ' VAL . 0.7 OUTLIER -160.66 133.98 6.68 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.324 -1.35 . . . . 0.0 111.807 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.59 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 4.9 p90 -139.25 -142.46 0.15 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.053 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.59 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 5.6 t70 -140.73 159.29 42.53 Favored 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 118.634 -1.227 . . . . 0.0 113.042 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.425 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -147.12 115.59 4.32 Favored Pre-proline 0 CA--C 1.563 1.446 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.945 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.34 -169.77 0.1 OUTLIER 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 120.392 0.728 . . . . 0.0 111.775 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.17 5.59 30.14 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.651 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -68.61 169.74 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 118.512 -1.275 . . . . 0.0 110.838 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.2 m -68.71 73.55 0.25 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.554 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 27' ' ' VAL . 2.4 t -70.08 127.92 32.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.985 -179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.411 ' H ' ' HA ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -68.75 -50.65 48.84 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.433 179.853 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.405 ' CE2' ' CG ' ' A' ' 30' ' ' ARG . 0.7 OUTLIER 177.28 168.89 0.6 Allowed 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.9 179.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -121.92 165.33 16.12 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 114.726 -1.125 . . . . 0.0 109.334 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -141.03 106.92 5.14 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 118.789 -1.164 . . . . 0.0 111.505 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 62.8 mt -98.43 111.55 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.43 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.464 HG22 ' HB2' ' A' ' 47' ' ' GLU . 15.3 p -124.34 133.22 53.5 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 120.013 -0.675 . . . . 0.0 111.106 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.628 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.2 OUTLIER -128.27 138.88 52.62 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.13 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.434 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -154.01 137.84 5.93 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.803 -1.189 . . . . 0.0 110.223 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -67.2 163.79 19.59 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.596 -0.842 . . . . 0.0 111.126 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 39' ' ' THR . 7.4 t -66.67 131.02 45.09 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.54 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 54.46 81.76 0.06 OUTLIER Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.158 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 43' ' ' SER . . . -143.77 111.78 0.65 Allowed Glycine 0 N--CA 1.493 2.473 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.99 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -59.38 -5.29 0.74 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.424 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.458 ' H ' ' C ' ' A' ' 41' ' ' GLY . 30.2 m -145.57 93.81 5.25 Favored Pre-proline 0 C--N 1.303 -1.438 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.227 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.56 151.58 45.58 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 120.428 0.752 . . . . 0.0 110.915 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.434 HG23 ' HA2' ' A' ' 37' ' ' GLY . 23.3 t -49.39 -75.94 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.987 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -171.84 169.54 5.77 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.837 -1.145 . . . . 0.0 111.466 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.464 ' HB2' HG22 ' A' ' 35' ' ' THR . 11.0 pt-20 -148.76 159.47 44.11 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.298 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -168.76 134.38 1.7 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 118.941 -1.104 . . . . 0.0 111.053 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.5 162.32 14.26 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.407 -0.815 . . . . 0.0 112.058 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -145.96 161.56 39.29 Favored Pre-proline 0 C--N 1.307 -1.265 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.104 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.96 20.09 0.08 OUTLIER 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 120.925 1.083 . . . . 0.0 111.858 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 55.2 22.89 31.06 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.335 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.24 -40.04 9.36 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.989 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.7 mmtm -72.82 117.2 14.24 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.77 -23.15 42.4 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.664 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 39.5 p -125.01 161.65 26.24 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.0 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.451 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -155.83 150.89 26.53 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 118.643 -1.223 . . . . 0.0 111.75 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.2 m -123.72 108.0 12.07 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.419 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.2 pt -108.75 159.24 8.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.832 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.3 t -145.27 140.99 28.2 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.181 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.522 ' C ' HD13 ' A' ' 62' ' ' LEU . . . 164.0 11.11 0.03 OUTLIER Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.455 -1.355 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.867 HD13 ' N ' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -131.09 150.59 52.08 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.886 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.772 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -126.24 -38.33 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.851 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.026 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.772 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 5.4 Cg_endo -80.81 -168.57 0.65 Allowed 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 121.425 1.417 . . . . 0.0 111.629 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -130.42 73.54 0.46 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.68 HG22 ' N ' ' A' ' 67' ' ' ASP . 14.1 p -114.14 174.5 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.573 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.68 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -59.97 140.34 56.81 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.991 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.35 123.41 20.32 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.553 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.85 113.23 25.97 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.73 -0.788 . . . . 0.0 110.17 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -102.19 150.11 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.108 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.44 HG23 ' CB ' ' A' ' 89' ' ' SER . 3.9 m -144.52 127.45 16.41 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.507 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.54 143.72 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.765 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -114.3 137.15 52.16 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.656 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.77 97.86 5.83 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.26 132.99 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.28 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 77' ' ' GLY . 4.0 m -137.97 -20.21 1.13 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.832 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 76' ' ' THR . . . 33.4 -110.03 0.05 OUTLIER Glycine 0 N--CA 1.503 3.132 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.817 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.6 mmt-85 -58.98 158.51 8.34 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.872 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.28 -27.89 2.84 Favored Glycine 0 N--CA 1.494 2.531 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.141 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 170.9 -58.02 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.432 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -116.65 83.96 14.6 Favored Pre-proline 0 C--N 1.31 -1.13 0 CA-C-N 115.547 -0.752 . . . . 0.0 110.448 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.63 83.77 0.08 OUTLIER 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 120.676 0.917 . . . . 0.0 110.873 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 81' ' ' SER . . . -130.7 101.1 5.53 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.553 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.8 p -49.71 108.75 0.22 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.809 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.87 -168.32 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.572 -0.851 . . . . 0.0 110.85 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -133.25 136.29 27.04 Favored Pre-proline 0 N--CA 1.487 1.413 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.833 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -60.73 149.27 88.61 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 120.681 0.92 . . . . 0.0 111.64 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.3 tt -137.09 135.06 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 119.567 -0.853 . . . . 0.0 109.117 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.44 ' CB ' HG23 ' A' ' 71' ' ' THR . 0.0 OUTLIER -136.04 164.81 27.14 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.196 -1.002 . . . . 0.0 112.697 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -146.37 154.13 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.574 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -103.57 145.75 29.57 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.257 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -159.98 147.27 16.45 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.164 -1.015 . . . . 0.0 111.075 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.556 ' N ' ' CD ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -88.01 103.24 15.52 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.739 179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 116.503 -1.713 . . . . 0.0 110.614 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 74.4 t . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.863 0.363 . . . . 0.0 110.066 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -88.96 -75.29 0.44 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.689 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -146.32 -51.02 0.22 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.421 -0.911 . . . . 0.0 110.661 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.3 t -90.54 132.82 34.15 Favored Pre-proline 0 C--N 1.306 -1.296 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.368 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -64.3 -65.56 0.05 OUTLIER 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 120.161 0.574 . . . . 0.0 111.64 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -167.08 -166.16 0.78 Allowed 'General case' 0 N--CA 1.502 2.156 0 C-N-CA 117.628 -1.629 . . . . 0.0 113.538 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.441 ' OD2' ' OE1' ' A' ' 9' ' ' GLU . 18.2 t0 -74.84 96.01 3.03 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.762 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 23' ' ' ASP . 5.3 tt -43.74 112.74 0.42 Allowed 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.316 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.441 ' OE1' ' OD2' ' A' ' 7' ' ' ASP . 5.8 pt-20 -179.04 163.81 1.37 Allowed 'General case' 0 N--CA 1.501 2.112 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.632 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 75.2 t -75.75 132.89 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.13 -1.028 . . . . 0.0 108.361 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.668 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 9.2 p -104.61 -23.07 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 118.601 -1.239 . . . . 0.0 112.383 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.668 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 165.78 174.66 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.067 -1.053 . . . . 0.0 111.568 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.39 152.31 42.71 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.715 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.95 163.41 22.96 Favored Pre-proline 0 N--CA 1.486 1.356 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.282 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.618 ' C ' HG23 ' A' ' 16' ' ' THR . 10.2 Cg_exo -46.84 103.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 120.54 0.827 . . . . 0.0 110.477 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.618 HG23 ' C ' ' A' ' 15' ' ' PRO . 1.6 p 69.7 37.9 1.79 Allowed 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.597 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.54 145.96 19.28 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.312 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 35.6 tp -123.41 122.53 38.51 Favored 'General case' 0 N--CA 1.503 2.198 0 C-N-CA 119.641 -0.824 . . . . 0.0 111.988 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.747 HD23 ' O ' ' A' ' 57' ' ' ALA . 1.2 mt -96.56 121.58 38.54 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.828 -0.749 . . . . 0.0 109.092 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -124.36 151.88 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -122.97 131.73 53.84 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 114.23 -1.35 . . . . 0.0 108.132 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.522 ' NE1' ' CE2' ' A' ' 32' ' ' TYR . 25.6 p90 -119.95 -175.01 2.89 Favored 'General case' 0 N--CA 1.513 2.711 0 N-CA-C 115.678 1.732 . . . . 0.0 115.678 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.557 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER 178.05 157.02 0.41 Allowed 'General case' 0 N--CA 1.5 2.057 0 CA-C-N 112.826 -1.988 . . . . 0.0 110.446 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.6 ' HB3' ' HD3' ' A' ' 25' ' ' PRO . . . 173.78 -46.46 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -68.01 148.36 75.66 Favored 'Trans proline' 0 C--O 1.211 -0.853 0 C-N-CA 121.186 1.257 . . . . 0.0 113.786 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.61 -16.74 14.44 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.543 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -120.53 179.44 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 CA-C-N 114.529 -1.214 . . . . 0.0 109.932 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 p -49.59 168.33 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 118.565 -1.254 . . . . 0.0 109.095 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.71 113.24 4.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 118.946 -1.102 . . . . 0.0 112.045 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -54.53 -60.39 3.42 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 118.783 -1.167 . . . . 0.0 108.143 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -154.13 161.48 41.85 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.036 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.522 ' CE2' ' NE1' ' A' ' 22' ' ' TRP . 3.2 m-85 -108.03 164.1 12.57 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.351 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -147.05 95.13 2.52 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.191 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.5 mt -91.26 135.15 27.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.399 -0.921 . . . . 0.0 111.605 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 p -138.63 137.38 36.86 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.825 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 1.0 OUTLIER -137.88 160.2 39.94 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.797 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -175.21 135.77 3.17 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.405 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.86 108.36 8.67 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.466 -0.893 . . . . 0.0 110.769 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 53.3 m -49.38 98.88 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.768 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.54 -56.62 0.08 OUTLIER Glycine 0 N--CA 1.489 2.183 0 C-N-CA 119.444 -1.36 . . . . 0.0 110.128 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -68.59 -174.07 8.78 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 119.406 -1.378 . . . . 0.0 110.315 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.84 5.12 47.59 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.535 -0.866 . . . . 0.0 110.823 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.59 150.07 30.03 Favored Pre-proline 0 C--N 1.307 -1.242 0 C-N-CA 119.235 -0.986 . . . . 0.0 110.463 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -64.23 169.42 10.82 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 121.122 1.214 . . . . 0.0 111.612 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 46' ' ' GLN . 3.3 t -75.99 -61.45 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.071 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.432 ' N ' HG12 ' A' ' 45' ' ' VAL . 3.6 tt0 -173.59 -170.26 0.58 Allowed 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.8 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -168.69 176.52 5.56 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.673 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -176.13 150.24 0.94 Allowed 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.336 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.5 p -111.58 153.65 25.99 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.682 -0.807 . . . . 0.0 112.05 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.5 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -143.06 150.14 51.58 Favored Pre-proline 0 C--N 1.303 -1.453 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.905 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.489 ' C ' ' H ' ' A' ' 53' ' ' SER . 3.7 Cg_endo -65.78 28.74 0.1 OUTLIER 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 120.923 1.082 . . . . 0.0 112.483 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 53.59 8.6 0.9 Allowed Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.063 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.489 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.2 OUTLIER -72.27 -32.14 66.38 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.547 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.8 tptt -95.72 154.44 17.22 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.29 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.9 m -104.01 -22.79 13.4 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.135 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.0 p -122.91 -175.25 3.12 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.324 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.747 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -171.11 175.09 4.43 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.297 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.8 t -131.08 141.71 50.2 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.528 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.403 ' O ' HG22 ' A' ' 59' ' ' ILE . 4.2 mt -132.31 111.32 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.408 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 16' ' ' THR . 0.3 OUTLIER -109.05 147.54 32.2 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.585 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 118.19 20.66 4.33 Favored Glycine 0 N--CA 1.501 2.996 0 C-N-CA 119.841 -1.171 . . . . 0.0 110.255 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.688 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -106.46 -174.28 2.5 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.42 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.5 tttm -136.84 122.55 13.21 Favored Pre-proline 0 N--CA 1.487 1.422 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.883 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -57.08 118.8 5.73 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 120.209 0.606 . . . . 0.0 111.671 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.38 64.7 0.7 Allowed Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.607 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 p -164.69 148.37 2.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 119.156 -1.017 . . . . 0.0 111.592 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -70.31 152.45 44.15 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.893 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -146.63 140.83 26.32 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.711 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.2 m -117.88 107.42 14.08 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.411 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.473 ' CG1' ' N ' ' A' ' 71' ' ' THR . 5.1 tt -102.61 160.92 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.014 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.498 HG23 ' OG ' ' A' ' 89' ' ' SER . 91.0 m -160.5 139.59 10.58 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.167 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.6 m -131.36 123.71 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.663 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -104.89 129.99 53.13 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.848 -1.069 . . . . 0.0 110.392 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.19 104.18 14.3 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.99 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.28 121.04 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 C-N-CA 119.049 -1.061 . . . . 0.0 112.443 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.1 p -89.95 -35.56 15.49 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.585 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 65.41 145.09 0.04 OUTLIER Glycine 0 N--CA 1.493 2.498 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.027 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -114.81 -27.14 7.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.066 -0.654 . . . . 0.0 110.678 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.0 -10.82 0.78 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.308 -1.425 . . . . 0.0 110.779 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -168.96 -57.13 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.343 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.7 115.8 62.38 Favored Pre-proline 0 C--N 1.306 -1.309 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.849 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.07 100.69 0.37 Allowed 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 120.451 0.767 . . . . 0.0 111.248 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.07 127.85 32.94 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.745 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.27 116.53 15.03 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.842 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.483 ' OG ' ' N ' ' A' ' 86' ' ' LYS . 16.4 t -85.67 -104.41 0.06 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.736 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.483 ' N ' ' OG ' ' A' ' 85' ' ' SER . 47.3 tttt -137.95 62.68 34.59 Favored Pre-proline 0 N--CA 1.486 1.332 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.397 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.08 164.48 14.34 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 121.348 1.365 . . . . 0.0 110.572 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.405 ' O ' HG23 ' A' ' 88' ' ' ILE . 9.3 tt -151.29 135.27 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 117.983 -1.487 . . . . 0.0 111.723 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.498 ' OG ' HG23 ' A' ' 71' ' ' THR . 1.0 OUTLIER -127.73 139.5 52.65 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.734 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 10.9 pt -149.7 157.94 6.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 118.749 -1.18 . . . . 0.0 111.806 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.479 ' ND2' ' H ' ' A' ' 91' ' ' ASN . 0.0 OUTLIER -95.97 159.77 14.8 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.796 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -167.69 130.86 1.66 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.06 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.3 mtm-85 -88.34 119.31 28.64 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.145 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 116.337 -1.792 . . . . 0.0 110.975 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.826 0.346 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.4 m -70.05 151.69 45.24 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.673 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -157.1 -14.93 0.09 Allowed 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.138 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -73.08 134.57 80.64 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.292 -179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -57.95 173.24 0.93 Allowed 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 120.522 0.814 . . . . 0.0 111.087 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.6 ptt85 -175.25 -163.27 0.12 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.489 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 57.05 7.76 0.46 Allowed 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.822 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.424 ' O ' ' OE1' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -56.9 122.44 12.24 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.209 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -157.92 158.24 34.64 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.748 -1.181 . . . . 0.0 111.871 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 20.3 t -93.56 115.22 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.576 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.487 ' CG2' ' OG ' ' A' ' 21' ' ' SER . 2.2 t -70.75 -68.71 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 118.818 -1.153 . . . . 0.0 111.197 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.12 174.82 12.76 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.522 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.54 162.87 34.34 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.411 ' C ' ' N ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -135.16 161.17 65.09 Favored Pre-proline 0 N--CA 1.484 1.238 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.734 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' O ' HG23 ' A' ' 16' ' ' THR . 2.7 Cg_exo -50.76 -14.38 1.21 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 120.893 1.062 . . . . 0.0 110.944 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 15' ' ' PRO . 7.8 p -158.4 50.8 0.4 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.69 179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.56 143.13 0.18 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.029 -1.068 . . . . 0.0 111.437 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.5 tp -130.16 140.83 50.72 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.111 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.91 110.19 17.43 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.42 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 pp -106.41 147.04 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.878 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.487 ' OG ' ' CG2' ' A' ' 11' ' ' VAL . 0.0 OUTLIER -145.46 136.74 24.95 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.271 -0.971 . . . . 0.0 110.609 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.633 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 4.0 p90 -138.15 -144.43 0.18 Allowed 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.653 -0.819 . . . . 0.0 110.523 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.633 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 12.5 t70 -148.49 168.23 23.27 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 118.347 -1.341 . . . . 0.0 112.994 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.45 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . -133.14 145.67 57.84 Favored Pre-proline 0 N--CA 1.486 1.364 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.991 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.93 -176.88 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 120.798 0.999 . . . . 0.0 111.333 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -94.47 -30.75 14.27 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.74 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.536 ' CG2' ' N ' ' A' ' 28' ' ' THR . 0.9 OUTLIER -61.74 164.21 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.593 179.988 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.536 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 1.0 OUTLIER -73.21 111.61 8.49 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.209 -179.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.905 HG13 HG22 ' A' ' 76' ' ' THR . 5.0 t -99.82 147.27 7.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.28 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -73.0 -70.17 0.37 Allowed 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.484 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -158.66 163.24 37.06 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.61 -1.236 . . . . 0.0 112.046 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -121.0 152.59 38.4 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.661 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 -131.0 115.33 16.34 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.296 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.6 mp -106.81 113.45 43.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.548 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -119.56 137.94 53.52 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.709 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.68 ' CE2' HD12 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -136.71 157.54 46.53 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.195 179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.53 153.23 9.78 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -67.9 160.29 28.8 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.638 -0.825 . . . . 0.0 110.457 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 m -75.24 152.33 38.31 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.0 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 44.78 41.64 7.29 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.482 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.14 142.15 15.91 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.277 -1.44 . . . . 0.0 110.304 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -63.65 -18.82 64.35 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.626 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 t -158.35 131.25 4.51 Favored Pre-proline 0 C--N 1.304 -1.376 0 C-N-CA 119.623 -0.831 . . . . 0.0 109.809 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.02 154.26 52.23 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 120.309 0.673 . . . . 0.0 111.161 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.499 HG12 ' N ' ' A' ' 46' ' ' GLN . 5.7 t -67.34 -67.44 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.812 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.499 ' N ' HG12 ' A' ' 45' ' ' VAL . 0.8 OUTLIER -175.19 178.48 1.71 Allowed 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.129 -1.028 . . . . 0.0 111.359 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -170.8 150.35 3.22 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.363 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.565 ' CE2' ' OH ' ' A' ' 36' ' ' TYR . 0.1 OUTLIER -146.03 164.62 31.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.673 179.714 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 65.2 p -116.89 156.3 27.58 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.436 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.695 HG23 ' H ' ' A' ' 52' ' ' GLY . 6.0 m -146.28 151.67 44.66 Favored Pre-proline 0 C--N 1.308 -1.228 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.805 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.96 20.83 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.074 1.182 . . . . 0.0 112.586 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.695 ' H ' HG23 ' A' ' 50' ' ' VAL . . . 66.75 4.75 27.79 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.219 -1.467 . . . . 0.0 110.211 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.71 -45.98 14.93 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.759 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.66 107.42 7.81 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.605 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.8 m -82.81 14.2 3.38 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.407 HG22 ' HB3' ' A' ' 21' ' ' SER . 1.3 p -138.65 163.42 32.14 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.633 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.5 139.43 7.92 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.063 -1.055 . . . . 0.0 111.587 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.9 m -110.12 134.12 52.51 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.607 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.68 HD12 ' CE2' ' A' ' 36' ' ' TYR . 0.3 OUTLIER -132.53 154.54 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 120.111 -0.636 . . . . 0.0 111.017 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.8 t -136.45 -167.89 2.15 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.511 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.499 ' O ' HD23 ' A' ' 62' ' ' LEU . . . 65.12 73.96 0.53 Allowed Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.309 -1.424 . . . . 0.0 109.867 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 61' ' ' GLY . 10.7 mt -126.74 177.57 6.48 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.312 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.54 128.27 25.88 Favored Pre-proline 0 CA--C 1.559 1.324 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -53.76 98.01 0.05 OUTLIER 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 120.415 0.743 . . . . 0.0 112.889 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.11 97.29 0.22 Allowed Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.124 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.5 p -167.11 138.72 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 119.271 -0.972 . . . . 0.0 111.639 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -59.35 109.8 0.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.882 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -108.8 140.39 42.31 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.962 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.57 130.39 52.6 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.548 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.67 162.57 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.618 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.6 m -150.55 116.31 5.53 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.761 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 72' ' ' VAL . 6.0 m -102.74 121.22 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.859 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -99.1 130.95 45.45 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.581 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -106.44 89.64 3.1 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.884 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.6 t -92.39 127.93 44.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.103 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.905 HG22 HG13 ' A' ' 29' ' ' VAL . 24.2 p -128.49 -109.4 0.28 Allowed 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.567 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 76' ' ' THR . . . 59.34 154.54 0.01 OUTLIER Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.427 -1.368 . . . . 0.0 110.321 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.2 mtm105 -120.18 17.15 12.38 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.543 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.24 73.25 1.26 Allowed Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.466 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 179.13 -54.7 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.84 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.5 t -131.79 72.57 79.73 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 119.951 -0.7 . . . . 0.0 111.548 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.04 105.76 0.71 Allowed 'Trans proline' 0 C--N 1.325 -0.685 0 C-N-CA 121.267 1.311 . . . . 0.0 111.189 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.37 79.13 1.88 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.106 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.4 p -79.95 86.68 5.43 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.928 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 p -115.24 20.31 15.0 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.992 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.672 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 12.2 mtmt -114.81 0.66 0.09 OUTLIER Pre-proline 0 CA--C 1.577 2.013 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 86' ' ' LYS . 2.9 Cg_endo -61.99 149.42 90.35 Favored 'Trans proline' 0 C--N 1.355 0.897 0 CA-C-N 120.258 1.128 . . . . 0.0 110.844 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -148.29 162.16 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 C-N-CA 118.554 -1.258 . . . . 0.0 110.732 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.88 164.71 28.96 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.086 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 6.8 pt -150.41 135.54 10.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.391 -0.923 . . . . 0.0 110.542 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -109.48 131.87 54.66 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.84 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -161.71 135.75 6.75 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.487 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.8 mtt85 -68.32 114.1 6.48 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.659 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 116.29 -1.814 . . . . 0.0 110.729 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 120.828 0.347 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.37 117.89 13.48 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.893 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -160.2 17.95 0.14 Allowed 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.847 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.2 t -50.67 122.68 16.67 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.24 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -64.1 -41.15 23.44 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 120.243 0.628 . . . . 0.0 111.932 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 22' ' ' TRP . 17.1 tpt180 -168.71 151.55 5.18 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.003 -1.079 . . . . 0.0 111.435 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.31 103.31 1.23 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.409 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mt -39.17 122.78 1.29 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.093 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -175.82 157.89 2.03 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 118.719 -1.192 . . . . 0.0 112.55 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.69 113.73 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.488 ' H ' HG23 ' A' ' 11' ' ' VAL . 1.4 t -71.72 -71.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 118.758 -1.177 . . . . 0.0 112.169 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -145.99 175.52 10.39 Favored 'General case' 0 C--N 1.292 -1.915 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.022 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.45 147.56 51.7 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 119.961 -0.696 . . . . 0.0 111.074 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.82 161.37 49.35 Favored Pre-proline 0 C--N 1.305 -1.335 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.355 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -54.58 106.96 0.19 Allowed 'Trans proline' 0 C--O 1.211 -0.832 0 C-N-CA 121.045 1.163 . . . . 0.0 112.156 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 72.66 -3.71 2.29 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.99 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.26 136.48 49.22 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.707 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 tp -130.86 154.19 48.32 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 120.112 -0.635 . . . . 0.0 110.791 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.5 tp -116.79 122.09 43.42 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 pt -124.25 160.41 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 m -134.18 140.52 46.58 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 113.963 -1.471 . . . . 0.0 107.325 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.422 ' O ' ' O ' ' A' ' 6' ' ' ARG . 14.5 p90 -123.29 -168.15 1.72 Allowed 'General case' 0 N--CA 1.505 2.31 0 C-N-CA 118.402 -1.319 . . . . 0.0 114.069 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.467 ' CG ' ' N ' ' A' ' 24' ' ' ALA . 1.5 p-10 -143.27 -155.62 0.61 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.961 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.807 ' HB2' ' OH ' ' A' ' 32' ' ' TYR . . . -172.1 179.18 0.64 Allowed Pre-proline 0 N--CA 1.504 2.268 0 C-N-CA 119.114 -1.035 . . . . 0.0 111.187 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.76 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 9.3 Cg_endo -76.44 -118.6 0.01 OUTLIER 'Trans proline' 0 CA--C 1.568 2.199 0 C-N-CA 121.136 1.224 . . . . 0.0 111.73 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.408 ' H ' ' HB2' ' A' ' 25' ' ' PRO . . . -106.6 -61.01 1.58 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 28' ' ' THR . 2.9 m -58.76 155.77 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 119.631 -0.828 . . . . 0.0 112.418 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -60.19 -176.05 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.073 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.545 ' N ' ' OG1' ' A' ' 28' ' ' THR . 2.0 t -135.74 107.43 7.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.747 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.414 ' CD ' ' CZ ' ' A' ' 31' ' ' TYR . 1.6 ttm-85 -57.83 -64.84 0.77 Allowed 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 118.668 -1.213 . . . . 0.0 109.115 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.414 ' CZ ' ' CD ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -127.26 147.51 50.22 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.117 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.807 ' OH ' ' HB2' ' A' ' 24' ' ' ALA . 0.8 OUTLIER -110.36 130.3 55.58 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.959 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -114.04 101.43 9.22 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.3 mt -92.94 123.86 45.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.862 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.2 p -124.93 135.11 52.54 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.765 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -130.06 155.49 46.07 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.086 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -174.11 151.32 12.78 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.215 -1.469 . . . . 0.0 110.977 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -85.92 136.17 33.39 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.662 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 m -44.74 106.59 0.08 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -172.37 73.67 0.1 OUTLIER Glycine 0 N--CA 1.492 2.418 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.439 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.68 -165.76 53.84 Favored Glycine 0 N--CA 1.493 2.475 0 C-N-CA 119.542 -1.313 . . . . 0.0 110.762 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -99.32 55.97 1.0 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.198 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -139.55 84.9 15.47 Favored Pre-proline 0 C--N 1.305 -1.363 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.521 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.92 168.29 9.1 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 120.752 0.968 . . . . 0.0 111.774 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 46' ' ' GLN . 24.4 t -74.8 -72.29 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.92 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.486 ' N ' HG12 ' A' ' 45' ' ' VAL . 6.4 tt0 -157.28 168.7 26.64 Favored 'General case' 0 C--N 1.293 -1.857 0 C-N-CA 119.196 -1.002 . . . . 0.0 111.076 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' OE1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -143.94 175.11 10.27 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.979 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.4 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 25.7 p90 -163.28 134.68 4.87 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.954 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.0 p -87.45 164.55 16.12 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.254 -0.979 . . . . 0.0 111.288 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.565 ' C ' ' H ' ' A' ' 52' ' ' GLY . 14.5 p -162.31 138.34 5.76 Favored Pre-proline 0 CA--C 1.562 1.411 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.069 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 53' ' ' SER . 3.2 Cg_exo -60.56 23.45 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 120.953 1.102 . . . . 0.0 113.258 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 49.67 12.31 0.39 Allowed Glycine 0 N--CA 1.495 2.625 0 C-N-CA 119.488 -1.339 . . . . 0.0 110.77 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.447 ' N ' ' O ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -59.77 -24.65 64.25 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.103 -1.039 . . . . 0.0 109.588 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -121.07 129.78 53.48 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.465 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -79.82 -9.62 59.68 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.037 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 21.3 p -140.09 154.86 47.17 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.763 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.84 160.67 25.39 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 118.674 -1.211 . . . . 0.0 111.499 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.6 m -90.24 157.47 17.67 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.535 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 59' ' ' ILE . 6.0 tt -150.75 128.96 2.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 119.396 -0.921 . . . . 0.0 110.416 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.1 t -134.66 117.29 15.91 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.699 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -167.69 -28.22 0.02 OUTLIER Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.607 -1.282 . . . . 0.0 110.146 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.534 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -78.85 -166.45 0.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.887 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.669 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.5 OUTLIER -165.33 -42.4 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.456 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.95 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.669 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 8.9 Cg_endo -85.56 -174.81 1.72 Allowed 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 121.358 1.372 . . . . 0.0 111.574 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.68 72.73 0.43 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.607 HG22 ' N ' ' A' ' 67' ' ' ASP . 5.1 p -124.31 169.52 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.239 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.607 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -49.1 110.51 0.37 Allowed 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.879 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.99 134.81 54.31 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.724 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.45 134.36 55.17 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 120.023 -0.671 . . . . 0.0 110.509 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.44 158.72 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 119.844 -0.742 . . . . 0.0 109.908 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.565 HG23 ' OG ' ' A' ' 89' ' ' SER . 6.1 m -153.31 140.83 19.81 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 118.326 -1.35 . . . . 0.0 112.521 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.8 m -114.39 121.84 67.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -94.15 109.81 21.57 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.746 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.3 94.11 8.37 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.674 -1.211 . . . . 0.0 109.625 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -101.09 125.98 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.867 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.6 m -117.65 -77.02 0.57 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.964 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.15 136.22 3.63 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.777 -1.201 . . . . 0.0 111.227 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -97.67 165.25 12.06 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.353 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 80' ' ' ASP . . . -75.22 76.08 1.29 Allowed Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.302 -1.428 . . . . 0.0 110.765 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.463 ' CG ' ' N ' ' A' ' 81' ' ' SER . 0.0 OUTLIER 169.32 -69.84 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.886 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.463 ' N ' ' CG ' ' A' ' 80' ' ' ASP . 17.3 t -117.43 101.51 52.64 Favored Pre-proline 0 N--CA 1.488 1.429 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.956 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -63.91 103.3 0.4 Allowed 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 120.534 0.823 . . . . 0.0 111.242 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -121.71 127.03 50.27 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.441 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.88 134.96 40.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.025 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.7 p -69.61 -111.13 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.404 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.9 pttt -145.1 123.13 6.48 Favored Pre-proline 0 C--N 1.306 -1.316 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.996 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -70.04 165.23 31.98 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 120.527 0.818 . . . . 0.0 111.592 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.563 HG23 ' O ' ' A' ' 88' ' ' ILE . 12.5 tt -138.65 121.66 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.746 -0.782 . . . . 0.0 108.916 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.565 ' OG ' HG23 ' A' ' 71' ' ' THR . 0.5 OUTLIER -121.49 164.9 16.44 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.61 140.38 20.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 113.927 -1.488 . . . . 0.0 109.051 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -103.09 146.56 28.19 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.528 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -172.53 142.08 1.21 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.541 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -75.2 108.87 8.25 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.311 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 116.389 -1.767 . . . . 0.0 110.714 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.406 ' O ' ' CB ' ' A' ' 2' ' ' SER . 1.4 t . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.979 0.419 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.406 ' CB ' ' O ' ' A' ' 1' ' ' VAL . 0.7 OUTLIER 69.06 -166.92 0.18 Allowed 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.565 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -164.59 80.74 0.38 Allowed 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.621 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' PRO . 2.6 t -67.28 130.63 93.52 Favored Pre-proline 0 C--N 1.298 -1.631 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.512 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.447 ' O ' ' O ' ' A' ' 4' ' ' VAL . 5.9 Cg_exo -57.68 -153.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 120.727 0.951 . . . . 0.0 110.239 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -163.99 163.27 23.47 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 117.431 -1.708 . . . . 0.0 113.866 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 6' ' ' ARG . 9.6 t70 12.27 87.02 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 CA-C-N 113.437 -1.711 . . . . 0.0 115.316 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mp -101.7 127.76 48.31 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -163.58 174.69 11.47 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 117.502 -1.679 . . . . 0.0 113.468 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.415 HG22 HG22 ' A' ' 20' ' ' ILE . 56.5 t -92.96 128.39 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-N 114.727 -1.124 . . . . 0.0 109.809 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -107.27 -2.41 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.47 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.556 ' HB3' ' HB3' ' A' ' 19' ' ' LEU . . . -169.19 160.42 9.65 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 118.914 -1.114 . . . . 0.0 111.251 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.62 150.01 27.23 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.529 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.418 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -137.4 162.11 56.92 Favored Pre-proline 0 N--CA 1.489 1.508 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.874 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -55.39 -6.74 0.98 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 121.056 1.171 . . . . 0.0 111.433 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 14' ' ' THR . 0.6 OUTLIER -160.09 42.88 0.2 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.11 -1.036 . . . . 0.0 111.382 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.5 146.87 0.21 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.045 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.1 tp -130.44 120.57 24.41 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.28 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 4.7 tt -96.8 104.68 16.7 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.274 -0.971 . . . . 0.0 110.502 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.415 HG22 HG22 ' A' ' 10' ' ' VAL . 1.2 pp -104.88 153.43 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.652 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.08 144.58 24.92 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.185 -1.006 . . . . 0.0 110.868 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.468 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 9.9 p90 -135.25 -129.75 0.16 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.041 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 24' ' ' ALA . 9.1 t70 -153.27 172.17 17.41 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 117.954 -1.498 . . . . 0.0 112.345 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . -140.7 130.9 13.43 Favored Pre-proline 0 CA--C 1.556 1.193 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.848 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -60.62 171.03 3.79 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 120.528 0.819 . . . . 0.0 111.585 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.04 92.43 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.277 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.514 ' CG2' ' N ' ' A' ' 28' ' ' THR . 1.0 OUTLIER -60.97 161.62 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.5 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.514 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 10.6 p -80.01 121.65 25.76 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.066 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.631 HG13 ' OG1' ' A' ' 76' ' ' THR . 0.6 OUTLIER -91.65 129.68 41.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.509 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.405 ' H ' ' HA ' ' A' ' 76' ' ' THR . 0.0 OUTLIER -54.15 -65.2 0.61 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.39 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -157.92 159.0 36.09 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.666 -1.214 . . . . 0.0 111.789 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.605 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 2.0 m-85 -119.4 146.04 45.7 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.56 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -129.56 111.21 12.5 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.4 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.8 mp -100.93 120.97 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.153 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 p -122.04 136.95 54.97 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.97 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.551 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 1.8 p90 -130.77 146.92 52.36 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.855 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.547 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -171.85 138.79 5.01 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.469 -1.348 . . . . 0.0 110.8 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -72.9 141.62 47.89 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.536 -0.866 . . . . 0.0 110.517 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 m -74.59 125.06 27.84 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.718 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -166.57 -82.65 0.05 OUTLIER Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.553 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 168.58 -12.04 0.06 OUTLIER Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.331 -1.414 . . . . 0.0 110.355 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -72.11 -83.79 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.166 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -170.81 153.38 4.0 Favored Pre-proline 0 C--N 1.302 -1.497 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.2 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.8 172.49 1.56 Allowed 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 121.07 1.18 . . . . 0.0 111.466 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.547 HG23 ' HA2' ' A' ' 37' ' ' GLY . 93.0 t -86.11 -65.29 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.403 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -172.24 -167.86 0.5 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.231 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.89 163.57 11.6 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.698 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 9.7 p90 -153.96 141.84 20.15 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.403 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 71.9 p -100.21 159.93 14.72 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.893 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.512 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -147.29 157.36 45.68 Favored Pre-proline 0 N--CA 1.482 1.149 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.121 179.877 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -63.56 10.76 0.1 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.141 1.227 . . . . 0.0 112.096 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 61.07 26.86 66.32 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.062 -1.542 . . . . 0.0 109.818 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.63 -53.65 4.43 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.63 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -90.62 123.37 34.2 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.43 -0.908 . . . . 0.0 110.28 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.1 m -86.39 27.62 0.92 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.244 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.8 p -145.44 162.98 36.05 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.5 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.1 154.53 5.07 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.805 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.2 m -130.93 115.69 16.87 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.053 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.37 171.49 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 119.949 -0.7 . . . . 0.0 111.673 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 53.0 m -148.57 173.12 13.49 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.619 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.75 49.19 1.3 Allowed Glycine 0 N--CA 1.498 2.799 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.891 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.505 ' C ' HD12 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -130.51 -175.37 3.63 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.866 -179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.9 mmtm -117.55 135.32 23.22 Favored Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.69 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.53 148.27 93.39 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.052 1.168 . . . . 0.0 112.799 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 47.18 82.91 0.03 OUTLIER Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.965 -1.112 . . . . 0.0 111.388 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -167.55 145.68 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 118.956 -1.098 . . . . 0.0 111.444 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -61.3 140.87 57.9 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.413 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.46 118.18 10.46 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.59 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.5 m -100.66 116.97 33.82 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.827 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.7 tt -107.37 149.13 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.11 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 m -141.81 120.6 12.68 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.912 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 72' ' ' VAL . 22.9 m -105.91 124.63 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 C-N-CA 119.556 -0.858 . . . . 0.0 110.596 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -102.51 94.15 5.51 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.972 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.605 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . . . -90.95 132.04 36.2 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.704 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.4 t -136.09 119.43 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.969 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.631 ' OG1' HG13 ' A' ' 29' ' ' VAL . 85.2 m -107.37 -18.12 13.95 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.898 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -154.86 138.44 6.13 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.4 169.34 1.25 Allowed 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.001 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -81.77 109.32 3.01 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.884 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -179.57 -89.63 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.116 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.588 ' H ' ' CD ' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -107.69 -44.16 0.12 Allowed Pre-proline 0 N--CA 1.486 1.334 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.913 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.588 ' CD ' ' H ' ' A' ' 81' ' ' SER . 2.0 Cg_endo -71.27 -163.37 0.13 Allowed 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 121.081 1.188 . . . . 0.0 111.311 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.01 139.93 57.68 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.736 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.84 -177.36 4.5 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.467 -0.893 . . . . 0.0 111.663 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.7 m -89.78 132.59 35.14 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.83 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -133.46 75.25 69.94 Favored Pre-proline 0 N--CA 1.491 1.597 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.703 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.14 158.58 51.23 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 121.492 1.461 . . . . 0.0 112.248 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.7 tt -145.89 153.42 13.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.092 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.43 151.58 46.37 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.069 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -145.76 140.25 21.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 119.604 -0.839 . . . . 0.0 110.58 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -88.88 151.28 22.44 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.755 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -162.46 134.94 5.64 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.138 -1.025 . . . . 0.0 111.102 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.2 mtt180 -93.84 110.69 22.33 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.427 -0.909 . . . . 0.0 109.992 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 116.395 -1.764 . . . . 0.0 110.574 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.895 0.379 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.45 109.35 6.08 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.3 -0.96 . . . . 0.0 110.496 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.02 -4.24 0.49 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.881 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.6 t -99.27 124.6 44.37 Favored Pre-proline 0 C--N 1.307 -1.276 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.208 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.61 164.61 4.14 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 CA-C-N 118.894 0.641 . . . . 0.0 110.905 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.7 ptt180 -165.35 165.87 19.05 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.229 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.2 t70 46.63 70.92 0.34 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 115.376 -0.829 . . . . 0.0 112.227 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -100.9 124.21 46.25 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.397 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -170.15 170.56 7.32 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.41 -1.316 . . . . 0.0 112.322 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.91 149.91 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.969 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 11' ' ' VAL . 7.6 p -129.98 -6.41 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.794 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -170.84 161.09 7.08 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.813 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.59 145.85 27.01 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.784 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.565 ' CB ' ' HG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -130.74 161.0 63.79 Favored Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.901 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -55.04 -10.08 2.54 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 121.236 1.29 . . . . 0.0 111.771 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 m -159.68 44.32 0.23 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.306 -0.958 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.565 ' HG ' ' CB ' ' A' ' 14' ' ' THR . 0.1 OUTLIER 177.26 149.45 0.15 Allowed 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.237 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.9 tp -131.18 148.64 52.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.062 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -122.71 116.91 24.56 Favored 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.696 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 40.3 pt -104.87 170.71 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.764 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.34 135.12 13.65 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.144 -1.023 . . . . 0.0 111.126 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.567 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 8.9 p90 -141.78 -140.78 0.13 Allowed 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.46 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.567 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 22.2 t70 -113.35 171.01 7.81 Favored 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 119.489 -0.885 . . . . 0.0 113.178 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.452 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -178.13 86.96 0.23 Allowed Pre-proline 0 N--CA 1.495 1.79 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.258 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -62.34 173.6 3.26 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.669 0.913 . . . . 0.0 111.794 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.51 -1.53 55.91 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.568 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.678 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.1 m -59.22 144.63 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 118.77 -1.172 . . . . 0.0 109.947 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.44 93.03 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 118.884 -1.126 . . . . 0.0 110.823 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.781 HG13 HG22 ' A' ' 76' ' ' THR . 4.5 t -91.2 133.96 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 119.31 -0.956 . . . . 0.0 110.756 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.486 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 3.8 mmm180 -73.79 -78.09 0.1 Allowed 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 118.32 -1.352 . . . . 0.0 108.773 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.486 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 0.1 OUTLIER -149.79 153.61 37.1 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.526 -1.27 . . . . 0.0 112.022 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.16 167.58 9.9 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.175 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 -145.07 106.65 4.24 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 118.674 -1.21 . . . . 0.0 111.419 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 mt -100.21 106.19 18.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.364 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.566 HG22 ' HB2' ' A' ' 47' ' ' GLU . 43.3 p -107.45 136.66 46.88 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.901 -0.719 . . . . 0.0 110.494 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.576 ' CZ ' HG11 ' A' ' 45' ' ' VAL . 0.0 OUTLIER -134.34 132.05 39.05 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.614 -0.834 . . . . 0.0 112.036 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -158.66 153.46 24.6 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.416 ' C ' ' H ' ' A' ' 40' ' ' GLY . 2.0 mt-10 -49.57 171.43 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.645 -0.822 . . . . 0.0 111.62 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -75.52 21.01 0.15 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.665 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 38' ' ' GLU . . . -148.28 -102.38 0.28 Allowed Glycine 0 N--CA 1.487 2.05 0 C-N-CA 119.028 -1.558 . . . . 0.0 110.47 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' A' ' 42' ' ' ASN . . . -178.54 13.75 0.03 OUTLIER Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.382 -1.39 . . . . 0.0 110.23 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.41 ' H ' ' H ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -59.83 -16.73 30.82 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.212 -0.995 . . . . 0.0 110.3 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 p 171.86 72.22 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.289 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.507 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.82 123.09 11.99 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 121.322 1.348 . . . . 0.0 110.384 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.576 HG11 ' CZ ' ' A' ' 36' ' ' TYR . 5.8 t -51.45 -89.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.965 -1.094 . . . . 0.0 111.313 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.592 ' CG ' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -174.48 -140.69 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.036 -1.066 . . . . 0.0 111.305 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.592 ' H ' ' CG ' ' A' ' 46' ' ' GLN . 9.1 pt-20 -171.91 168.48 5.99 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.667 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -161.61 141.37 10.29 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.941 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.63 165.76 11.82 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.419 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.567 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -150.28 160.3 33.43 Favored Pre-proline 0 C--N 1.304 -1.411 0 C-N-CA 119.486 -0.885 . . . . 0.0 110.005 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -64.09 21.11 0.06 OUTLIER 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.158 1.239 . . . . 0.0 112.254 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 42.81 32.59 1.42 Allowed Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.675 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.14 -53.29 3.69 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.554 -0.858 . . . . 0.0 111.267 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -75.86 136.22 40.16 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.08 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.9 m -83.83 -13.58 53.38 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.529 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.4 p -131.4 152.95 50.19 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.915 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.413 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -155.35 157.51 37.24 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.292 -1.363 . . . . 0.0 112.137 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 49.4 m -98.5 130.97 45.09 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.708 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 59' ' ' ILE . 5.1 tp -130.43 121.64 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.433 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.9 t -117.23 -168.77 1.53 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.88 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.32 51.11 5.1 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.73 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -130.36 -160.97 1.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.701 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.4 mttm -136.35 139.25 29.17 Favored Pre-proline 0 N--CA 1.483 1.216 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.215 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -61.94 118.13 5.0 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 120.935 1.09 . . . . 0.0 111.614 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.79 89.08 0.07 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.531 -1.318 . . . . 0.0 111.031 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.5 p -163.48 138.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 C-N-CA 119.47 -0.892 . . . . 0.0 111.135 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.89 114.38 5.67 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.824 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -119.89 145.92 46.25 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 120.029 -0.668 . . . . 0.0 111.978 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.6 m -112.92 111.44 22.2 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.294 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.901 HD12 ' N ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -102.36 130.46 52.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.081 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.901 ' N ' HD12 ' A' ' 70' ' ' ILE . 2.2 m -133.41 141.83 48.05 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.398 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.416 HG13 HD11 ' A' ' 70' ' ' ILE . 33.1 m -130.18 138.22 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.275 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -120.36 122.95 41.91 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.006 -0.997 . . . . 0.0 108.733 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.792 ' HB3' ' OG ' ' A' ' 85' ' ' SER . . . -101.59 116.41 32.68 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.244 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 t -113.33 108.76 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.468 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.781 HG22 HG13 ' A' ' 29' ' ' VAL . 13.0 p -120.62 -82.96 0.65 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.406 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.7 109.59 0.64 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.74 -1.219 . . . . 0.0 110.409 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.8 mtp85 -100.97 -11.81 19.41 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.169 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.07 35.17 4.6 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.601 -1.285 . . . . 0.0 110.759 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -141.32 -48.5 0.4 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.481 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.77 164.99 23.48 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.714 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 84' ' ' SER . 2.8 Cg_exo -52.2 140.72 50.82 Favored 'Trans proline' 0 C--O 1.217 -0.575 0 C-N-CA 120.81 1.006 . . . . 0.0 111.319 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.74 -8.64 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.503 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 82' ' ' PRO . 93.9 p -58.92 99.03 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.329 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.792 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 61.3 p -84.17 -3.67 58.29 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.259 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.553 ' CB ' ' O ' ' A' ' 85' ' ' SER . 0.0 OUTLIER 96.8 67.16 0.01 OUTLIER Pre-proline 0 N--CA 1.518 2.929 0 O-C-N 124.598 1.186 . . . . 0.0 111.536 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.441 ' HD3' ' H ' ' A' ' 86' ' ' LYS . 2.9 Cg_exo -58.41 157.64 25.85 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.069 1.179 . . . . 0.0 110.598 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -150.94 156.4 6.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 C-N-CA 118.595 -1.242 . . . . 0.0 111.17 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 70.3 p -142.04 144.84 33.81 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.66 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -149.54 145.76 17.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.141 -1.024 . . . . 0.0 111.24 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.81 141.64 28.44 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.069 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -149.02 128.36 12.96 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.893 -1.123 . . . . 0.0 111.623 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -78.97 106.88 11.31 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.708 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 116.142 -1.885 . . . . 0.0 111.016 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 1' ' ' VAL . 2.5 p . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.847 0.356 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.59 -60.12 2.0 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.852 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -150.4 22.43 0.83 Allowed 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.896 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.4 t -59.88 133.34 89.58 Favored Pre-proline 0 CA--C 1.562 1.416 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.624 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.67 165.58 13.41 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 120.744 0.963 . . . . 0.0 111.13 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 ptt180 -172.4 144.23 1.5 Allowed 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.054 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 1.0 OUTLIER -71.72 89.21 1.01 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.486 -0.886 . . . . 0.0 111.053 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.466 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.4 mp -42.63 -79.53 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.728 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -175.38 -176.72 0.94 Allowed 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.649 -1.22 . . . . 0.0 112.229 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.2 t -93.35 146.95 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.64 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -94.25 -63.47 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.472 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.49 172.4 15.03 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.173 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.8 174.8 10.18 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.428 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -148.71 160.77 35.05 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.533 179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -52.98 -6.29 0.25 Allowed 'Trans proline' 0 C--O 1.216 -0.587 0 C-N-CA 121.364 1.376 . . . . 0.0 111.851 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 14' ' ' THR . 2.0 t -165.22 48.94 0.1 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.023 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.452 ' HG ' ' CB ' ' A' ' 14' ' ' THR . 0.1 OUTLIER 174.87 147.5 0.08 Allowed 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.336 -0.945 . . . . 0.0 110.798 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 tp -127.29 133.96 50.09 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.457 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.427 ' HA ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -98.83 111.75 24.04 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.395 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 pp -110.95 145.25 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.678 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.7 m -141.95 126.1 17.42 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.189 -1.004 . . . . 0.0 111.046 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.591 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 8.6 p90 -119.48 -144.1 0.36 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.14 -0.937 . . . . 0.0 109.778 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.591 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 19.7 t70 -136.07 172.09 13.51 Favored 'General case' 0 N--CA 1.514 2.729 0 C-N-CA 118.506 -1.278 . . . . 0.0 113.455 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.527 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -140.39 112.26 7.18 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.031 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.439 ' HB2' HG12 ' A' ' 27' ' ' VAL . 1.0 OUTLIER -63.51 -176.66 0.33 Allowed 'Trans proline' 0 C--O 1.213 -0.726 0 C-N-CA 120.308 0.672 . . . . 0.0 111.647 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.76 -28.36 33.34 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.841 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.473 ' CG2' ' N ' ' A' ' 28' ' ' THR . 1.4 p -59.74 157.99 2.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 118.685 -1.206 . . . . 0.0 110.74 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.473 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 0.2 OUTLIER -81.24 115.37 20.6 Favored 'General case' 0 C--N 1.293 -1.882 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.896 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.441 HG11 ' CD1' ' A' ' 32' ' ' TYR . 78.5 t -101.22 124.9 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.798 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.542 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.24 -63.68 1.11 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 118.715 -1.194 . . . . 0.0 110.126 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 9.0 m-85 -143.93 164.31 30.95 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.089 -1.045 . . . . 0.0 112.282 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.441 ' CD1' HG11 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -126.99 146.05 50.48 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.396 -1.274 . . . . 0.0 108.298 179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.572 ' C ' HD12 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -137.19 136.36 38.12 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.597 -1.241 . . . . 0.0 111.778 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.763 ' N ' HD12 ' A' ' 34' ' ' ILE . 3.5 mp -121.09 119.92 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 114.775 -1.102 . . . . 0.0 111.293 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.5 p -114.19 138.06 50.96 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.593 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.475 ' CE2' HG11 ' A' ' 45' ' ' VAL . 8.3 p90 -135.84 154.2 51.25 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.803 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.448 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -171.16 169.61 42.61 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -76.01 -162.9 0.25 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.297 -0.961 . . . . 0.0 111.847 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.8 t -75.92 144.02 41.32 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.31 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 37.2 50.44 1.64 Allowed Glycine 0 N--CA 1.499 2.878 0 C-N-CA 120.499 -0.857 . . . . 0.0 111.827 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 43' ' ' SER . . . -103.15 99.16 1.74 Allowed Glycine 0 N--CA 1.493 2.472 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.417 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -60.07 -7.42 1.81 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.663 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 41' ' ' GLY . 79.4 p -131.14 84.61 56.84 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.18 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -55.29 151.61 35.44 Favored 'Trans proline' 0 C--O 1.214 -0.685 0 C-N-CA 120.687 0.925 . . . . 0.0 111.858 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.475 HG11 ' CE2' ' A' ' 36' ' ' TYR . 50.6 t -48.78 -60.49 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.796 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -175.69 -169.79 0.37 Allowed 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.194 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -164.36 160.48 20.86 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.855 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.436 ' O ' ' CD1' ' A' ' 48' ' ' PHE . 42.3 p90 -155.51 142.46 19.08 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.726 -1.189 . . . . 0.0 111.185 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.9 140.78 29.13 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.124 -1.03 . . . . 0.0 111.348 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.6 155.69 80.3 Favored Pre-proline 0 C--N 1.305 -1.328 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.056 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' A' ' 53' ' ' SER . 0.9 OUTLIER -61.66 118.23 5.09 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 120.436 0.757 . . . . 0.0 110.795 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -49.41 -6.46 0.06 OUTLIER Glycine 0 N--CA 1.487 2.085 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.034 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -64.12 -36.45 84.06 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.25 179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.0 mtmt -83.72 157.63 22.08 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.059 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -120.65 -6.28 9.69 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.607 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.6 p -133.22 161.8 33.5 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.163 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.14 165.18 27.37 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.8 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.1 m -128.98 118.24 22.27 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.493 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.1 pt -108.4 149.23 11.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.701 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.4 t -144.88 151.27 38.46 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.971 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 136.19 7.6 1.71 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.715 ' H ' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -130.62 -179.61 5.39 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.12 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.551 ' N ' HD22 ' A' ' 62' ' ' LEU . 4.2 mptp? -125.66 118.05 24.5 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.814 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.1 112.64 1.74 Allowed 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 120.399 0.733 . . . . 0.0 111.346 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 94' ' ' THR . . . 158.28 30.84 0.02 OUTLIER Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.324 -1.417 . . . . 0.0 110.687 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.508 HG22 ' N ' ' A' ' 67' ' ' ASP . 7.7 p -165.68 164.8 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.406 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.508 ' N ' HG22 ' A' ' 66' ' ' VAL . 24.0 t70 -67.33 104.64 1.55 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.2 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.13 152.9 26.47 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.376 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.6 m -121.05 128.06 52.29 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.87 -0.732 . . . . 0.0 111.539 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.979 HD12 ' N ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -114.02 136.32 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.63 179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.979 ' N ' HD12 ' A' ' 70' ' ' ILE . 47.2 m -132.96 145.48 50.93 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.512 -0.875 . . . . 0.0 111.95 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.0 m -128.57 140.54 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.383 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -118.42 141.47 48.52 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.439 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.08 105.86 12.28 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.075 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.542 ' CG2' ' HE ' ' A' ' 33' ' ' ARG . 3.5 t -108.03 130.86 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.489 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.519 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 43.1 p -131.03 -119.94 0.22 Allowed 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.629 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.519 ' N ' ' OG1' ' A' ' 76' ' ' THR . . . 71.1 163.63 5.39 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.403 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.3 mtm180 -99.99 -76.8 0.54 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.212 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.04 33.17 0.15 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.356 -1.402 . . . . 0.0 110.804 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.461 ' CG ' ' N ' ' A' ' 81' ' ' SER . 14.8 t70 -130.92 -95.31 0.37 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.886 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.461 ' N ' ' CG ' ' A' ' 80' ' ' ASP . 0.8 OUTLIER -79.74 126.6 80.01 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.523 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -60.59 103.03 0.21 Allowed 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 120.508 0.806 . . . . 0.0 111.299 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.19 123.26 39.75 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.823 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.3 p -110.91 123.65 50.56 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.79 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.507 ' OG ' ' N ' ' A' ' 86' ' ' LYS . 37.0 t -67.33 -118.43 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.386 -0.925 . . . . 0.0 111.008 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.507 ' N ' ' OG ' ' A' ' 85' ' ' SER . 1.3 ttpp -151.53 85.92 4.79 Favored Pre-proline 0 C--N 1.305 -1.35 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.364 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -61.27 154.78 55.78 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 120.932 1.088 . . . . 0.0 110.977 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.5 tt -150.65 154.09 9.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 C-N-CA 118.851 -1.14 . . . . 0.0 111.27 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.609 ' OG ' HG23 ' A' ' 71' ' ' THR . 14.8 m -134.94 163.07 30.66 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.72 -0.792 . . . . 0.0 111.412 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.5 pt -145.64 137.74 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.648 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.06 128.99 46.06 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.702 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.521 ' CZ ' ' O ' ' A' ' 93' ' ' ARG . 13.5 t80 -152.23 149.51 28.8 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.246 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.521 ' O ' ' CZ ' ' A' ' 92' ' ' TYR . 0.0 OUTLIER -83.4 120.53 26.0 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.878 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 116.313 -1.803 . . . . 0.0 110.62 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -82.4 149.1 27.85 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.076 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -154.17 -5.1 0.17 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.728 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.4 t -59.79 127.02 84.68 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 119.708 -0.797 . . . . 0.0 110.485 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -56.33 176.55 0.19 Allowed 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 120.435 0.757 . . . . 0.0 111.324 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -172.14 -168.04 0.52 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.78 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 51.25 38.37 21.11 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.381 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mt -89.45 126.22 35.48 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.266 -0.973 . . . . 0.0 111.099 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -175.32 172.92 2.63 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.308 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.61 133.97 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.891 -0.724 . . . . 0.0 110.69 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.6 t -92.97 -39.44 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.266 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -164.37 166.33 20.81 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.876 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -148.63 82.71 1.46 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.746 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.69 160.73 58.82 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.234 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -60.5 -4.84 3.63 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 121.093 1.196 . . . . 0.0 111.499 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.424 ' O ' ' OG ' ' A' ' 60' ' ' SER . 16.2 m -149.13 39.93 0.85 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.523 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 172.68 143.7 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.097 -1.041 . . . . 0.0 111.515 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.54 140.01 53.34 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.231 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.35 116.74 26.83 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.915 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 pp -112.55 150.51 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.228 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.12 140.36 29.38 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 118.908 -1.117 . . . . 0.0 111.652 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.616 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 3.6 p90 -142.9 -147.78 0.22 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.555 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.616 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 18.1 t70 -154.06 154.46 33.7 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 117.738 -1.585 . . . . 0.0 112.721 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -118.2 149.54 45.92 Favored Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.214 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.74 -171.66 0.09 OUTLIER 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 121.126 1.217 . . . . 0.0 111.414 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.07 -25.18 16.56 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.261 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 m -61.58 146.09 12.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.975 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.37 92.28 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.229 -0.989 . . . . 0.0 110.773 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.441 ' H ' HG23 ' A' ' 29' ' ' VAL . 2.1 t -77.7 149.56 5.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.369 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.7 mmm180 -78.44 -70.75 0.47 Allowed 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.649 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.63 161.32 41.94 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.125 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -120.51 131.97 54.96 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.957 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.9 ttp-105 -118.59 113.09 20.72 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.244 -0.983 . . . . 0.0 110.525 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.0 mt -95.84 122.91 47.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 114.803 -1.09 . . . . 0.0 110.338 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.4 p -125.69 130.87 52.41 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.212 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.728 ' CZ ' HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -148.14 166.73 27.0 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.671 -1.212 . . . . 0.0 112.306 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 161.94 146.73 4.76 Favored Glycine 0 N--CA 1.485 1.922 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.55 ' CG ' ' H ' ' A' ' 41' ' ' GLY . 4.7 pt-20 -53.53 169.93 0.12 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.577 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 63.4 m -50.62 -62.34 1.66 Allowed 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.717 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.91 54.93 0.1 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.593 -1.289 . . . . 0.0 110.434 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.55 ' H ' ' CG ' ' A' ' 38' ' ' GLU . . . -75.26 -109.44 0.1 OUTLIER Glycine 0 N--CA 1.486 2.03 0 C-N-CA 119.098 -1.525 . . . . 0.0 110.614 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -135.2 10.05 3.51 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.485 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.7 m -167.06 69.85 0.99 Allowed Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 118.559 -1.256 . . . . 0.0 112.232 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.34 153.63 77.37 Favored 'Trans proline' 0 C--N 1.321 -0.912 0 C-N-CA 121.199 1.266 . . . . 0.0 110.75 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.7 HG12 ' N ' ' A' ' 46' ' ' GLN . 49.3 t -74.47 -116.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.008 -1.077 . . . . 0.0 111.17 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.7 ' N ' HG12 ' A' ' 45' ' ' VAL . 4.3 pt20 -176.1 -133.12 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.361 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -171.1 161.26 6.72 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.346 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.564 ' CE2' ' OH ' ' A' ' 36' ' ' TYR . 2.7 p90 -152.56 161.22 42.88 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.0 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 p -113.75 156.85 23.08 Favored 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 119.534 -0.866 . . . . 0.0 112.293 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.779 HG23 ' H ' ' A' ' 52' ' ' GLY . 2.4 m -147.42 154.29 45.06 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.956 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.408 ' C ' ' N ' ' A' ' 53' ' ' SER . 1.1 Cg_endo -63.1 23.28 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 121.016 1.144 . . . . 0.0 112.931 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.779 ' H ' HG23 ' A' ' 50' ' ' VAL . . . 52.57 13.93 2.19 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 119.083 -1.532 . . . . 0.0 110.693 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.408 ' N ' ' C ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -74.93 -39.51 61.34 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.194 -179.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.422 ' HG2' ' H ' ' A' ' 56' ' ' THR . 3.2 ttpt -96.72 130.47 43.96 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.119 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.9 m -87.95 24.46 1.79 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.558 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.422 ' H ' ' HG2' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -143.2 164.27 30.64 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.591 -0.844 . . . . 0.0 110.789 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.63 141.22 17.87 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.273 -0.971 . . . . 0.0 110.668 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.0 m -117.19 139.33 50.9 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.049 -0.66 . . . . 0.0 111.401 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.728 HD12 ' CZ ' ' A' ' 36' ' ' TYR . 11.0 tt -141.59 140.41 31.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.319 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 16' ' ' THR . 4.2 t -141.86 176.45 8.92 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 80.22 48.48 6.41 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.506 -1.331 . . . . 0.0 110.193 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.37 -158.83 0.91 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.114 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -135.41 101.52 11.0 Favored Pre-proline 0 N--CA 1.487 1.421 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.828 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -61.95 153.86 65.69 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 120.598 0.865 . . . . 0.0 111.671 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.61 47.97 4.1 Favored Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.608 -1.282 . . . . 0.0 110.577 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.468 HG22 ' N ' ' A' ' 67' ' ' ASP . 8.9 p -161.87 160.31 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 C-N-CA 119.009 -1.077 . . . . 0.0 111.595 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.468 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.3 OUTLIER -62.84 153.61 32.61 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.081 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -149.81 117.48 6.19 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.774 -1.171 . . . . 0.0 111.648 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.53 119.52 36.23 Favored 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.487 -0.885 . . . . 0.0 109.313 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.736 HD12 ' N ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -112.7 125.98 70.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 119.423 -0.911 . . . . 0.0 111.403 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.736 ' N ' HD12 ' A' ' 70' ' ' ILE . 54.6 m -131.14 138.86 49.67 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.485 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 72' ' ' VAL . 17.8 m -126.22 131.3 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.76 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -100.95 117.0 34.14 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.232 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.05 110.21 22.49 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.528 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.6 t -110.35 117.04 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 119.205 -0.998 . . . . 0.0 111.956 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.417 HG22 HG13 ' A' ' 29' ' ' VAL . 1.3 p -121.32 -170.05 1.96 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.586 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 169.31 158.86 13.78 Favored Glycine 0 N--CA 1.485 1.934 0 C-N-CA 117.978 -2.058 . . . . 0.0 111.753 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -113.4 -172.34 2.05 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.797 -0.702 . . . . 0.0 109.299 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 44.1 -102.15 0.03 OUTLIER Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.022 -1.561 . . . . 0.0 110.436 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -159.27 -23.41 0.07 Allowed 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.49 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.78 162.42 70.44 Favored Pre-proline 0 C--N 1.307 -1.248 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.653 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -61.89 154.09 63.74 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 121.398 1.398 . . . . 0.0 111.326 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.2 -139.52 0.22 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.567 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.499 ' OG ' ' N ' ' A' ' 85' ' ' SER . 0.1 OUTLIER -98.54 171.4 8.17 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.524 -0.871 . . . . 0.0 111.084 179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 86' ' ' LYS . 52.8 m -115.52 -75.51 0.58 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.806 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 85' ' ' SER . 4.2 ttmt 83.96 67.34 0.09 OUTLIER Pre-proline 0 N--CA 1.499 1.983 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.324 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.428 ' HD3' ' H ' ' A' ' 86' ' ' LYS . 5.5 Cg_endo -72.22 166.86 28.47 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 121.842 1.694 . . . . 0.0 112.944 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 88' ' ' ILE . 13.1 tt -152.27 127.86 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.37 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 86.6 p -117.17 150.88 37.99 Favored 'General case' 0 N--CA 1.496 1.872 0 C-N-CA 119.592 -0.843 . . . . 0.0 112.339 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.82 133.37 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.283 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 91' ' ' ASN . 19.2 p-10 -80.57 145.41 31.77 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.1 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -160.1 132.67 6.47 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.46 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 1.4 ptp180 -90.94 123.84 34.74 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.109 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.837 0 CA-C-O 116.343 -1.789 . . . . 0.0 110.663 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.617 ' O ' HG12 ' A' ' 1' ' ' VAL . 92.5 t . . . . . 0 C--O 1.214 -0.797 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.762 ' O ' HG21 ' A' ' 29' ' ' VAL . 50.7 m -146.27 143.74 29.38 Favored 'General case' 0 C--O 1.203 -1.363 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.735 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.591 ' H ' ' HD2' ' A' ' 25' ' ' PRO . 4.5 t0 -141.71 -64.73 0.43 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.961 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.7 t -100.29 109.57 57.18 Favored Pre-proline 0 N--CA 1.499 2.015 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.002 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -74.41 120.52 6.27 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 120.669 0.912 . . . . 0.0 110.679 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.502 ' O ' ' N ' ' A' ' 8' ' ' LEU . 1.8 mtm180 -105.8 -158.67 0.67 Allowed 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.354 -0.939 . . . . 0.0 112.511 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -39.32 86.19 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.126 -0.943 . . . . 0.0 113.502 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.841 HD23 ' H ' ' A' ' 8' ' ' LEU . 1.0 OUTLIER -101.76 170.07 8.4 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.501 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -175.72 -179.02 1.15 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.392 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.4 t -91.21 127.56 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.857 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 4.2 p -92.96 -21.1 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.584 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . -179.86 161.8 1.0 Allowed 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.478 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -134.81 115.66 13.94 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.219 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -96.09 162.07 25.09 Favored Pre-proline 0 C--N 1.299 -1.619 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.533 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.608 ' C ' HG23 ' A' ' 16' ' ' THR . 7.9 Cg_exo -47.23 96.6 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 120.763 0.976 . . . . 0.0 110.704 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.608 HG23 ' C ' ' A' ' 15' ' ' PRO . 2.2 p 70.49 47.15 0.52 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.662 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -165.56 119.73 1.22 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.388 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 tp -105.72 137.0 44.31 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.287 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.28 103.03 8.26 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.855 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pt -97.95 173.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.505 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.57 131.28 3.03 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.865 -1.134 . . . . 0.0 111.242 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.426 ' CE3' ' N ' ' A' ' 22' ' ' TRP . 10.4 p90 -123.62 175.33 6.88 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 119.156 -1.017 . . . . 0.0 111.028 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' CG ' ' N ' ' A' ' 24' ' ' ALA . 31.0 t70 -104.59 171.82 7.12 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 114.35 -1.296 . . . . 0.0 112.11 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' A' ' 2' ' ' SER . . . -173.12 158.95 3.41 Favored Pre-proline 0 C--N 1.306 -1.307 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.312 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.591 ' HD2' ' H ' ' A' ' 3' ' ' ASP . 11.0 Cg_endo -74.17 -169.71 0.62 Allowed 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 121.086 1.191 . . . . 0.0 111.336 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.82 12.52 28.89 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.127 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 28' ' ' THR . 2.3 p -79.29 162.33 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.202 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.547 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 7.8 p -80.28 132.07 35.77 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.825 -1.08 . . . . 0.0 110.574 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.762 HG21 ' O ' ' A' ' 2' ' ' SER . 74.3 t -133.71 157.54 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.245 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.464 ' N ' HG12 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -74.58 -65.43 0.86 Allowed 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.658 -0.817 . . . . 0.0 111.047 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.485 ' HE1' HG21 ' A' ' 75' ' ' VAL . 8.6 p90 -160.25 -178.62 7.09 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 117.924 -1.51 . . . . 0.0 113.317 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.42 174.41 10.65 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.704 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -142.59 148.28 37.25 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.17 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.6 mp -140.28 108.11 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.121 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -119.18 137.63 53.5 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.476 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -137.54 140.18 40.9 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 118.846 -1.142 . . . . 0.0 110.899 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.38 151.7 21.03 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.72 159.34 33.97 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.634 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.726 HG22 ' O ' ' A' ' 39' ' ' THR . 22.2 m -76.07 48.59 0.51 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.885 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 41' ' ' GLY . . . 154.5 -83.86 0.15 Allowed Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.693 -1.241 . . . . 0.0 110.128 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 40' ' ' GLY . . . 38.72 -150.17 0.07 OUTLIER Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.012 -1.089 . . . . 0.0 110.869 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.85 -14.13 14.64 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.476 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 176.88 157.53 0.45 Allowed Pre-proline 0 C--N 1.305 -1.335 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.329 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -62.32 132.04 36.83 Favored 'Trans proline' 0 C--O 1.216 -0.616 0 C-N-CA 121.199 1.266 . . . . 0.0 111.481 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.0 t -54.36 -75.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.257 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.444 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.7 OUTLIER -175.71 -176.29 0.85 Allowed 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 118.525 -1.27 . . . . 0.0 111.513 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' A' ' 46' ' ' GLN . 9.0 pt-20 -158.16 170.53 22.06 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.205 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.485 ' HE1' HD11 ' A' ' 59' ' ' ILE . 8.8 p90 -165.92 145.9 6.42 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 118.959 -1.096 . . . . 0.0 111.02 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 69.9 p -91.14 169.92 10.45 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.404 -0.919 . . . . 0.0 111.79 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 52' ' ' GLY . 9.3 p -161.36 136.31 5.49 Favored Pre-proline 0 C--N 1.304 -1.399 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.25 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.6 Cg_endo -61.7 22.88 0.05 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 C-N-CA 120.955 1.103 . . . . 0.0 112.828 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 53.26 7.86 0.63 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.491 -1.338 . . . . 0.0 110.312 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.493 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -71.62 -29.42 64.64 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.86 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.7 mttm -94.45 153.0 18.15 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.808 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.75 -12.65 17.48 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.721 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 p -130.61 170.99 13.55 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.092 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -156.37 132.06 9.59 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.578 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.7 m -104.13 128.75 51.82 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.205 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.485 HD11 ' HE1' ' A' ' 48' ' ' PHE . 10.7 mt -126.82 139.76 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.992 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.91 131.73 47.59 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.411 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 152.67 2.29 0.19 Allowed Glycine 0 N--CA 1.484 1.881 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.587 ' N ' HD12 ' A' ' 62' ' ' LEU . 7.2 mp -91.43 178.1 6.05 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.29 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.639 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 1.0 OUTLIER -176.82 -42.38 0.0 OUTLIER Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.733 179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.639 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 4.3 Cg_endo -79.81 -172.02 1.41 Allowed 'Trans proline' 0 C--O 1.217 -0.564 0 C-N-CA 121.548 1.499 . . . . 0.0 111.734 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -142.91 81.61 0.23 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.575 -1.81 . . . . 0.0 108.575 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.8 HG22 ' H ' ' A' ' 67' ' ' ASP . 11.8 p -132.05 -177.78 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.942 -0.703 . . . . 0.0 111.998 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.8 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -66.93 125.38 25.75 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.142 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -125.09 130.96 53.31 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.831 -0.747 . . . . 0.0 111.318 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.81 123.81 48.56 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.721 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 pp -116.05 164.16 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.165 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 95.9 m -152.18 143.74 23.48 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.632 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.91 139.73 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.715 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -109.07 143.26 38.64 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.536 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 3' ' ' ASP . . . -120.13 91.48 3.55 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.086 -0.961 . . . . 0.0 108.812 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.485 HG21 ' HE1' ' A' ' 31' ' ' TYR . 13.2 t -94.9 107.65 19.75 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 C-N-CA 119.095 -1.042 . . . . 0.0 113.277 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 77' ' ' GLY . 80.6 m -125.27 -24.22 4.01 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 76' ' ' THR . . . 53.42 127.34 0.01 OUTLIER Glycine 0 N--CA 1.497 2.715 0 CA-C-N 113.977 -1.465 . . . . 0.0 112.587 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.417 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -104.68 136.04 44.96 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.093 -0.643 . . . . 0.0 109.717 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.06 -101.98 0.8 Allowed Glycine 0 N--CA 1.489 2.17 0 C-N-CA 118.824 -1.655 . . . . 0.0 109.819 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.436 ' H ' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -160.53 -40.02 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.724 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.537 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -83.41 -43.91 0.83 Allowed Pre-proline 0 N--CA 1.486 1.333 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.66 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' A' ' 81' ' ' SER . 3.2 Cg_exo -68.04 31.1 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.127 1.218 . . . . 0.0 112.511 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 81' ' ' SER . . . -49.15 -54.3 16.97 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 119.065 -1.054 . . . . 0.0 110.487 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.2 t -52.8 115.63 1.92 Allowed 'General case' 0 C--N 1.296 -1.72 0 C-N-CA 119.375 -0.93 . . . . 0.0 110.067 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.4 m -92.57 -148.52 0.24 Allowed 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.762 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.11 86.73 57.3 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.451 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.71 167.42 8.47 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 120.866 1.044 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 88' ' ' ILE . 9.4 tt -143.9 139.59 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.949 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 80.1 p -124.63 150.99 45.42 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.859 -0.737 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -143.72 163.0 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.505 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -103.05 147.64 26.71 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.147 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -154.12 135.49 14.15 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.811 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.444 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 5.6 ptt85 -90.32 107.04 18.9 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.46 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 116.33 -1.795 . . . . 0.0 110.681 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 120.972 0.415 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 p -166.25 148.25 6.82 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.928 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.4 -8.29 15.08 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.956 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.438 ' O ' ' O ' ' A' ' 5' ' ' PRO . 44.1 t -93.73 133.89 27.23 Favored Pre-proline 0 C--N 1.305 -1.338 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.837 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.438 ' O ' ' O ' ' A' ' 4' ' ' VAL . 3.7 Cg_exo -54.56 -166.59 0.01 OUTLIER 'Trans proline' 0 C--O 1.214 -0.682 0 N-CA-C 110.225 -0.721 . . . . 0.0 110.225 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.575 ' O ' HD13 ' A' ' 8' ' ' LEU . 13.8 ptt180 -163.25 175.0 11.37 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 118.106 -1.438 . . . . 0.0 112.73 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 8' ' ' LEU . 57.4 m-20 -25.04 98.36 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.234 -1.348 . . . . 0.0 113.46 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.799 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -57.08 -163.53 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.75 179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -168.65 136.44 2.05 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 118.026 -1.47 . . . . 0.0 112.646 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -88.46 142.4 12.96 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.156 -0.929 . . . . 0.0 108.879 179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 11' ' ' VAL . 3.6 p -130.52 1.62 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 119.074 -1.05 . . . . 0.0 112.177 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.487 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 177.79 155.61 0.34 Allowed 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.6 -1.24 . . . . 0.0 111.395 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -156.74 104.79 2.17 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.2 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -91.66 160.81 35.66 Favored Pre-proline 0 C--N 1.309 -1.153 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.002 179.88 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.29 -0.4 0.31 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 120.998 1.132 . . . . 0.0 112.098 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.472 ' H ' ' C ' ' A' ' 14' ' ' THR . 25.5 p -151.39 28.97 0.64 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.955 -1.098 . . . . 0.0 111.699 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.47 151.05 0.57 Allowed 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.69 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.6 123.98 30.71 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.975 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 tp -104.14 116.66 32.59 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.803 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.0 pt -107.1 173.49 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.123 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -162.68 139.03 7.47 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.295 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.589 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 18.3 p90 -140.22 -154.15 0.5 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.402 -1.319 . . . . 0.0 113.052 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.589 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 36.3 t70 -99.48 -177.28 3.53 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.958 -0.697 . . . . 0.0 112.408 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.548 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . -164.6 119.98 1.04 Allowed Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.12 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.63 167.78 4.8 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 120.435 0.757 . . . . 0.0 111.757 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.83 24.51 6.06 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.731 -0.787 . . . . 0.0 111.104 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.694 HG12 ' N ' ' A' ' 28' ' ' THR . 44.9 t -101.79 173.48 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.473 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.694 ' N ' HG12 ' A' ' 27' ' ' VAL . 25.5 m -74.5 78.25 1.94 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.352 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 27' ' ' VAL . 2.2 t -79.62 114.9 21.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.499 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.428 ' H ' ' HA ' ' A' ' 76' ' ' THR . 2.7 tpt85 -56.03 -61.46 2.36 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.315 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.74 169.33 21.66 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 118.611 -1.236 . . . . 0.0 112.151 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -116.55 158.32 23.85 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.96 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -138.58 112.25 8.29 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.215 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.4 mt -102.18 127.37 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.866 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.9 137.57 51.5 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-N 115.425 -0.807 . . . . 0.0 108.958 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.574 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 3.0 p90 -145.55 154.93 42.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 118.351 -1.339 . . . . 0.0 112.204 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -176.24 138.53 4.14 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -64.23 145.48 55.91 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 118.976 -1.09 . . . . 0.0 110.538 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 m -75.31 160.08 30.73 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.238 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.29 -44.04 3.3 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.56 -1.305 . . . . 0.0 110.49 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 43' ' ' SER . . . -76.82 123.59 6.69 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.596 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -75.86 18.86 0.23 Allowed 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.535 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.481 ' H ' ' C ' ' A' ' 41' ' ' GLY . 12.9 t -132.05 81.4 62.08 Favored Pre-proline 0 N--CA 1.486 1.337 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.758 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -60.99 150.77 82.42 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 121.015 1.144 . . . . 0.0 111.305 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.452 HG11 ' CE2' ' A' ' 36' ' ' TYR . 95.0 t -57.01 -81.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.475 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.462 ' CG ' ' H ' ' A' ' 47' ' ' GLU . 3.8 tp60 -171.57 -151.38 0.07 Allowed 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.659 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.462 ' H ' ' CG ' ' A' ' 46' ' ' GLN . 3.2 pt-20 -170.18 161.69 8.5 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.377 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -159.02 156.6 29.63 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.869 -1.132 . . . . 0.0 111.054 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.4 p -101.67 157.97 16.44 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.754 -0.779 . . . . 0.0 111.641 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 50' ' ' VAL . 11.4 p -165.61 134.14 2.51 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.462 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.491 ' C ' ' H ' ' A' ' 53' ' ' SER . 6.3 Cg_exo -56.49 124.97 17.54 Favored 'Trans proline' 0 C--O 1.216 -0.595 0 C-N-CA 120.274 0.649 . . . . 0.0 111.484 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.05 1.7 0.79 Allowed Glycine 0 N--CA 1.483 1.806 0 C-N-CA 119.45 -1.357 . . . . 0.0 110.694 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.491 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -59.57 -35.28 73.94 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 118.845 -1.142 . . . . 0.0 109.636 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -98.4 120.25 38.5 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.059 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.1 m -79.59 21.25 0.52 Allowed 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.122 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 65.4 p -143.72 149.3 36.96 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.308 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.62 150.11 26.03 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.394 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.1 m -95.05 158.44 15.46 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.128 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -146.9 139.01 19.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 C-N-CA 119.506 -0.877 . . . . 0.0 110.026 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -149.3 -178.08 6.2 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.238 -0.985 . . . . 0.0 111.061 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.32 21.65 21.76 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.779 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.06 -164.65 1.39 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.993 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.645 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -177.68 -42.39 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.355 0 C-N-CA 119.433 -0.907 . . . . 0.0 112.295 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.645 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 1.9 Cg_endo -77.16 -170.16 0.87 Allowed 'Trans proline' 0 C--O 1.214 -0.725 0 C-N-CA 121.762 1.641 . . . . 0.0 112.87 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -144.71 84.21 0.19 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.688 HG22 ' N ' ' A' ' 67' ' ' ASP . 12.2 p -130.2 177.55 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 120.168 -0.613 . . . . 0.0 111.387 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.688 ' N ' HG22 ' A' ' 66' ' ' VAL . 7.9 t70 -45.44 148.27 0.7 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.097 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.58 111.3 5.02 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 118.528 -1.269 . . . . 0.0 112.294 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.48 132.98 34.27 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.181 -1.008 . . . . 0.0 108.85 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.549 HG23 ' O ' ' A' ' 70' ' ' ILE . 7.2 tt -127.64 132.17 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.192 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.586 HG22 ' CB ' ' A' ' 89' ' ' SER . 24.1 p -125.1 121.98 35.86 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.575 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.37 129.0 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.641 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -103.72 140.81 37.1 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.406 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -118.97 91.22 3.5 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.135 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.0 t -93.8 124.03 46.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.717 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.574 HG23 ' N ' ' A' ' 77' ' ' GLY . 13.3 t -112.14 -159.0 0.67 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.062 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.574 ' N ' HG23 ' A' ' 76' ' ' THR . . . 156.92 109.3 0.29 Allowed Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.267 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.8 tpt180 -65.81 -46.28 79.2 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.849 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -94.69 -93.21 1.66 Allowed Glycine 0 N--CA 1.487 2.051 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.198 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 2.1 p-10 -156.31 -11.61 0.1 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 119.421 -0.911 . . . . 0.0 111.166 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.7 152.78 78.04 Favored Pre-proline 0 N--CA 1.484 1.259 0 C-N-CA 118.824 -1.151 . . . . 0.0 110.697 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.64 146.18 95.26 Favored 'Trans proline' 0 C--O 1.217 -0.57 0 C-N-CA 121.205 1.27 . . . . 0.0 111.836 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.86 108.67 10.01 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.69 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.4 t -67.01 122.11 17.03 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.377 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.434 ' OG ' ' N ' ' A' ' 86' ' ' LYS . 94.1 p -113.69 -128.74 0.29 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.538 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.434 ' N ' ' OG ' ' A' ' 85' ' ' SER . 1.4 pttt -152.08 91.96 3.61 Favored Pre-proline 0 N--CA 1.484 1.272 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.86 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -57.71 -179.76 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.108 1.205 . . . . 0.0 112.227 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.412 ' O ' ' OG ' ' A' ' 89' ' ' SER . 12.4 tt -145.89 154.62 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 119.561 -0.856 . . . . 0.0 109.696 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.586 ' CB ' HG22 ' A' ' 71' ' ' THR . 15.2 m -161.34 147.21 14.15 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 118.446 -1.302 . . . . 0.0 112.204 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.553 HD11 ' CD2' ' A' ' 8' ' ' LEU . 1.2 pt -150.01 164.38 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.228 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -93.74 136.4 34.06 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.497 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -140.88 133.55 28.74 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.851 -0.739 . . . . 0.0 110.371 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -87.84 108.51 19.19 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.329 -0.948 . . . . 0.0 110.589 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 116.502 -1.713 . . . . 0.0 110.745 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.661 ' O ' HG22 ' A' ' 1' ' ' VAL . 5.8 p . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 121.014 0.435 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 m 53.82 -168.21 0.06 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.171 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -133.13 32.36 3.74 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.531 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.2 t -62.26 145.2 94.2 Favored Pre-proline 0 C--N 1.303 -1.429 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.768 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -51.28 169.87 0.19 Allowed 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 120.784 0.99 . . . . 0.0 111.204 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.49 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 6.1 ptm180 -175.46 173.88 2.4 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.61 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 2.9 t70 74.72 37.99 0.5 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.371 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 mp -86.69 110.79 20.11 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.592 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -139.46 162.36 35.24 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.8 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.477 HG13 HD11 ' A' ' 18' ' ' LEU . 54.0 t -92.6 102.25 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.123 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.643 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 47.8 t -71.78 3.42 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 119.296 -0.961 . . . . 0.0 111.474 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 168.81 154.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.019 -1.072 . . . . 0.0 111.341 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.58 93.85 2.11 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.684 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -91.27 162.27 32.63 Favored Pre-proline 0 N--CA 1.485 1.288 0 C-N-CA 119.436 -0.905 . . . . 0.0 110.613 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.72 9.55 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 121.428 1.419 . . . . 0.0 112.089 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 14' ' ' THR . 4.4 t -168.77 28.1 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.063 -1.055 . . . . 0.0 110.806 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -173.65 141.68 0.87 Allowed 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.553 -0.859 . . . . 0.0 110.526 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.623 HD12 ' H ' ' A' ' 19' ' ' LEU . 19.2 tp -130.62 146.49 52.13 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.789 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.623 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -128.33 106.64 9.16 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.184 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.415 HG21 HD13 ' A' ' 20' ' ' ILE . 2.2 pt -103.35 169.7 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.461 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 20' ' ' ILE . 8.2 m -164.04 134.03 4.11 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.457 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.527 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 14.3 p90 -133.76 -157.83 0.84 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.682 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.527 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 30.4 t70 -106.42 176.31 5.21 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.493 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -154.71 100.39 2.39 Favored Pre-proline 0 CA--C 1.558 1.258 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.77 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -57.15 175.61 0.32 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 120.788 0.992 . . . . 0.0 112.231 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -93.07 -5.22 50.91 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.5 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.421 ' H ' HG23 ' A' ' 27' ' ' VAL . 3.2 t -60.75 163.32 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 118.905 -1.118 . . . . 0.0 110.132 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.4 m -62.76 98.48 0.12 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.656 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 t -95.19 129.74 44.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.345 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.14 -65.85 0.96 Allowed 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.069 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -160.48 163.59 32.83 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.038 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -120.42 146.89 45.76 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.691 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -129.03 110.08 11.75 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.779 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.858 ' N ' HD12 ' A' ' 34' ' ' ILE . 2.7 mp -100.81 108.48 23.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.788 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 p -104.63 147.71 27.35 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.213 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.735 ' CD2' HD11 ' A' ' 59' ' ' ILE . 26.5 p90 -149.39 148.36 29.39 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 117.987 -1.485 . . . . 0.0 112.088 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 174.26 150.85 7.92 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -78.56 -174.54 3.89 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.767 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.458 ' OG1' ' N ' ' A' ' 40' ' ' GLY . 3.5 t -51.52 176.78 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.684 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.458 ' N ' ' OG1' ' A' ' 39' ' ' THR . . . 103.35 83.28 1.7 Allowed Glycine 0 N--CA 1.494 2.56 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.089 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.28 -136.54 28.48 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.138 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -86.41 -66.91 0.85 Allowed 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.316 -0.953 . . . . 0.0 110.606 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 p 175.19 71.88 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.377 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.869 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -73.07 42.52 0.63 Allowed 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 121.7 1.6 . . . . 0.0 111.914 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.671 HG12 ' N ' ' A' ' 46' ' ' GLN . 21.3 t -110.22 -86.05 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.099 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.671 ' N ' HG12 ' A' ' 45' ' ' VAL . 30.7 tt0 -168.72 166.98 11.5 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 117.482 -1.687 . . . . 0.0 112.606 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.488 ' N ' ' CG ' ' A' ' 46' ' ' GLN . 3.3 pt-20 -161.17 156.42 24.3 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.445 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 1.4 p90 -139.58 167.13 22.8 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.488 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 81.5 p -131.27 148.66 52.71 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.606 -0.837 . . . . 0.0 111.538 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.688 HG23 ' H ' ' A' ' 52' ' ' GLY . 10.3 m -140.72 151.78 64.09 Favored Pre-proline 0 N--CA 1.486 1.349 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.861 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.16 14.35 0.05 OUTLIER 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 120.898 1.065 . . . . 0.0 112.173 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.688 ' H ' HG23 ' A' ' 50' ' ' VAL . . . 70.69 16.41 74.17 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.809 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.82 -40.34 20.5 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.441 -0.904 . . . . 0.0 110.915 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -84.16 121.44 27.46 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.623 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.7 m -83.03 -9.79 59.08 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.062 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.66 168.63 11.19 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.285 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -162.1 136.15 6.59 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 118.514 -1.275 . . . . 0.0 111.947 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.3 m -105.14 136.88 43.82 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.826 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.735 HD11 ' CD2' ' A' ' 36' ' ' TYR . 0.8 OUTLIER -134.13 144.56 35.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.429 179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.14 135.62 20.63 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.112 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 166.86 -37.44 0.24 Allowed Glycine 0 N--CA 1.486 1.981 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.387 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -163.32 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.75 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.647 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -176.91 -40.79 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.561 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.604 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.647 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 8.7 Cg_endo -83.4 -169.34 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 121.579 1.519 . . . . 0.0 111.731 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -124.33 74.68 0.4 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.667 HG22 ' N ' ' A' ' 67' ' ' ASP . 8.9 p -119.4 170.81 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 120.253 -0.579 . . . . 0.0 112.077 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.667 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -64.86 97.51 0.23 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.442 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -89.59 130.26 35.92 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.631 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.41 149.2 29.06 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.793 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.5 pp -140.6 161.09 24.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.629 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 20.4 m -149.61 123.32 9.22 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.68 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.7 m -110.03 136.92 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.616 -0.834 . . . . 0.0 110.355 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -110.47 116.25 31.06 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.294 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.66 97.64 8.88 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.256 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 64.0 t -99.53 116.9 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.483 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 68.7 p -116.72 -123.69 0.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.683 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.93 142.36 0.02 OUTLIER Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.553 -1.308 . . . . 0.0 110.573 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 mmm180 -71.0 -74.96 0.13 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.836 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.3 18.88 0.02 OUTLIER Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.589 -1.291 . . . . 0.0 110.451 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 11.6 p-10 -137.32 -53.33 0.68 Allowed 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.867 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.29 134.17 31.83 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.392 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.09 102.72 0.39 Allowed 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 120.764 0.976 . . . . 0.0 111.462 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -131.07 70.7 1.46 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.99 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.8 t -92.46 137.04 32.7 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.746 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 14.1 m -82.01 -134.19 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.419 -0.912 . . . . 0.0 111.452 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -149.56 110.39 3.38 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.308 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -59.87 170.66 3.46 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 120.452 0.768 . . . . 0.0 111.231 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -155.81 156.04 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 118.819 -1.153 . . . . 0.0 110.992 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.39 156.52 46.37 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.684 -0.807 . . . . 0.0 110.942 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -145.49 152.06 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.979 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.98 146.92 34.43 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.77 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -158.66 145.86 17.63 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.308 -0.957 . . . . 0.0 110.682 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.465 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 1.5 ptt85 -83.85 98.79 9.93 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.026 -1.069 . . . . 0.0 110.863 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 116.359 -1.781 . . . . 0.0 110.254 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 t -61.86 117.35 5.77 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.903 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.423 ' H ' ' H ' ' A' ' 4' ' ' VAL . 1.2 m-20 -161.27 -11.65 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.694 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.439 ' H ' HG23 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -49.4 133.02 18.0 Favored Pre-proline 0 N--CA 1.486 1.365 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.257 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 4' ' ' VAL . 4.6 Cg_exo -55.6 -164.07 0.01 OUTLIER 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 120.464 0.776 . . . . 0.0 111.365 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -174.61 178.82 1.85 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.117 -1.033 . . . . 0.0 111.617 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 52.94 43.08 32.1 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.576 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 mp -92.58 126.3 37.6 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.369 -0.933 . . . . 0.0 110.273 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -171.97 161.17 5.63 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.357 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.9 t -89.06 115.34 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.32 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.663 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 2.7 t -69.43 -26.58 31.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.106 -1.037 . . . . 0.0 111.565 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 167.59 178.51 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.209 -0.996 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -140.96 119.74 12.56 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.626 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.9 162.49 22.06 Favored Pre-proline 0 C--N 1.3 -1.584 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.708 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.489 ' O ' ' CB ' ' A' ' 16' ' ' THR . 4.5 Cg_exo -53.95 94.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 120.733 0.955 . . . . 0.0 110.673 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.489 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 1.0 OUTLIER 81.06 41.66 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.881 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.32 137.51 1.89 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.685 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 mt -119.64 148.6 43.16 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.895 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 19' ' ' LEU . 1.7 tt -129.66 105.53 8.11 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.006 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.45 168.3 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.449 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -161.82 132.21 4.93 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.591 -1.244 . . . . 0.0 111.584 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.549 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 6.8 p90 -131.21 -141.97 0.22 Allowed 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.556 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.549 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 6.7 t70 -166.33 163.97 17.55 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 117.633 -1.627 . . . . 0.0 112.645 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.517 ' N ' ' OD1' ' A' ' 23' ' ' ASP . . . -130.79 136.17 28.5 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.588 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.17 -170.98 0.05 OUTLIER 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 120.423 0.749 . . . . 0.0 111.183 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -95.18 6.46 48.97 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.82 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.764 HG22 ' H ' ' A' ' 28' ' ' THR . 13.0 p -76.84 179.21 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.802 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.764 ' H ' HG22 ' A' ' 27' ' ' VAL . 97.3 m -66.06 123.34 19.58 Favored 'General case' 0 C--N 1.288 -2.074 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.303 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.4 t -131.03 110.6 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.319 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.03 -76.59 0.1 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.393 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -147.13 168.17 22.3 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.148 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -120.83 160.32 23.64 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.285 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.451 ' HE ' ' HB ' ' A' ' 49' ' ' THR . 1.4 ttm180 -127.33 146.15 50.55 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.466 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.449 ' O ' HG22 ' A' ' 34' ' ' ILE . 17.4 mt -137.8 99.46 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.679 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.28 137.61 43.92 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.108 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.621 ' CE2' HD11 ' A' ' 59' ' ' ILE . 11.0 p90 -145.28 148.03 33.01 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.242 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -163.58 140.75 6.66 Favored Glycine 0 N--CA 1.485 1.951 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.58 143.42 48.25 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.09 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.9 m -74.71 107.3 6.73 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.725 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.45 -17.33 0.02 OUTLIER Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.335 -1.412 . . . . 0.0 110.527 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 73.81 8.2 76.89 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.323 -1.418 . . . . 0.0 110.258 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -82.87 -47.28 12.02 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.725 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 170.74 108.79 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.33 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.103 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -59.51 151.71 67.02 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.214 0.61 . . . . 0.0 111.036 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.568 HG11 ' CZ ' ' A' ' 36' ' ' TYR . 48.4 t -62.14 -89.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.787 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 47' ' ' GLU . 3.8 pt20 -173.25 -152.71 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.019 -1.073 . . . . 0.0 111.404 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.484 ' N ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -159.19 173.4 16.42 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.163 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -165.08 148.24 8.34 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.94 -0.704 . . . . 0.0 109.517 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.451 ' HB ' ' HE ' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -113.21 167.22 10.73 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.339 -0.944 . . . . 0.0 112.682 -179.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.493 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -147.21 158.18 44.74 Favored Pre-proline 0 C--N 1.31 -1.139 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.667 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.16 6.26 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 121.175 1.25 . . . . 0.0 112.172 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 70.52 -1.14 22.56 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.338 -1.411 . . . . 0.0 110.275 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.39 -37.09 57.67 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.884 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -80.63 116.32 20.6 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.575 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.9 m -82.31 -2.07 51.58 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.111 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 77.2 p -133.09 157.56 44.97 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.513 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.03 140.67 13.36 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.579 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 1.2 m -103.77 139.64 38.72 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.274 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.621 HD11 ' CE2' ' A' ' 36' ' ' TYR . 2.2 tt -135.42 149.2 28.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.843 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 7.9 t -141.48 -154.68 0.53 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.397 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 60.91 46.25 94.93 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.276 -1.44 . . . . 0.0 110.629 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.508 ' C ' HD12 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -130.45 -172.94 2.93 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.04 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 mtpp -118.05 130.03 24.99 Favored Pre-proline 0 N--CA 1.49 1.526 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.967 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.62 140.51 87.03 Favored 'Trans proline' 0 C--O 1.217 -0.546 0 C-N-CA 120.409 0.74 . . . . 0.0 111.353 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.57 83.76 0.05 OUTLIER Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.462 -1.352 . . . . 0.0 110.553 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.1 p -165.29 148.97 2.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.153 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.92 149.49 47.74 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.505 -0.878 . . . . 0.0 109.616 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.37 137.09 21.59 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.846 -1.142 . . . . 0.0 111.9 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -116.57 119.35 35.28 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.918 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.414 ' CG1' ' N ' ' A' ' 71' ' ' THR . 3.7 tt -118.38 152.66 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 C-N-CA 119.537 -0.865 . . . . 0.0 112.064 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.442 HG23 ' HB3' ' A' ' 89' ' ' SER . 50.7 m -140.51 126.15 19.12 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.656 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.9 m -115.18 144.84 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.782 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -119.22 125.19 48.57 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.782 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.81 86.78 4.8 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.427 ' H ' HG23 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -86.41 118.57 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 118.962 -1.095 . . . . 0.0 112.338 -179.728 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.569 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 0.5 OUTLIER -101.69 -68.3 0.83 Allowed 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.906 179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.569 ' N ' ' OG1' ' A' ' 76' ' ' THR . . . 98.99 116.27 3.73 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.347 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -75.23 -36.03 61.37 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.541 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.55 4.75 0.09 OUTLIER Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.193 -1.479 . . . . 0.0 111.397 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.05 -85.9 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.588 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.05 148.07 97.74 Favored Pre-proline 0 C--N 1.306 -1.296 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.733 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -62.83 128.92 24.47 Favored 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 120.778 0.985 . . . . 0.0 111.162 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.8 59.51 1.46 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.707 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.5 t -94.76 64.86 2.98 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.753 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 m -114.15 29.86 7.7 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.12 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.66 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 0.1 OUTLIER -137.07 27.82 0.11 Allowed Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 86' ' ' LYS . 2.2 Cg_endo -58.39 138.68 87.14 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 120.614 0.876 . . . . 0.0 111.363 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.464 HG23 ' O ' ' A' ' 88' ' ' ILE . 13.1 tt -146.49 132.13 12.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.236 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.442 ' HB3' HG23 ' A' ' 71' ' ' THR . 21.7 p -130.79 152.33 50.25 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.494 -0.882 . . . . 0.0 112.19 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -146.91 146.4 18.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.187 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -92.24 151.19 20.46 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.832 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -155.04 136.85 14.46 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.649 -1.22 . . . . 0.0 111.699 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.09 110.69 22.9 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.633 -0.827 . . . . 0.0 109.85 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 116.338 -1.792 . . . . 0.0 110.769 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -151.59 -147.8 0.24 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.66 -179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -166.19 -36.41 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 119.147 -1.021 . . . . 0.0 111.002 179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.21 139.86 28.12 Favored Pre-proline 0 N--CA 1.498 1.926 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.039 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -55.79 169.25 1.36 Allowed 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.04 1.16 . . . . 0.0 111.525 179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.5 ptt180 -174.9 178.04 1.89 Allowed 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.72 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 52.68 62.35 2.73 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.78 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 mp -98.62 111.74 24.01 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.907 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.521 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 12.3 mp0 -135.38 163.88 29.02 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.776 -179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.9 t -89.48 116.5 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.697 179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.635 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 1.9 t -82.51 -6.97 10.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 118.962 -1.095 . . . . 0.0 111.649 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.635 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 169.23 166.3 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.526 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -151.38 144.77 24.81 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.164 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -138.38 160.16 64.93 Favored Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.528 -179.941 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.413 ' C ' ' OG1' ' A' ' 16' ' ' THR . 5.4 Cg_exo -48.36 -8.88 0.07 OUTLIER 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 121.404 1.403 . . . . 0.0 112.306 -179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.482 ' N ' ' O ' ' A' ' 14' ' ' THR . 0.2 OUTLIER -164.29 41.7 0.09 Allowed 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 119.169 -1.012 . . . . 0.0 111.007 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -175.09 136.04 0.37 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.229 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 62' ' ' LEU . 1.1 tp -130.5 125.63 34.83 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.071 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 20' ' ' ILE . 1.2 tt -106.53 126.63 52.5 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.716 -0.793 . . . . 0.0 110.365 179.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.661 ' N ' HD23 ' A' ' 19' ' ' LEU . 9.5 pt -126.76 164.58 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.966 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.421 ' OG ' HG21 ' A' ' 11' ' ' VAL . 5.2 m -161.62 146.66 13.37 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 119.057 -1.057 . . . . 0.0 110.542 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.447 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 37.2 p90 -141.26 -139.87 0.13 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.975 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 24' ' ' ALA . 34.1 t70 -98.02 173.98 6.78 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.171 -1.012 . . . . 0.0 111.813 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.611 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -96.73 165.53 15.8 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.731 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.611 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -62.21 169.15 8.22 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 121.244 1.296 . . . . 0.0 111.865 179.938 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -106.22 -79.65 0.56 Allowed 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.691 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.444 HG23 ' N ' ' A' ' 28' ' ' THR . 3.2 m -91.64 -164.71 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.652 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.444 ' N ' HG23 ' A' ' 27' ' ' VAL . 1.5 p -39.23 151.7 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.043 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.6 t -138.55 147.53 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 119.026 -1.069 . . . . 0.0 112.152 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 19.8 mtp180 -108.92 -53.12 2.68 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.095 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 30' ' ' ARG . 44.3 m-85 -160.28 157.96 29.01 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.221 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.46 111.64 20.28 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.52 -1.218 . . . . 0.0 107.954 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.9 mtt-85 -100.12 145.06 28.42 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.5 ' N ' HD12 ' A' ' 34' ' ' ILE . 4.2 mp -141.21 110.4 2.83 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.601 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 p -121.73 151.4 40.56 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.036 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 15.2 p90 -144.13 155.34 43.89 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 118.584 -1.246 . . . . 0.0 111.67 179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.45 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . 171.48 147.19 5.58 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.75 -1.214 . . . . 0.0 110.795 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -62.17 166.7 4.58 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.763 -0.775 . . . . 0.0 111.444 179.98 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -75.81 143.34 41.94 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.814 -0.755 . . . . 0.0 110.81 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 176.06 -28.84 0.07 OUTLIER Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.43 -1.367 . . . . 0.0 110.241 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 158.36 -101.86 0.21 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.122 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -135.28 62.15 1.64 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.382 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.0 t -135.39 69.51 68.1 Favored Pre-proline 0 N--CA 1.49 1.525 0 C-N-CA 119.865 -0.734 . . . . 0.0 111.195 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -61.22 131.1 34.93 Favored 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.24 1.293 . . . . 0.0 111.061 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.45 HG23 ' HA2' ' A' ' 37' ' ' GLY . 26.5 t -49.74 -49.21 20.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.366 -179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -164.01 167.95 19.83 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.594 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -148.0 146.87 29.09 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.186 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 10.6 p90 -154.23 134.89 13.57 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 118.72 -1.192 . . . . 0.0 111.276 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 t -100.49 147.52 25.8 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.496 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -140.81 150.83 61.13 Favored Pre-proline 0 C--N 1.301 -1.527 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.252 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.564 ' C ' ' H ' ' A' ' 53' ' ' SER . 6.2 Cg_exo -52.77 125.17 17.23 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 120.499 0.8 . . . . 0.0 110.882 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.66 17.6 0.07 OUTLIER Glycine 0 N--CA 1.487 2.09 0 C-N-CA 119.61 -1.281 . . . . 0.0 111.726 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.564 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -73.18 -41.54 63.73 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 118.859 -1.136 . . . . 0.0 110.184 179.875 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -87.71 -172.5 3.9 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.341 -0.943 . . . . 0.0 110.63 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.37 14.06 2.38 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.749 -0.78 . . . . 0.0 110.441 -179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 24.0 p -126.82 174.4 8.81 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.615 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.18 122.52 0.67 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.006 -1.078 . . . . 0.0 111.443 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.25 146.54 24.27 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.698 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.7 mt -136.78 147.11 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.995 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.5 t -150.57 153.97 36.72 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.276 -0.97 . . . . 0.0 111.419 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 62' ' ' LEU . . . 123.07 -9.27 9.0 Favored Glycine 0 N--CA 1.498 2.815 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 18' ' ' LEU . 2.1 mt -49.79 -178.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.785 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -176.39 -43.24 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 119.416 -0.914 . . . . 0.0 112.36 179.948 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.607 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 4.2 Cg_endo -79.46 -168.17 0.6 Allowed 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 121.657 1.571 . . . . 0.0 111.776 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -154.66 87.47 0.13 Allowed Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.744 -1.743 . . . . 0.0 108.744 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.848 HG22 ' H ' ' A' ' 67' ' ' ASP . 11.5 p -156.54 -177.2 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 C-N-CA 118.944 -1.103 . . . . 0.0 111.715 -179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.848 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -57.75 98.65 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.634 179.982 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -94.11 132.03 39.04 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.278 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.1 m -112.85 127.57 56.22 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.747 -179.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 pp -113.86 151.2 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.203 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 89' ' ' SER . 97.3 m -143.32 120.85 11.73 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.016 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.6 m -100.43 141.21 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.768 179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 97.15 6.52 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.343 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -75.29 92.2 2.74 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.533 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.54 115.67 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.696 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 p -119.25 -39.15 2.93 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.43 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 68.08 141.49 0.08 OUTLIER Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.747 -1.216 . . . . 0.0 110.481 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 11.8 ttm-85 -81.35 -59.06 2.77 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.993 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.19 3.71 0.17 Allowed Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.428 -1.368 . . . . 0.0 110.759 179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -142.23 -63.62 0.43 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.988 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.13 115.92 63.2 Favored Pre-proline 0 N--CA 1.485 1.296 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.801 -179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -65.2 96.66 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.656 0 N-CA-C 110.266 -0.705 . . . . 0.0 110.266 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -118.97 149.5 41.51 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.322 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.2 p -64.06 127.0 29.52 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.524 -0.871 . . . . 0.0 110.824 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -65.99 -109.45 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.686 179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.84 63.62 26.04 Favored Pre-proline 0 N--CA 1.486 1.365 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.948 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -55.1 158.4 11.72 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 121.413 1.409 . . . . 0.0 111.286 179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -146.0 156.5 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 C-N-CA 118.785 -1.166 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.404 ' HB3' HG23 ' A' ' 71' ' ' THR . 53.4 p -145.27 159.89 42.33 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.235 -179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -148.76 149.71 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.6 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.38 154.55 18.7 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.542 179.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -175.55 135.07 0.31 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.737 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 93' ' ' ARG . 2.6 ptm180 -61.65 96.42 0.06 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.295 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 116.502 -1.713 . . . . 0.0 110.583 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 120.929 0.395 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.2 p -86.26 -147.53 0.12 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.846 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -113.64 -37.19 4.66 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.227 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 t -61.47 129.61 91.26 Favored Pre-proline 0 CA--C 1.562 1.418 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.219 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -73.18 106.32 2.14 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 120.921 1.081 . . . . 0.0 111.386 179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.465 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -175.33 -151.18 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.694 -1.202 . . . . 0.0 111.621 179.947 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 2.2 t70 74.47 22.39 2.13 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.661 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mp -52.43 144.82 12.45 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.59 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -159.73 140.84 12.55 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.869 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.83 109.64 13.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.391 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 27.1 t -70.17 -64.01 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.221 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.59 166.62 30.64 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.861 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -126.32 127.39 45.48 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.8 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.26 161.85 21.82 Favored Pre-proline 0 C--N 1.308 -1.206 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.299 -180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.617 ' C ' HG23 ' A' ' 16' ' ' THR . 4.9 Cg_exo -49.28 99.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 120.547 0.831 . . . . 0.0 110.614 179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.617 HG23 ' C ' ' A' ' 15' ' ' PRO . 1.7 p 69.14 44.59 0.97 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.52 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.33 146.92 7.52 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.274 179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mt -128.31 142.94 50.99 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.759 -0.777 . . . . 0.0 111.497 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.438 HD23 ' C ' ' A' ' 19' ' ' LEU . 2.0 tt -115.91 102.23 9.48 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.831 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -99.57 146.58 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.72 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 m -139.77 132.3 28.7 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.227 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.547 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 12.6 p90 -132.69 -144.4 0.24 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.796 -1.162 . . . . 0.0 112.447 -179.788 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.547 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 22.3 t0 -99.11 162.48 13.04 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.383 -0.927 . . . . 0.0 112.942 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -168.38 78.76 0.81 Allowed Pre-proline 0 N--CA 1.487 1.412 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.8 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -64.79 167.53 15.39 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 121.46 1.44 . . . . 0.0 111.81 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -87.04 4.29 42.58 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.646 -0.821 . . . . 0.0 111.21 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.83 HG22 ' H ' ' A' ' 28' ' ' THR . 10.4 p -62.79 -179.21 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.624 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.83 ' H ' HG22 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -67.52 119.6 12.58 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.678 -179.979 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 43.1 t -137.13 128.31 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.341 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.523 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -87.81 -61.47 1.71 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 118.854 -1.138 . . . . 0.0 110.483 -179.984 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.523 ' CD1' ' O ' ' A' ' 30' ' ' ARG . 46.3 m-85 -147.45 168.0 23.0 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.807 -1.157 . . . . 0.0 112.167 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.28 137.47 42.53 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.256 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.09 128.9 23.24 Favored 'General case' 0 N--CA 1.5 2.048 0 C-N-CA 118.236 -1.386 . . . . 0.0 111.274 179.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.2 mt -111.54 135.17 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.891 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 p -128.05 135.07 49.35 Favored 'General case' 0 N--CA 1.486 1.354 0 CA-C-N 115.175 -0.92 . . . . 0.0 109.463 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 6.7 p90 -135.91 160.6 38.08 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.653 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . 165.65 139.87 2.75 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -57.35 -161.01 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.48 179.901 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.517 ' OG1' ' N ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER -53.98 173.1 0.07 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.392 -0.923 . . . . 0.0 110.92 -179.921 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.517 ' N ' ' OG1' ' A' ' 39' ' ' THR . . . -44.68 -70.48 0.59 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.533 -1.318 . . . . 0.0 110.756 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 52.41 -130.01 37.5 Favored Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.307 -1.425 . . . . 0.0 109.964 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.24 -63.51 1.35 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.246 -0.981 . . . . 0.0 110.35 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.0 162.95 17.87 Favored Pre-proline 0 C--N 1.304 -1.412 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.193 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.61 158.3 28.53 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 121.25 1.3 . . . . 0.0 111.237 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.403 HG11 ' CE2' ' A' ' 36' ' ' TYR . 39.7 t -67.57 -67.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 C-N-CA 118.997 -1.081 . . . . 0.0 110.288 179.935 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.614 ' NE2' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -175.22 -175.5 0.84 Allowed 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.13 -179.883 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.614 ' H ' ' NE2' ' A' ' 46' ' ' GLN . 6.5 pt-20 -157.6 167.79 29.12 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.222 179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -159.47 147.53 17.46 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 118.796 -1.162 . . . . 0.0 111.237 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 70.5 p -97.66 124.64 42.05 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.399 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -118.64 151.29 49.68 Favored Pre-proline 0 N--CA 1.49 1.574 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.292 179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 53' ' ' SER . 1.2 Cg_endo -61.66 126.42 19.0 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 120.678 0.918 . . . . 0.0 110.517 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -48.46 -9.25 0.08 OUTLIER Glycine 0 N--CA 1.491 2.354 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.98 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -71.3 -43.18 67.62 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.496 179.983 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.1 mmtm -67.77 132.72 47.96 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.301 179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 14.8 m -103.07 -5.29 23.48 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.465 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 75.6 p -134.8 172.93 12.28 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -169.46 151.84 4.6 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.464 -0.894 . . . . 0.0 111.102 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.5 m -121.38 117.56 27.23 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.701 179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -109.12 157.96 9.18 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.929 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -145.61 178.2 8.31 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.146 179.94 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 86.98 53.39 2.86 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.239 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.57 -156.4 0.75 Allowed 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.809 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.7 mtpm? -140.28 148.83 55.72 Favored Pre-proline 0 N--CA 1.49 1.55 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.43 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -68.21 123.13 10.24 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 121.052 1.168 . . . . 0.0 112.439 -179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.22 91.75 0.04 OUTLIER Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.787 -1.197 . . . . 0.0 111.777 179.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.2 p -167.48 144.96 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.211 -0.996 . . . . 0.0 110.864 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.29 153.76 6.74 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.16 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -148.79 134.48 18.81 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 118.845 -1.142 . . . . 0.0 112.238 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.1 m -125.61 120.92 32.11 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.623 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 pp -115.63 163.12 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.92 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.598 HG23 ' OG ' ' A' ' 89' ' ' SER . 17.1 m -152.54 127.73 9.8 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.361 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.6 m -121.91 136.86 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.274 -0.971 . . . . 0.0 111.796 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -115.34 126.63 54.67 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.389 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.08 98.14 7.82 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.583 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.429 HG12 ' HB1' ' A' ' 83' ' ' ALA . 1.6 t -86.36 117.54 31.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 119.142 -1.023 . . . . 0.0 111.644 -179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -90.52 -64.21 1.16 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.732 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.505 ' H ' ' HA ' ' A' ' 83' ' ' ALA . . . 159.68 179.96 34.84 Favored Glycine 0 N--CA 1.495 2.623 0 C-N-CA 119.429 -1.367 . . . . 0.0 111.841 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -120.05 62.47 0.84 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.606 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.02 -28.58 4.38 Favored Glycine 0 N--CA 1.5 2.947 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -147.6 -51.99 0.19 Allowed 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.41 153.06 42.98 Favored Pre-proline 0 C--N 1.311 -1.066 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.485 179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.43 ' C ' ' N ' ' A' ' 84' ' ' SER . 1.7 Cg_endo -60.79 123.41 12.93 Favored 'Trans proline' 0 C--O 1.216 -0.596 0 C-N-CA 120.846 1.03 . . . . 0.0 111.405 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.505 ' HA ' ' H ' ' A' ' 77' ' ' GLY . . . -48.49 -17.3 0.15 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.953 179.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 85' ' ' SER . 2.9 p -86.2 69.92 10.51 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.29 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.441 ' O ' ' O ' ' A' ' 84' ' ' SER . 39.7 m -50.89 -102.03 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.023 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.1 ttmm -146.88 77.05 11.29 Favored Pre-proline 0 C--N 1.295 -1.768 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.691 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -52.8 162.7 2.35 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 120.616 0.877 . . . . 0.0 110.264 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.9 tt -153.57 160.12 3.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 117.961 -1.496 . . . . 0.0 112.304 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.598 ' OG ' HG23 ' A' ' 71' ' ' THR . 16.3 m -145.55 149.43 34.58 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.222 -179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.4 pt -147.03 154.9 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 118.956 -1.098 . . . . 0.0 111.387 -179.962 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 92' ' ' TYR . 16.9 t-20 -89.77 164.15 14.78 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.554 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.447 ' N ' ' OD1' ' A' ' 91' ' ' ASN . 22.6 t80 -172.32 129.67 0.58 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.209 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.481 ' N ' ' CD ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -90.39 111.06 22.15 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.082 179.852 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 116.295 -1.812 . . . . 0.0 110.666 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.85 -48.24 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 118.847 -1.141 . . . . 0.0 111.761 179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -134.72 12.16 3.7 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.603 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 t -116.32 107.13 47.79 Favored Pre-proline 0 N--CA 1.495 1.821 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.009 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -67.88 -124.64 0.0 OUTLIER 'Trans proline' 0 CA--C 1.563 1.963 0 C-N-CA 120.446 0.764 . . . . 0.0 110.128 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.498 ' O ' ' O ' ' A' ' 22' ' ' TRP . 5.4 ptp180 -172.02 178.36 2.97 Favored 'General case' 0 N--CA 1.506 2.327 0 C-N-CA 117.624 -1.63 . . . . 0.0 114.158 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -33.07 102.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.839 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.518 HD12 ' H ' ' A' ' 23' ' ' ASP . 0.4 OUTLIER -53.91 125.12 17.49 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.676 179.821 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -174.14 159.16 3.17 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.89 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 55.1 t -91.98 135.51 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.516 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.77 -59.19 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 C-N-CA 118.677 -1.209 . . . . 0.0 111.81 -179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.39 169.25 21.28 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.568 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.96 80.92 1.7 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.938 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -66.92 161.18 64.53 Favored Pre-proline 0 N--CA 1.49 1.532 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.24 -179.945 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -54.36 -10.12 2.01 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 121.362 1.375 . . . . 0.0 111.757 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.5 m -159.07 44.61 0.26 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.504 -0.879 . . . . 0.0 110.476 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.427 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -175.86 114.82 0.13 Allowed 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.555 180.0 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.444 ' HB2' HD21 ' A' ' 62' ' ' LEU . 5.5 tp -109.81 112.15 24.03 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.336 -179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.22 122.48 31.08 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.297 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.71 148.23 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.73 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -132.45 136.41 46.7 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.954 179.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.498 ' O ' ' O ' ' A' ' 6' ' ' ARG . 45.7 p90 -118.35 -173.2 2.42 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 118.334 -1.346 . . . . 0.0 113.221 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.518 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -147.91 168.27 22.68 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.396 -179.686 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -177.15 179.56 0.36 Allowed Pre-proline 0 N--CA 1.499 1.977 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.955 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 3.0 Cg_exo -64.12 165.15 20.13 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 C-N-CA 120.867 1.044 . . . . 0.0 111.76 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -92.85 42.75 1.11 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.574 -0.85 . . . . 0.0 111.592 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.71 HG22 ' N ' ' A' ' 28' ' ' THR . 14.0 p -103.3 177.07 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.679 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.71 ' N ' HG22 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -80.31 105.46 11.58 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.83 -179.95 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.489 HG11 ' CE1' ' A' ' 32' ' ' TYR . 37.1 t -103.26 123.5 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.579 -0.849 . . . . 0.0 111.035 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -65.34 -47.3 76.94 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.031 -1.068 . . . . 0.0 109.931 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -159.06 168.55 26.39 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.324 179.92 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.503 ' OH ' ' HB3' ' A' ' 24' ' ' ALA . 4.4 m-85 -113.87 165.91 12.11 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.457 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -141.64 100.19 3.71 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.849 -0.741 . . . . 0.0 109.356 179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.12 131.46 45.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.469 -0.892 . . . . 0.0 112.342 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.497 HG22 ' CB ' ' A' ' 47' ' ' GLU . 36.2 p -127.08 136.73 52.56 Favored 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.383 179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 2.3 p90 -142.46 159.66 41.79 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 118.556 -1.258 . . . . 0.0 111.682 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 162.58 150.06 5.88 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -70.26 156.97 38.52 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.491 -179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.0 m -73.72 151.04 40.81 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.08 -1.048 . . . . 0.0 110.539 -179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.02 -87.13 0.09 OUTLIER Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.256 -1.45 . . . . 0.0 110.578 -179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 148.21 -5.4 0.89 Allowed Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.416 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -76.51 -57.53 3.81 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.748 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 p 178.16 123.55 0.19 Allowed Pre-proline 0 C--N 1.304 -1.375 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.384 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -59.15 166.58 7.02 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 120.465 0.776 . . . . 0.0 111.188 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.43 HG11 ' CE2' ' A' ' 36' ' ' TYR . 47.5 t -63.24 -70.74 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.084 179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -174.68 -166.11 0.23 Allowed 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.827 -179.966 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.497 ' CB ' HG22 ' A' ' 35' ' ' THR . 8.3 pt-20 -162.07 174.49 12.93 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.004 -179.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.582 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -170.59 153.7 4.28 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.256 -0.978 . . . . 0.0 110.997 179.677 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 p -113.01 157.33 21.66 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.475 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.548 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -145.44 159.88 46.9 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.493 179.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -64.81 22.65 0.07 OUTLIER 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 121.372 1.381 . . . . 0.0 112.179 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.548 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 48.33 20.71 1.61 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.148 -1.501 . . . . 0.0 110.394 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -45.98 16.8 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.663 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -90.55 130.4 36.59 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.274 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 15.4 m -81.32 -4.47 55.73 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.622 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -133.74 162.35 32.2 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.73 -0.788 . . . . 0.0 111.188 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -138.92 171.77 13.83 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.589 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.6 m -144.44 117.06 8.64 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.133 -1.027 . . . . 0.0 111.633 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.412 HG21 HD13 ' A' ' 59' ' ' ILE . 12.2 mt -111.39 150.02 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.559 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 3.3 m -136.92 -8.13 1.83 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.788 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.41 52.17 1.81 Allowed Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.443 -1.36 . . . . 0.0 110.419 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -130.29 -172.97 2.92 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.998 -179.976 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 mmtt -131.91 102.15 14.93 Favored Pre-proline 0 N--CA 1.493 1.708 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.911 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.29 144.22 61.5 Favored 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 120.657 0.905 . . . . 0.0 111.321 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 109.37 38.62 1.76 Allowed Glycine 0 N--CA 1.498 2.793 0 C-N-CA 119.814 -1.184 . . . . 0.0 110.672 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.591 HG22 ' N ' ' A' ' 67' ' ' ASP . 5.3 p -169.05 165.76 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 119.116 -1.034 . . . . 0.0 111.631 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.591 ' N ' HG22 ' A' ' 66' ' ' VAL . 4.4 t70 -60.31 145.89 46.01 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.675 179.813 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.451 ' O ' ' O ' ' A' ' 92' ' ' TYR . 0.3 OUTLIER -145.32 119.06 9.2 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.135 -1.026 . . . . 0.0 111.422 -179.904 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -105.59 136.77 44.58 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.565 179.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.443 ' CG1' ' N ' ' A' ' 71' ' ' THR . 2.1 tt -134.36 156.54 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.876 179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.443 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 48.9 m -147.99 138.1 22.72 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.585 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.418 ' O ' HG23 ' A' ' 72' ' ' VAL . 2.4 m -114.28 129.87 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.407 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -111.23 114.86 28.38 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.585 -0.734 . . . . 0.0 112.639 -179.765 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -94.07 96.52 9.7 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.172 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.34 146.24 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.517 -0.873 . . . . 0.0 112.161 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.843 HG23 ' H ' ' A' ' 77' ' ' GLY . 0.0 OUTLIER -122.26 -91.99 0.54 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.141 179.969 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.843 ' H ' HG23 ' A' ' 76' ' ' THR . . . 50.57 -167.25 0.46 Allowed Glycine 0 N--CA 1.494 2.536 0 C-N-CA 119.783 -1.198 . . . . 0.0 110.852 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.39 -0.04 22.62 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.247 179.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.41 0.9 40.69 Favored Glycine 0 N--CA 1.498 2.827 0 C-N-CA 119.644 -1.265 . . . . 0.0 111.256 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -130.1 -15.3 3.78 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.726 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.89 74.7 79.66 Favored Pre-proline 0 C--N 1.309 -1.16 0 C-N-CA 120.131 -0.627 . . . . 0.0 110.545 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -63.72 112.73 1.88 Allowed 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 121.186 1.257 . . . . 0.0 111.346 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -112.25 119.91 39.96 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.616 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.3 m -57.59 103.01 0.11 Allowed 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.812 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.2 m -74.93 -93.46 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.603 -179.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 20.7 mttm -140.14 67.44 33.14 Favored Pre-proline 0 C--N 1.301 -1.502 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.439 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -72.2 157.9 52.98 Favored 'Trans proline' 0 C--N 1.325 -0.668 0 C-N-CA 121.494 1.463 . . . . 0.0 110.351 179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.3 tt -144.19 138.43 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 118.66 -1.216 . . . . 0.0 110.61 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 89.4 p -119.42 122.36 41.57 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.597 -179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.063 ' H ' HD12 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -120.5 145.09 27.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.681 -179.971 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -97.45 153.4 18.14 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.861 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.451 ' O ' ' O ' ' A' ' 68' ' ' TYR . 24.5 t80 -165.18 135.43 3.74 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 119.234 -0.986 . . . . 0.0 111.026 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.33 127.35 43.21 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.91 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 116.339 -1.791 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.484 1.265 0 CA-C-O 120.812 0.339 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.81 131.65 44.12 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.213 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -162.01 -52.56 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.072 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.411 ' O ' ' O ' ' A' ' 5' ' ' PRO . 41.9 t -62.81 136.87 96.6 Favored Pre-proline 0 C--N 1.303 -1.442 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.916 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 4' ' ' VAL . 12.4 Cg_exo -47.97 177.54 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 120.694 0.929 . . . . 0.0 110.792 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -172.03 166.94 6.18 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.183 -1.407 . . . . 0.0 113.041 -179.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 41.65 86.59 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 114.599 -1.182 . . . . 0.0 113.983 179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -101.27 149.28 24.18 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -164.75 161.65 20.69 Favored 'General case' 0 N--CA 1.501 2.122 0 C-N-CA 117.206 -1.798 . . . . 0.0 113.78 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.9 t -103.53 135.36 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-N 114.238 -1.346 . . . . 0.0 108.502 179.792 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.547 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -112.49 -10.08 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.227 -0.989 . . . . 0.0 112.762 -179.811 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 175.22 170.0 0.3 Allowed 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.413 -1.315 . . . . 0.0 111.886 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -150.59 134.31 16.6 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.656 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -126.45 162.01 49.12 Favored Pre-proline 0 N--CA 1.493 1.69 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.73 179.986 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -52.04 -12.88 1.55 Allowed 'Trans proline' 0 C--O 1.213 -0.745 0 C-N-CA 121.135 1.223 . . . . 0.0 111.865 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -158.14 48.99 0.39 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.06 -1.056 . . . . 0.0 111.03 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.434 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.2 OUTLIER 173.06 139.1 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.983 -179.998 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 tp -130.65 132.33 45.38 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.493 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.438 HD23 ' HB ' ' A' ' 11' ' ' VAL . 2.2 tp -93.56 126.67 38.84 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.034 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 pp -128.17 156.14 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.166 179.858 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.91 145.11 29.7 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.936 -1.105 . . . . 0.0 111.61 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.613 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 7.3 p90 -144.84 -147.56 0.22 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.153 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.613 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 27.6 t70 -154.35 150.05 27.53 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 117.937 -1.505 . . . . 0.0 112.621 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.59 127.29 25.25 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.24 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.53 ' HB2' HG12 ' A' ' 27' ' ' VAL . 1.7 Cg_endo -62.06 171.03 5.44 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 120.626 0.884 . . . . 0.0 111.62 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.67 19.26 4.07 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.119 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.609 HG22 ' N ' ' A' ' 28' ' ' THR . 4.1 p -84.4 165.41 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 119.173 -1.011 . . . . 0.0 110.909 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.609 ' N ' HG22 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -57.64 95.35 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.606 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.5 t -108.08 137.67 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.719 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.0 mtp85 -93.4 -57.57 2.56 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.169 -1.012 . . . . 0.0 109.975 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -165.03 166.73 19.04 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.826 -1.149 . . . . 0.0 112.028 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 74' ' ' ALA . 2.1 m-85 -120.0 156.0 31.74 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.439 -179.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -135.19 104.6 5.96 Favored 'General case' 0 N--CA 1.502 2.157 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.864 179.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -96.28 122.03 47.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.682 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.1 p -120.18 141.38 49.94 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.638 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.463 ' CG ' HD11 ' A' ' 59' ' ' ILE . 28.9 p90 -139.16 144.38 38.56 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.898 -1.121 . . . . 0.0 111.28 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.674 ' HA2' HG21 ' A' ' 45' ' ' VAL . . . -172.42 153.26 18.66 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -74.31 166.83 22.8 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.006 -179.944 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.415 HG22 ' N ' ' A' ' 40' ' ' GLY . 39.9 m -75.1 157.64 34.41 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.915 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.415 ' N ' HG22 ' A' ' 39' ' ' THR . . . 142.74 -69.67 0.42 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.288 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.69 -134.46 3.83 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -73.36 -96.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.349 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.477 ' C ' ' H ' ' A' ' 45' ' ' VAL . 3.2 m -172.92 66.89 0.36 Allowed Pre-proline 0 C--N 1.305 -1.351 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.995 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -74.48 40.95 0.65 Allowed 'Trans proline' 0 C--N 1.327 -0.6 0 C-N-CA 121.656 1.571 . . . . 0.0 110.27 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.674 HG21 ' HA2' ' A' ' 37' ' ' GLY . 61.4 t -109.57 -95.78 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.081 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.48 174.1 8.17 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 117.061 -1.856 . . . . 0.0 113.02 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -169.06 167.18 10.72 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 114.805 -1.089 . . . . 0.0 110.226 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -164.11 160.55 21.63 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.94 161.53 20.73 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.643 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -148.66 159.41 38.37 Favored Pre-proline 0 C--N 1.309 -1.187 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.129 179.977 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -64.99 22.25 0.08 OUTLIER 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 121.002 1.135 . . . . 0.0 112.107 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 49.3 17.65 1.17 Allowed Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.776 -179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.56 -43.33 14.59 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.91 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -79.09 123.33 27.24 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.951 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 39.7 m -81.2 -12.68 59.1 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.446 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.0 p -138.62 148.56 44.25 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.173 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -160.95 165.03 30.65 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.921 -1.111 . . . . 0.0 111.435 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.7 m -104.17 130.23 51.91 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.167 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.463 HD11 ' CG ' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -112.21 123.29 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.719 179.979 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 51.6 m -129.81 157.48 42.09 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.639 -0.824 . . . . 0.0 111.307 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 145.78 -20.44 1.81 Allowed Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.576 179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.53 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -79.35 -172.03 3.01 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.016 179.956 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.68 ' H ' ' CD ' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -157.3 -43.73 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.487 0 C-N-CA 119.301 -0.959 . . . . 0.0 111.487 179.967 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.68 ' CD ' ' H ' ' A' ' 63' ' ' LYS . 10.3 Cg_endo -89.19 -167.65 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.517 1.478 . . . . 0.0 111.658 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -132.53 81.18 0.32 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 107.483 -2.247 . . . . 0.0 107.483 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.673 HG22 ' N ' ' A' ' 67' ' ' ASP . 7.5 p -133.61 175.33 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 119.933 -0.707 . . . . 0.0 112.055 -179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.673 ' N ' HG22 ' A' ' 66' ' ' VAL . 4.3 t70 -50.8 120.55 4.89 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.135 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.02 129.11 46.19 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.173 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.0 126.48 52.38 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.06 -179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 pp -112.23 152.66 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.847 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.471 ' HG1' ' CB ' ' A' ' 89' ' ' SER . 52.9 m -145.49 143.95 30.29 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.081 -1.048 . . . . 0.0 111.955 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.2 m -125.19 139.34 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.635 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -117.49 100.45 7.66 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.794 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -79.44 83.35 5.46 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.691 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.86 140.03 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 118.997 -1.081 . . . . 0.0 113.544 -179.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 p -126.99 -161.03 1.04 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.134 -1.393 . . . . 0.0 108.128 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 144.46 179.39 20.86 Favored Glycine 0 N--CA 1.499 2.893 0 C-N-CA 118.549 -1.786 . . . . 0.0 111.836 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.6 mtt180 -91.96 -15.27 28.22 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.232 179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 104.22 17.39 15.97 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.321 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -161.38 -33.23 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.762 -1.175 . . . . 0.0 111.845 -179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -96.78 139.47 21.61 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 119.213 -0.995 . . . . 0.0 110.882 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.12 113.06 1.42 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 120.711 0.941 . . . . 0.0 110.957 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.96 118.46 36.81 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.6 t -71.76 141.02 49.75 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.882 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 74' ' ' ALA . 4.8 t -115.25 -177.62 3.18 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.964 -0.694 . . . . 0.0 111.877 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.3 mptt -118.74 84.3 24.74 Favored Pre-proline 0 N--CA 1.494 1.745 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.952 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -70.69 158.93 54.34 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 120.997 1.131 . . . . 0.0 112.752 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 88' ' ' ILE . 13.8 tt -149.3 137.03 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.373 179.874 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.471 ' CB ' ' HG1' ' A' ' 71' ' ' THR . 4.2 m -128.2 134.63 49.06 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.902 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.496 ' N ' HD13 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -116.7 136.01 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.104 179.814 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.18 145.18 26.29 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.867 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.455 ' CG ' ' N ' ' A' ' 93' ' ' ARG . 24.3 t80 -167.28 158.2 11.65 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.984 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.455 ' N ' ' CG ' ' A' ' 92' ' ' TYR . 7.2 mtm-85 -93.34 113.55 25.76 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.105 -1.038 . . . . 0.0 111.975 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 116.581 -1.676 . . . . 0.0 110.436 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.409 ' O ' ' O ' ' A' ' 2' ' ' SER . 3.2 t . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 120.824 0.345 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 1' ' ' VAL . 38.0 m -56.87 -107.61 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.82 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -157.45 -20.29 0.09 Allowed 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.479 -0.889 . . . . 0.0 110.933 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 t -90.35 135.07 30.06 Favored Pre-proline 0 N--CA 1.488 1.427 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.369 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.44 165.37 7.65 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 120.415 0.743 . . . . 0.0 111.237 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.43 ' H ' ' HB3' ' A' ' 23' ' ' ASP . 1.8 ptp180 -175.13 171.27 3.02 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.173 -1.011 . . . . 0.0 111.022 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.424 ' CB ' ' O ' ' A' ' 6' ' ' ARG . 3.3 t70 70.63 44.22 0.68 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.092 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 8' ' ' LEU . 9.5 mp -88.08 121.76 30.86 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.543 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -171.32 166.07 7.09 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.587 -1.245 . . . . 0.0 111.933 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.6 t -92.62 143.48 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.848 179.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 1.6 p -128.92 -2.93 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.48 -179.859 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -179.81 147.54 0.29 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.491 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.486 ' HB1' HD12 ' A' ' 18' ' ' LEU . . . -176.57 112.17 0.1 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.583 -0.847 . . . . 0.0 110.631 -179.85 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.64 ' O ' ' N ' ' A' ' 16' ' ' THR . 0.2 OUTLIER -148.51 -75.62 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 117.921 -1.512 . . . . 0.0 113.049 179.968 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.529 ' O ' ' N ' ' A' ' 17' ' ' SER . 6.8 Cg_endo -53.21 78.37 0.02 OUTLIER 'Trans proline' 0 C--O 1.212 -0.779 0 CA-C-N 119.491 0.854 . . . . 0.0 110.863 -179.571 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.64 ' N ' ' O ' ' A' ' 14' ' ' THR . 3.0 m 35.51 32.49 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.074 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 15' ' ' PRO . 1.6 m -139.79 148.95 42.94 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.941 -1.103 . . . . 0.0 112.447 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.53 HD13 ' CD2' ' A' ' 62' ' ' LEU . 5.6 tp -113.09 142.04 46.19 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.575 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.421 HD12 HG23 ' A' ' 58' ' ' THR . 1.1 tp -117.2 107.29 14.26 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.047 179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 pt -106.24 157.95 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.361 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.98 138.3 18.46 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.824 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.543 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 9.3 p90 -144.35 -156.17 0.67 Allowed 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 118.816 -1.154 . . . . 0.0 111.346 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.543 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 27.7 t70 -102.57 163.44 12.22 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -179.52 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.429 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -145.98 101.8 4.18 Favored Pre-proline 0 C--N 1.307 -1.281 0 CA-C-N 114.539 -1.209 . . . . 0.0 109.071 179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.503 ' HB2' HG22 ' A' ' 27' ' ' VAL . 7.4 Cg_exo -56.4 -176.66 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 120.615 0.876 . . . . 0.0 112.255 -179.783 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.95 -13.88 20.92 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.755 -0.778 . . . . 0.0 112.122 -179.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 25' ' ' PRO . 2.6 m -59.17 145.73 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 118.281 -1.367 . . . . 0.0 110.013 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.8 m -68.53 72.52 0.22 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.612 -179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 27' ' ' VAL . 24.0 t -66.36 126.57 26.01 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 119.404 -0.918 . . . . 0.0 110.785 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.1 mmm-85 -54.61 -42.88 71.67 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.23 179.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -179.58 165.71 1.36 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 118.443 -1.303 . . . . 0.0 112.234 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -115.73 163.08 16.35 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.14 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.49 HH21 ' CG2' ' A' ' 49' ' ' THR . 21.2 ttm180 -146.56 106.16 3.95 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.39 -1.324 . . . . 0.0 111.038 179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.818 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.9 mp -99.9 122.02 51.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.329 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.7 p -119.59 139.08 52.73 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.699 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.543 ' CE2' HG11 ' A' ' 45' ' ' VAL . 6.4 p90 -136.51 155.35 50.09 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 119.011 -1.076 . . . . 0.0 111.14 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.401 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -177.57 143.36 6.11 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.464 ' CD ' ' N ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -71.54 176.62 4.6 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.636 -0.825 . . . . 0.0 110.808 179.931 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.2 m -63.5 137.26 58.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.017 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.28 -72.42 0.25 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.454 -1.355 . . . . 0.0 110.648 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.21 -9.69 75.93 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.258 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -87.22 -11.57 49.39 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.601 -0.84 . . . . 0.0 110.86 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.4 t -173.74 78.41 0.38 Allowed Pre-proline 0 C--N 1.306 -1.286 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.752 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -60.6 163.46 15.49 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 120.996 1.131 . . . . 0.0 111.17 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.543 HG11 ' CE2' ' A' ' 36' ' ' TYR . 96.2 t -72.07 -78.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 118.968 -1.093 . . . . 0.0 111.505 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -172.11 -163.49 0.25 Allowed 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 118.476 -1.289 . . . . 0.0 111.966 -179.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -162.71 168.77 21.07 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.771 -179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -159.84 139.27 11.17 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.548 -179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.49 ' CG2' HH21 ' A' ' 33' ' ' ARG . 23.3 p -105.07 164.74 11.58 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.644 -0.822 . . . . 0.0 112.393 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.557 ' C ' ' H ' ' A' ' 52' ' ' GLY . 26.9 m -148.06 152.58 40.25 Favored Pre-proline 0 C--N 1.307 -1.24 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.42 179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -55.63 6.52 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 120.942 1.095 . . . . 0.0 112.612 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 80.86 -4.05 72.24 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.978 179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.67 -27.19 45.16 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.079 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -80.45 108.74 14.33 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.01 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.0 m -81.31 -19.64 42.49 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.394 179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.8 p -135.17 150.08 50.07 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -153.8 168.36 26.58 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.997 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.421 HG23 HD12 ' A' ' 19' ' ' LEU . 97.3 m -117.11 158.31 24.43 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.398 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.43 HD13 HG21 ' A' ' 59' ' ' ILE . 5.6 mt -143.03 155.06 17.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.396 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.483 ' HG ' ' HG ' ' A' ' 17' ' ' SER . 0.3 OUTLIER -139.52 135.64 33.67 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.875 -179.999 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.4 44.37 0.18 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.53 ' CD2' HD13 ' A' ' 18' ' ' LEU . 7.5 mp -107.16 175.66 5.42 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.573 -179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.58 141.39 28.82 Favored Pre-proline 0 CA--C 1.555 1.137 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.02 100.29 0.08 OUTLIER 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 120.748 0.965 . . . . 0.0 112.505 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.43 95.22 0.05 OUTLIER Glycine 0 N--CA 1.492 2.396 0 C-N-CA 119.845 -1.169 . . . . 0.0 111.59 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 p -160.59 159.04 2.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 119.136 -1.025 . . . . 0.0 111.328 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.3 146.41 45.34 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.264 -0.974 . . . . 0.0 108.874 179.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -144.9 145.2 31.47 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.724 -1.19 . . . . 0.0 112.458 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 m -125.29 126.06 44.51 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.407 179.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.3 tt -111.46 150.15 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.606 -0.838 . . . . 0.0 111.164 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.13 124.9 19.63 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.815 -179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.01 130.27 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.594 179.928 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.09 105.35 13.1 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.625 -179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.37 129.69 39.41 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.353 -0.939 . . . . 0.0 109.246 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.7 t -135.57 130.62 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 C-N-CA 119.115 -1.034 . . . . 0.0 112.25 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.445 ' H ' ' CB ' ' A' ' 84' ' ' SER . 53.6 m -128.76 -96.31 0.4 Allowed 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 114.579 -1.192 . . . . 0.0 109.583 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 76' ' ' THR . . . 60.21 145.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.673 -1.251 . . . . 0.0 111.092 179.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -108.22 179.59 4.16 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.565 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.19 -105.44 1.35 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.161 -1.495 . . . . 0.0 110.394 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.467 ' CG ' ' N ' ' A' ' 81' ' ' SER . 13.1 p-10 -153.2 -52.32 0.1 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.958 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.467 ' N ' ' CG ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -51.82 127.92 35.45 Favored Pre-proline 0 CA--C 1.562 1.434 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.692 -179.998 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.53 122.84 11.37 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 120.533 0.822 . . . . 0.0 111.527 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.64 16.34 5.35 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.032 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.445 ' CB ' ' H ' ' A' ' 76' ' ' THR . 8.6 m -118.36 86.43 2.53 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.798 179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 16.5 m -115.24 78.12 1.14 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.91 -0.716 . . . . 0.0 111.315 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 14.5 mmtm -136.74 61.57 36.83 Favored Pre-proline 0 N--CA 1.493 1.686 0 C-N-CA 119.726 -0.79 . . . . 0.0 111.452 -179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -71.07 160.35 49.51 Favored 'Trans proline' 0 C--O 1.217 -0.568 0 C-N-CA 121.571 1.514 . . . . 0.0 111.392 179.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 88' ' ' ILE . 16.1 tt -149.76 128.55 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 118.934 -1.106 . . . . 0.0 109.753 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 99.6 p -121.04 152.04 39.08 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.769 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -148.77 142.57 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.339 179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -92.92 154.65 18.07 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.325 -0.95 . . . . 0.0 110.598 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -164.48 131.69 3.18 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.121 179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 14.9 mtm180 -89.69 117.26 28.42 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.172 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 116.299 -1.81 . . . . 0.0 110.597 -179.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -54.81 116.99 3.03 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.982 -179.991 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 2' ' ' SER . 69.6 m-20 -155.04 49.01 0.56 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.389 -179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.0 t -107.91 135.51 19.83 Favored Pre-proline 0 N--CA 1.488 1.452 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.612 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -58.16 -166.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 120.477 0.784 . . . . 0.0 110.352 -179.987 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 7' ' ' ASP . 4.9 ptp180 -166.85 168.09 14.39 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 117.613 -1.635 . . . . 0.0 113.483 179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 18.86 78.34 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 113.693 -1.594 . . . . 0.0 114.651 179.924 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mp -101.28 123.55 45.58 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -161.75 171.3 18.08 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 117.942 -1.503 . . . . 0.0 112.813 -179.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -86.41 129.85 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.08 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.487 HG23 ' OG ' ' A' ' 21' ' ' SER . 4.9 t -95.59 -25.13 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 119.235 -0.986 . . . . 0.0 111.244 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -167.76 172.63 9.02 Favored 'General case' 0 C--N 1.293 -1.865 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.93 -179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -155.31 100.24 2.13 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.088 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.53 ' CB ' ' HG ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -70.52 162.26 71.67 Favored Pre-proline 0 C--N 1.307 -1.271 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.563 179.858 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -53.94 -7.52 0.67 Allowed 'Trans proline' 0 C--O 1.214 -0.716 0 C-N-CA 121.008 1.139 . . . . 0.0 111.712 -179.955 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.434 ' H ' ' C ' ' A' ' 14' ' ' THR . 7.2 m -160.29 35.99 0.17 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.53 ' HG ' ' CB ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -167.55 120.31 0.92 Allowed 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.207 179.89 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 tp -96.81 123.81 40.61 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.724 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.48 114.59 28.79 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.688 -179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.5 169.45 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.768 -0.773 . . . . 0.0 110.733 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.487 ' OG ' HG23 ' A' ' 11' ' ' VAL . 0.1 OUTLIER -158.65 139.51 12.87 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.7 -179.91 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.471 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 12.7 p90 -139.39 -134.15 0.12 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 119.649 -0.821 . . . . 0.0 110.321 179.846 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.493 ' CG ' ' N ' ' A' ' 24' ' ' ALA . 37.2 t70 -155.95 174.83 14.77 Favored 'General case' 0 N--CA 1.5 2.038 0 C-N-CA 117.671 -1.612 . . . . 0.0 112.594 -179.877 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.493 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -142.53 126.55 9.74 Favored Pre-proline 0 CA--C 1.559 1.298 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.854 179.899 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.64 -170.85 0.05 OUTLIER 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 120.285 0.657 . . . . 0.0 111.42 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.87 -12.72 49.99 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.346 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.539 ' O ' HG23 ' A' ' 29' ' ' VAL . 14.1 m -60.96 142.03 16.55 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 119.015 -1.074 . . . . 0.0 110.672 179.948 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.8 m -54.95 89.93 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.588 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 27' ' ' VAL . 3.6 t -76.53 115.19 17.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.134 -179.944 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -66.33 -57.81 6.67 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.631 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -165.45 169.02 16.07 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.539 179.788 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -122.65 148.7 44.96 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.902 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -126.73 108.66 11.27 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.536 -0.865 . . . . 0.0 109.531 179.782 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.03 128.71 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.875 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.3 p -128.64 139.72 52.12 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.149 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.493 ' CE2' HG11 ' A' ' 45' ' ' VAL . 10.8 p90 -141.95 166.7 23.99 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.725 -179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 164.02 158.68 10.25 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -51.79 158.74 0.93 Allowed 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.279 -0.969 . . . . 0.0 110.603 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.8 m -66.56 104.5 1.28 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.245 -0.982 . . . . 0.0 111.052 -179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.46 -41.91 0.02 OUTLIER Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.674 -1.25 . . . . 0.0 110.07 -179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.95 -12.25 50.14 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.488 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -126.88 16.32 7.4 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.566 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.5 p -148.7 70.52 10.43 Favored Pre-proline 0 N--CA 1.488 1.457 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.35 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -69.57 118.47 5.7 Favored 'Trans proline' 0 C--N 1.319 -1.003 0 C-N-CA 121.686 1.591 . . . . 0.0 111.891 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.493 HG11 ' CE2' ' A' ' 36' ' ' TYR . 2.3 t -57.91 -57.27 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.626 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.432 ' N ' HG12 ' A' ' 45' ' ' VAL . 2.9 tt0 -172.78 179.8 2.28 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.339 179.969 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' H ' ' HG2' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -164.49 158.45 18.3 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.281 -0.968 . . . . 0.0 110.844 -179.968 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -159.25 157.55 30.86 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.606 179.884 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -119.73 168.41 11.09 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.112 -179.868 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -147.66 158.89 42.4 Favored Pre-proline 0 C--N 1.309 -1.171 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.681 179.971 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.463 ' C ' ' H ' ' A' ' 53' ' ' SER . 1.9 Cg_endo -61.7 15.42 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 121.0 1.133 . . . . 0.0 112.72 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.534 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 54.19 7.98 0.98 Allowed Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.111 -1.518 . . . . 0.0 110.533 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -70.07 -34.74 73.57 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.291 -179.982 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -119.33 121.68 40.12 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.837 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 m -79.66 46.63 0.78 Allowed 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.979 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.12 151.34 43.85 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.719 -0.792 . . . . 0.0 110.378 179.886 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.13 159.21 40.02 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.735 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.07 148.95 52.19 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.699 -179.961 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.2 mt -138.21 146.89 26.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.587 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.7 m -139.43 155.42 47.62 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.231 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.46 8.71 55.99 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.928 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.23 -156.05 0.16 Allowed 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.855 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.67 103.62 0.94 Allowed Pre-proline 0 N--CA 1.485 1.319 0 C-N-CA 119.649 -0.821 . . . . 0.0 110.617 -179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.94 158.71 32.51 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 120.375 0.717 . . . . 0.0 111.639 -179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 97.63 35.91 5.0 Favored Glycine 0 N--CA 1.486 2.023 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.186 -179.934 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -165.22 154.68 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 118.878 -1.129 . . . . 0.0 111.943 179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -72.3 113.76 9.67 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.412 179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.0 148.23 30.0 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 119.879 -0.729 . . . . 0.0 111.247 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.2 m -122.93 140.21 53.24 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.708 179.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.6 tt -130.84 148.63 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.394 -179.946 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 65.4 m -140.5 126.03 19.01 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.249 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' ' 72' ' ' VAL . 23.3 m -117.81 129.71 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 C-N-CA 119.677 -0.809 . . . . 0.0 111.141 -179.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -107.59 106.86 17.41 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.617 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.52 107.85 14.62 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.182 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.3 t -100.39 113.7 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.526 -0.87 . . . . 0.0 111.23 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.4 m -128.34 -54.47 1.27 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.578 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 63.75 119.25 0.01 OUTLIER Glycine 0 N--CA 1.496 2.658 0 C-N-CA 119.934 -1.127 . . . . 0.0 110.617 -179.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.66 -80.01 0.4 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 119.379 -0.928 . . . . 0.0 110.864 179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -169.79 17.13 0.06 OUTLIER Glycine 0 N--CA 1.49 2.299 0 C-N-CA 119.554 -1.308 . . . . 0.0 110.459 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -144.63 -70.84 0.28 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.075 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.56 162.69 60.5 Favored Pre-proline 0 C--N 1.306 -1.304 0 C-N-CA 119.176 -1.01 . . . . 0.0 110.32 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.06 168.1 2.79 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 121.158 1.239 . . . . 0.0 111.243 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.63 -26.62 67.16 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.158 -1.017 . . . . 0.0 110.293 179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -66.39 109.1 2.59 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.4 179.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 20.7 p -83.27 -86.74 0.11 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.236 -179.966 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -143.99 70.1 16.54 Favored Pre-proline 0 C--N 1.299 -1.626 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.388 -179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -59.58 149.38 82.65 Favored 'Trans proline' 0 C--N 1.322 -0.855 0 C-N-CA 121.002 1.135 . . . . 0.0 110.429 179.862 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.1 tp -150.12 161.31 4.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 118.493 -1.283 . . . . 0.0 111.224 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 63.8 p -143.73 148.95 36.42 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.595 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -146.87 146.23 18.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.91 -179.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.21 160.07 17.14 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.557 -0.857 . . . . 0.0 110.417 179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -171.95 140.45 1.24 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.994 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.2 ttt180 -87.24 112.52 22.1 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.394 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.04 0 CA-C-O 116.337 -1.792 . . . . 0.0 110.827 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.48 1.053 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 t -179.77 -73.74 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.404 -0.919 . . . . 0.0 110.787 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -151.09 45.16 0.82 Allowed 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.404 -0.919 . . . . 0.0 110.777 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.436 ' O ' ' O ' ' A' ' 5' ' ' PRO . 84.2 t -49.42 125.9 16.03 Favored Pre-proline 0 C--N 1.302 -1.487 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.447 179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.436 ' O ' ' O ' ' A' ' 4' ' ' VAL . 6.1 Cg_exo -56.96 -161.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-N 118.729 0.582 . . . . 0.0 110.619 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -104.35 -154.65 0.51 Allowed 'General case' 0 N--CA 1.5 2.031 0 C-N-CA 118.892 -1.123 . . . . 0.0 112.67 -179.891 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -42.58 99.45 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.61 -179.685 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 mp -96.09 143.33 27.32 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 10' ' ' VAL . 1.8 tm-20 -167.63 166.72 13.84 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 117.844 -1.542 . . . . 0.0 112.897 -179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.471 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 97.6 t -99.62 108.55 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.618 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 90.3 t -70.49 -42.88 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 C-N-CA 119.141 -1.023 . . . . 0.0 111.918 -179.875 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.27 173.48 16.62 Favored 'General case' 0 C--N 1.291 -1.951 0 C-N-CA 118.913 -1.115 . . . . 0.0 111.757 -179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -153.59 142.45 21.11 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.697 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 17' ' ' SER . 1.1 p -140.63 155.58 69.48 Favored Pre-proline 0 N--CA 1.489 1.524 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.769 -179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -53.83 -7.92 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 121.389 1.393 . . . . 0.0 112.279 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.9 p -147.09 27.54 1.05 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.858 -1.137 . . . . 0.0 111.739 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.423 ' O ' ' OG1' ' A' ' 14' ' ' THR . 0.0 OUTLIER -177.53 147.84 0.54 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.728 -179.992 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.35 134.36 47.11 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.443 179.857 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.0 tp -115.65 103.1 10.37 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.508 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.426 ' H ' HG23 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -99.35 165.61 2.29 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.257 179.852 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 m -156.06 136.53 13.18 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 118.708 -1.197 . . . . 0.0 111.258 -179.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.556 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 16.0 p90 -138.66 -140.32 0.14 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.566 -0.853 . . . . 0.0 110.796 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.556 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 36.9 t70 -165.1 153.79 12.15 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.52 -1.272 . . . . 0.0 112.003 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.39 134.76 20.5 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.662 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -59.28 -159.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 120.658 0.905 . . . . 0.0 111.442 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -96.34 -18.64 19.82 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.965 179.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 29' ' ' VAL . 34.5 m -60.07 151.41 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.786 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.93 104.07 0.17 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.247 179.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 27' ' ' VAL . 2.9 t -94.26 118.35 40.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.494 -0.882 . . . . 0.0 111.494 -179.89 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -85.05 -55.4 4.07 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.055 -1.058 . . . . 0.0 109.486 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -157.95 163.99 37.29 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.629 -1.229 . . . . 0.0 111.924 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -119.46 160.46 22.31 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.739 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.38 98.03 3.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.808 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.712 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.7 mp -89.58 134.01 30.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.627 -0.829 . . . . 0.0 112.247 -179.781 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.2 p -135.79 134.5 39.01 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.771 179.802 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -141.92 155.56 45.49 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.124 -1.43 . . . . 0.0 112.547 -179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.549 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . 171.1 152.28 8.13 Favored Glycine 0 N--CA 1.479 1.558 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.697 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -48.81 175.02 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.342 -179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.527 HG22 ' N ' ' A' ' 40' ' ' GLY . 19.9 m -51.79 164.11 0.27 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.527 ' N ' HG22 ' A' ' 39' ' ' THR . . . 84.6 86.67 0.9 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.393 179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -76.1 74.73 1.61 Allowed Glycine 0 N--CA 1.488 2.165 0 C-N-CA 119.367 -1.397 . . . . 0.0 110.588 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.12 -19.16 1.75 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.039 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.425 ' N ' ' CD ' ' A' ' 44' ' ' PRO . 11.0 m -168.36 57.12 0.34 Allowed Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.457 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 43' ' ' SER . 3.4 Cg_exo -52.62 164.27 1.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 121.314 1.343 . . . . 0.0 111.927 -179.928 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.549 HG23 ' HA2' ' A' ' 37' ' ' GLY . 86.1 t -50.05 -67.11 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.263 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.99 -169.91 0.7 Allowed 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.874 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -158.1 166.97 31.14 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.108 -1.037 . . . . 0.0 110.95 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 13.6 p90 -162.5 153.3 17.24 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.424 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.87 160.45 16.76 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.685 -0.806 . . . . 0.0 112.187 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.579 ' C ' ' H ' ' A' ' 52' ' ' GLY . 22.8 m -148.66 153.08 39.06 Favored Pre-proline 0 C--N 1.306 -1.304 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.265 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.474 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.3 Cg_endo -60.01 16.89 0.04 OUTLIER 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 120.872 1.048 . . . . 0.0 112.758 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.579 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 53.33 6.87 0.47 Allowed Glycine 0 N--CA 1.498 2.784 0 C-N-CA 119.578 -1.296 . . . . 0.0 111.093 179.917 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -74.98 -44.41 48.39 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.503 -179.977 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -99.55 116.25 31.25 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.467 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.7 m -84.6 53.74 2.78 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.042 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.1 143.68 22.66 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.97 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -147.96 148.24 30.55 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 118.804 -1.159 . . . . 0.0 111.842 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.1 m -121.91 104.13 9.33 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.926 179.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.2 pt -109.12 136.36 45.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.209 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.8 m -118.24 -176.68 3.11 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.721 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.83 40.05 9.86 Favored Glycine 0 N--CA 1.49 2.275 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.514 179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.73 -158.35 0.65 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.971 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -148.58 134.93 10.02 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.209 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -56.74 107.25 0.26 Allowed 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 120.489 0.793 . . . . 0.0 112.072 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.57 87.71 0.52 Allowed Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.565 -1.302 . . . . 0.0 111.286 179.902 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 10.6 p -161.28 135.27 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.037 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.6 120.93 8.58 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.92 179.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.5 118.56 26.89 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.631 -0.828 . . . . 0.0 111.972 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 93.6 m -103.73 114.74 29.22 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.08 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.9 tt -103.64 150.56 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 C-N-CA 119.287 -0.965 . . . . 0.0 112.06 -179.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.542 HG23 ' OG ' ' A' ' 89' ' ' SER . 85.5 m -139.75 116.51 10.87 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.002 179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 18.6 m -103.22 144.17 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 119.194 -1.002 . . . . 0.0 110.768 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -112.2 128.97 56.39 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.319 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.97 86.76 2.38 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.728 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.0 t -97.01 129.81 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 119.164 -1.015 . . . . 0.0 113.113 -179.629 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.769 HG23 ' H ' ' A' ' 77' ' ' GLY . 0.7 OUTLIER -99.35 -109.39 0.19 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.859 179.835 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.769 ' H ' HG23 ' A' ' 76' ' ' THR . . . 132.17 127.35 2.82 Favored Glycine 0 N--CA 1.497 2.738 0 C-N-CA 119.625 -1.274 . . . . 0.0 111.116 179.907 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.435 ' HD3' ' H ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -89.29 -10.12 48.0 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.682 179.844 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -149.68 -73.75 0.01 OUTLIER Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -172.18 -4.71 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.44 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.6 148.13 51.11 Favored Pre-proline 0 C--N 1.306 -1.294 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.811 -179.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.59 115.3 2.45 Favored 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 121.009 1.139 . . . . 0.0 111.357 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.27 116.32 32.4 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.813 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 84' ' ' SER . 86.6 p -61.12 100.61 0.12 Allowed 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.568 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.1 t -90.09 -151.47 0.24 Allowed 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.019 -179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -118.53 93.9 46.47 Favored Pre-proline 0 N--CA 1.489 1.481 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.863 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -71.38 167.98 24.78 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 121.112 1.208 . . . . 0.0 111.413 -179.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 2.7 tt -149.49 147.38 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 118.832 -1.147 . . . . 0.0 110.601 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.542 ' OG ' HG23 ' A' ' 71' ' ' THR . 0.8 OUTLIER -135.17 155.23 51.04 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.437 -0.905 . . . . 0.0 111.681 -179.858 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -143.76 142.97 24.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.014 179.875 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -82.44 142.77 31.65 Favored 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.061 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -158.99 108.99 1.97 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.284 -0.966 . . . . 0.0 111.185 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.409 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 5.5 ptt-85 -79.04 116.81 19.57 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.887 -1.125 . . . . 0.0 109.114 179.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 116.367 -1.778 . . . . 0.0 110.972 -179.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.739 ' O ' HG22 ' A' ' 1' ' ' VAL . 7.5 p . . . . . 0 N--CA 1.484 1.231 0 CA-C-O 121.216 0.531 . . . . 0.0 109.936 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.2 p -160.84 -170.45 2.73 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.547 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.27 46.99 0.95 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.829 179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.6 t -130.38 86.36 53.8 Favored Pre-proline 0 N--CA 1.489 1.485 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.471 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.19 -170.91 0.04 OUTLIER 'Trans proline' 0 C--O 1.215 -0.672 0 N-CA-C 109.89 -0.85 . . . . 0.0 109.89 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.488 ' O ' ' O ' ' A' ' 22' ' ' TRP . 0.3 OUTLIER -176.43 172.77 2.18 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 117.154 -1.818 . . . . 0.0 114.71 -179.712 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' ARG . 38.5 t70 27.19 102.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 113.524 -1.671 . . . . 0.0 113.443 179.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.48 HD12 ' H ' ' A' ' 23' ' ' ASP . 0.5 OUTLIER -82.13 99.54 9.28 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.142 179.747 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -167.03 167.44 14.6 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.591 179.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -87.67 145.71 7.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.225 0 C-N-CA 119.649 -0.82 . . . . 0.0 109.986 179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.612 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -117.75 0.13 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 C-N-CA 119.578 -0.849 . . . . 0.0 111.603 -179.853 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 171.97 161.19 0.1 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.7 -1.2 . . . . 0.0 111.904 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -158.74 126.75 5.14 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.831 179.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.57 161.68 61.62 Favored Pre-proline 0 N--CA 1.487 1.392 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.011 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' O ' ' CB ' ' A' ' 16' ' ' THR . 5.1 Cg_exo -49.79 104.79 0.08 OUTLIER 'Trans proline' 0 C--O 1.214 -0.699 0 C-N-CA 121.042 1.161 . . . . 0.0 112.051 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.463 ' CB ' ' O ' ' A' ' 15' ' ' PRO . 0.2 OUTLIER 75.46 33.34 0.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.555 179.886 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 p -159.99 126.45 4.33 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.25 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.8 tp -130.42 140.07 50.58 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.77 -0.772 . . . . 0.0 111.347 -179.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.61 126.09 45.99 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.985 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 pt -133.66 162.15 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 119.286 -0.966 . . . . 0.0 112.932 -179.817 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 m -134.58 140.22 45.94 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.55 -1.205 . . . . 0.0 108.256 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.488 ' O ' ' O ' ' A' ' 6' ' ' ARG . 29.1 p90 -119.5 176.78 5.19 Favored 'General case' 0 N--CA 1.506 2.34 0 C-N-CA 118.712 -1.195 . . . . 0.0 113.506 -179.843 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.48 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -136.51 162.02 34.24 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.971 -1.468 . . . . 0.0 110.496 -179.881 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.768 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -172.47 -175.63 0.3 Allowed Pre-proline 0 N--CA 1.496 1.827 0 C-N-CA 119.718 -0.793 . . . . 0.0 109.542 -179.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.768 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 5.9 Cg_exo -67.58 152.08 78.71 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 120.625 0.883 . . . . 0.0 111.009 -179.761 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.85 44.03 0.45 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.511 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.713 HG22 ' N ' ' A' ' 28' ' ' THR . 13.9 p -107.57 175.36 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 C-N-CA 119.572 -0.851 . . . . 0.0 111.008 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.713 ' N ' HG22 ' A' ' 27' ' ' VAL . 4.2 m -80.52 128.97 34.2 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.97 179.91 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.7 t -123.42 132.0 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.653 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -80.16 -41.65 24.92 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.141 -179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -143.09 175.06 10.14 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.79 -179.912 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -143.12 140.5 30.88 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 113.926 -1.488 . . . . 0.0 109.746 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -123.28 107.95 12.24 Favored 'General case' 0 N--CA 1.513 2.708 0 C-N-CA 119.118 -1.033 . . . . 0.0 109.98 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.7 mt -100.98 111.34 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 119.602 -0.839 . . . . 0.0 112.099 -179.823 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.402 HG22 ' OE2' ' A' ' 47' ' ' GLU . 9.0 p -117.35 137.46 52.43 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.593 179.846 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.417 ' CE2' HG11 ' A' ' 45' ' ' VAL . 42.6 p90 -141.4 138.21 32.81 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.029 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -168.12 136.78 4.25 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -82.75 169.51 16.08 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.742 -179.966 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.523 HG22 ' N ' ' A' ' 40' ' ' GLY . 54.9 m -70.87 162.29 29.52 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.786 -0.766 . . . . 0.0 111.756 -179.801 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 39' ' ' THR . . . 115.3 93.02 1.86 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 -179.949 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -51.83 94.05 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.624 -1.274 . . . . 0.0 111.252 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 40' ' ' GLY . 0.8 OUTLIER -135.53 -58.95 0.77 Allowed 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.757 179.902 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.66 154.89 1.95 Allowed Pre-proline 0 C--N 1.306 -1.315 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.161 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.12 137.37 61.21 Favored 'Trans proline' 0 C--O 1.216 -0.607 0 C-N-CA 121.078 1.185 . . . . 0.0 111.207 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.656 HG12 ' N ' ' A' ' 46' ' ' GLN . 4.2 t -81.15 -80.85 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 118.813 -1.155 . . . . 0.0 110.162 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.656 ' N ' HG12 ' A' ' 45' ' ' VAL . 1.1 mt-30 -163.3 171.93 15.42 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 117.509 -1.676 . . . . 0.0 112.556 179.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' OE2' HG22 ' A' ' 35' ' ' THR . 2.3 tt0 -170.6 143.28 2.17 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.127 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 4.6 p90 -147.34 141.55 26.17 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.837 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.8 p -98.98 156.94 16.66 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.769 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.506 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -150.07 157.88 37.19 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.321 179.942 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.41 13.61 0.09 OUTLIER 'Trans proline' 0 C--O 1.212 -0.785 0 C-N-CA 121.319 1.346 . . . . 0.0 112.234 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 57.66 27.81 59.27 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 118.886 -1.626 . . . . 0.0 109.901 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.21 -31.3 19.16 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -95.91 135.24 37.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 119.425 -0.91 . . . . 0.0 110.982 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.8 m -79.71 -15.61 57.2 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.109 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 p -139.08 -179.61 5.95 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.134 180.0 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -170.04 157.83 6.74 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.042 -1.063 . . . . 0.0 111.346 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.6 m -114.32 136.74 52.65 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.624 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -125.65 155.22 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.487 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 11.1 t -147.74 127.05 13.05 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.937 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 161.34 -34.15 0.38 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.672 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.48 -158.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.798 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 8.3 tttt -176.11 -43.43 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 119.334 -0.947 . . . . 0.0 112.586 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.607 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 4.4 Cg_endo -78.86 -175.52 2.79 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 121.497 1.465 . . . . 0.0 112.096 -179.829 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -138.2 80.07 0.29 Allowed Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.847 HG22 ' H ' ' A' ' 67' ' ' ASP . 13.8 p -122.81 -174.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 120.323 -0.551 . . . . 0.0 111.241 -179.79 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.847 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -65.49 95.13 0.2 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.084 179.92 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -90.88 127.95 36.56 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.597 -0.841 . . . . 0.0 111.109 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 m -94.05 117.92 30.78 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.94 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.467 HD12 ' H ' ' A' ' 71' ' ' THR . 2.6 tp -104.89 141.92 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.534 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.467 ' H ' HD12 ' A' ' 70' ' ' ILE . 97.3 m -141.48 130.05 22.68 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.373 -179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -125.12 128.06 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 C-N-CA 119.309 -0.956 . . . . 0.0 110.947 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -98.33 146.74 25.38 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.699 179.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.35 85.33 2.37 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 123.981 0.8 . . . . 0.0 109.485 179.875 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.413 HG22 ' OG ' ' A' ' 85' ' ' SER . 18.6 t -81.4 128.25 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.735 -1.186 . . . . 0.0 111.319 -179.823 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.0 m -128.84 -57.57 1.18 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.635 -179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.89 159.98 53.91 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.458 -1.353 . . . . 0.0 109.932 179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.78 -162.98 0.9 Allowed 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.77 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 43.3 -113.43 0.68 Allowed Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.558 179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -166.4 -19.17 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.191 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.591 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 0.2 OUTLIER -75.53 -41.48 3.68 Favored Pre-proline 0 C--N 1.304 -1.397 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.259 179.955 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.591 ' CD ' ' N ' ' A' ' 81' ' ' SER . 5.8 Cg_exo -66.47 -177.35 0.87 Allowed 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 120.974 1.116 . . . . 0.0 111.795 -179.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -50.09 126.28 14.14 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.126 -179.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.6 t -88.45 178.65 6.49 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.763 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.413 ' OG ' HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -77.34 172.52 13.18 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.987 -179.976 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -132.15 75.08 75.51 Favored Pre-proline 0 N--CA 1.49 1.529 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.897 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -60.39 130.43 33.82 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 121.666 1.577 . . . . 0.0 113.161 -179.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 1.1 tt -133.07 145.28 34.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.456 179.761 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 54.4 p -144.46 153.53 41.98 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.301 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.53 141.83 19.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.701 -0.8 . . . . 0.0 110.376 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -71.34 154.54 41.51 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.122 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -152.25 122.26 7.08 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.405 -179.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.54 75.93 1.07 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.648 179.858 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.453 ' O ' ' N ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 116.212 -1.851 . . . . 0.0 110.417 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.8 p . . . . . 0 N--CA 1.482 1.158 0 CA-C-O 120.888 0.375 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 t -146.02 147.29 31.49 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.818 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.61 25.58 1.99 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.717 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.455 ' O ' ' O ' ' A' ' 5' ' ' PRO . 17.5 t -86.0 137.1 35.56 Favored Pre-proline 0 C--N 1.3 -1.548 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.305 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 4' ' ' VAL . 3.4 Cg_exo -54.17 -163.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 120.69 0.926 . . . . 0.0 110.574 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 7' ' ' ASP . 0.0 OUTLIER -167.54 171.47 10.31 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 117.032 -1.867 . . . . 0.0 114.223 -179.92 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' C ' ' O ' ' A' ' 6' ' ' ARG . 4.4 m-20 2.38 95.59 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 CA-C-N 112.859 -1.973 . . . . 0.0 115.923 -179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mp -101.49 139.46 37.11 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.487 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.95 168.05 27.68 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 117.693 -1.603 . . . . 0.0 113.69 -179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.9 t -103.34 115.75 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.559 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.483 ' CG2' ' OG ' ' A' ' 21' ' ' SER . 2.3 t -72.52 -74.11 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.007 -1.077 . . . . 0.0 111.726 -179.823 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.81 179.0 6.84 Favored 'General case' 0 C--N 1.296 -1.732 0 C-N-CA 119.89 -0.724 . . . . 0.0 110.73 -179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.14 100.73 3.6 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 119.314 -0.955 . . . . 0.0 111.499 -179.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.16 164.44 23.08 Favored Pre-proline 0 C--N 1.305 -1.327 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.797 179.848 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.532 ' O ' HG23 ' A' ' 16' ' ' THR . 5.0 Cg_exo -54.27 -12.52 3.97 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 121.213 1.275 . . . . 0.0 111.714 179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 15' ' ' PRO . 2.2 p -158.85 33.35 0.22 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.607 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -161.45 137.96 8.33 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.124 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 13.6 tp -114.27 126.97 55.63 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.55 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 19' ' ' LEU . 2.8 tt -100.07 98.75 9.45 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.584 179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 pp -96.61 148.8 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 119.546 -0.862 . . . . 0.0 110.394 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.483 ' OG ' ' CG2' ' A' ' 11' ' ' VAL . 0.2 OUTLIER -145.82 134.43 22.16 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 118.95 -1.1 . . . . 0.0 111.352 -179.938 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.555 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 5.8 p90 -136.42 -140.83 0.16 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.707 179.828 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.555 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 18.4 t70 -150.46 166.95 28.57 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 117.999 -1.48 . . . . 0.0 113.207 -179.754 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.461 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -142.25 136.36 14.81 Favored Pre-proline 0 CA--C 1.557 1.23 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.844 179.892 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.57 172.51 1.45 Allowed 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 120.754 0.969 . . . . 0.0 111.705 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.58 -26.62 37.78 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.469 179.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 27' ' ' VAL . 1.8 t -60.0 160.59 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.53 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.4 t -64.57 132.05 48.74 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 118.725 -1.19 . . . . 0.0 109.6 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.797 HG13 HG22 ' A' ' 76' ' ' THR . 3.1 t -110.08 122.53 64.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.171 -179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.434 ' CG ' ' CE2' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -54.34 -55.67 26.17 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.149 179.955 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.434 ' CE2' ' CG ' ' A' ' 30' ' ' ARG . 2.1 p90 178.42 171.43 0.75 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.493 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -128.07 161.57 28.91 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.175 -179.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.74 104.68 4.76 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.373 179.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.9 mp -99.37 120.21 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 119.789 -0.765 . . . . 0.0 110.796 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -120.35 137.09 54.47 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.663 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.69 ' CZ ' HG11 ' A' ' 45' ' ' VAL . 11.2 p90 -142.2 157.75 44.51 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 118.623 -1.231 . . . . 0.0 111.585 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.91 170.58 42.92 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 40' ' ' GLY . 3.9 mt-10 -61.4 -162.48 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.959 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.0 t -46.73 -14.15 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.199 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' GLU . . . 80.58 98.06 0.35 Allowed Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.415 -1.374 . . . . 0.0 110.491 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 146.32 -7.96 1.39 Allowed Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.447 -1.358 . . . . 0.0 110.409 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -120.32 -46.52 2.39 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.981 -0.687 . . . . 0.0 111.029 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 m -175.39 78.41 0.31 Allowed Pre-proline 0 C--N 1.307 -1.279 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.298 -179.874 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -64.73 153.37 78.03 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 121.068 1.179 . . . . 0.0 111.252 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.69 HG11 ' CZ ' ' A' ' 36' ' ' TYR . 86.0 t -77.54 -90.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.502 -179.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.465 ' N ' HG12 ' A' ' 45' ' ' VAL . 9.3 tt0 -175.17 -143.88 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.94 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -165.39 168.3 16.88 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 119.261 -0.975 . . . . 0.0 111.394 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 8.7 p90 -153.61 136.48 15.39 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 119.807 -0.757 . . . . 0.0 110.146 179.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.9 p -100.1 159.79 14.83 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.702 -179.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.545 ' C ' ' H ' ' A' ' 52' ' ' GLY . 34.1 m -147.9 150.53 36.08 Favored Pre-proline 0 C--N 1.307 -1.275 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.666 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -56.95 5.75 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.725 0 C-N-CA 120.849 1.033 . . . . 0.0 112.383 179.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 81.72 7.49 88.01 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.354 -1.403 . . . . 0.0 110.324 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.44 -35.77 27.22 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.761 -179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -72.66 106.44 4.67 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.842 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.6 m -79.83 -18.32 51.12 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.859 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.2 p -132.67 158.82 41.35 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 114.79 -1.096 . . . . 0.0 109.273 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -159.11 149.25 19.24 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 118.549 -1.26 . . . . 0.0 111.569 -179.922 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 57.8 m -121.87 117.89 27.61 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.054 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.5 pt -108.27 149.47 11.55 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.406 -179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -127.9 175.76 8.1 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.522 -179.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.507 ' C ' HD23 ' A' ' 62' ' ' LEU . . . 83.84 49.6 4.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 -179.884 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.507 HD23 ' C ' ' A' ' 61' ' ' GLY . 0.8 OUTLIER -117.46 -168.58 1.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.614 0.721 . . . . 0.0 111.536 -179.881 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -148.98 82.82 6.97 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.011 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -54.46 140.54 74.29 Favored 'Trans proline' 0 C--O 1.216 -0.578 0 C-N-CA 120.846 1.03 . . . . 0.0 111.815 -179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.8 31.4 2.73 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 67' ' ' ASP . 2.4 p -162.17 169.94 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 119.361 -0.935 . . . . 0.0 111.255 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.465 ' H ' HG22 ' A' ' 66' ' ' VAL . 6.4 t0 -82.45 126.48 32.26 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.999 179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.2 133.36 56.09 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 120.144 -0.623 . . . . 0.0 110.7 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.4 m -103.46 138.4 40.23 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.444 ' CG1' ' N ' ' A' ' 71' ' ' THR . 6.1 tt -132.04 157.03 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.457 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.444 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 26.9 m -151.43 123.03 7.93 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.551 179.989 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.7 m -115.18 135.09 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.901 179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -112.77 121.38 44.55 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.984 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.63 105.2 16.1 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.658 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.414 HG21 ' HE1' ' A' ' 31' ' ' TYR . 10.6 t -105.32 99.33 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.717 -0.793 . . . . 0.0 111.271 -179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.797 HG22 HG13 ' A' ' 29' ' ' VAL . 34.6 p -113.73 154.06 27.96 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.23 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 169.73 155.48 10.09 Favored Glycine 0 N--CA 1.489 2.196 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.471 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -81.56 2.49 28.93 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.681 -179.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.01 10.59 71.6 Favored Glycine 0 N--CA 1.488 2.148 0 C-N-CA 119.417 -1.373 . . . . 0.0 110.556 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -131.45 -69.84 0.61 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.768 179.992 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.12 128.74 56.61 Favored Pre-proline 0 CA--C 1.562 1.407 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.508 -179.985 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.2 128.49 25.29 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 120.413 0.742 . . . . 0.0 110.829 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.32 38.04 3.81 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.794 -0.763 . . . . 0.0 111.473 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.1 t -56.05 127.46 30.64 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.415 179.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.7 m -88.97 -110.65 0.07 Allowed 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.333 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.471 ' CG ' ' O ' ' A' ' 86' ' ' LYS . 0.1 OUTLIER -156.2 101.78 2.08 Favored Pre-proline 0 C--N 1.303 -1.423 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.882 -179.971 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -55.74 168.02 1.9 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 120.76 0.974 . . . . 0.0 111.678 -179.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 88' ' ' ILE . 13.2 tt -151.39 146.72 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 118.769 -1.172 . . . . 0.0 111.195 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 90.0 p -141.5 146.35 36.3 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.204 179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.2 pt -146.53 151.8 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.311 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.53 160.27 15.12 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.629 -0.829 . . . . 0.0 109.429 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -161.35 141.05 10.46 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.374 -1.33 . . . . 0.0 112.157 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -96.01 99.72 11.46 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.311 179.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 116.329 -1.796 . . . . 0.0 110.706 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.1 p -166.6 100.94 0.58 Allowed 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.513 179.976 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.39 5.69 0.95 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.462 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -87.86 138.34 31.28 Favored Pre-proline 0 C--N 1.304 -1.39 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.151 179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.8 165.73 6.1 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 N-CA-C 109.989 -0.812 . . . . 0.0 109.989 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.429 ' O ' HD23 ' A' ' 8' ' ' LEU . 5.0 ptm180 -170.71 168.33 7.46 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 118.121 -1.432 . . . . 0.0 112.705 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 55.27 49.8 16.36 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.594 179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 6' ' ' ARG . 0.1 OUTLIER -97.29 135.08 39.72 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.349 -0.941 . . . . 0.0 110.22 179.863 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -173.44 168.29 4.57 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.881 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.1 t -96.05 117.29 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.711 179.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.537 HG12 ' N ' ' A' ' 12' ' ' ALA . 39.8 t -71.49 -79.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 C-N-CA 118.792 -1.163 . . . . 0.0 110.786 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.537 ' N ' HG12 ' A' ' 11' ' ' VAL . . . -139.58 179.35 6.62 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 119.819 -0.752 . . . . 0.0 110.476 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -144.96 170.54 15.96 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.195 -1.002 . . . . 0.0 111.502 -179.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 17' ' ' SER . 52.9 p -142.58 153.04 61.42 Favored Pre-proline 0 C--N 1.306 -1.321 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.693 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -50.95 -5.33 0.08 OUTLIER 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 120.599 0.866 . . . . 0.0 111.98 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.504 ' H ' ' C ' ' A' ' 14' ' ' THR . 10.0 t -154.74 28.43 0.43 Allowed 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.131 -1.028 . . . . 0.0 111.61 179.996 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.518 ' N ' ' OG1' ' A' ' 14' ' ' THR . 0.4 OUTLIER -173.93 135.88 0.51 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.665 -1.214 . . . . 0.0 111.985 179.905 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 31.9 tp -112.71 146.52 38.58 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.046 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.8 tp -121.23 104.45 9.75 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.756 -0.777 . . . . 0.0 110.999 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pt -97.81 150.56 4.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 C-N-CA 119.555 -0.858 . . . . 0.0 109.929 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.5 m -145.53 138.12 25.87 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 118.989 -1.085 . . . . 0.0 111.255 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 10.7 p90 -144.79 -157.77 0.82 Allowed 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.585 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 24' ' ' ALA . 6.6 t70 -139.22 141.88 37.87 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.187 -1.005 . . . . 0.0 112.198 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.442 ' O ' ' OD1' ' A' ' 23' ' ' ASP . . . -96.26 155.18 38.38 Favored Pre-proline 0 N--CA 1.482 1.164 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.076 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.77 170.37 5.92 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 120.991 1.127 . . . . 0.0 111.811 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.65 -38.27 83.58 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.228 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.468 ' H ' HG23 ' A' ' 27' ' ' VAL . 0.6 OUTLIER -61.78 159.24 2.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.53 179.973 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.29 159.09 35.22 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 118.506 -1.278 . . . . 0.0 108.854 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.0 t -139.55 122.07 17.12 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.372 -179.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -53.64 -52.34 60.23 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.729 -1.188 . . . . 0.0 108.754 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -171.78 162.89 6.32 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.711 -1.196 . . . . 0.0 112.294 179.746 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -109.35 171.69 7.29 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.515 179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.474 ' C ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -137.57 108.84 6.84 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.198 179.962 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.791 ' N ' HD12 ' A' ' 34' ' ' ILE . 1.8 mp -98.93 113.29 33.34 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.749 -179.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.514 HG22 ' HB2' ' A' ' 47' ' ' GLU . 17.6 p -117.51 135.82 53.66 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.282 179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.449 ' CE2' HG11 ' A' ' 45' ' ' VAL . 5.6 p90 -141.17 157.61 45.02 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 118.753 -1.179 . . . . 0.0 111.138 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . -171.82 148.41 10.9 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 179.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.447 ' O ' ' O ' ' A' ' 39' ' ' THR . 6.3 pt-20 -56.17 -163.5 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.082 -1.047 . . . . 0.0 110.964 -179.886 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.723 HG23 ' H ' ' A' ' 40' ' ' GLY . 3.4 t -58.38 -119.35 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.321 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.723 ' H ' HG23 ' A' ' 39' ' ' THR . . . -50.69 -78.05 0.11 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.098 -179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 40' ' ' GLY . . . 60.66 125.2 0.01 OUTLIER Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.541 179.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 34.0 m-80 -56.95 -19.48 18.28 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.407 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -161.29 162.43 21.8 Favored Pre-proline 0 C--N 1.305 -1.34 0 C-N-CA 119.675 -0.81 . . . . 0.0 110.031 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -63.65 158.03 48.34 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 121.293 1.329 . . . . 0.0 111.596 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.449 HG11 ' CE2' ' A' ' 36' ' ' TYR . 4.1 t -72.95 -57.52 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 119.084 -1.046 . . . . 0.0 109.816 179.868 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -171.05 -166.91 0.5 Allowed 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.402 179.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.514 ' HB2' HG22 ' A' ' 35' ' ' THR . 5.8 pt-20 -169.49 159.47 8.52 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.2 -1.0 . . . . 0.0 110.734 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -160.22 143.38 13.67 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.166 -1.013 . . . . 0.0 110.512 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.429 HG22 ' HG3' ' A' ' 33' ' ' ARG . 4.1 p -106.73 162.28 13.92 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.983 -0.687 . . . . 0.0 111.584 -179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.523 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -142.02 159.22 59.85 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.868 179.952 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 53' ' ' SER . 2.5 Cg_endo -63.9 14.85 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 120.99 1.126 . . . . 0.0 112.345 179.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 57.54 2.05 0.65 Allowed Glycine 0 N--CA 1.496 2.688 0 C-N-CA 119.432 -1.366 . . . . 0.0 111.112 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -74.3 -44.02 54.38 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.66 179.94 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -93.03 116.33 28.95 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.304 -0.959 . . . . 0.0 110.693 180.0 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.59 21.15 0.67 Allowed 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.771 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.7 p -138.67 130.64 28.1 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.658 -0.817 . . . . 0.0 110.947 -179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -136.2 165.48 25.65 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.576 179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.0 t -136.62 144.03 43.85 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.598 179.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -119.76 160.06 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.131 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.33 140.47 24.09 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.14 -1.024 . . . . 0.0 111.25 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.86 -15.84 5.37 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.744 ' C ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -83.56 167.0 17.76 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.324 179.992 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.425 ' N ' HD22 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -134.6 128.43 19.03 Favored Pre-proline 0 CA--C 1.556 1.193 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.202 179.803 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -57.22 112.64 1.18 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.408 0.739 . . . . 0.0 111.8 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.22 22.4 0.26 Allowed Glycine 0 N--CA 1.498 2.788 0 C-N-CA 119.202 -1.475 . . . . 0.0 111.608 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.509 HG22 ' N ' ' A' ' 67' ' ' ASP . 6.9 p -151.74 158.69 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 118.689 -1.205 . . . . 0.0 112.037 179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.509 ' N ' HG22 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -73.29 147.02 44.92 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.791 179.995 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -147.66 127.0 13.07 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.649 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.5 m -111.18 132.06 54.61 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.227 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 pt -119.52 154.33 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 119.213 -0.995 . . . . 0.0 112.067 -179.844 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 89' ' ' SER . 0.1 OUTLIER -134.91 131.82 37.74 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.42 179.991 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.1 m -122.14 142.35 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.439 179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -126.18 133.07 51.66 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 120.039 -0.664 . . . . 0.0 110.176 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.15 108.68 20.25 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.598 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.8 t -109.09 113.55 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.449 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.5 m -114.32 -12.47 12.41 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.253 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -49.49 140.9 13.56 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.317 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.0 mtp85 -118.23 -27.56 6.02 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.853 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -45.39 -82.12 0.03 OUTLIER Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.536 -1.316 . . . . 0.0 110.249 179.98 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -175.43 -54.46 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 119.889 -0.724 . . . . 0.0 110.565 -179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 t -69.72 118.02 58.93 Favored Pre-proline 0 C--N 1.306 -1.319 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.824 179.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.37 117.52 4.39 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 120.349 0.699 . . . . 0.0 112.07 -179.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.99 136.14 34.59 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.463 179.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.1 m -70.68 96.48 1.22 Allowed 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.946 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 86' ' ' LYS . 25.6 t -64.52 -109.23 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.575 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.488 ' N ' ' OG ' ' A' ' 85' ' ' SER . 18.0 mtpp -138.06 60.34 22.6 Favored Pre-proline 0 C--N 1.305 -1.341 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.083 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -54.77 161.66 5.87 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 121.361 1.374 . . . . 0.0 111.246 -179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.421 ' CG1' ' N ' ' A' ' 89' ' ' SER . 6.6 tt -152.64 166.3 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.86 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.493 ' HB3' HG22 ' A' ' 71' ' ' THR . 88.6 p -148.97 157.72 43.63 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.864 -179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.01 137.85 15.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.169 -1.013 . . . . 0.0 110.819 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.83 139.8 32.34 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.5 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -162.02 148.06 13.4 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.029 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 9.7 mtt180 -88.61 119.81 29.42 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.536 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 116.206 -1.854 . . . . 0.0 110.377 -179.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 1' ' ' VAL . 3.3 m . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 120.864 0.364 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.3 p -160.16 145.75 15.23 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.722 179.979 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -145.42 -20.86 0.48 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.291 -0.964 . . . . 0.0 111.384 -179.902 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.1 t -97.04 136.34 21.57 Favored Pre-proline 0 N--CA 1.487 1.393 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.292 -179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -55.49 161.78 7.07 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 120.515 0.81 . . . . 0.0 111.176 179.926 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -172.03 174.8 3.98 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.791 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.9 t70 55.22 51.98 12.31 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.28 179.801 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 mp -93.44 120.91 34.28 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.311 -0.956 . . . . 0.0 110.53 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -164.85 159.85 18.83 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 118.738 -1.185 . . . . 0.0 111.772 179.922 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 t -94.56 134.83 30.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.922 179.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.49 -67.88 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 118.725 -1.19 . . . . 0.0 110.866 -179.994 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.93 172.24 13.32 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.457 179.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.41 175.46 9.76 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.815 -179.959 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.2 OUTLIER -140.63 158.43 65.77 Favored Pre-proline 0 C--N 1.307 -1.278 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.077 179.95 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -57.97 0.33 0.33 Allowed 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 121.006 1.137 . . . . 0.0 111.666 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.487 ' H ' ' C ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -155.83 26.17 0.38 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.149 -1.021 . . . . 0.0 111.375 -179.95 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.64 157.3 4.66 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.343 -179.975 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.5 tp -129.19 147.06 51.0 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.174 -179.953 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -128.67 122.39 30.7 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.506 -0.878 . . . . 0.0 111.03 -179.961 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 20' ' ' ILE . 2.1 pt -123.58 169.85 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.861 179.944 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.47 139.32 11.68 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.449 179.987 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' A' ' 23' ' ' ASP . 13.8 p90 -137.12 -138.9 0.15 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.985 179.978 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.553 ' O ' ' CD1' ' A' ' 22' ' ' TRP . 33.0 t70 -125.69 171.81 10.3 Favored 'General case' 0 N--CA 1.505 2.277 0 C-N-CA 119.23 -0.988 . . . . 0.0 112.875 -179.816 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.474 ' N ' ' CG ' ' A' ' 23' ' ' ASP . . . -143.85 118.22 6.04 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-N 115.272 -0.877 . . . . 0.0 109.803 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -61.6 166.53 11.49 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 120.19 0.593 . . . . 0.0 111.726 -179.871 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.77 -20.04 34.02 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.044 179.987 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 28' ' ' THR . 4.5 t -60.19 163.47 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 119.059 -1.056 . . . . 0.0 110.556 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.444 ' N ' HG12 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -80.89 90.48 5.91 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.281 -0.967 . . . . 0.0 110.408 179.96 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 66.8 t -85.86 129.03 38.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.163 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -54.45 -66.46 0.4 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.953 -1.099 . . . . 0.0 110.086 -179.9 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.79 160.62 39.41 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 118.966 -1.093 . . . . 0.0 111.076 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -103.49 156.15 17.98 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.916 -179.989 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -137.13 111.69 8.67 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.4 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -101.75 148.03 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.209 -179.951 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.4 p -138.57 133.75 32.93 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.267 -0.878 . . . . 0.0 109.809 179.904 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.514 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 0.6 OUTLIER -130.12 121.73 26.89 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.283 179.93 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.467 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . -151.82 137.33 5.91 Favored Glycine 0 N--CA 1.487 2.058 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.572 -179.851 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -52.65 175.81 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.943 179.97 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.481 HG22 ' N ' ' A' ' 40' ' ' GLY . 84.1 m -75.24 160.8 29.95 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.402 -0.919 . . . . 0.0 111.297 -179.923 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 39' ' ' THR . . . 88.31 -30.85 5.03 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.817 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 72.66 19.39 79.15 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.155 -1.498 . . . . 0.0 109.941 179.996 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.15 -10.66 60.01 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.244 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.0 p -176.98 81.35 0.25 Allowed Pre-proline 0 N--CA 1.487 1.416 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.397 -179.915 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -63.66 130.88 29.36 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 121.016 1.144 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.467 HG23 ' HA2' ' A' ' 37' ' ' GLY . 5.1 t -58.7 -74.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.297 -179.856 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -173.54 -176.89 1.36 Allowed 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 118.718 -1.193 . . . . 0.0 111.7 -179.992 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.505 ' N ' ' CD ' ' A' ' 47' ' ' GLU . 1.1 mp0 -135.02 174.91 10.08 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.759 -179.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -175.28 132.67 0.3 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.493 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.54 148.92 24.64 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.687 -0.805 . . . . 0.0 112.045 -179.886 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 m -142.32 151.62 58.64 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.431 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 53' ' ' SER . 3.9 Cg_exo -55.25 120.86 8.9 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 120.308 0.672 . . . . 0.0 110.805 179.952 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -46.87 -11.39 0.05 OUTLIER Glycine 0 N--CA 1.486 2.03 0 C-N-CA 119.305 -1.426 . . . . 0.0 110.725 179.875 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -65.32 -33.16 75.32 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.48 -179.894 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.2 mtpp -77.38 135.69 38.36 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.593 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.65 -1.74 25.96 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.098 -179.991 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 66.4 p -132.69 162.64 30.87 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.773 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.466 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -159.04 161.11 36.52 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.016 -1.073 . . . . 0.0 111.583 179.972 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.2 m -137.63 123.09 19.59 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.505 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.32 156.52 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.594 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 16' ' ' THR . 0.2 OUTLIER -142.48 176.82 8.72 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.504 -179.93 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 74.64 58.0 4.33 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.657 -1.258 . . . . 0.0 110.202 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.511 HD12 ' H ' ' A' ' 63' ' ' LYS . 0.5 OUTLIER -130.65 -127.83 0.2 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.068 -179.926 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.511 ' H ' HD12 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -172.44 99.63 0.36 Allowed Pre-proline 0 N--CA 1.486 1.363 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.979 -179.915 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.97 149.36 90.6 Favored 'Trans proline' 0 C--O 1.213 -0.729 0 C-N-CA 120.903 1.069 . . . . 0.0 112.237 -179.851 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.82 55.17 2.73 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.583 -1.294 . . . . 0.0 110.926 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.4 p -168.94 150.81 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.932 179.985 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -62.52 152.04 35.82 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.503 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.09 138.85 24.28 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 118.777 -1.169 . . . . 0.0 111.982 -179.929 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.84 108.0 16.81 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.712 179.843 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -95.44 157.97 3.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.111 -179.898 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -158.98 141.57 14.17 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.432 179.953 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.7 m -132.15 138.87 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.83 179.972 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -119.63 104.55 10.37 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.947 -179.903 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -81.83 116.67 21.61 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.721 179.828 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 79.3 t -109.94 109.33 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.94 -179.917 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 3.8 p -101.1 -173.9 2.48 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.973 179.878 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 175.41 115.18 0.4 Allowed Glycine 0 N--CA 1.491 2.334 0 C-N-CA 118.96 -1.59 . . . . 0.0 111.012 179.975 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.91 -41.37 11.19 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.354 179.97 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.21 -106.13 3.01 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 110.279 -1.128 . . . . 0.0 110.279 -179.983 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.92 -4.73 0.54 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.498 -0.881 . . . . 0.0 111.085 -179.969 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.58 138.92 66.82 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 119.066 -1.053 . . . . 0.0 110.718 -179.923 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.66 99.21 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 120.72 0.947 . . . . 0.0 110.855 179.854 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.14 128.76 48.48 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.599 -0.841 . . . . 0.0 111.258 -179.941 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.06 126.8 43.66 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.727 179.929 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 86' ' ' LYS . 91.5 p -81.85 -125.5 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.143 -179.978 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.402 ' N ' ' OG ' ' A' ' 85' ' ' SER . 5.1 mtpm? -135.27 73.2 64.64 Favored Pre-proline 0 N--CA 1.492 1.64 0 C-N-CA 119.973 -0.691 . . . . 0.0 111.035 -179.924 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -59.0 164.77 9.58 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.302 1.335 . . . . 0.0 111.577 179.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 88' ' ' ILE . 7.9 tt -159.57 156.83 3.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 118.715 -1.194 . . . . 0.0 111.091 179.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.1 p -134.69 144.02 47.55 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.579 179.987 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 90' ' ' ILE . 0.9 OUTLIER -139.0 156.7 28.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 119.521 -0.871 . . . . 0.0 110.782 179.945 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.77 146.41 25.94 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.795 -0.762 . . . . 0.0 110.714 -179.968 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -153.62 144.48 22.71 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.239 -0.985 . . . . 0.0 110.737 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.05 118.79 37.59 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.134 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 116.313 -1.804 . . . . 0.0 110.835 -179.878 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 88.4 t . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.56 158.15 29.99 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.715 -179.997 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.57 -30.54 1.12 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.713 179.933 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 t -83.04 134.26 46.71 Favored Pre-proline 0 C--N 1.302 -1.466 0 C-N-CA 119.831 -0.747 . . . . 0.0 109.914 179.986 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -51.9 161.61 2.22 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 N-CA-C 110.151 -0.75 . . . . 0.0 110.151 179.899 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.446 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 0.7 OUTLIER -164.1 -179.22 6.04 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 117.998 -1.481 . . . . 0.0 113.281 -179.973 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 6' ' ' ARG . 42.7 p30 19.14 74.81 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.078 -1.419 . . . . 0.0 114.161 179.97 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mp -99.65 132.61 44.88 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.81 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -162.95 173.33 13.79 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 117.789 -1.564 . . . . 0.0 112.999 -179.832 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.524 HG13 HD21 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -87.27 142.25 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.875 179.9 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 11' ' ' VAL . 1.8 p -130.95 -8.69 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.695 -179.965 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.655 ' HB3' ' HB3' ' A' ' 19' ' ' LEU . . . -170.14 161.3 8.43 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.713 -1.195 . . . . 0.0 111.638 -179.977 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.21 149.13 26.69 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.193 -179.94 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.434 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -136.41 161.47 61.94 Favored Pre-proline 0 N--CA 1.491 1.583 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.762 179.89 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.434 ' O ' ' OG1' ' A' ' 16' ' ' THR . 2.9 Cg_exo -50.55 -11.33 0.36 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 121.221 1.281 . . . . 0.0 111.795 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 16' ' ' THR . 96.6 m -164.39 49.22 0.12 Allowed 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.432 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.63 143.62 0.16 Allowed 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.322 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.524 HD21 HG13 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -131.02 140.39 50.09 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.912 -179.938 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.655 ' HB3' ' HB3' ' A' ' 12' ' ' ALA . 8.6 tp -113.05 113.29 25.23 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.285 179.783 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.8 167.05 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.553 -179.933 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -151.34 134.57 16.01 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 118.82 -1.152 . . . . 0.0 111.447 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.632 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 5.8 p90 -142.23 -143.7 0.15 Allowed 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.413 179.926 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.632 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 5.3 t70 -131.23 147.03 52.55 Favored 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 119.335 -0.946 . . . . 0.0 112.863 -179.787 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.69 126.8 24.54 Favored Pre-proline 0 N--CA 1.491 1.575 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.009 179.89 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.71 172.06 3.11 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 120.586 0.857 . . . . 0.0 111.997 -179.964 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -100.22 -24.51 14.54 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.54 179.95 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 29' ' ' VAL . 2.9 m -60.31 166.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 119.188 -1.005 . . . . 0.0 110.229 179.861 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.39 90.64 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.004 -1.079 . . . . 0.0 110.999 -179.962 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.834 HG13 HG22 ' A' ' 76' ' ' THR . 1.6 t -85.05 122.42 38.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.513 -0.875 . . . . 0.0 110.64 -179.979 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -54.56 -52.62 61.51 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 118.65 -1.22 . . . . 0.0 109.473 179.88 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 175.1 171.27 0.28 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.371 -0.932 . . . . 0.0 111.691 179.834 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -118.38 161.87 19.25 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.475 179.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -138.48 104.66 5.21 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.991 -1.084 . . . . 0.0 110.799 179.858 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.547 HD13 ' CE1' ' A' ' 48' ' ' PHE . 4.7 mp -96.78 105.09 16.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.94 -179.972 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.6 p -103.55 143.32 32.9 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.347 179.876 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.469 ' CE2' HG11 ' A' ' 45' ' ' VAL . 8.2 p90 -145.92 166.96 24.45 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 118.464 -1.295 . . . . 0.0 111.38 -179.993 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' GLU . . . 160.0 162.86 12.7 Favored Glycine 0 N--CA 1.482 1.719 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.93 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 37' ' ' GLY . 2.5 mt-10 -49.13 177.98 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.716 179.995 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.3 m -74.11 -24.34 59.44 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.745 -179.984 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 176.6 55.82 0.06 OUTLIER Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.607 179.97 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -77.06 -159.69 10.47 Favored Glycine 0 N--CA 1.49 2.249 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.313 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -61.31 -25.07 66.88 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.138 -179.988 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -174.21 158.64 2.69 Favored Pre-proline 0 C--N 1.305 -1.368 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.89 179.877 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.09 156.35 55.52 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.885 1.057 . . . . 0.0 111.007 179.877 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 46' ' ' GLN . 24.1 t -76.99 -77.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 118.864 -1.134 . . . . 0.0 110.616 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.567 ' N ' HG12 ' A' ' 45' ' ' VAL . 1.2 tt0 -175.68 -169.07 0.33 Allowed 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.922 -1.111 . . . . 0.0 111.329 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.41 171.55 19.15 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.987 179.976 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.547 ' CE1' HD13 ' A' ' 34' ' ' ILE . 23.9 p90 -159.73 130.85 5.91 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.867 179.979 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -95.67 163.21 13.29 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 119.391 -0.924 . . . . 0.0 112.493 -179.87 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.575 ' C ' ' H ' ' A' ' 52' ' ' GLY . 11.8 p -150.74 140.38 13.79 Favored Pre-proline 0 CA--C 1.561 1.374 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.017 -179.939 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.56 16.02 0.03 OUTLIER 'Trans proline' 0 CA--C 1.547 1.156 0 C-N-CA 121.0 1.134 . . . . 0.0 113.673 -179.97 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.575 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 64.94 4.44 14.73 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.359 -1.4 . . . . 0.0 111.288 179.885 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.79 -27.32 64.81 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.042 -179.919 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.13 140.07 35.94 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.229 -179.946 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.451 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 4.6 m -96.94 -26.42 15.05 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.405 179.919 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 64.3 p -124.01 159.22 30.32 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.538 179.922 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.6 162.54 24.39 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.19 -1.404 . . . . 0.0 112.275 -179.92 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 94.6 m -107.99 134.01 51.51 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.449 179.95 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 tt -126.27 137.2 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.177 179.989 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 16.9 t -138.01 111.31 7.96 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.309 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 168.56 33.15 0.02 OUTLIER Glycine 0 N--CA 1.486 1.979 0 C-N-CA 119.63 -1.271 . . . . 0.0 110.211 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.51 -155.67 0.71 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.63 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.2 mttm -147.84 162.08 32.71 Favored Pre-proline 0 C--N 1.311 -1.104 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.692 -179.903 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -74.69 159.64 42.12 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 121.586 1.524 . . . . 0.0 112.97 179.906 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 34.65 69.93 0.18 Allowed Glycine 0 N--CA 1.499 2.841 0 CA-C-N 114.957 -1.02 . . . . 0.0 113.316 179.793 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 p -159.14 143.52 6.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.745 179.688 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.82 130.54 46.23 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.073 -179.95 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -141.63 138.4 32.53 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.705 179.944 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.3 m -120.9 134.71 55.3 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.864 -0.735 . . . . 0.0 110.479 -179.953 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.97 154.87 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.138 -179.999 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.458 ' OG1' ' CB ' ' A' ' 89' ' ' SER . 2.5 m -147.98 159.14 44.2 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.954 -179.957 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 72' ' ' VAL . 32.9 m -139.81 129.07 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.072 -179.955 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.89 117.95 35.52 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.147 179.79 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.5 113.61 25.93 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.489 -0.885 . . . . 0.0 110.94 -179.828 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.08 109.89 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.799 -179.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.834 HG22 HG13 ' A' ' 29' ' ' VAL . 15.8 p -106.74 -87.41 0.47 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.022 -179.951 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.97 72.64 0.93 Allowed Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.857 -1.164 . . . . 0.0 110.459 179.977 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -78.05 120.24 22.61 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.571 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.3 -98.1 0.42 Allowed Glycine 0 N--CA 1.488 2.116 0 C-N-CA 119.137 -1.506 . . . . 0.0 109.938 -179.9 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -145.86 -15.02 0.47 Allowed 'General case' 0 C--N 1.298 -1.668 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.769 179.937 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 t -76.91 137.16 66.05 Favored Pre-proline 0 CA--C 1.557 1.249 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.507 179.977 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -62.4 137.8 67.28 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 120.668 0.912 . . . . 0.0 111.181 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.92 -9.62 3.89 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.858 -0.737 . . . . 0.0 111.186 -179.945 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.9 t -79.63 62.47 3.93 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.946 -1.102 . . . . 0.0 110.542 -179.895 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.1 p -117.43 34.33 5.19 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.077 179.916 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.596 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 4.2 tptp -144.1 38.69 0.25 Allowed Pre-proline 0 N--CA 1.488 1.451 0 C-N-CA 118.674 -1.21 . . . . 0.0 114.152 -179.936 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 86' ' ' LYS . 1.4 Cg_endo -57.06 160.69 12.21 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 N-CA-C 109.342 -1.061 . . . . 0.0 109.342 179.7 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.3 tt -151.67 131.24 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 C-N-CA 118.034 -1.466 . . . . 0.0 111.804 -179.972 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.458 ' CB ' ' OG1' ' A' ' 71' ' ' THR . 59.2 p -118.7 147.13 44.14 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.69 -179.987 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -143.1 139.77 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.231 179.959 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.3 154.3 17.91 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.423 179.944 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -169.56 139.25 2.03 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.01 -1.076 . . . . 0.0 111.157 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.432 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 11.0 ptt-85 -88.15 115.15 25.43 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.387 179.895 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.421 HG21 HD11 ' A' ' 18' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.647 -179.919 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.482 1.159 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.436 ' O ' ' OD1' ' A' ' 3' ' ' ASP . 5.0 t -146.09 140.87 27.05 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.825 -179.941 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 2' ' ' SER . 0.5 OUTLIER -148.4 -16.49 0.33 Allowed 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.637 -179.94 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 95.3 t -49.24 108.66 1.01 Allowed Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.964 -179.944 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.35 -179.64 0.93 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 120.5 0.8 . . . . 0.0 110.835 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.51 -165.94 1.96 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.497 -179.98 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -118.16 65.65 0.75 Allowed 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.199 -179.935 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -75.36 -155.67 0.05 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.559 -0.856 . . . . 0.0 110.342 -179.966 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -177.25 -164.15 0.09 Allowed 'General case' 0 N--CA 1.515 2.825 0 C-N-CA 117.894 -1.522 . . . . 0.0 113.239 -179.694 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.426 ' H ' HG23 ' A' ' 10' ' ' VAL . 2.8 t -70.4 151.67 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-N 114.35 -1.296 . . . . 0.0 111.339 179.917 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 11' ' ' VAL . 39.1 t -130.79 -8.03 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.114 179.914 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -172.64 157.49 3.86 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.805 179.934 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -142.85 157.09 44.94 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.484 -0.887 . . . . 0.0 111.089 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.36 162.04 51.79 Favored Pre-proline 0 N--CA 1.485 1.306 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.436 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -54.71 -23.61 33.86 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 121.074 1.183 . . . . 0.0 111.663 -179.977 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.1 p -143.1 39.93 1.47 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.329 -0.948 . . . . 0.0 111.325 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.98 149.84 0.73 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 118.687 -1.205 . . . . 0.0 111.895 179.967 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.9 tp -130.43 117.24 19.38 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.758 179.94 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.4 tt -90.94 103.74 16.42 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.577 -179.982 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.3 pt -97.69 158.52 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 119.359 -0.936 . . . . 0.0 110.65 179.966 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.0 127.76 15.3 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.951 -1.1 . . . . 0.0 111.507 -179.919 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.622 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 4.4 p90 -138.43 -152.79 0.44 Allowed 'General case' 0 C--O 1.214 -0.791 0 C-N-CA 119.215 -0.994 . . . . 0.0 111.618 179.861 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.622 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 33.1 t70 -101.55 -178.39 3.71 Favored 'General case' 0 N--CA 1.508 2.461 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.581 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.537 ' H ' ' CG ' ' A' ' 23' ' ' ASP . . . -171.24 109.3 0.4 Allowed Pre-proline 0 CA--C 1.563 1.452 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.819 -179.97 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -61.45 173.34 2.75 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 120.62 0.88 . . . . 0.0 111.93 -179.888 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.71 -23.16 16.05 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.054 -179.929 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.48 HG13 ' H ' ' A' ' 27' ' ' VAL . 2.1 m -59.65 165.64 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 C-N-CA 119.04 -1.064 . . . . 0.0 110.206 179.977 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.743 HG23 ' O ' ' A' ' 28' ' ' THR . 3.4 t -65.52 95.48 0.22 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.026 -1.07 . . . . 0.0 110.483 -179.994 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.414 ' H ' HG23 ' A' ' 29' ' ' VAL . 1.0 OUTLIER -87.54 127.56 40.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.155 -179.938 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -59.5 4.81 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.608 179.874 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -173.7 168.55 4.36 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.074 -1.05 . . . . 0.0 112.027 179.929 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.82 139.58 50.89 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.85 179.856 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.71 109.58 20.78 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 119.346 -0.941 . . . . 0.0 110.241 -179.975 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.0 mp -105.42 99.36 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.37 -179.886 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -103.59 141.35 36.18 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.914 179.92 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.532 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 4.2 p90 -143.78 163.36 33.55 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 118.827 -1.149 . . . . 0.0 111.009 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 163.84 149.61 5.81 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.731 -1.347 . . . . 0.0 109.731 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.41 144.89 24.0 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.115 -1.034 . . . . 0.0 110.567 -179.981 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.1 t -75.18 148.93 39.15 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.131 -179.996 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.27 85.63 0.08 OUTLIER Glycine 0 N--CA 1.49 2.265 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.527 -179.999 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 43' ' ' SER . . . 171.29 123.16 0.68 Allowed Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.019 -1.562 . . . . 0.0 110.665 179.977 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -75.48 38.47 0.15 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.285 179.933 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 41' ' ' GLY . 35.1 t -157.4 68.65 4.17 Favored Pre-proline 0 C--N 1.304 -1.4 0 C-N-CA 119.645 -0.822 . . . . 0.0 110.86 -179.911 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -61.24 150.85 82.73 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 121.329 1.353 . . . . 0.0 111.095 -179.972 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.546 HG12 ' N ' ' A' ' 46' ' ' GLN . 55.2 t -57.06 -83.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.42 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.546 ' N ' HG12 ' A' ' 45' ' ' VAL . 0.5 OUTLIER -171.57 -160.97 0.18 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 118.855 -1.138 . . . . 0.0 111.575 -179.899 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.502 ' N ' ' CD ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -164.05 158.48 19.48 Favored 'General case' 0 C--N 1.308 -1.209 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.088 -179.995 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -149.1 142.86 25.59 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.66 -179.94 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.462 ' OG1' ' N ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -92.34 166.4 12.6 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.435 -179.929 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.641 ' CG1' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -148.55 148.58 28.79 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.913 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -50.27 -4.17 0.06 OUTLIER 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 121.522 1.481 . . . . 0.0 112.911 -179.821 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.641 ' H ' ' CG1' ' A' ' 50' ' ' VAL . . . 70.87 -0.87 26.69 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.646 -1.264 . . . . 0.0 111.42 179.955 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.2 -30.29 22.54 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.895 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.66 129.57 35.74 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.097 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.13 -16.04 34.52 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.582 179.976 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 36.1 p -134.36 152.92 52.09 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.073 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -155.14 163.92 39.56 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.771 -1.171 . . . . 0.0 111.611 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.3 m -117.84 112.5 20.47 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.432 -179.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.67 137.81 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.021 -179.914 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 2.6 t -96.42 -156.56 0.53 Allowed 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.388 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 63.3 83.96 0.07 OUTLIER Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.231 -1.461 . . . . 0.0 109.989 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 4.6 mp -119.47 -175.43 2.94 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.3 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -172.29 85.15 0.44 Allowed Pre-proline 0 C--N 1.303 -1.443 0 CA-C-N 114.902 -1.044 . . . . 0.0 108.686 179.888 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -55.45 133.27 57.11 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 120.787 0.992 . . . . 0.0 111.923 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.43 41.61 3.89 Favored Glycine 0 N--CA 1.484 1.895 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.398 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.4 p -159.96 154.48 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 118.667 -1.213 . . . . 0.0 111.691 -179.977 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.53 105.88 17.62 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.446 179.851 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -89.11 118.23 28.67 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.399 -179.78 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.19 131.11 45.46 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.348 179.849 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 pp -130.15 154.54 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.184 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.0 m -144.33 128.26 17.43 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.789 -179.998 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.9 m -110.69 137.19 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.099 -179.942 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -120.07 113.69 20.87 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.636 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -88.14 105.21 17.36 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.104 179.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.4 t -110.2 119.54 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.261 -179.924 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 2.4 p -105.98 -40.21 5.76 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.894 179.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 70.12 145.49 0.26 Allowed Glycine 0 N--CA 1.487 2.057 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.918 179.932 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -103.68 -79.29 0.54 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.543 -179.979 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 176.83 -0.66 0.03 OUTLIER Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.615 -179.991 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.68 -40.4 0.06 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.757 -179.992 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 40.8 t -115.82 87.59 18.69 Favored Pre-proline 0 N--CA 1.489 1.479 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -60.17 120.06 7.61 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 120.691 0.928 . . . . 0.0 111.044 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.59 134.09 46.71 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.891 -0.723 . . . . 0.0 111.06 -179.931 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 89.6 p -90.13 141.79 28.35 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.299 179.867 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 70.4 m -66.56 -79.34 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.998 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.1 tttm -167.52 77.82 0.94 Allowed Pre-proline 0 C--N 1.291 -1.969 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.433 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -57.33 156.02 27.52 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 120.963 1.109 . . . . 0.0 110.702 -179.924 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 tt -151.68 160.35 3.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 118.332 -1.347 . . . . 0.0 111.476 -179.855 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.1 158.63 41.11 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 119.872 -0.731 . . . . 0.0 111.187 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.13 141.99 16.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.842 179.957 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -100.29 136.28 40.42 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.502 179.949 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -144.39 135.02 24.8 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.847 -179.981 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 ttp85 -83.45 107.42 15.93 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.168 179.887 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 116.306 -1.806 . . . . 0.0 110.351 -179.918 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 120.817 0.341 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.01 171.15 1.83 Allowed 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.492 179.983 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -146.61 -16.25 0.43 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.149 -1.02 . . . . 0.0 111.422 179.986 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 t -86.43 133.61 39.94 Favored Pre-proline 0 C--N 1.305 -1.367 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.986 -179.952 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -52.64 171.93 0.19 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 120.355 0.704 . . . . 0.0 111.062 179.938 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.485 ' O ' HD23 ' A' ' 8' ' ' LEU . 14.9 mtt-85 -118.1 -176.18 3.0 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.569 -0.852 . . . . 0.0 112.055 -179.894 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -68.55 94.14 0.55 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.452 -179.916 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 6' ' ' ARG . 0.1 OUTLIER -45.53 174.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.369 179.969 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -155.83 153.09 29.22 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.88 -1.128 . . . . 0.0 112.054 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.8 t -87.81 129.02 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.576 179.876 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.423 HG23 ' OG ' ' A' ' 21' ' ' SER . 48.1 t -104.63 -56.09 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.839 -179.922 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -141.71 161.43 37.96 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.684 -0.806 . . . . 0.0 111.033 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -149.16 87.57 1.54 Allowed 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.937 -179.987 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.442 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.1 OUTLIER -70.64 158.33 88.13 Favored Pre-proline 0 C--N 1.305 -1.361 0 C-N-CA 119.107 -1.037 . . . . 0.0 110.068 -179.983 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.55 -5.16 1.55 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 121.054 1.17 . . . . 0.0 111.217 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.442 ' H ' ' C ' ' A' ' 14' ' ' THR . 14.5 p -151.08 33.2 0.59 Allowed 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.311 -0.956 . . . . 0.0 111.261 179.997 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.98 122.01 0.31 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.071 -1.052 . . . . 0.0 111.091 179.969 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -97.65 127.66 43.77 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.067 179.945 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 tp -110.0 125.4 52.86 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.912 -0.715 . . . . 0.0 111.538 -179.875 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.405 HD13 HG21 ' A' ' 20' ' ' ILE . 4.2 pt -127.22 174.24 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.317 179.829 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.561 ' HB3' HG22 ' A' ' 56' ' ' THR . 1.0 OUTLIER -163.06 137.16 6.12 Favored 'General case' 0 C--N 1.295 -1.768 0 C-N-CA 119.296 -0.962 . . . . 0.0 110.077 179.978 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.609 ' CD1' ' N ' ' A' ' 23' ' ' ASP . 11.6 p90 -134.54 -147.6 0.29 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.765 179.998 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.669 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 24.0 t0 -99.38 177.06 5.3 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.53 -0.868 . . . . 0.0 113.333 -179.63 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 23' ' ' ASP . . . 161.96 83.97 0.0 OUTLIER Pre-proline 0 N--CA 1.487 1.401 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.331 -179.944 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.12 -177.36 0.19 Allowed 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 121.035 1.157 . . . . 0.0 112.284 -179.815 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.82 0.66 57.4 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.195 -179.923 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.654 HG22 ' N ' ' A' ' 28' ' ' THR . 7.9 p -60.39 170.78 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 118.928 -1.109 . . . . 0.0 110.45 -179.976 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.654 ' N ' HG22 ' A' ' 27' ' ' VAL . 60.7 m -61.65 109.36 1.18 Allowed 'General case' 0 C--N 1.286 -2.173 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.589 -179.981 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.72 141.24 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.907 -179.991 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.492 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -91.73 -79.13 0.38 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.987 179.884 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.492 ' CD1' ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -150.62 171.92 16.36 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.26 179.875 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -131.87 160.57 35.29 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.341 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.31 119.18 13.3 Favored 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 118.415 -1.314 . . . . 0.0 110.975 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.0 mt -105.1 115.77 47.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.368 -179.876 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.2 p -111.4 138.07 48.37 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.564 179.91 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.689 ' CZ ' HG11 ' A' ' 45' ' ' VAL . 8.9 p90 -139.29 148.65 43.28 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.271 179.992 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -172.74 156.58 25.24 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.957 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -66.65 143.04 57.22 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.167 -1.013 . . . . 0.0 110.774 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 m -68.98 150.04 48.14 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.752 -179.95 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.09 -5.42 10.36 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 119.967 -1.111 . . . . 0.0 110.552 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 57.2 37.83 82.67 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.375 -1.393 . . . . 0.0 110.204 179.995 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -92.1 -73.93 0.53 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.187 -179.986 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.8 m -139.95 88.39 11.95 Favored Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.858 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -60.69 134.61 55.13 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 120.598 0.866 . . . . 0.0 111.179 -179.907 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.689 HG11 ' CZ ' ' A' ' 36' ' ' TYR . 63.4 t -59.07 -80.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.803 -179.995 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -173.26 -159.71 0.11 Allowed 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 118.986 -1.086 . . . . 0.0 111.036 -179.907 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -162.75 158.67 23.2 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.025 179.975 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 2.9 p90 -146.98 162.55 38.53 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.004 -179.933 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 44.2 p -114.99 154.82 28.08 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.889 -0.724 . . . . 0.0 111.351 179.968 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.524 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -136.87 157.99 73.78 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.971 -179.976 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -61.23 8.73 0.09 OUTLIER 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 121.212 1.275 . . . . 0.0 112.261 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.524 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 56.27 13.63 7.44 Favored Glycine 0 N--CA 1.497 2.701 0 C-N-CA 119.484 -1.341 . . . . 0.0 111.127 -179.935 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.49 -57.34 2.91 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.433 179.984 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.7 mtmp? -64.41 123.39 19.07 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.436 -179.878 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.54 8.45 6.37 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.601 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.561 HG22 ' HB3' ' A' ' 21' ' ' SER . 0.8 OUTLIER -129.57 158.16 40.04 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.884 -179.947 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -157.1 169.09 25.59 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.496 179.965 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.4 t -142.9 162.03 36.56 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.237 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.0 mt -139.56 143.46 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.513 179.959 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.07 143.37 31.12 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.318 -0.953 . . . . 0.0 110.646 -179.979 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.07 50.61 1.23 Allowed Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.964 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.911 HD23 ' H ' ' A' ' 62' ' ' LEU . 1.3 pt? -130.19 -171.71 2.6 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 120.05 -0.66 . . . . 0.0 111.419 -179.96 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -117.77 89.84 34.5 Favored Pre-proline 0 N--CA 1.488 1.455 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.502 -179.99 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.39 146.19 95.63 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 120.892 1.062 . . . . 0.0 111.684 -179.875 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.47 43.94 5.39 Favored Glycine 0 N--CA 1.487 2.098 0 C-N-CA 119.559 -1.305 . . . . 0.0 109.958 -179.912 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.5 p -166.19 157.74 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.318 -0.953 . . . . 0.0 111.194 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -63.11 142.96 58.18 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.949 -0.7 . . . . 0.0 110.585 179.98 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -145.9 135.26 22.99 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.272 -0.971 . . . . 0.0 111.123 -179.953 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.33 132.59 53.57 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.173 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 pp -124.1 157.96 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.251 -179.935 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.7 m -148.43 127.57 12.88 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.133 180.0 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.9 m -108.11 138.19 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.009 -179.997 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -106.42 139.75 40.42 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.276 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -121.17 104.97 10.16 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.7 t -126.86 110.07 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.997 179.909 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.472 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 76.9 p -113.93 -115.72 0.33 Allowed 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.976 -179.979 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.472 ' N ' ' OG1' ' A' ' 76' ' ' THR . . . 172.81 141.13 3.35 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.66 -1.257 . . . . 0.0 110.325 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -80.6 8.5 7.75 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.364 -0.935 . . . . 0.0 111.017 -179.932 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.65 -23.89 1.82 Allowed Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.386 -1.387 . . . . 0.0 110.553 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -173.46 -46.29 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.475 -179.945 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.0 137.47 79.38 Favored Pre-proline 0 C--N 1.306 -1.313 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.758 -179.87 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -64.87 101.89 0.4 Allowed 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 120.765 0.977 . . . . 0.0 111.135 179.854 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.4 176.7 1.01 Allowed 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.766 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.3 p -65.57 177.39 1.21 Allowed 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.94 179.931 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 3.6 p -112.4 -86.31 0.56 Allowed 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.447 179.98 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 3.1 mmtp 75.84 70.78 0.22 Allowed Pre-proline 0 N--CA 1.501 2.123 0 CA-C-N 114.951 -1.022 . . . . 0.0 110.209 179.943 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -68.57 171.4 13.17 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.024 1.816 . . . . 0.0 112.176 -179.878 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 88' ' ' ILE . 14.1 tt -142.15 137.44 29.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.204 179.912 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 p -127.73 158.55 37.33 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.298 -0.961 . . . . 0.0 112.15 -179.827 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 90' ' ' ILE . 10.4 pt -153.44 148.22 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.883 -179.978 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.95 156.9 16.62 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.161 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -172.38 138.49 0.93 Allowed 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.414 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.444 ' NE ' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -80.64 118.62 22.36 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.32 -179.943 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 116.292 -1.813 . . . . 0.0 110.64 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.3 t . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.86 0.362 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 t 49.97 -176.44 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.824 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -168.77 -24.97 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.18 179.987 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.421 ' H ' HG23 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -101.8 131.12 23.21 Favored Pre-proline 0 N--CA 1.489 1.48 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.708 -179.958 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -61.57 172.64 3.38 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 120.667 0.911 . . . . 0.0 111.25 179.972 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.84 -176.96 4.98 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.476 -0.889 . . . . 0.0 110.722 179.991 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.593 ' OD2' HD13 ' A' ' 88' ' ' ILE . 3.2 m-20 -106.66 77.29 1.18 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.517 -179.901 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.669 HD22 ' HA ' ' A' ' 22' ' ' TRP . 7.2 mp -63.06 -116.78 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.494 179.972 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 179.06 -171.69 0.14 Allowed 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 117.894 -1.523 . . . . 0.0 112.506 -179.802 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.3 t -83.75 141.28 15.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.471 179.892 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.66 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 3.4 p -99.52 -14.37 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.112 -179.983 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.66 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 166.66 178.4 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.958 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.74 108.94 2.96 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.475 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.0 OUTLIER -62.57 161.14 29.24 Favored Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.051 179.936 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -58.8 -3.2 1.37 Allowed 'Trans proline' 0 C--O 1.214 -0.694 0 C-N-CA 121.031 1.154 . . . . 0.0 111.029 -179.944 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 14' ' ' THR . 15.7 p -153.19 37.24 0.48 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.283 -0.967 . . . . 0.0 111.247 -179.891 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 179.8 155.48 0.57 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.451 179.948 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.6 130.78 55.28 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.704 -179.913 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.459 HD23 ' O ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -114.32 107.29 15.38 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.269 -179.962 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.442 HG21 HD13 ' A' ' 20' ' ' ILE . 5.0 pt -97.94 168.65 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 C-N-CA 119.091 -1.044 . . . . 0.0 110.336 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.56 130.85 9.54 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 118.574 -1.25 . . . . 0.0 112.187 179.978 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.669 ' HA ' HD22 ' A' ' 8' ' ' LEU . 6.0 p90 -138.49 -171.25 3.01 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.974 179.855 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -113.67 136.59 52.66 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 119.648 -0.821 . . . . 0.0 112.893 -179.606 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.43 130.0 23.32 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.064 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -56.5 152.27 41.2 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 120.484 0.79 . . . . 0.0 111.387 -179.997 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.12 -37.05 72.33 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.705 -179.956 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.545 HG22 ' N ' ' A' ' 28' ' ' THR . 2.1 p -60.43 165.05 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 119.246 -0.981 . . . . 0.0 110.756 -179.977 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.545 ' N ' HG22 ' A' ' 27' ' ' VAL . 0.1 OUTLIER -70.34 136.43 49.73 Favored 'General case' 0 C--N 1.295 -1.761 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.922 -179.96 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.486 HG13 HG22 ' A' ' 76' ' ' THR . 87.0 t -124.88 139.05 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.835 179.999 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.81 -64.66 0.8 Allowed 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.393 179.98 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.97 166.93 15.1 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 118.901 -1.12 . . . . 0.0 111.639 179.974 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -121.35 160.01 24.92 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 114.849 -1.069 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -143.71 112.42 6.55 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.415 179.796 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.466 ' N ' HD12 ' A' ' 34' ' ' ILE . 5.3 mp -102.77 124.67 56.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.298 -179.956 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.559 HG22 ' CB ' ' A' ' 47' ' ' GLU . 71.7 p -121.53 134.09 55.03 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.767 179.915 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.568 ' CE2' HG11 ' A' ' 45' ' ' VAL . 5.3 p90 -137.01 162.9 32.04 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.094 -179.867 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 160.41 156.65 8.28 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.946 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.412 ' HB2' ' H ' ' A' ' 41' ' ' GLY . 3.3 mt-10 -43.71 166.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.08 179.996 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 97.8 m -74.73 -22.77 58.63 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.411 -179.898 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.78 35.9 0.12 Allowed Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.137 -1.506 . . . . 0.0 110.724 -179.966 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' A' ' 38' ' ' GLU . . . -71.21 -157.29 2.52 Favored Glycine 0 N--CA 1.487 2.078 0 C-N-CA 119.178 -1.487 . . . . 0.0 109.968 179.943 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -56.51 -33.62 66.2 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.521 179.969 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.11 162.99 0.73 Allowed Pre-proline 0 C--N 1.307 -1.264 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.584 179.878 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -58.93 159.21 22.1 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 121.186 1.258 . . . . 0.0 111.128 179.936 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.568 HG11 ' CE2' ' A' ' 36' ' ' TYR . 39.1 t -85.05 -72.04 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.926 179.973 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.459 ' N ' HG12 ' A' ' 45' ' ' VAL . 2.4 tt0 -172.13 -164.41 0.29 Allowed 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.635 -179.948 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.559 ' CB ' HG22 ' A' ' 35' ' ' THR . 2.4 pt-20 -166.86 152.83 8.14 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.236 -179.996 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 3.1 p90 -144.43 146.52 32.52 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.854 179.921 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 63.4 p -91.37 168.0 11.88 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.924 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.539 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -158.22 145.14 13.11 Favored Pre-proline 0 C--N 1.303 -1.44 0 C-N-CA 119.557 -0.857 . . . . 0.0 108.991 179.972 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.36 28.47 0.08 OUTLIER 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 121.037 1.158 . . . . 0.0 112.424 179.843 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.539 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 49.11 22.84 3.46 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.095 -179.978 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.84 -38.29 12.42 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.047 -179.93 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -85.22 134.14 34.16 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.729 -179.98 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.2 m -91.21 -15.49 29.18 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.958 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 60.5 p -127.37 165.95 18.78 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.232 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.459 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -149.69 137.36 20.13 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.732 -179.975 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.3 m -118.27 107.27 13.7 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.635 179.869 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.21 164.18 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.973 -179.861 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 10.8 t -146.84 177.3 9.23 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.02 179.97 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.45 8.02 50.4 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.307 -179.939 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.26 -160.97 0.74 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.019 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 mtpp -148.14 112.8 3.84 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.237 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -60.7 156.8 40.72 Favored 'Trans proline' 0 C--O 1.214 -0.717 0 C-N-CA 120.555 0.837 . . . . 0.0 111.744 -179.954 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 96.09 52.18 1.66 Allowed Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.531 -1.319 . . . . 0.0 110.598 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 p -170.71 154.86 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.95 133.41 56.07 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.517 179.923 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 92' ' ' TYR . 0.2 OUTLIER -133.02 139.69 47.35 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.731 -179.87 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.9 m -122.53 136.79 54.97 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.629 179.907 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 pt -132.08 161.0 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.7 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.49 146.85 30.68 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.503 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.4 m -132.52 135.59 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.264 179.982 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -117.56 131.03 56.75 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 114.686 -1.143 . . . . 0.0 110.213 -179.998 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.38 101.02 7.66 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 120.046 -0.662 . . . . 0.0 109.959 -179.997 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.0 t -105.45 126.46 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 119.179 -1.009 . . . . 0.0 111.813 -179.917 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.519 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 30.1 p -124.1 -124.87 0.25 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.019 179.923 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.519 ' N ' ' OG1' ' A' ' 76' ' ' THR . . . 150.21 112.5 0.59 Allowed Glycine 0 N--CA 1.497 2.728 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.217 179.931 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -86.99 -11.32 50.83 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.262 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -167.64 -80.03 0.04 OUTLIER Glycine 0 N--CA 1.487 2.086 0 C-N-CA 119.612 -1.28 . . . . 0.0 110.449 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.461 ' H ' ' HD2' ' A' ' 82' ' ' PRO . 5.6 m-20 -156.38 -56.79 0.09 Allowed 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.602 -179.975 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.531 ' N ' ' CD ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -85.41 -43.98 0.64 Allowed Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 119.537 -0.865 . . . . 0.0 113.247 -179.872 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 81' ' ' SER . 2.2 Cg_endo -66.66 3.59 1.4 Allowed 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 120.899 1.066 . . . . 0.0 112.425 -179.795 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -72.77 67.81 0.83 Allowed 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.779 179.891 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.79 143.82 35.82 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 120.009 -0.677 . . . . 0.0 109.407 179.852 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 15.1 m -112.6 175.21 5.53 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.643 -0.823 . . . . 0.0 112.311 -179.888 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 32.2 tttm -136.99 67.44 56.3 Favored Pre-proline 0 C--N 1.306 -1.31 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.842 179.95 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -56.77 167.86 2.72 Favored 'Trans proline' 0 C--O 1.214 -0.707 0 C-N-CA 121.577 1.518 . . . . 0.0 111.948 -179.816 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.593 HD13 ' OD2' ' A' ' 7' ' ' ASP . 4.0 tt -150.08 155.13 8.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.011 179.945 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 93.7 p -129.31 145.77 51.31 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.481 -179.9 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -146.61 139.0 19.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.057 179.95 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -98.08 134.79 40.68 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.07 -179.978 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' A' ' 68' ' ' TYR . 31.9 t80 -146.96 129.75 16.16 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.558 179.999 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.6 132.32 36.97 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.796 -179.923 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 116.354 -1.784 . . . . 0.0 110.631 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.427 ' O ' ' OG ' ' A' ' 2' ' ' SER . 24.4 t . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 1' ' ' VAL . 21.2 p 42.99 77.32 0.06 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.86 -0.736 . . . . 0.0 111.223 179.972 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -114.17 -70.1 0.82 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.602 179.97 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.75 ' H ' ' CD ' ' A' ' 5' ' ' PRO . 1.1 t -126.01 -41.18 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 119.637 -0.825 . . . . 0.0 112.013 179.893 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.75 ' CD ' ' H ' ' A' ' 4' ' ' VAL . 13.2 Cg_endo -84.6 -127.89 0.01 OUTLIER 'Trans proline' 0 CA--C 1.568 2.198 0 C-N-CA 120.909 1.073 . . . . 0.0 109.878 -179.971 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.463 ' O ' ' O ' ' A' ' 22' ' ' TRP . 9.6 ptm85 -171.42 177.44 3.51 Favored 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 118.351 -1.339 . . . . 0.0 112.837 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.6 96.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.051 179.968 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 tt -41.1 129.59 2.8 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.374 179.955 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -175.85 176.12 1.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.265 179.961 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.523 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 2.4 t -96.8 116.67 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.395 179.974 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.652 ' O ' ' HB2' ' A' ' 12' ' ' ALA . 0.8 OUTLIER -92.15 -4.55 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.878 179.992 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.652 ' HB2' ' O ' ' A' ' 11' ' ' VAL . . . 168.74 148.99 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.319 -0.953 . . . . 0.0 110.588 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.57 137.47 15.4 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.206 -0.998 . . . . 0.0 111.246 -179.861 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.515 ' C ' ' H ' ' A' ' 16' ' ' THR . 0.9 OUTLIER -148.81 155.26 41.06 Favored Pre-proline 0 C--N 1.301 -1.503 0 C-N-CA 119.564 -0.855 . . . . 0.0 109.887 179.908 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.77 5.39 0.12 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 121.098 1.199 . . . . 0.0 112.163 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.515 ' H ' ' C ' ' A' ' 14' ' ' THR . 49.0 p -144.63 14.78 1.58 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.801 -179.939 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.41 139.64 0.19 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.165 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.88 121.23 24.85 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.586 -179.973 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.36 105.05 14.8 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.776 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 20' ' ' ILE . 1.4 pt -109.09 167.29 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 118.93 -1.108 . . . . 0.0 113.561 -179.641 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.48 135.35 35.06 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.389 -1.732 . . . . 0.0 107.206 179.805 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.62 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 44.7 p90 -119.21 -171.39 2.1 Favored 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 118.11 -1.436 . . . . 0.0 113.657 -179.809 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.46 ' CG ' ' N ' ' A' ' 24' ' ' ALA . 27.8 t70 -136.89 171.85 13.89 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.321 -1.308 . . . . 0.0 111.276 -179.843 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.618 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -115.64 166.63 11.72 Favored Pre-proline 0 N--CA 1.493 1.681 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.44 -179.949 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.618 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 19.2 Cg_endo -71.95 -99.42 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.115 0 C-N-CA 121.165 1.243 . . . . 0.0 110.715 179.941 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -107.71 -83.42 0.54 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.573 -179.956 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.837 HG22 ' H ' ' A' ' 28' ' ' THR . 1.7 p -70.76 -170.13 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.979 -179.934 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.837 ' H ' HG22 ' A' ' 27' ' ' VAL . 37.9 p -69.64 -178.43 1.47 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.563 -179.842 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.4 t -141.11 142.15 30.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.309 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.497 ' HE ' ' CA ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -77.14 -64.86 1.04 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.176 179.797 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.7 158.2 33.77 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.279 179.718 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.62 ' CE2' ' CD1' ' A' ' 22' ' ' TRP . 0.6 OUTLIER -116.2 125.51 52.36 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.916 179.97 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.578 ' NH1' HG21 ' A' ' 75' ' ' VAL . 0.7 OUTLIER -106.5 99.18 8.77 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.842 -0.743 . . . . 0.0 110.397 -179.922 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mp -96.17 135.46 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 C-N-CA 119.132 -1.027 . . . . 0.0 111.459 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.6 p -138.96 138.34 37.22 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.749 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 36' ' ' TYR . 1.6 p90 -138.57 153.78 48.7 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.824 -1.15 . . . . 0.0 111.836 -179.958 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' HA2' HG23 ' A' ' 45' ' ' VAL . . . 171.86 142.7 3.81 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.34 155.05 7.37 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.962 -179.974 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.3 m -75.21 152.84 38.33 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.096 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.1 83.35 0.05 OUTLIER Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.552 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.469 ' C ' ' H ' ' A' ' 43' ' ' SER . . . -178.15 120.02 0.7 Allowed Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.283 -1.437 . . . . 0.0 110.505 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -78.02 31.69 0.17 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.352 179.973 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 41' ' ' GLY . 9.1 t -149.94 71.03 9.49 Favored Pre-proline 0 C--N 1.304 -1.37 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.668 179.978 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -61.18 152.15 73.9 Favored 'Trans proline' 0 C--N 1.323 -0.797 0 C-N-CA 121.445 1.43 . . . . 0.0 111.18 -179.849 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.462 HG23 ' HA2' ' A' ' 37' ' ' GLY . 62.4 t -62.95 -77.73 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 C-N-CA 119.031 -1.068 . . . . 0.0 111.461 -179.91 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -173.55 -168.25 0.43 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.445 -1.302 . . . . 0.0 112.265 -179.932 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -166.16 177.66 6.8 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.655 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -173.69 155.79 2.76 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.202 179.792 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.456 HG22 ' CD ' ' A' ' 33' ' ' ARG . 33.2 p -104.15 159.48 15.65 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.356 -179.983 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.504 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -151.91 154.65 33.03 Favored Pre-proline 0 C--N 1.306 -1.311 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.712 179.769 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -64.48 12.94 0.09 OUTLIER 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 121.173 1.248 . . . . 0.0 112.132 179.944 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 50' ' ' VAL . . . 59.25 23.13 57.25 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.111 -1.519 . . . . 0.0 109.849 -179.952 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.14 -47.23 13.75 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.897 -179.975 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.0 mtpt -84.51 133.18 34.47 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.779 179.918 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.0 m -80.67 -8.12 59.54 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.223 179.989 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.3 p -134.91 -174.12 3.51 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.091 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -163.99 146.09 9.14 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.989 -179.997 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 m -108.02 110.67 22.43 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.726 -179.924 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 30.5 mt -108.97 144.48 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.024 179.974 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 48.3 m -148.28 110.04 4.49 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.224 -179.946 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.51 -11.42 0.03 OUTLIER Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.126 -1.511 . . . . 0.0 110.88 179.992 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.603 HD23 ' N ' ' A' ' 62' ' ' LEU . 1.4 pt? -68.28 -164.07 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.947 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.626 ' H ' ' HD2' ' A' ' 64' ' ' PRO . 5.1 ttpt -176.06 -42.29 0.0 OUTLIER Pre-proline 0 C--N 1.302 -1.462 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.801 -179.946 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.626 ' HD2' ' H ' ' A' ' 63' ' ' LYS . 5.6 Cg_endo -81.36 -169.22 0.74 Allowed 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 121.457 1.438 . . . . 0.0 111.985 -179.907 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -148.29 83.62 0.18 Allowed Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.359 -1.896 . . . . 0.0 108.359 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.91 HG22 ' H ' ' A' ' 67' ' ' ASP . 10.9 p -142.78 -173.88 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.534 -179.716 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.91 ' H ' HG22 ' A' ' 66' ' ' VAL . 0.6 OUTLIER -56.83 99.66 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.639 179.998 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -97.77 120.83 38.86 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.59 179.891 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.4 m -95.73 124.47 39.76 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.806 -179.925 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.489 ' CG1' ' N ' ' A' ' 71' ' ' THR . 3.9 tt -112.08 157.38 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.13 179.857 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.489 ' N ' ' CG1' ' A' ' 70' ' ' ILE . 0.2 OUTLIER -154.96 136.22 14.02 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.194 -179.955 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.4 m -131.88 117.34 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.648 179.832 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -93.5 111.66 23.38 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.152 -179.958 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -84.5 96.81 9.25 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 118.85 -1.14 . . . . 0.0 110.636 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.578 HG21 ' NH1' ' A' ' 33' ' ' ARG . 9.3 t -93.77 129.43 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.992 -1.083 . . . . 0.0 110.966 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 20.8 p -102.21 -138.22 0.34 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.723 -0.791 . . . . 0.0 111.039 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.437 ' N ' ' OG1' ' A' ' 76' ' ' THR . . . 149.02 99.6 0.21 Allowed Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.489 -1.338 . . . . 0.0 110.682 180.0 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -121.03 -44.49 2.4 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.765 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.41 -93.33 0.24 Allowed Glycine 0 N--CA 1.493 2.466 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.194 179.999 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -143.54 -60.23 0.41 Allowed 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.81 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -83.39 149.3 57.72 Favored Pre-proline 0 C--N 1.308 -1.231 0 C-N-CA 118.943 -1.103 . . . . 0.0 110.305 -179.943 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.39 107.9 0.54 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 120.914 1.076 . . . . 0.0 111.433 179.914 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.09 105.81 16.78 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.254 -0.978 . . . . 0.0 110.632 179.958 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.4 t -50.72 126.61 16.14 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.449 -0.901 . . . . 0.0 110.936 -179.973 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.7 p -93.78 -111.65 0.11 Allowed 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.033 179.977 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.9 mmtt -140.61 83.64 14.63 Favored Pre-proline 0 C--N 1.306 -1.319 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.212 179.943 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -58.05 164.21 8.61 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 121.209 1.273 . . . . 0.0 111.578 -179.947 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 88' ' ' ILE . 7.7 tt -135.01 144.63 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.443 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.3 p -137.07 133.01 34.94 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.133 -179.957 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.37 148.52 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.14 179.954 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.539 ' ND2' ' OD1' ' A' ' 67' ' ' ASP . 0.1 OUTLIER -98.11 152.63 19.13 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.534 179.951 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -155.28 140.56 17.62 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.958 -1.097 . . . . 0.0 111.372 -179.963 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.99 98.32 11.7 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 119.342 -0.943 . . . . 0.0 109.873 179.917 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 116.476 -1.725 . . . . 0.0 110.787 -179.903 . . . . . . . . 1 1 . 1 stop_ save_